1	Interindividual	JJ	O	interindividual	amod	2	SENT_1	[p1l55t159r708b229],
2	Variability	NN	O	variability	_	0	SENT_1	[p1l739t159r1194b251],
3	in	IN	O	in	_	0	SENT_1	[p1l1226t162r1308b228],
4	Pharmacokinetics	NNS	O	pharmacokinetic	prep_in	2	SENT_1	[p1l1338t159r2104b229],
5	of	IN	O	of	_	0	SENT_1	[p1l122t267r210b337],
6	Generic	JJ	O	generic	amod	9	SENT_1	[p1l232t269r561b337],
7	Nucleoside	NNP	O	Nucleoside	nn	9	SENT_1	[p1l595t267r1064b337],
8	Reverse	NN	O	reverse	nn	9	SENT_1	[p1l1097t272r1428b337],
9	Transcriptase	NN	O	transcriptase	prep_of	2	SENT_1	[p1l1460t269r2038b359],

1	Inhibitors	NNS	O	inhibitor	_	0	SENT_2	[p1l175t375r593b444],
2	in	IN	O	in	_	0	SENT_2	[p1l626t377r709b444],
3	TB/I-IIV-Coinfected	JJ	O	tb/i-iiv-coinfected	amod	4	SENT_2	[p1l739t375r1534b444],
4	Ghanaian	JJ	MISC	ghanaian	prep_in	1	SENT_2	[p1l1568t375r1986b444],

1	Patients	NNS	O	patient	_	0	SENT_3	[p1l65t486r425b553],
2	:	:	O	:	_	0	SENT_3	[p1l65t486r425b553],
3	UGT2B7	NN	O	ugt2b7	dep	1	SENT_3	[p1l469t487r970b553],
4	*	CD	NUMBER	*	num	5	SENT_3	[p1l469t487r970b553],
5	1c	NN	O	1c	nsubj	7	SENT_3	[p1l469t487r970b553],
6	Is	VBZ	O	be	cop	7	SENT_3	[p1l1004t488r1075b553],
7	Associated	NNP	O	Associated	rcmod	3	SENT_3	[p1l1107t483r1567b553],
8	With	IN	O	with	_	0	SENT_3	[p1l1599t483r1802b553],
9	Faster	NNP	O	Faster	prep_with	7	SENT_3	[p1l1833t488r2095b553],

1	Zidovudine	NNP	O	Zidovudine	nn	2	SENT_4	[p1l141t592r630b662],
2	Clearance	NNP	O	Clearance	_	0	SENT_4	[p1l664t592r1086b662],
3	and	CC	O	and	_	0	SENT_4	[p1l1122t592r1278b662],
4	Glucuronidation	NNP	O	Glucuronidation	conj_and	2	SENT_4	[p1l1312t592r2020b662],

1	Awewura	NNP	LOCATION	Awewura	nn	2	SENT_5	[p1l200t740r413b775],
2	Kwara	NNP	LOCATION	Kwara	_	0	SENT_5	[p1l430t740r587b782],
3	,	,	O	,	_	0	SENT_5	[p1l430t740r587b782],
4	MD	NNP	O	MD	dep	2	SENT_5	[p1l605t740r697b782],
5	,	,	O	,	_	0	SENT_5	[p1l605t740r697b782],
6	Margaret	NNP	PERSON	Margaret	nn	7	SENT_5	[p1l715t740r922b788],
7	Lartey	NNP	PERSON	Lartey	appos	4	SENT_5	[p1l936t740r1086b788],
8	,	,	O	,	_	0	SENT_5	[p1l936t740r1086b788],
9	MBChB	NNP	O	MBChB	appos	4	SENT_5	[p1l1104t737r1288b782],
10	,	,	O	,	_	0	SENT_5	[p1l1104t737r1288b782],
11	F	NN	O	f	nn	12	SENT_5	[p1l1307t740r1340b775],
12	WACP	NN	O	wacp	appos	4	SENT_5	[p1l1342t739r1484b782],
13	,	,	O	,	_	0	SENT_5	[p1l1342t739r1484b782],
14	Isaac	NNP	PERSON	Isaac	nn	15	SENT_5	[p1l1503t740r1623b776],
15	Boamah	NNP	PERSON	Boamah	appos	4	SENT_5	[p1l1638t737r1839b782],
16	,	,	O	,	_	0	SENT_5	[p1l1638t737r1839b782],
17	BSO	NN	ORGANIZATION	bso	appos	4	SENT_5	[p1l1858t739r1956b782],
18	,	,	O	,	_	0	SENT_5	[p1l1858t739r1956b782],
19	Naser	NNP	PERSON	Naser	nn	21	SENT_5	[p1l221t797r356b833],
20	L.	NNP	PERSON	L.	nn	21	SENT_5	[p1l369t797r407b833],
21	Rezk	NNP	PERSON	Rezk	appos	4	SENT_5	[p1l426t795r547b839],
22	,	,	O	,	_	0	SENT_5	[p1l426t795r547b839],
23	PhD	NNP	O	PhD	appos	4	SENT_5	[p1l566t795r674b839],
24	,	,	O	,	_	0	SENT_5	[p1l566t795r674b839],
25	Ioseph	NNP	PERSON	Ioseph	nn	26	SENT_5	[p1l690t795r843b845],
26	Oliver-Commey	NNP	PERSON	Oliver-Commey	appos	4	SENT_5	[p1l864t795r1224b845],
27	,	,	O	,	_	0	SENT_5	[p1l864t795r1224b845],
28	MBChB	NNP	O	MBChB	appos	4	SENT_5	[p1l1243t795r1426b839],
29	,	,	O	,	_	0	SENT_5	[p1l1243t795r1426b839],
30	Ernest	NNP	PERSON	Ernest	nn	31	SENT_5	[p1l1445t797r1591b833],
31	Kenu	NNP	PERSON	Kenu	appos	4	SENT_5	[p1l1605t797r1735b839],
32	,	,	O	,	_	0	SENT_5	[p1l1605t797r1735b839],
33	MBChB	NNP	O	MBChB	appos	4	SENT_5	[p1l1754t795r1937b839],
34	,	,	O	,	_	0	SENT_5	[p1l1754t795r1937b839],

1	Angela	NNP	PERSON	Angela	nn	2	SENT_6	[p1l101t852r262b902],
2	D.	NNP	PERSON	D.	_	0	SENT_6	[p1l279t855r325b890],
3	M.	NNP	PERSON	M.	nn	4	SENT_6	[p1l344t855r399b890],
4	Kashuba	NNP	PERSON	Kashuba	dep	2	SENT_6	[p1l418t852r628b896],
5	,	,	O	,	_	0	SENT_6	[p1l418t852r628b896],
6	BScPhm	NN	O	bscphm	dep	2	SENT_6	[p1l647t852r851b897],
7	,	,	O	,	_	0	SENT_6	[p1l647t852r851b897],
8	PharmD	NN	O	pharmd	dep	2	SENT_6	[p1l870t852r1069b897],
9	,	,	O	,	_	0	SENT_6	[p1l870t852r1069b897],
10	DABCP	NN	O	dabcp	conj_and	4	SENT_6	[p1l1088t854r1261b896],
11	,	,	O	,	_	0	SENT_6	[p1l1088t854r1261b896],
12	and	CC	O	and	_	0	SENT_6	[p1l1282t852r1369b890],
13	Michael	NNP	PERSON	Michael	nn	19	SENT_6	[p1l1384t852r1569b890],
14	H.	NNP	PERSON	H.	nn	19	SENT_6	[p1l1584t855r1633b890],
15	Court	NNP	PERSON	Court	nn	19	SENT_6	[p1l1655t854r1790b896],
16	,	,	O	,	_	0	SENT_6	[p1l1655t854r1790b896],
17	BVSC	NNP	O	BVSC	appos	19	SENT_6	[p1l1809t854r1943b897],
18	,	,	O	,	_	0	SENT_6	[p1l1809t854r1943b897],
19	PhD	NN	O	phd	conj_and	4	SENT_6	[p1l1962t852r2060b890],

1	There	EX	O	there	expl	2	SENT_7	[p1l16t1037r222b1098],
2	are	VBP	O	be	_	0	SENT_7	[p1l246t1058r358b1098],
3	limited	JJ	O	limited	amod	4	SENT_7	[p1l379t1037r645b1098],
4	data	NNS	O	datum	nsubj	2	SENT_7	[p1l668t1037r825b1098],
5	on	IN	O	on	_	0	SENT_7	[p1l853t1058r938b1098],
6	the	DT	O	the	det	7	SENT_7	[p1l967t1037r1077b1098],
7	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	4	SENT_7	[p1l1096t1037r1762b1117],
8	of	IN	O	of	_	0	SENT_7	[p1l1787t1037r1865b1117],
9	generic	JJ	O	generic	amod	13	SENT_7	[p1l1872t1040r2141b1117],
10	nucleoside	JJ	O	nucleoside	amod	13	SENT_7	[p1l9t1133r407b1194],
11	reverse	JJ	O	reverse	amod	13	SENT_7	[p1l462t1155r723b1194],
12	transcriptase	NN	O	transcriptase	nn	13	SENT_7	[p1l782t1137r1259b1214],
13	inhibitors	NNS	O	inhibitor	prep_of	7	SENT_7	[p1l1315t1133r1672b1194],
14	(	VBN	O	(	partmod	13	SENT_7	[p1l1731t1134r2013b1206],
15	NRTIs	NNS	O	nrti	dobj	14	SENT_7	[p1l1731t1134r2013b1206],
16	)	CD	NUMBER	)	num	15	SENT_7	[p1l1731t1134r2013b1206],
17	in	IN	O	in	_	0	SENT_7	[p1l2068t1137r2137b1194],
18	native	JJ	O	native	amod	20	SENT_7	[p1l9t1234r236b1291],
19	African	JJ	MISC	african	amod	20	SENT_7	[p1l264t1230r540b1310],
20	populations	NNS	O	population	prep_in	15	SENT_7	[p1l569t1230r1033b1310],
21	,	,	O	,	_	0	SENT_7	[p1l569t1230r1033b1310],
22	in	IN	O	in	_	0	SENT_7	[p1l1067t1234r1137b1291],
23	whom	WP	O	whom	rel	27	SENT_7	[p1l1174t1230r1391b1291],
24	they	PRP	O	they	nsubjpass	27	SENT_7	[p1l1427t1230r1586b1311],
25	are	VBP	O	be	auxpass	27	SENT_7	[p1l1612t1252r1723b1291],
26	commonly	RB	O	commonly	advmod	27	SENT_7	[p1l1756t1230r2147b1310],
27	used	VBN	O	use	rcmod	20	SENT_7	[p1l15t1328r202b1389],
28	.	.	O	.	_	0	SENT_7	[p1l15t1328r202b1389],

1	The	DT	O	the	det	2	SENT_8	[p1l255t1328r390b1389],
2	authors	NNS	O	author	nsubj	3	SENT_8	[p1l434t1328r716b1389],
3	characterized	VBD	O	characterize	ccomp	25	SENT_8	[p1l760t1328r1271b1389],
4	the	DT	O	the	det	5	SENT_8	[p1l1314t1328r1426b1389],
5	pharmacokinetics	NNS	O	pharmacokinetic	nn	12	SENT_8	[p1l1464t1328r2141b1408],
6	of	IN	O	of	_	0	SENT_8	[p1l12t1424r92b1504],
7	lamivudine	NN	O	lamivudine	nn	9	SENT_8	[p1l117t1424r539b1485],
8	(	CD	NUMBER	(	num	9	SENT_8	[p1l577t1424r645b1497],
9	n	NN	O	n	prep_of	5	SENT_8	[p1l577t1424r645b1497],
10	=	JJ	O	=	amod	12	SENT_8	[p1l682t1454r724b1473],
11	27	CD	NUMBER	27	tmod	10	SENT_8	[p1l761t1424r892b1497],
12	)	NN	O	)	dobj	3	SENT_8	[p1l761t1424r892b1497],
13	,	,	O	,	_	0	SENT_8	[p1l761t1424r892b1497],
14	zidovudine	NN	O	zidovudine	nn	16	SENT_8	[p1l933t1424r1347b1485],
15	(	NN	O	(	nn	16	SENT_8	[p1l1385t1424r1453b1497],
16	n	NN	O	n	nsubj	25	SENT_8	[p1l1385t1424r1453b1497],
17	=	JJ	O	=	amod	16	SENT_8	[p1l1490t1454r1532b1473],
18	16	CD	NUMBER	16	num	19	SENT_8	[p1l1574t1424r1700b1497],
19	)	NN	O	)	tmod	17	SENT_8	[p1l1574t1424r1700b1497],
20	,	,	O	,	_	0	SENT_8	[p1l1574t1424r1700b1497],
21	and	CC	O	and	_	0	SENT_8	[p1l1743t1424r1883b1485],
22	stavudine	NN	O	stavudine	nn	24	SENT_8	[p1l1918t1432r2139b1485, p1l13t1521r171b1582],
23	(	NN	O	(	nn	24	SENT_8	[p1l215t1521r282b1593],
24	n	NN	O	n	conj_and	19	SENT_8	[p1l215t1521r282b1593],
25	=	JJ	O	=	_	0	SENT_8	[p1l324t1551r366b1570],
26	11	CD	NUMBER	11	num	27	SENT_8	[p1l412t1521r519b1594],
27	)	NN	O	)	dobj	25	SENT_8	[p1l412t1521r519b1594],
28	in	IN	O	in	_	0	SENT_8	[p1l558t1525r627b1581],
29	human	JJ	O	human	amod	34	SENT_8	[p1l669t1521r927b1582],
30	immunodeﬁciency	NN	O	immunodeﬁciency	nn	34	SENT_8	[p1l969t1521r1659b1601],
31	virus	NN	O	virus	nn	34	SENT_8	[p1l1695t1525r1873b1582],
32	(	CD	NUMBER	(	num	34	SENT_8	[p1l1915t1521r2147b1594],
33	HIV	NN	MISC	hiv	nn	34	SENT_8	[p1l1915t1521r2147b1594],
34	)	NN	O	)	prep_in	27	SENT_8	[p1l1915t1521r2147b1594],
35	/	:	O	/	punct	36	SENT_8	[p1l1915t1521r2147b1594],
36	tuberculosis	NN	O	tuberculosis	dep	34	SENT_8	[p1l13t1619r460b1680],
37	(	CD	NUMBER	(	num	39	SENT_8	[p1l509t1619r1096b1699],
38	TB	NN	O	tb	nn	39	SENT_8	[p1l509t1619r1096b1699],
39	)	NN	O	)	dep	36	SENT_8	[p1l509t1619r1096b1699],
40	.	.	O	.	_	0	SENT_8	[p1l509t1619r1096b1699],

1	—	NN	O	—	_	0	SENT_9	[p1l509t1619r1096b1699],
2	.	.	O	.	_	0	SENT_9	[p1l509t1619r1096b1699],

1	coinfected	VBN	O	coinfect	_	0	SENT_10	[p1l509t1619r1096b1699],
2	Ghanaians	NNPS	MISC	Ghanaians	dobj	1	SENT_10	[p1l1145t1619r1542b1680],
3	and	CC	O	and	_	0	SENT_10	[p1l1591t1619r1733b1680],
4	evaluated	VBD	O	evaluate	conj_and	1	SENT_10	[p1l1779t1619r2143b1680],
5	associations	NNS	O	association	iobj	4	SENT_10	[p1l12t1719r463b1776],
6	between	IN	O	between	_	0	SENT_10	[p1l506t1715r800b1776],
7	zidovudine	NN	O	zidovudine	nn	8	SENT_10	[p1l845t1715r1255b1776],
8	metabolism	NN	O	metabolism	prep_between	5	SENT_10	[p1l1296t1715r1720b1776],
9	and	CC	O	and	_	0	SENT_10	[p1l1768t1715r1907b1776],
10	UDPglucuronosyltransferase	NN	O	udpglucuronosyltransferase	prep_between	5	SENT_10	[p1l1956t1719r2140b1776, p1l7t1813r886b1893],
11	(	CD	NUMBER	(	num	15	SENT_10	[p1l988t1813r1210b1885],
12	UGT	NNP	ORGANIZATION	UGT	nn	15	SENT_10	[p1l988t1813r1210b1885],
13	)	CD	NUMBER	)	num	15	SENT_10	[p1l988t1813r1210b1885],
14	2B7	NN	O	2b7	nn	15	SENT_10	[p1l1311t1817r1452b1873],
15	polymorphisms	NNS	O	polymorphism	dobj	4	SENT_10	[p1l1545t1813r2135b1893],
16	.	.	O	.	_	0	SENT_10	[p1l1545t1813r2135b1893],

1	Lamivudine	NNP	O	Lamivudine	nsubj	14	SENT_11	[p1l8t1910r463b1981],
2	,	,	O	,	_	0	SENT_11	[p1l8t1910r463b1981],
3	zidovudine	NN	O	zidovudine	conj_and	1	SENT_11	[p1l522t1910r949b1981],
4	,	,	O	,	_	0	SENT_11	[p1l522t1910r949b1981],
5	and	CC	O	and	_	0	SENT_11	[p1l1010t1910r1150b1971],
6	stavudine	NN	O	stavudine	nn	9	SENT_11	[p1l1203t1910r1559b1971],
7	apparent	JJ	O	apparent	amod	9	SENT_11	[p1l1615t1918r1946b1990],
8	oral	JJ	O	oral	amod	9	SENT_11	[p1l2001t1910r2143b1971],
9	clearance	NN	O	clearance	nsubj	14	SENT_11	[p1l12t2006r361b2067],
10	(	CD	NUMBER	(	num	13	SENT_11	[p1l413t2006r638b2079],
11	CL/F	NN	O	cl/f	nn	13	SENT_11	[p1l413t2006r638b2079],
12	)	NN	O	)	nn	13	SENT_11	[p1l413t2006r638b2079],
13	values	NNS	O	value	dep	9	SENT_11	[p1l688t2006r919b2067],
14	(	VBP	O	(	_	0	SENT_11	[p1l971t2006r1194b2079],
15	mean	JJ	O	mean	dobj	14	SENT_11	[p1l971t2006r1194b2079],
16	i	FW	O	i	dep	20	SENT_11	[p1l1244t2016r1286b2067],
17	SD	NN	O	sd	dep	16	SENT_11	[p1l1339t2009r1442b2067],
18	[	CD	PERCENT	[	num	19	SENT_11	[p1l1490t2006r1586b2077],
19	%	NN	PERCENT	%	dep	20	SENT_11	[p1l1490t2006r1586b2077],
20	coefficient	NN	O	coefficient	dep	28	SENT_11	[p1l1644t2006r2025b2086],
21	of	IN	O	of	_	0	SENT_11	[p1l2075t2006r2152b2086],
22	variation	NN	O	variation	nn	24	SENT_11	[p1l12t2109r336b2166],
23	[	NN	O	[	nn	24	SENT_11	[p1l372t2105r559b2178],
24	CV	NN	O	cv	prep_of	20	SENT_11	[p1l372t2105r559b2178],
25	]	CD	NUMBER	]	num	26	SENT_11	[p1l372t2105r559b2178],
26	)	NN	O	)	nsubj	28	SENT_11	[p1l372t2105r559b2178],
27	were	VBD	O	be	cop	28	SENT_11	[p1l593t2126r758b2166],
28	7.3	CD	NUMBER	7.3	dep	15	SENT_11	[p1l795t2114r897b2166],
29	i	FW	O	i	dep	28	SENT_11	[p1l928t2115r970b2165],
30	2.8	CD	PERCENT	2.8	number	31	SENT_11	[p1l1002t2114r1109b2166],
31	(	CD	PERCENT	(	dep	29	SENT_11	[p1l1144t2105r1378b2178],
32	39	CD	PERCENT	39	num	33	SENT_11	[p1l1144t2105r1378b2178],
33	%	NN	PERCENT	%	dep	41	SENT_11	[p1l1144t2105r1378b2178],
34	)	CD	NUMBER	)	dep	33	SENT_11	[p1l1144t2105r1378b2178],
35	,	,	O	,	_	0	SENT_11	[p1l1144t2105r1378b2178],
36	31.9	CD	NUMBER	31.9	appos	34	SENT_11	[p1l1416t2114r1567b2166],
37	i	FW	O	i	dep	36	SENT_11	[p1l1596t2115r1638b2165],
38	33.6	CD	NUMBER	33.6	num	39	SENT_11	[p1l1673t2114r1824b2166],
39	(	NN	O	(	dep	41	SENT_11	[p1l1856t2105r2135b2178],
40	106	CD	PERCENT	106	num	41	SENT_11	[p1l1856t2105r2135b2178],
41	%	NN	PERCENT	%	dep	46	SENT_11	[p1l1856t2105r2135b2178],
42	)	CD	NUMBER	)	dep	41	SENT_11	[p1l1856t2105r2135b2178],
43	,	,	O	,	_	0	SENT_11	[p1l1856t2105r2135b2178],
44	and	CC	O	and	cc	45	SENT_11	[p1l12t2201r152b2262],
45	16.4	CD	NUMBER	16.4	appos	42	SENT_11	[p1l197t2210r342b2262],
46	i	FW	O	i	dep	52	SENT_11	[p1l385t2211r427b2262],
47	5.8	CD	PERCENT	5.8	number	48	SENT_11	[p1l472t2210r578b2262],
48	(	CD	PERCENT	(	dep	46	SENT_11	[p1l623t2202r840b2274],
49	35	CD	PERCENT	35	num	50	SENT_11	[p1l623t2202r840b2274],
50	%	NN	PERCENT	%	dep	48	SENT_11	[p1l623t2202r840b2274],
51	)	CD	NUMBER	)	num	52	SENT_11	[p1l623t2202r840b2274],
52	mL/min/kg	NN	O	ml/min/kg	dep	28	SENT_11	[p1l881t2201r1304b2282],
53	,	,	O	,	_	0	SENT_11	[p1l881t2201r1304b2282],
54	respectively	RB	O	respectively	advmod	28	SENT_11	[p1l1350t2201r1795b2282],
55	,	,	O	,	_	0	SENT_11	[p1l1350t2201r1795b2282],
56	Whereas	IN	O	whereas	mark	60	SENT_11	[p1l1846t2201r2140b2262],
57	half-life	NN	O	half-life	nn	58	SENT_11	[p1l8t2298r296b2378],
58	values	NNS	O	value	nsubj	60	SENT_11	[p1l326t2298r556b2359],
59	were	VBD	O	be	cop	60	SENT_11	[p1l588t2320r753b2359],
60	4.2	CD	NUMBER	4.2	dep	28	SENT_11	[p1l782t2307r888b2359],
61	i	FW	O	i	dep	60	SENT_11	[p1l915t2308r957b2359],
62	1.9	CD	PERCENT	1.9	number	63	SENT_11	[p1l991t2307r1094b2359],
63	(	CD	PERCENT	(	amod	61	SENT_11	[p1l1124t2298r1358b2371],
64	46	CD	PERCENT	46	num	65	SENT_11	[p1l1124t2298r1358b2371],
65	%	NN	PERCENT	%	dep	63	SENT_11	[p1l1124t2298r1358b2371],
66	)	CD	NUMBER	)	dep	60	SENT_11	[p1l1124t2298r1358b2371],
67	,	,	O	,	_	0	SENT_11	[p1l1124t2298r1358b2371],
68	8.1	CD	NUMBER	8.1	dep	28	SENT_11	[p1l1394t2307r1490b2359],
69	i	FW	O	i	dep	68	SENT_11	[p1l1526t2308r1567b2359],
70	7.9	CD	PERCENT	7.9	number	71	SENT_11	[p1l1601t2307r1704b2359],
71	(	CD	PERCENT	(	amod	69	SENT_11	[p1l1734t2298r1968b2371],
72	98	CD	PERCENT	98	num	73	SENT_11	[p1l1734t2298r1968b2371],
73	%	NN	PERCENT	%	dep	71	SENT_11	[p1l1734t2298r1968b2371],
74	)	CD	NUMBER	)	dep	68	SENT_11	[p1l1734t2298r1968b2371],
75	,	,	O	,	_	0	SENT_11	[p1l1734t2298r1968b2371],
76	and	CC	O	and	_	0	SENT_11	[p1l2003t2298r2143b2359],
77	1.5	CD	NUMBER	1.5	conj_and	60	SENT_11	[p1l15t2405r118b2457],
78	i	FW	O	i	dep	77	SENT_11	[p1l147t2406r189b2456],
79	1.0	CD	PERCENT	1.0	number	80	SENT_11	[p1l226t2405r328b2457],
80	(	CD	PERCENT	(	amod	78	SENT_11	[p1l361t2396r579b2469],
81	65	CD	PERCENT	65	num	82	SENT_11	[p1l361t2396r579b2469],
82	%	NN	PERCENT	%	dep	80	SENT_11	[p1l361t2396r579b2469],
83	)	CD	NUMBER	)	num	84	SENT_11	[p1l361t2396r579b2469],
84	hours	NNS	NUMBER	hour	tmod	60	SENT_11	[p1l607t2396r832b2467],
85	,	,	O	,	_	0	SENT_11	[p1l607t2396r832b2467],
86	respectively	RB	O	respectively	advmod	60	SENT_11	[p1l865t2396r1311b2476],
87	.	.	O	.	_	0	SENT_11	[p1l865t2396r1311b2476],

1	Zidovudine	NN	O	zidovudine	nn	2	SENT_12	[p1l1344t2396r1768b2457],
2	CL/F	NN	O	cl/f	nsubj	3	SENT_12	[p1l1803t2396r1979b2457],
3	was	VBD	O	be	_	0	SENT_12	[p1l2007t2417r2141b2457],
4	196	CD	PERCENT	196	num	5	SENT_12	[p1l15t2493r214b2558],
5	%	NN	PERCENT	%	npadvmod	6	SENT_12	[p1l15t2493r214b2558],
6	higher	JJR	O	higher	advmod	3	SENT_12	[p1l244t2493r483b2573],
7	(	CD	NUMBER	(	num	8	SENT_12	[p1l505t2493r573b2565],
8	P	NN	O	p	dep	22	SENT_12	[p1l505t2493r573b2565],
9	=	JJ	O	=	amod	11	SENT_12	[p1l599t2523r641b2542],
10	.004	CD	NUMBER	.004	tmod	9	SENT_12	[p1l671t2493r848b2565],
11	)	NN	O	)	dep	8	SENT_12	[p1l671t2493r848b2565],
12	in	IN	O	in	_	0	SENT_12	[p1l871t2496r941b2553],
13	UGT2B7	NN	O	ugt2b7	prep_in	11	SENT_12	[p1l968t2496r1414b2554],
14	*	CD	NUMBER	*	num	13	SENT_12	[p1l968t2496r1414b2554],
15	1c	NN	O	1c	nn	18	SENT_12	[p1l968t2496r1414b2554],
16	(	CD	NUMBER	(	num	18	SENT_12	[p1l1440t2493r1849b2565],
17	c.	NN	O	c.	nn	18	SENT_12	[p1l1440t2493r1849b2565],
18	735A	NN	O	735a	dep	11	SENT_12	[p1l1440t2493r1849b2565],
19	>	JJR	O	>	amod	20	SENT_12	[p1l1440t2493r1849b2565],
20	G	NN	O	g	dep	22	SENT_12	[p1l1440t2493r1849b2565],
21	)	CD	NUMBER	)	num	22	SENT_12	[p1l1440t2493r1849b2565],
22	carriers	NNS	O	carrier	dep	3	SENT_12	[p1l1875t2496r2150b2554],
23	versus	CC	O	versus	prep	22	SENT_12	[p1l11t2611r240b2650],
24	noncarriers	NNS	O	noncarrier	dep	23	SENT_12	[p1l264t2593r702b2650],
25	.	.	O	.	_	0	SENT_12	[p1l264t2593r702b2650],

1	This	DT	O	this	nsubjpass	3	SENT_13	[p1l738t2590r893b2650],
2	was	VBD	O	be	auxpass	3	SENT_13	[p1l921t2611r1057b2650],
3	confirmed	VBN	O	confirm	dep	9	SENT_13	[p1l1084t2589r1459b2670],
4	using	VBG	O	use	xcomp	3	SENT_13	[p1l1487t2593r1682b2670],
5	human	JJ	O	human	amod	8	SENT_13	[p1l1702t2590r1961b2650],
6	liver	NN	O	liver	nn	8	SENT_13	[p1l1988t2589r2154b2650],
7	bank	NN	O	bank	nn	8	SENT_13	[p1l10t2686r193b2747],
8	samples	NNS	O	sample	dobj	4	SENT_13	[p1l230t2686r528b2766],
9	(	VBP	O	(	_	0	SENT_13	[p1l571t2686r638b2759],
10	n	NN	O	n	nsubj	11	SENT_13	[p1l571t2686r638b2759],
11	=	JJ	O	=	xcomp	9	SENT_13	[p1l680t2716r722b2735],
12	52	CD	NUMBER	52	num	13	SENT_13	[p1l765t2686r893b2759],
13	)	NN	O	)	nsubj	9	SENT_13	[p1l765t2686r893b2759],
14	,	,	O	,	_	0	SENT_13	[p1l765t2686r893b2759],
15	which	WDT	O	which	nsubj	16	SENT_13	[p1l942t2686r1156b2747],
16	showed	VBD	O	show	rcmod	13	SENT_13	[p1l1201t2686r1479b2747],
17	48	CD	PERCENT	48	num	18	SENT_13	[p1l1519t2686r1677b2751],
18	%	NN	PERCENT	%	npadvmod	19	SENT_13	[p1l1519t2686r1677b2751],
19	higher	JJR	O	higher	advmod	16	SENT_13	[p1l1722t2686r1960b2766],
20	(	CD	NUMBER	(	num	21	SENT_13	[p1l1998t2686r2065b2758],
21	P	NN	O	p	iobj	16	SENT_13	[p1l1998t2686r2065b2758],
22	=	JJ	O	=	amod	21	SENT_13	[p1l2107t2716r2149b2735],
23	.020	CD	NUMBER	.020	tmod	22	SENT_13	[p1l13t2784r190b2856],
24	)	CD	NUMBER	)	num	26	SENT_13	[p1l13t2784r190b2856],
25	zidovudine	NN	O	zidovudine	nn	26	SENT_13	[p1l232t2784r644b2845],
26	glucuronidation	NN	O	glucuronidation	dobj	16	SENT_13	[p1l684t2784r1275b2864],
27	and	CC	O	and	_	0	SENT_13	[p1l1324t2784r1465b2845],
28	33	CD	PERCENT	33	num	29	SENT_13	[p1l1508t2784r1666b2849],
29	%	NN	PERCENT	%	npadvmod	30	SENT_13	[p1l1508t2784r1666b2849],
30	higher	JJR	O	higher	advmod	26	SENT_13	[p1l1714t2784r1953b2864],
31	(	CD	NUMBER	(	num	32	SENT_13	[p1l1994t2784r2062b2856],
32	P	NN	O	p	dobj	16	SENT_13	[p1l1994t2784r2062b2856],
33	=	JJ	O	=	amod	26	SENT_13	[p1l2107t2814r2149b2833],
34	.015	CD	NUMBER	.015	number	35	SENT_13	[p1l13t2880r190b2953],
35	)	CD	NUMBER	)	num	37	SENT_13	[p1l13t2880r190b2953],
36	UGTZB7	NN	O	ugtzb7	nn	37	SENT_13	[p1l226t2883r533b2941],
37	protein	NN	O	protein	dobj	16	SENT_13	[p1l555t2884r819b2961],
38	in	IN	O	in	_	0	SENT_13	[p1l849t2884r918b2941],
39	UGT2B7	NN	O	ugt2b7	nn	42	SENT_13	[p1l949t2883r1392b2941],
40	*	CD	NUMBER	*	num	42	SENT_13	[p1l949t2883r1392b2941],
41	1c	NN	O	1c	nn	42	SENT_13	[p1l949t2883r1392b2941],
42	carriers	NNS	O	carrier	prep_in	16	SENT_13	[p1l1421t2884r1696b2941],
43	versus	CC	O	versus	prep	16	SENT_13	[p1l1726t2902r1955b2941],
44	noncarriers	NNS	O	noncarrier	dep	43	SENT_13	[p1l1982t2902r2149b2941, p1l11t2981r303b3038],
45	.	.	O	.	_	0	SENT_13	[p1l1982t2902r2149b2941, p1l11t2981r303b3038],

1	In	IN	O	in	_	0	SENT_14	[p1l333t2981r405b3038],
2	conclusion	NN	O	conclusion	prep_in	10	SENT_14	[p1l436t2977r852b3048],
3	,	,	O	,	_	0	SENT_14	[p1l436t2977r852b3048],
4	generic	JJ	O	generic	amod	6	SENT_14	[p1l880t2981r1148b3057],
5	NRTI	NN	ORGANIZATION	nrtus	nn	6	SENT_14	[p1l1172t2981r1374b3038],
6	pharmacokinetics	NNS	O	pharmacokinetic	nsubj	10	SENT_14	[p1l1389t2977r2052b3057],
7	in	IN	O	in	_	0	SENT_14	[p1l2077t2981r2147b3037],
8	HIV/TB	NN	O	hiv/tb	nn	9	SENT_14	[p1l7t3075r702b3155],
9	—	NN	O	—	prep_in	6	SENT_14	[p1l7t3075r702b3155],
10	coinfected	VBD	O	coinfect	_	0	SENT_14	[p1l7t3075r702b3155],
11	Ghanaians	NNS	MISC	ghanaian	nsubj	13	SENT_14	[p1l727t3075r1121b3136],
12	are	VBP	O	be	cop	13	SENT_14	[p1l1146t3096r1257b3136],
13	similar	JJ	O	similar	ccomp	10	SENT_14	[p1l1281t3075r1541b3136],
14	to	TO	O	to	_	0	SENT_14	[p1l1563t3083r1628b3136],
15	other	JJ	O	other	amod	16	SENT_14	[p1l1654t3075r1845b3136],
16	populations	NNS	O	population	prep_to	13	SENT_14	[p1l1860t3075r2149b3155, p1l12t3175r205b3242],
17	,	,	O	,	_	0	SENT_14	[p1l1860t3075r2149b3155, p1l12t3175r205b3242],
18	Whereas	IN	O	whereas	mark	25	SENT_14	[p1l234t3171r529b3232],
19	the	DT	O	the	det	23	SENT_14	[p1l552t3171r662b3232],
20	UGTZB7	NN	O	ugtzb7	nn	23	SENT_14	[p1l682t3174r992b3232],
21	*	CD	NUMBER	*	num	23	SENT_14	[p1l1010t3174r1124b3232],
22	1c	NN	O	1c	nn	23	SENT_14	[p1l1010t3174r1124b3232],
23	polymorphism	NN	O	polymorphism	nsubj	25	SENT_14	[p1l1140t3171r1676b3252],
24	may	MD	O	may	aux	25	SENT_14	[p1l1698t3193r1860b3252],
25	explain	VB	O	explain	dep	13	SENT_14	[p1l1876t3171r2147b3252],
26	in	IN	O	in	_	0	SENT_14	[p1l8t3273r78b3329],
27	part	NN	O	part	prep_in	25	SENT_14	[p1l111t3277r266b3349],
28	relatively	RB	O	relatively	advmod	29	SENT_14	[p1l295t3269r643b3349],
29	high	JJ	O	high	amod	31	SENT_14	[p1l669t3269r828b3349],
30	interindividual	JJ	O	interindividual	amod	31	SENT_14	[p1l864t3269r1421b3330],
31	variability	NN	O	variability	dobj	25	SENT_14	[p1l1455t3269r1834b3349],
32	in	IN	O	in	_	0	SENT_14	[p1l1860t3273r1929b3329],
33	zidovudine	NN	O	zidovudine	nn	34	SENT_14	[p1l1966t3269r2149b3330, p1l11t3366r260b3427],
34	clearance	NN	O	clearance	prep_in	31	SENT_14	[p1l290t3366r658b3427],
35	.	.	O	.	_	0	SENT_14	[p1l290t3366r658b3427],

1	Key	NN	O	key	nn	2	SENT_15	[p1l6t3574r157b3650],
2	Words	NNS	O	word	_	0	SENT_15	[p1l182t3570r433b3631],
3	:	:	O	:	_	0	SENT_15	[p1l182t3570r433b3631],
4	NRTIs	NNS	O	nrti	dep	2	SENT_15	[p1l519t3570r1453b3651],
5	,	,	O	,	_	0	SENT_15	[p1l519t3570r1453b3651],
6	pharmacol	NN	O	pharmacol	appos	4	SENT_15	[p1l519t3570r1453b3651],
7	<	JJR	O	<	amod	8	SENT_15	[p1l519t3570r1453b3651],
8	inetics	NNS	O	inetic	dep	6	SENT_15	[p1l519t3570r1453b3651],
9	,	,	O	,	_	0	SENT_15	[p1l519t3570r1453b3651],
10	UGT2B7	NN	O	ugt2b7	appos	4	SENT_15	[p1l1475t3570r2146b3651],
11	,	,	O	,	_	0	SENT_15	[p1l1475t3570r2146b3651],
12	rifampin	NN	O	rifampin	appos	4	SENT_15	[p1l1475t3570r2146b3651],
13	,	,	O	,	_	0	SENT_15	[p1l1475t3570r2146b3651],

1	interindividual	JJ	O	interindividual	amod	2	SENT_16	[p2l519t19r1076b80],
2	Variability	NN	O	variability	_	0	SENT_16	[p2l1104t19r1482b100],

1	Iournal	NNP	O	Iournal	_	0	SENT_17	[p2l115t116r405b193],
2	of	IN	O	of	_	0	SENT_17	[p2l431t116r513b196],
3	Clinical	JJ	O	clinical	amod	4	SENT_17	[p2l534t116r831b177],
4	Pharmacology	NN	O	pharmacology	prep_of	1	SENT_17	[p2l854t116r1415b196],
5	,	,	O	,	_	0	SENT_17	[p2l854t116r1415b196],
6	2009	CD	DATE	2009	appos	4	SENT_17	[p2l1450t124r2150b188],
7	;	:	O	;	_	0	SENT_17	[p2l1450t124r2150b188],
8	49:1079	CD	DURATION	49:1079	number	9	SENT_17	[p2l1450t124r2150b188],
9	-1090	CD	DURATION	-1090	dep	1	SENT_17	[p2l1450t124r2150b188],
10	©	CD	NUMBER	©	num	11	SENT_17	[p2l11t216r67b274],
11	2009	CD	DATE	2009	dep	9	SENT_17	[p2l94t221r269b273],
12	the	DT	O	the	det	14	SENT_17	[p2l298t212r412b273],
13	American	NNP	O	American	nn	14	SENT_17	[p2l438t215r815b273],
14	College	NNP	O	College	dep	1	SENT_17	[p2l850t212r1132b293],
15	of	IN	O	of	_	0	SENT_17	[p2l1162t213r1244b293],
16	Clinical	JJ	O	clinical	amod	17	SENT_17	[p2l1265t212r1563b273],
17	Pharmacology	NN	O	pharmacology	prep_of	14	SENT_17	[p2l1586t212r2143b293],

1	Antiretroviral	JJ	O	antiretroviral	amod	3	SENT_18	[p2l11t490r717b661],
2	combination	NN	O	combination	nn	3	SENT_18	[p2l777t490r1306b559],
3	regimens	NNS	O	regimen	nsubjpass	33	SENT_18	[p2l1362t494r1741b580],
4	of	IN	O	of	_	0	SENT_18	[p2l1803t491r1886b559],
5	dualnucleoside	NN	O	dualnucleoside	prep_of	3	SENT_18	[p2l1939t490r2151b559, p2l203t593r669b661],
6	/	:	O	/	punct	11	SENT_18	[p2l1939t490r2151b559, p2l203t593r669b661],
7	nucleotide	NN	O	nucleotide	nn	10	SENT_18	[p2l671t593r1083b661],
8	reverse	JJ	O	reverse	amod	10	SENT_18	[p2l1105t617r1380b661],
9	transcriptase	NN	O	transcriptase	nn	10	SENT_18	[p2l1402t597r1897b683],
10	inhibitors	NNS	O	inhibitor	nsubj	11	SENT_18	[p2l1920t593r2151b661, p2l10t700r178b764],
11	(	VBP	O	(	dep	3	SENT_18	[p2l215t696r514b777],
12	NRTIS	NN	O	nrti	nn	13	SENT_18	[p2l215t696r514b777],
13	)	NN	O	)	dobj	11	SENT_18	[p2l215t696r514b777],
14	plus	CC	O	plus	prep	13	SENT_18	[p2l550t696r720b786],
15	either	CC	O	either	preconj	19	SENT_18	[p2l755t696r984b764],
16	a	DT	O	a	det	19	SENT_18	[p2l1016t720r1056b764],
17	protease	NN	O	protease	nn	19	SENT_18	[p2l1087t706r1417b786],
18	inhibitor	NN	O	inhibitor	nn	19	SENT_18	[p2l1451t696r1802b764],
19	(	NN	O	(	dep	14	SENT_18	[p2l1837t696r1965b777],
20	P1	NN	O	p1	dep	19	SENT_18	[p2l1837t696r1965b777],
21	)	CD	NUMBER	)	num	20	SENT_18	[p2l1837t696r1965b777],
22	or	CC	O	or	_	0	SENT_18	[p2l2003t720r2081b764],
23	a	DT	O	a	det	27	SENT_18	[p2l2113t720r2153b764],
24	nonnucleoside	JJ	O	nonnucleoside	amod	27	SENT_18	[p2l9t798r600b866],
25	reverse	JJ	O	reverse	amod	27	SENT_18	[p2l617t822r900b866],
26	transcriptase	NN	O	transcriptase	nn	27	SENT_18	[p2l917t801r1428b887],
27	inhibitor	NN	O	inhibitor	conj_or	19	SENT_18	[p2l1447t798r1798b866],
28	(	NN	O	(	nn	30	SENT_18	[p2l1819t798r2148b879],
29	NNRTI	NN	ORGANIZATION	nnrtus	nn	30	SENT_18	[p2l1819t798r2148b879],
30	)	NN	O	)	dep	3	SENT_18	[p2l1819t798r2148b879],
31	are	VBP	O	be	auxpass	33	SENT_18	[p2l11t924r126b968],
32	preferentially	RB	O	preferentially	advmod	33	SENT_18	[p2l189t900r731b989],
33	used	VBN	O	use	_	0	SENT_18	[p2l791t900r979b968],
34	in	IN	O	in	_	0	SENT_18	[p2l1041t903r1119b967],
35	treatment-naive	JJ	O	treatment-naive	amod	36	SENT_18	[p2l1180t903r1809b968],
36	human	JJ	O	human	prep_in	33	SENT_18	[p2l1871t900r2153b968],

1	From	IN	O	from	dep	61	SENT_19	[p2l13t1145r153b1198],
2	the	DT	O	the	det	6	SENT_19	[p2l180t1142r267b1198],
3	Warren	NNP	ORGANIZATION	Warren	nn	6	SENT_19	[p2l292t1144r503b1198],
4	Alpert	NNP	ORGANIZATION	Alpert	nn	6	SENT_19	[p2l529t1142r703b1213],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_19	[p2l727t1142r957b1199],
6	School	NNP	ORGANIZATION	School	pobj	1	SENT_19	[p2l986t1142r1180b1199],
7	of	IN	ORGANIZATION	of	_	0	SENT_19	[p2l1210t1142r1266b1198],
8	Brown	NNP	ORGANIZATION	Brown	nn	14	SENT_19	[p2l1293t1145r1467b1198],
9	University	NNP	ORGANIZATION	University	dep	14	SENT_19	[p2l1499t1145r1786b1213],
10	,	,	O	,	_	0	SENT_19	[p2l1499t1145r1786b1213],
11	Providence	NNP	LOCATION	Providence	dep	9	SENT_19	[p2l1817t1142r2150b1208],
12	,	,	O	,	_	0	SENT_19	[p2l1817t1142r2150b1208],
13	Rhode	NNP	LOCATION	Rhode	nn	14	SENT_19	[p2l13t1230r194b1286],
14	Island	NNP	LOCATION	Island	prep_of	6	SENT_19	[p2l231t1230r396b1286],
15	(	CD	NUMBER	(	num	18	SENT_19	[p2l436t1231r523b1300],
16	Dr	NNP	O	Dr	nn	18	SENT_19	[p2l436t1231r523b1300],
17	Kwara	NNP	LOCATION	Kwara	nn	18	SENT_19	[p2l557t1231r776b1300],
18	)	NN	O	)	dep	6	SENT_19	[p2l557t1231r776b1300],
19	;	:	O	;	_	0	SENT_19	[p2l557t1231r776b1300],
20	University	NNP	ORGANIZATION	University	dep	6	SENT_19	[p2l814t1233r1090b1300],
21	of	IN	ORGANIZATION	of	_	0	SENT_19	[p2l1123t1229r1179b1286],
22	Ghana	NNP	ORGANIZATION	Ghana	nn	24	SENT_19	[p2l1210t1230r1412b1286],
23	Medical	NNP	ORGANIZATION	Medical	nn	24	SENT_19	[p2l1449t1230r1679b1286],
24	School	NNP	ORGANIZATION	School	prep_of	20	SENT_19	[p2l1716t1230r1932b1296],
25	,	,	O	,	_	0	SENT_19	[p2l1716t1230r1932b1296],
26	Accra	NNP	LOCATION	Accra	appos	24	SENT_19	[p2l1964t1231r2150b1296],
27	,	,	O	,	_	0	SENT_19	[p2l1964t1231r2150b1296],
28	Ghana	NNP	LOCATION	Ghana	nn	31	SENT_19	[p2l11t1318r212b1374],
29	(	CD	NUMBER	(	num	31	SENT_19	[p2l247t1319r335b1388],
30	Dr	NNP	O	Dr	nn	31	SENT_19	[p2l247t1319r335b1388],
31	Lartey	NNP	PERSON	Lartey	appos	24	SENT_19	[p2l363t1321r539b1389],
32	,	,	O	,	_	0	SENT_19	[p2l363t1321r539b1389],
33	Mr	NNP	PERSON	Mr	nn	35	SENT_19	[p2l569t1320r650b1374],
34	Boamah	NNP	PERSON	Boamah	nn	35	SENT_19	[p2l679t1318r961b1388],
35	)	NN	O	)	appos	24	SENT_19	[p2l679t1318r961b1388],
36	;	:	O	;	_	0	SENT_19	[p2l679t1318r961b1388],
37	University	NNP	ORGANIZATION	University	dep	6	SENT_19	[p2l995t1321r1270b1389],
38	of	IN	ORGANIZATION	of	_	0	SENT_19	[p2l1298t1318r1354b1374],
39	North	NNP	ORGANIZATION	North	nn	40	SENT_19	[p2l1383t1318r1542b1374],
40	Carolina	NNP	ORGANIZATION	Carolina	prep_of	37	SENT_19	[p2l1575t1318r1827b1374],
41	at	IN	O	at	_	0	SENT_19	[p2l1859t1329r1913b1374],
42	Chapel	NN	LOCATION	chapel	nn	43	SENT_19	[p2l1940t1318r2149b1389],
43	Hill	NNP	LOCATION	Hill	prep_at	40	SENT_19	[p2l13t1406r123b1472],
44	,	,	O	,	_	0	SENT_19	[p2l13t1406r123b1472],
45	Chapel	NN	LOCATION	chapel	appos	6	SENT_19	[p2l173t1406r382b1477],
46	Hill	NNP	LOCATION	Hill	dep	45	SENT_19	[p2l436t1406r546b1472],
47	,	,	O	,	_	0	SENT_19	[p2l436t1406r546b1472],
48	North	NNP	LOCATION	North	nn	49	SENT_19	[p2l599t1406r759b1462],
49	Carolina	NNP	LOCATION	Carolina	appos	6	SENT_19	[p2l810t1406r1062b1462],
50	(	CD	NUMBER	(	num	52	SENT_19	[p2l1116t1407r1203b1476],
51	Dr	NN	O	dr	nn	52	SENT_19	[p2l1116t1407r1203b1476],
52	Rezl	NN	O	rezl	dep	53	SENT_19	[p2l1250t1406r1393b1472],
53	<	JJR	O	<	dep	49	SENT_19	[p2l1250t1406r1393b1472],
54	,	,	O	,	_	0	SENT_19	[p2l1250t1406r1393b1472],
55	Dr	NNP	O	Dr	nn	56	SENT_19	[p2l1445t1409r1513b1461],
56	Kashuba	NNP	LOCATION	Kashuba	appos	6	SENT_19	[p2l1560t1406r1850b1477],
57	)	NN	O	)	dep	56	SENT_19	[p2l1560t1406r1850b1477],
58	;	:	O	;	_	0	SENT_19	[p2l1560t1406r1850b1477],
59	Korle-Bu	NNP	O	Korle-Bu	nn	61	SENT_19	[p2l1903t1406r2149b1462],
60	Teaching	NNP	O	Teaching	nn	61	SENT_19	[p2l8t1494r266b1564],
61	Hospital	NNP	O	Hospital	_	0	SENT_19	[p2l309t1494r564b1564],
62	,	,	O	,	_	0	SENT_19	[p2l309t1494r564b1564],
63	Accra	NNP	LOCATION	Accra	appos	61	SENT_19	[p2l600t1495r786b1560],
64	,	,	O	,	_	0	SENT_19	[p2l600t1495r786b1560],
65	Ghana	NNP	LOCATION	Ghana	nn	68	SENT_19	[p2l826t1494r1028b1550],
66	(	CD	NUMBER	(	num	68	SENT_19	[p2l1071t1495r1158b1564],
67	Dr	NNP	O	Dr	nn	68	SENT_19	[p2l1071t1495r1158b1564],
68	Oliver	NNP	PERSON	Oliver	appos	61	SENT_19	[p2l1193t1494r1675b1564],
69	.	.	O	.	_	0	SENT_19	[p2l1193t1494r1675b1564],

1	—	NN	O	—	_	0	SENT_20	[p2l1193t1494r1675b1564],
2	.	.	O	.	_	0	SENT_20	[p2l1193t1494r1675b1564],

1	Commey	NNP	PERSON	Commey	_	0	SENT_21	[p2l1193t1494r1675b1564],
2	,	,	O	,	_	0	SENT_21	[p2l1193t1494r1675b1564],
3	Dr	NNP	O	Dr	nn	5	SENT_21	[p2l1717t1497r1785b1549],
4	Kenu	NNP	O	Kenu	nn	5	SENT_21	[p2l1822t1495r2004b1564],
5	)	NN	O	)	appos	1	SENT_21	[p2l1822t1495r2004b1564],
6	;	:	O	;	_	0	SENT_21	[p2l1822t1495r2004b1564],
7	and	CC	O	and	_	0	SENT_21	[p2l2042t1494r2149b1550],
8	Tufts	NNP	ORGANIZATION	Tufts	nn	10	SENT_21	[p2l8t1582r134b1638],
9	University	NNP	ORGANIZATION	University	nn	10	SENT_21	[p2l172t1585r447b1653],
10	School	NNP	ORGANIZATION	School	conj_and	1	SENT_21	[p2l480t1582r674b1638],
11	of	IN	ORGANIZATION	of	_	0	SENT_21	[p2l711t1582r767b1638],
12	Medicine	NNP	ORGANIZATION	Medicine	nn	18	SENT_21	[p2l799t1582r1085b1648],
13	,	,	O	,	_	0	SENT_21	[p2l799t1582r1085b1648],
14	Boston	NNP	LOCATION	Boston	appos	18	SENT_21	[p2l1124t1585r1336b1648],
15	,	,	O	,	_	0	SENT_21	[p2l1124t1585r1336b1648],
16	Massachusetts	NNP	LOCATION	Massachusetts	appos	18	SENT_21	[p2l1372t1582r1792b1638],
17	(	CD	NUMBER	(	num	18	SENT_21	[p2l1830t1583r1917b1652],
18	Dr	NNP	O	Dr	prep_of	10	SENT_21	[p2l1830t1583r1917b1652],
19	Court	NNP	O	Court	nn	20	SENT_21	[p2l1949t1583r2148b1652],
20	)	NN	O	)	dep	18	SENT_21	[p2l1949t1583r2148b1652],
21	.	.	O	.	_	0	SENT_21	[p2l1949t1583r2148b1652],

1	Submitted	VBN	O	submit	_	0	SENT_22	[p2l10t1670r297b1726],
2	for	IN	O	for	_	0	SENT_22	[p2l329t1670r410b1726],
3	publication	NN	O	publication	nn	5	SENT_22	[p2l440t1670r761b1741],
4	February	NNP	DATE	February	nn	5	SENT_22	[p2l797t1670r1048b1741],
5	l9	NN	O	l9	prep_for	1	SENT_22	[p2l1085t1673r1173b1736],
6	,	,	O	,	_	0	SENT_22	[p2l1085t1673r1173b1736],
7	2009	CD	DATE	2009	appos	5	SENT_22	[p2l1206t1673r1387b1736],
8	;	:	O	;	_	0	SENT_22	[p2l1206t1673r1387b1736],
9	revised	VBN	O	revise	amod	10	SENT_22	[p2l1422t1670r1618b1726],
10	version	NN	O	version	dep	7	SENT_22	[p2l1649t1678r1854b1726],
11	accepted	VBN	O	accept	partmod	10	SENT_22	[p2l1887t1670r2149b1741],
12	April	NNP	DATE	April	tmod	11	SENT_22	[p2l7t1758r139b1828],
13	30	CD	DATE	30	num	12	SENT_22	[p2l169t1760r265b1824],
14	,	,	DATE	,	_	0	SENT_22	[p2l169t1760r265b1824],
15	2009	CD	DATE	2009	num	12	SENT_22	[p2l294t1760r470b1815],
16	.	.	O	.	_	0	SENT_22	[p2l294t1760r470b1815],

1	Address	NN	O	address	_	0	SENT_23	[p2l498t1758r729b1814],
2	for	IN	O	for	_	0	SENT_23	[p2l754t1757r836b1814],
3	correspondence	NN	O	correspondence	prep_for	1	SENT_23	[p2l859t1758r1347b1828],
4	:	:	O	:	_	0	SENT_23	[p2l859t1758r1347b1828],
5	Awewura	NNP	PERSON	Awewura	nn	6	SENT_23	[p2l1376t1759r1641b1814],
6	Kwara	NNP	PERSON	Kwara	dep	3	SENT_23	[p2l1674t1761r1872b1824],
7	,	,	O	,	_	0	SENT_23	[p2l1674t1761r1872b1824],
8	MD	NNP	O	MD	appos	6	SENT_23	[p2l1901t1760r2020b1824],
9	,	,	O	,	_	0	SENT_23	[p2l1901t1760r2020b1824],
10	The	DT	O	the	det	12	SENT_23	[p2l2047t1758r2152b1814],
11	Miriam	NNP	ORGANIZATION	Miriam	nn	12	SENT_23	[p2l10t1848r212b1902],
12	Hospital	NNP	ORGANIZATION	Hospital	appos	6	SENT_23	[p2l255t1846r511b1917],
13	,	,	O	,	_	0	SENT_23	[p2l255t1846r511b1917],
14	l64	NN	O	l64	nn	16	SENT_23	[p2l556t1848r664b1902],
15	Summit	NNP	O	Summit	nn	16	SENT_23	[p2l703t1848r921b1902],
16	Avenue	NNP	O	Avenue	appos	6	SENT_23	[p2l951t1848r1188b1912],
17	,	,	O	,	_	0	SENT_23	[p2l951t1848r1188b1912],
18	Providence	NNP	LOCATION	Providence	appos	6	SENT_23	[p2l1229t1846r1562b1912],
19	,	,	O	,	_	0	SENT_23	[p2l1229t1846r1562b1912],
20	RI	NN	O	rus	appos	6	SENT_23	[p2l1603t1849r1646b1901],
21	02906	CD	DATE	02906	num	20	SENT_23	[p2l1687t1848r1907b1912],
22	;	:	O	;	_	0	SENT_23	[p2l1687t1848r1907b1912],
23	e	SYM	O	e	dep	25	SENT_23	[p2l1945t1846r2147b1902],
24	—	CD	NUMBER	—	num	25	SENT_23	[p2l1945t1846r2147b1902],
25	mail	NN	O	mail	dep	1	SENT_23	[p2l1945t1846r2147b1902],
26	:	:	O	:	_	0	SENT_23	[p2l1945t1846r2147b1902],
27	a	DT	O	a	det	29	SENT_23	[p2l10t1934r661b2005],
28	|	NN	O	|	dep	29	SENT_23	[p2l10t1934r661b2005],
29	<	JJR	O	<	dep	1	SENT_23	[p2l10t1934r661b2005],
30	wara@lifespan.org	CD	NUMBER	wara@lifespan.org	dep	29	SENT_23	[p2l10t1934r661b2005],
31	.	.	O	.	_	0	SENT_23	[p2l10t1934r661b2005],

1	DOI	NNP	O	DOI	_	0	SENT_24	[p2l13t2025r152b2080],
2	:	:	O	:	_	0	SENT_24	[p2l13t2025r152b2080],
3	lo	FW	O	lo	dep	1	SENT_24	[p2l192t2026r309b2080],
4	.	.	O	.	_	0	SENT_24	[p2l192t2026r309b2080],

1	l	NN	O	l	_	0	SENT_25	[p2l192t2026r309b2080],
2	l	NN	O	l	dep	1	SENT_25	[p2l336t2027r351b2078],
3	77/009l	CD	NUMBER	77/009l	num	4	SENT_25	[p2l374t2025r627b2085],
4	270009338482	CD	NUMBER	270009338482	dep	1	SENT_25	[p2l647t2026r1133b2080],

1	I	PRP	O	I	nsubj	2	SENT_26	[p2l8t2250r37b2323],
2	Clin	VBP	O	clin	_	0	SENT_26	[p2l66t2246r219b2307],
3	Pharmacol	NNP	O	Pharmacol	dobj	2	SENT_26	[p2l245t2246r650b2307],
4	2009	CD	DATE	2009	num	3	SENT_26	[p2l680t2255r1371b2318],
5	;	:	O	;	_	0	SENT_26	[p2l680t2255r1371b2318],
6	419:1079	CD	DURATION	419:1079	number	7	SENT_26	[p2l680t2255r1371b2318],
7	-1090	CD	DURATION	-1090	num	12	SENT_26	[p2l680t2255r1371b2318],
8	immunodeficiency	NN	O	immunodeficiency	nn	12	SENT_26	[p2l7t2342r766b2432],
9	virus	NN	O	virus	nn	12	SENT_26	[p2l814t2346r1015b2411],
10	(	CD	NUMBER	(	num	12	SENT_26	[p2l1072t2342r1659b2423],
11	HIV	NN	O	hiv	nn	12	SENT_26	[p2l1072t2342r1659b2423],
12	)	NN	O	)	dep	3	SENT_26	[p2l1072t2342r1659b2423],
13	.	.	O	.	_	0	SENT_26	[p2l1072t2342r1659b2423],

1	—	NN	O	—	_	0	SENT_27	[p2l1072t2342r1659b2423],
2	.	.	O	.	_	0	SENT_27	[p2l1072t2342r1659b2423],

1	infected	JJ	O	infected	amod	2	SENT_28	[p2l1072t2342r1659b2423],
2	patients	NNS	O	patient	nsubj	4	SENT_28	[p2l1710t2346r2025b2432],
3	to	TO	O	to	aux	4	SENT_28	[p2l2077t2353r2150b2411],
4	achieve	VB	O	achieve	_	0	SENT_28	[p2l8t2444r309b2512],
5	maximum	NN	O	maximum	dobj	4	SENT_28	[p2l360t2448r769b2512],
6	durable	JJ	O	durable	amod	8	SENT_28	[p2l822t2444r1122b2512],
7	antiviral	JJ	O	antiviral	amod	8	SENT_28	[p2l1175t2444r1509b2512],
8	activity	NN	O	activity	dep	5	SENT_28	[p2l1562t2444r1947b2534],
9	.	.	O	.	_	0	SENT_28	[p2l1562t2444r1947b2534],

1	”	NN	O	”	nsubj	56	SENT_29	[p2l1562t2444r1947b2534],
2	The	DT	O	the	det	5	SENT_29	[p2l2000t2444r2151b2512],
3	dual-NRTI	JJ	O	dual-nrti	amod	5	SENT_29	[p2l9t2546r428b2614],
4	backbone	NN	O	backbone	nn	5	SENT_29	[p2l489t2546r868b2614],
5	drugs	NNS	O	drug	nsubj	6	SENT_29	[p2l936t2546r1152b2635],
6	differ	VBP	O	differ	rcmod	1	SENT_29	[p2l1221t2546r1434b2614],
7	substantially	RB	O	substantially	advmod	6	SENT_29	[p2l1499t2546r2010b2635],
8	in	IN	O	in	_	0	SENT_29	[p2l2073t2550r2153b2614],
9	pharmacokinetic	JJ	O	pharmacokinetic	amod	10	SENT_29	[p2l7t2648r679b2738],
10	properties	NNS	O	property	prep_in	6	SENT_29	[p2l722t2652r1148b2738],
11	,	,	O	,	_	0	SENT_29	[p2l722t2652r1148b2738],
12	potency	NN	O	potency	conj_and	10	SENT_29	[p2l1192t2658r1525b2738],
13	,	,	O	,	_	0	SENT_29	[p2l1192t2658r1525b2738],
14	and	CC	O	and	_	0	SENT_29	[p2l1569t2648r1717b2716],
15	durability	NN	O	durability	conj_and	10	SENT_29	[p2l1760t2648r2153b2737],
16	of	IN	O	of	_	0	SENT_29	[p2l8t2750r88b2818],
17	virologic	JJ	O	virologic	amod	18	SENT_29	[p2l104t2750r455b2839],
18	suppression	NN	O	suppression	prep_of	15	SENT_29	[p2l483t2753r987b2839],
19	,	,	O	,	_	0	SENT_29	[p2l483t2753r987b2839],
20	incidence	NN	O	incidence	nsubj	56	SENT_29	[p2l1015t2750r1426b2828],
21	,	,	O	,	_	0	SENT_29	[p2l1015t2750r1426b2828],
22	and	CC	O	and	_	0	SENT_29	[p2l1455t2750r1603b2818],
23	type	NN	O	type	conj_and	1	SENT_29	[p2l1626t2760r1797b2839],
24	of	IN	O	of	_	0	SENT_29	[p2l1825t2750r1905b2818],
25	shortand	NN	O	shortand	nn	27	SENT_29	[p2l1924t2750r2151b2818, p2l8t2853r155b2921],
26	long-term	JJ	O	long-term	amod	27	SENT_29	[p2l180t2853r566b2942],
27	toxicities	NNS	O	toxicity	prep_of	23	SENT_29	[p2l590t2856r977b2931],
28	;	:	O	;	_	0	SENT_29	[p2l590t2856r977b2931],
29	propensity	NN	O	propensity	dep	23	SENT_29	[p2l1005t2856r1436b2942],
30	to	TO	O	to	aux	31	SENT_29	[p2l1459t2863r1533b2921],
31	select	VB	O	select	infmod	29	SENT_29	[p2l1561t2853r1786b2921],
32	for	IN	O	for	_	0	SENT_29	[p2l1810t2853r1919b2921],
33	resistance	NN	O	resistance	nn	34	SENT_29	[p2l1941t2856r2151b2921, p2l6t2966r216b3024],
34	mutations	NNS	O	mutation	prep_for	31	SENT_29	[p2l251t2959r674b3034],
35	;	:	O	;	_	0	SENT_29	[p2l251t2959r674b3034],
36	dosing	NN	O	dosing	nn	37	SENT_29	[p2l714t2955r976b3045],
37	convenience	NN	O	convenience	conj_and	1	SENT_29	[p2l1012t2959r1535b3034],
38	;	:	O	;	_	0	SENT_29	[p2l1012t2959r1535b3034],
39	and	CC	O	and	_	0	SENT_29	[p2l1575t2955r1722b3024],
40	drug-drug	JJ	O	drug-drug	amod	41	SENT_29	[p2l1759t2955r2152b3045],
41	interaction	NN	O	interaction	conj_and	1	SENT_29	[p2l7t3061r442b3125],
42	potential	JJ	O	potential	amod	43	SENT_29	[p2l492t3057r899b3147],
43	}	CD	NUMBER	}	dep	41	SENT_29	[p2l492t3057r899b3147],
44	The	DT	O	the	det	48	SENT_29	[p2l952t3057r1104b3125],
45	newer	JJR	O	newer	amod	48	SENT_29	[p2l1155t3081r1402b3125],
46	once-daily	JJ	O	once-daily	amod	48	SENT_29	[p2l1453t3057r1873b3147],
47	fixeddose	NN	O	fixeddose	nn	48	SENT_29	[p2l1923t3057r2151b3125, p2l9t3159r189b3227],
48	combinations	NNS	O	combination	dep	41	SENT_29	[p2l271t3159r815b3227],
49	of	IN	O	of	_	0	SENT_29	[p2l899t3159r979b3227],
50	tenofovir/emtricitabine	NN	O	tenofovir/emtricitabine	prep_of	48	SENT_29	[p2l1051t3159r1992b3227],
51	or	CC	O	or	_	0	SENT_29	[p2l2074t3183r2153b3227],
52	lamivudine/abacavir	NN	O	lamivudine/abacavir	conj_or	50	SENT_29	[p3l7t24r840b92],
53	are	VBP	O	be	cop	56	SENT_29	[p3l906t48r1021b92],
54	the	DT	O	the	det	56	SENT_29	[p3l1087t24r1210b92],
55	preferred	JJ	O	preferred	amod	56	SENT_29	[p3l1277t24r1644b114],
56	choices	NNS	O	choice	_	0	SENT_29	[p3l1710t24r2005b92],
57	in	IN	O	in	_	0	SENT_29	[p3l2073t28r2152b92],
58	industrialized	JJ	O	industrialized	amod	59	SENT_29	[p3l7t126r568b194],
59	countries	NNS	O	country	prep_in	56	SENT_29	[p3l628t129r996b194],
60	because	IN	O	because	_	0	SENT_29	[p3l1054t126r1370b194],
61	of	IN	O	of	_	0	SENT_29	[p3l1432t126r1512b194],
62	dosing	NN	O	dosing	nn	63	SENT_29	[p3l1566t126r1828b215],
63	convenience	NN	O	convenience	prep_because_of	56	SENT_29	[p3l1889t150r2151b194, p3l6t232r270b297],
64	and	CC	O	and	_	0	SENT_29	[p3l312t229r459b297],
65	lower	JJR	O	lower	amod	66	SENT_29	[p3l499t229r725b297],
66	incidence	NN	O	incidence	conj_and	63	SENT_29	[p3l765t229r1154b297],
67	of	IN	O	of	_	0	SENT_29	[p3l1197t229r1277b297],
68	short	JJ	O	short	amod	72	SENT_29	[p3l1311t229r1537b297],
69	-	:	O	-	_	0	SENT_29	[p3l1311t229r1537b297],
70	and	CC	O	and	_	0	SENT_29	[p3l1580t229r1726b297],
71	long-term	JJ	O	long-term	amod	72	SENT_29	[p3l1767t229r2153b318],
72	toxicities	NNS	O	toxicity	prep_of	66	SENT_29	[p3l6t330r467b399],
73	.	.	O	.	_	0	SENT_29	[p3l6t330r467b399],

1	”	NN	O	”	nsubj	25	SENT_30	[p3l6t330r467b399],
2	However	RB	O	however	advmod	1	SENT_30	[p3l503t335r878b409],
3	,	,	O	,	_	0	SENT_30	[p3l503t335r878b409],
4	in	IN	O	in	_	0	SENT_30	[p3l915t334r995b398],
5	resource-poor	JJ	O	resource-poor	amod	6	SENT_30	[p3l1027t355r1581b420],
6	settings	NNS	O	setting	prep_in	25	SENT_30	[p3l1616t334r1938b420],
7	,	,	O	,	_	0	SENT_30	[p3l1616t334r1938b420],
8	lowcost	JJ	O	lowcost	amod	10	SENT_30	[p3l1976t330r2151b399, p3l8t442r165b500],
9	generic	JJ	O	generic	amod	10	SENT_30	[p3l188t436r475b522],
10	forms	NNS	O	form	nsubj	25	SENT_30	[p3l503t432r726b500],
11	of	IN	O	of	_	0	SENT_30	[p3l755t432r835b500],
12	lamivudine	NN	O	lamivudine	prep_of	10	SENT_30	[p3l853t432r1311b500],
13	in	IN	O	in	_	0	SENT_30	[p3l1338t436r1417b500],
14	combination	NN	O	combination	prep_in	12	SENT_30	[p3l1443t432r1946b500],
15	with	IN	O	with	dep	14	SENT_30	[p3l1969t432r2153b500],
16	zidovudine	NN	O	zidovudine	pobj	15	SENT_30	[p3l7t534r461b602],
17	or	CC	O	or	_	0	SENT_30	[p3l493t558r572b602],
18	coadministered	VBN	O	coadminister	dep	14	SENT_30	[p3l601t534r1221b602],
19	with	IN	O	with	_	0	SENT_30	[p3l1249t534r1433b602],
20	stavudine	NN	O	stavudine	prep_with	18	SENT_30	[p3l1463t534r1851b602],
21	are	VBP	O	be	cop	25	SENT_30	[p3l1883t558r1998b602],
22	the	DT	O	the	det	25	SENT_30	[p3l2028t534r2151b602],
23	predominant	JJ	O	predominant	amod	25	SENT_30	[p3l7t637r527b727],
24	dual-NRTI	NN	O	dual-nrtus	nn	25	SENT_30	[p3l559t637r977b705],
25	bacl	NN	O	bacl	_	0	SENT_30	[p3l1004t636r1436b705],
26	<	JJR	O	<	amod	28	SENT_30	[p3l1004t636r1436b705],
27	bone	NN	O	bone	nn	28	SENT_30	[p3l1004t636r1436b705],
28	.3	NN	NUMBER	.3	attr	25	SENT_30	[p3l1004t636r1436b705],

1	KWARA	NNP	LOCATION	KWARA	nn	3	SENT_31	[p3l936t1029r1089b1059],
2	ET	NNP	O	ET	nn	3	SENT_31	[p3l1104t1029r1160b1059],
3	AL	NNP	O	AL	_	0	SENT_31	[p3l1169t1029r1225b1059],

1	The	DT	O	the	det	2	SENT_32	[p3l117t1239r268b1307],
2	pharmacokinetics	NNS	O	pharmacokinetic	nsubj	8	SENT_32	[p3l316t1239r1024b1329],
3	of	IN	O	of	_	0	SENT_32	[p3l1075t1239r1154b1307],
4	the	DT	O	the	det	6	SENT_32	[p3l1192t1239r1315b1307],
5	antiretroviral	JJ	O	antiretroviral	amod	6	SENT_32	[p3l1364t1239r1885b1307],
6	drugs	NNS	O	drug	prep_of	2	SENT_32	[p3l1935t1239r2150b1329],
7	may	MD	O	may	aux	8	SENT_32	[p3l9t1365r180b1430],
8	depend	VB	O	depend	ccomp	20	SENT_32	[p3l240t1341r542b1431],
9	on	IN	O	on	_	0	SENT_32	[p3l601t1365r700b1409],
10	genetic	JJ	O	genetic	amod	11	SENT_32	[p3l756t1345r1044b1430],
11	polymorphisms	NNS	O	polymorphism	prep_on	8	SENT_32	[p3l1104t1341r1745b1431],
12	of	IN	O	of	_	0	SENT_32	[p3l1807t1341r1888b1409],
13	drugmetabolizing	VBG	O	drugmetabolize	prepc_of	11	SENT_32	[p3l1940t1341r2151b1430, p3l9t1443r502b1532],
14	enzymes	NNS	O	enzyme	dobj	13	SENT_32	[p3l534t1467r860b1532],
15	or	CC	O	or	_	0	SENT_32	[p3l895t1467r969b1511],
16	transporters	NNS	O	transporter	conj_or	14	SENT_32	[p3l998t1453r1470b1532],
17	,	,	O	,	_	0	SENT_32	[p3l998t1453r1470b1532],
18	biological	JJ	O	biological	amod	19	SENT_32	[p3l1500t1443r1872b1532],
19	factors	NNS	O	factor	nsubj	20	SENT_32	[p3l1904t1443r2150b1511],
20	(	VBP	O	(	_	0	SENT_32	[p3l14t1546r225b1626],
21	such	JJ	O	such	_	0	SENT_32	[p3l14t1546r225b1626],
22	as	IN	O	as	_	0	SENT_32	[p3l267t1570r342b1614],
23	age	NN	O	age	prep_such_as	20	SENT_32	[p3l386t1570r533b1635],
24	,	,	O	,	_	0	SENT_32	[p3l386t1570r533b1635],
25	gender	NN	O	gender	prep_such_as	20	SENT_32	[p3l576t1546r861b1635],
26	,	,	O	,	_	0	SENT_32	[p3l576t1546r861b1635],
27	body	NN	O	body	nn	28	SENT_32	[p3l902t1546r1102b1635],
28	weight	NN	O	weight	prep_such_as	20	SENT_32	[p3l1141t1546r1431b1635],
29	,	,	O	,	_	0	SENT_32	[p3l1141t1546r1431b1635],
30	or	CC	O	or	_	0	SENT_32	[p3l1477t1570r1555b1614],
31	disease	NN	O	disease	nn	33	SENT_32	[p3l1598t1546r1881b1614],
32	state	NN	O	state	nn	33	SENT_32	[p3l1925t1546r2149b1627],
33	)	NN	O	)	prep_such_as	20	SENT_32	[p3l1925t1546r2149b1627],
34	,	,	O	,	_	0	SENT_32	[p3l1925t1546r2149b1627],
35	drug-drug	JJ	O	drug-drug	amod	36	SENT_32	[p3l12t1647r400b1737],
36	interactions	NNS	O	interaction	appos	33	SENT_32	[p3l465t1651r949b1726],
37	,	,	O	,	_	0	SENT_32	[p3l465t1651r949b1726],
38	and/or	IN	O	and/or	_	0	SENT_32	[p3l1018t1647r1279b1716],
39	drug	NN	O	drug	nn	40	SENT_32	[p3l1345t1647r1522b1737],
40	formulation	NN	O	formulation	prep_and/or	20	SENT_32	[p3l1587t1647r2152b1716],
41	.	.	O	.	_	0	SENT_32	[p3l1587t1647r2152b1716],

1	“	NN	O	“	_	0	SENT_33	[p3l1587t1647r2152b1716],
2	Although	IN	O	although	mark	11	SENT_33	[p3l9t1749r383b1839],
3	the	DT	O	the	det	4	SENT_33	[p3l434t1749r556b1818],
4	pharmacokinetics	NNS	O	pharmacokinetic	nsubjpass	11	SENT_33	[p3l609t1749r1312b1839],
5	of	IN	O	of	_	0	SENT_33	[p3l1368t1750r1447b1818],
6	the	DT	O	the	det	7	SENT_33	[p3l1491t1750r1613b1818],
7	NRTIs	NNS	MISC	nrti	prep_of	4	SENT_33	[p3l1666t1754r1912b1818],
8	have	VBP	O	have	aux	11	SENT_33	[p3l1966t1749r2151b1818],
9	been	VBN	O	be	auxpass	11	SENT_33	[p3l7t1851r195b1920],
10	well	RB	O	well	advmod	11	SENT_33	[p3l237t1851r407b1920],
11	established	VBN	O	establish	dep	1	SENT_33	[p3l453t1851r895b1920],
12	for	IN	O	for	_	0	SENT_33	[p3l938t1851r1045b1920],
13	the	DT	O	the	det	15	SENT_33	[p3l1087t1851r1208b1920],
14	brand	NN	O	brand	nn	15	SENT_33	[p3l1249t1851r1481b1920],
15	formulations	NNS	O	formulation	prep_for	11	SENT_33	[p3l1525t1851r2028b1920],
16	in	IN	O	in	prep	11	SENT_33	[p3l2074t1855r2153b1919],

1	HIV-infectedpopulationsinindustrializedcountries	JJ	O	hiv-infectedpopulationsinindustrializedcountries	amod	2	SENT_34	[p3l9t1954r2152b2044],
2	,7	NN	O	,7	_	0	SENT_34	[p3l9t1954r2152b2044],
3	'	''	O	'	_	0	SENT_34	[p3l9t1954r2152b2044],
4	1	CD	NUMBER	1	number	5	SENT_34	[p3l9t1954r2152b2044],
5	°	CD	NUMBER	°	dep	2	SENT_34	[p3l9t1954r2152b2044],
6	there	EX	O	there	expl	7	SENT_34	[p3l9t2056r207b2124],
7	are	VBP	O	be	rcmod	2	SENT_34	[p3l242t2080r356b2124],
8	limited	JJ	O	limited	amod	9	SENT_34	[p3l390t2056r674b2124],
9	data	NNS	O	datum	nsubj	7	SENT_34	[p3l709t2056r873b2124],
10	on	IN	O	on	_	0	SENT_34	[p3l905t2080r1002b2124],
11	the	DT	O	the	det	12	SENT_34	[p3l1033t2056r1155b2124],
12	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	9	SENT_34	[p3l1188t2056r1890b2145],
13	of	IN	O	of	_	0	SENT_34	[p3l1926t2056r2006b2124],
14	the	DT	O	the	det	16	SENT_34	[p3l2029t2056r2151b2124],
15	generic	JJ	O	generic	amod	16	SENT_34	[p3l9t2162r293b2248],
16	equivalents	NNS	O	equivalent	prep_of	12	SENT_34	[p3l326t2159r775b2248],
17	in	IN	O	in	_	0	SENT_34	[p3l808t2162r886b2226],
18	African	JJ	MISC	african	amod	19	SENT_34	[p3l914t2159r1211b2227],
19	populations	NNS	O	population	prep_in	16	SENT_34	[p3l1240t2159r1731b2248],
20	.	.	O	.	_	0	SENT_34	[p3l1240t2159r1731b2248],

1	The	DT	O	the	det	2	SENT_35	[p3l1766t2159r1916b2227],
2	pharmacokinetics	NNS	O	pharmacokinetic	nsubjpass	25	SENT_35	[p3l1947t2159r2151b2248, p3l9t2260r529b2329],
3	of	IN	O	of	_	0	SENT_35	[p3l562t2261r641b2329],
4	generic	JJ	O	generic	amod	5	SENT_35	[p3l662t2264r945b2350],
5	tablets	NNS	O	tablet	prep_of	2	SENT_35	[p3l975t2260r1229b2329],
6	of	IN	O	of	_	0	SENT_35	[p3l1262t2261r1342b2329],
7	the	DT	O	the	det	9	SENT_35	[p3l1362t2260r1483b2329],
8	fixed-dose	JJ	O	fixed-dose	amod	9	SENT_35	[p3l1514t2260r1926b2329],
9	combination	NN	O	combination	prep_of	5	SENT_35	[p3l1958t2285r2151b2329, p3l7t2362r341b2431],
10	of	IN	O	of	_	0	SENT_35	[p3l424t2363r503b2431],
11	lamivudine/stavudine/nevirapine	NN	O	lamivudine/stavudine/nevirapine	prep_of	9	SENT_35	[p3l578t2362r1924b2452],
12	and	CC	O	and	_	0	SENT_35	[p3l2007t2362r2152b2431],
13	brand-name	JJ	O	brand-name	amod	15	SENT_35	[p3l7t2464r483b2532],
14	separate	JJ	O	separate	amod	15	SENT_35	[p3l516t2474r837b2554],
15	formulations	NNS	O	formulation	prep_of	5	SENT_35	[p3l869t2464r1373b2532],
16	of	IN	O	of	_	0	SENT_35	[p3l1407t2464r1486b2532],
17	lamivudine	NN	O	lamivudine	prep_of	15	SENT_35	[p3l1509t2464r1983b2543],
18	,	,	O	,	_	0	SENT_35	[p3l1509t2464r1983b2543],
19	stavudine	NN	O	stavudine	conj_and	17	SENT_35	[p3l2019t2474r2151b2532, p3l8t2566r306b2645],
20	,	,	O	,	_	0	SENT_35	[p3l2019t2474r2151b2532, p3l8t2566r306b2645],
21	and	CC	O	and	_	0	SENT_35	[p3l348t2566r494b2634],
22	nevirapine	NN	O	nevirapine	prep_of	15	SENT_35	[p3l531t2570r955b2656],
23	have	VBP	O	have	aux	25	SENT_35	[p3l993t2566r1177b2634],
24	been	VBN	O	be	auxpass	25	SENT_35	[p3l1213t2566r1402b2634],
25	evaluated	VBN	O	evaluate	_	0	SENT_35	[p3l1441t2566r1821b2634],
26	in	IN	O	in	_	0	SENT_35	[p3l1859t2570r1937b2634],
27	HIVinfected	JJ	O	hivinfected	amod	28	SENT_35	[p3l1974t2571r2151b2634, p3l10t2667r328b2735],
28	patients	NNS	O	patient	prep_in	25	SENT_35	[p3l363t2670r674b2756],
29	in	IN	O	in	_	0	SENT_35	[p3l712t2670r791b2734],
30	sub-Saharan	JJ	O	sub-saharan	amod	31	SENT_35	[p3l827t2667r1314b2735],
31	Africa	NNP	LOCATION	Africa	prep_in	28	SENT_35	[p3l1348t2666r1742b2735],
32	.	.	O	.	_	0	SENT_35	[p3l1348t2666r1742b2735],

1	“’	NN	O	“’	dep	9	SENT_36	[p3l1348t2666r1742b2735],
2	12	CD	NUMBER	12	num	1	SENT_36	[p3l1348t2666r1742b2735],
3	Although	IN	O	although	dep	9	SENT_36	[p3l1778t2667r2153b2756],
4	plasma	NN	O	plasma	nn	5	SENT_36	[p3l10t2771r293b2860],
5	levels	NNS	O	level	nsubjpass	9	SENT_36	[p3l322t2771r547b2839],
6	of	IN	O	of	_	0	SENT_36	[p3l581t2771r661b2839],
7	lamivudine	NN	O	lamivudine	prep_of	5	SENT_36	[p3l684t2771r1137b2839],
8	were	VBD	O	be	auxpass	9	SENT_36	[p3l1168t2795r1358b2839],
9	found	VBN	O	find	advcl	28	SENT_36	[p3l1391t2771r1624b2839],
10	to	TO	O	to	aux	12	SENT_36	[p3l1653t2781r1726b2839],
11	be	VB	O	be	cop	12	SENT_36	[p3l1755t2771r1845b2839],
12	similar	JJ	O	similar	xcomp	9	SENT_36	[p3l1879t2771r2153b2839],
13	for	IN	O	for	_	0	SENT_36	[p3l10t2873r118b2941],
14	the	DT	O	the	det	18	SENT_36	[p3l146t2872r268b2941],
15	generic	JJ	O	generic	amod	18	SENT_36	[p3l299t2876r583b2962],
16	and	CC	O	and	_	0	SENT_36	[p3l616t2872r762b2941],
17	brand-name	JJ	O	brand-name	amod	18	SENT_36	[p3l789t2872r1266b2941],
18	formulations	NNS	O	formulation	prep_for	12	SENT_36	[p3l1298t2872r1802b2941],
19	in	IN	O	in	_	0	SENT_36	[p3l1835t2876r1914b2940],
20	those	DT	O	those	det	21	SENT_36	[p3l1943t2872r2151b2941],
21	studies	NNS	O	study	prep_in	12	SENT_36	[p3l11t2973r310b3052],
22	,	,	O	,	_	0	SENT_36	[p3l11t2973r310b3052],
23	one	CD	NUMBER	one	nsubj	28	SENT_36	[p3l361t2997r500b3041],
24	of	IN	O	of	_	0	SENT_36	[p3l548t2974r628b3041],
25	the	DT	O	the	det	26	SENT_36	[p3l665t2973r787b3041],
26	studies	NNS	O	study	prep_of	23	SENT_36	[p3l836t2973r1169b3041],
27	“	RB	O	“	advmod	28	SENT_36	[p3l836t2973r1169b3041],
28	found	VBD	O	find	_	0	SENT_36	[p3l1218t2973r1451b3041],
29	lower	JJR	O	lower	amod	31	SENT_36	[p3l1497t2974r1721b3041],
30	stavudine	NN	O	stavudine	nn	31	SENT_36	[p3l1768t2974r2151b3041],
31	concentrations	NNS	O	concentration	dobj	28	SENT_36	[p3l11t3079r613b3154],
32	,	,	O	,	_	0	SENT_36	[p3l11t3079r613b3154],
33	and	CC	O	and	_	0	SENT_36	[p3l668t3075r814b3143],
34	the	DT	O	the	det	37	SENT_36	[p3l863t3075r984b3143],
35	other	JJ	O	other	amod	37	SENT_36	[p3l1038t3075r1241b3143],
36	study	NN	O	study	nn	37	SENT_36	[p3l1292t3075r1564b3165],
37	”	NN	O	”	nsubj	38	SENT_36	[p3l1292t3075r1564b3165],
38	found	VBD	O	find	conj_and	28	SENT_36	[p3l1617t3075r1850b3143],
39	higher	JJR	O	higher	amod	42	SENT_36	[p3l1900t3075r2153b3165],
40	stavudine	NN	O	stavudine	nn	42	SENT_36	[p3l11t3178r395b3246],
41	peak	NN	O	peak	nn	42	SENT_36	[p3l437t3178r624b3268],
42	concentrations	NNS	O	concentration	dobj	38	SENT_36	[p3l664t3182r1243b3246],
43	for	IN	O	for	_	0	SENT_36	[p3l1287t3178r1394b3246],
44	generic	JJ	O	generic	prep_for	42	SENT_36	[p3l1433t3182r1716b3267],
45	compared	VBN	O	compare	_	0	SENT_36	[p3l1761t3178r2153b3268],
46	with	IN	O	with	prepc_compared_with	38	SENT_36	[p3l9t3280r191b3348],
47	nongeneric	JJ	O	nongeneric	amod	48	SENT_36	[p3l218t3283r657b3369],
48	formulations	NNS	O	formulation	pobj	38	SENT_36	[p3l688t3280r1212b3348],
49	.	.	O	.	_	0	SENT_36	[p3l688t3280r1212b3348],

1	In	IN	O	in	_	0	SENT_37	[p3l117t3387r198b3450],
2	HIV-infected	JJ	MISC	hiv-infected	amod	3	SENT_37	[p3l243t3383r769b3451],
3	patients	NNS	O	patient	prep_in	60	SENT_37	[p3l815t3386r1142b3472],
4	with	IN	O	with	_	0	SENT_37	[p3l1189t3383r1377b3451],
5	tuberculosis	NN	O	tuberculosis	nn	9	SENT_37	[p3l1422t3383r1928b3451],
6	(	CD	NUMBER	(	num	9	SENT_37	[p3l1980t3383r2148b3463],
7	TB	NN	O	tb	nn	9	SENT_37	[p3l1980t3383r2148b3463],
8	)	NN	O	)	nn	9	SENT_37	[p3l1980t3383r2148b3463],
9	coinfection	NN	O	coinfection	prep_with	3	SENT_37	[p3l11t3486r477b3554],
10	who	WP	O	who	nsubj	11	SENT_37	[p3l520t3485r695b3554],
11	require	VBP	O	require	rcmod	3	SENT_37	[p3l741t3489r1035b3575],
12	rifampin-containing	JJ	O	rifampin-containing	amod	13	SENT_37	[p3l1080t3486r1918b3575],
13	therapy	NN	O	therapy	dobj	11	SENT_37	[p3l1962t3485r2151b3554, p3l11t3612r172b3677],
14	,	,	O	,	_	0	SENT_37	[p3l1962t3485r2151b3554, p3l11t3612r172b3677],
15	the	DT	O	the	det	19	SENT_37	[p3l211t3587r337b3656],
16	World	NNP	ORGANIZATION	World	nn	19	SENT_37	[p3l373t3587r627b3656],
17	Health	NNP	ORGANIZATION	Health	nn	19	SENT_37	[p3l663t3588r937b3656],
18	Organization	NNP	ORGANIZATION	Organization	nn	19	SENT_37	[p3l974t3591r1510b3677],
19	(	NNP	O	(	appos	13	SENT_37	[p3l1550t3588r1829b3668],
20	WHO	WP	O	who	nsubj	22	SENT_37	[p3l1550t3588r1829b3668],
21	)	RB	O	)	advmod	22	SENT_37	[p3l1550t3588r1829b3668],
22	recommends	VBZ	O	recommend	rcmod	19	SENT_37	[p3l1868t3612r2151b3656, p3l9t3689r280b3758],
23	efavirenz	NN	O	efavirenz	dobj	22	SENT_37	[p3l360t3689r738b3758],
24	with	IN	O	with	_	0	SENT_37	[p3l814t3689r995b3758],
25	lamivudine/zidovudine	NN	O	lamivudine/zidovudine	prep_with	23	SENT_37	[p3l1066t3689r2002b3758],
26	or	CC	O	or	_	0	SENT_37	[p3l2076t3714r2153b3758],
27	lamivudine/stavudine	NN	O	lamivudine/stavudine	prep_with	23	SENT_37	[p4l10t24r890b92],
28	as	IN	O	as	_	0	SENT_37	[p4l930t48r1007b92],
29	the	DT	O	the	det	33	SENT_37	[p4l1046t24r1172b92],
30	first-line	JJ	O	first-line	amod	33	SENT_37	[p4l1211t24r1565b92],
31	antiretroviral	JJ	O	antiretroviral	amod	33	SENT_37	[p4l1605t24r2152b92],
32	regimen	NN	O	regimen	nn	33	SENT_37	[p4l8t125r398b215],
33	.3	NN	NUMBER	.3	prep_as	22	SENT_37	[p4l8t125r398b215],
34	Although	IN	O	although	mark	41	SENT_37	[p4l453t126r844b215],
35	the	DT	O	the	det	36	SENT_37	[p4l898t126r1024b194],
36	pharmacokinetics	NNS	O	pharmacokinetic	nsubjpass	41	SENT_37	[p4l1080t126r1817b215],
37	of	IN	O	of	_	0	SENT_37	[p4l1876t126r1958b194],
38	efavirenz	NN	O	efavirenz	prep_of	36	SENT_37	[p4l2007t126r2151b194, p4l8t233r267b298],
39	have	VBP	O	have	aux	41	SENT_37	[p4l293t230r484b298],
40	been	VBN	O	be	auxpass	41	SENT_37	[p4l508t230r704b298],
41	studied	VBN	O	study	advcl	60	SENT_37	[p4l730t230r1038b298],
42	in	IN	O	in	_	0	SENT_37	[p4l1064t233r1144b297],
43	this	DT	O	this	det	44	SENT_37	[p4l1169t230r1319b298],
44	population	NN	O	population	prep_in	41	SENT_37	[p4l1347t230r1803b319],
45	because	IN	O	because	_	0	SENT_37	[p4l1825t230r2151b298],
46	of	IN	O	of	_	0	SENT_37	[p4l12t332r93b400],
47	the	DT	O	the	det	48	SENT_37	[p4l122t331r248b400],
48	concern	NN	O	concern	prep_of	53	SENT_37	[p4l287t356r615b400],
49	of	IN	O	of	_	0	SENT_37	[p4l653t332r735b400],
50	drug-drug	JJ	O	drug-drug	amod	51	SENT_37	[p4l767t331r1174b421],
51	interactions	NNS	O	interaction	prep_of	48	SENT_37	[p4l1211t331r1866b410],
52	,13	CD	NUMBER	,13	number	53	SENT_37	[p4l1211t331r1866b410],
53	’“	CD	NUMBER	’“	nn	54	SENT_37	[p4l1211t331r1866b410],
54	‘	NN	O	‘	prep_because	41	SENT_37	[p4l1211t331r1866b410],
55	to	TO	O	to	_	0	SENT_37	[p4l1902t342r1977b400],
56	our	PRP$	O	we	poss	57	SENT_37	[p4l2018t356r2153b400],
57	knowledge	NN	O	knowledge	prep_to	54	SENT_37	[p4l9t433r482b523],
58	,	,	O	,	_	0	SENT_37	[p4l9t433r482b523],
59	there	EX	O	there	expl	60	SENT_37	[p4l527t433r734b502],
60	are	VBP	O	be	_	0	SENT_37	[p4l779t458r898b502],
61	no	DT	O	no	det	63	SENT_37	[p4l941t458r1041b502],
62	pharmacokinetic	JJ	O	pharmacokinetic	amod	63	SENT_37	[p4l1085t433r1782b523],
63	data	NNS	O	datum	nsubj	60	SENT_37	[p4l1829t433r2000b502],
64	for	IN	O	for	_	0	SENT_37	[p4l2041t434r2153b502],
65	the	DT	O	the	det	68	SENT_37	[p4l9t535r135b603],
66	generic	JJ	O	generic	amod	68	SENT_37	[p4l161t539r459b625],
67	NRTI	NN	ORGANIZATION	nrtus	nn	68	SENT_37	[p4l486t540r704b603],
68	components	NNS	O	component	prep_for	63	SENT_37	[p4l731t546r1233b625],
69	in	IN	O	in	_	0	SENT_37	[p4l1261t539r1342b603],
70	HIV/TB-coinfected	JJ	O	hiv/tb-coinfected	amod	71	SENT_37	[p4l1367t535r2152b603],
71	individuals	NNS	O	individual	prep_in	68	SENT_37	[p4l10t637r484b705],
72	on	IN	O	on	_	0	SENT_37	[p4l547t661r646b705],
73	TB	NN	O	tb	nn	74	SENT_37	[p4l705t642r816b705],
74	therapy	NN	O	therapy	prep_on	71	SENT_37	[p4l878t637r1206b727],
75	.	.	O	.	_	0	SENT_37	[p4l878t637r1206b727],

1	Apart	RB	O	apart	_	0	SENT_38	[p4l1270t642r1505b727],
2	from	IN	O	from	_	0	SENT_38	[p4l1563t637r1755b705],
3	possible	JJ	O	possible	amod	4	SENT_38	[p4l1813t637r2151b727],
4	impairment	NN	O	impairment	prep_apart_from	23	SENT_38	[p4l10t742r497b828],
5	of	IN	O	of	_	0	SENT_38	[p4l542t739r623b807],
6	drug	NN	O	drug	nn	7	SENT_38	[p4l664t739r848b828],
7	absorption	NN	O	absorption	prep_of	4	SENT_38	[p4l894t739r1334b828],
8	resulting	VBG	O	result	partmod	7	SENT_38	[p4l1378t739r1744b828],
9	from	IN	O	from	_	0	SENT_38	[p4l1790t739r1981b807],
10	the	DT	O	the	det	11	SENT_38	[p4l2025t739r2151b807],
11	effects	NNS	O	effect	prep_from	8	SENT_38	[p4l11t841r271b908],
12	of	IN	O	of	_	0	SENT_38	[p4l297t841r378b908],
13	advanced	JJ	O	advanced	amod	15	SENT_38	[p4l393t841r787b908],
14	HIV	NN	MISC	hiv	nn	15	SENT_38	[p4l807t845r970b908],
15	disease	NN	O	disease	prep_of	11	SENT_38	[p4l992t841r1287b908],
16	and	CC	O	and	_	0	SENT_38	[p4l1311t841r1461b908],
17	TB	NN	O	tb	nn	18	SENT_38	[p4l1482t845r1594b908],
18	infection	NN	O	infection	prep_of	11	SENT_38	[p4l1619t840r2152b919],
19	,15	CD	NUMBER	,15	number	20	SENT_38	[p4l1619t840r2152b919],
20	’16	CD	NUMBER	’16	dep	15	SENT_38	[p4l1619t840r2152b919],
21	coadministered	VBN	O	coadminister	partmod	15	SENT_38	[p4l11t943r610b1011],
22	rifampin	NN	O	rifampin	dobj	21	SENT_38	[p4l633t943r970b1032],
23	has	VBZ	O	have	_	0	SENT_38	[p4l993t943r1120b1011],
24	the	DT	O	the	det	25	SENT_38	[p4l1146t943r1264b1011],
25	propensity	NN	O	propensity	dobj	23	SENT_38	[p4l1290t946r1706b1032],
26	to	TO	O	to	aux	27	SENT_38	[p4l1729t953r1799b1011],
27	enhance	VB	O	enhance	infmod	25	SENT_38	[p4l1827t943r2151b1011],
28	drug	NN	O	drug	nn	29	SENT_38	[p4l13t1044r206b1134],
29	clearance	NN	O	clearance	dobj	27	SENT_38	[p4l268t1044r675b1113],
30	through	IN	O	through	_	0	SENT_38	[p4l735t1044r1077b1134],
31	mechanisms	NNS	O	mechanism	prep_through	27	SENT_38	[p4l1135t1044r1675b1113],
32	involving	VBG	O	involve	_	0	SENT_38	[p4l1738t1044r2152b1134],
33	cytochrome	NN	O	cytochrome	nn	34	SENT_38	[p4l11t1146r503b1236],
34	P450	NN	O	p450	prep_involving	31	SENT_38	[p4l584t1151r809b1225],
35	,	,	O	,	_	0	SENT_38	[p4l584t1151r809b1225],
36	uridine	NN	O	uridine	nn	37	SENT_38	[p4l892t1146r1196b1214],
37	diphosphate	NN	O	diphosphate	appos	34	SENT_38	[p4l1280t1146r1792b1236],
38	(	CD	NUMBER	(	num	41	SENT_38	[p4l1879t1146r2151b1227, p4l9t1248r953b1337],
39	UDP	NN	ORGANIZATION	udp	nn	41	SENT_38	[p4l1879t1146r2151b1227, p4l9t1248r953b1337],
40	)	NN	O	)	nn	41	SENT_38	[p4l1879t1146r2151b1227, p4l9t1248r953b1337],
41	glucuronosyltransferase	NN	O	glucuronosyltransferase	dep	37	SENT_38	[p4l1879t1146r2151b1227, p4l9t1248r953b1337],
42	(	CD	NUMBER	(	num	43	SENT_38	[p4l987t1248r1244b1329],
43	UGT	NNP	ORGANIZATION	UGT	nsubj	23	SENT_38	[p4l987t1248r1244b1329],
44	)	CD	NUMBER	)	num	43	SENT_38	[p4l987t1248r1244b1329],
45	,	,	O	,	_	0	SENT_38	[p4l987t1248r1244b1329],
46	and	CC	O	and	_	0	SENT_38	[p4l1277t1248r1420b1316],
47	drug	NN	O	drug	nn	48	SENT_38	[p4l1452t1248r1626b1337],
48	transporters	NNS	O	transporter	conj_and	43	SENT_38	[p4l1655t1258r2149b1338],
49	,	,	O	,	_	0	SENT_38	[p4l1655t1258r2149b1338],
50	which	WDT	O	which	nsubj	52	SENT_38	[p4l9t1350r268b1418],
51	may	MD	O	may	aux	52	SENT_38	[p4l299t1374r471b1439],
52	result	VB	O	result	rcmod	43	SENT_38	[p4l502t1350r737b1418],
53	in	IN	O	in	_	0	SENT_38	[p4l769t1353r850b1417],
54	detrimental	JJ	O	detrimental	amod	56	SENT_38	[p4l884t1350r1362b1418],
55	drug-drug	JJ	O	drug-drug	amod	56	SENT_38	[p4l1398t1350r1805b1439],
56	interactions	NNS	O	interaction	prep_in	52	SENT_38	[p4l1838t1353r2151b1418, p4l9t1453r299b1521],
57	.	.	O	.	_	0	SENT_38	[p4l1838t1353r2151b1418, p4l9t1453r299b1521],

1	”	NN	O	”	nn	3	SENT_39	[p4l1838t1353r2151b1418, p4l9t1453r299b1521],
2	Rifampin	NN	O	rifampin	nn	3	SENT_39	[p4l339t1453r724b1542],
3	coadministration	NN	O	coadministration	nsubjpass	6	SENT_39	[p4l766t1453r1475b1521],
4	was	VBD	O	be	auxpass	6	SENT_39	[p4l1513t1477r1669b1521],
5	previously	RB	DATE	previously	advmod	6	SENT_39	[p4l1712t1453r2153b1542],
6	associated	VBN	O	associate	_	0	SENT_39	[p4l11t1554r436b1623],
7	with	IN	O	with	_	0	SENT_39	[p4l474t1554r663b1623],
8	an	DT	O	a	det	15	SENT_39	[p4l703t1579r798b1623],
9	average	JJ	O	average	amod	15	SENT_39	[p4l838t1579r1144b1644],
10	47	CD	PERCENT	47	number	14	SENT_39	[p4l1185t1554r1363b1628],
11	%	NN	PERCENT	%	dep	14	SENT_39	[p4l1185t1554r1363b1628],
12	to	TO	O	to	dep	14	SENT_39	[p4l1410t1565r1485b1623],
13	50	CD	PERCENT	50	number	14	SENT_39	[p4l1530t1554r1704b1628],
14	%	NN	PERCENT	%	num	15	SENT_39	[p4l1530t1554r1704b1628],
15	reduction	NN	O	reduction	prep_with	6	SENT_39	[p4l1751t1554r2153b1623],
16	in	IN	O	in	_	0	SENT_39	[p4l10t1660r91b1724],
17	zidovudine	NN	O	zidovudine	nn	18	SENT_39	[p4l133t1656r602b1725],
18	area	NN	O	area	prep_in	15	SENT_39	[p4l646t1680r813b1725],
19	under	IN	O	under	_	0	SENT_39	[p4l853t1656r1098b1725],
20	the	DT	O	the	det	21	SENT_39	[p4l1138t1656r1264b1725],
21	curve	NN	O	curve	prep_under	6	SENT_39	[p4l1308t1681r1533b1725],
22	in	IN	O	in	_	0	SENT_39	[p4l1577t1660r1658b1724],
23	asymptomatic	JJ	O	asymptomatic	amod	25	SENT_39	[p4l1701t1667r2151b1746, p4l11t1762r152b1826],
24	HIV-infected	JJ	MISC	hiv-infected	amod	25	SENT_39	[p4l212t1758r729b1826],
25	patients	NNS	O	patient	prep_in	21	SENT_39	[p4l787t1758r1209b1848],
26	.	.	O	.	_	0	SENT_39	[p4l787t1758r1209b1848],

1	“	NN	O	“	nsubjpass	18	SENT_40	[p4l787t1758r1209b1848],
2	Significant	JJ	O	significant	amod	5	SENT_40	[p4l1271t1758r1712b1848],
3	rifampininduced	JJ	O	rifampininduced	amod	5	SENT_40	[p4l1768t1758r2151b1848, p4l10t1860r343b1928],
4	drug-drug	NN	O	drug-drug	nn	5	SENT_40	[p4l408t1860r808b1949],
5	interactions	NNS	O	interaction	nsubjpass	8	SENT_40	[p4l871t1864r1351b1928],
6	are	VBP	O	be	auxpass	8	SENT_40	[p4l1416t1884r1534b1928],
7	not	RB	O	not	neg	8	SENT_40	[p4l1597t1870r1728b1928],
8	expected	VBN	O	expect	rcmod	1	SENT_40	[p4l1791t1860r2152b1950],
9	with	IN	O	with	_	0	SENT_40	[p4l9t1962r195b2030],
10	the	DT	O	the	det	12	SENT_40	[p4l299t1962r423b2030],
11	other	JJ	O	other	amod	12	SENT_40	[p4l531t1962r739b2030],
12	NRTIS	NN	O	nrti	prep_with	8	SENT_40	[p4l843t1966r1096b2030],
13	as	IN	O	as	_	0	SENT_40	[p4l1204t1986r1281b2030],
14	these	DT	O	these	det	15	SENT_40	[p4l1387t1962r1596b2030],
15	drugs	NNS	O	drug	prep_as	12	SENT_40	[p4l1706t1962r1925b2051],
16	are	VBP	O	be	auxpass	18	SENT_40	[p4l2034t1986r2151b2030],
17	not	RB	O	not	neg	18	SENT_40	[p4l9t2075r139b2133],
18	metabolized	VBN	O	metabolize	_	0	SENT_40	[p4l163t2065r658b2133],
19	by	IN	O	by	_	0	SENT_40	[p4l680t2065r779b2154],
20	hepatic	JJ	O	hepatic	amod	22	SENT_40	[p4l803t2065r1098b2154],
21	CYP	NN	O	cyp	nn	22	SENT_40	[p4l1127t2068r1298b2133],
22	enzymes	NNS	O	enzyme	agent	18	SENT_40	[p4l1327t2089r1674b2154],
23	and	CC	O	and	_	0	SENT_40	[p4l1704t2065r1852b2133],
24	are	VBP	O	be	auxpass	26	SENT_40	[p4l1878t2089r1995b2133],
25	not	RB	O	not	neg	26	SENT_40	[p4l2022t2075r2153b2133],
26	considered	VBN	O	consider	conj_and	18	SENT_40	[p4l11t2166r466b2235],
27	substrates	NNS	O	substrate	dobj	26	SENT_40	[p4l538t2166r945b2235],
28	of	IN	O	of	_	0	SENT_40	[p4l1020t2167r1101b2235],
29	the	DT	O	the	det	32	SENT_40	[p4l1163t2166r1290b2235],
30	rifampin-inducible	JJ	O	rifampin-inducible	amod	32	SENT_40	[p4l1360t2166r2151b2256],
31	P-glycoprotein	NN	O	p-glycoprotein	nn	32	SENT_40	[p4l9t2268r619b2358],
32	transporter	NN	O	transporter	prep_of	27	SENT_40	[p4l669t2279r1142b2358],
33	.	.	O	.	_	0	SENT_40	[p4l669t2279r1142b2358],

1	Zidovudine	NN	O	zidovudine	nsubjpass	5	SENT_41	[p4l1200t2268r1684b2337],
2	and	CC	O	and	_	0	SENT_41	[p4l1738t2268r1888b2337],
3	lamivudine	NN	O	lamivudine	nsubjpass	5	SENT_41	[p4l1940t2268r2151b2337, p4l8t2370r297b2439],
4	are	VBP	O	be	auxpass	5	SENT_41	[p4l348t2395r468b2439],
5	known	VBN	O	know	_	0	SENT_41	[p4l518t2370r801b2439],
6	to	TO	O	to	aux	8	SENT_41	[p4l849t2381r924b2439],
7	be	VB	O	be	cop	8	SENT_41	[p4l973t2370r1065b2439],
8	substrates	NNS	O	substrate	xcomp	5	SENT_41	[p4l1118t2370r1525b2439],
9	for	IN	O	for	_	0	SENT_41	[p4l1577t2370r1689b2439],
10	the	DT	O	the	det	15	SENT_41	[p4l1737t2370r1863b2439],
11	efﬂux	NN	O	efﬂux	nn	15	SENT_41	[p4l1915t2370r2153b2439],
12	transporter	NN	O	transporter	nn	15	SENT_41	[p4l9t2483r468b2563],
13	multidrug	JJ	O	multidrug	amod	15	SENT_41	[p4l502t2473r918b2562],
14	resistance	NN	O	resistance	nn	15	SENT_41	[p4l953t2477r1364b2541],
15	protein	NN	O	protein	prep_for	8	SENT_41	[p4l1401t2477r1701b2563],
16	4	CD	NUMBER	4	number	17	SENT_41	[p4l1737t2484r1780b2541],
17	(	CD	NUMBER	(	num	19	SENT_41	[p4l1823t2473r2149b2554],
18	MRP4	NN	O	mrp4	nn	19	SENT_41	[p4l1823t2473r2149b2554],
19	)	NN	O	)	dep	15	SENT_41	[p4l1823t2473r2149b2554],
20	,	,	O	,	_	0	SENT_41	[p4l1823t2473r2149b2554],
21	and	CC	O	and	_	0	SENT_41	[p4l11t2575r161b2643],
22	overexpression	NN	O	overexpression	nsubjpass	27	SENT_41	[p4l194t2578r821b2664],
23	of	IN	O	of	_	0	SENT_41	[p4l854t2575r935b2643],
24	this	DT	O	this	det	25	SENT_41	[p4l958t2575r1109b2643],
25	transporter	NN	O	transporter	prep_of	22	SENT_41	[p4l1141t2585r1599b2664],
26	is	VBZ	O	be	auxpass	27	SENT_41	[p4l1630t2578r1694b2643],
27	associated	VBN	O	associate	conj_and	5	SENT_41	[p4l1728t2575r2153b2643],
28	with	IN	O	with	_	0	SENT_41	[p4l9t2678r197b2746],
29	impaired	JJ	O	impaired	amod	30	SENT_41	[p4l257t2678r631b2767],
30	intracellular	JJ	O	intracellular	amod	31	SENT_41	[p4l692t2678r1205b2746],
31	accumulation	NN	O	accumulation	prep_with	27	SENT_41	[p4l1265t2678r1831b2746],
32	of	IN	O	of	_	0	SENT_41	[p4l1892t2678r1974b2746],
33	the	DT	O	the	det	34	SENT_41	[p4l2025t2678r2151b2746],
34	monophosphates	NNS	O	monophosphate	prep_of	31	SENT_41	[p4l9t2779r804b2869],
35	.	.	O	.	_	0	SENT_41	[p4l9t2779r804b2869],

1	”	NN	O	”	npadvmod	4	SENT_42	[p4l9t2779r804b2869],
2	However	RB	O	however	advmod	1	SENT_42	[p4l856t2784r1243b2858],
3	,	,	O	,	_	0	SENT_42	[p4l856t2784r1243b2858],
4	in	IN	O	in	_	0	SENT_42	[p4l1299t2783r1380b2847],
5	one	CD	NUMBER	one	num	7	SENT_42	[p4l1434t2804r1577b2848],
6	small	JJ	O	small	amod	7	SENT_42	[p4l1632t2779r1853b2848],
7	study	NN	O	study	pobj	4	SENT_42	[p4l1907t2779r2149b2869],
8	,	,	O	,	_	0	SENT_42	[p4l1907t2779r2149b2869],

1	1080	CD	DATE	1080	dep	13	SENT_43	[p4l13t3030r204b3097],
2	-	:	O	-	_	0	SENT_43	[p4l267t3056r296b3086],
3	]	CD	NUMBER	]	num	5	SENT_43	[p4l358t3034r569b3111],
4	Clin	NNP	O	Clin	nn	5	SENT_43	[p4l358t3034r569b3111],
5	Pharmacol	NNP	O	Pharmacol	nsubj	13	SENT_43	[p4l595t3034r999b3096],
6	2009	CD	DATE	2009	num	5	SENT_43	[p4l1029t3043r1721b3107],
7	;	:	O	;	_	0	SENT_43	[p4l1029t3043r1721b3107],
8	419:1079	CD	DURATION	419:1079	num	10	SENT_43	[p4l1029t3043r1721b3107],
9	-1090	CD	DURATION	-1090	num	10	SENT_43	[p4l1029t3043r1721b3107],
10	rifampin	NN	O	rifampin	dep	5	SENT_43	[p4l6t3130r367b3220],
11	did	VBD	O	do	aux	13	SENT_43	[p4l424t3130r558b3198],
12	not	RB	O	not	neg	13	SENT_43	[p4l612t3140r746b3198],
13	appear	VB	O	appear	_	0	SENT_43	[p4l800t3154r1078b3220],
14	to	TO	O	to	aux	15	SENT_43	[p4l1131t3141r1206b3198],
15	have	VB	O	have	xcomp	13	SENT_43	[p4l1262t3130r1453b3198],
16	any	DT	O	any	det	18	SENT_43	[p4l1511t3154r1657b3220],
17	significant	JJ	O	significant	amod	18	SENT_43	[p4l1713t3130r2148b3220],
18	effect	NN	O	effect	dobj	15	SENT_43	[p4l9t3232r232b3300],
19	on	IN	O	on	_	0	SENT_43	[p4l266t3256r365b3300],
20	the	DT	O	the	det	21	SENT_43	[p4l398t3232r524b3300],
21	expression	NN	O	expression	prep_on	18	SENT_43	[p4l560t3236r1004b3322],
22	of	IN	O	of	_	0	SENT_43	[p4l1039t3232r1121b3300],
23	MRP4	NN	O	mrp4	prep_of	21	SENT_43	[p4l1146t3232r1479b3300],
24	.	.	O	.	_	0	SENT_43	[p4l1146t3232r1479b3300],

1	”	NN	O	”	_	0	SENT_44	[p4l1146t3232r1479b3300],

1	Zidovudine	NN	O	zidovudine	nsubjpass	8	SENT_45	[p4l115t3334r590b3402],
2	undergoes	VBZ	O	undergo	ccomp	38	SENT_45	[p4l619t3334r1035b3423],
3	extensive	JJ	O	extensive	amod	5	SENT_45	[p4l1068t3337r1448b3402],
4	first-pass	JJ	O	first-pass	amod	5	SENT_45	[p4l1478t3334r1842b3423],
5	extraction	NN	O	extraction	dobj	2	SENT_45	[p4l1875t3344r2146b3402, p4l7t3440r167b3505],
6	and	CC	O	and	_	0	SENT_45	[p4l223t3437r372b3505],
7	is	VBZ	O	be	auxpass	8	SENT_45	[p4l427t3440r489b3505],
8	eliminated	VBN	O	eliminate	conj_and	2	SENT_45	[p4l548t3437r984b3505],
9	primarily	RB	O	primarily	advmod	8	SENT_45	[p4l1038t3437r1421b3526],
10	through	IN	O	through	_	0	SENT_45	[p4l1474t3437r1794b3526],
11	hepatic	JJ	O	hepatic	amod	12	SENT_45	[p4l1847t3437r2145b3526],
12	glucuronidation	NN	O	glucuronidation	prep_through	8	SENT_45	[p4l7t3538r663b3628],
13	by	IN	O	by	_	0	SENT_45	[p4l704t3538r803b3628],
14	UGT2B7	NN	O	ugt2b7	nn	15	SENT_45	[p4l846t3538r1278b3607],
15	.2	NN	NUMBER	.2	agent	8	SENT_45	[p4l846t3538r1278b3607],
16	°	CD	NUMBER	°	num	15	SENT_45	[p4l846t3538r1278b3607],
17	The	DT	O	the	det	20	SENT_45	[p4l1323t3538r1476b3607],
18	large	JJ	O	large	amod	20	SENT_45	[p4l1522t3538r1714b3628],
19	interindividual	JJ	O	interindividual	amod	20	SENT_45	[p4l1760t3538r2146b3607, p4l6t3639r266b3707],
20	variation	NN	O	variation	dobj	2	SENT_45	[p4l307t3643r672b3707],
21	in	IN	O	in	_	0	SENT_45	[p4l715t3643r795b3706],
22	zidovudine	NN	O	zidovudine	nn	23	SENT_45	[p4l838t3639r1298b3707],
23	kinetics	NNS	O	kinetics	prep_in	20	SENT_45	[p4l1341t3639r1681b3718],
24	,	,	O	,	_	0	SENT_45	[p4l1341t3639r1681b3718],
25	as	RB	O	as	_	0	SENT_45	[p4l1728t3663r1805b3707],
26	well	RB	O	well	_	0	SENT_45	[p4l1849t3640r2023b3707],
27	as	IN	O	as	_	0	SENT_45	[p4l2068t3663r2145b3707],
28	the	DT	O	the	det	29	SENT_45	[p5l7t18r131b86],
29	variability	NN	O	variability	dobj	2	SENT_45	[p5l157t18r576b108],
30	in	IN	O	in	_	0	SENT_45	[p5l603t22r683b86],
31	the	DT	O	the	det	32	SENT_45	[p5l708t18r832b86],
32	ability	NN	O	ability	prep_in	29	SENT_45	[p5l861t18r1119b108],
33	to	TO	O	to	_	0	SENT_45	[p5l1143t28r1217b86],
34	glucuronidate	NN	O	glucuronidate	nn	35	SENT_45	[p5l1245t18r1811b108],
35	zidovudine	NN	O	zidovudine	prep_to	32	SENT_45	[p5l1839t18r2145b86, p5l10t120r208b199],
36	,	,	O	,	_	0	SENT_45	[p5l1839t18r2145b86, p5l10t120r208b199],
37	would	MD	O	would	aux	38	SENT_45	[p5l255t120r515b188],
38	indicate	VB	O	indicate	_	0	SENT_45	[p5l560t120r886b188],
39	that	IN	O	that	complm	44	SENT_45	[p5l932t120r1088b188],
40	there	EX	O	there	expl	44	SENT_45	[p5l1131t120r1334b188],
41	may	MD	O	may	aux	44	SENT_45	[p5l1380t144r1551b209],
42	be	VB	O	be	cop	44	SENT_45	[p5l1592t120r1684b188],
43	functional	JJ	O	functional	amod	44	SENT_45	[p5l1730t120r2147b188],
44	polymorphisms	NNS	O	polymorphism	ccomp	38	SENT_45	[p5l8t222r646b311],
45	of	IN	O	of	_	0	SENT_45	[p5l698t222r779b290],
46	UGTZB7	NN	O	ugtzb7	prep_of	44	SENT_45	[p5l819t225r1165b290],
47	that	WDT	O	that	nsubj	48	SENT_45	[p5l1215t222r1371b290],
48	affect	VBP	O	affect	rcmod	44	SENT_45	[p5l1419t222r1638b290],
49	zidovudine	NN	O	zidovudine	nn	50	SENT_45	[p5l1685t222r2146b290],
50	disposition	NN	O	disposition	dobj	48	SENT_45	[p5l10t324r621b414],
51	.21	CD	NUMBER	.21	number	52	SENT_45	[p5l10t324r621b414],
52	’22	CD	NUMBER	’22	nsubj	38	SENT_45	[p5l10t324r621b414],
53	Although	IN	O	although	mark	62	SENT_45	[p5l657t325r1041b414],
54	several	JJ	O	several	amod	55	SENT_45	[p5l1077t325r1357b393],
55	polymorphisms	NNS	O	polymorphism	nsubjpass	62	SENT_45	[p5l1392t325r2031b414],
56	in	IN	O	in	_	0	SENT_45	[p5l2068t328r2148b392],
57	the	DT	O	the	det	59	SENT_45	[p5l7t426r131b495],
58	UGTZB7	NN	O	ugtzb7	nn	59	SENT_45	[p5l189t430r530b495],
59	gene	NN	O	gene	prep_in	55	SENT_45	[p5l571t450r754b516],
60	have	VBP	O	have	aux	62	SENT_45	[p5l801t426r990b495],
61	been	VBN	O	be	auxpass	62	SENT_45	[p5l1035t426r1227b495],
62	identified	VBN	O	identify	advcl	88	SENT_45	[p5l1274t426r1671b495],
63	that	WDT	O	that	nsubj	66	SENT_45	[p5l1716t426r1873b495],
64	could	MD	O	could	aux	66	SENT_45	[p5l1920t426r2147b495],
65	potentially	RB	O	potentially	advmod	66	SENT_45	[p5l8t528r450b618],
66	affect	VB	O	affect	ccomp	62	SENT_45	[p5l495t529r714b597],
67	zidovudine	NN	O	zidovudine	nn	68	SENT_45	[p5l757t528r1217b597],
68	pharmacol	NN	O	pharmacol	dobj	66	SENT_45	[p5l1263t528r2147b618],
69	<	JJR	O	<	dep	68	SENT_45	[p5l1263t528r2147b618],
70	inetics	CD	NUMBER	inetics	number	71	SENT_45	[p5l1263t528r2147b618],
71	,23	CD	NUMBER	,23	num	72	SENT_45	[p5l1263t528r2147b618],
72	’	NN	O	’	dep	69	SENT_45	[p5l1263t528r2147b618],
73	2	CD	NUMBER	2	number	74	SENT_45	[p5l1263t528r2147b618],
74	‘	CD	NUMBER	‘	num	75	SENT_45	[p5l1263t528r2147b618],
75	*	NN	O	*	npadvmod	76	SENT_45	[p5l1263t528r2147b618],
76	as	IN	O	as	advmod	81	SENT_45	[p5l9t654r85b698],
77	far	RB	O	far	advmod	76	SENT_45	[p5l122t630r226b698],
78	as	IN	O	as	dep	81	SENT_45	[p5l260t654r336b698],
79	we	PRP	O	we	nsubj	81	SENT_45	[p5l371t654r485b698],
80	are	VBP	O	be	cop	81	SENT_45	[p5l521t654r638b698],
81	aware	JJ	O	aware	dep	66	SENT_45	[p5l674t654r933b709],
82	,	,	O	,	_	0	SENT_45	[p5l674t654r933b709],
83	this	DT	O	this	det	84	SENT_45	[p5l969t630r1117b698],
84	hypothesis	NN	O	hypothesis	nsubjpass	88	SENT_45	[p5l1152t630r1592b720],
85	has	VBZ	O	have	aux	88	SENT_45	[p5l1627t630r1760b698],
86	not	RB	O	not	neg	88	SENT_45	[p5l1795t640r1926b698],
87	been	VBN	O	be	auxpass	88	SENT_45	[p5l1955t630r2148b698],
88	evaluated	VBN	O	evaluate	rcmod	52	SENT_45	[p5l9t732r400b800],
89	yet	RB	O	yet	advmod	88	SENT_45	[p5l430t742r571b821],
90	.	.	O	.	_	0	SENT_45	[p5l430t742r571b821],

1	In	IN	O	in	_	0	SENT_46	[p5l114t838r195b901],
2	this	DT	O	this	det	3	SENT_46	[p5l230t834r377b902],
3	study	NN	O	study	prep_in	6	SENT_46	[p5l417t834r654b923],
4	,	,	O	,	_	0	SENT_46	[p5l417t834r654b923],
5	we	PRP	O	we	nsubj	6	SENT_46	[p5l692t858r807b902],
6	determined	VBD	O	determine	_	0	SENT_46	[p5l846t834r1311b902],
7	the	DT	O	the	det	8	SENT_46	[p5l1345t834r1469b902],
8	pharmacol	NN	O	pharmacol	nsubj	10	SENT_46	[p5l1506t834r2146b923, p5l8t940r115b1004],
9	<	JJR	O	<	amod	10	SENT_46	[p5l1506t834r2146b923, p5l8t940r115b1004],
10	inetics	NNS	O	inetic	xcomp	6	SENT_46	[p5l1506t834r2146b923, p5l8t940r115b1004],
11	of	IN	O	of	_	0	SENT_46	[p5l163t937r244b1004],
12	lamivudine	NN	O	lamivudine	prep_of	10	SENT_46	[p5l281t937r769b1015],
13	,	,	O	,	_	0	SENT_46	[p5l281t937r769b1015],
14	zidovudine	NN	O	zidovudine	conj_and	12	SENT_46	[p5l817t937r1300b1015],
15	,	,	O	,	_	0	SENT_46	[p5l817t937r1300b1015],
16	and	CC	O	and	_	0	SENT_46	[p5l1349t937r1497b1004],
17	stavudine	NN	O	stavudine	conj_and	12	SENT_46	[p5l1543t937r1937b1004],
18	in	IN	O	in	_	0	SENT_46	[p5l1983t940r2063b1004],
19	a	DT	O	a	det	20	SENT_46	[p5l2108t961r2148b1004],
20	cohort	NN	O	cohort	prep_in	12	SENT_46	[p5l9t1038r267b1107],
21	of	IN	O	of	_	0	SENT_46	[p5l315t1039r395b1107],
22	27	CD	NUMBER	27	num	25	SENT_46	[p5l437t1048r526b1106],
23	HIV/TB-coinfected	JJ	O	hiv/tb-coinfected	amod	25	SENT_46	[p5l574t1038r1344b1107],
24	Ghanaian	JJ	MISC	ghanaian	amod	25	SENT_46	[p5l1391t1038r1778b1107],
25	patients	NNS	O	patient	prep_of	20	SENT_46	[p5l1824t1042r2145b1128],
26	receiving	VBG	O	receive	partmod	25	SENT_46	[p5l6t1144r380b1230],
27	generic	JJ	O	generic	amod	28	SENT_46	[p5l410t1144r702b1230],
28	preparations	NNS	O	preparation	dobj	26	SENT_46	[p5l734t1144r1243b1230],
29	of	IN	O	of	_	0	SENT_46	[p5l1278t1141r1358b1209],
30	either	CC	O	either	preconj	31	SENT_46	[p5l1383t1140r1616b1209],
31	lamivudine	NN	O	lamivudine	prep_of	28	SENT_46	[p5l1646t1140r2146b1209],
32	/	:	O	/	punct	33	SENT_46	[p5l1646t1140r2146b1209],
33	zidovudine	NN	O	zidovudine	dep	31	SENT_46	[p5l8t1241r468b1309],
34	(	CD	NUMBER	(	num	33	SENT_46	[p5l508t1241r955b1322],
35	fixed-dose	JJ	O	fixed-dose	amod	37	SENT_46	[p5l508t1241r955b1322],
36	combination	NN	O	combination	nn	37	SENT_46	[p5l992t1241r1527b1322],
37	)	NN	O	)	dep	31	SENT_46	[p5l992t1241r1527b1322],
38	or	CC	O	or	_	0	SENT_46	[p5l1568t1265r1647b1309],
39	lamivudine	NN	O	lamivudine	conj_or	31	SENT_46	[p5l1681t1241r2146b1309],
40	and	CC	O	and	_	0	SENT_46	[p5l9t1343r156b1411],
41	stavudine	NN	O	stavudine	conj_and	39	SENT_46	[p5l180t1343r569b1411],
42	during	IN	O	during	_	0	SENT_46	[p5l596t1343r857b1432],
43	concurrent	JJ	O	concurrent	amod	46	SENT_46	[p5l882t1353r1318b1411],
44	rifampin-containing	JJ	O	rifampin-containing	amod	46	SENT_46	[p5l1338t1343r2147b1433],
45	TB	NN	O	tb	nn	46	SENT_46	[p5l8t1449r118b1512],
46	therapy	NN	O	therapy	prep_during	26	SENT_46	[p5l158t1445r480b1534],
47	.	.	O	.	_	0	SENT_46	[p5l158t1445r480b1534],

1	In	IN	O	in	_	0	SENT_47	[p5l521t1449r602b1512],
2	addition	NN	O	addition	_	0	SENT_47	[p5l639t1445r981b1513],
3	to	TO	O	to	_	0	SENT_47	[p5l1016t1455r1090b1513],
4	comparing	VBG	O	compare	prepc_in_addition_to	25	SENT_47	[p5l1130t1448r1560b1534],
5	our	PRP$	O	we	poss	6	SENT_47	[p5l1599t1469r1732b1513],
6	results	NNS	O	result	dobj	4	SENT_47	[p5l1766t1445r2034b1513],
7	to	TO	O	to	_	0	SENT_47	[p5l2071t1455r2145b1513],
8	published	VBN	O	publish	amod	9	SENT_47	[p5l8t1548r415b1637],
9	data	NNS	O	datum	prep_to	4	SENT_47	[p5l460t1548r627b1616],
10	for	IN	O	for	_	0	SENT_47	[p5l669t1548r779b1616],
11	sub-Saharan	JJ	MISC	sub-saharan	amod	15	SENT_47	[p5l822t1548r1322b1616],
12	black	JJ	O	black	amod	15	SENT_47	[p5l1360t1548r1580b1616],
13	African	JJ	MISC	african	amod	15	SENT_47	[p5l1618t1548r1923b1616],
14	HIVinfected	JJ	MISC	hivinfected	amod	15	SENT_47	[p5l1964t1552r2146b1615, p5l8t1649r336b1718],
15	patients	NNS	O	patient	prep_for	9	SENT_47	[p5l375t1653r695b1739],
16	who	WP	O	who	nsubj	19	SENT_47	[p5l736t1649r909b1718],
17	were	VBD	O	be	aux	19	SENT_47	[p5l949t1674r1143b1718],
18	not	RB	O	not	neg	19	SENT_47	[p5l1183t1660r1315b1718],
19	receiving	VBG	O	receive	rcmod	15	SENT_47	[p5l1351t1653r1725b1739],
20	rifampincontaining	JJ	O	rifampincontaining	amod	22	SENT_47	[p5l1763t1650r2146b1739, p5l9t1755r439b1841],
21	TB	NN	O	tb	nn	22	SENT_47	[p5l497t1756r606b1819],
22	therapy	NN	O	therapy	dobj	19	SENT_47	[p5l666t1751r990b1841],
23	,	,	O	,	_	0	SENT_47	[p5l666t1751r990b1841],
24	we	PRP	O	we	nsubj	25	SENT_47	[p5l1049t1776r1164b1820],
25	compared	VBD	O	compare	_	0	SENT_47	[p5l1223t1751r1624b1841],
26	lamivudine	NN	O	lamivudine	nn	27	SENT_47	[p5l1681t1751r2146b1820],
27	pharmacokinetics	NNS	O	pharmacokinetic	dobj	25	SENT_47	[p5l8t1853r730b1943],
28	between	IN	O	between	_	0	SENT_47	[p5l785t1853r1126b1921],
29	drug	NN	O	drug	nn	30	SENT_47	[p5l1184t1853r1365b1943],
30	formulations	NNS	O	formulation	prep_between	27	SENT_47	[p5l1422t1853r1961b1921],
31	.	.	O	.	_	0	SENT_47	[p5l1422t1853r1961b1921],

1	We	PRP	O	we	nsubj	3	SENT_48	[p5l2021t1858r2146b1921],
2	also	RB	O	also	advmod	3	SENT_48	[p5l9t1955r165b2023],
3	evaluated	VBD	O	evaluate	_	0	SENT_48	[p5l215t1955r605b2023],
4	the	DT	O	the	det	5	SENT_48	[p5l650t1955r774b2023],
5	association	NN	O	association	dobj	3	SENT_48	[p5l823t1959r1274b2023],
6	between	IN	O	between	_	0	SENT_48	[p5l1316t1955r1657b2023],
7	2	CD	NUMBER	2	prep_between	5	SENT_48	[p5l1706t1965r1743b2023],
8	common	JJ	O	common	amod	7	SENT_48	[p5l1795t1979r2147b2023],

1	UGTZB7	NN	O	ugtzb7	nn	2	SENT_49	[p5l18t2061r360b2126],
2	polymorphisms	NNS	O	polymorphism	dep	7	SENT_49	[p5l408t2058r1046b2147],
3	(	CD	NUMBER	(	num	4	SENT_49	[p5l1106t2058r1550b2139],
4	c.	NN	O	c.	dep	2	SENT_49	[p5l1106t2058r1550b2139],
5	735A	NN	O	735a	dep	7	SENT_49	[p5l1106t2058r1550b2139],
6	>	JJR	O	>	amod	7	SENT_49	[p5l1106t2058r1550b2139],
7	G	NN	O	g	dep	22	SENT_49	[p5l1106t2058r1550b2139],
8	,	,	O	,	_	0	SENT_49	[p5l1106t2058r1550b2139],
9	a	DT	O	a	det	10	SENT_49	[p5l1608t2082r1648b2126],
10	marker	NN	O	marker	appos	7	SENT_49	[p5l1699t2058r1985b2126],
11	for	IN	O	for	_	0	SENT_49	[p5l2038t2058r2148b2126],
12	the	DT	O	the	det	16	SENT_49	[p5l7t2161r131b2228],
13	UGT2B7	NN	O	ugt2b7	nn	16	SENT_49	[p5l185t2164r660b2228],
14	*	CD	NUMBER	*	num	16	SENT_49	[p5l185t2164r660b2228],
15	1c	NN	O	1c	nn	16	SENT_49	[p5l185t2164r660b2228],
16	allele	NN	O	allele	prep_for	7	SENT_49	[p5l707t2161r946b2239],
17	,	,	O	,	_	0	SENT_49	[p5l707t2161r946b2239],
18	and	CC	O	and	_	0	SENT_49	[p5l994t2161r1142b2228],
19	c.	NN	O	c.	nn	20	SENT_49	[p5l1186t2164r1581b2239],
20	802C	NN	O	802c	conj_and	16	SENT_49	[p5l1186t2164r1581b2239],
21	>	JJR	O	>	amod	22	SENT_49	[p5l1186t2164r1581b2239],
22	T	NN	O	t	dep	37	SENT_49	[p5l1186t2164r1581b2239],
23	,	,	O	,	_	0	SENT_49	[p5l1186t2164r1581b2239],
24	a	DT	O	a	det	25	SENT_49	[p5l1628t2185r1669b2228],
25	marker	NN	O	marker	dep	32	SENT_49	[p5l1710t2161r1995b2228],
26	for	IN	O	for	_	0	SENT_49	[p5l2038t2161r2148b2228],
27	the	DT	O	the	det	28	SENT_49	[p5l7t2262r131b2331],
28	UGT2B7	NN	O	ugt2b7	prep_for	25	SENT_49	[p5l182t2266r612b2331],
29	*	NN	O	*	dep	32	SENT_49	[p5l182t2266r612b2331],
30	2	CD	NUMBER	2	num	29	SENT_49	[p5l182t2266r612b2331],
31	allele	NN	O	allele	nn	32	SENT_49	[p5l658t2262r901b2343],
32	)	NN	O	)	dep	37	SENT_49	[p5l658t2262r901b2343],
33	and	CC	O	and	_	0	SENT_49	[p5l946t2262r1094b2331],
34	zidovudine	NN	O	zidovudine	nn	35	SENT_49	[p5l1135t2262r1595b2331],
35	pharmacol	NN	O	pharmacol	dep	37	SENT_49	[p5l1635t2262r2146b2352, p5l7t2368r244b2433],
36	<	JJR	O	<	amod	37	SENT_49	[p5l1635t2262r2146b2352, p5l7t2368r244b2433],
37	inetics	NNS	O	inetic	_	0	SENT_49	[p5l1635t2262r2146b2352, p5l7t2368r244b2433],
38	in	IN	O	in	_	0	SENT_49	[p5l297t2368r377b2432],
39	the	DT	O	the	det	41	SENT_49	[p5l426t2364r550b2433],
40	16	CD	NUMBER	16	num	41	SENT_49	[p5l606t2374r694b2433],
41	patients	NNS	O	patient	prep_in	37	SENT_49	[p5l747t2368r1067b2454],
42	who	WP	O	who	nsubj	43	SENT_49	[p5l1119t2364r1292b2433],
43	received	VBD	O	receive	rcmod	37	SENT_49	[p5l1343t2364r1688b2433],
44	this	DT	O	this	det	45	SENT_49	[p5l1737t2364r1885b2433],
45	drug	NN	O	drug	dobj	43	SENT_49	[p5l1941t2364r2141b2454],
46	.	.	O	.	_	0	SENT_49	[p5l1941t2364r2141b2454],

1	These	DT	O	these	det	3	SENT_50	[p5l8t2466r246b2534],
2	pharmacogenetic	JJ	O	pharmacogenetic	amod	3	SENT_50	[p5l329t2466r1025b2556],
3	results	NNS	O	result	nsubjpass	5	SENT_50	[p5l1108t2466r1377b2534],
4	were	VBD	O	be	auxpass	5	SENT_50	[p5l1460t2490r1654b2534],
5	replicated	VBN	O	replicate	_	0	SENT_50	[p5l1737t2466r2147b2556],
6	using	VBG	O	use	xcomp	5	SENT_50	[p5l7t2572r227b2657],
7	a	DT	O	a	det	9	SENT_50	[p5l284t2592r324b2636],
8	retrospective	JJ	O	retrospective	amod	9	SENT_50	[p5l377t2572r905b2658],
9	analysis	NN	O	analysis	dobj	6	SENT_50	[p5l963t2568r1289b2657],
10	of	IN	O	of	_	0	SENT_50	[p5l1348t2568r1429b2636],
11	a	DT	O	a	det	13	SENT_50	[p5l1478t2592r1518b2636],
12	large	JJ	O	large	amod	13	SENT_50	[p5l1573t2568r1766b2657],
13	bank	NN	O	bank	prep_of	9	SENT_50	[p5l1819t2568r2019b2636],
14	of	IN	O	of	_	0	SENT_50	[p5l2074t2568r2154b2636],
15	human	JJ	O	human	amod	16	SENT_50	[p5l7t2670r292b2738],
16	livers	NNS	O	liver	prep_of	13	SENT_50	[p5l333t2670r552b2738],
17	that	WDT	O	that	nsubjpass	19	SENT_50	[p5l592t2670r747b2738],
18	were	VBD	O	be	auxpass	19	SENT_50	[p5l784t2694r977b2738],
19	phenotyped	VBN	O	phenotype	rcmod	9	SENT_50	[p5l1017t2670r1501b2759],
20	for	IN	O	for	_	0	SENT_50	[p5l1541t2670r1650b2738],
21	zidovudine	NN	O	zidovudine	nn	23	SENT_50	[p5l1689t2670r2146b2738],
22	glucuronidation	NN	O	glucuronidation	nn	23	SENT_50	[p5l7t2773r663b2862],
23	activity	NN	O	activity	prep_for	19	SENT_50	[p5l698t2776r1001b2862],
24	as	RB	O	as	_	0	SENT_50	[p5l1036t2797r1112b2841],
25	well	RB	O	well	_	0	SENT_50	[p5l1148t2773r1322b2841],
26	as	IN	O	as	_	0	SENT_50	[p5l1359t2797r1435b2841],
27	UGTZB7	NN	O	ugtzb7	nn	28	SENT_50	[p5l1471t2776r1817b2841],
28	protein	NN	O	protein	prep_for	19	SENT_50	[p5l1854t2776r2148b2862],
29	and	CC	O	and	_	0	SENT_50	[p5l9t2874r157b2943],
30	mRNA	NN	O	mrna	nn	31	SENT_50	[p5l188t2879r463b2942],
31	content	NN	O	content	conj_and	28	SENT_50	[p5l496t2885r817b2943],
32	.	.	O	.	_	0	SENT_50	[p5l496t2885r817b2943],

1	METHODS	NNS	O	method	_	0	SENT_51	[p5l7t3079r458b3143],

1	Study	NNP	O	Study	nn	2	SENT_52	[p5l9t3289r247b3378],
2	Patients	NNPS	O	Patients	_	0	SENT_52	[p5l277t3292r605b3357],

1	HIV/TB-coinfected	JJ	O	hiv/tb-coinfected	amod	2	SENT_53	[p6l7t62r777b131],
2	patients	NNS	O	patient	nsubjpass	20	SENT_53	[p6l819t66r1140b152],
3	aged	VBN	O	age	partmod	2	SENT_53	[p6l1185t62r1368b152],
4	18	CD	DURATION	18	num	5	SENT_53	[p6l1414t72r1501b131],
5	years	NNS	NUMBER	year	dobj	3	SENT_53	[p6l1545t87r1752b152],
6	or	CC	O	or	_	0	SENT_53	[p6l1798t87r1878b131],
7	older	JJR	O	older	conj_or	5	SENT_53	[p6l1920t62r2144b141],
8	,	,	O	,	_	0	SENT_53	[p6l1920t62r2144b141],
9	with	IN	O	with	_	0	SENT_53	[p6l6t164r192b233],
10	CD4	NN	O	cd4	nn	12	SENT_53	[p6l236t168r403b233],
11	cell	NN	O	cell	nn	12	SENT_53	[p6l451t164r593b233],
12	count	NN	O	count	prep_with	3	SENT_53	[p6l639t175r868b233],
13	3250	CD	NUMBER	3250	num	14	SENT_53	[p6l911t174r1102b233],
14	cells/uL	NN	O	cells/ul	dep	12	SENT_53	[p6l1150t164r1472b251],
15	on	IN	O	on	_	0	SENT_53	[p6l1519t189r1618b233],
16	TB	NN	O	tb	nn	17	SENT_53	[p6l1662t169r1772b232],
17	therapy	NN	O	therapy	prep_on	14	SENT_53	[p6l1819t164r2143b254],
18	,	,	O	,	_	0	SENT_53	[p6l1819t164r2143b254],
19	were	VBD	O	be	auxpass	20	SENT_53	[p6l6t290r200b334],
20	enrolled	VBN	O	enrol	_	0	SENT_53	[p6l258t266r613b334],
21	.	.	O	.	_	0	SENT_53	[p6l258t266r613b334],

1	The	DT	O	the	det	3	SENT_54	[p6l673t266r826b334],
2	antituberculosis	JJ	O	antituberculosis	amod	3	SENT_54	[p6l883t266r1534b334],
3	regimen	NN	O	regimen	nsubj	4	SENT_54	[p6l1589t270r1919b356],
4	consisted	VBD	O	consist	_	0	SENT_54	[p6l1974t290r2146b334, p6l9t368r242b436],
5	of	IN	O	of	_	0	SENT_54	[p6l280t368r360b436],
6	isoniazid	NN	O	isoniazid	nn	8	SENT_54	[p6l390t368r762b436],
7	5	CD	NUMBER	5	num	8	SENT_54	[p6l802t379r839b436],
8	mg/kg	NN	O	mg/kg	prep_of	4	SENT_54	[p6l880t368r1129b457],
9	(	CD	NUMBER	(	num	8	SENT_54	[p6l1171t368r1366b449],
10	max	NN	O	max	nn	13	SENT_54	[p6l1171t368r1366b449],
11	300	CD	NUMBER	300	num	13	SENT_54	[p6l1406t378r1544b436],
12	mg	NN	O	mg	nn	13	SENT_54	[p6l1582t368r1754b457],
13	)	NN	O	)	dobj	4	SENT_54	[p6l1582t368r1754b457],
14	,	,	O	,	_	0	SENT_54	[p6l1582t368r1754b457],
15	rifampin	NN	O	rifampin	nn	17	SENT_54	[p6l1793t368r2147b458],
16	10	CD	NUMBER	10	num	17	SENT_54	[p6l12t480r99b538],
17	mg	NN	O	mg	dobj	4	SENT_54	[p6l126t470r278b559],
18	/	:	O	/	punct	33	SENT_54	[p6l126t470r278b559],
19	kg	NN	O	kg	nn	21	SENT_54	[p6l282t470r372b559],
20	(	NN	O	(	nn	21	SENT_54	[p6l401t470r595b551],
21	max	NN	O	max	dep	33	SENT_54	[p6l401t470r595b551],
22	600	CD	NUMBER	600	num	23	SENT_54	[p6l621t480r759b538],
23	mg	NN	O	mg	dep	21	SENT_54	[p6l785t470r955b559],
24	)	NN	O	)	nn	33	SENT_54	[p6l785t470r955b559],
25	,	,	O	,	_	0	SENT_54	[p6l785t470r955b559],
26	pyrazinamide	NN	O	pyrazinamide	dep	33	SENT_54	[p6l983t470r1535b559],
27	25	CD	NUMBER	25	num	33	SENT_54	[p6l1564t480r1650b538],
28	mg/kg	NN	O	mg/kg	nn	33	SENT_54	[p6l1679t470r1926b559],
29	(	CD	NUMBER	(	num	33	SENT_54	[p6l1954t470r2148b551],
30	max	NN	O	max	nn	33	SENT_54	[p6l1954t470r2148b551],
31	2	CD	NUMBER	2	num	33	SENT_54	[p6l11t582r48b640],
32	g	NN	O	g	nn	33	SENT_54	[p6l93t573r183b662],
33	)	NN	O	)	dep	17	SENT_54	[p6l93t573r183b662],
34	,	,	O	,	_	0	SENT_54	[p6l93t573r183b662],
35	and	CC	O	and	_	0	SENT_54	[p6l228t573r375b641],
36	ethambutol	NN	O	ethambutol	nn	38	SENT_54	[p6l417t573r870b641],
37	15	CD	NUMBER	15	num	38	SENT_54	[p6l916t583r1001b641],
38	mg/kg	NN	O	mg/kg	conj_and	13	SENT_54	[p6l1045t573r1292b662],
39	(	CD	NUMBER	(	num	40	SENT_54	[p6l1337t573r1530b653],
40	max	NN	O	max	tmod	38	SENT_54	[p6l1337t573r1530b653],
41	2	CD	NUMBER	2	num	43	SENT_54	[p6l1573t582r1610b640],
42	g	NN	O	g	nn	43	SENT_54	[p6l1654t573r1720b662],
43	)	NN	O	)	npadvmod	44	SENT_54	[p6l1654t573r1720b662],
44	daily	RB	SET	daily	advmod	40	SENT_54	[p6l1768t573r1978b662],
45	.	.	O	.	_	0	SENT_54	[p6l1768t573r1978b662],

1	All	DT	O	all	det	2	SENT_55	[p6l2023t573r2147b640],
2	patients	NNS	O	patient	nsubj	3	SENT_55	[p6l8t678r323b764],
3	were	VBD	O	be	_	0	SENT_55	[p6l349t699r541b743],
4	also	RB	O	also	advmod	3	SENT_55	[p6l567t674r721b743],
5	on	IN	O	on	_	0	SENT_55	[p6l750t699r848b743],
6	trimethoprim-sulfamethoxazole	NN	O	trimethoprim-sulfamethoxazole	prep_on	3	SENT_55	[p6l871t674r2146b764],
7	at	IN	O	at	_	0	SENT_55	[p6l9t787r78b845],
8	the	DT	O	the	det	9	SENT_55	[p6l120t776r243b845],
9	time	NN	O	time	prep_at	3	SENT_55	[p6l287t780r464b845],
10	of	IN	O	of	_	0	SENT_55	[p6l511t777r590b845],
11	initiating	VBG	O	initiate	prepc_of	9	SENT_55	[p6l628t780r993b866],
12	highly	RB	O	highly	advmod	13	SENT_55	[p6l1037t776r1293b866],
13	active	JJ	O	active	amod	18	SENT_55	[p6l1337t780r1570b845],
14	antiretroviral	JJ	O	antiretroviral	amod	18	SENT_55	[p6l1617t776r2146b845],
15	treatment	NN	O	treatment	nn	18	SENT_55	[p6l7t888r396b946],
16	(	CD	NUMBER	(	num	18	SENT_55	[p6l437t878r810b959],
17	HAART	NN	O	haart	nn	18	SENT_55	[p6l437t878r810b959],
18	)	NN	O	)	dobj	11	SENT_55	[p6l437t878r810b959],
19	and	CC	O	and	_	0	SENT_55	[p6l853t878r1001b946],
20	at	IN	O	at	_	0	SENT_55	[p6l1039t889r1109b946],
21	the	DT	O	the	det	22	SENT_55	[p6l1144t878r1269b946],
22	time	NN	O	time	prep_at	3	SENT_55	[p6l1306t882r1485b946],
23	of	IN	O	of	_	0	SENT_55	[p6l1525t878r1605b946],
24	pharmacol	NN	O	pharmacol	prep_of	22	SENT_55	[p6l1635t878r2145b968, p6l7t984r204b1048],
25	<	JJR	O	<	amod	27	SENT_55	[p6l1635t878r2145b968, p6l7t984r204b1048],
26	inetic	JJ	O	inetic	amod	27	SENT_55	[p6l1635t878r2145b968, p6l7t984r204b1048],
27	sampling	NN	O	sampling	dep	24	SENT_55	[p6l252t980r642b1070],
28	.	.	O	.	_	0	SENT_55	[p6l252t980r642b1070],

1	Antiretroviral	JJ	O	antiretroviral	amod	2	SENT_56	[p6l690t980r1251b1048],
2	therapy	NN	O	therapy	nsubj	3	SENT_56	[p6l1294t980r1604b1070],
3	consisted	VBD	O	consist	_	0	SENT_56	[p6l1648t980r2029b1048],
4	of	IN	O	of	_	0	SENT_56	[p6l2074t980r2154b1048],
5	efavirenz	NN	O	efavirenz	nn	7	SENT_56	[p6l9t1082r379b1150],
6	600	CD	NUMBER	600	num	7	SENT_56	[p6l413t1092r553b1150],
7	mg	NN	O	mg	prep_of	3	SENT_56	[p6l585t1106r705b1171],
8	daily	JJ	SET	daily	dobj	33	SENT_56	[p6l739t1082r941b1171],
9	plus	CC	O	plus	prep	8	SENT_56	[p6l971t1082r1142b1171],
10	lamivudine	NN	O	lamivudine	nn	12	SENT_56	[p6l1176t1082r1641b1150],
11	150	CD	NUMBER	150	num	12	SENT_56	[p6l1677t1092r1815b1150],
12	mg	NN	O	mg	dep	9	SENT_56	[p6l1847t1106r1967b1171],
13	and	CC	O	and	_	0	SENT_56	[p6l1999t1082r2148b1150],
14	zidovudine	NN	O	zidovudine	nn	17	SENT_56	[p6l8t1185r468b1253],
15	300	CD	NUMBER	300	num	17	SENT_56	[p6l505t1194r643b1253],
16	mg	NN	O	mg	nn	17	SENT_56	[p6l676t1209r796b1274],
17	(	NN	O	(	dep	9	SENT_56	[p6l832t1185r1143b1266],
18	duovir	NN	O	duovir	nsubj	33	SENT_56	[p6l832t1185r1143b1266],
19	,	,	O	,	_	0	SENT_56	[p6l832t1185r1143b1266],
20	Cipla	NNP	ORGANIZATION	Cipla	nsubj	33	SENT_56	[p6l1178t1185r1413b1274],
21	,	,	O	,	_	0	SENT_56	[p6l1178t1185r1413b1274],
22	Goa	NNP	LOCATION	Goa	nsubj	33	SENT_56	[p6l1448t1188r1624b1263],
23	,	,	O	,	_	0	SENT_56	[p6l1448t1188r1624b1263],
24	India	NNP	LOCATION	India	dep	26	SENT_56	[p6l1658t1185r1893b1266],
25	)	CD	NUMBER	)	num	24	SENT_56	[p6l1658t1185r1893b1266],
26	twice	JJ	O	twice	nsubj	33	SENT_56	[p6l1927t1188r2146b1253],
27	daily	JJ	SET	daily	amod	26	SENT_56	[p6l10t1286r212b1376],
28	or	CC	O	or	_	0	SENT_56	[p6l291t1311r371b1355],
29	lamivudine	NN	O	lamivudine	nn	32	SENT_56	[p6l448t1286r913b1355],
30	150	CD	NUMBER	150	num	32	SENT_56	[p6l997t1296r1135b1355],
31	mg	NN	O	mg	nn	32	SENT_56	[p6l1215t1311r1334b1376],
32	(	NN	O	(	conj_or	18	SENT_56	[p6l1417t1286r1723b1367],
33	Strides	VBZ	O	stride	ccomp	3	SENT_56	[p6l1417t1286r1723b1367],
34	Arcolab	NNP	O	Arcolab	dobj	33	SENT_56	[p6l1803t1286r2143b1365],
35	,	,	O	,	_	0	SENT_56	[p6l1803t1286r2143b1365],

1	GENERIC	JJ	O	generic	amod	2	SENT_57	[p6l441t1452r623b1483],
2	NRTIS	NN	O	nrti	_	0	SENT_57	[p6l634t1452r761b1483],
3	IN	IN	O	in	_	0	SENT_57	[p6l774t1453r824b1483],
4	TB/HIV	NN	O	tb/hiv	prep_in	2	SENT_57	[p6l837t1451r1260b1483],
5	.	.	O	.	_	0	SENT_57	[p6l837t1451r1260b1483],

1	—	NN	O	—	_	0	SENT_58	[p6l837t1451r1260b1483],
2	.	.	O	.	_	0	SENT_58	[p6l837t1451r1260b1483],

1	COINFECTED	JJ	O	coinfected	_	0	SENT_59	[p6l837t1451r1260b1483],
2	GHANAIAN	JJ	MISC	ghanaian	amod	3	SENT_59	[p6l1275t1452r1511b1483],
3	PATIENTS	NNS	O	patient	dep	1	SENT_59	[p6l1521t1452r1723b1483],

1	Bangalore	NNP	LOCATION	Bangalore	nsubj	10	SENT_60	[p6l8t1663r432b1753],
2	,	,	O	,	_	0	SENT_60	[p6l8t1663r432b1753],
3	India	NNP	LOCATION	India	nn	4	SENT_60	[p6l501t1663r736b1744],
4	)	NN	O	)	nsubj	10	SENT_60	[p6l501t1663r736b1744],
5	and	CC	O	and	_	0	SENT_60	[p6l808t1663r956b1731],
6	stavudine	NN	O	stavudine	nn	9	SENT_60	[p6l1024t1663r1419b1731],
7	40	CD	NUMBER	40	num	9	SENT_60	[p6l1486t1673r1579b1731],
8	mg	NN	O	mg	nn	9	SENT_60	[p6l1647t1687r1767b1753],
9	(	NN	O	(	conj_and	1	SENT_60	[p6l1839t1663r2145b1744],
10	Strides	VBZ	O	stride	_	0	SENT_60	[p6l1839t1663r2145b1744],
11	Arcolab	NNP	O	Arcolab	nn	15	SENT_60	[p6l7t1765r347b1844],
12	,	,	O	,	_	0	SENT_60	[p6l7t1765r347b1844],
13	Bangalore	NNP	LOCATION	Bangalore	appos	15	SENT_60	[p6l389t1765r813b1854],
14	,	,	O	,	_	0	SENT_60	[p6l389t1765r813b1854],
15	India	NNP	LOCATION	India	dobj	10	SENT_60	[p6l855t1765r1090b1846],
16	)	CD	NUMBER	)	num	15	SENT_60	[p6l855t1765r1090b1846],
17	twice	RB	O	twice	advmod	15	SENT_60	[p6l1132t1769r1350b1833],
18	daily	RB	SET	daily	advmod	10	SENT_60	[p6l1393t1765r1607b1854],
19	.	.	O	.	_	0	SENT_60	[p6l1393t1765r1607b1854],

1	For	IN	O	for	_	0	SENT_61	[p6l1651t1770r1786b1833],
2	patients	NNS	O	patient	prep_for	14	SENT_61	[p6l1824t1769r2145b1855],
3	with	IN	O	with	_	0	SENT_61	[p6l6t1867r192b1935],
4	body	NN	O	body	nn	5	SENT_61	[p6l219t1867r422b1956],
5	weight	NN	O	weight	prep_with	2	SENT_61	[p6l451t1867r726b1956],
6	<	JJR	O	<	dep	5	SENT_61	[p6l755t1877r897b1935],
7	50	CD	NUMBER	50	num	8	SENT_61	[p6l755t1877r897b1935],
8	kg	NN	O	kg	dep	6	SENT_61	[p6l929t1867r1041b1956],
9	,	,	O	,	_	0	SENT_61	[p6l929t1867r1041b1956],
10	stavudine	NN	O	stavudine	nn	11	SENT_61	[p6l1077t1867r1471b1935],
11	dose	NN	O	dose	nsubj	14	SENT_61	[p6l1506t1867r1686b1935],
12	was	VBD	O	be	cop	14	SENT_61	[p6l1716t1891r1869b1935],
13	30	CD	NUMBER	30	num	14	SENT_61	[p6l1906t1877r1995b1935],
14	mg	NN	O	mg	_	0	SENT_61	[p6l2027t1891r2147b1956],
15	daily	RB	SET	daily	advmod	14	SENT_61	[p6l10t1970r224b2059],
16	.	.	O	.	_	0	SENT_61	[p6l10t1970r224b2059],

1	The	DT	O	the	det	3	SENT_62	[p6l267t1970r420b2038],
2	median	JJ	O	median	amod	3	SENT_62	[p6l457t1970r762b2038],
3	duration	NN	O	duration	nsubj	14	SENT_62	[p6l801t1970r1147b2038],
4	of	IN	O	of	_	0	SENT_62	[p6l1185t1970r1266b2038],
5	TB	NN	O	tb	nn	6	SENT_62	[p6l1295t1974r1405b2037],
6	therapy	NN	O	therapy	prep_of	3	SENT_62	[p6l1445t1970r1755b2059],
7	to	TO	O	to	_	0	SENT_62	[p6l1791t1980r1865b2038],
8	initiation	NN	O	initiation	prep_to	6	SENT_62	[p6l1904t1973r2146b2038, p6l7t2075r167b2140],
9	of	IN	O	of	_	0	SENT_62	[p6l203t2072r284b2140],
10	HAART	NNP	O	HAART	prep_of	8	SENT_62	[p6l310t2076r633b2139],
11	was	VBD	O	be	cop	14	SENT_62	[p6l666t2096r820b2140],
12	35	CD	NUMBER	35	num	14	SENT_62	[p6l860t2081r946b2140],
13	(	NN	O	(	nn	14	SENT_62	[p6l990t2072r1255b2161],
14	range	NN	O	range	_	0	SENT_62	[p6l990t2072r1255b2161],
15	,	,	O	,	_	0	SENT_62	[p6l990t2072r1255b2161],
16	14-70	CD	NUMBER	14-70	appos	14	SENT_62	[p6l1297t2072r1542b2152],
17	)	CD	NUMBER	)	num	18	SENT_62	[p6l1297t2072r1542b2152],
18	days	NNS	NUMBER	day	tmod	16	SENT_62	[p6l1584t2071r1784b2161],
19	.	.	O	.	_	0	SENT_62	[p6l1584t2071r1784b2161],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_63	[p6l1823t2075r2144b2140],
2	were	VBD	O	be	auxpass	3	SENT_63	[p6l6t2198r200b2242],
3	instructed	VBN	O	instruct	_	0	SENT_63	[p6l254t2173r666b2242],
4	to	TO	O	to	aux	5	SENT_63	[p6l716t2184r790b2242],
5	switch	VB	O	switch	xcomp	3	SENT_63	[p6l845t2173r1112b2242],
6	their	PRP$	O	they	poss	9	SENT_63	[p6l1163t2173r1354b2242],
7	evening	NN	TIME	evening	nn	9	SENT_63	[p6l1406t2177r1722b2263],
8	efavirenz	NN	O	efavirenz	nn	9	SENT_63	[p6l1776t2174r2146b2242],
9	administration	NN	O	administration	tmod	5	SENT_63	[p6l9t2275r609b2343],
10	to	TO	O	to	_	0	SENT_63	[p6l651t2285r725b2343],
11	mornings	NNS	TIME	morning	prep_to	5	SENT_63	[p6l770t2279r1151b2365],
12	3	CD	DURATION	3	num	13	SENT_63	[p6l1200t2285r1237b2343],
13	days	NNS	NUMBER	day	npadvmod	11	SENT_63	[p6l1288t2275r1467b2365],
14	prior	RB	O	prior	_	0	SENT_63	[p6l1513t2279r1713b2365],
15	to	TO	O	to	_	0	SENT_63	[p6l1754t2285r1828b2343],
16	admission	NN	O	admission	prep_prior_to	11	SENT_63	[p6l1875t2275r2146b2343, p6l9t2381r177b2445],
17	to	TO	O	to	_	0	SENT_63	[p6l228t2387r302b2445],
18	the	DT	O	the	det	19	SENT_63	[p6l356t2377r480b2445],
19	hospital	NN	O	hospital	prep_to	5	SENT_63	[p6l533t2377r861b2467],
20	for	IN	O	for	_	0	SENT_63	[p6l915t2377r1024b2445],
21	sampling	NN	O	sampling	prep_for	19	SENT_63	[p6l1078t2377r1468b2467],
22	.	.	O	.	_	0	SENT_63	[p6l1078t2377r1468b2467],

1	On	IN	O	on	_	0	SENT_64	[p6l1527t2381r1646b2445],
2	the	DT	DATE	the	det	3	SENT_64	[p6l1697t2377r1821b2445],
3	day	NN	DATE	day	prep_on	15	SENT_64	[p6l1877t2377r2020b2466],
4	of	IN	O	of	_	0	SENT_64	[p6l2073t2377r2154b2445],
5	pharmacokinetic	JJ	O	pharmacokinetic	amod	6	SENT_64	[p6l8t2479r691b2568],
6	testing	NN	O	testing	prep_of	3	SENT_64	[p6l747t2482r1038b2568],
7	,	,	O	,	_	0	SENT_64	[p6l747t2482r1038b2568],
8	all	DT	O	all	det	9	SENT_64	[p6l1098t2479r1196b2547],
9	drugs	NNS	O	drug	nsubjpass	15	SENT_64	[p6l1254t2479r1496b2568],
10	,	,	O	,	_	0	SENT_64	[p6l1254t2479r1496b2568],
11	including	VBG	O	include	_	0	SENT_64	[p6l1556t2479r1947b2568],
12	efavirenz	NN	O	efavirenz	prep_including	9	SENT_64	[p6l2005t2479r2146b2547, p6l6t2585r283b2660],
13	,	,	O	,	_	0	SENT_64	[p6l2005t2479r2146b2547, p6l6t2585r283b2660],
14	were	VBD	O	be	auxpass	15	SENT_64	[p6l337t2606r530b2650],
15	coadministered	VBN	O	coadminister	_	0	SENT_64	[p6l585t2582r1214b2650],
16	in	IN	O	in	_	0	SENT_64	[p6l1266t2585r1346b2649],
17	the	DT	O	the	det	18	SENT_64	[p6l1396t2582r1520b2650],
18	morning	NN	TIME	morning	prep_in	15	SENT_64	[p6l1573t2585r1935b2671],
19	.	.	O	.	_	0	SENT_64	[p6l1573t2585r1935b2671],

1	The	DT	O	the	det	4	SENT_65	[p6l1993t2582r2146b2650],
2	Institutional	JJ	O	institutional	amod	4	SENT_65	[p6l7t2683r508b2752],
3	Review	NN	O	review	nn	4	SENT_65	[p6l568t2687r868b2752],
4	Boards	NNS	O	board	nsubj	16	SENT_65	[p6l927t2683r1203b2752],
5	of	IN	O	of	_	0	SENT_65	[p6l1267t2684r1348b2752],
6	the	DT	O	the	det	7	SENT_65	[p6l1399t2684r1524b2752],
7	University	NNP	ORGANIZATION	University	prep_of	4	SENT_65	[p6l1585t2687r2013b2773],
8	of	IN	ORGANIZATION	of	_	0	SENT_65	[p6l2074t2684r2154b2752],
9	Ghana	NNP	ORGANIZATION	Ghana	nn	11	SENT_65	[p6l8t2786r267b2854],
10	Medical	NNP	ORGANIZATION	Medical	nn	11	SENT_65	[p6l321t2785r648b2854],
11	School	NNP	ORGANIZATION	School	prep_of	7	SENT_65	[p6l707t2786r982b2854],
12	and	CC	O	and	_	0	SENT_65	[p6l1038t2785r1187b2854],
13	The	DT	ORGANIZATION	the	det	15	SENT_65	[p6l1242t2785r1394b2854],
14	Miriam	NNP	ORGANIZATION	Miriam	nn	15	SENT_65	[p6l1450t2789r1749b2854],
15	Hospital	NNP	ORGANIZATION	Hospital	conj_and	11	SENT_65	[p6l1803t2785r2146b2875],
16	approved	VBD	O	approve	_	0	SENT_65	[p6l9t2887r390b2977],
17	the	DT	O	the	det	18	SENT_65	[p6l424t2887r548b2955],
18	study	NN	O	study	dobj	16	SENT_65	[p6l586t2887r820b2977],
19	.	.	O	.	_	0	SENT_65	[p6l586t2887r820b2977],

1	A	DT	O	a	det	3	SENT_66	[p6l859t2892r926b2955],
2	signed	VBN	O	sign	amod	3	SENT_66	[p6l962t2887r1223b2977],
3	consent	NN	O	consent	nsubjpass	5	SENT_66	[p6l1259t2897r1572b2955],
4	was	VBD	O	be	auxpass	5	SENT_66	[p6l1604t2911r1757b2955],
5	obtained	VBN	O	obtain	_	0	SENT_66	[p6l1796t2887r2147b2955],
6	from	IN	O	from	_	0	SENT_66	[p6l8t2989r197b3057],
7	all	DT	O	all	det	8	SENT_66	[p6l230t2989r328b3057],
8	patients	NNS	O	patient	prep_from	5	SENT_66	[p6l360t2993r681b3079],
9	prior	RB	O	prior	_	0	SENT_66	[p6l715t2993r915b3079],
10	to	TO	O	to	_	0	SENT_66	[p6l945t2999r1018b3057],
11	enrollment	NN	O	enrollment	prep_prior_to	5	SENT_66	[p6l1054t2989r1519b3057],
12	.	.	O	.	_	0	SENT_66	[p6l1054t2989r1519b3057],

1	Clinical	JJ	O	clinical	amod	2	SENT_67	[p6l8t3185r331b3254],
2	Monitoring	NN	O	monitoring	_	0	SENT_67	[p6l362t3188r825b3275],
3	and	CC	O	and	_	0	SENT_67	[p6l858t3185r1011b3254],
4	Pharmacokinetic	JJ	O	pharmacokinetic	amod	5	SENT_67	[p6l6t3291r711b3360],
5	Sampling	NN	O	sampling	conj_and	2	SENT_67	[p6l746t3291r1138b3381],

1	Study	NN	O	study	nn	2	SENT_68	[p6l10t3501r247b3591],
2	participants	NNS	O	participant	nsubjpass	4	SENT_68	[p6l297t3505r782b3591],
3	were	VBD	O	be	auxpass	4	SENT_68	[p6l834t3525r1028b3569],
4	evaluated	VBN	O	evaluate	_	0	SENT_68	[p6l1082t3501r1473b3569],
5	at	IN	O	at	_	0	SENT_68	[p6l1525t3512r1595b3569],
6	study	NN	O	study	nn	7	SENT_68	[p6l1647t3501r1869b3591],
7	entry	NN	O	entry	prep_at	4	SENT_68	[p6l1921t3511r2143b3591],
8	,	,	O	,	_	0	SENT_68	[p6l1921t3511r2143b3591],
9	and	CC	O	and	_	0	SENT_68	[p6l9t3602r157b3670],
10	baseline	NN	O	baseline	nn	13	SENT_68	[p6l180t3602r515b3670],
11	liver	NN	O	liver	nn	13	SENT_68	[p6l543t3602r727b3670],
12	function	NN	O	function	nn	13	SENT_68	[p6l753t3602r1096b3670],
13	tests	NNS	O	test	prep_at	4	SENT_68	[p6l1121t3612r1322b3680],
14	,	,	O	,	_	0	SENT_68	[p6l1121t3612r1322b3680],
15	CD4	NN	O	cd4	nn	17	SENT_68	[p6l1352t3606r1518b3670],
16	cell	NN	O	cell	nn	17	SENT_68	[p6l1548t3602r1691b3670],
17	count	NN	O	count	appos	13	SENT_68	[p6l1719t3612r1968b3681],
18	,	,	O	,	_	0	SENT_68	[p6l1719t3612r1968b3681],
19	and	CC	O	and	advmod	7	SENT_68	[p6l1998t3602r2147b3670],

1	HIV	NN	O	hiv	nn	2	SENT_69	[p7l7t22r168b85],
2	RNA	NN	O	rna	nsubjpass	4	SENT_69	[p7l211t22r407b85],
3	were	VBD	O	be	auxpass	4	SENT_69	[p7l450t42r644b86],
4	done	VBN	O	do	_	0	SENT_69	[p7l694t18r888b86],
5	prior	RB	O	prior	_	0	SENT_69	[p7l935t21r1135b107],
6	to	TO	O	to	_	0	SENT_69	[p7l1178t28r1252b86],
7	starting	VBG	O	start	prepc_prior_to	4	SENT_69	[p7l1301t21r1602b107],
8	HAART	NNP	O	HAART	dobj	7	SENT_69	[p7l1647t22r1982b86],
9	.	.	O	.	_	0	SENT_69	[p7l1647t22r1982b86],

1	No	DT	O	no	det	2	SENT_70	[p7l2032t22r2145b86],
2	patients	NNS	O	patient	nsubj	3	SENT_70	[p7l8t124r328b210],
3	discontinued	VBN	O	discontinue	_	0	SENT_70	[p7l367t121r900b189],
4	study	NN	O	study	nn	5	SENT_70	[p7l935t121r1158b210],
5	medications	NNS	O	medication	dobj	3	SENT_70	[p7l1190t121r1685b189],
6	because	IN	O	because	_	0	SENT_70	[p7l1717t121r2037b189],
7	of	IN	O	of	prepc_because_of	3	SENT_70	[p7l2074t121r2154b189],
8	clinical	JJ	O	clinical	amod	11	SENT_70	[p7l9t222r310b291],
9	or	CC	O	or	_	0	SENT_70	[p7l364t247r443b291],
10	laboratory	JJ	O	laboratory	amod	11	SENT_70	[p7l494t222r907b312],
11	toxicity	NN	O	toxicity	pobj	3	SENT_70	[p7l957t226r1281b312],
12	,	,	O	,	_	0	SENT_70	[p7l957t226r1281b312],
13	and	CC	O	and	_	0	SENT_70	[p7l1337t222r1485b291],
14	1	CD	NUMBER	1	num	15	SENT_70	[p7l1541t233r1576b290],
15	patient	NN	O	patient	nsubj	16	SENT_70	[p7l1633t226r1918b312],
16	died	VBD	O	die	conj_and	3	SENT_70	[p7l1971t222r2147b291],
17	prior	RB	O	prior	_	0	SENT_70	[p7l8t328r208b414],
18	to	TO	O	to	_	0	SENT_70	[p7l248t335r322b393],
19	pharmacokinetic	JJ	O	pharmacokinetic	amod	20	SENT_70	[p7l366t324r1049b414],
20	testing	NN	O	testing	prep_prior_to	16	SENT_70	[p7l1093t328r1381b414],
21	.	.	O	.	_	0	SENT_70	[p7l1093t328r1381b414],

1	To	TO	O	to	aux	2	SENT_71	[p7l1429t329r1524b393],
2	determine	VB	O	determine	purpcl	20	SENT_71	[p7l1571t324r1979b393],
3	the	DT	O	the	det	5	SENT_71	[p7l2021t324r2146b393],
4	steady-state	JJ	O	steady-state	amod	5	SENT_71	[p7l9t426r483b516],
5	pharmacokinetics	NNS	O	pharmacokinetic	dobj	2	SENT_71	[p7l535t426r1258b516],
6	of	IN	O	of	_	0	SENT_71	[p7l1312t426r1393b494],
7	the	DT	O	the	det	9	SENT_71	[p7l1435t426r1559b494],
8	antiretroviral	JJ	O	antiretroviral	amod	9	SENT_71	[p7l1612t426r2147b494],
9	drugs	NNS	O	drug	prep_of	5	SENT_71	[p7l10t528r229b617],
10	in	IN	O	in	_	0	SENT_71	[p7l265t532r345b596],
11	a	DT	O	a	det	13	SENT_71	[p7l378t552r419b596],
12	rifampin-induced	JJ	O	rifampin-induced	amod	13	SENT_71	[p7l449t528r1170b618],
13	sate	NN	O	sate	prep_in	9	SENT_71	[p7l1204t538r1378b607],
14	,	,	O	,	_	0	SENT_71	[p7l1204t538r1378b607],
15	sampling	NN	O	sampling	nsubjpass	20	SENT_71	[p7l1416t528r1787b618],
16	for	IN	O	for	_	0	SENT_71	[p7l1821t528r1931b596],
17	drug	NN	O	drug	nn	18	SENT_71	[p7l1965t528r2147b617],
18	concentrations	NNS	O	concentration	prep_for	15	SENT_71	[p7l9t633r606b698],
19	was	VBD	O	be	auxpass	20	SENT_71	[p7l642t654r795b698],
20	performed	VBN	O	perform	_	0	SENT_71	[p7l832t630r1255b719],
21	on	IN	O	on	_	0	SENT_71	[p7l1291t654r1389b698],
22	day	NN	DURATION	day	prep_on	20	SENT_71	[p7l1426t630r1569b719],
23	14	CD	NUMBER	14	num	22	SENT_71	[p7l1607t641r1695b697],
24	of	IN	O	of	_	0	SENT_71	[p7l1735t630r1815b698],
25	concurrent	JJ	O	concurrent	amod	26	SENT_71	[p7l1843t654r2146b698, p7l6t743r168b801],
26	HIV	NN	MISC	hiv	prep_of	22	SENT_71	[p7l186t737r345b800],
27	and	CC	O	and	_	0	SENT_71	[p7l363t733r510b801],
28	TB	NN	O	tb	nn	29	SENT_71	[p7l528t737r637b800],
29	therapy	NN	O	therapy	prep_of	22	SENT_71	[p7l659t733r974b822],
30	.	.	O	.	_	0	SENT_71	[p7l659t733r974b822],

1	Blood	NN	O	blood	nn	2	SENT_72	[p7l997t733r1233b801],
2	samples	NNS	O	sample	nsubjpass	4	SENT_72	[p7l1252t733r1571b822],
3	were	VBD	O	be	auxpass	4	SENT_72	[p7l1590t757r1781b801],
4	obtained	VBN	O	obtain	_	0	SENT_72	[p7l1802t733r2147b801],
5	at	IN	O	at	_	0	SENT_72	[p7l9t843r78b901],
6	times	NNS	O	time	prepc_at	4	SENT_72	[p7l107t837r321b901],
7	0,0.5	CD	NUMBER	0,0.5	num	6	SENT_72	[p7l356t843r593b912],
8	,	,	O	,	_	0	SENT_72	[p7l356t843r593b912],
9	1	CD	NUMBER	1	num	6	SENT_72	[p7l632t844r693b912],
10	,	,	O	,	_	0	SENT_72	[p7l632t844r693b912],
11	1.5	CD	NUMBER	1.5	num	6	SENT_72	[p7l733t844r866b912],
12	,	,	O	,	_	0	SENT_72	[p7l733t844r866b912],
13	2	CD	NUMBER	2	num	6	SENT_72	[p7l904t843r967b912],
14	,	,	O	,	_	0	SENT_72	[p7l904t843r967b912],
15	3,4	CD	NUMBER	3,4	num	6	SENT_72	[p7l1005t843r1167b912],
16	,	,	O	,	_	0	SENT_72	[p7l1005t843r1167b912],
17	6	CD	NUMBER	6	num	6	SENT_72	[p7l1204t843r1268b912],
18	,	,	O	,	_	0	SENT_72	[p7l1204t843r1268b912],
19	8	CD	NUMBER	8	num	6	SENT_72	[p7l1304t843r1368b912],
20	,	,	O	,	_	0	SENT_72	[p7l1304t843r1368b912],
21	and	CC	DURATION	and	_	0	SENT_72	[p7l1404t833r1550b901],
22	12	CD	DURATION	12	conj_and	6	SENT_72	[p7l1586t843r1670b901],
23	hours	NNS	NUMBER	hour	npadvmod	24	SENT_72	[p7l1706t833r1933b901],
24	after	IN	O	after	dep	6	SENT_72	[p7l1969t834r2148b901],
25	observed	VBN	O	observe	pcomp	24	SENT_72	[p7l10t935r371b1004],
26	administration	NN	O	administration	dobj	25	SENT_72	[p7l446t935r1046b1004],
27	of	IN	O	of	_	0	SENT_72	[p7l1121t936r1201b1004],
28	antituberculosis	NN	O	antituberculosis	nn	31	SENT_72	[p7l1269t935r1921b1004],
29	and	CC	O	and	_	0	SENT_72	[p7l1999t935r2147b1004],
30	antiretroviral	JJ	O	antiretroviral	conj_and	28	SENT_72	[p7l9t1038r543b1106],
31	drugs	NNS	O	drug	prep_of	26	SENT_72	[p7l582t1038r822b1128],
32	.	.	O	.	_	0	SENT_72	[p7l582t1038r822b1128],

1	Then	RB	O	then	advmod	10	SENT_73	[p7l863t1038r1094b1117],
2	,	,	O	,	_	0	SENT_73	[p7l863t1038r1094b1117],
3	7	CD	NUMBER	7	number	5	SENT_73	[p7l1138t1049r1175b1106],
4	to	TO	O	to	dep	5	SENT_73	[p7l1212t1048r1286b1106],
5	10	CD	NUMBER	10	num	6	SENT_73	[p7l1328t1048r1416b1106],
6	mL	NN	O	ml	nsubjpass	10	SENT_73	[p7l1453t1043r1582b1106],
7	of	IN	O	of	_	0	SENT_73	[p7l1620t1038r1701b1106],
8	blood	NN	O	blood	prep_of	6	SENT_73	[p7l1725t1038r1958b1106],
9	was	VBD	O	be	auxpass	10	SENT_73	[p7l1991t1062r2145b1106],
10	collected	VBN	O	collect	_	0	SENT_73	[p7l9t1140r376b1208],
11	in	IN	O	in	_	0	SENT_73	[p7l427t1144r507b1208],
12	heparinized	VBN	O	heparinize	prepc_in	10	SENT_73	[p7l558t1140r1046b1230],
13	plastic	NN	O	plastic	nn	14	SENT_73	[p7l1097t1140r1363b1230],
14	tubes	NNS	O	tube	dobj	12	SENT_73	[p7l1416t1140r1629b1208],
15	and	CC	O	and	_	0	SENT_73	[p7l1684t1140r1832b1208],
16	centrifuged	VBN	O	centrifuge	prepc_in	10	SENT_73	[p7l1885t1144r2146b1208, p7l8t1242r231b1331],
17	at	IN	O	at	_	0	SENT_73	[p7l277t1252r347b1310],
18	3000	CD	NUMBER	3000	num	19	SENT_73	[p7l395t1252r583b1310],
19	g	NN	O	g	prep_at	16	SENT_73	[p7l627t1266r676b1331],
20	for	IN	O	for	_	0	SENT_73	[p7l715t1242r825b1310],
21	10	CD	DURATION	10	num	22	SENT_73	[p7l874t1252r961b1310],
22	minutes	NNS	NUMBER	minute	prep_for	19	SENT_73	[p7l1008t1245r1356b1310],
23	.	.	O	.	_	0	SENT_73	[p7l1008t1245r1356b1310],

1	Plasma	NN	O	plasma	nsubjpass	12	SENT_74	[p7l1405t1242r1695b1310],
2	was	VBD	O	be	auxpass	3	SENT_74	[p7l1738t1266r1891b1310],
3	separated	VBN	O	separate	_	0	SENT_74	[p7l1940t1266r2146b1331, p7l6t1345r233b1423],
4	,	,	O	,	_	0	SENT_74	[p7l1940t1266r2146b1331, p7l6t1345r233b1423],
5	transferred	VBN	O	transfer	conj_and	3	SENT_74	[p7l267t1345r710b1413],
6	into	IN	O	into	_	0	SENT_74	[p7l743t1348r899b1413],
7	labeled	VBN	O	label	amod	9	SENT_74	[p7l934t1345r1227b1413],
8	1.2-mL	NN	O	1.2-ml	nn	9	SENT_74	[p7l1263t1349r1541b1413],
9	cryovials	NNS	O	cryovial	prep_into	5	SENT_74	[p7l1575t1345r1962b1434],
10	,	,	O	,	_	0	SENT_74	[p7l1575t1345r1962b1434],
11	and	CC	O	and	_	0	SENT_74	[p7l1999t1345r2147b1413],
12	frozen	VBN	O	freeze	conj_and	3	SENT_74	[p7l8t1447r261b1515],
13	at	IN	O	at	_	0	SENT_74	[p7l298t1457r368b1515],
14	—	CD	NUMBER	—	number	15	SENT_74	[p7l399t1450r641b1515],
15	70	CD	NUMBER	70	num	17	SENT_74	[p7l399t1450r641b1515],
16	°	NN	O	°	nn	17	SENT_74	[p7l399t1450r641b1515],
17	C	NN	O	c	prep_at	12	SENT_74	[p7l399t1450r641b1515],
18	until	IN	O	until	_	0	SENT_74	[p7l676t1446r870b1515],
19	shipping	VBG	O	ship	prepc_until	12	SENT_74	[p7l908t1446r1264b1536],
20	to	TO	O	to	_	0	SENT_74	[p7l1298t1457r1372b1515],
21	the	DT	O	the	det	23	SENT_74	[p7l1409t1446r1533b1515],
22	United	NNP	LOCATION	United	nn	23	SENT_74	[p7l1570t1446r1848b1515],
23	States	NNPS	LOCATION	States	prep_to	19	SENT_74	[p7l1886t1450r2141b1515],
24	.	.	O	.	_	0	SENT_74	[p7l1886t1450r2141b1515],

1	The	DT	O	the	det	4	SENT_75	[p7l8t1548r161b1617],
2	frozen	JJ	O	frozen	amod	4	SENT_75	[p7l193t1549r447b1617],
3	plasma	NN	O	plasma	nn	4	SENT_75	[p7l477t1548r766b1638],
4	samples	NNS	O	sample	nsubjpass	6	SENT_75	[p7l797t1548r1121b1638],
5	were	VBD	O	be	auxpass	6	SENT_75	[p7l1153t1573r1347b1617],
6	shipped	VBN	O	ship	_	0	SENT_75	[p7l1380t1548r1706b1638],
7	on	IN	O	on	_	0	SENT_75	[p7l1739t1573r1837b1617],
8	dry	JJ	O	dry	amod	9	SENT_75	[p7l1870t1548r2002b1638],
9	ice	NN	O	ice	prep_on	6	SENT_75	[p7l2033t1552r2146b1617],
10	for	IN	O	for	_	0	SENT_75	[p7l8t1650r118b1718],
11	analysis	NN	O	analysis	prep_for	9	SENT_75	[p7l165t1650r489b1740],
12	and	CC	O	and	_	0	SENT_75	[p7l539t1650r687b1718],
13	were	VBD	O	be	auxpass	14	SENT_75	[p7l732t1674r926b1718],
14	received	VBN	O	receive	conj_and	6	SENT_75	[p7l972t1650r1317b1718],
15	in	IN	O	in	_	0	SENT_75	[p7l1364t1654r1443b1718],
16	good	JJ	O	good	amod	17	SENT_75	[p7l1488t1650r1683b1740],
17	condition	NN	O	condition	prep_in	14	SENT_75	[p7l1731t1650r2141b1718],
18	.	.	O	.	_	0	SENT_75	[p7l1731t1650r2141b1718],

1	Plasma	NN	O	plasma	nn	2	SENT_76	[p7l7t1752r297b1820],
2	samples	NNS	O	sample	nsubjpass	4	SENT_76	[p7l325t1752r649b1842],
3	were	VBD	O	be	auxpass	4	SENT_76	[p7l677t1776r871b1820],
4	stored	VBN	O	store	_	0	SENT_76	[p7l902t1752r1149b1820],
5	at	IN	O	at	_	0	SENT_76	[p7l1177t1762r1247b1820],
6	—	CD	NUMBER	—	number	7	SENT_76	[p7l1271t1756r1511b1820],
7	70	CD	NUMBER	70	num	9	SENT_76	[p7l1271t1756r1511b1820],
8	°	NN	O	°	nn	9	SENT_76	[p7l1271t1756r1511b1820],
9	C	NN	O	c	prep_at	4	SENT_76	[p7l1271t1756r1511b1820],
10	until	IN	O	until	_	0	SENT_76	[p7l1539t1752r1733b1820],
11	drug	NN	O	drug	nn	13	SENT_76	[p7l1764t1752r1945b1841],
12	concentration	NN	O	concentration	nn	13	SENT_76	[p7l1974t1776r2146b1820, p7l9t1857r420b1922],
13	assay	NN	O	assay	prep_until	4	SENT_76	[p7l453t1878r678b1943],
14	.	.	O	.	_	0	SENT_76	[p7l453t1878r678b1943],

1	Analytical	NNP	O	Analytical	_	0	SENT_77	[p7l7t2068r440b2157],
2	and	CC	O	and	_	0	SENT_77	[p7l474t2068r626b2136],
3	Pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_77	[p7l656t2068r1362b2136],
4	Analysis	NN	O	analysis	conj_and	1	SENT_77	[p7l1394t2068r1752b2157],

1	Drug	NN	O	drug	nn	2	SENT_78	[p7l7t2269r201b2354],
2	concentrations	NNS	O	concentration	nsubjpass	7	SENT_78	[p7l230t2268r827b2332],
3	in	IN	O	in	_	0	SENT_78	[p7l857t2268r936b2332],
4	blood	NN	O	blood	nn	5	SENT_78	[p7l960t2264r1192b2332],
5	plasma	NN	O	plasma	prep_in	2	SENT_78	[p7l1218t2264r1508b2354],
6	were	VBD	O	be	auxpass	7	SENT_78	[p7l1532t2288r1726b2332],
7	measured	VBN	O	measure	_	0	SENT_78	[p7l1754t2264r2147b2332],
8	simultaneously	RB	O	simultaneously	advmod	7	SENT_78	[p7l9t2366r634b2455],
9	using	VBG	O	use	xcomp	7	SENT_78	[p7l670t2370r890b2455],
10	a	DT	O	a	dobj	9	SENT_78	[p7l929t2390r970b2434],
11	validated	VBN	O	validate	partmod	10	SENT_78	[p7l1005t2366r1384b2434],
12	high-performance	JJ	O	high-performance	amod	14	SENT_78	[p7l1421t2366r2146b2456],
13	liquid	JJ	O	liquid	amod	14	SENT_78	[p7l8t2468r252b2557],
14	chromatography	NN	O	chromatography	dep	11	SENT_78	[p7l348t2468r1013b2557],
15	(	CD	NUMBER	(	num	16	SENT_78	[p7l1112t2468r1864b2549],
16	HPLC	NN	O	hplc	dep	14	SENT_78	[p7l1112t2468r1864b2549],
17	)	CD	NUMBER	)	dep	14	SENT_78	[p7l1112t2468r1864b2549],
18	/	:	O	/	punct	22	SENT_78	[p7l1112t2468r1864b2549],
19	ultraviolet	JJ	O	ultraviolet	amod	22	SENT_78	[p7l1112t2468r1864b2549],
20	(	NN	O	(	nn	22	SENT_78	[p7l1962t2468r2142b2549],
21	UV	NN	O	uv	nn	22	SENT_78	[p7l1962t2468r2142b2549],
22	)	NN	O	)	dep	17	SENT_78	[p7l1962t2468r2142b2549],
23	method	NN	O	method	dep	17	SENT_78	[p7l7t2570r398b2639],
24	.	.	O	.	_	0	SENT_78	[p7l7t2570r398b2639],

1	”	NN	O	”	nsubjpass	5	SENT_79	[p7l7t2570r398b2639],
2	The	DT	O	the	det	3	SENT_79	[p7l434t2571r587b2639],
3	method	NN	O	method	dep	1	SENT_79	[p7l621t2571r930b2639],
4	was	VBD	O	be	auxpass	5	SENT_79	[p7l962t2595r1115b2639],
5	validated	VBN	O	validate	_	0	SENT_79	[p7l1149t2571r1529b2639],
6	over	IN	O	over	_	0	SENT_79	[p7l1564t2595r1737b2639],
7	the	DT	O	the	det	8	SENT_79	[p7l1769t2571r1893b2639],
8	range	NN	O	range	prep_over	5	SENT_79	[p7l1927t2595r2145b2660],
9	of	IN	O	of	_	0	SENT_79	[p7l10t2673r90b2741],
10	10	CD	NUMBER	10	number	12	SENT_79	[p7l117t2682r205b2741],
11	to	TO	O	to	dep	12	SENT_79	[p7l236t2683r310b2741],
12	10	CD	NUMBER	10	num	14	SENT_79	[p7l347t2682r435b2741],
13	ooo	NN	O	ooo	nn	14	SENT_79	[p7l466t2682r606b2741],
14	ng/mL	NN	O	ng/ml	prep_of	8	SENT_79	[p7l638t2672r901b2762],
15	for	IN	O	for	_	0	SENT_79	[p7l933t2673r1043b2741],
16	all	DT	O	all	det	18	SENT_79	[p7l1073t2672r1171b2741],
17	3	CD	NUMBER	3	num	18	SENT_79	[p7l1205t2682r1242b2741],
18	analytes	NNS	O	analyte	prep_for	14	SENT_79	[p7l1278t2672r1629b2762],
19	.	.	O	.	_	0	SENT_79	[p7l1278t2672r1629b2762],

1	Assay	NN	O	assay	nn	2	SENT_80	[p7l1664t2677r1904b2762],
2	accuracy	NN	O	accuracy	nsubj	3	SENT_80	[p7l1934t2697r2146b2741, p7l6t2799r178b2864],
3	estimates	VBZ	O	estimate	_	0	SENT_80	[p7l218t2778r591b2843],
4	determined	VBN	O	determine	dep	3	SENT_80	[p7l636t2774r1100b2843],
5	at	IN	O	at	_	0	SENT_80	[p7l1140t2785r1210b2843],
6	3	CD	NUMBER	3	prep_at	4	SENT_80	[p7l1252t2784r1288b2843],
7	different	JJ	O	different	amod	8	SENT_80	[p7l1335t2774r1681b2843],
8	concentrations	NNS	O	concentration	nsubj	9	SENT_80	[p7l1721t2785r2145b2843, p7l7t2880r204b2944],
9	ranged	VBD	O	range	parataxis	3	SENT_80	[p7l297t2876r572b2966],
10	from	IN	O	from	_	0	SENT_80	[p7l665t2876r854b2944],
11	97.2	CD	PERCENT	97.2	number	15	SENT_80	[p7l948t2876r1196b2950],
12	%	NN	PERCENT	%	dep	15	SENT_80	[p7l948t2876r1196b2950],
13	to	TO	O	to	dep	15	SENT_80	[p7l1295t2887r1369b2944],
14	105	CD	PERCENT	105	number	15	SENT_80	[p7l1468t2876r1718b2955],
15	%	NN	PERCENT	%	prep_from	9	SENT_80	[p7l1468t2876r1718b2955],
16	,	,	O	,	_	0	SENT_80	[p7l1468t2876r1718b2955],
17	Whereas	IN	O	whereas	mark	24	SENT_80	[p7l1813t2876r2145b2944],
18	within	IN	O	within	nsubj	24	SENT_80	[p7l6t2978r304b3046],
19	-	:	O	-	_	0	SENT_80	[p7l6t2978r304b3046],
20	and	CC	O	and	_	0	SENT_80	[p7l336t2978r484b3046],
21	between-day	JJ	O	between-day	amod	23	SENT_80	[p7l511t2978r1031b3067],
22	precision	NN	O	precision	nn	23	SENT_80	[p7l1060t2982r1438b3068],
23	measures	NNS	O	measure	conj_and	18	SENT_80	[p7l1466t3002r1842b3046],
24	ranged	VBD	O	range	dep	3	SENT_80	[p7l1872t2978r2147b3067],
25	from	IN	O	from	_	0	SENT_80	[p7l8t3080r197b3148],
26	0.5	CD	PERCENT	0.5	number	30	SENT_80	[p7l234t3080r433b3153],
27	%	NN	PERCENT	%	dep	30	SENT_80	[p7l234t3080r433b3153],
28	to	TO	O	to	dep	30	SENT_80	[p7l475t3090r549b3148],
29	5.1	CD	PERCENT	5.1	number	30	SENT_80	[p7l589t3080r787b3153],
30	%	NN	PERCENT	%	prep_from	24	SENT_80	[p7l589t3080r787b3153],
31	and	CC	O	and	_	0	SENT_80	[p7l831t3080r979b3148],
32	0.5	CD	PERCENT	0.5	number	36	SENT_80	[p7l1016t3080r1215b3153],
33	%	NN	PERCENT	%	dep	36	SENT_80	[p7l1016t3080r1215b3153],
34	to	TO	O	to	dep	36	SENT_80	[p7l1257t3090r1331b3148],
35	5.6	CD	PERCENT	5.6	number	36	SENT_80	[p7l1371t3080r1599b3159],
36	%	NN	PERCENT	%	conj_and	30	SENT_80	[p7l1371t3080r1599b3159],
37	,	,	O	,	_	0	SENT_80	[p7l1371t3080r1599b3159],
38	respectively	RB	O	respectively	advmod	24	SENT_80	[p7l1635t3080r2141b3169],
39	.	.	O	.	_	0	SENT_80	[p7l1635t3080r2141b3169],

1	Pharmacokinetic	JJ	O	pharmacokinetic	amod	2	SENT_81	[p7l7t3183r691b3251],
2	parameters	NNS	O	parameter	_	0	SENT_81	[p7l768t3193r1237b3272],
3	,	,	O	,	_	0	SENT_81	[p7l768t3193r1237b3272],
4	including	VBG	O	include	_	0	SENT_81	[p7l1316t3183r1707b3272],
5	the	DT	O	the	det	6	SENT_81	[p7l1782t3183r1906b3251],
6	area	NN	O	area	prep_including	2	SENT_81	[p7l1984t3207r2148b3251],
7	under	IN	O	under	_	0	SENT_81	[p7l7t3284r247b3353],
8	the	DT	O	the	det	10	SENT_81	[p7l305t3284r429b3353],
9	concentration-time	JJ	O	concentration-time	amod	10	SENT_81	[p7l492t3288r1264b3353],
10	curve	NN	O	curve	prep_under	6	SENT_81	[p7l1327t3309r1548b3353],
11	for	IN	O	for	_	0	SENT_81	[p7l1610t3285r1720b3353],
12	the	DT	O	the	det	13	SENT_81	[p7l1778t3284r1902b3353],
13	dose	NN	O	dose	prep_for	10	SENT_81	[p7l1966t3284r2146b3353],

1	SPECIAL	JJ	O	special	amod	2	SENT_82	[p7l8t3514r284b3575],
2	POPULATIONS	NNS	O	population	_	0	SENT_82	[p7l318t3514r819b3575],

1	interval	NN	O	interval	nn	4	SENT_83	[p8l9t24r322b92],
2	(	CD	NUMBER	(	num	4	SENT_83	[p8l354t24r679b116],
3	AUC042	NN	O	auc042	nn	4	SENT_83	[p8l354t24r679b116],
4	h	NN	O	h	dep	8	SENT_83	[p8l697t24r779b115],
5	)	NN	O	)	dep	4	SENT_83	[p8l697t24r779b115],
6	,	,	O	,	_	0	SENT_83	[p8l697t24r779b115],
7	were	VBD	O	be	auxpass	8	SENT_83	[p8l808t48r1002b92],
8	estimated	VBN	O	estimate	_	0	SENT_83	[p8l1032t24r1424b92],
9	using	VBG	O	use	xcomp	8	SENT_83	[p8l1450t28r1670b114],
10	WinNonlin	NNP	O	WinNonlin	dobj	9	SENT_83	[p8l1695t24r2151b92],
11	(	CD	NUMBER	(	num	10	SENT_83	[p8l13t126r344b207],
12	Version	NNP	O	Version	nsubjpass	8	SENT_83	[p8l13t126r344b207],
13	5.2	CD	NUMBER	5.2	num	12	SENT_83	[p8l444t136r582b205],
14	,	,	O	,	_	0	SENT_83	[p8l444t136r582b205],
15	Pharsight	NNP	ORGANIZATION	Pharsight	nn	20	SENT_83	[p8l681t126r1087b215],
16	,	,	O	,	_	0	SENT_83	[p8l681t126r1087b215],
17	Inc	NNP	ORGANIZATION	Inc	appos	20	SENT_83	[p8l1187t131r1333b205],
18	,	,	O	,	_	0	SENT_83	[p8l1187t131r1333b205],
19	Mountain	NNP	O	Mountain	appos	20	SENT_83	[p8l1433t130r1832b194],
20	View	NNP	O	View	appos	12	SENT_83	[p8l1927t130r2148b205],
21	,	,	O	,	_	0	SENT_83	[p8l1927t130r2148b205],
22	California	NNP	LOCATION	California	nn	23	SENT_83	[p8l9t228r461b309],
23	)	NN	O	)	appos	20	SENT_83	[p8l9t228r461b309],
24	.	.	O	.	_	0	SENT_83	[p8l9t228r461b309],

1	For	IN	O	for	_	0	SENT_84	[p8l521t233r657b296],
2	drug	NN	O	drug	nn	4	SENT_84	[p8l712t228r894b317],
3	concentration	NN	O	concentration	nn	4	SENT_84	[p8l950t231r1511b296],
4	measurements	NNS	O	measurement	prep_for	17	SENT_84	[p8l1564t238r2149b296],
5	below	IN	O	below	_	0	SENT_84	[p8l6t331r254b398],
6	the	DT	O	the	det	8	SENT_84	[p8l284t331r408b398],
7	lower	JJR	O	lower	amod	8	SENT_84	[p8l441t331r671b398],
8	limit	NN	O	limit	prep_below	4	SENT_84	[p8l702t331r897b398],
9	of	IN	O	of	_	0	SENT_84	[p8l929t331r1010b398],
10	detection	NN	O	detection	prep_of	8	SENT_84	[p8l1036t331r1412b398],
11	at	IN	O	at	_	0	SENT_84	[p8l1444t341r1514b398],
12	12	CD	DURATION	12	num	13	SENT_84	[p8l1549t340r1635b398],
13	hours	NNS	NUMBER	hour	prep_at	10	SENT_84	[p8l1671t331r1922b409],
14	,	,	O	,	_	0	SENT_84	[p8l1671t331r1922b409],
15	AUC	NN	O	auc	nsubjpass	17	SENT_84	[p8l1956t334r2150b398],
16	was	VBD	O	be	auxpass	17	SENT_84	[p8l7t456r161b501],
17	computed	VBN	O	compute	_	0	SENT_84	[p8l201t432r607b522],
18	from	IN	O	from	_	0	SENT_84	[p8l645t433r834b501],
19	time	NN	O	time	nn	20	SENT_84	[p8l868t436r1047b501],
20	O	NN	O	o	prep_from	17	SENT_84	[p8l1087t432r1347b501],
21	—	VBD	O	—	rcmod	20	SENT_84	[p8l1087t432r1347b501],
22	the	DT	O	the	det	24	SENT_84	[p8l1087t432r1347b501],
23	last	JJ	O	last	amod	24	SENT_84	[p8l1386t432r1526b501],
24	time	NN	O	time	dobj	21	SENT_84	[p8l1560t436r1739b501],
25	that	WDT	O	that	dobj	32	SENT_84	[p8l1775t432r1932b501],
26	drug	NN	O	drug	nn	27	SENT_84	[p8l1970t432r2151b522],
27	concentration	NN	O	concentration	nsubj	32	SENT_84	[p8l10t538r571b603],
28	was	VBD	O	be	cop	32	SENT_84	[p8l638t558r792b603],
29	measurable	JJ	O	measurable	amod	32	SENT_84	[p8l862t534r1324b603],
30	(	NN	O	(	nn	32	SENT_84	[p8l1398t535r1664b626],
31	O-tlast	NN	O	o-tlast	nn	32	SENT_84	[p8l1398t535r1664b626],
32	)	NN	O	)	rcmod	24	SENT_84	[p8l1398t535r1664b626],
33	.	.	O	.	_	0	SENT_84	[p8l1398t535r1664b626],

1	For	IN	O	for	_	0	SENT_85	[p8l1738t539r1874b603],
2	these	DT	O	these	det	3	SENT_85	[p8l1941t534r2150b603],
3	computations	NNS	O	computation	prep_for	14	SENT_85	[p8l10t640r587b726],
4	,	,	O	,	_	0	SENT_85	[p8l10t640r587b726],
5	concentration	NN	O	concentration	nn	6	SENT_85	[p8l648t640r1209b704],
6	measurements	NNS	O	measurement	nsubj	14	SENT_85	[p8l1264t646r1849b704],
7	below	IN	O	below	_	0	SENT_85	[p8l1904t636r2152b704],
8	the	DT	O	the	det	10	SENT_85	[p8l8t738r132b806],
9	lower	JJR	O	lower	amod	10	SENT_85	[p8l168t738r397b806],
10	limit	NN	O	limit	prep_below	6	SENT_85	[p8l431t738r626b806],
11	of	IN	O	of	_	0	SENT_85	[p8l660t738r740b806],
12	detection	NN	O	detection	prep_of	10	SENT_85	[p8l770t738r1145b806],
13	were	VBD	O	be	cop	14	SENT_85	[p8l1178t762r1372b806],
14	imputed	JJ	O	imputed	_	0	SENT_85	[p8l1408t738r1751b828],
15	as	IN	O	as	_	0	SENT_85	[p8l1785t762r1862b806],
16	o	NN	O	o	prep_as	14	SENT_85	[p8l1900t748r1964b817],
17	,	,	O	,	_	0	SENT_85	[p8l1900t748r1964b817],
18	and	CC	O	and	_	0	SENT_85	[p8l2003t738r2151b806],
19	those	DT	O	those	nsubj	30	SENT_85	[p8l8t840r222b908],
20	below	IN	O	below	_	0	SENT_85	[p8l267t840r515b908],
21	the	DT	O	the	det	23	SENT_85	[p8l560t840r685b908],
22	lower	JJR	O	lower	amod	23	SENT_85	[p8l734t840r963b908],
23	limit	NN	O	limit	prep_below	19	SENT_85	[p8l1010t840r1205b908],
24	of	IN	O	of	_	0	SENT_85	[p8l1253t840r1333b908],
25	quantitation	NN	O	quantitation	nn	28	SENT_85	[p8l1374t843r1871b929],
26	(	CD	NUMBER	(	num	28	SENT_85	[p8l1922t840r2147b925],
27	LLQ	NN	O	llq	nn	28	SENT_85	[p8l1922t840r2147b925],
28	)	NN	O	)	prep_of	23	SENT_85	[p8l1922t840r2147b925],
29	were	VBD	O	be	cop	30	SENT_85	[p8l8t967r202b1011],
30	imputed	JJ	O	imputed	conj_and	14	SENT_85	[p8l241t943r585b1032],
31	as	IN	O	as	_	0	SENT_85	[p8l623t967r700b1011],
32	50	CD	PERCENT	50	number	33	SENT_85	[p8l743t943r916b1016],
33	%	NN	PERCENT	%	amod	34	SENT_85	[p8l743t943r916b1016],
34	LLQ	NN	O	llq	prep_as	30	SENT_85	[p8l962t946r1156b1028],
35	.	.	O	.	_	0	SENT_85	[p8l962t946r1156b1028],

1	Weighting	NN	O	weighting	nsubjpass	3	SENT_86	[p8l1198t943r1612b1032],
2	was	VBD	O	be	auxpass	3	SENT_86	[p8l1649t967r1802b1011],
3	applied	VBN	O	apply	_	0	SENT_86	[p8l1844t943r2151b1032],
4	during	IN	O	during	_	0	SENT_86	[p8l11t1044r278b1134],
5	HPLC	NN	O	hplc	prep_during	3	SENT_86	[p8l303t1044r571b1113],
6	/	:	O	/	punct	8	SENT_86	[p8l303t1044r571b1113],
7	UV	NN	O	uv	nn	8	SENT_86	[p8l577t1049r707b1113],
8	analysis	NN	O	analysis	dep	3	SENT_86	[p8l734t1044r1058b1134],
9	of	IN	O	of	_	0	SENT_86	[p8l1088t1045r1169b1113],
10	samples	NNS	O	sample	prep_of	8	SENT_86	[p8l1189t1044r1537b1134],
11	,	,	O	,	_	0	SENT_86	[p8l1189t1044r1537b1134],
12	but	CC	O	but	_	0	SENT_86	[p8l1563t1044r1697b1113],
13	no	DT	O	no	det	14	SENT_86	[p8l1721t1069r1820b1113],
14	weighting	NN	O	weighting	nsubjpass	16	SENT_86	[p8l1847t1044r2150b1134, p8l9t1150r133b1236],
15	was	VBD	O	be	auxpass	16	SENT_86	[p8l158t1170r311b1215],
16	used	VBN	O	use	conj_but	3	SENT_86	[p8l340t1146r529b1215],
17	for	IN	O	for	_	0	SENT_86	[p8l557t1147r666b1215],
18	the	DT	O	the	det	20	SENT_86	[p8l691t1146r815b1215],
19	noncompartmental	JJ	O	noncompartmental	amod	20	SENT_86	[p8l843t1146r1613b1236],
20	pharmacol	NN	O	pharmacol	prep_for	16	SENT_86	[p8l1641t1146r2150b1236, p8l8t1252r201b1316],
21	<	JJR	O	<	amod	23	SENT_86	[p8l1641t1146r2150b1236, p8l8t1252r201b1316],
22	inetic	JJ	O	inetic	amod	23	SENT_86	[p8l1641t1146r2150b1236, p8l8t1252r201b1316],
23	analysis	NN	O	analysis	dep	20	SENT_86	[p8l225t1248r561b1338],
24	.	.	O	.	_	0	SENT_86	[p8l225t1248r561b1338],

1	Drug	NN	O	drug	nn	3	SENT_87	[p8l587t1253r778b1338],
2	concentration	NN	O	concentration	nn	3	SENT_87	[p8l800t1252r1346b1316],
3	measurements	NNS	O	measurement	nsubjpass	5	SENT_87	[p8l1366t1258r1937b1316],
4	were	VBD	O	be	auxpass	5	SENT_87	[p8l1959t1272r2150b1316],
5	performed	VBN	O	perform	_	0	SENT_87	[p8l9t1350r422b1440],
6	at	IN	O	at	_	0	SENT_87	[p8l456t1360r525b1418],
7	the	DT	O	the	det	8	SENT_87	[p8l555t1350r677b1418],
8	University	NNP	ORGANIZATION	University	prep_at	5	SENT_87	[p8l710t1354r1128b1439],
9	of	IN	ORGANIZATION	of	_	0	SENT_87	[p8l1162t1350r1241b1418],
10	North	NNP	ORGANIZATION	North	nn	12	SENT_87	[p8l1266t1350r1496b1418],
11	Carolina	NNP	ORGANIZATION	Carolina	nn	12	SENT_87	[p8l1529t1350r1864b1418],
12	Center	NNP	ORGANIZATION	Center	prep_of	8	SENT_87	[p8l1896t1354r2152b1418],
13	for	IN	ORGANIZATION	for	_	0	SENT_87	[p8l9t1452r116b1520],
14	AIDS	NNP	ORGANIZATION	AIDS	nn	17	SENT_87	[p8l140t1455r347b1520],
15	Research	NNP	ORGANIZATION	Research	nn	17	SENT_87	[p8l375t1452r728b1520],
16	(	CD	NUMBER	(	num	17	SENT_87	[p8l757t1452r1036b1533],
17	CFAR	NNP	ORGANIZATION	CFAR	prep_for	12	SENT_87	[p8l757t1452r1036b1533],
18	)	CD	NUMBER	)	num	20	SENT_87	[p8l757t1452r1036b1533],
19	Clinical	JJ	O	clinical	amod	20	SENT_87	[p8l1066t1452r1373b1520],
20	Pharmacology	NN	O	pharmacology	dep	17	SENT_87	[p8l1397t1452r1976b1541],
21	and	CC	O	and	_	0	SENT_87	[p8l2006t1452r2152b1520],
22	Analytical	NNP	O	Analytical	nn	24	SENT_87	[p8l8t1555r420b1644],
23	Chemistry	NNP	O	Chemistry	nn	24	SENT_87	[p8l518t1555r926b1644],
24	Core	NNP	O	Core	prep_for	12	SENT_87	[p8l1022t1558r1223b1633],
25	,	,	O	,	_	0	SENT_87	[p8l1022t1558r1223b1633],
26	which	WDT	O	which	nsubj	29	SENT_87	[p8l1322t1555r1572b1623],
27	is	VBZ	O	be	cop	29	SENT_87	[p8l1669t1558r1731b1623],
28	Clinical	JJ	O	clinical	amod	29	SENT_87	[p8l1834t1555r2151b1623],
29	Laboratory	NN	O	laboratory	rcmod	24	SENT_87	[p8l9t1656r447b1746],
30	Improvements	NNP	O	Improvements	nn	33	SENT_87	[p8l485t1661r1070b1746],
31	Amendments	NNP	O	Amendments	nn	33	SENT_87	[p8l1110t1656r1656b1725],
32	(	NNP	O	(	nn	33	SENT_87	[p8l1702t1657r1962b1737],
33	CLIA	NNP	ORGANIZATION	CLIA	nsubj	34	SENT_87	[p8l1702t1657r1962b1737],
34	)	VBD	O	)	rcmod	29	SENT_87	[p8l1702t1657r1962b1737],
35	certified	VBN	O	certify	dep	34	SENT_87	[p8l2007t1681r2150b1725, p8l8t1758r223b1827],
36	and	CC	O	and	_	0	SENT_87	[p8l286t1758r434b1827],
37	participates	VBZ	O	participate	conj_and	34	SENT_87	[p8l496t1762r971b1848],
38	in	IN	O	in	_	0	SENT_87	[p8l1035t1762r1115b1826],
39	quarterly	JJ	SET	quarterly	amod	40	SENT_87	[p8l1178t1758r1546b1848],
40	national	JJ	O	national	prep_in	37	SENT_87	[p8l1606t1758r1939b1827],
41	and	CC	O	and	_	0	SENT_87	[p8l2003t1758r2152b1827],
42	international	JJ	O	international	amod	45	SENT_87	[p8l9t1860r535b1928],
43	external	JJ	O	external	amod	45	SENT_87	[p8l569t1860r896b1928],
44	proficiency	NN	O	proficiency	nn	45	SENT_87	[p8l928t1860r1391b1950],
45	testing	NN	O	testing	conj_and	40	SENT_87	[p8l1422t1864r1711b1950],
46	.	.	O	.	_	0	SENT_87	[p8l1422t1864r1711b1950],

1	Zidovudine	NNP	O	Zidovudine	nn	2	SENT_88	[p8l8t2056r486b2125],
2	Glucuronidation	NNP	O	Glucuronidation	_	0	SENT_88	[p8l520t2056r1232b2137],
3	,	,	O	,	_	0	SENT_88	[p8l520t2056r1232b2137],
4	UGTZB7	NNP	O	UGTZB7	nn	5	SENT_88	[p8l8t2167r360b2232],
5	Protein	NN	O	protein	conj_and	2	SENT_88	[p8l392t2166r715b2244],
6	,	,	O	,	_	0	SENT_88	[p8l392t2166r715b2244],
7	and	CC	O	and	_	0	SENT_88	[p8l751t2163r904b2232],
8	mRNA	NN	O	mrna	nn	9	SENT_88	[p8l935t2168r1216b2231],
9	Content	NN	O	content	conj_and	2	SENT_88	[p8l1247t2167r1566b2232],

1	Demographic	JJ	MISC	demographic	amod	2	SENT_89	[p8l8t2374r549b2463],
2	details	NNS	O	detail	nsubjpass	22	SENT_89	[p8l607t2373r871b2442],
3	of	IN	O	of	_	0	SENT_89	[p8l928t2374r1009b2442],
4	the	DT	O	the	det	9	SENT_89	[p8l1054t2373r1178b2442],
5	52	CD	NUMBER	52	num	9	SENT_89	[p8l1237t2383r1323b2442],
6	human	JJ	O	human	amod	9	SENT_89	[p8l1381t2373r1666b2442],
7	liver	NN	O	liver	nn	9	SENT_89	[p8l1720t2373r1904b2442],
8	bank	NN	O	bank	nn	9	SENT_89	[p8l1954t2373r2154b2442],
9	samples	NNS	O	sample	prep_of	2	SENT_89	[p8l10t2475r335b2565],
10	used	VBN	O	use	partmod	9	SENT_89	[p8l362t2475r553b2543],
11	to	TO	O	to	aux	12	SENT_89	[p8l578t2485r651b2543],
12	prepare	VB	O	prepare	xcomp	10	SENT_89	[p8l680t2499r987b2565],
13	matched	VBN	O	match	amod	14	SENT_89	[p8l1014t2475r1363b2543],
14	microsomes	NNS	O	microsome	dobj	12	SENT_89	[p8l1388t2479r1898b2554],
15	,	,	O	,	_	0	SENT_89	[p8l1388t2479r1898b2554],
16	DNA	NN	O	dna	dobj	12	SENT_89	[p8l1926t2480r2148b2554],
17	,	,	O	,	_	0	SENT_89	[p8l1926t2480r2148b2554],
18	and	CC	O	and	_	0	SENT_89	[p8l10t2577r159b2645],
19	RNA	NN	O	rna	dobj	12	SENT_89	[p8l192t2582r388b2645],
20	have	VBP	O	have	aux	22	SENT_89	[p8l421t2577r610b2645],
21	been	VBN	O	be	auxpass	22	SENT_89	[p8l643t2577r836b2645],
22	published	VBN	O	publish	_	0	SENT_89	[p8l871t2577r1279b2667],
23	previously	RB	DATE	previously	advmod	22	SENT_89	[p8l1313t2577r1824b2667],
24	.	.	O	.	_	0	SENT_89	[p8l1313t2577r1824b2667],

1	”	NN	O	”	ccomp	5	SENT_90	[p8l1313t2577r1824b2667],
2	Briefly	RB	O	briefly	advmod	1	SENT_90	[p8l1859t2577r2148b2666],
3	,	,	O	,	_	0	SENT_90	[p8l1859t2577r2148b2666],
4	donors	NNS	O	donor	nsubj	18	SENT_90	[p8l11t2679r285b2747],
5	included	VBD	O	include	_	0	SENT_90	[p8l331t2679r694b2747],
6	48	CD	NUMBER	48	num	7	SENT_90	[p8l737t2689r828b2747],
7	men	NNS	O	man	dobj	5	SENT_90	[p8l874t2703r1050b2747],
8	and	CC	O	and	_	0	SENT_90	[p8l1093t2679r1242b2747],
9	14	CD	NUMBER	14	num	10	SENT_90	[p8l1289t2690r1377b2747],
10	women	NNS	O	woman	dobj	5	SENT_90	[p8l1421t2703r1722b2747],
11	and	CC	O	and	_	0	SENT_90	[p8l1765t2679r1914b2747],
12	were	VBD	O	be	cop	15	SENT_90	[p8l1955t2703r2150b2747],
13	primarily	RB	O	primarily	advmod	15	SENT_90	[p8l9t2783r389b2872],
14	white	JJ	O	white	amod	15	SENT_90	[p8l408t2783r635b2851],
15	American	JJ	MISC	american	conj_and	5	SENT_90	[p8l656t2786r1053b2851],
16	but	CC	O	but	_	0	SENT_90	[p8l1070t2783r1203b2851],
17	also	RB	O	also	advmod	18	SENT_90	[p8l1223t2783r1379b2851],
18	included	VBD	O	include	conj_but	5	SENT_90	[p8l1401t2783r1762b2851],
19	3	CD	NUMBER	3	num	21	SENT_90	[p8l1786t2792r1822b2851],
20	African	JJ	MISC	african	amod	21	SENT_90	[p8l1847t2783r2152b2851],
21	Americans	NNPS	MISC	Americans	dobj	18	SENT_90	[p8l8t2888r444b2953],
22	and	CC	O	and	_	0	SENT_90	[p8l489t2884r637b2953],
23	2	CD	NUMBER	2	num	24	SENT_90	[p8l682t2894r719b2952],
24	Hispanics	NNPS	MISC	Hispanics	conj_and	21	SENT_90	[p8l765t2888r1187b2974],
25	.	.	O	.	_	0	SENT_90	[p8l765t2888r1187b2974],

1	Mean	NN	O	mean	nsubj	7	SENT_91	[p8l1233t2889r1459b2953],
2	i	FW	O	i	dep	1	SENT_91	[p8l1498t2896r1545b2952],
3	SD	NN	O	sd	nn	5	SENT_91	[p8l1588t2888r1698b2953],
4	donor	NN	O	donor	nn	5	SENT_91	[p8l1744t2884r1981b2953],
5	age	NN	O	age	dep	1	SENT_91	[p8l2023t2909r2150b2974],
6	was	VBD	O	be	cop	7	SENT_91	[p8l7t3011r161b3055],
7	40	CD	NUMBER	40	_	0	SENT_91	[p8l219t2996r312b3055],
8	i	FW	O	i	dep	7	SENT_91	[p8l369t2998r416b3054],
9	20	CD	DURATION	20	num	10	SENT_91	[p8l475t2996r564b3055],
10	years	NNS	NUMBER	year	tmod	7	SENT_91	[p8l621t3011r851b3076],
11	.	.	O	.	_	0	SENT_91	[p8l621t3011r851b3076],

1	The	DT	O	the	det	6	SENT_92	[p8l913t2986r1066b3055],
2	human	JJ	O	human	amod	6	SENT_92	[p8l1122t2986r1407b3055],
3	liver	NN	O	liver	nn	6	SENT_92	[p8l1464t2986r1648b3055],
4	microsome	NN	O	microsome	nn	6	SENT_92	[p8l1703t2990r2150b3055],
5	(	CD	NUMBER	(	num	6	SENT_92	[p8l13t3088r268b3169],
6	HLM	NN	O	hlm	nsubjpass	22	SENT_92	[p8l13t3088r268b3169],
7	)	CD	NUMBER	)	num	10	SENT_92	[p8l13t3088r268b3169],
8	Zidovudine	NN	O	zidovudine	nn	10	SENT_92	[p8l333t3088r794b3156],
9	glucuronidation	NN	O	glucuronidation	nn	10	SENT_92	[p8l855t3088r1513b3178],
10	activities	NNS	O	activity	dep	6	SENT_92	[p8l1574t3092r1939b3156],
11	and	CC	O	and	_	0	SENT_92	[p8l2003t3088r2151b3156],
12	UGTZB7	NN	O	ugtzb7	nn	15	SENT_92	[p8l9t3194r354b3258],
13	protein	NN	O	protein	nn	15	SENT_92	[p8l419t3194r714b3280],
14	content	NN	O	content	nn	15	SENT_92	[p8l777t3200r1080b3258],
15	measurements	NNS	O	measurement	conj_and	6	SENT_92	[p8l1140t3200r1726b3258],
16	used	VBN	O	use	partmod	15	SENT_92	[p8l1789t3190r1979b3258],
17	for	IN	O	for	_	0	SENT_92	[p8l2042t3190r2152b3258],
18	analysis	NN	O	analysis	prep_for	16	SENT_92	[p8l10t3292r335b3381],
19	here	RB	O	here	advmod	22	SENT_92	[p8l389t3292r563b3360],
20	have	VBP	O	have	aux	22	SENT_92	[p8l617t3292r805b3360],
21	been	VBN	O	be	auxpass	22	SENT_92	[p8l856t3292r1049b3360],
22	reported	VBN	O	report	_	0	SENT_92	[p8l1100t3292r1445b3381],
23	in	IN	O	in	_	0	SENT_92	[p8l1498t3295r1578b3359],
24	detail	NN	O	detail	prepc_in	22	SENT_92	[p8l1633t3292r1859b3360],
25	previously	RB	DATE	previously	advmod	24	SENT_92	[p8l1912t3295r2150b3381, p8l11t3394r304b3484],
26	,23	CD	NUMBER	,23	pobj	25	SENT_92	[p8l1912t3295r2150b3381, p8l11t3394r304b3484],
27	whereas	IN	O	whereas	mark	36	SENT_92	[p8l346t3395r678b3463],
28	UGTZB7	NN	O	ugtzb7	nn	32	SENT_92	[p8l722t3398r1068b3463],
29	and	CC	O	and	_	0	SENT_92	[p8l1112t3395r1261b3463],
30	GAPDH	NN	O	gapdh	conj_and	28	SENT_92	[p8l1303t3398r1621b3463],
31	mRNA	NN	O	mrna	nn	32	SENT_92	[p8l1661t3399r1936b3462],
32	contents	NNS	O	contents	nsubjpass	36	SENT_92	[p8l1978t3419r2150b3463, p8l8t3507r200b3565],
33	have	VBP	O	have	aux	36	SENT_92	[p8l256t3497r444b3565],
34	not	RB	O	not	neg	36	SENT_92	[p8l499t3507r630b3565],
35	been	VBN	O	be	auxpass	36	SENT_92	[p8l680t3497r872b3565],
36	reported	VBN	O	report	advcl	24	SENT_92	[p8l925t3497r1270b3586],
37	previously	RB	DATE	previously	advmod	36	SENT_92	[p8l1323t3497r1769b3586],
38	.	.	O	.	_	0	SENT_92	[p8l1323t3497r1769b3586],

1	Enzyme	NN	O	enzyme	nn	2	SENT_93	[p8l1826t3501r2150b3586],
2	activities	NNS	O	activity	nsubjpass	4	SENT_93	[p8l10t3603r374b3668],
3	were	VBD	O	be	auxpass	4	SENT_93	[p8l415t3624r609b3668],
4	expressed	VBN	O	express	_	0	SENT_93	[p8l651t3599r1053b3689],
5	as	IN	O	as	_	0	SENT_93	[p8l1093t3624r1170b3668],
6	nanomoles	NNS	O	nanomole	prep_as	4	SENT_93	[p8l1210t3599r1652b3668],
7	per	IN	O	per	_	0	SENT_93	[p8l1693t3624r1824b3689],
8	minute	NN	DURATION	minute	prep_per	6	SENT_93	[p8l1862t3603r2150b3668],
9	per	IN	O	per	_	0	SENT_93	[p8l9t3725r139b3791],
10	milligram	NN	O	milligram	prep_per	8	SENT_93	[p8l220t3701r619b3791],
11	of	IN	O	of	_	0	SENT_93	[p8l702t3701r783b3769],
12	microsomal	JJ	O	microsomal	amod	13	SENT_93	[p8l857t3701r1334b3769],
13	protein	NN	O	protein	prep_of	10	SENT_93	[p8l1417t3705r1732b3791],
14	,	,	O	,	_	0	SENT_93	[p8l1417t3705r1732b3791],
15	whereas	IN	O	whereas	prep	4	SENT_93	[p8l1817t3701r2149b3769],

1	UGTZB7-specific	JJ	O	ugtzb7-specific	amod	3	SENT_94	[p9l9t13r703b103],
2	protein	NN	O	protein	nn	3	SENT_94	[p9l795t17r1089b103],
3	content	NN	O	content	nsubjpass	8	SENT_94	[p9l1180t23r1484b81],
4	measured	VBN	O	measure	partmod	3	SENT_94	[p9l1572t13r1966b81],
5	by	IN	O	by	_	0	SENT_94	[p9l2053t13r2152b102],
6	immunoblotting	NN	O	immunoblotting	agent	4	SENT_94	[p9l9t115r670b204],
7	was	VBD	O	be	auxpass	8	SENT_94	[p9l708t139r862b183],
8	expressed	VBN	O	express	_	0	SENT_94	[p9l905t115r1306b204],
9	relative	JJ	O	relative	advmod	8	SENT_94	[p9l1344t115r1648b183],
10	to	TO	O	to	_	0	SENT_94	[p9l1687t125r1761b183],
11	the	DT	O	the	det	12	SENT_94	[p9l1802t115r1926b183],
12	liver	NN	O	liver	prep_to	9	SENT_94	[p9l1967t115r2152b183],
13	with	IN	O	with	_	0	SENT_94	[p9l8t218r194b286],
14	the	DT	O	the	det	17	SENT_94	[p9l241t218r366b286],
15	lowest	JJS	O	lowest	amod	17	SENT_94	[p9l416t218r680b286],
16	UGTZB7	NN	O	ugtzb7	nn	17	SENT_94	[p9l728t221r1074b286],
17	content	NN	O	content	prep_with	8	SENT_94	[p9l1127t228r1449b286],
18	.	.	O	.	_	0	SENT_94	[p9l1127t228r1449b286],

1	Total	JJ	O	total	amod	2	SENT_95	[p9l1503t218r1703b286],
2	RNA	NN	O	rna	nsubjpass	5	SENT_95	[p9l1752t222r1948b285],
3	was	VBD	O	be	auxpass	5	SENT_95	[p9l1995t242r2149b286],
4	also	RB	O	also	advmod	5	SENT_95	[p9l10t320r166b389],
5	extracted	VBN	O	extract	_	0	SENT_95	[p9l214t320r586b389],
6	from	IN	O	from	_	0	SENT_95	[p9l631t321r820b389],
7	these	DT	O	these	det	10	SENT_95	[p9l863t320r1071b389],
8	same	JJ	O	same	amod	10	SENT_95	[p9l1119t345r1320b389],
9	liver	NN	O	liver	nn	10	SENT_95	[p9l1366t320r1551b389],
10	samples	NNS	O	sample	prep_from	5	SENT_95	[p9l1596t320r1920b410],
11	with	IN	O	with	_	0	SENT_95	[p9l1966t320r2152b389],
12	Trizol	NN	O	trizol	nn	13	SENT_95	[p9l9t422r244b491],
13	reagent	NN	O	reagent	prep_with	10	SENT_95	[p9l279t433r575b512],
14	(	CD	NUMBER	(	num	17	SENT_95	[p9l614t423r1080b512],
15	Invitrogen	NNP	ORGANIZATION	Invitrogen	nn	17	SENT_95	[p9l614t423r1080b512],
16	,	,	O	,	_	0	SENT_95	[p9l614t423r1080b512],
17	Carlsbad	NNP	LOCATION	Carlsbad	tmod	10	SENT_95	[p9l1119t422r1494b501],
18	,	,	O	,	_	0	SENT_95	[p9l1119t422r1494b501],
19	California	NNP	LOCATION	California	nn	20	SENT_95	[p9l1533t422r1961b503],
20	)	NN	O	)	appos	17	SENT_95	[p9l1533t422r1961b503],
21	and	CC	O	and	_	0	SENT_95	[p9l2003t422r2151b491],
22	used	VBN	O	use	conj_and	5	SENT_95	[p9l8t524r198b593],
23	to	TO	O	to	aux	24	SENT_95	[p9l237t535r310b593],
24	measure	VB	O	measure	xcomp	22	SENT_95	[p9l351t549r689b593],
25	UGTZB7	NNP	O	UGTZB7	nn	29	SENT_95	[p9l729t528r1075b593],
26	and	CC	O	and	_	0	SENT_95	[p9l1118t524r1267b593],
27	GAPDH	NNP	O	GAPDH	conj_and	25	SENT_95	[p9l1307t528r1625b593],
28	mRNA	NN	O	mrna	nn	29	SENT_95	[p9l1663t529r1938b592],
29	content	NN	O	content	dobj	24	SENT_95	[p9l1979t549r2150b593, p9l8t637r165b695],
30	with	IN	O	with	_	0	SENT_95	[p9l186t627r372b695],
31	a	DT	O	a	det	36	SENT_95	[p9l397t651r437b695],
32	branched	VBN	O	branch	amod	36	SENT_95	[p9l457t627r838b695],
33	DNA	NN	O	dna	nn	36	SENT_95	[p9l860t632r1061b695],
34	signal	NN	O	signal	nn	36	SENT_95	[p9l1087t627r1323b716],
35	amplification	NN	O	amplification	nn	36	SENT_95	[p9l1349t627r1895b717],
36	assay	NN	O	assay	prep_with	24	SENT_95	[p9l1920t651r2146b716],
37	.	.	O	.	_	0	SENT_95	[p9l1920t651r2146b716],

1	Capture	RB	O	capture	advmod	4	SENT_96	[p9l9t732r326b818],
2	well	RB	O	well	advmod	3	SENT_96	[p9l381t729r556b797],
3	plates	NNS	O	plate	nsubj	4	SENT_96	[p9l611t729r848b818],
4	were	VBD	O	be	dep	8	SENT_96	[p9l904t753r1099b797],
5	from	IN	O	from	_	0	SENT_96	[p9l1156t729r1345b797],
6	Bayer	NNP	ORGANIZATION	Bayer	nn	7	SENT_96	[p9l1399t733r1629b818],
7	Diagnostics	NNPS	ORGANIZATION	Diagnostics	prep_from	4	SENT_96	[p9l1683t732r2149b818],
8	(	VBP	O	(	_	0	SENT_96	[p9l13t832r547b917],
9	QuantiGene	NN	O	quantigene	dobj	8	SENT_96	[p9l13t832r547b917],
10	,	,	O	,	_	0	SENT_96	[p9l13t832r547b917],
11	Bayer	NNP	ORGANIZATION	Bayer	nn	12	SENT_96	[p9l640t836r870b921],
12	Diagnostics	NNPS	ORGANIZATION	Diagnostics	appos	9	SENT_96	[p9l957t835r1447b921],
13	,	,	O	,	_	0	SENT_96	[p9l957t835r1447b921],
14	East	NNP	LOCATION	East	nn	15	SENT_96	[p9l1538t836r1705b900],
15	Walpole	NNP	LOCATION	Walpole	appos	9	SENT_96	[p9l1791t832r2148b921],
16	,	,	O	,	_	0	SENT_96	[p9l1791t832r2148b921],
17	Massachusetts	NNP	LOCATION	Massachusetts	nn	18	SENT_96	[p9l8t933r647b1015],
18	)	NN	O	)	appos	9	SENT_96	[p9l8t933r647b1015],
19	,	,	O	,	_	0	SENT_96	[p9l8t933r647b1015],
20	whereas	IN	O	whereas	mark	27	SENT_96	[p9l722t933r1054b1002],
21	UGT2B7	NN	O	ugt2b7	nsubj	27	SENT_96	[p9l1129t937r1506b1002],
22	-	:	O	-	_	0	SENT_96	[p9l1129t937r1506b1002],
23	and	CC	O	and	_	0	SENT_96	[p9l1582t933r1730b1002],
24	GAPDHspecific	JJ	O	gapdhspecific	amod	26	SENT_96	[p9l1804t937r2150b1002, p9l10t1037r320b1126],
25	probe	NN	O	probe	nn	26	SENT_96	[p9l348t1036r576b1126],
26	sets	NNS	O	set	nsubj	27	SENT_96	[p9l606t1047r751b1105],
27	were	VBD	O	be	dep	9	SENT_96	[p9l779t1061r973b1105],
28	from	IN	O	from	_	0	SENT_96	[p9l1001t1037r1190b1105],
29	XenoTech	NNP	ORGANIZATION	XenoTech	nn	30	SENT_96	[p9l1215t1036r1622b1105],
30	LLC	NNP	ORGANIZATION	LLC	prep_from	27	SENT_96	[p9l1647t1040r1810b1105],
31	(	CD	NUMBER	(	num	33	SENT_96	[p9l1842t1037r2149b1117],
32	Kansas	NNP	LOCATION	Kansas	nn	33	SENT_96	[p9l1842t1037r2149b1117],
33	City	NNP	LOCATION	City	nsubj	8	SENT_96	[p9l9t1142r188b1228],
34	,	,	O	,	_	0	SENT_96	[p9l9t1142r188b1228],
35	Kansas	NNP	LOCATION	Kansas	appos	33	SENT_96	[p9l240t1138r573b1219],
36	)	CD	NUMBER	)	num	35	SENT_96	[p9l240t1138r573b1219],
37	.	.	O	.	_	0	SENT_96	[p9l240t1138r573b1219],

1	The	DT	O	the	det	3	SENT_97	[p9l626t1138r779b1206],
2	assay	NN	O	assay	nn	3	SENT_97	[p9l829t1162r1043b1228],
3	technique	NN	O	technique	nsubj	5	SENT_97	[p9l1090t1138r1492b1228],
4	was	VBD	O	be	cop	5	SENT_97	[p9l1540t1162r1694b1206],
5	similar	JJ	O	similar	_	0	SENT_97	[p9l1746t1138r2029b1206],
6	to	TO	O	to	_	0	SENT_97	[p9l2075t1149r2149b1206],
7	that	DT	O	that	dobj	11	SENT_97	[p9l8t1240r165b1308],
8	we	PRP	O	we	nsubj	11	SENT_97	[p9l231t1264r346b1308],
9	have	VBP	O	have	aux	11	SENT_97	[p9l415t1240r604b1308],
10	previously	RB	DATE	previously	advmod	11	SENT_97	[p9l675t1240r1108b1330],
11	described	VBN	O	describe	prepc_to	5	SENT_97	[p9l1179t1240r1570b1308],
12	for	IN	O	for	_	0	SENT_97	[p9l1640t1240r1749b1308],
13	CYPZBB	NN	O	cypzbb	nn	16	SENT_97	[p9l1818t1244r2149b1308],
14	mRNA	NN	O	mrna	nn	16	SENT_97	[p9l8t1345r283b1408],
15	content	NN	O	content	nn	16	SENT_97	[p9l317t1351r620b1409],
16	quantification	NN	O	quantification	prep_for	11	SENT_97	[p9l653t1340r1308b1430],
17	.	.	O	.	_	0	SENT_97	[p9l653t1340r1308b1430],

1	“	NN	O	“	nn	2	SENT_98	[p9l653t1340r1308b1430],
2	Luminescence	NN	O	luminescence	nsubjpass	8	SENT_98	[p9l1342t1344r1928b1409],
3	from	IN	O	from	_	0	SENT_98	[p9l1963t1341r2152b1409],
4	the	DT	O	the	det	6	SENT_98	[p9l8t1445r132b1513],
5	capture	NN	O	capture	nn	6	SENT_98	[p9l183t1455r484b1534],
6	Wells	NNP	PERSON	Wells	prep_from	2	SENT_98	[p9l532t1445r745b1513],
7	was	VBD	O	be	auxpass	8	SENT_98	[p9l794t1469r947b1513],
8	measured	VBN	O	measure	_	0	SENT_98	[p9l996t1445r1390b1513],
9	using	VBG	O	use	xcomp	8	SENT_98	[p9l1437t1448r1657b1534],
10	a	DT	O	a	det	12	SENT_98	[p9l1706t1469r1746b1513],
11	luminescence	NN	O	luminescence	nn	12	SENT_98	[p9l1794t1445r2150b1513, p9l10t1571r236b1615],
12	counter	NN	O	counter	nsubj	15	SENT_98	[p9l301t1557r609b1615],
13	(	CD	NUMBER	(	num	15	SENT_98	[p9l674t1546r1017b1628],
14	Wallace	NNP	PERSON	Wallace	nn	15	SENT_98	[p9l674t1546r1017b1628],
15	Trilux	NNP	PERSON	Trilux	xcomp	9	SENT_98	[p9l1080t1546r1347b1626],
16	,	,	O	,	_	0	SENT_98	[p9l1080t1546r1347b1626],
17	#	#	MONEY	#	number	18	SENT_98	[p9l1412t1556r1654b1615],
18	1450	CD	MONEY	1450	num	19	SENT_98	[p9l1412t1556r1654b1615],
19	Microbeta	NN	O	microbeta	appos	15	SENT_98	[p9l1718t1546r2148b1626],
20	,	,	O	,	_	0	SENT_98	[p9l1718t1546r2148b1626],

1	KWARA	NNP	LOCATION	KWARA	nn	3	SENT_99	[p9l936t1931r1089b1961],
2	ET	NNP	O	ET	nn	3	SENT_99	[p9l1104t1931r1160b1961],
3	AL	NNP	O	AL	_	0	SENT_99	[p9l1169t1931r1225b1961],

1	PerkinElmer	NNP	ORGANIZATION	PerkinElmer	nn	3	SENT_100	[p9l9t2141r516b2209],
2	Life	NNP	ORGANIZATION	Life	nn	3	SENT_100	[p9l555t2141r707b2209],
3	Sciences	NNPS	ORGANIZATION	Sciences	_	0	SENT_100	[p9l751t2145r1121b2220],
4	,	,	O	,	_	0	SENT_100	[p9l751t2145r1121b2220],
5	Boston	NNP	LOCATION	Boston	appos	3	SENT_100	[p9l1164t2146r1463b2220],
6	,	,	O	,	_	0	SENT_100	[p9l1164t2146r1463b2220],
7	Massachusetts	NNP	LOCATION	Massachusetts	nn	8	SENT_100	[p9l1505t2141r2139b2221],
8	)	NN	O	)	appos	5	SENT_100	[p9l1505t2141r2139b2221],
9	.	.	O	.	_	0	SENT_100	[p9l1505t2141r2139b2221],

1	UGTZB7	NN	O	ugtzb7	nn	3	SENT_101	[p9l10t2246r354b2309],
2	mRNA	NN	O	mrna	nn	3	SENT_101	[p9l406t2247r680b2309],
3	data	NNS	O	datum	nsubjpass	5	SENT_101	[p9l732t2242r900b2309],
4	were	VBD	O	be	auxpass	5	SENT_101	[p9l947t2266r1141b2309],
5	normalized	VBN	O	normalize	_	0	SENT_101	[p9l1191t2242r1653b2309],
6	to	TO	O	to	_	0	SENT_101	[p9l1702t2252r1776b2309],
7	GAPDH	NNP	O	GAPDH	nn	8	SENT_101	[p9l1828t2246r2145b2309],
8	data	NNS	O	datum	prep_to	5	SENT_101	[p9l12t2344r180b2412],
9	and	CC	O	and	_	0	SENT_101	[p9l207t2344r355b2412],
10	expressed	VBN	O	express	conj_and	5	SENT_101	[p9l383t2344r784b2433],
11	relative	JJ	O	relative	advmod	10	SENT_101	[p9l809t2344r1112b2412],
12	to	TO	O	to	_	0	SENT_101	[p9l1139t2354r1213b2412],
13	the	DT	O	the	det	14	SENT_101	[p9l1241t2344r1365b2412],
14	liver	NN	O	liver	prep_to	11	SENT_101	[p9l1394t2344r1578b2412],
15	with	IN	O	with	_	0	SENT_101	[p9l1603t2344r1788b2412],
16	the	DT	O	the	det	18	SENT_101	[p9l1814t2344r1938b2412],
17	lowest	JJS	O	lowest	amod	18	SENT_101	[p9l1967t2344r2144b2412, p9l11t2457r118b2515],
18	value	NN	O	value	prep_with	10	SENT_101	[p9l139t2447r373b2515],
19	.	.	O	.	_	0	SENT_101	[p9l139t2447r373b2515],

1	Determinations	NNS	O	determination	nsubjpass	3	SENT_102	[p9l400t2450r1010b2515],
2	were	VBD	O	be	auxpass	3	SENT_102	[p9l1034t2471r1224b2515],
3	made	VBN	O	make	_	0	SENT_102	[p9l1248t2447r1463b2515],
4	in	IN	O	in	_	0	SENT_102	[p9l1488t2450r1566b2514],
5	quadruplicate	NN	O	quadruplicate	prep_in	3	SENT_102	[p9l1590t2447r2144b2536],
6	on	IN	O	on	_	0	SENT_102	[p9l12t2573r110b2617],
7	4	CD	NUMBER	4	num	9	SENT_102	[p9l148t2559r190b2616],
8	separate	JJ	O	separate	amod	9	SENT_102	[p9l233t2559r562b2638],
9	days	NNS	DURATION	day	prep_on	5	SENT_102	[p9l605t2548r784b2638],
10	and	CC	O	and	_	0	SENT_102	[p9l825t2548r973b2617],
11	results	NNS	O	result	nsubj	12	SENT_102	[p9l1010t2548r1277b2617],
12	averaged	VBD	O	average	conj_and	3	SENT_102	[p9l1319t2548r1694b2638],
13	.	.	O	.	_	0	SENT_102	[p9l1319t2548r1694b2638],

1	Interassay	JJ	O	interassay	amod	2	SENT_103	[p9l1738t2553r2146b2638],
2	variability	NN	O	variability	nsubj	3	SENT_103	[p9l8t2650r427b2740],
3	averaged	VBD	O	average	_	0	SENT_103	[p9l502t2650r859b2740],
4	29	CD	PERCENT	29	num	5	SENT_103	[p9l937t2650r1109b2724],
5	%	NN	PERCENT	%	nn	12	SENT_103	[p9l937t2650r1109b2724],
6	(	CD	NUMBER	(	num	9	SENT_103	[p9l1197t2651r1629b2740],
7	Spearman	NNP	PERSON	Spearman	nn	9	SENT_103	[p9l1197t2651r1629b2740],
8	correlation	NN	O	correlation	nn	9	SENT_103	[p9l1705t2650r2145b2719],
9	coefficient	NN	O	coefficient	dep	5	SENT_103	[p9l11t2751r437b2819],
10	=	JJ	O	=	amod	12	SENT_103	[p9l467t2784r513b2806],
11	0.91	CD	NUMBER	0.91	tmod	10	SENT_103	[p9l546t2751r762b2831],
12	)	NN	O	)	dobj	3	SENT_103	[p9l546t2751r762b2831],
13	.	.	O	.	_	0	SENT_103	[p9l546t2751r762b2831],

1	UGTZB7	NN	O	ugtzb7	nn	2	SENT_104	[p9l9t2981r360b3046],
2	Genotyping	NN	O	genotyping	_	0	SENT_104	[p9l395t2980r870b3067],

1	Genomic	JJ	O	genomic	amod	2	SENT_105	[p9l10t3190r370b3255],
2	DNA	NN	O	dna	nsubjpass	4	SENT_105	[p9l418t3191r618b3254],
3	was	VBD	O	be	auxpass	4	SENT_105	[p9l663t3211r816b3255],
4	isolated	VBN	O	isolate	_	0	SENT_105	[p9l866t3186r1183b3255],
5	from	IN	O	from	_	0	SENT_105	[p9l1230t3187r1418b3255],
6	blood	NN	O	blood	nn	7	SENT_105	[p9l1462t3186r1693b3255],
7	spots	NNS	O	spot	prep_from	4	SENT_105	[p9l1742t3197r1947b3276],
8	collected	VBN	O	collect	partmod	7	SENT_105	[p9l1997t3186r2143b3255, p9l10t3288r253b3357],
9	from	IN	O	from	_	0	SENT_105	[p9l313t3289r501b3357],
10	patients	NNS	O	patient	prep_from	8	SENT_105	[p9l560t3292r880b3378],
11	onto	IN	O	onto	_	0	SENT_105	[p9l944t3299r1119b3357],
12	Whatman	NNP	PERSON	Whatman	nn	24	SENT_105	[p9l1178t3288r1572b3357],
13	FTA	NNP	O	FTA	nn	24	SENT_105	[p9l1631t3293r1803b3356],
14	Classic	NNP	O	Classic	nn	24	SENT_105	[p9l1863t3288r2143b3357],
15	Cards	NNP	O	Cards	nn	24	SENT_105	[p9l10t3389r236b3457],
16	(	NNP	O	(	nn	24	SENT_105	[p9l304t3389r722b3469],
17	Whatman	NNP	ORGANIZATION	Whatman	nn	24	SENT_105	[p9l304t3389r722b3469],
18	International	NNP	ORGANIZATION	International	nn	24	SENT_105	[p9l783t3389r1308b3457],
19	Ltd	NNP	ORGANIZATION	Ltd	nn	24	SENT_105	[p9l1371t3389r1526b3468],
20	,	,	O	,	_	0	SENT_105	[p9l1371t3389r1526b3468],
21	Kent	NNP	PERSON	Kent	appos	24	SENT_105	[p9l1592t3394r1802b3468],
22	,	,	O	,	_	0	SENT_105	[p9l1592t3394r1802b3468],
23	United	NNP	LOCATION	United	appos	24	SENT_105	[p9l1867t3389r2145b3457],
24	Kingdom	NNP	LOCATION	Kingdom	prep_onto	8	SENT_105	[p9l10t3491r407b3580],
25	)	CD	NUMBER	)	num	24	SENT_105	[p9l10t3491r407b3580],
26	according	VBG	O	accord	_	0	SENT_105	[p9l447t3491r842b3580],
27	to	TO	O	to	prepc_according_to	24	SENT_105	[p9l875t3501r949b3559],
28	the	DT	O	the	det	29	SENT_105	[p9l985t3491r1108b3559],
29	manufacturer	NN	O	manufacturer	poss	31	SENT_105	[p9l1143t3491r1746b3559],
30	’s	POS	O	’s	_	0	SENT_105	[p9l1143t3491r1746b3559],
31	protocol	NN	O	protocol	pobj	24	SENT_105	[p9l1783t3491r2139b3581],
32	.	.	O	.	_	0	SENT_105	[p9l1783t3491r2139b3581],

1	Genomic	JJ	O	genomic	amod	2	SENT_106	[p9l10t3595r370b3659],
2	DNA	NN	O	dna	nsubjpass	5	SENT_106	[p9l421t3596r620b3659],
3	was	VBD	O	be	auxpass	5	SENT_106	[p9l669t3616r821b3659],
4	also	RB	O	also	advmod	5	SENT_106	[p9l875t3592r1031b3659],
5	isolated	VBN	O	isolate	_	0	SENT_106	[p9l1083t3592r1400b3659],
6	from	IN	O	from	_	0	SENT_106	[p9l1450t3592r1639b3659],
7	the	DT	O	the	det	11	SENT_106	[p9l1687t3592r1811b3659],
8	human	JJ	O	human	amod	11	SENT_106	[p9l1861t3592r2145b3659],
9	liver	NN	O	liver	nn	11	SENT_106	[p10l10t25r194b93],
10	bank	NN	O	bank	nn	11	SENT_106	[p10l227t25r426b93],
11	tissues	NNS	O	tissue	prep_from	5	SENT_106	[p10l459t28r730b93],
12	using	VBG	O	use	xcomp	5	SENT_106	[p10l768t28r987b114],
13	DNAzol	NN	O	dnazol	nn	14	SENT_106	[p10l1022t25r1346b93],
14	reagent	NN	O	reagent	dobj	12	SENT_106	[p10l1381t35r1676b114],
15	and	CC	O	and	_	0	SENT_106	[p10l1713t25r1861b93],
16	stored	VBD	O	store	conj_and	5	SENT_106	[p10l1899t25r2145b93],
17	at	IN	O	at	_	0	SENT_106	[p10l11t136r81b195],
18	—	CD	NUMBER	—	number	19	SENT_106	[p10l111t130r352b195],
19	80	CD	NUMBER	80	num	21	SENT_106	[p10l111t130r352b195],
20	°	NN	O	°	nn	21	SENT_106	[p10l111t130r352b195],
21	C	NN	O	c	prep_at	16	SENT_106	[p10l111t130r352b195],
22	until	IN	O	until	_	0	SENT_106	[p10l387t126r580b195],
23	use	NN	O	use	prep_until	16	SENT_106	[p10l614t151r769b195],
24	.	.	O	.	_	0	SENT_106	[p10l614t151r769b195],

1	Genotypes	NNS	O	genotype	nsubj	9	SENT_107	[p10l809t130r1232b216],
2	for	IN	O	for	_	0	SENT_107	[p10l1269t127r1380b195],
3	the	DT	O	the	det	5	SENT_107	[p10l1412t126r1536b195],
4	UGTZB7	NN	O	ugtzb7	nn	5	SENT_107	[p10l1581t130r1922b195],
5	exon	NN	O	exon	prep_for	1	SENT_107	[p10l1953t151r2145b195],
6	2	CD	NUMBER	2	num	8	SENT_107	[p10l13t238r50b296],
7	single-nucleotide	JJ	O	single-nucleotide	amod	8	SENT_107	[p10l80t228r780b318],
8	polymorphisms	NNS	O	polymorphism	dep	5	SENT_107	[p10l805t228r1442b318],
9	(	VBP	O	(	_	0	SENT_107	[p10l1472t229r1736b309],
10	SNPs	NNS	O	snp	dobj	9	SENT_107	[p10l1472t229r1736b309],
11	)	CD	NUMBER	)	num	12	SENT_107	[p10l1472t229r1736b309],
12	o.	NN	O	o.	dep	10	SENT_107	[p10l1765t232r2144b297],
13	802C	NN	O	802c	dep	31	SENT_107	[p10l1765t232r2144b297],
14	>	JJR	O	>	amod	15	SENT_107	[p10l1765t232r2144b297],
15	T	NN	O	t	dep	13	SENT_107	[p10l1765t232r2144b297],
16	(	CD	NUMBER	(	num	17	SENT_107	[p10l14t329r332b409],
17	HZBSY	NN	O	hzbsy	dep	15	SENT_107	[p10l14t329r332b409],
18	;	:	O	;	_	0	SENT_107	[p10l14t329r332b409],
19	UGT2B7	NN	O	ugt2b7	nn	20	SENT_107	[p10l433t333r889b408],
20	*	NN	O	*	dep	15	SENT_107	[p10l433t333r889b408],
21	2	CD	NUMBER	2	dep	20	SENT_107	[p10l433t333r889b408],
22	;	:	O	;	_	0	SENT_107	[p10l433t333r889b408],
23	137439366	CD	NUMBER	137439366	num	24	SENT_107	[p10l978t329r1421b410],
24	)	CD	NUMBER	)	dep	15	SENT_107	[p10l978t329r1421b410],
25	and	CC	O	and	_	0	SENT_107	[p10l1514t329r1662b397],
26	C.	NNP	O	C.	nn	27	SENT_107	[p10l1750t333r2147b397],
27	735A	NNP	O	735A	dep	15	SENT_107	[p10l1750t333r2147b397],
28	>	JJR	O	>	amod	29	SENT_107	[p10l1750t333r2147b397],
29	G	NN	O	g	dep	31	SENT_107	[p10l1750t333r2147b397],
30	(	CD	NUMBER	(	num	31	SENT_107	[p10l14t431r550b512],
31	UGT2B7	NN	O	ugt2b7	dep	10	SENT_107	[p10l14t431r550b512],
32	*	CD	NUMBER	*	num	33	SENT_107	[p10l14t431r550b512],
33	1c	NN	O	1c	dep	31	SENT_107	[p10l14t431r550b512],
34	;	:	O	;	_	0	SENT_107	[p10l14t431r550b512],
35	rs28365062	NN	O	rs28365062	nn	36	SENT_107	[p10l637t431r1130b512],
36	)	NN	O	)	nsubjpass	38	SENT_107	[p10l637t431r1130b512],
37	were	VBD	O	be	auxpass	38	SENT_107	[p10l1219t455r1412b499],
38	determined	VBN	O	determine	parataxis	9	SENT_107	[p10l1502t431r1965b499],
39	by	IN	O	by	_	0	SENT_107	[p10l2047t431r2146b520],
40	genomic	JJ	O	genomic	amod	42	SENT_107	[p10l9t536r350b622],
41	PCR	NN	O	pcr	nn	42	SENT_107	[p10l379t536r551b601],
42	amplification	NN	O	amplification	agent	38	SENT_107	[p10l577t533r1122b622],
43	and	CC	O	and	_	0	SENT_107	[p10l1150t533r1298b601],
44	direct	JJ	O	direct	amod	45	SENT_107	[p10l1328t533r1560b601],
45	sequencing	NN	O	sequencing	agent	38	SENT_107	[p10l1588t536r2043b622],
46	of	IN	O	of	_	0	SENT_107	[p10l2072t533r2152b601],
47	exon	NN	O	exon	prep_of	42	SENT_107	[p10l11t660r204b704],
48	2	CD	NUMBER	2	num	47	SENT_107	[p10l240t645r277b703],
49	as	IN	O	as	mark	53	SENT_107	[p10l316t660r392b704],
50	we	PRP	O	we	nsubj	53	SENT_107	[p10l426t660r540b704],
51	have	VBP	O	have	aux	53	SENT_107	[p10l574t636r762b704],
52	previously	RB	DATE	previously	advmod	53	SENT_107	[p10l796t636r1228b725],
53	described	VBN	O	describe	advcl	38	SENT_107	[p10l1263t636r1652b704],
54	with	IN	O	with	_	0	SENT_107	[p10l1684t636r1869b704],
55	minor	JJ	O	minor	amod	56	SENT_107	[p10l1901t639r2146b704],
56	modifications	NNS	O	modification	prep_with	53	SENT_107	[p10l9t736r652b804],
57	.	.	O	.	_	0	SENT_107	[p10l9t736r652b804],

1	”	NN	O	”	nn	2	SENT_108	[p10l9t736r652b804],
2	Primers	NNS	O	primer	nsubj	3	SENT_108	[p10l692t740r1003b804],
3	included	VBD	O	include	_	0	SENT_108	[p10l1046t736r1407b804],
4	forward	RB	O	forward	advmod	3	SENT_108	[p10l1447t736r1764b804],
5	PRI-122	NN	O	pri-122	dobj	3	SENT_108	[p10l1802t741r2141b815],
6	,	,	O	,	_	0	SENT_108	[p10l1802t741r2141b815],
7	5	CD	NUMBER	5	appos	5	SENT_108	[p10l13t842r289b905],
8	'	''	O	'	_	0	SENT_108	[p10l13t842r289b905],
9	-	:	O	-	_	0	SENT_108	[p10l13t842r289b905],
10	TTA	NNP	ORGANIZATION	TTA	nn	11	SENT_108	[p10l13t842r289b905],
11	TGA	NNP	O	TGA	dep	13	SENT_108	[p10l328t841r517b905],
12	TTA	NNP	O	TTA	nn	13	SENT_108	[p10l557t842r734b904],
13	TGA	NNP	O	TGA	dobj	3	SENT_108	[p10l774t841r963b905],
14	GCA	NN	O	gca	nn	17	SENT_108	[p10l1003t841r1191b905],
15	TAC	NN	O	tac	nn	17	SENT_108	[p10l1231t841r1407b905],
16	TGA	NN	O	tga	nn	17	SENT_108	[p10l1448t841r1637b905],
17	TGC-3	NN	O	tgc-3	dep	13	SENT_108	[p10l1676t841r1953b905],
18	'	''	O	'	_	0	SENT_108	[p10l1676t841r1953b905],
19	and	CC	O	and	_	0	SENT_108	[p10l1997t837r2145b905],
20	reverse	VB	O	reverse	dep	21	SENT_108	[p10l8t963r296b1007],
21	PR1-123	NN	O	pr1-123	dep	13	SENT_108	[p10l345t944r685b1018],
22	,	,	O	,	_	0	SENT_108	[p10l345t944r685b1018],
23	5	CD	NUMBER	5	dep	3	SENT_108	[p10l741t943r1015b1007],
24	'	''	O	'	_	0	SENT_108	[p10l741t943r1015b1007],
25	-	:	O	-	_	0	SENT_108	[p10l741t943r1015b1007],
26	TAC	NN	O	tac	dep	23	SENT_108	[p10l741t943r1015b1007],
27	TTG	NN	O	ttg	nn	30	SENT_108	[p10l1065t943r1245b1007],
28	CAC	NN	O	cac	nn	30	SENT_108	[p10l1293t943r1475b1007],
29	ATA	NN	ORGANIZATION	ata	nn	30	SENT_108	[p10l1524t944r1705b1006],
30	TTC	NN	O	ttc	dep	26	SENT_108	[p10l1753t943r1926b1007],
31	TAT	NN	O	tat	nn	33	SENT_108	[p10l1976t944r2144b1006],
32	CTT	NN	O	ctt	nn	33	SENT_108	[p10l10t1045r183b1109],
33	TTG-3	NN	O	ttg-3	dep	23	SENT_108	[p10l257t1045r556b1109],
34	'	''	O	'	_	0	SENT_108	[p10l257t1045r556b1109],
35	.	.	O	.	_	0	SENT_108	[p10l257t1045r556b1109],

1	The	DT	O	the	det	5	SENT_109	[p10l635t1041r788b1109],
2	PCR	NN	O	pcr	nn	5	SENT_109	[p10l862t1045r1033b1109],
3	method	NN	O	method	nn	5	SENT_109	[p10l1104t1041r1412b1109],
4	(	NN	O	(	nn	5	SENT_109	[p10l1490t1041r2141b1131],
5	GeneAmp9600	NN	O	geneamp9600	nsubj	15	SENT_109	[p10l1490t1041r2141b1131],
6	,	,	O	,	_	0	SENT_109	[p10l1490t1041r2141b1131],
7	Applied	NNP	O	Applied	nn	8	SENT_109	[p10l9t1143r345b1232],
8	Biosystems	NNP	O	Biosystems	appos	5	SENT_109	[p10l395t1146r878b1232],
9	,	,	O	,	_	0	SENT_109	[p10l395t1146r878b1232],
10	Foster	NNP	LOCATION	Foster	nn	11	SENT_109	[p10l932t1148r1184b1211],
11	City	NNP	LOCATION	City	appos	5	SENT_109	[p10l1234t1146r1414b1232],
12	,	,	O	,	_	0	SENT_109	[p10l1234t1146r1414b1232],
13	California	NNP	LOCATION	California	nn	14	SENT_109	[p10l1468t1143r1900b1224],
14	)	NN	O	)	appos	5	SENT_109	[p10l1468t1143r1900b1224],
15	used	VBD	O	use	_	0	SENT_109	[p10l1954t1143r2145b1211],
16	an	DT	O	a	det	18	SENT_109	[p10l11t1270r106b1313],
17	initial	JJ	O	initial	amod	18	SENT_109	[p10l147t1246r390b1313],
18	denaturation	NN	O	denaturation	dobj	15	SENT_109	[p10l434t1246r954b1313],
19	at	IN	O	at	_	0	SENT_109	[p10l995t1256r1065b1313],
20	94	CD	NUMBER	94	number	21	SENT_109	[p10l1108t1249r1294b1313],
21	°	CD	NUMBER	°	num	22	SENT_109	[p10l1108t1249r1294b1313],
22	C	NN	O	c	prep_at	18	SENT_109	[p10l1108t1249r1294b1313],
23	for	IN	O	for	_	0	SENT_109	[p10l1337t1246r1446b1313],
24	4	CD	DURATION	4	num	25	SENT_109	[p10l1486t1256r1529b1313],
25	minutes	NNS	NUMBER	minute	prep_for	18	SENT_109	[p10l1571t1249r1922b1324],
26	,	,	O	,	_	0	SENT_109	[p10l1571t1249r1922b1324],
27	then	RB	O	then	advmod	18	SENT_109	[p10l1965t1246r2145b1313],
28	40	CD	NUMBER	40	num	29	SENT_109	[p10l10t1357r102b1416],
29	cycles	NNS	O	cycle	dep	18	SENT_109	[p10l149t1347r393b1437],
30	of	IN	O	of	_	0	SENT_109	[p10l441t1348r521b1416],
31	94	CD	NUMBER	94	number	32	SENT_109	[p10l559t1351r745b1416],
32	°	CD	NUMBER	°	num	33	SENT_109	[p10l559t1351r745b1416],
33	C	NN	O	c	prep_of	29	SENT_109	[p10l559t1351r745b1416],
34	for	IN	O	for	_	0	SENT_109	[p10l790t1348r899b1416],
35	30	CD	DURATION	30	num	36	SENT_109	[p10l945t1357r1033b1416],
36	seconds	NNS	NUMBER	seconds	prep_for	33	SENT_109	[p10l1080t1347r1422b1426],
37	,	,	O	,	_	0	SENT_109	[p10l1080t1347r1422b1426],
38	62	CD	NUMBER	62	num	40	SENT_109	[p10l1471t1351r1657b1416],
39	°	NN	O	°	nn	40	SENT_109	[p10l1471t1351r1657b1416],
40	C	NN	O	c	dobj	15	SENT_109	[p10l1471t1351r1657b1416],
41	for	IN	O	for	_	0	SENT_109	[p10l1702t1348r1812b1416],
42	30	CD	DURATION	30	num	43	SENT_109	[p10l1857t1357r1946b1416],
43	seconds	NNS	NUMBER	seconds	prep_for	40	SENT_109	[p10l1993t1372r2144b1416, p10l12t1449r225b1528],
44	,	,	O	,	_	0	SENT_109	[p10l1993t1372r2144b1416, p10l12t1449r225b1528],
45	and	CC	O	and	_	0	SENT_109	[p10l260t1449r408b1518],
46	72	CD	NUMBER	72	num	48	SENT_109	[p10l444t1453r627b1518],
47	°	NN	O	°	nn	48	SENT_109	[p10l444t1453r627b1518],
48	C	NN	O	c	dobj	15	SENT_109	[p10l444t1453r627b1518],
49	for	IN	O	for	_	0	SENT_109	[p10l659t1450r769b1518],
50	30	CD	DURATION	30	num	51	SENT_109	[p10l803t1459r891b1518],
51	seconds	NNS	NUMBER	seconds	prep_for	48	SENT_109	[p10l926t1449r1268b1528],
52	,	,	O	,	_	0	SENT_109	[p10l926t1449r1268b1528],
53	followed	VBN	O	follow	_	0	SENT_109	[p10l1302t1449r1659b1518],
54	by	IN	O	by	prepc_followed_by	15	SENT_109	[p10l1686t1449r1785b1539],
55	72	CD	NUMBER	72	number	56	SENT_109	[p10l1820t1453r2003b1518],
56	°	CD	NUMBER	°	num	57	SENT_109	[p10l1820t1453r2003b1518],
57	C	NN	O	c	pobj	15	SENT_109	[p10l1820t1453r2003b1518],
58	for	IN	O	for	_	0	SENT_109	[p10l2036t1450r2146b1518],
59	15	CD	DURATION	15	num	60	SENT_109	[p10l14t1562r99b1619],
60	minutes	NNS	NUMBER	minute	prep_for	57	SENT_109	[p10l152t1555r499b1619],
61	.	.	O	.	_	0	SENT_109	[p10l152t1555r499b1619],

1	The	DT	O	the	det	4	SENT_110	[p10l553t1551r706b1619],
2	829-bp	JJ	O	829-bp	amod	4	SENT_110	[p10l758t1551r1030b1641],
3	PCR	NN	MISC	pcr	nn	4	SENT_110	[p10l1081t1555r1253b1619],
4	product	NN	O	product	nsubjpass	6	SENT_110	[p10l1299t1551r1618b1641],
5	was	VBD	O	be	auxpass	6	SENT_110	[p10l1664t1575r1816b1619],
6	treated	VBN	O	treat	_	0	SENT_110	[p10l1866t1551r2145b1619],
7	with	IN	O	with	_	0	SENT_110	[p10l9t1653r194b1721],
8	ExoSapit	NN	O	exosapit	prep_with	6	SENT_110	[p10l234t1657r599b1743],
9	(	CD	NUMBER	(	num	8	SENT_110	[p10l644t1653r844b1734],
10	USB	JJ	ORGANIZATION	usb	amod	11	SENT_110	[p10l644t1653r844b1734],
11	Corporation	NNP	ORGANIZATION	Corporation	tmod	6	SENT_110	[p10l891t1657r1398b1743],
12	,	,	O	,	_	0	SENT_110	[p10l891t1657r1398b1743],
13	Cleveland	NNP	LOCATION	Cleveland	appos	11	SENT_110	[p10l1444t1653r1871b1732],
14	,	,	O	,	_	0	SENT_110	[p10l1444t1653r1871b1732],
15	Ohio	NNP	LOCATION	Ohio	nn	16	SENT_110	[p10l1918t1653r2140b1734],
16	)	NN	O	)	appos	13	SENT_110	[p10l1918t1653r2140b1734],
17	and	CC	O	and	_	0	SENT_110	[p10l11t1755r159b1823],
18	cycle	NN	O	cycle	appos	13	SENT_110	[p10l224t1755r430b1844],
19	sequenced	VBN	O	sequence	partmod	16	SENT_110	[p10l497t1755r922b1844],
20	(	CD	NUMBER	(	num	22	SENT_110	[p10l990t1755r1169b1836],
21	ABI	NNP	O	ABI	nn	22	SENT_110	[p10l990t1755r1169b1836],
22	Prism	NNP	O	Prism	dobj	19	SENT_110	[p10l1232t1758r1467b1823],
23	3100	CD	NUMBER	3100	num	22	SENT_110	[p10l1534t1765r1746b1834],
24	,	,	O	,	_	0	SENT_110	[p10l1534t1765r1746b1834],
25	Applied	NNP	ORGANIZATION	Applied	nn	27	SENT_110	[p10l1812t1755r2145b1844],
26	Biosystems	NNP	ORGANIZATION	Biosystems	nn	27	SENT_110	[p10l10t1858r491b1947],
27	)	NN	O	)	appos	22	SENT_110	[p10l10t1858r491b1947],
28	using	VBG	O	use	partmod	27	SENT_110	[p10l521t1861r740b1947],
29	PRI-123	NN	O	pri-123	dobj	28	SENT_110	[p10l765t1862r1103b1926],
30	.	.	O	.	_	0	SENT_110	[p10l765t1862r1103b1926],

1	UGT2B7	NN	O	ugt2b7	_	0	SENT_111	[p10l1145t1861r1646b1936],
2	*	CD	NUMBER	*	num	3	SENT_111	[p10l1145t1861r1646b1936],
3	1a	NN	O	1a	nsubj	13	SENT_111	[p10l1145t1861r1646b1936],
4	,	,	O	,	_	0	SENT_111	[p10l1145t1861r1646b1936],
5	UGT2B7	NN	O	ugt2b7	nn	6	SENT_111	[p10l1685t1861r2141b1936],
6	*	NN	O	*	appos	3	SENT_111	[p10l1685t1861r2141b1936],
7	2	CD	NUMBER	2	dep	6	SENT_111	[p10l1685t1861r2141b1936],
8	,	,	O	,	_	0	SENT_111	[p10l1685t1861r2141b1936],
9	and	CC	O	and	_	0	SENT_111	[p10l11t1960r159b2028],
10	UGT2B7	NN	O	ugt2b7	conj_and	3	SENT_111	[p10l195t1963r672b2028],
11	*	CD	NUMBER	*	num	13	SENT_111	[p10l195t1963r672b2028],
12	1c	NN	O	1c	nn	13	SENT_111	[p10l195t1963r672b2028],
13	alleles	NNS	O	allele	rcmod	1	SENT_111	[p10l701t1960r956b2028],
14	(	VBP	O	(	rcmod	13	SENT_111	[p10l988t1960r1410b2049],
15	according	VBG	O	accord	_	0	SENT_111	[p10l988t1960r1410b2049],
16	to	TO	O	to	prepc_according_to	14	SENT_111	[p10l1435t1970r1509b2028],
17	the	DT	O	the	det	22	SENT_111	[p10l1536t1960r1660b2028],
18	UGT	NNP	ORGANIZATION	UGT	nn	22	SENT_111	[p10l1687t1963r1875b2028],
19	Allele	NNP	ORGANIZATION	Allele	nn	22	SENT_111	[p10l1901t1960r2144b2028],
20	Nomenclature	NNP	ORGANIZATION	Nomenclature	nn	22	SENT_111	[p10l9t2061r584b2130],
21	Committee	NNP	ORGANIZATION	Committee	nn	22	SENT_111	[p10l635t2065r1074b2130],
22	recommendation	NN	O	recommendation	pobj	14	SENT_111	[p10l1123t2061r1834b2140],
23	;	:	O	;	_	0	SENT_111	[p10l1123t2061r1834b2140],
24	http	NN	O	http	dep	13	SENT_111	[p10l1886t2061r2144b2151],
25	:	:	O	:	_	0	SENT_111	[p10l1886t2061r2144b2151],
26	/	:	O	/	punct	24	SENT_111	[p10l1886t2061r2144b2151],
27	/	:	O	/	punct	1	SENT_111	[p10l1886t2061r2144b2151],
28	www.ugtalleles.ulaval.ca	NN	O	www.ugtalleles.ulaval.ca	nn	29	SENT_111	[p10l9t2163r1054b2253],
29	)	NN	O	)	nsubjpass	31	SENT_111	[p10l9t2163r1054b2253],
30	were	VBD	O	be	auxpass	31	SENT_111	[p10l1122t2187r1315b2231],
31	inferred	VBN	O	infer	dep	1	SENT_111	[p10l1381t2163r1703b2231],
32	from	IN	O	from	_	0	SENT_111	[p10l1768t2163r1956b2231],
33	the	DT	O	the	det	36	SENT_111	[p10l2019t2163r2144b2231],
34	SNP	NN	O	snp	nn	36	SENT_111	[p10l12t2269r182b2333],
35	genotype	NN	O	genotype	nn	36	SENT_111	[p10l214t2275r581b2355],
36	data	NNS	O	datum	prep_from	31	SENT_111	[p10l617t2265r802b2333],
37	.	.	O	.	_	0	SENT_111	[p10l617t2265r802b2333],

1	Statistical	JJ	O	statistical	amod	2	SENT_112	[p10l11t2491r421b2560],
2	Analysis	NN	O	analysis	_	0	SENT_112	[p10l452t2491r810b2581],

1	All	DT	O	all	det	4	SENT_113	[p10l9t2700r133b2768],
2	analytic	JJ	O	analytic	amod	4	SENT_113	[p10l204t2700r523b2790],
3	statistical	JJ	O	statistical	amod	4	SENT_113	[p10l596t2700r980b2769],
4	analyses	NNS	O	analysis	nsubjpass	6	SENT_113	[p10l1051t2700r1389b2790],
5	were	VBD	O	be	auxpass	6	SENT_113	[p10l1460t2725r1653b2769],
6	performed	VBN	O	perform	_	0	SENT_113	[p10l1723t2700r2145b2790],
7	using	VBG	O	use	xcomp	6	SENT_113	[p10l9t2806r228b2892],
8	Sigmaplot	NNP	O	Sigmaplot	dobj	7	SENT_113	[p10l304t2802r714b2892],
9	11	CD	NUMBER	11	num	8	SENT_113	[p10l790t2813r875b2870],
10	software	NN	O	software	nn	12	SENT_113	[p10l955t2802r1294b2870],
11	(	CD	NUMBER	(	num	12	SENT_113	[p10l1373t2802r1663b2892],
12	Systat	NNP	O	Systat	dep	8	SENT_113	[p10l1373t2802r1663b2892],
13	,	,	O	,	_	0	SENT_113	[p10l1373t2802r1663b2892],
14	San	NNP	LOCATION	San	nn	15	SENT_113	[p10l1742t2806r1888b2870],
15	Jose	NNP	LOCATION	Jose	appos	8	SENT_113	[p10l1957t2807r2141b2887],
16	,	,	O	,	_	0	SENT_113	[p10l1957t2807r2141b2887],
17	California	NNP	LOCATION	California	nn	18	SENT_113	[p10l10t2904r461b2985],
18	)	NN	O	)	appos	15	SENT_113	[p10l10t2904r461b2985],
19	.	.	O	.	_	0	SENT_113	[p10l10t2904r461b2985],

1	This	DT	O	this	det	2	SENT_114	[p10l535t2904r711b2972],
2	software	NN	O	software	nsubj	4	SENT_114	[p10l784t2904r1123b2972],
3	automatically	RB	O	automatically	advmod	4	SENT_114	[p10l1195t2904r1750b2993],
4	assesses	VBZ	O	assess	_	0	SENT_114	[p10l1819t2928r2143b2972],
5	data	NNS	O	datum	dobj	4	SENT_114	[p10l12t3006r181b3074],
6	for	IN	O	for	_	0	SENT_114	[p10l229t3006r339b3074],
7	normality	NN	O	normality	prep_for	4	SENT_114	[p10l387t3006r787b3095],
8	of	IN	O	of	_	0	SENT_114	[p10l837t3006r918b3074],
9	distribution	NN	O	distribution	nn	12	SENT_114	[p10l962t3006r1445b3074],
10	and	CC	O	and	_	0	SENT_114	[p10l1494t3006r1643b3074],
11	equal	JJ	O	equal	nn	12	SENT_114	[p10l1693t3006r1910b3095],
12	variance	NN	O	variance	prep_of	7	SENT_114	[p10l1958t3009r2144b3074, p10l11t3133r193b3177],
13	to	TO	O	to	aux	14	SENT_114	[p10l229t3119r303b3177],
14	ensure	VB	O	ensure	xcomp	4	SENT_114	[p10l341t3133r606b3177],
15	appropriateness	NN	O	appropriateness	dobj	14	SENT_114	[p10l643t3112r1289b3198],
16	of	IN	O	of	_	0	SENT_114	[p10l1328t3109r1409b3177],
17	parametric	JJ	O	parametric	amod	20	SENT_114	[p10l1436t3112r1870b3198],
18	statistical	JJ	O	statistical	amod	20	SENT_114	[p10l1909t3112r2144b3177, p10l9t3210r183b3279],
19	testing	NN	O	testing	nn	20	SENT_114	[p10l201t3214r470b3300],
20	methods	NNS	O	method	prep_of	15	SENT_114	[p10l488t3210r858b3289],
21	,	,	O	,	_	0	SENT_114	[p10l488t3210r858b3289],
22	and	CC	O	and	_	0	SENT_114	[p10l881t3210r1029b3279],
23	if	IN	O	if	mark	24	SENT_114	[p10l1048t3211r1110b3278],
24	necessary	JJ	O	necessary	advcl	29	SENT_114	[p10l1121t3235r1528b3300],
25	,	,	O	,	_	0	SENT_114	[p10l1121t3235r1528b3300],
26	nonparametric	JJ	O	nonparametric	amod	27	SENT_114	[p10l1549t3214r2143b3300],
27	tests	NNS	O	test	nsubjpass	29	SENT_114	[p10l9t3321r186b3379],
28	are	VBP	O	be	auxpass	29	SENT_114	[p10l223t3335r340b3379],
29	used	VBN	O	use	conj_and	4	SENT_114	[p10l373t3311r562b3379],
30	instead	RB	O	instead	advmod	29	SENT_114	[p10l596t3311r907b3379],
31	.	.	O	.	_	0	SENT_114	[p10l596t3311r907b3379],

1	All	DT	O	all	det	2	SENT_115	[p10l945t3311r1069b3378],
2	data	NNS	O	datum	nsubjpass	4	SENT_115	[p10l1106t3312r1273b3379],
3	were	VBD	O	be	auxpass	4	SENT_115	[p10l1304t3335r1497b3379],
4	summarized	VBN	O	summarize	_	0	SENT_115	[p10l1533t3311r2032b3379],
5	as	IN	O	as	_	0	SENT_115	[p10l2066t3335r2143b3379],
6	mean	NN	O	mean	prep_as	4	SENT_115	[p11l9t48r229b92],
7	and	CC	O	and	_	0	SENT_115	[p11l256t24r404b92],
8	standard	JJ	O	standard	prep_as	4	SENT_115	[p11l433t24r783b92],
9	deviation	NN	O	deviation	nn	12	SENT_115	[p11l812t24r1192b92],
10	(	CD	NUMBER	(	num	12	SENT_115	[p11l1222t24r1411b105],
11	SD	NN	O	sd	nn	12	SENT_115	[p11l1222t24r1411b105],
12	)	NN	O	)	dep	6	SENT_115	[p11l1222t24r1411b105],
13	.	.	O	.	_	0	SENT_115	[p11l1222t24r1411b105],

1	Univariate	JJ	O	univariate	amod	2	SENT_116	[p11l1443t28r1869b92],
2	analyses	NNS	O	analysis	nsubjpass	15	SENT_116	[p11l1897t24r2143b114, p11l11t150r127b194],
3	of	IN	O	of	_	0	SENT_116	[p11l161t126r241b194],
4	effects	NNS	O	effect	prep_of	2	SENT_116	[p11l265t126r519b194],
5	of	IN	O	of	_	0	SENT_116	[p11l553t126r634b194],
6	patient	NN	O	patient	nn	7	SENT_116	[p11l656t130r940b216],
7	demographics	NNS	O	demographic	prep_of	4	SENT_116	[p11l971t126r1536b216],
8	on	IN	O	on	_	0	SENT_116	[p11l1570t150r1669b194],
9	mean	NN	O	mean	nn	10	SENT_116	[p11l1697t150r1917b194],
10	CL/F	NN	O	cl/f	prep_on	7	SENT_116	[p11l1947t126r2144b194],
11	of	IN	O	of	_	0	SENT_116	[p11l12t228r92b296],
12	each	DT	O	each	det	13	SENT_116	[p11l123t228r306b296],
13	drug	NN	O	drug	prep_of	10	SENT_116	[p11l345t228r526b317],
14	were	VBD	O	be	auxpass	15	SENT_116	[p11l562t252r755b296],
15	assessed	VBN	O	assess	_	0	SENT_116	[p11l795t228r1136b296],
16	by	IN	O	by	_	0	SENT_116	[p11l1170t228r1268b317],
17	unpaired	JJ	O	unpaired	amod	19	SENT_116	[p11l1303t228r1672b317],
18	t	NN	O	t	nn	19	SENT_116	[p11l1712t237r1738b296],
19	test	NN	O	test	agent	15	SENT_116	[p11l1770t238r1911b296],
20	(	CD	NUMBER	(	num	21	SENT_116	[p11l1951t228r2144b317, p11l12t331r140b399],
21	gender	NN	O	gender	nsubj	24	SENT_116	[p11l1951t228r2144b317, p11l12t331r140b399],
22	and	CC	O	and	_	0	SENT_116	[p11l172t331r320b399],
23	alcohol	NN	O	alcohol	conj_and	21	SENT_116	[p11l352t331r648b399],
24	use	VBP	O	use	rcmod	19	SENT_116	[p11l679t331r840b412],
25	)	CD	NUMBER	)	dobj	24	SENT_116	[p11l679t331r840b412],
26	or	CC	O	or	_	0	SENT_116	[p11l877t355r956b399],
27	by	IN	O	by	_	0	SENT_116	[p11l983t331r1082b420],
28	linear	JJ	O	linear	amod	30	SENT_116	[p11l1113t331r1347b399],
29	regression	NN	O	regression	nn	30	SENT_116	[p11l1376t334r1789b420],
30	(	NN	O	(	agent	15	SENT_116	[p11l1825t331r1960b412],
31	for	IN	O	for	_	0	SENT_116	[p11l1825t331r1960b412],
32	age	NN	O	age	prep_for	30	SENT_116	[p11l1992t355r2141b420],
33	,	,	O	,	_	0	SENT_116	[p11l1992t355r2141b420],
34	body	NN	O	body	nn	35	SENT_116	[p11l7t432r209b522],
35	weight	NN	O	weight	conj_and	30	SENT_116	[p11l235t432r510b522],
36	and	CC	O	and	_	0	SENT_116	[p11l537t432r685b501],
37	body	NN	O	body	nn	39	SENT_116	[p11l709t432r912b522],
38	mass	NN	O	mass	nn	39	SENT_116	[p11l938t457r1135b501],
39	index	NN	O	index	conj_and	30	SENT_116	[p11l1165t432r1414b511],
40	,	,	O	,	_	0	SENT_116	[p11l1165t432r1414b511],
41	baseline	NN	O	baseline	nn	43	SENT_116	[p11l1442t432r1776b501],
42	CD4	NN	O	cd4	nn	43	SENT_116	[p11l1805t436r1971b501],
43	cell	NN	O	cell	appos	39	SENT_116	[p11l2002t432r2144b501],

1	1082	CD	DATE	1082	num	2	SENT_117	[p11l13t683r202b749],
2	o	NN	O	o	_	0	SENT_117	[p11l266t709r295b738],
3	I	PRP	O	I	nsubj	4	SENT_117	[p11l357t691r386b763],
4	Clin	VBP	O	clin	rcmod	2	SENT_117	[p11l414t687r567b748],
5	Pharmacol	NNP	O	Pharmacol	dobj	4	SENT_117	[p11l593t687r996b748],
6	2009	CD	DATE	2009	num	5	SENT_117	[p11l1026t696r1715b759],
7	;	:	O	;	_	0	SENT_117	[p11l1026t696r1715b759],
8	419:1079	CD	DURATION	419:1079	num	10	SENT_117	[p11l1026t696r1715b759],
9	-1090	CD	DURATION	-1090	num	10	SENT_117	[p11l1026t696r1715b759],
10	count	NN	O	count	dep	2	SENT_117	[p11l10t792r259b861],
11	,	,	O	,	_	0	SENT_117	[p11l10t792r259b861],
12	and	CC	O	and	_	0	SENT_117	[p11l309t782r457b850],
13	HIV	NN	O	hiv	nn	16	SENT_117	[p11l502t787r663b850],
14	RNA	NN	O	rna	nn	16	SENT_117	[p11l708t787r902b850],
15	level	NN	O	level	nn	16	SENT_117	[p11l949t782r1191b863],
16	)	NN	O	)	dep	2	SENT_117	[p11l949t782r1191b863],
17	.	.	O	.	_	0	SENT_117	[p11l949t782r1191b863],

1	A	DT	O	a	det	5	SENT_118	[p11l1242t787r1308b850],
2	backward	RB	O	backward	advmod	5	SENT_118	[p11l1350t782r1746b850],
3	stepwise	JJ	O	stepwise	amod	5	SENT_118	[p11l1793t786r2142b872],
4	regression	NN	O	regression	nn	5	SENT_118	[p11l7t889r421b974],
5	analysis	NN	O	analysis	nsubjpass	12	SENT_118	[p11l451t885r775b974],
6	containing	VBG	O	contain	partmod	5	SENT_118	[p11l809t889r1239b974],
7	the	DT	O	the	det	10	SENT_118	[p11l1268t885r1392b953],
8	above	JJ	O	above	amod	10	SENT_118	[p11l1425t885r1656b953],
9	patient	NN	O	patient	nn	10	SENT_118	[p11l1687t889r1971b975],
10	factors	NNS	O	factor	dobj	6	SENT_118	[p11l2001t885r2143b953, p11l8t997r156b1055],
11	was	VBD	O	be	auxpass	12	SENT_118	[p11l180t1011r333b1055],
12	performed	VBN	O	perform	_	0	SENT_118	[p11l359t987r780b1076],
13	to	TO	O	to	aux	14	SENT_118	[p11l803t997r876b1055],
14	identify	VB	O	identify	xcomp	12	SENT_118	[p11l902t987r1220b1076],
15	independent	JJ	O	independent	amod	16	SENT_118	[p11l1243t987r1759b1076],
16	variables	NNS	O	variable	dobj	14	SENT_118	[p11l1781t987r2141b1055],
17	associated	VBN	O	associate	partmod	16	SENT_118	[p11l10t1090r425b1158],
18	with	IN	O	with	_	0	SENT_118	[p11l450t1090r635b1158],
19	CL	NN	O	cl	prep_with	17	SENT_118	[p11l660t1090r803b1158],
20	/	:	O	/	punct	21	SENT_118	[p11l660t1090r803b1158],
21	F	NN	O	f	dep	17	SENT_118	[p11l808t1094r858b1157],
22	of	IN	O	of	_	0	SENT_118	[p11l886t1090r966b1158],
23	each	DT	O	each	det	24	SENT_118	[p11l986t1090r1169b1158],
24	drug	NN	O	drug	prep_of	21	SENT_118	[p11l1197t1090r1397b1179],
25	.	.	O	.	_	0	SENT_118	[p11l1197t1090r1397b1179],

1	Possible	JJ	O	possible	amod	2	SENT_119	[p11l1427t1090r1759b1158],
2	effects	NNS	O	effect	nsubjpass	26	SENT_119	[p11l1787t1090r2042b1158],
3	of	IN	O	of	_	0	SENT_119	[p11l2071t1090r2152b1158],
4	UGTZB7	NN	O	ugtzb7	nn	7	SENT_119	[p11l19t1195r360b1260],
5	allele	NN	O	allele	nn	7	SENT_119	[p11l386t1191r602b1260],
6	carrier	NN	O	carrier	nn	7	SENT_119	[p11l635t1195r897b1260],
7	status	NN	O	status	prep_of	2	SENT_119	[p11l928t1202r1157b1260],
8	on	IN	O	on	_	0	SENT_119	[p11l1192t1216r1290b1260],
9	patient	NN	O	patient	nn	11	SENT_119	[p11l1320t1195r1604b1281],
10	pharmacokinetic	JJ	O	pharmacokinetic	amod	11	SENT_119	[p11l1633t1191r2142b1281, p11l8t1297r205b1362],
11	parameters	NNS	O	parameter	prep_on	7	SENT_119	[p11l251t1304r695b1383],
12	and	CC	O	and	_	0	SENT_119	[p11l741t1293r889b1362],
13	human	JJ	O	human	amod	17	SENT_119	[p11l932t1293r1216b1362],
14	liver	NN	O	liver	nn	17	SENT_119	[p11l1259t1293r1443b1362],
15	zidovudine	NN	O	zidovudine	nn	17	SENT_119	[p11l1486t1293r1945b1362],
16	glucuronidation	NN	O	glucuronidation	nn	17	SENT_119	[p11l1989t1294r2143b1383, p11l10t1395r535b1463],
17	rate	NN	O	rate	prep_of	2	SENT_119	[p11l603t1405r774b1474],
18	,	,	O	,	_	0	SENT_119	[p11l603t1405r774b1474],
19	UGTZB7	NN	O	ugtzb7	nn	20	SENT_119	[p11l848t1399r1192b1463],
20	protein	NN	O	protein	conj_and	7	SENT_119	[p11l1265t1399r1579b1485],
21	,	,	O	,	_	0	SENT_119	[p11l1265t1399r1579b1485],
22	and	CC	O	and	_	0	SENT_119	[p11l1653t1395r1801b1463],
23	mRNA	NN	O	mrna	nn	24	SENT_119	[p11l1870t1400r2144b1463],
24	content	NN	O	content	conj_and	7	SENT_119	[p11l10t1507r312b1565],
25	were	VBD	O	be	auxpass	26	SENT_119	[p11l336t1521r529b1565],
26	evaluated	VBN	O	evaluate	_	0	SENT_119	[p11l558t1497r948b1565],
27	using	VBG	O	use	xcomp	26	SENT_119	[p11l973t1501r1192b1586],
28	Student	NN	O	student	nn	30	SENT_119	[p11l1221t1497r1537b1565],
29	unpaired	JJ	O	unpaired	amod	30	SENT_119	[p11l1560t1497r1928b1587],
30	ttest	NN	O	ttest	dobj	27	SENT_119	[p11l1958t1507r2145b1565],
31	or	CC	O	or	_	0	SENT_119	[p11l11t1623r90b1667],
32	by	IN	O	by	conj_or	26	SENT_119	[p11l122t1599r220b1688],
33	Mann-Whitney	JJ	O	mann-whitney	amod	35	SENT_119	[p11l256t1599r872b1688],
34	rank	NN	O	rank	nn	35	SENT_119	[p11l907t1599r1089b1667],
35	sum	NN	O	sum	pobj	32	SENT_119	[p11l1125t1623r1292b1667],
36	test	NN	O	test	dep	40	SENT_119	[p11l1328t1609r1469b1667],
37	(	CD	NUMBER	(	num	36	SENT_119	[p11l1509t1599r1596b1680],
38	if	IN	O	if	dep	40	SENT_119	[p11l1509t1599r1596b1680],
39	data	NNS	O	datum	nsubj	40	SENT_119	[p11l1629t1599r1796b1667],
40	showed	VBD	O	show	ccomp	32	SENT_119	[p11l1833t1599r2144b1667],
41	nonnormal	JJ	O	nonnormal	amod	42	SENT_119	[p11l8t1702r454b1770],
42	distribution	NN	O	distribution	dobj	40	SENT_119	[p11l497t1702r975b1770],
43	and	CC	O	and	_	0	SENT_119	[p11l1015t1702r1197b1770],
44	/	:	O	/	punct	48	SENT_119	[p11l1015t1702r1197b1770],
45	or	CC	O	or	dep	48	SENT_119	[p11l1204t1726r1283b1770],
46	unequal	JJ	O	unequal	dep	48	SENT_119	[p11l1320t1702r1648b1791],
47	group	NN	O	group	nn	48	SENT_119	[p11l1687t1726r1918b1791],
48	variance	NN	O	variance	dep	42	SENT_119	[p11l1958t1705r2142b1770, p11l10t1804r241b1884],
49	)	NN	O	)	dobj	40	SENT_119	[p11l1958t1705r2142b1770, p11l10t1804r241b1884],
50	.	.	O	.	_	0	SENT_119	[p11l1958t1705r2142b1770, p11l10t1804r241b1884],

1	The	DT	O	the	det	2	SENT_120	[p11l290t1803r443b1872],
2	effect	NN	O	effect	nsubjpass	11	SENT_120	[p11l490t1804r708b1872],
3	of	IN	O	of	_	0	SENT_120	[p11l752t1804r832b1872],
4	UGTZB7	NN	O	ugtzb7	nn	5	SENT_120	[p11l879t1807r1219b1872],
5	diplotype	NN	O	diplotype	prep_of	2	SENT_120	[p11l1261t1803r1648b1893],
6	on	IN	O	on	_	0	SENT_120	[p11l1695t1828r1793b1872],
7	zidovudine	NN	O	zidovudine	nn	9	SENT_120	[p11l1837t1804r2142b1872, p11l11t1905r186b1974],
8	glucuronidation	NN	O	glucuronidation	nn	9	SENT_120	[p11l256t1905r911b1995],
9	activities	NNS	O	activity	prep_on	5	SENT_120	[p11l980t1909r1344b1974],
10	was	VBD	O	be	auxpass	11	SENT_120	[p11l1414t1930r1567b1974],
11	assessed	VBN	O	assess	_	0	SENT_120	[p11l1639t1905r1980b1974],
12	by	IN	O	by	_	0	SENT_120	[p11l2046t1905r2145b1995],
13	analysis	NN	O	analysis	agent	11	SENT_120	[p11l10t2007r333b2097],
14	of	IN	O	of	_	0	SENT_120	[p11l383t2007r464b2075],
15	variance	NN	O	variance	prep_of	13	SENT_120	[p11l500t2011r843b2075],
16	(	CD	NUMBER	(	num	15	SENT_120	[p11l894t2007r1276b2088],
17	ANOVA	NNP	ORGANIZATION	ANOVA	tmod	11	SENT_120	[p11l894t2007r1276b2088],
18	)	CD	NUMBER	)	num	17	SENT_120	[p11l894t2007r1276b2088],
19	with	IN	O	with	_	0	SENT_120	[p11l1324t2007r1509b2075],
20	post	NN	O	post	amod	24	SENT_120	[p11l1555t2018r1724b2097],
21	hoc	FW	O	hoc	dep	20	SENT_120	[p11l1768t2007r1911b2075],
22	pairwise	JJ	O	pairwise	amod	24	SENT_120	[p11l1959t2011r2143b2097, p11l7t2113r191b2177],
23	multiple	JJ	O	multiple	amod	24	SENT_120	[p11l217t2109r563b2199],
24	comparisons	NNS	O	comparison	prep_with	11	SENT_120	[p11l591t2113r1104b2199],
25	by	IN	O	by	_	0	SENT_120	[p11l1128t2109r1227b2198],
26	the	DT	O	the	det	28	SENT_120	[p11l1250t2109r1374b2177],
27	StudentNewmanKuels	NNPS	O	StudentNewmanKuels	nn	28	SENT_120	[p11l1403t2109r2142b2177, p11l9t2210r235b2277],
28	test	NN	O	test	prep_by	24	SENT_120	[p11l265t2220r424b2277],
29	.	.	O	.	_	0	SENT_120	[p11l265t2220r424b2277],

1	A	DT	O	a	det	3	SENT_121	[p11l457t2215r524b2277],
2	P	NN	O	p	nn	3	SENT_121	[p11l550t2214r608b2277],
3	value	NN	O	value	nsubjpass	9	SENT_121	[p11l629t2210r848b2277],
4	of	IN	O	of	_	0	SENT_121	[p11l880t2210r960b2277],
5	less	JJR	O	less	mwe	6	SENT_121	[p11l982t2210r1128b2277],
6	than	IN	O	than	quantmod	7	SENT_121	[p11l1158t2210r1339b2277],
7	.05	CD	NUMBER	.05	prep_of	3	SENT_121	[p11l1371t2219r1481b2277],
8	was	VBD	O	be	auxpass	9	SENT_121	[p11l1514t2234r1667b2277],
9	considered	VBN	O	consider	_	0	SENT_121	[p11l1699t2210r2145b2277],
10	significant	JJ	O	significant	acomp	9	SENT_121	[p11l10t2313r454b2402],
11	.	.	O	.	_	0	SENT_121	[p11l10t2313r454b2402],

1	Genotype	NN	O	genotype	nn	2	SENT_122	[p11l518t2316r903b2402],
2	frequencies	NNS	O	frequency	nsubjpass	4	SENT_122	[p11l963t2313r1426b2402],
3	were	VBD	O	be	auxpass	4	SENT_122	[p11l1485t2337r1679b2381],
4	tested	VBN	O	test	_	0	SENT_122	[p11l1738t2313r1977b2381],
5	for	IN	O	for	_	0	SENT_122	[p11l2035t2313r2145b2381],
6	consistency	NN	O	consistency	prep_for	4	SENT_122	[p11l10t2418r485b2504],
7	with	IN	O	with	_	0	SENT_122	[p11l517t2414r703b2483],
8	expected	VBN	O	expect	amod	10	SENT_122	[p11l739t2414r1099b2504],
9	Hardy-Weinberg	JJ	O	hardy-weinberg	amod	10	SENT_122	[p11l1132t2414r1797b2504],
10	equilibrium	NN	O	equilibrium	prep_with	4	SENT_122	[p11l1833t2414r2143b2504, p11l7t2520r203b2585],
11	by	IN	O	by	_	0	SENT_122	[p11l246t2516r344b2606],
12	the	DT	O	the	det	14	SENT_122	[p11l390t2516r514b2585],
13	chi-squared	JJ	O	chi-squared	amod	14	SENT_122	[p11l564t2516r1038b2606],
14	test	NN	O	test	prep_by	10	SENT_122	[p11l1084t2527r1244b2585],
15	.	.	O	.	_	0	SENT_122	[p11l1084t2527r1244b2585],

1	Differences	NNS	O	difference	nsubjpass	13	SENT_123	[p11l1295t2517r1750b2585],
2	in	IN	O	in	_	0	SENT_123	[p11l1800t2520r1879b2584],
3	allele	NN	O	allele	nn	4	SENT_123	[p11l1927t2516r2143b2585],
4	frequencies	NNS	O	frequency	prep_in	1	SENT_123	[p11l9t2618r472b2708],
5	between	IN	O	between	_	0	SENT_123	[p11l504t2618r845b2686],
6	patient	NN	O	patient	nn	10	SENT_123	[p11l877t2622r1161b2708],
7	and	CC	O	and	_	0	SENT_123	[p11l1193t2618r1341b2686],
8	liver	NN	O	liver	nn	10	SENT_123	[p11l1374t2618r1558b2686],
9	bank	NN	O	bank	nn	10	SENT_123	[p11l1587t2618r1786b2686],
10	samples	NNS	O	sample	prep_between	4	SENT_123	[p11l1818t2618r2141b2708],
11	were	VBD	O	be	auxpass	13	SENT_123	[p11l7t2744r201b2788],
12	also	RB	O	also	advmod	13	SENT_123	[p11l235t2720r391b2788],
13	assessed	VBN	O	assess	_	0	SENT_123	[p11l426t2720r767b2788],
14	by	IN	O	by	_	0	SENT_123	[p11l795t2720r894b2809],
15	the	DT	O	the	det	17	SENT_123	[p11l924t2720r1048b2788],
16	chi-squared	JJ	O	chi-squared	amod	17	SENT_123	[p11l1082t2720r1557b2810],
17	test	NN	O	test	agent	13	SENT_123	[p11l1588t2730r1747b2788],
18	.	.	O	.	_	0	SENT_123	[p11l1588t2730r1747b2788],

1	RESULTS	NNS	O	result	_	0	SENT_124	[p11l9t2937r405b3001],

1	Patient	NN	O	patient	nn	2	SENT_125	[p11l7t3150r298b3214],
2	Characteristics	NNS	O	characteristic	_	0	SENT_125	[p11l329t3147r947b3214],

1	Twenty-seven	CD	NUMBER	twenty-seven	num	4	SENT_126	[p12l9t83r569b167],
2	HIV/TB-coinfected	JJ	O	hiv/tb-coinfected	amod	4	SENT_126	[p12l601t78r1370b146],
3	Ghanaian	JJ	MISC	ghanaian	amod	4	SENT_126	[p12l1403t78r1789b146],
4	patients	NNS	O	patient	nsubjpass	6	SENT_126	[p12l1821t81r2142b167],
5	were	VBD	O	be	auxpass	6	SENT_126	[p12l7t205r201b249],
6	studied	VBN	O	study	_	0	SENT_126	[p12l236t181r556b249],
7	.	.	O	.	_	0	SENT_126	[p12l236t181r556b249],

1	All	DT	O	all	det	2	SENT_127	[p12l592t181r716b248],
2	patients	NNS	O	patient	nsubj	21	SENT_127	[p12l748t184r1068b270],
3	were	VBD	O	be	cop	4	SENT_127	[p12l1101t205r1294b249],
4	black	JJ	O	black	_	0	SENT_127	[p12l1324t181r1562b259],
5	,	,	O	,	_	0	SENT_127	[p12l1324t181r1562b259],
6	had	VBD	O	have	conj_and	4	SENT_127	[p12l1597t181r1747b249],
7	a	DT	O	a	det	11	SENT_127	[p12l1779t205r1819b249],
8	mean	JJ	O	mean	amod	11	SENT_127	[p12l1849t205r2069b249],
9	i	FW	O	i	nn	11	SENT_127	[p12l2098t192r2145b248],
10	SD	NN	O	sd	nn	11	SENT_127	[p12l11t285r121b350],
11	CD4	NN	O	cd4	dobj	6	SENT_127	[p12l150t285r315b350],
12	cell	NN	O	cell	nn	13	SENT_127	[p12l346t281r488b350],
13	count	NN	O	count	dep	11	SENT_127	[p12l516t292r744b350],
14	of	IN	O	of	_	0	SENT_127	[p12l771t282r851b350],
15	101	CD	NUMBER	101	prep_of	13	SENT_127	[p12l874t291r1008b350],
16	i	FW	O	i	dep	13	SENT_127	[p12l1039t293r1086b349],
17	80	CD	NUMBER	80	num	18	SENT_127	[p12l1113t291r1203b350],
18	cells/uL	NNS	O	cells/ul	dep	16	SENT_127	[p12l1233t281r1577b368],
19	,	,	O	,	_	0	SENT_127	[p12l1233t281r1577b368],
20	and	CC	O	and	_	0	SENT_127	[p12l1608t281r1756b350],
21	included	VBD	O	include	conj_and	4	SENT_127	[p12l1783t281r2144b350],
22	20	CD	NUMBER	20	num	23	SENT_127	[p12l12t394r100b453],
23	men	NNS	O	man	dobj	21	SENT_127	[p12l130t408r304b453],
24	and	CC	O	and	_	0	SENT_127	[p12l332t384r479b453],
25	7	CD	NUMBER	7	num	26	SENT_127	[p12l513t395r549b452],
26	Women	NNS	O	woman	conj_and	23	SENT_127	[p12l579t409r894b453],
27	.	.	O	.	_	0	SENT_127	[p12l579t409r894b453],

1	The	DT	O	the	det	2	SENT_128	[p12l928t384r1079b453],
2	mean	NN	O	mean	tmod	16	SENT_128	[p12l1108t409r1325b453],
3	i	FW	O	i	nsubj	7	SENT_128	[p12l1352t396r1399b452],
4	SD	NN	O	sd	nn	5	SENT_128	[p12l1429t388r1537b453],
5	age	NN	O	age	dep	3	SENT_128	[p12l1568t409r1694b474],
6	was	VBD	O	be	cop	7	SENT_128	[p12l1722t409r1874b453],
7	40.2	CD	NUMBER	40.2	rcmod	2	SENT_128	[p12l1904t394r2066b453],
8	i	FW	O	i	dep	7	SENT_128	[p12l2098t396r2145b452],
9	7.6	CD	DURATION	7.6	num	10	SENT_128	[p12l14t496r126b554],
10	years	NNS	NUMBER	year	tmod	7	SENT_128	[p12l163t510r394b576],
11	,	,	O	,	_	0	SENT_128	[p12l163t510r394b576],
12	body	NN	O	body	nn	13	SENT_128	[p12l431t486r633b576],
13	weight	NN	O	weight	nsubj	16	SENT_128	[p12l667t486r943b576],
14	was	VBD	O	be	cop	16	SENT_128	[p12l976t510r1129b554],
15	56.1	CD	NUMBER	56.1	advmod	16	SENT_128	[p12l1171t496r1331b554],
16	i	FW	O	i	dep	28	SENT_128	[p12l1372t498r1418b554],
17	9.7	CD	NUMBER	9.7	num	18	SENT_128	[p12l1456t496r1570b554],
18	kg	NN	O	kg	dep	16	SENT_128	[p12l1608t486r1720b576],
19	,	,	O	,	_	0	SENT_128	[p12l1608t486r1720b576],
20	and	CC	O	and	_	0	SENT_128	[p12l1761t486r1909b554],
21	body	NN	O	body	nn	23	SENT_128	[p12l1942t486r2145b576],
22	mass	NN	O	mass	nn	23	SENT_128	[p12l8t612r205b656],
23	index	NN	O	index	conj_and	16	SENT_128	[p12l239t588r468b656],
24	(	CD	NUMBER	(	num	26	SENT_128	[p12l503t588r723b669],
25	BMI	NN	O	bmus	nn	26	SENT_128	[p12l503t588r723b669],
26	)	NN	O	)	dep	23	SENT_128	[p12l503t588r723b669],
27	was	VBD	O	be	cop	28	SENT_128	[p12l758t612r911b656],
28	19.0	CD	NUMBER	19.0	_	0	SENT_128	[p12l949t598r1111b656],
29	i	FW	O	i	dep	28	SENT_128	[p12l1144t599r1191b655],
30	3.1	CD	NUMBER	3.1	num	31	SENT_128	[p12l1225t598r1335b656],
31	kg/m2	NN	O	kg/m2	nsubj	28	SENT_128	[p12l1372t588r1626b677],
32	.	.	O	.	_	0	SENT_128	[p12l1372t588r1626b677],

1	Lamivudine	NNP	O	Lamivudine	_	0	SENT_129	[p12l8t815r527b895],
2	,	,	O	,	_	0	SENT_129	[p12l8t815r527b895],
3	Zidovudine	NNP	O	Zidovudine	conj_and	1	SENT_129	[p12l561t815r1059b895],
4	,	,	O	,	_	0	SENT_129	[p12l561t815r1059b895],
5	and	CC	O	and	_	0	SENT_129	[p12l1095t815r1247b883],
6	Stavudine	NNP	O	Stavudine	nn	7	SENT_129	[p12l10t920r424b988],
7	Pharmacokinetics	NNPS	O	Pharmacokinetics	conj_and	1	SENT_129	[p12l455t920r1200b988],

1	The	DT	O	the	det	7	SENT_130	[p12l9t1129r161b1198],
2	mean	NN	O	mean	nn	7	SENT_130	[p12l207t1154r427b1198],
3	steady-state	JJ	O	steady-state	amod	7	SENT_130	[p12l473t1129r946b1219],
4	plasma	NN	O	plasma	nn	7	SENT_130	[p12l992t1129r1281b1219],
5	drug	NN	O	drug	nn	7	SENT_130	[p12l1328t1129r1509b1219],
6	concentrationtime	NN	O	concentrationtime	nn	7	SENT_130	[p12l1555t1133r2142b1198, p12l8t1235r186b1299],
7	profiles	NNS	O	profile	nsubjpass	15	SENT_130	[p12l220t1231r525b1321],
8	of	IN	O	of	_	0	SENT_130	[p12l561t1231r641b1299],
9	each	DT	O	each	det	10	SENT_130	[p12l667t1231r850b1299],
10	drug	NN	O	drug	prep_of	7	SENT_130	[p12l884t1231r1065b1321],
11	for	IN	O	for	_	0	SENT_130	[p12l1098t1231r1208b1299],
12	all	DT	O	all	det	13	SENT_130	[p12l1240t1231r1338b1299],
13	patients	NNS	O	patient	prep_for	10	SENT_130	[p12l1370t1235r1690b1321],
14	are	VBP	O	be	auxpass	15	SENT_130	[p12l1726t1255r1843b1299],
15	shown	VBN	O	show	_	0	SENT_130	[p12l1878t1231r2144b1299],
16	in	IN	O	in	_	0	SENT_130	[p12l9t1337r89b1401],
17	Figure	NNP	O	Figure	prep_in	15	SENT_130	[p12l115t1337r372b1422],
18	1	CD	NUMBER	1	num	17	SENT_130	[p12l405t1344r464b1401],
19	.	.	O	.	_	0	SENT_130	[p12l405t1344r464b1401],

1	Derived	VBN	O	derive	csubjpass	13	SENT_131	[p12l496t1333r814b1401],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_131	[p12l841t1333r1523b1423],
3	parameters	NNS	O	parameter	nsubjpass	5	SENT_131	[p12l1552t1343r1995b1423],
4	are	VBP	O	be	auxpass	5	SENT_131	[p12l2026t1357r2142b1401],
5	given	VBN	O	give	ccomp	1	SENT_131	[p12l8t1438r228b1524],
6	in	IN	O	in	_	0	SENT_131	[p12l274t1438r354b1502],
7	Table	NNP	MISC	Table	nn	10	SENT_131	[p12l401t1435r615b1503],
8	I.	NNP	MISC	I.	nn	10	SENT_131	[p12l663t1439r708b1503],
9	All	NNP	MISC	All	nn	10	SENT_131	[p12l759t1435r883b1502],
10	drugs	NNS	O	drug	prep_in	5	SENT_131	[p12l934t1435r1152b1524],
11	were	VBD	O	be	auxpass	13	SENT_131	[p12l1200t1459r1394b1503],
12	rapidly	RB	O	rapidly	advmod	13	SENT_131	[p12l1441t1435r1736b1524],
13	absorbed	VBN	O	absorb	dep	18	SENT_131	[p12l1783t1435r2144b1503],
14	with	IN	O	with	_	0	SENT_131	[p12l8t1538r193b1606],
15	a	DT	O	a	det	17	SENT_131	[p12l223t1562r263b1606],
16	mean	NN	O	mean	nn	17	SENT_131	[p12l290t1562r510b1606],
17	Cmax	NN	MISC	cmax	prep_with	13	SENT_131	[p12l539t1541r699b1629],
18	achieved	VBD	O	achieve	_	0	SENT_131	[p12l728t1538r1089b1606],
19	between	IN	O	between	quantmod	20	SENT_131	[p12l1115t1538r1456b1606],
20	1	CD	NUMBER	1	num	23	SENT_131	[p12l1489t1548r1524b1605],
21	and	CC	O	and	_	0	SENT_131	[p12l1560t1538r1708b1606],
22	3	CD	DURATION	3	num	23	SENT_131	[p12l1741t1547r1777b1606],
23	hours	NNS	NUMBER	hour	dobj	18	SENT_131	[p12l1811t1538r2038b1606],
24	of	IN	O	of	_	0	SENT_131	[p12l2071t1538r2151b1606],
25	administration	NN	O	administration	prep_of	23	SENT_131	[p12l10t1639r609b1708],
26	(	CD	NUMBER	(	num	29	SENT_131	[p12l653t1640r935b1729],
27	Figure	NN	O	figure	nn	29	SENT_131	[p12l653t1640r935b1729],
28	1	CD	NUMBER	1	num	29	SENT_131	[p12l981t1640r1071b1720],
29	)	NN	O	)	nsubj	18	SENT_131	[p12l981t1640r1071b1720],
30	.	.	O	.	_	0	SENT_131	[p12l981t1640r1071b1720],

1	Lamivudine	NN	O	lamivudine	nn	5	SENT_132	[p12l1116t1639r1606b1708],
2	and	CC	O	and	_	0	SENT_132	[p12l1648t1639r1797b1708],
3	zidovudine	NN	O	zidovudine	nn	5	SENT_132	[p12l1837t1640r2143b1708, p12l11t1741r182b1810],
4	plasma	NN	O	plasma	nn	5	SENT_132	[p12l207t1741r488b1831],
5	concentrations	NNS	O	concentration	nsubj	7	SENT_132	[p12l512t1745r1090b1810],
6	were	VBD	O	be	cop	7	SENT_132	[p12l1114t1766r1304b1810],
7	quantifiable	JJ	O	quantifiable	_	0	SENT_132	[p12l1329t1741r1797b1831],
8	(	CD	NUMBER	(	num	9	SENT_132	[p12l1827t1742r1989b1822],
9	>	JJR	O	>	tmod	7	SENT_132	[p12l1827t1742r1989b1822],
10	10	CD	NUMBER	10	num	11	SENT_132	[p12l1827t1742r1989b1822],
11	ng	NN	O	ng	npadvmod	25	SENT_132	[p12l2014t1741r2143b1831],
12	/	:	O	/	punct	14	SENT_132	[p12l2014t1741r2143b1831],
13	mL	NN	O	ml	nn	14	SENT_132	[p12l8t1843r163b1924],
14	)	NN	O	)	dep	11	SENT_132	[p12l8t1843r163b1924],
15	in	IN	O	in	_	0	SENT_132	[p12l198t1847r278b1911],
16	most	JJS	O	most	amod	17	SENT_132	[p12l306t1854r502b1911],
17	patients	NNS	O	patient	prep_in	14	SENT_132	[p12l530t1847r850b1933],
18	prior	RB	O	prior	_	0	SENT_132	[p12l882t1847r1082b1933],
19	to	TO	O	to	_	0	SENT_132	[p12l1110t1854r1184b1911],
20	dosing	NN	O	dosing	prep_prior_to	25	SENT_132	[p12l1218t1843r1483b1933],
21	and	CC	O	and	_	0	SENT_132	[p12l1514t1843r1662b1911],
22	at	IN	O	at	conj_and	25	SENT_132	[p12l1693t1854r1763b1911],
23	12	CD	DURATION	12	num	24	SENT_132	[p12l1796t1853r1881b1911],
24	hours	NNS	NUMBER	hour	pobj	22	SENT_132	[p12l1915t1843r2142b1911],
25	postdosing	VBG	O	postdose	partmod	9	SENT_132	[p12l9t1945r450b2035],
26	(	CD	NUMBER	(	num	27	SENT_132	[p12l487t1945r769b2034],
27	Figure	NN	O	figure	dobj	25	SENT_132	[p12l487t1945r769b2034],
28	1	CD	NUMBER	1	num	29	SENT_132	[p12l807t1945r897b2026],
29	)	NN	O	)	dep	9	SENT_132	[p12l807t1945r897b2026],
30	.	.	O	.	_	0	SENT_132	[p12l807t1945r897b2026],

1	In	IN	O	in	_	0	SENT_133	[p12l934t1950r1015b2013],
2	contrast	NN	O	contrast	prep_in	7	SENT_133	[p12l1049t1955r1391b2024],
3	,	,	O	,	_	0	SENT_133	[p12l1049t1955r1391b2024],
4	stavudine	NN	O	stavudine	nn	6	SENT_133	[p12l1429t1945r1822b2013],
5	plasma	NN	O	plasma	nn	6	SENT_133	[p12l1856t1945r2145b2035],
6	concentrations	NNS	O	concentration	nsubj	7	SENT_133	[p12l10t2050r606b2115],
7	were	VBD	O	be	_	0	SENT_133	[p12l642t2071r836b2115],
8	below	IN	O	below	_	0	SENT_133	[p12l869t2047r1116b2115],
9	the	DT	O	the	det	10	SENT_133	[p12l1149t2047r1273b2115],
10	limit	NN	O	limit	prep_below	7	SENT_133	[p12l1310t2047r1504b2115],
11	of	IN	O	of	_	0	SENT_133	[p12l1540t2047r1620b2115],
12	quantitation	NN	O	quantitation	prep_of	10	SENT_133	[p12l1649t2050r2144b2136],
13	for	IN	O	for	_	0	SENT_133	[p12l9t2150r120b2218],
14	all	DT	O	all	det	15	SENT_133	[p12l159t2150r258b2218],
15	patients	NNS	O	patient	prep_for	12	SENT_133	[p12l298t2153r621b2239],
16	prior	RB	O	prior	_	0	SENT_133	[p12l663t2153r864b2239],
17	to	TO	O	to	_	0	SENT_133	[p12l901t2160r975b2218],
18	dosing	NN	O	dosing	prep_prior_to	7	SENT_133	[p12l1019t2150r1287b2239],
19	and	CC	O	and	_	0	SENT_133	[p12l1327t2150r1477b2218],
20	for	IN	O	for	conj_and	7	SENT_133	[p12l1516t2150r1627b2218],
21	1	CD	NUMBER	1	num	22	SENT_133	[p12l1669t2160r1704b2217],
22	patient	NN	O	patient	pobj	20	SENT_133	[p12l1749t2153r2036b2239],
23	at	IN	O	at	_	0	SENT_133	[p12l2075t2160r2146b2218],
24	12	CD	DURATION	12	num	25	SENT_133	[p12l13t2261r99b2319],
25	hours	NNS	NUMBER	hour	prep_at	22	SENT_133	[p12l136t2251r362b2320],
26	postdosing	VBG	O	postdose	partmod	25	SENT_133	[p12l397t2251r858b2341],
27	.	.	O	.	_	0	SENT_133	[p12l397t2251r858b2341],

1	The	DT	O	the	det	2	SENT_134	[p12l116t2353r266b2422],
2	coefficients	NNS	O	coefficient	nsubj	11	SENT_134	[p12l307t2354r758b2422],
3	of	IN	O	of	_	0	SENT_134	[p12l800t2354r880b2422],
4	variation	NN	O	variation	prep_of	2	SENT_134	[p12l909t2357r1264b2422],
5	for	IN	O	for	_	0	SENT_134	[p12l1303t2354r1411b2422],
6	zidovudine	NN	O	zidovudine	nn	8	SENT_134	[p12l1449t2353r1898b2422],
7	pharmacokinetic	JJ	O	pharmacokinetic	amod	8	SENT_134	[p12l1938t2354r2142b2443, p12l8t2455r492b2523],
8	parameters	NNS	O	parameter	prep_for	4	SENT_134	[p12l533t2466r968b2545],
9	were	VBD	O	be	cop	11	SENT_134	[p12l1008t2479r1199b2523],
10	consistently	RB	O	consistently	advmod	11	SENT_134	[p12l1241t2455r1719b2545],
11	higher	JJR	O	higher	_	0	SENT_134	[p12l1757t2455r2012b2545],
12	by	IN	O	by	_	0	SENT_134	[p12l2047t2455r2145b2545],
13	as	RB	O	as	quantmod	14	SENT_134	[p12l10t2581r85b2625],
14	much	JJ	O	much	prep_by	11	SENT_134	[p12l135t2557r362b2625],
15	as	IN	O	as	mark	24	SENT_134	[p12l411t2581r486b2625],
16	2-fold	JJ	O	2-fold	amod	23	SENT_134	[p12l541t2557r771b2625],
17	compared	VBN	O	compare	_	0	SENT_134	[p12l821t2557r1214b2647],
18	with	IN	O	with	prepc_compared_with	16	SENT_134	[p12l1261t2557r1443b2625],
19	lamivudine	NN	O	lamivudine	pobj	16	SENT_134	[p12l1492t2557r1947b2625],
20	and	CC	O	and	_	0	SENT_134	[p12l1998t2557r2144b2625],
21	stavudine	NN	O	stavudine	conj_and	19	SENT_134	[p12l10t2659r395b2727],
22	pharmacokinetic	JJ	O	pharmacokinetic	amod	23	SENT_134	[p12l431t2659r1098b2748],
23	parameters	NNS	O	parameter	nsubj	24	SENT_134	[p12l1135t2669r1569b2748],
24	(	VBP	O	(	advcl	11	SENT_134	[p12l1610t2659r1844b2740],
25	Table	NNP	O	Table	dobj	24	SENT_134	[p12l1610t2659r1844b2740],
26	I	PRP	O	I	nsubj	27	SENT_134	[p12l1880t2659r1952b2740],
27	)	VBP	O	)	rcmod	25	SENT_134	[p12l1880t2659r1952b2740],
28	.	.	O	.	_	0	SENT_134	[p12l1880t2659r1952b2740],

1	The	DT	O	the	det	3	SENT_135	[p12l1992t2659r2143b2727],
2	greatest	JJS	O	greatest	amod	3	SENT_135	[p12l8t2772r310b2851],
3	difference	NN	O	difference	nsubjpass	5	SENT_135	[p12l364t2762r756b2830],
4	was	VBD	O	be	auxpass	5	SENT_135	[p12l809t2786r959b2830],
5	observed	VBN	O	observe	_	0	SENT_135	[p12l1016t2762r1369b2830],
6	for	IN	O	for	mark	8	SENT_135	[p12l1421t2762r1529b2830],
7	body	NN	O	body	nsubj	8	SENT_135	[p12l1577t2762r1777b2851],
8	weightnormalized	VBD	O	weightnormalize	advcl	5	SENT_135	[p12l1827t2762r2146b2851, p12l8t2862r460b2930],
9	CL	NN	O	cl	dobj	8	SENT_135	[p12l485t2862r626b2930],
10	/	:	O	/	punct	12	SENT_135	[p12l485t2862r626b2930],
11	F	NN	O	f	nn	12	SENT_135	[p12l630t2867r679b2929],
12	values	NNS	O	value	dep	9	SENT_135	[p12l703t2862r955b2930],
13	with	IN	O	with	_	0	SENT_135	[p12l981t2862r1163b2930],
14	a	DT	O	a	det	15	SENT_135	[p12l1188t2886r1229b2930],
15	coefficient	NN	O	coefficient	prep_with	12	SENT_135	[p12l1253t2863r1669b2930],
16	of	IN	O	of	_	0	SENT_135	[p12l1694t2863r1773b2930],
17	variation	NN	O	variation	prep_of	9	SENT_135	[p12l1789t2866r2145b2930],

1	GENERIC	JJ	O	generic	amod	2	SENT_136	[p12l441t3006r623b3037],
2	NRTIS	NN	O	nrti	_	0	SENT_136	[p12l634t3006r761b3037],
3	IN	IN	O	in	_	0	SENT_136	[p12l774t3007r824b3037],
4	TB/HIV	NN	O	tb/hiv	prep_in	2	SENT_136	[p12l837t3005r1260b3037],
5	.	.	O	.	_	0	SENT_136	[p12l837t3005r1260b3037],

1	—	NN	O	—	_	0	SENT_137	[p12l837t3005r1260b3037],
2	.	.	O	.	_	0	SENT_137	[p12l837t3005r1260b3037],

1	COINFECTED	JJ	O	coinfected	_	0	SENT_138	[p12l837t3005r1260b3037],
2	GHANAIAN	JJ	MISC	ghanaian	amod	3	SENT_138	[p12l1275t3006r1511b3037],
3	PATIENTS	NNS	O	patient	dep	1	SENT_138	[p12l1521t3006r1723b3037],

1	Table	NNP	O	Table	dep	5	SENT_139	[p12l359t3131r463b3163],
2	I	PRP	O	I	dep	1	SENT_139	[p12l477t3133r492b3163],
3	Plasma	NN	O	plasma	dep	5	SENT_139	[p12l535t3131r671b3163],
4	Pharmacokinetic	JJ	O	pharmacokinetic	amod	5	SENT_139	[p12l684t3131r1004b3163],
5	Parameters	NNS	O	parameter	_	0	SENT_139	[p12l1019t3133r1227b3163],
6	for	IN	O	for	_	0	SENT_139	[p12l1243t3131r1295b3163],
7	Lamivudine	NNP	O	Lamivudine	nn	9	SENT_139	[p12l1309t3131r1548b3168],
8	,	,	O	,	_	0	SENT_139	[p12l1309t3131r1548b3168],
9	Zidovudine	NNP	O	Zidovudine	prep_for	5	SENT_139	[p12l1565t3131r1797b3168],
10	,	,	O	,	_	0	SENT_139	[p12l1565t3131r1797b3168],

1	and	CC	O	and	dep	2	SENT_140	[p12l515t3177r584b3209],
2	Stavudine	NNP	O	Stavudine	_	0	SENT_140	[p12l600t3177r791b3209],
3	in	IN	O	in	_	0	SENT_140	[p12l806t3179r844b3209],
4	27	CD	NUMBER	27	num	7	SENT_140	[p12l860t3182r901b3209],
5	Ghanaian	JJ	MISC	ghanaian	amod	7	SENT_140	[p12l918t3177r1098b3209],
6	HIV/TB-Coinfeoted	JJ	O	hiv/tb-coinfeoted	amod	7	SENT_140	[p12l1113t3177r1479b3209],
7	Patients	NNS	O	patient	prep_in	2	SENT_140	[p12l1493t3179r1644b3209],

1	Parameter	NN	O	parameter	nn	2	SENT_141	[p12l42t3265r203b3289],
2	Lan1ivudine	NN	O	lan1ivudine	_	0	SENT_141	[p12l627t3263r812b3289],
3	(	CD	NUMBER	(	num	4	SENT_141	[p12l825t3263r855b3293],
4	n	NN	O	n	dep	2	SENT_141	[p12l825t3263r855b3293],
5	=	JJ	O	=	dep	4	SENT_141	[p12l865t3275r883b3284],
6	27	CD	NUMBER	27	num	7	SENT_141	[p12l895t3263r940b3293],
7	)	CD	NUMBER	)	iobj	5	SENT_141	[p12l895t3263r940b3293],
8	Zidovudine	NN	O	zidovudine	nn	10	SENT_141	[p12l1235t3263r1413b3289],
9	(	NN	O	(	nn	10	SENT_141	[p12l1426t3263r1455b3293],
10	n	NN	O	n	nn	19	SENT_141	[p12l1426t3263r1455b3293],
11	=	JJ	O	=	amod	10	SENT_141	[p12l1466t3275r1484b3284],
12	16	CD	NUMBER	16	tmod	11	SENT_141	[p12l1496t3263r1541b3293],
13	)	CD	NUMBER	)	num	16	SENT_141	[p12l1496t3263r1541b3293],
14	Stavudine	NN	O	stavudine	nn	16	SENT_141	[p12l1830t3263r1985b3289],
15	[	NN	O	[	nn	16	SENT_141	[p12l1998t3263r2028b3293],
16	n	NN	O	n	dep	10	SENT_141	[p12l1998t3263r2028b3293],
17	=	JJ	O	=	amod	19	SENT_141	[p12l2039t3275r2056b3284],
18	11	CD	NUMBER	11	tmod	17	SENT_141	[p12l2068t3263r2113b3293],
19	)	NN	O	)	dobj	5	SENT_141	[p12l2068t3263r2113b3293],

1	cm	NN	O	cm	dep	119	SENT_142	[p12l43t3353r119b3391],
2	,	,	O	,	_	0	SENT_142	[p12l43t3353r119b3391],
3	ng/mL	NN	O	ng/ml	dep	119	SENT_142	[p12l134t3352r244b3390],
4	1095	CD	DATE	1095	dep	119	SENT_142	[p12l642t3356r720b3381],
5	1	CD	NUMBER	1	dep	119	SENT_142	[p12l734t3357r754b3381],
6	506	CD	NUMBER	506	dep	119	SENT_142	[p12l768t3356r827b3381],
7	(	NN	O	(	dep	119	SENT_142	[p12l843t3352r904b3386],
8	46	CD	NUMBER	46	dep	119	SENT_142	[p12l843t3352r904b3386],
9	)	CD	NUMBER	)	dep	119	SENT_142	[p12l843t3352r904b3386],
10	1092	CD	DATE	1092	dep	119	SENT_142	[p12l1242t3356r1320b3381],
11	1	CD	NUMBER	1	dep	119	SENT_142	[p12l1335t3357r1354b3381],
12	811	CD	NUMBER	811	dep	119	SENT_142	[p12l1368t3356r1426b3381],
13	(	NN	O	(	dep	119	SENT_142	[p12l1443t3352r1504b3386],
14	74	CD	NUMBER	74	dep	119	SENT_142	[p12l1443t3352r1504b3386],
15	)	NN	O	)	dep	119	SENT_142	[p12l1443t3352r1504b3386],
16	310	CD	NUMBER	310	dep	119	SENT_142	[p12l1854t3356r1913b3381],
17	1	CD	NUMBER	1	dep	119	SENT_142	[p12l1926t3357r1946b3381],
18	173	CD	NUMBER	173	dep	119	SENT_142	[p12l1961t3356r2018b3381],
19	(	NN	O	(	dep	119	SENT_142	[p12l2035t3352r2096b3387],
20	56	CD	NUMBER	56	dep	119	SENT_142	[p12l2035t3352r2096b3387],
21	)	CD	NUMBER	)	dep	119	SENT_142	[p12l2035t3352r2096b3387],
22	tm	NN	O	tm	dep	119	SENT_142	[p12l43t3411r107b3446],
23	,	,	O	,	_	0	SENT_142	[p12l43t3411r107b3446],
24	h	NN	O	h	dep	119	SENT_142	[p12l121t3407r143b3436],
25	2.3	CD	NUMBER	2.3	dep	119	SENT_142	[p12l673t3411r720b3436],
26	1	CD	NUMBER	1	dep	119	SENT_142	[p12l734t3411r754b3436],
27	1.5	CD	NUMBER	1.5	dep	119	SENT_142	[p12l769t3411r815b3436],
28	(	NN	O	(	dep	119	SENT_142	[p12l832t3407r894b3441],
29	66	CD	NUMBER	66	dep	119	SENT_142	[p12l832t3407r894b3441],
30	)	CD	NUMBER	)	dep	119	SENT_142	[p12l832t3407r894b3441],
31	1.6	CD	NUMBER	1.6	dep	119	SENT_142	[p12l1273t3411r1321b3436],
32	1	CD	NUMBER	1	dep	119	SENT_142	[p12l1335t3411r1354b3436],
33	1.1	CD	NUMBER	1.1	dep	119	SENT_142	[p12l1369t3411r1415b3436],
34	(	NN	O	(	dep	119	SENT_142	[p12l1433t3407r1494b3441],
35	70	CD	NUMBER	70	dep	119	SENT_142	[p12l1433t3407r1494b3441],
36	)	NN	O	)	dep	119	SENT_142	[p12l1433t3407r1494b3441],
37	2.6	CD	NUMBER	2.6	dep	119	SENT_142	[p12l1865t3411r1913b3436],
38	1	CD	NUMBER	1	dep	119	SENT_142	[p12l1926t3411r1946b3436],
39	1.6	CD	NUMBER	1.6	dep	119	SENT_142	[p12l1961t3411r2008b3436],
40	(	NN	O	(	dep	119	SENT_142	[p12l2024t3407r2086b3441],
41	63	CD	NUMBER	63	dep	119	SENT_142	[p12l2024t3407r2086b3441],
42	)	CD	NUMBER	)	dep	119	SENT_142	[p12l2024t3407r2086b3441],
43	Half-life	NN	O	half-life	dep	119	SENT_142	[p12l43t3450r192b3483],
44	,	,	O	,	_	0	SENT_142	[p12l43t3450r192b3483],
45	h	NN	O	h	dep	119	SENT_142	[p12l206t3450r228b3478],
46	4.2	CD	NUMBER	4.2	dep	119	SENT_142	[p12l671t3454r720b3479],
47	1	CD	NUMBER	1	dep	119	SENT_142	[p12l734t3455r754b3478],
48	1.9	CD	NUMBER	1.9	dep	119	SENT_142	[p12l769t3454r816b3479],
49	(	NN	O	(	dep	119	SENT_142	[p12l833t3450r894b3484],
50	46	CD	NUMBER	46	dep	119	SENT_142	[p12l833t3450r894b3484],
51	)	NN	O	)	dep	119	SENT_142	[p12l833t3450r894b3484],
52	8.1	CD	NUMBER	8.1	dep	119	SENT_142	[p12l1272t3454r1320b3479],
53	1	CD	NUMBER	1	dep	119	SENT_142	[p12l1335t3455r1354b3478],
54	7.9	CD	NUMBER	7.9	dep	119	SENT_142	[p12l1370t3454r1417b3479],
55	(	NN	O	(	dep	119	SENT_142	[p12l1433t3450r1494b3484],
56	98	CD	NUMBER	98	dep	119	SENT_142	[p12l1433t3450r1494b3484],
57	)	CD	NUMBER	)	dep	119	SENT_142	[p12l1433t3450r1494b3484],
58	1.5	CD	NUMBER	1.5	dep	119	SENT_142	[p12l1865t3454r1912b3479],
59	1	CD	NUMBER	1	dep	119	SENT_142	[p12l1926t3455r1946b3478],
60	1.0	CD	NUMBER	1.0	dep	119	SENT_142	[p12l1961t3454r2008b3479],
61	(	NN	O	(	dep	119	SENT_142	[p12l2025t3450r2086b3484],
62	65	CD	NUMBER	65	dep	119	SENT_142	[p12l2025t3450r2086b3484],
63	)	CD	NUMBER	)	dep	119	SENT_142	[p12l2025t3450r2086b3484],
64	AUG	NN	DATE	aug	dep	119	SENT_142	[p12l43t3494r134b3526],
65	,	,	O	,	_	0	SENT_142	[p12l43t3494r134b3526],
66	ng/mL	NN	O	ng/ml	dep	119	SENT_142	[p12l148t3493r292b3531],
67	~	NN	O	~	dep	119	SENT_142	[p12l148t3493r292b3531],
68	h	NN	O	h	dep	119	SENT_142	[p12l148t3493r292b3531],
69	5843	CD	NUMBER	5843	dep	119	SENT_142	[p12l641t3497r720b3522],
70	1	CD	NUMBER	1	dep	119	SENT_142	[p12l735t3497r754b3522],
71	2580	CD	DATE	2580	dep	119	SENT_142	[p12l768t3497r848b3522],
72	(	CD	NUMBER	(	dep	119	SENT_142	[p12l864t3493r925b3527],
73	44	CD	NUMBER	44	dep	119	SENT_142	[p12l864t3493r925b3527],
74	)	CD	NUMBER	)	dep	119	SENT_142	[p12l864t3493r925b3527],
75	3368	CD	NUMBER	3368	dep	119	SENT_142	[p12l1242t3497r1321b3522],
76	1	CD	NUMBER	1	dep	119	SENT_142	[p12l1335t3497r1355b3522],
77	2747	CD	DATE	2747	dep	119	SENT_142	[p12l1369t3497r1448b3522],
78	(	CD	NUMBER	(	dep	119	SENT_142	[p12l1464t3493r1525b3527],
79	82	CD	NUMBER	82	dep	119	SENT_142	[p12l1464t3493r1525b3527],
80	)	NN	O	)	dep	119	SENT_142	[p12l1464t3493r1525b3527],
81	865	CD	NUMBER	865	dep	119	SENT_142	[p12l1854t3497r1912b3522],
82	1	CD	NUMBER	1	dep	119	SENT_142	[p12l1926t3497r1946b3522],
83	223	CD	NUMBER	223	dep	119	SENT_142	[p12l1960t3497r2018b3522],
84	(	NN	O	(	dep	119	SENT_142	[p12l2035t3493r2096b3527],
85	26	CD	NUMBER	26	dep	119	SENT_142	[p12l2035t3493r2096b3527],
86	)	CD	NUMBER	)	dep	119	SENT_142	[p12l2035t3493r2096b3527],
87	CL/F	NN	O	cl/f	dep	119	SENT_142	[p12l43t3536r132b3570],
88	,	,	O	,	_	0	SENT_142	[p12l43t3536r132b3570],
89	mL/min/kg	NN	O	ml/min/kg	dep	119	SENT_142	[p12l146t3536r338b3574],
90	7.3	CD	NUMBER	7.3	dep	119	SENT_142	[p12l674t3540r720b3565],
91	1	CD	NUMBER	1	dep	119	SENT_142	[p12l735t3541r754b3565],
92	2.8	CD	NUMBER	2.8	dep	119	SENT_142	[p12l769t3540r816b3565],
93	(	CD	NUMBER	(	dep	119	SENT_142	[p12l833t3536r894b3571],
94	40	CD	NUMBER	40	dep	119	SENT_142	[p12l833t3536r894b3571],
95	)	NN	O	)	dep	119	SENT_142	[p12l833t3536r894b3571],
96	31.9	CD	NUMBER	31.9	dep	119	SENT_142	[p12l1252t3540r1321b3565],
97	1	CD	NUMBER	1	dep	119	SENT_142	[p12l1335t3541r1355b3565],
98	33.6	CD	NUMBER	33.6	dep	119	SENT_142	[p12l1369t3540r1437b3565],
99	(	NN	O	(	dep	119	SENT_142	[p12l1454t3536r1536b3571],
100	106	CD	NUMBER	106	dep	119	SENT_142	[p12l1454t3536r1536b3571],
101	)	CD	NUMBER	)	dep	119	SENT_142	[p12l1454t3536r1536b3571],
102	16.4	CD	NUMBER	16.4	dep	119	SENT_142	[p12l1844t3540r1913b3565],
103	1	CD	NUMBER	1	dep	119	SENT_142	[p12l1927t3541r1946b3565],
104	5.8	CD	NUMBER	5.8	dep	119	SENT_142	[p12l1960t3540r2008b3565],
105	(	NN	O	(	dep	119	SENT_142	[p12l2025t3536r2086b3571],
106	35	CD	NUMBER	35	dep	119	SENT_142	[p12l2025t3536r2086b3571],
107	)	CD	NUMBER	)	dep	119	SENT_142	[p12l2025t3536r2086b3571],
108	Vd/F	NN	O	vd/f	dep	119	SENT_142	[p12l43t3580r134b3613],
109	,	,	O	,	_	0	SENT_142	[p12l43t3580r134b3613],
110	L/kg	NN	O	l/kg	dep	119	SENT_142	[p12l149t3580r224b3618],
111	2.6	CD	NUMBER	2.6	dep	119	SENT_142	[p12l673t3584r721b3609],
112	1	CD	NUMBER	1	dep	119	SENT_142	[p12l735t3584r754b3609],
113	1.5	CD	NUMBER	1.5	dep	119	SENT_142	[p12l769t3584r815b3609],
114	9.9	CD	NUMBER	9.9	dep	119	SENT_142	[p12l1273t3584r1321b3609],
115	1	CD	NUMBER	1	dep	119	SENT_142	[p12l1335t3584r1355b3609],
116	4.7	CD	NUMBER	4.7	dep	119	SENT_142	[p12l1367t3584r1417b3609],
117	1.7	CD	NUMBER	1.7	dep	119	SENT_142	[p12l1865t3584r1913b3609],
118	1	CD	NUMBER	1	dep	119	SENT_142	[p12l1927t3584r1946b3609],
119	0.7	CD	NUMBER	0.7	_	0	SENT_142	[p12l1960t3584r2008b3609],

1	All	DT	O	all	det	2	SENT_143	[p12l92t3660r134b3682],
2	patients	NNS	O	patient	nsubj	4	SENT_143	[p12l143t3661r248b3689],
3	also	RB	O	also	advmod	4	SENT_143	[p12l259t3660r310b3682],
4	received	VBD	O	receive	_	0	SENT_143	[p12l320t3660r433b3682],
5	efavirenz	NN	O	efavirenz	nn	9	SENT_143	[p12l443t3660r564b3682],
6	and	CC	O	and	_	0	SENT_143	[p12l575t3660r623b3682],
7	rifampin-containing	JJ	O	rifampin-containing	conj_and	5	SENT_143	[p12l632t3660r901b3689],
8	TB	NN	O	tb	nn	9	SENT_143	[p12l910t3661r946b3682],
9	therapy	NN	O	therapy	dobj	4	SENT_143	[p12l957t3660r1063b3689],
10	.	.	O	.	_	0	SENT_143	[p12l957t3660r1063b3689],

1	Values	NNS	O	value	nsubj	2	SENT_144	[p12l1074t3660r1161b3682],
2	represent	VBP	O	represent	_	0	SENT_144	[p12l1171t3663r1295b3689],
3	mean	JJ	O	mean	amod	5	SENT_144	[p12l1304t3668r1376b3682],
4	i	FW	O	i	nn	5	SENT_144	[p12l1385t3664r1401b3682],
5	SD	NN	O	sd	dobj	2	SENT_144	[p12l1411t3661r1447b3682],
6	[	CD	PERCENT	[	num	7	SENT_144	[p12l1459t3660r1492b3687],
7	%	NN	PERCENT	%	dep	5	SENT_144	[p12l1459t3660r1492b3687],
8	coefficient	NN	O	coefficient	tmod	2	SENT_144	[p12l1505t3660r1645b3682],
9	of	IN	O	of	_	0	SENT_144	[p12l1655t3660r1681b3682],
10	variation	NN	O	variation	nn	11	SENT_144	[p12l1688t3660r1823b3687],
11	)	NN	O	)	prep_of	8	SENT_144	[p12l1688t3660r1823b3687],
12	.	.	O	.	_	0	SENT_144	[p12l1688t3660r1823b3687],

1	Cm	NN	O	cm	nn	2	SENT_145	[p12l1835t3661r1894b3690],
2	”	NN	O	”	_	0	SENT_145	[p12l1835t3661r1894b3690],
3	,	,	O	,	_	0	SENT_145	[p12l1835t3661r1894b3690],
4	peak	NN	O	peak	nn	5	SENT_145	[p12l1905t3660r1967b3689],
5	concentration	NN	O	concentration	appos	2	SENT_145	[p12l1977t3664r2115b3682, p12l93t3691r152b3716],
6	;	:	O	;	_	0	SENT_145	[p12l1977t3664r2115b3682, p12l93t3691r152b3716],
7	tmax	NN	O	tmax	nn	8	SENT_145	[p12l164t3694r207b3720],
8	time	NN	O	time	dep	2	SENT_145	[p12l225t3691r283b3712],
9	to	TO	O	to	aux	10	SENT_145	[p12l294t3693r318b3713],
10	peak	VB	O	peak	infmod	8	SENT_145	[p12l330t3690r393b3720],
11	concentration	NN	O	concentration	dobj	10	SENT_145	[p12l403t3691r593b3716],
12	;	:	O	;	_	0	SENT_145	[p12l403t3691r593b3716],
13	AUC	NN	O	auc	dep	8	SENT_145	[p12l604t3691r675b3716],
14	,	,	O	,	_	0	SENT_145	[p12l604t3691r675b3716],
15	area	NN	O	area	appos	13	SENT_145	[p12l688t3698r742b3712],
16	under	IN	O	under	_	0	SENT_145	[p12l751t3690r830b3712],
17	curve	NN	O	curve	prep_under	15	SENT_145	[p12l841t3698r921b3716],
18	;	:	O	;	_	0	SENT_145	[p12l841t3698r921b3716],
19	CL/F	NN	O	cl/f	nn	23	SENT_145	[p12l933t3690r1002b3716],
20	,	,	O	,	_	0	SENT_145	[p12l933t3690r1002b3716],
21	apparent	JJ	O	apparent	amod	23	SENT_145	[p12l1014t3694r1131b3720],
22	oral	JJ	O	oral	amod	23	SENT_145	[p12l1142t3690r1192b3712],
23	clearance	NN	O	clearance	nsubj	24	SENT_145	[p12l1203t3690r1327b3713],
24	normalized	VBD	O	normalize	dep	13	SENT_145	[p12l1338t3690r1490b3713],
25	for	IN	O	for	_	0	SENT_145	[p12l1500t3690r1536b3712],
26	body	NN	O	body	nn	27	SENT_145	[p12l1546t3690r1612b3719],
27	weight	NN	O	weight	prep_for	24	SENT_145	[p12l1622t3690r1719b3719],
28	;	:	O	;	_	0	SENT_145	[p12l1622t3690r1719b3719],
29	Vd/F	NN	O	vd/f	nsubj	34	SENT_145	[p12l1731t3690r1802b3716],
30	,	,	O	,	_	0	SENT_145	[p12l1731t3690r1802b3716],
31	volume	NN	O	volume	appos	29	SENT_145	[p12l1813t3690r1912b3712],
32	of	IN	O	of	_	0	SENT_145	[p12l1924t3690r1950b3712],
33	distribution	NN	O	distribution	prep_of	31	SENT_145	[p12l1960t3690r2116b3712],
34	normalized	VBD	O	normalize	parataxis	24	SENT_145	[p12l93t3726r244b3748],
35	for	IN	O	for	_	0	SENT_145	[p12l254t3726r291b3748],
36	body	NN	O	body	nn	37	SENT_145	[p12l299t3726r366b3755],
37	weight	NN	O	weight	prep_for	34	SENT_145	[p12l375t3726r472b3755],
38	;	:	O	;	_	0	SENT_145	[p12l375t3726r472b3755],
39	HIV	NN	MISC	hiv	dep	8	SENT_145	[p12l483t3727r540b3751],
40	,	,	O	,	_	0	SENT_145	[p12l483t3727r540b3751],
41	human	JJ	O	human	amod	43	SENT_145	[p12l550t3726r644b3748],
42	immunodeﬁciency	NN	O	immunodeﬁciency	nn	43	SENT_145	[p12l654t3726r906b3755],
43	virus	NN	O	virus	appos	39	SENT_145	[p12l915t3727r989b3752],
44	;	:	O	;	_	0	SENT_145	[p12l915t3727r989b3752],
45	TB	NN	O	tb	dep	8	SENT_145	[p12l1001t3727r1045b3752],
46	,	,	O	,	_	0	SENT_145	[p12l1001t3727r1045b3752],
47	tuberculosis	NN	O	tuberculosis	appos	45	SENT_145	[p12l1056t3726r1225b3748],
48	.	.	O	.	_	0	SENT_145	[p12l1056t3726r1225b3748],

1	+	CC	O	+	cc	2	SENT_146	[p13l1608t288r1675b316],
2	Lamivudine	NN	O	lamivudine	_	0	SENT_146	[p13l1694t274r2039b325],

1	4	CD	NUMBER	4	number	2	SENT_147	[p13l1608t377r1675b405],
2	}	CD	NUMBER	}	num	3	SENT_147	[p13l1608t377r1675b405],
3	Zidovudine	NN	O	zidovudine	_	0	SENT_147	[p13l1690t363r2024b414],

1	+	CC	O	+	cc	2	SENT_148	[p13l1608t464r1675b494],
2	Stavudine	NNP	O	Stavudine	_	0	SENT_148	[p13l1692t451r1993b503],

1	%	NN	O	%	_	0	SENT_149	[p13l59t256r125b276],
2	_	CD	NUMBER	_	number	3	SENT_149	[p13l60t279r110b314],
3	|	CD	NUMBER	|	num	8	SENT_149	[p13l60t279r110b314],
4	E	NN	O	e	nn	8	SENT_149	[p13l72t323r110b377],
5	E	NN	O	e	nn	8	SENT_149	[p13l58t379r111b402],
6	51	CD	PERCENT	51	num	8	SENT_149	[p13l72t404r125b440],
7	c	NN	PERCENT	c	nn	8	SENT_149	[p13l72t446r110b480],
8	%	NN	PERCENT	%	dep	1	SENT_149	[p13l59t486r125b505],
9	c	NN	O	c	nn	10	SENT_149	[p13l72t531r110b565],
10	o	NN	O	o	dep	8	SENT_149	[p13l72t571r111b609],
11	‘	NN	O	‘	prep	10	SENT_149	[p13l59t616r111b653, p13l72t655r111b690],
12	=	JJ	O	=	amod	13	SENT_149	[p13l59t616r111b653, p13l72t655r111b690],
13	cu	NN	O	cu	dep	11	SENT_149	[p13l59t616r111b653, p13l72t655r111b690],
14	&	CC	O	&	_	0	SENT_149	[p13l72t693r110b715],
15	II	NNP	O	II	dep	11	SENT_149	[p13l63t720r111b741],
16	-	:	O	-	_	0	SENT_149	[p13l63t720r111b741],
17	'	''	O	'	_	0	SENT_149	[p13l63t720r111b741],
18	:	:	O	:	_	0	SENT_149	[p13l72t746r110b780],
19	tn	NN	O	tn	nn	23	SENT_149	[p13l72t786r111b821],
20	o	NN	O	o	nn	23	SENT_149	[p13l72t824r111b858],
21	c	NN	O	c	nn	23	SENT_149	[p13l72t865r110b899],
22	o	NN	O	o	nn	23	SENT_149	[p13l72t905r111b943],
23	o	NN	O	o	dep	8	SENT_149	[p13l72t947r111b981],
24	as	IN	O	as	_	0	SENT_149	[p13l72t1004r111b1039],
25	E	NN	O	e	nn	26	SENT_149	[p13l72t1045r110b1098],
26	(	NN	O	(	prep_as	23	SENT_149	[p13l72t1105r111b1139],
27	D	NN	O	d	nn	29	SENT_149	[p13l72t1105r111b1139],
28	2	CD	NUMBER	2	num	29	SENT_149	[p13l60t1143r111b1194],
29	D.	NNP	O	D.	dep	1	SENT_149	[p13l72t1200r124b1237],

1	c	NN	O	c	_	0	SENT_150	[p13l72t1264r110b1298],
2	:5	CD	NUMBER	:5	num	4	SENT_150	[p13l72t1304r111b1339],
3	cu	NN	O	cu	nn	4	SENT_150	[p13l72t1342r111b1377],
4	E	NN	O	e	dep	1	SENT_150	[p13l60t1383r110b1432],

1	Time	NNP	O	Time	_	0	SENT_151	[p13l1033t1653r1192b1705],
2	(	CD	NUMBER	(	num	3	SENT_151	[p13l1215t1652r1448b1718],
3	hours	NNS	NUMBER	hour	dep	1	SENT_151	[p13l1215t1652r1448b1718],
4	)	IN	O	)	amod	3	SENT_151	[p13l1215t1652r1448b1718],

1	Figure	NNP	O	Figure	_	0	SENT_152	[p13l12t1861r219b1930],
2	1	CD	NUMBER	1	dep	1	SENT_152	[p13l249t1866r297b1913],
3	.	.	O	.	_	0	SENT_152	[p13l249t1866r297b1913],

1	Mean	NN	O	mean	_	0	SENT_153	[p13l373t1862r552b1913],
2	steady-state	JJ	O	steady-state	amod	5	SENT_153	[p13l582t1858r967b1930],
3	plasma	NN	O	plasma	nn	5	SENT_153	[p13l990t1858r1229b1930],
4	concentration-time	NN	O	concentration-time	nn	5	SENT_153	[p13l1259t1861r1877b1913],
5	profiles	NNS	O	profile	dep	1	SENT_153	[p13l1900t1858r2148b1930],
6	of	IN	O	of	_	0	SENT_153	[p13l16t1946r85b2017],
7	Iamivudine	NN	LOCATION	iamivudine	prep_of	5	SENT_153	[p13l100t1946r487b2009],
8	,	,	O	,	_	0	SENT_153	[p13l100t1946r487b2009],
9	zidovudine	NN	O	zidovudine	prep_of	5	SENT_153	[p13l518t1945r898b2009],
10	,	,	O	,	_	0	SENT_153	[p13l518t1945r898b2009],
11	and	CC	O	and	_	0	SENT_153	[p13l931t1946r1055b2000],
12	stavudine	NN	O	stavudine	prep_of	5	SENT_153	[p13l1080t1946r1398b2000],
13	in	IN	O	in	_	0	SENT_153	[p13l1423t1949r1485b2000],
14	human	JJ	O	human	amod	19	SENT_153	[p13l1513t1945r1742b2000],
15	immunodeﬁciency	NN	O	immunodeﬁciency	nn	19	SENT_153	[p13l1770t1945r2147b2000, p13l7t2034r273b2106],
16	virus	NN	O	virus	nn	19	SENT_153	[p13l295t2037r454b2089],
17	(	CD	NUMBER	(	num	19	SENT_153	[p13l482t2034r1080b2099],
18	HIV	NN	O	hiv	nn	19	SENT_153	[p13l482t2034r1080b2099],
19	)	NN	O	)	prep_in	7	SENT_153	[p13l482t2034r1080b2099],
20	/	:	O	/	punct	21	SENT_153	[p13l482t2034r1080b2099],
21	tuberculosis	NN	O	tuberculosis	dep	19	SENT_153	[p13l482t2034r1080b2099],
22	{	CD	NUMBER	{	num	24	SENT_153	[p13l1109t2034r1622b2106],
23	TB	NN	O	tb	nn	24	SENT_153	[p13l1109t2034r1622b2106],
24	)	NN	O	)	dep	21	SENT_153	[p13l1109t2034r1622b2106],
25	.	.	O	.	_	0	SENT_153	[p13l1109t2034r1622b2106],

1	—	NN	O	—	_	0	SENT_154	[p13l1109t2034r1622b2106],
2	.	.	O	.	_	0	SENT_154	[p13l1109t2034r1622b2106],

1	coinfected	VBN	O	coinfect	_	0	SENT_155	[p13l1109t2034r1622b2106],
2	patients	NNS	O	patient	dobj	1	SENT_155	[p13l1643t2037r1907b2106],
3	during	IN	O	during	_	0	SENT_155	[p13l1937t2034r2151b2106],
4	concurrent	JJ	O	concurrent	amod	5	SENT_155	[p13l16t2130r370b2177],
5	HIV	NN	MISC	hiv	prep_during	1	SENT_155	[p13l391t2126r528b2176],
6	and	CC	O	and	_	0	SENT_155	[p13l547t2122r672b2177],
7	TB	NN	O	tb	nn	8	SENT_155	[p13l700t2126r787b2176],
8	therapy	NN	O	therapy	prep_during	1	SENT_155	[p13l814t2122r1069b2194],
9	.	.	O	.	_	0	SENT_155	[p13l814t2122r1069b2194],

1	Of	IN	O	of	_	0	SENT_156	[p13l1103t2122r1186b2194],
2	the	DT	O	the	det	5	SENT_156	[p13l1203t2122r1301b2177],
3	27	CD	NUMBER	27	num	5	SENT_156	[p13l1327t2130r1406b2176],
4	total	JJ	O	total	amod	5	SENT_156	[p13l1431t2122r1576b2177],
5	patients	NNS	O	patient	prep_of	10	SENT_156	[p13l1596t2125r1861b2194],
6	studied	VBN	O	study	partmod	5	SENT_156	[p13l1887t2122r2143b2186],
7	,	,	O	,	_	0	SENT_156	[p13l1887t2122r2143b2186],
8	16	CD	NUMBER	16	num	9	SENT_156	[p13l19t2217r91b2264],
9	patients	NNS	O	patient	nsubj	10	SENT_156	[p13l114t2213r379b2281],
10	received	VBD	O	receive	_	0	SENT_156	[p13l404t2209r678b2264],
11	the	DT	O	the	det	12	SENT_156	[p13l706t2210r804b2264],
12	Iamivudine	NN	LOCATION	iamivudine	dobj	10	SENT_156	[p13l829t2209r1201b2264],
13	with	IN	O	with	_	0	SENT_156	[p13l1232t2209r1366b2264],
14	zidovudine	NN	O	zidovudine	nn	18	SENT_156	[p13l1397t2209r1761b2264],
15	[	CD	NUMBER	[	num	18	SENT_156	[p13l1790t2209r2148b2281],
16	fixed-dose	JJ	O	fixed-dose	amod	18	SENT_156	[p13l1790t2209r2148b2281],
17	combination	NN	O	combination	nn	18	SENT_156	[p13l16t2298r463b2363],
18	]	NN	O	]	prep_with	10	SENT_156	[p13l16t2298r463b2363],
19	,	,	O	,	_	0	SENT_156	[p13l16t2298r463b2363],
20	and	CC	O	and	_	0	SENT_156	[p13l503t2298r628b2353],
21	11	CD	NUMBER	11	num	22	SENT_156	[p13l665t2306r729b2352],
22	patients	NNS	O	patient	nsubj	23	SENT_156	[p13l767t2301r1032b2370],
23	received	VBD	O	receive	conj_and	10	SENT_156	[p13l1065t2298r1338b2353],
24	Iamivudine	NN	PERSON	iamivudine	dobj	23	SENT_156	[p13l1370t2298r1742b2353],
25	with	IN	O	with	_	0	SENT_156	[p13l1779t2298r1914b2353],
26	stavudine	NN	O	stavudine	prep_with	23	SENT_156	[p13l1952t2305r2147b2353, p13l17t2386r171b2441],
27	.	.	O	.	_	0	SENT_156	[p13l1952t2305r2147b2353, p13l17t2386r171b2441],

1	Error	NN	O	error	nn	2	SENT_157	[p13l199t2390r368b2441],
2	bars	NNS	O	bar	nsubj	3	SENT_157	[p13l390t2386r524b2441],
3	indicate	VBP	O	indicate	_	0	SENT_157	[p13l547t2386r813b2441],
4	standard	JJ	O	standard	amod	5	SENT_157	[p13l838t2386r1129b2441],
5	error	NN	O	error	dobj	3	SENT_157	[p13l1153t2405r1311b2441],
6	of	IN	O	of	_	0	SENT_157	[p13l1334t2386r1403b2458],
7	the	DT	O	the	det	8	SENT_157	[p13l1419t2386r1517b2441],
8	mean	NN	O	mean	prep_of	5	SENT_157	[p13l1540t2405r1736b2441],
9	.	.	O	.	_	0	SENT_157	[p13l1540t2405r1736b2441],

1	(	NN	O	(	nn	2	SENT_158	[p13l23t2618r190b2699],
2	CV	NN	O	cv	nsubj	9	SENT_158	[p13l23t2618r190b2699],
3	)	CD	NUMBER	)	npadvmod	2	SENT_158	[p13l23t2618r190b2699],
4	of	IN	O	of	_	0	SENT_158	[p13l220t2618r299b2686],
5	106	CD	PERCENT	106	num	6	SENT_158	[p13l320t2618r537b2691],
6	%	NN	PERCENT	%	prep_of	2	SENT_158	[p13l320t2618r537b2691],
7	for	IN	O	for	_	0	SENT_158	[p13l570t2618r678b2686],
8	zidovudine	NN	O	zidovudine	prep_for	6	SENT_158	[p13l701t2618r1150b2686],
9	compared	VBN	O	compare	_	0	SENT_158	[p13l1177t2618r1570b2707],
10	with	IN	O	with	_	0	SENT_158	[p13l1592t2618r1774b2686],
11	39	CD	PERCENT	39	num	12	SENT_158	[p13l1801t2618r1971b2691],
12	%	NN	PERCENT	%	prep_with	9	SENT_158	[p13l1801t2618r1971b2691],
13	and	CC	O	and	_	0	SENT_158	[p13l2004t2618r2150b2686],
14	35	CD	PERCENT	35	num	15	SENT_158	[p13l22t2720r192b2793],
15	%	NN	PERCENT	%	conj_and	12	SENT_158	[p13l22t2720r192b2793],
16	for	IN	O	for	_	0	SENT_158	[p13l230t2720r337b2788],
17	lamivudine	NN	O	lamivudine	prep_for	9	SENT_158	[p13l367t2720r820b2788],
18	and	CC	O	and	_	0	SENT_158	[p13l853t2720r998b2788],
19	Stavudine	NN	O	stavudine	prep_for	9	SENT_158	[p13l1029t2720r1435b2798],
20	,	,	O	,	_	0	SENT_158	[p13l1029t2720r1435b2798],
21	respectively	RB	O	respectively	advmod	9	SENT_158	[p13l1467t2720r1958b2809],
22	.	.	O	.	_	0	SENT_158	[p13l1467t2720r1958b2809],

1	Average	JJ	O	average	amod	3	SENT_159	[p13l124t2827r442b2912],
2	lamivudine	NN	O	lamivudine	nn	3	SENT_159	[p13l486t2823r949b2891],
3	concentrations	NNS	O	concentration	nsubj	6	SENT_159	[p13l994t2826r1589b2891],
4	were	VBD	O	be	cop	6	SENT_159	[p13l1632t2847r1825b2891],
5	consistently	RB	O	consistently	advmod	6	SENT_159	[p13l1870t2826r2149b2891, p13l17t2924r252b3014],
6	higher	JJR	O	higher	_	0	SENT_159	[p13l294t2924r553b3014],
7	in	IN	O	in	_	0	SENT_159	[p13l596t2928r675b2992],
8	patients	NNS	O	patient	prep_in	6	SENT_159	[p13l718t2928r1038b3014],
9	who	WP	O	who	nsubj	10	SENT_159	[p13l1082t2924r1255b2993],
10	received	VBD	O	receive	rcmod	8	SENT_159	[p13l1299t2924r1642b2993],
11	lamivudine	NN	O	lamivudine	dobj	10	SENT_159	[p13l1686t2924r2149b2993],
12	with	IN	O	with	_	0	SENT_159	[p13l17t3026r202b3094],
13	stavudine	NN	O	stavudine	prep_with	10	SENT_159	[p13l229t3026r621b3094],
14	as	IN	O	as	_	0	SENT_159	[p13l649t3050r725b3094],
15	separate	JJ	O	separate	amod	16	SENT_159	[p13l754t3036r1083b3116],
16	preparations	NNS	O	preparation	prep_as	13	SENT_159	[p13l1109t3030r1617b3116],
17	as	IN	O	as	prep	10	SENT_159	[p13l1645t3050r1722b3094],
18	compared	VBN	O	compare	_	0	SENT_159	[p13l1750t3026r2150b3116],
19	to	TO	O	to	prepc_compared_to	10	SENT_159	[p13l17t3137r91b3194],
20	those	DT	O	those	pobj	10	SENT_159	[p13l133t3127r346b3194],
21	who	WP	O	who	nsubj	22	SENT_159	[p13l386t3127r559b3194],
22	received	VBD	O	receive	rcmod	20	SENT_159	[p13l601t3127r944b3194],
23	the	DT	O	the	det	27	SENT_159	[p13l983t3127r1107b3194],
24	fixed-dose	JJ	O	fixed-dose	amod	27	SENT_159	[p13l1150t3127r1569b3194],
25	coformulated	JJ	O	coformulated	amod	27	SENT_159	[p13l1612t3127r2151b3194],
26	lamivudine/zidovudine	NN	O	lamivudine/zidovudine	nn	27	SENT_159	[p14l19t24r981b92],
27	tablets	NNS	O	tablet	dobj	22	SENT_159	[p14l1023t24r1285b92],
28	at	IN	O	at	_	0	SENT_159	[p14l1329t34r1399b92],
29	each	DT	O	each	det	31	SENT_159	[p14l1440t24r1622b92],
30	timed	VBN	O	time	amod	31	SENT_159	[p14l1662t24r1896b92],
31	point	NN	O	point	prep_at	22	SENT_159	[p14l1937t27r2152b113],
32	(	CD	NUMBER	(	num	33	SENT_159	[p14l23t126r218b207],
33	data	NNS	O	datum	npadvmod	34	SENT_159	[p14l23t126r218b207],
34	not	RB	O	not	neg	35	SENT_159	[p14l259t136r390b194],
35	shown	VBN	O	show	partmod	31	SENT_159	[p14l433t126r747b207],
36	)	NN	O	)	dobj	35	SENT_159	[p14l433t126r747b207],
37	.	.	O	.	_	0	SENT_159	[p14l433t126r747b207],

1	This	DT	O	this	det	2	SENT_160	[p14l796t126r972b194],
2	difference	NN	O	difference	nsubjpass	4	SENT_160	[p14l1019t126r1421b194],
3	was	VBD	O	be	auxpass	4	SENT_160	[p14l1464t150r1616b194],
4	reﬂected	VBN	O	reﬂected	_	0	SENT_160	[p14l1660t126r2013b194],
5	by	IN	O	by	_	0	SENT_160	[p14l2052t126r2151b215],
6	mean	NN	O	mean	nn	8	SENT_160	[p14l17t253r237b297],
7	lamivudine	NN	O	lamivudine	nn	8	SENT_160	[p14l268t229r732b297],
8	AUC	NN	O	auc	agent	4	SENT_160	[p14l763t232r957b297],
9	and	CC	O	and	_	0	SENT_160	[p14l990t229r1138b297],
10	Cmax	NN	MISC	cmax	nn	11	SENT_160	[p14l1170t232r1330b320],
11	values	NNS	O	value	agent	4	SENT_160	[p14l1358t229r1638b307],
12	,	,	O	,	_	0	SENT_160	[p14l1358t229r1638b307],
13	which	WDT	O	which	nsubj	16	SENT_160	[p14l1672t229r1926b297],
14	were	VBD	O	be	cop	16	SENT_160	[p14l1956t253r2149b297],
15	26	CD	PERCENT	26	num	16	SENT_160	[p14l22t330r194b404],
16	%	NN	PERCENT	%	rcmod	11	SENT_160	[p14l22t330r194b404],
17	(	CD	NUMBER	(	num	18	SENT_160	[p14l244t331r326b411],
18	P	NN	O	p	attr	16	SENT_160	[p14l244t331r326b411],
19	=	JJ	O	=	amod	18	SENT_160	[p14l357t364r403b385],
20	.031	CD	NUMBER	.031	tmod	19	SENT_160	[p14l445t340r631b409],
21	,	,	O	,	_	0	SENT_160	[p14l445t340r631b409],
22	unpaired	JJ	O	unpaired	amod	24	SENT_160	[p14l671t330r1039b420],
23	ttest	NN	O	ttest	nn	24	SENT_160	[p14l1081t331r1305b411],
24	)	NN	O	)	conj_and	18	SENT_160	[p14l1081t331r1305b411],
25	and	CC	O	and	_	0	SENT_160	[p14l1348t330r1496b399],
26	41	CD	PERCENT	41	num	27	SENT_160	[p14l1534t330r1710b404],
27	%	NN	PERCENT	%	conj_and	18	SENT_160	[p14l1534t330r1710b404],
28	(	CD	NUMBER	(	num	29	SENT_160	[p14l1761t331r1842b411],
29	P	NN	O	p	dep	27	SENT_160	[p14l1761t331r1842b411],
30	=	JJ	O	=	amod	29	SENT_160	[p14l1873t364r1919b385],
31	.025	CD	NUMBER	.025	tmod	30	SENT_160	[p14l1961t340r2147b409],
32	,	,	O	,	_	0	SENT_160	[p14l1961t340r2147b409],
33	unpaired	JJ	O	unpaired	amod	34	SENT_160	[p14l17t432r385b522],
34	ttest	NN	O	ttest	appos	31	SENT_160	[p14l413t432r623b513],
35	)	CD	NUMBER	)	npadvmod	36	SENT_160	[p14l413t432r623b513],
36	higher	JJR	O	higher	advmod	29	SENT_160	[p14l651t432r926b522],
37	,	,	O	,	_	0	SENT_160	[p14l651t432r926b522],
38	respectively	RB	O	respectively	advmod	4	SENT_160	[p14l953t432r1459b522],
39	,	,	O	,	_	0	SENT_160	[p14l953t432r1459b522],
40	in	IN	O	in	_	0	SENT_160	[p14l1487t436r1567b500],
41	those	DT	O	those	det	42	SENT_160	[p14l1590t432r1803b500],
42	patients	NNS	O	patient	prep_in	4	SENT_160	[p14l1829t436r2148b522],
43	who	WP	O	who	nsubj	44	SENT_160	[p14l17t534r190b602],
44	received	VBD	O	receive	rcmod	42	SENT_160	[p14l225t534r568b602],
45	lamivudine	NN	O	lamivudine	dobj	44	SENT_160	[p14l603t534r1066b602],
46	with	IN	O	with	_	0	SENT_160	[p14l1100t534r1286b602],
47	stavudine	NN	O	stavudine	prep_with	44	SENT_160	[p14l1321t534r1714b602],
48	compared	VBN	O	compare	_	0	SENT_160	[p14l1751t534r2151b624],
49	to	TO	O	to	prepc_compared_to	44	SENT_160	[p14l17t646r91b704],
50	the	DT	O	the	det	52	SENT_160	[p14l115t636r239b704],
51	lamivudine/zidovudine	NN	O	lamivudine/zidovudine	nn	52	SENT_160	[p14l264t636r1227b704],
52	preparation	NN	O	preparation	pobj	44	SENT_160	[p14l1251t639r1741b725],
53	.	.	O	.	_	0	SENT_160	[p14l1251t639r1741b725],

1	Although	IN	O	although	mark	6	SENT_161	[p14l1768t636r2151b725],
2	mean	JJ	O	mean	amod	4	SENT_161	[p14l18t762r237b806],
3	body	NN	O	body	nn	4	SENT_161	[p14l261t738r463b827],
4	weight	NN	O	weight	nsubj	6	SENT_161	[p14l489t738r1277b827],
5	—	CD	NUMBER	—	dep	4	SENT_161	[p14l489t738r1277b827],
6	normalized	VBD	O	normalize	_	0	SENT_161	[p14l489t738r1277b827],
7	CL	NN	O	cl	dobj	6	SENT_161	[p14l1305t738r1447b806],
8	/	:	O	/	punct	13	SENT_161	[p14l1305t738r1447b806],
9	F	NN	O	f	nsubj	13	SENT_161	[p14l1452t743r1502b805],
10	was	VBD	O	be	cop	13	SENT_161	[p14l1529t762r1681b806],
11	12	CD	PERCENT	12	num	12	SENT_161	[p14l1716t738r1886b811],
12	%	NN	PERCENT	%	npadvmod	13	SENT_161	[p14l1716t738r1886b811],
13	lower	JJR	O	lower	dep	7	SENT_161	[p14l1923t738r2151b806],

1	SPECIAL	JJ	O	special	amod	2	SENT_162	[p14l19t987r294b1048],
2	POPULATIONS	NNS	O	population	_	0	SENT_162	[p14l327t987r827b1048],

1	in	IN	O	in	_	0	SENT_163	[p14l10t1086r90b1150],
2	the	DT	O	the	det	3	SENT_163	[p14l117t1083r241b1151],
3	patients	NNS	O	patient	prep_in	14	SENT_163	[p14l271t1086r591b1172],
4	who	WP	O	who	nsubj	5	SENT_163	[p14l621t1083r793b1151],
5	received	VBD	O	receive	rcmod	3	SENT_163	[p14l823t1083r1167b1151],
6	lamivudine	NN	O	lamivudine	dobj	5	SENT_163	[p14l1196t1083r1660b1151],
7	with	IN	O	with	_	0	SENT_163	[p14l1689t1083r1874b1151],
8	stavudine	NN	O	stavudine	prep_with	5	SENT_163	[p14l1904t1093r2144b1151, p14l12t1184r210b1263],
9	,	,	O	,	_	0	SENT_163	[p14l1904t1093r2144b1151, p14l12t1184r210b1263],
10	this	DT	O	this	det	11	SENT_163	[p14l252t1184r400b1253],
11	difference	NN	O	difference	appos	8	SENT_163	[p14l445t1184r847b1253],
12	did	VBD	O	do	aux	14	SENT_163	[p14l891t1184r1023b1253],
13	not	RB	O	not	neg	14	SENT_163	[p14l1062t1195r1193b1253],
14	achieve	VB	O	achieve	_	0	SENT_163	[p14l1233t1184r1538b1253],
15	statistical	JJ	O	statistical	amod	16	SENT_163	[p14l1581t1184r1965b1253],
16	significance	NN	O	significance	nsubj	19	SENT_163	[p14l2008t1188r2144b1274, p14l9t1286r380b1354],
17	(	CD	NUMBER	(	num	18	SENT_163	[p14l422t1286r503b1367],
18	P	NN	O	p	npadvmod	19	SENT_163	[p14l422t1286r503b1367],
19	>	JJR	O	>	xcomp	14	SENT_163	[p14l533t1307r578b1353],
20	.05	CD	NUMBER	.05	nsubj	14	SENT_163	[p14l619t1296r755b1365],
21	,	,	O	,	_	0	SENT_163	[p14l619t1296r755b1365],
22	unpaired	JJ	O	unpaired	amod	24	SENT_163	[p14l793t1286r1162b1376],
23	ttest	NN	O	ttest	nn	24	SENT_163	[p14l1202t1286r1447b1367],
24	)	NN	O	)	appos	20	SENT_163	[p14l1202t1286r1447b1367],
25	.	.	O	.	_	0	SENT_163	[p14l1202t1286r1447b1367],

1	Lamivudine	NN	O	lamivudine	nn	2	SENT_164	[p14l1489t1286r1978b1354],
2	tmax	NN	O	tmax	nsubj	10	SENT_164	[p14l2015t1296r2147b1378],
3	and	CC	O	and	_	0	SENT_164	[p14l11t1387r159b1454],
4	half	NN	O	half	nn	6	SENT_164	[p14l200t1387r517b1454],
5	—	JJ	O	—	amod	6	SENT_164	[p14l200t1387r517b1454],
6	life	NN	O	life	nsubj	10	SENT_164	[p14l200t1387r517b1454],
7	were	VBD	O	be	cop	10	SENT_164	[p14l559t1411r753b1454],
8	also	RB	O	also	advmod	10	SENT_164	[p14l797t1387r953b1454],
9	not	RB	O	not	neg	10	SENT_164	[p14l996t1397r1127b1454],
10	different	JJ	O	different	dep	14	SENT_164	[p14l1171t1387r1516b1454],
11	between	IN	O	between	_	0	SENT_164	[p14l1554t1387r1895b1454],
12	these	DT	O	these	det	13	SENT_164	[p14l1935t1387r2143b1454],
13	preparations	NNS	O	preparation	prep_between	10	SENT_164	[p14l10t1493r518b1579],
14	(	VBP	O	(	_	0	SENT_164	[p14l580t1489r662b1570],
15	P	NN	O	p	dep	16	SENT_164	[p14l580t1489r662b1570],
16	>	JJR	O	>	dobj	14	SENT_164	[p14l711t1510r756b1556],
17	.05	CD	NUMBER	.05	nsubj	14	SENT_164	[p14l816t1499r952b1568],
18	,	,	O	,	_	0	SENT_164	[p14l816t1499r952b1568],
19	unpaired	JJ	O	unpaired	amod	22	SENT_164	[p14l1010t1489r1378b1579],
20	t	NN	O	t	nn	22	SENT_164	[p14l1437t1499r1463b1557],
21	test	NN	O	test	nn	22	SENT_164	[p14l1513t1489r1702b1570],
22	)	NN	O	)	appos	17	SENT_164	[p14l1513t1489r1702b1570],
23	.	.	O	.	_	0	SENT_164	[p14l1513t1489r1702b1570],

1	However	RB	O	however	advmod	4	SENT_165	[p14l1762t1494r2141b1568],
2	,	,	O	,	_	0	SENT_165	[p14l1762t1494r2141b1568],
3	there	EX	O	there	expl	4	SENT_165	[p14l9t1591r212b1659],
4	were	VBD	O	be	_	0	SENT_165	[p14l273t1615r467b1659],
5	significant	JJ	O	significant	amod	6	SENT_165	[p14l531t1591r957b1680],
6	differences	NNS	O	difference	nsubj	4	SENT_165	[p14l1020t1591r1461b1659],
7	in	IN	O	in	_	0	SENT_165	[p14l1526t1594r1605b1658],
8	mean	JJ	O	mean	amod	10	SENT_165	[p14l1665t1615r1885b1659],
9	body	NN	O	body	nn	10	SENT_165	[p14l1943t1591r2145b1680],
10	weight	NN	O	weight	prep_in	4	SENT_165	[p14l9t1694r284b1783],
11	(	CD	NUMBER	(	number	12	SENT_165	[p14l314t1694r506b1775],
12	49.7	CD	NUMBER	49.7	dep	10	SENT_165	[p14l314t1694r506b1775],
13	vs	CC	O	vs	_	0	SENT_165	[p14l534t1718r618b1762],
14	60.5	CD	NUMBER	60.5	num	15	SENT_165	[p14l649t1703r811b1762],
15	kg	NN	O	kg	conj_vs	10	SENT_165	[p14l842t1694r954b1783],
16	,	,	O	,	_	0	SENT_165	[p14l842t1694r954b1783],
17	P	NN	O	p	appos	15	SENT_165	[p14l983t1698r1107b1761],
18	:	:	O	:	_	0	SENT_165	[p14l983t1698r1107b1761],
19	.003	CD	NUMBER	.003	dep	15	SENT_165	[p14l1138t1703r1324b1772],
20	,	,	O	,	_	0	SENT_165	[p14l1138t1703r1324b1772],
21	unpaired	JJ	O	unpaired	amod	23	SENT_165	[p14l1353t1694r1721b1783],
22	ttest	NN	O	ttest	nn	23	SENT_165	[p14l1752t1694r1965b1774],
23	)	NN	O	)	appos	19	SENT_165	[p14l1752t1694r1965b1774],
24	and	CC	O	and	_	0	SENT_165	[p14l1997t1694r2145b1762],
25	BMI	NN	O	bmus	conj_and	10	SENT_165	[p14l10t1800r179b1863],
26	(	CD	NUMBER	(	number	27	SENT_165	[p14l224t1796r416b1876],
27	16.9	CD	NUMBER	16.9	dep	25	SENT_165	[p14l224t1796r416b1876],
28	vs	CC	O	vs	_	0	SENT_165	[p14l457t1820r541b1864],
29	20.4	CD	NUMBER	20.4	num	30	SENT_165	[p14l587t1805r751b1864],
30	kg/m2	NN	O	kg/m2	conj_vs	25	SENT_165	[p14l793t1795r1048b1885],
31	,	,	O	,	_	0	SENT_165	[p14l793t1795r1048b1885],
32	P	NN	O	p	appos	30	SENT_165	[p14l1091t1800r1149b1863],
33	=	JJ	O	=	amod	30	SENT_165	[p14l1182t1829r1229b1850],
34	.002	CD	NUMBER	.002	tmod	33	SENT_165	[p14l1273t1805r1459b1874],
35	,	,	O	,	_	0	SENT_165	[p14l1273t1805r1459b1874],
36	unpaired	JJ	O	unpaired	amod	38	SENT_165	[p14l1502t1795r1870b1885],
37	ttest	NN	O	ttest	nn	38	SENT_165	[p14l1914t1796r2140b1876],
38	)	NN	O	)	appos	30	SENT_165	[p14l1914t1796r2140b1876],
39	between	IN	O	between	_	0	SENT_165	[p14l7t1897r342b1965],
40	the	DT	O	the	det	41	SENT_165	[p14l377t1897r499b1965],
41	patients	NNS	O	patient	prep_between	38	SENT_165	[p14l537t1901r850b1987],
42	who	WP	O	who	nsubj	43	SENT_165	[p14l888t1897r1059b1965],
43	received	VBD	O	receive	rcmod	38	SENT_165	[p14l1096t1897r1433b1965],
44	lamivudine	NN	O	lamivudine	dobj	43	SENT_165	[p14l1470t1897r1926b1965],
45	with	IN	O	with	_	0	SENT_165	[p14l1963t1897r2146b1965],
46	stavudine	NN	O	stavudine	prep_with	43	SENT_165	[p14l11t1999r398b2067],
47	compared	VBN	O	compare	_	0	SENT_165	[p14l425t1999r819b2089],
48	with	IN	O	with	prepc_compared_with	43	SENT_165	[p14l841t1999r1024b2067],
49	the	DT	O	the	det	51	SENT_165	[p14l1047t1999r1169b2067],
50	lamivudine/zidovudine	NN	O	lamivudine/zidovudine	nn	51	SENT_165	[p14l1194t1999r2144b2067],
51	preparation	NN	O	preparation	pobj	43	SENT_165	[p14l10t2105r502b2191],
52	,	,	O	,	_	0	SENT_165	[p14l10t2105r502b2191],
53	respectively	RB	O	respectively	advmod	4	SENT_165	[p14l536t2101r1041b2191],
54	.	.	O	.	_	0	SENT_165	[p14l536t2101r1041b2191],

1	Possible	JJ	O	possible	amod	2	SENT_166	[p14l116t2203r448b2271],
2	effects	NNS	O	effect	nsubj	9	SENT_166	[p14l487t2203r742b2271],
3	of	IN	O	of	_	0	SENT_166	[p14l783t2203r863b2271],
4	age	NN	O	age	prep_of	2	SENT_166	[p14l894t2227r1020b2292],
5	and	CC	O	and	_	0	SENT_166	[p14l1060t2203r1208b2271],
6	BMI	NN	O	bmus	prep_of	2	SENT_166	[p14l1245t2207r1414b2271],
7	on	IN	O	on	_	0	SENT_166	[p14l1452t2227r1550b2271],
8	body	NN	O	body	prep_on	4	SENT_166	[p14l1584t2203r1786b2292],
9	weightnormalized	VBD	O	weightnormalize	_	0	SENT_166	[p14l1821t2203r2147b2292, p14l9t2306r471b2374],
10	CL/F	NN	O	cl/f	nsubjpass	15	SENT_166	[p14l522t2306r719b2374],
11	of	IN	O	of	_	0	SENT_166	[p14l772t2306r852b2374],
12	each	DT	O	each	det	13	SENT_166	[p14l897t2306r1080b2374],
13	drug	NN	O	drug	prep_of	10	SENT_166	[p14l1133t2306r1313b2395],
14	were	VBD	O	be	auxpass	15	SENT_166	[p14l1363t2330r1556b2374],
15	evaluated	VBN	O	evaluate	ccomp	9	SENT_166	[p14l1610t2306r2000b2374],
16	by	IN	O	by	_	0	SENT_166	[p14l2047t2306r2146b2395],
17	linear	JJ	O	linear	amod	18	SENT_166	[p14l10t2407r244b2476],
18	regression	NN	O	regression	agent	15	SENT_166	[p14l269t2411r703b2497],
19	,	,	O	,	_	0	SENT_166	[p14l269t2411r703b2497],
20	whereas	IN	O	whereas	mark	24	SENT_166	[p14l732t2408r1063b2476],
21	sex	NN	O	sex	nn	22	SENT_166	[p14l1094t2432r1222b2476],
22	effects	NNS	O	effect	nsubjpass	24	SENT_166	[p14l1250t2408r1504b2476],
23	were	VBD	O	be	auxpass	24	SENT_166	[p14l1532t2432r1725b2476],
24	evaluated	VBN	O	evaluate	advcl	15	SENT_166	[p14l1755t2407r2145b2476],
25	by	IN	O	by	_	0	SENT_166	[p14l7t2509r105b2599],
26	unpaired	JJ	O	unpaired	amod	28	SENT_166	[p14l148t2509r516b2599],
27	t	NN	O	t	nn	28	SENT_166	[p14l563t2519r590b2577],
28	test	NN	O	test	agent	24	SENT_166	[p14l628t2519r787b2577],
29	.	.	O	.	_	0	SENT_166	[p14l628t2519r787b2577],

1	Stavudine	NN	O	stavudine	nn	2	SENT_167	[p14l840t2509r1247b2577],
2	CL/F	NN	O	cl/f	nsubj	5	SENT_167	[p14l1293t2509r1491b2577],
3	was	VBD	O	be	cop	5	SENT_167	[p14l1534t2533r1687b2577],
4	somewhat	RB	O	somewhat	advmod	5	SENT_167	[p14l1735t2509r2146b2577],
5	higher	JJR	O	higher	_	0	SENT_167	[p14l9t2611r269b2700],
6	in	IN	O	in	mark	8	SENT_167	[p14l309t2615r388b2679],
7	women	NNS	O	woman	nsubj	8	SENT_167	[p14l427t2635r726b2679],
8	(	VBP	O	(	ccomp	5	SENT_167	[p14l771t2611r847b2692],
9	n	NN	O	n	dobj	8	SENT_167	[p14l771t2611r847b2692],
10	=	JJ	O	=	amod	9	SENT_167	[p14l886t2644r932b2666],
11	3	CD	NUMBER	3	num	12	SENT_167	[p14l975t2611r1042b2692],
12	)	NN	O	)	dep	10	SENT_167	[p14l975t2611r1042b2692],
13	than	IN	O	than	dep	8	SENT_167	[p14l1086t2611r1266b2679],
14	in	IN	O	in	_	0	SENT_167	[p14l1307t2615r1386b2679],
15	men	NNS	O	man	prep_in	13	SENT_167	[p14l1426t2635r1601b2679],
16	(	CD	NUMBER	(	num	17	SENT_167	[p14l1645t2611r1721b2692],
17	n	NN	O	n	dep	25	SENT_167	[p14l1645t2611r1721b2692],
18	=	JJ	O	=	amod	20	SENT_167	[p14l1760t2644r1807b2666],
19	8	CD	NUMBER	8	tmod	18	SENT_167	[p14l1848t2611r1917b2692],
20	)	NN	O	)	dep	17	SENT_167	[p14l1848t2611r1917b2692],
21	with	IN	O	with	_	0	SENT_167	[p14l1960t2611r2146b2679],
22	mean	JJ	O	mean	amod	23	SENT_167	[p14l9t2736r229b2779],
23	i	FW	O	i	prep_with	20	SENT_167	[p14l264t2723r311b2779],
24	SD	NN	O	sd	dep	25	SENT_167	[p14l350t2716r460b2779],
25	values	NNS	O	value	dep	28	SENT_167	[p14l497t2712r754b2779],
26	of	IN	O	of	_	0	SENT_167	[p14l795t2712r876b2779],
27	23.0	CD	NUMBER	23.0	prep_of	25	SENT_167	[p14l909t2722r1073b2779],
28	i	FW	O	i	dep	34	SENT_167	[p14l1111t2723r1157b2779],
29	6.7	CD	NUMBER	6.7	dep	28	SENT_167	[p14l1196t2722r1310b2779],
30	and	CC	O	and	_	0	SENT_167	[p14l1351t2712r1500b2779],
31	14.0	CD	NUMBER	14.0	dep	28	SENT_167	[p14l1541t2722r1703b2779],
32	i	FW	O	i	dep	29	SENT_167	[p14l1742t2723r1788b2779],
33	3.1	CD	NUMBER	3.1	num	34	SENT_167	[p14l1828t2722r1938b2779],
34	mL	NN	O	ml	dep	15	SENT_167	[p14l1980t2712r2144b2779],
35	/	:	O	/	punct	13	SENT_167	[p14l1980t2712r2144b2779],

1	min/kg	NN	O	min/kg	_	0	SENT_168	[p14l9t2814r319b2903],
2	,	,	O	,	_	0	SENT_168	[p14l9t2814r319b2903],
3	respectively	RB	O	respectively	advmod	5	SENT_168	[p14l382t2814r875b2903],
4	(	CD	NUMBER	(	num	5	SENT_168	[p14l940t2814r1021b2895],
5	P	NN	O	p	appos	1	SENT_168	[p14l940t2814r1021b2895],
6	=	JJ	O	=	amod	5	SENT_168	[p14l1075t2847r1122b2869],
7	.014	CD	NUMBER	.014	tmod	6	SENT_168	[p14l1187t2824r1372b2893],
8	,	,	O	,	_	0	SENT_168	[p14l1187t2824r1372b2893],
9	unpaired	JJ	O	unpaired	amod	12	SENT_168	[p14l1436t2814r1804b2903],
10	t	NN	O	t	nn	12	SENT_168	[p14l1869t2823r1895b2882],
11	test	NN	O	test	nn	12	SENT_168	[p14l1951t2814r2139b2895],
12	)	NN	O	)	appos	1	SENT_168	[p14l1951t2814r2139b2895],
13	.	.	O	.	_	0	SENT_168	[p14l1951t2814r2139b2895],

1	Lamivudine	NN	O	lamivudine	nn	2	SENT_169	[p14l10t2917r499b2985],
2	CL/F	NN	O	cl/f	nsubj	3	SENT_169	[p14l582t2917r779b2985],
3	normalized	VBD	O	normalize	_	0	SENT_169	[p14l860t2917r1322b2985],
4	for	IN	O	for	mark	7	SENT_169	[p14l1403t2917r1513b2985],
5	body	NN	O	body	nn	6	SENT_169	[p14l1590t2917r1792b3006],
6	weight	NN	O	weight	nsubj	7	SENT_169	[p14l1871t2917r2146b3006],
7	appeared	VBD	O	appear	advcl	3	SENT_169	[p14l11t3018r382b3108],
8	to	TO	O	to	aux	9	SENT_169	[p14l411t3029r485b3087],
9	decline	VB	O	decline	xcomp	7	SENT_169	[p14l521t3018r814b3087],
10	modestly	RB	O	modestly	advmod	9	SENT_169	[p14l846t3018r1219b3108],
11	with	IN	O	with	_	0	SENT_169	[p14l1248t3018r1433b3087],
12	increasing	VBG	O	increase	amod	13	SENT_169	[p14l1464t3022r1879b3108],
13	age	NN	O	age	prep_with	9	SENT_169	[p14l1911t3043r2038b3108],
14	of	IN	O	of	_	0	SENT_169	[p14l2072t3019r2152b3087],
15	the	DT	O	the	det	16	SENT_169	[p14l9t3120r133b3188],
16	patients	NNS	O	patient	prep_of	13	SENT_169	[p14l196t3124r516b3210],
17	in	IN	O	in	_	0	SENT_169	[p14l581t3124r661b3188],
18	both	DT	O	both	det	24	SENT_169	[p14l720t3120r903b3188],
19	univariate	JJ	O	univariate	amod	24	SENT_169	[p14l963t3124r1374b3188],
20	and	CC	O	and	_	0	SENT_169	[p14l1439t3120r1587b3188],
21	multivariate	JJ	O	multivariate	amod	24	SENT_169	[p14l1649t3120r2144b3188],
22	analysis	NN	O	analysis	nn	24	SENT_169	[p14l11t3222r335b3311],
23	(	CD	NUMBER	(	num	24	SENT_169	[p14l379t3222r461b3303],
24	P	NN	O	p	prep_in	16	SENT_169	[p14l379t3222r461b3303],
25	=	JJ	O	=	amod	24	SENT_169	[p14l491t3255r538b3277],
26	.021	CD	NUMBER	.021	tmod	25	SENT_169	[p14l579t3232r765b3301],
27	;	:	O	;	_	0	SENT_169	[p14l579t3232r765b3301],
28	Figure	NNP	O	Figure	dep	13	SENT_169	[p14l806t3226r1062b3311],
29	2	CD	NUMBER	2	number	30	SENT_169	[p14l1105t3222r1196b3303],
30	)	CD	NUMBER	)	dep	28	SENT_169	[p14l1105t3222r1196b3303],
31	.	.	O	.	_	0	SENT_169	[p14l1105t3222r1196b3303],

1	Sex	NN	O	sex	nsubj	4	SENT_170	[p14l1242t3226r1384b3290],
2	did	VBD	O	do	aux	4	SENT_170	[p14l1423t3222r1555b3290],
3	not	RB	O	not	neg	4	SENT_170	[p14l1592t3232r1723b3290],
4	appear	VB	O	appear	_	0	SENT_170	[p14l1761t3246r2033b3312],
5	to	TO	O	to	aux	6	SENT_170	[p14l2069t3232r2143b3290],
6	inﬂuence	VB	O	inﬂuence	xcomp	4	SENT_170	[p14l10t3323r390b3390],
7	the	DT	O	the	det	8	SENT_170	[p14l418t3323r542b3390],
8	clearance	NN	O	clearance	dobj	6	SENT_170	[p14l573t3323r952b3390],
9	of	IN	O	of	_	0	SENT_170	[p14l982t3323r1063b3390],
10	lamivudine	NN	O	lamivudine	prep_of	8	SENT_170	[p14l1083t3323r1548b3390],
11	or	CC	O	or	_	0	SENT_170	[p14l1578t3347r1657b3390],
12	zidovudine	NN	O	zidovudine	conj_or	10	SENT_170	[p14l1684t3323r2144b3390],

1	(	NN	O	(	nn	2	SENT_171	[p14l14t3425r96b3506],
2	P	NN	O	p	dep	3	SENT_171	[p14l14t3425r96b3506],
3	>	JJR	O	>	_	0	SENT_171	[p14l116t3446r160b3492],
4	.05	CD	NUMBER	.05	dep	3	SENT_171	[p14l191t3435r328b3504],
5	,	,	O	,	_	0	SENT_171	[p14l191t3435r328b3504],
6	unpaired	JJ	O	unpaired	amod	8	SENT_171	[p14l356t3425r725b3514],
7	ttest	NN	O	ttest	nn	8	SENT_171	[p14l755t3425r992b3506],
8	)	NN	O	)	appos	4	SENT_171	[p14l755t3425r992b3506],
9	.	.	O	.	_	0	SENT_171	[p14l755t3425r992b3506],

1	and	CC	O	and	cc	5	SENT_172	[p14l1023t3425r1171b3493],
2	BMI	NNP	O	BMI	nsubjpass	5	SENT_172	[p14l1198t3429r1367b3493],
3	was	VBD	O	be	auxpass	5	SENT_172	[p14l1391t3449r1544b3493],
4	not	RB	O	not	neg	5	SENT_172	[p14l1572t3435r1703b3493],
5	associated	VBN	O	associate	dep	13	SENT_172	[p14l1729t3425r2145b3493],
6	with	IN	O	with	_	0	SENT_172	[p14l9t3528r190b3596],
7	clearance	NN	O	clearance	prep_with	5	SENT_172	[p14l215t3528r584b3596],
8	of	IN	O	of	_	0	SENT_172	[p14l610t3528r690b3596],
9	any	DT	O	any	prep_of	7	SENT_172	[p14l707t3552r848b3617],
10	of	IN	O	of	_	0	SENT_172	[p14l873t3528r952b3596],
11	the	DT	O	the	det	12	SENT_172	[p14l967t3528r1088b3596],
12	drugs	NNS	O	drug	prep_of	9	SENT_172	[p14l1116t3528r1329b3617],
13	evaluated	VBD	O	evaluate	_	0	SENT_172	[p14l1357t3528r1737b3596],
14	(	CD	NUMBER	(	num	15	SENT_172	[p14l1765t3527r1870b3609],
15	R2	NN	O	r2	npadvmod	16	SENT_172	[p14l1765t3527r1870b3609],
16	<	JJR	O	<	acomp	13	SENT_172	[p14l1888t3549r1933b3594],
17	0.30	CD	NUMBER	0.30	dep	16	SENT_172	[p14l1958t3538r2141b3606],
18	,	,	O	,	_	0	SENT_172	[p14l1958t3538r2141b3606],
19	P	NN	O	p	dep	20	SENT_172	[p14l8t3634r66b3697],
20	>	JJR	O	>	appos	17	SENT_172	[p14l91t3650r136b3696],
21	.05	CD	NUMBER	.05	nsubj	13	SENT_172	[p14l172t3639r309b3708],
22	,	,	O	,	_	0	SENT_172	[p14l172t3639r309b3708],
23	linear	JJ	O	linear	amod	25	SENT_172	[p14l344t3629r578b3698],
24	regression	NN	O	regression	nn	25	SENT_172	[p14l607t3630r1069b3719],
25	)	NN	O	)	appos	21	SENT_172	[p14l607t3630r1069b3719],
26	.	.	O	.	_	0	SENT_172	[p14l607t3630r1069b3719],

1	Effect	NN	O	effect	_	0	SENT_173	[p15l9t60r239b128],
2	of	IN	O	of	_	0	SENT_173	[p15l271t60r356b128],
3	UGTZB7	NNP	O	UGTZB7	nn	4	SENT_173	[p15l375t63r727b128],
4	Polymorphisms	NNP	O	Polymorphisms	prep_of	1	SENT_173	[p15l759t60r1404b149],
5	on	IN	O	on	_	0	SENT_173	[p15l1437t83r1537b128],
6	Zidovudine	NNP	O	Zidovudine	nn	7	SENT_173	[p15l10t165r485b232],
7	Pharmacokinetics	NNPS	O	Pharmacokinetics	prep_on	1	SENT_173	[p15l516t165r1260b232],
8	and	CC	O	and	_	0	SENT_173	[p15l1295t165r1447b232],
9	Metabolism	NN	O	metabolism	prep_on	1	SENT_173	[p15l1478t165r1961b232],

1	The	DT	O	the	dep	101	SENT_174	[p15l10t374r162b441],
2	UGTZB7	NN	O	ugtzb7	dep	101	SENT_174	[p15l210t377r552b441],
3	exon	NN	O	exon	dep	101	SENT_174	[p15l584t397r777b441],
4	2	CD	NUMBER	2	dep	101	SENT_174	[p15l817t383r853b440],
5	SNPs	NNS	O	snp	dep	101	SENT_174	[p15l898t377r1106b441],
6	c.	VBP	O	c.	dep	101	SENT_174	[p15l1146t377r1526b441],
7	802C	NN	O	802c	dep	101	SENT_174	[p15l1146t377r1526b441],
8	>	JJR	O	>	dep	101	SENT_174	[p15l1146t377r1526b441],
9	T	NN	O	t	dep	101	SENT_174	[p15l1146t377r1526b441],
10	and	CC	O	and	dep	101	SENT_174	[p15l1564t374r1712b441],
11	c.	NN	O	c.	dep	101	SENT_174	[p15l1750t377r2147b441],
12	735A	NN	O	735a	dep	101	SENT_174	[p15l1750t377r2147b441],
13	>	JJR	O	>	dep	101	SENT_174	[p15l1750t377r2147b441],
14	G	NN	O	g	dep	101	SENT_174	[p15l1750t377r2147b441],
15	were	VBD	O	be	dep	101	SENT_174	[p15l8t500r202b544],
16	genotyped	VBN	O	genotype	dep	101	SENT_174	[p15l234t475r656b565],
17	in	IN	O	in	dep	101	SENT_174	[p15l688t479r767b543],
18	the	DT	O	the	dep	101	SENT_174	[p15l797t475r921b544],
19	16	CD	NUMBER	16	dep	101	SENT_174	[p15l958t485r1045b544],
20	patients	NNS	O	patient	dep	101	SENT_174	[p15l1079t479r1399b565],
21	from	IN	O	from	dep	101	SENT_174	[p15l1433t476r1622b544],
22	the	DT	O	the	dep	101	SENT_174	[p15l1651t476r1776b544],
23	pharmacokinetic	JJ	O	pharmacokinetic	dep	101	SENT_174	[p15l1808t475r2144b565, p15l11t577r380b645],
24	study	NN	O	study	dep	101	SENT_174	[p15l428t577r650b667],
25	who	WP	O	who	dep	101	SENT_174	[p15l692t577r865b645],
26	had	VBD	O	have	dep	101	SENT_174	[p15l911t577r1060b645],
27	received	VBN	O	receive	dep	101	SENT_174	[p15l1103t577r1447b645],
28	Zidovudine	NNP	O	Zidovudine	dep	101	SENT_174	[p15l1492t577r1951b645],
29	and	CC	O	and	dep	101	SENT_174	[p15l1997t577r2145b645],
30	also	RB	O	also	dep	101	SENT_174	[p15l11t679r167b747],
31	in	IN	O	in	dep	101	SENT_174	[p15l198t683r278b747],
32	52	CD	NUMBER	52	dep	101	SENT_174	[p15l310t689r397b747],
33	of	IN	O	of	dep	101	SENT_174	[p15l433t679r513b747],
34	the	DT	O	the	dep	101	SENT_174	[p15l534t679r658b747],
35	liver	NN	O	liver	dep	101	SENT_174	[p15l689t679r873b747],
36	bank	NN	O	bank	dep	101	SENT_174	[p15l898t679r1097b747],
37	samples	NNS	O	sample	dep	101	SENT_174	[p15l1126t679r1449b769],
38	that	IN	O	that	dep	101	SENT_174	[p15l1480t679r1636b747],
39	we	PRP	O	we	dep	101	SENT_174	[p15l1663t703r1777b747],
40	had	VBD	O	have	dep	101	SENT_174	[p15l1807t679r1957b747],
41	previously	RB	DATE	previously	dep	101	SENT_174	[p15l1986t703r2144b769, p15l8t781r308b870],
42	assayed	VBN	O	assay	dep	101	SENT_174	[p15l383t781r695b870],
43	for	IN	O	for	dep	101	SENT_174	[p15l771t781r880b849],
44	Zidovudine	NN	O	zidovudine	dep	101	SENT_174	[p15l955t781r1414b849],
45	glucuronidation	NN	O	glucuronidation	dep	101	SENT_174	[p15l1490t781r2146b870],
46	activity	NN	O	activity	dep	101	SENT_174	[p15l11t885r327b971],
47	,	,	O	,	_	0	SENT_174	[p15l11t885r327b971],
48	UGTZB7	NN	O	ugtzb7	dep	101	SENT_174	[p15l384t885r728b950],
49	protein	NN	O	protein	dep	101	SENT_174	[p15l785t885r1098b971],
50	,	,	O	,	_	0	SENT_174	[p15l785t885r1098b971],
51	and	CC	O	and	dep	101	SENT_174	[p15l1156t882r1304b950],
52	mRNA	NN	O	mrna	dep	101	SENT_174	[p15l1357t886r1631b949],
53	content	NN	O	content	dep	101	SENT_174	[p15l1685t881r2144b950],
54	.23	CD	NUMBER	.23	dep	101	SENT_174	[p15l1685t881r2144b950],
55	’24	CD	NUMBER	’24	dep	101	SENT_174	[p15l1685t881r2144b950],
56	Derived	VBN	O	derive	dep	101	SENT_174	[p15l9t986r329b1054],
57	genotype	NN	O	genotype	dep	101	SENT_174	[p15l356t996r725b1075],
58	frequencies	NNS	O	frequency	dep	101	SENT_174	[p15l754t986r1220b1075],
59	of	IN	O	of	dep	101	SENT_174	[p15l1251t986r1332b1054],
60	the	DT	O	the	dep	101	SENT_174	[p15l1351t986r1475b1054],
61	UGTZB7	NN	O	ugtzb7	dep	101	SENT_174	[p15l1513t989r1857b1054],
62	exon	NN	O	exon	dep	101	SENT_174	[p15l1880t1010r2073b1054],
63	2	CD	NUMBER	2	dep	101	SENT_174	[p15l2103t995r2140b1053],
64	SNPS	NNS	O	snp	dep	101	SENT_174	[p15l12t1091r219b1156],
65	c.	VBP	O	c.	dep	101	SENT_174	[p15l250t1091r599b1166],
66	802CC	NN	O	802cc	dep	101	SENT_174	[p15l250t1091r599b1166],
67	,	,	O	,	_	0	SENT_174	[p15l250t1091r599b1166],
68	CT	NN	O	ct	dep	101	SENT_174	[p15l630t1091r756b1166],
69	,	,	O	,	_	0	SENT_174	[p15l630t1091r756b1166],
70	and	CC	O	and	dep	101	SENT_174	[p15l787t1087r935b1156],
71	TT	NN	O	tt	dep	101	SENT_174	[p15l961t1092r1075b1155],
72	genotype	NN	O	genotype	dep	101	SENT_174	[p15l1101t1098r1464b1177],
73	were	VBD	O	be	dep	101	SENT_174	[p15l1491t1112r1683b1156],
74	62.5	CD	PERCENT	62.5	dep	101	SENT_174	[p15l1714t1087r1959b1161],
75	%	NN	PERCENT	%	dep	101	SENT_174	[p15l1714t1087r1959b1161],
76	(	CD	NUMBER	(	dep	101	SENT_174	[p15l1999t1088r2074b1168],
77	n	NN	O	n	dep	101	SENT_174	[p15l1999t1088r2074b1168],
78	=	JJ	O	=	dep	101	SENT_174	[p15l2099t1121r2146b1142],
79	10	CD	NUMBER	10	dep	101	SENT_174	[p15l14t1189r156b1270],
80	)	NN	O	)	dep	101	SENT_174	[p15l14t1189r156b1270],
81	,	,	O	,	_	0	SENT_174	[p15l14t1189r156b1270],
82	31.3	CD	PERCENT	31.3	dep	101	SENT_174	[p15l193t1189r439b1263],
83	%	NN	PERCENT	%	dep	101	SENT_174	[p15l193t1189r439b1263],
84	(	CD	NUMBER	(	dep	101	SENT_174	[p15l482t1189r558b1270],
85	n	NN	O	n	dep	101	SENT_174	[p15l482t1189r558b1270],
86	=	JJ	O	=	dep	101	SENT_174	[p15l587t1223r633b1244],
87	5	CD	NUMBER	5	dep	101	SENT_174	[p15l666t1189r759b1270],
88	)	NN	O	)	dep	101	SENT_174	[p15l666t1189r759b1270],
89	,	,	O	,	_	0	SENT_174	[p15l666t1189r759b1270],
90	and	CC	O	and	dep	101	SENT_174	[p15l794t1189r942b1257],
91	6.3	CD	PERCENT	6.3	dep	101	SENT_174	[p15l974t1189r1172b1263],
92	%	NN	PERCENT	%	dep	101	SENT_174	[p15l974t1189r1172b1263],
93	(	CD	NUMBER	(	dep	101	SENT_174	[p15l1216t1189r1291b1270],
94	n	NN	O	n	dep	101	SENT_174	[p15l1216t1189r1291b1270],
95	=	JJ	O	=	dep	101	SENT_174	[p15l1320t1223r1367b1244],
96	1	CD	NUMBER	1	dep	101	SENT_174	[p15l1401t1189r1492b1270],
97	)	NN	O	)	dep	101	SENT_174	[p15l1401t1189r1492b1270],
98	,	,	O	,	_	0	SENT_174	[p15l1401t1189r1492b1270],
99	respectively	RB	O	respectively	dep	101	SENT_174	[p15l1525t1189r2031b1279],
100	,	,	O	,	_	0	SENT_174	[p15l1525t1189r2031b1279],
101	in	IN	O	in	_	0	SENT_174	[p15l2066t1193r2146b1257],

1	KWARA	NNP	LOCATION	KWARA	nn	3	SENT_175	[p15l936t1581r1089b1611],
2	ET	NNP	O	ET	nn	3	SENT_175	[p15l1104t1581r1160b1611],
3	AL	NNP	O	AL	_	0	SENT_175	[p15l1169t1581r1225b1611],

1	_	NN	O	_	nn	2	SENT_176	[p15l178t1853r197b1903],
2	L	NN	O	l	_	0	SENT_176	[p15l178t1853r197b1903],
3	.07	CD	NUMBER	.07	num	4	SENT_176	[p15l213t1853r263b1904],
4	3	CD	NUMBER	3	dep	2	SENT_176	[p15l271t1853r305b1904],

1	Y	NN	O	y	nsubj	2	SENT_177	[p15l1417t1924r1461b1975],
2	=	JJ	O	=	_	0	SENT_177	[p15l1484t1947r1520b1967],
3	.	.	O	.	_	0	SENT_177	[p15l1542t1925r1751b1976],

1	—	NN	O	—	_	0	SENT_178	[p15l1542t1925r1751b1976],
2	.	.	O	.	_	0	SENT_178	[p15l1542t1925r1751b1976],

1	O.	NNP	O	O.	_	0	SENT_179	[p15l1542t1925r1751b1976],
2	16x	NN	O	16x	dep	1	SENT_179	[p15l1542t1925r1751b1976],
3	+	CC	O	+	_	0	SENT_179	[p15l1774t1939r1810b1975],
4	13.9	CD	NUMBER	13.9	dep	1	SENT_179	[p15l1838t1925r1965b1976],

1	R2	NN	O	r2	_	0	SENT_180	[p15l1632t1999r1698b2065],
2	=	JJ	O	=	amod	1	SENT_180	[p15l1722t2038r1758b2057],
3	0.20	CD	NUMBER	0.20	tmod	2	SENT_180	[p15l1783t2016r1914b2067],

1	_	NN	O	_	nn	3	SENT_181	[p15l178t2008r197b2057],
2	L	NN	O	l	nn	3	SENT_181	[p15l178t2008r197b2057],
3	P	NN	O	p	_	0	SENT_181	[p15l212t2008r263b2057],
4	‘	CD	NUMBER	‘	num	5	SENT_181	[p15l212t2008r263b2057],
5	C	NN	O	c	dep	3	SENT_181	[p15l271t2008r305b2059],

1	mL/minlkg	NN	O	ml/minlkg	_	0	SENT_182	[p15l73t1969r140b2336],
2	)	CD	NUMBER	)	num	3	SENT_182	[p15l73t1969r140b2336],
3	K3	NN	O	k3	dep	1	SENT_182	[p15l178t2162r246b2212],

1	‘	NN	O	‘	nn	3	SENT_183	[p15l255t2163r305b2214],
2	o	NN	O	o	nn	3	SENT_183	[p15l255t2163r305b2214],
3	E	NN	O	e	_	0	SENT_183	[p15l73t2384r126b2506],
4	3	CD	NUMBER	3	dep	3	SENT_183	[p15l73t2509r126b2568],
5	U	NNP	O	U	rcmod	4	SENT_183	[p15l73t2576r126b2621],
6	a	DT	O	a	dep	5	SENT_183	[p15l86t2644r126b2680],
7	:	:	O	:	_	0	SENT_183	[p15l86t2644r126b2680],
8	.	.	O	.	_	0	SENT_183	[p15l74t2686r125b2740],

1	E	NN	O	e	nn	3	SENT_184	[p15l74t2686r125b2740],
2	‘	CD	NUMBER	‘	num	3	SENT_184	[p15l74t2748r126b2785],
3	O	NN	O	o	_	0	SENT_184	[p15l74t2748r126b2785],
4	:5	CD	NUMBER	:5	num	6	SENT_184	[p15l87t2791r126b2825],
5	.2	NN	NUMBER	.2	nn	6	SENT_184	[p15l74t2830r125b2883],
6	E	NN	O	e	nsubj	8	SENT_184	[p15l86t2892r125b2945],
7	to	TO	O	to	aux	8	SENT_184	[p15l86t2951r126b2987],
8	_	VB	O	_	infmod	3	SENT_184	[p15l74t2990r125b3026],
9	|	SYM	O	|	dep	8	SENT_184	[p15l74t2990r125b3026],

1	Age	NNP	O	Age	_	0	SENT_185	[p15l1016t3273r1144b3339],
2	(	CD	NUMBER	(	num	3	SENT_185	[p15l1168t3272r1393b3339],
3	years	NNS	NUMBER	year	dep	1	SENT_185	[p15l1168t3272r1393b3339],
4	)	IN	O	)	amod	3	SENT_185	[p15l1168t3272r1393b3339],

1	Figure	NN	O	figure	_	0	SENT_186	[p16l9t65r212b133],
2	2	CD	NUMBER	2	dep	1	SENT_186	[p16l240t69r291b116],
3	.	.	O	.	_	0	SENT_186	[p16l240t69r291b116],

1	Relationship	NN	O	relationship	nsubj	8	SENT_187	[p16l366t62r771b133],
2	between	IN	O	between	_	0	SENT_187	[p16l802t61r1058b116],
3	apparent	JJ	O	apparent	amod	5	SENT_187	[p16l1091t69r1380b133],
4	oral	JJ	O	oral	amod	5	SENT_187	[p16l1408t62r1532b116],
5	clearance	NN	O	clearance	prep_between	1	SENT_187	[p16l1561t61r1865b116],
6	of	IN	O	of	_	0	SENT_187	[p16l1896t62r1964b133],
7	lamivudine	NN	O	lamivudine	prep_of	5	SENT_187	[p16l1981t61r2147b116, p16l13t151r230b206],
8	normalized	VBD	O	normalize	_	0	SENT_187	[p16l249t151r615b206],
9	for	IN	O	for	_	0	SENT_187	[p16l626t151r724b223],
10	body	NN	O	body	nn	11	SENT_187	[p16l741t151r900b223],
11	weight	NN	O	weight	prep_for	8	SENT_187	[p16l917t151r1125b223],
12	and	CC	O	and	_	0	SENT_187	[p16l1143t151r1266b206],
13	the	DT	O	the	det	14	SENT_187	[p16l1287t151r1383b206],
14	age	NN	O	age	nsubj	28	SENT_187	[p16l1404t170r1509b223],
15	of	IN	O	of	_	0	SENT_187	[p16l1531t151r1599b223],
16	human	JJ	O	human	amod	21	SENT_187	[p16l1607t151r1833b206],
17	immunodeﬁciency	NN	O	immunodeﬁciency	nn	21	SENT_187	[p16l1855t154r2147b206, p16l14t239r342b311],
18	virus	NN	O	virus	nn	21	SENT_187	[p16l416t243r571b294],
19	[	CD	NUMBER	[	num	21	SENT_187	[p16l650t239r1235b304],
20	HIV	NN	O	hiv	nn	21	SENT_187	[p16l650t239r1235b304],
21	]	NN	O	]	prep_of	14	SENT_187	[p16l650t239r1235b304],
22	/	:	O	/	punct	23	SENT_187	[p16l650t239r1235b304],
23	tuberculosis	NN	O	tuberculosis	dep	21	SENT_187	[p16l650t239r1235b304],
24	[	CD	NUMBER	[	num	25	SENT_187	[p16l1315t239r1816b311],
25	TB	NN	O	tb	dep	23	SENT_187	[p16l1315t239r1816b311],
26	]	SYM	O	]	dep	28	SENT_187	[p16l1315t239r1816b311],
27	-	:	O	-	_	0	SENT_187	[p16l1315t239r1816b311],
28	coinfected	VBN	O	coinfect	conj_and	8	SENT_187	[p16l1315t239r1816b311],
29	patients	NNS	O	patient	dobj	28	SENT_187	[p16l1889t243r2148b311],
30	receiving	VBG	O	receive	xcomp	28	SENT_187	[p16l9t332r301b400],
31	Iamivudine	NNP	O	Iamivudine	dobj	30	SENT_187	[p16l312t328r692b392],
32	,	,	O	,	_	0	SENT_187	[p16l312t328r692b392],
33	with	IN	O	with	_	0	SENT_187	[p16l715t329r848b383],
34	zidovudine	NN	O	zidovudine	prep_with	28	SENT_187	[p16l867t328r1224b383],
35	or	CC	O	or	_	0	SENT_187	[p16l1242t348r1308b383],
36	stavudine	NN	O	stavudine	conj_or	34	SENT_187	[p16l1321t328r1646b383],
37	.	.	O	.	_	0	SENT_187	[p16l1321t328r1646b383],

1	All	PDT	O	all	predet	3	SENT_188	[p16l1664t329r1764b383],
2	the	DT	O	the	det	3	SENT_188	[p16l1780t329r1876b383],
3	patients	NNS	O	patient	nsubj	4	SENT_188	[p16l1889t332r2148b400],
4	received	VBD	O	receive	_	0	SENT_188	[p16l9t418r278b473],
5	efavirenz	NN	O	efavirenz	dobj	4	SENT_188	[p16l314t418r619b490],
6	,	,	O	,	_	0	SENT_188	[p16l314t418r619b490],
7	4-drug	JJ	O	4-drug	amod	9	SENT_188	[p16l662t418r870b490],
8	TB	NN	O	tb	nn	9	SENT_188	[p16l909t422r995b472],
9	therapy	NN	O	therapy	appos	5	SENT_188	[p16l1033t418r1283b490],
10	,	,	O	,	_	0	SENT_188	[p16l1033t418r1283b490],
11	as	RB	O	as	_	0	SENT_188	[p16l1326t437r1392b473],
12	well	RB	O	well	_	0	SENT_188	[p16l1432t418r1560b473],
13	as	IN	O	as	_	0	SENT_188	[p16l1597t437r1663b473],
14	trimethoprimsulfamethoxazole	NN	O	trimethoprimsulfamethoxazole	dobj	4	SENT_188	[p16l1702t418r2147b490, p16l12t506r589b578],
15	.	.	O	.	_	0	SENT_188	[p16l1702t418r2147b490, p16l12t506r589b578],

1	the	DT	O	the	det	2	SENT_189	[p16l10t739r134b807],
2	16	CD	NUMBER	16	_	0	SENT_189	[p16l198t749r285b807],
3	HIV/TB-coinfected	JJ	O	hiv/tb-coinfected	amod	5	SENT_189	[p16l345t739r1114b807],
4	Ghanaian	JJ	MISC	ghanaian	amod	5	SENT_189	[p16l1173t739r1559b807],
5	patients	NNS	O	patient	dep	2	SENT_189	[p16l1617t743r1937b829],
6	and	CC	O	and	_	0	SENT_189	[p16l1998t739r2146b807],
7	23.1	CD	PERCENT	23.1	num	8	SENT_189	[p16l14t841r261b914],
8	%	NN	PERCENT	%	dep	2	SENT_189	[p16l14t841r261b914],
9	(	CD	NUMBER	(	num	10	SENT_189	[p16l306t841r382b921],
10	n	NN	O	n	dep	2	SENT_189	[p16l306t841r382b921],
11	=	JJ	O	=	amod	13	SENT_189	[p16l413t874r459b895],
12	12	CD	NUMBER	12	tmod	11	SENT_189	[p16l496t841r637b921],
13	)	NN	O	)	dep	10	SENT_189	[p16l496t841r637b921],
14	,	,	O	,	_	0	SENT_189	[p16l496t841r637b921],
15	42.3	CD	PERCENT	42.3	num	16	SENT_189	[p16l672t841r923b914],
16	%	NN	PERCENT	%	appos	2	SENT_189	[p16l672t841r923b914],
17	(	CD	NUMBER	(	num	18	SENT_189	[p16l968t841r1044b921],
18	n	NN	O	n	npadvmod	19	SENT_189	[p16l968t841r1044b921],
19	=	JJ	O	=	amod	16	SENT_189	[p16l1075t874r1121b895],
20	22	CD	NUMBER	22	num	21	SENT_189	[p16l1157t841r1299b921],
21	)	NN	O	)	dep	2	SENT_189	[p16l1157t841r1299b921],
22	,	,	O	,	_	0	SENT_189	[p16l1157t841r1299b921],
23	and	CC	O	and	_	0	SENT_189	[p16l1336t841r1484b908],
24	34.6	CD	PERCENT	34.6	num	25	SENT_189	[p16l1520t841r1767b914],
25	%	NN	PERCENT	%	conj_and	21	SENT_189	[p16l1520t841r1767b914],
26	(	CD	NUMBER	(	num	27	SENT_189	[p16l1812t841r1887b921],
27	n	NN	O	n	dep	2	SENT_189	[p16l1812t841r1887b921],
28	=	JJ	O	=	amod	30	SENT_189	[p16l1919t874r1965b895],
29	18	CD	NUMBER	18	tmod	28	SENT_189	[p16l2001t841r2142b921],
30	)	NN	O	)	rcmod	27	SENT_189	[p16l2001t841r2142b921],
31	,	,	O	,	_	0	SENT_189	[p16l2001t841r2142b921],
32	respectively	RB	O	respectively	advmod	30	SENT_189	[p16l9t943r516b1032],
33	,	,	O	,	_	0	SENT_189	[p16l9t943r516b1032],
34	among	IN	O	among	_	0	SENT_189	[p16l554t967r820b1032],
35	the	DT	O	the	det	38	SENT_189	[p16l853t943r977b1011],
36	52	CD	NUMBER	52	num	38	SENT_189	[p16l1015t952r1101b1011],
37	liver	NN	O	liver	nn	38	SENT_189	[p16l1139t943r1323b1011],
38	samples	NNS	O	sample	prep_among	2	SENT_189	[p16l1357t943r1702b1032],
39	.	.	O	.	_	0	SENT_189	[p16l1357t943r1702b1032],

1	The	DT	O	the	det	3	SENT_190	[p16l1741t943r1893b1011],
2	genotype	NN	O	genotype	nn	3	SENT_190	[p16l1927t967r2145b1032, p16l10t1055r184b1134],
3	frequencies	NNS	O	frequency	nsubj	10	SENT_190	[p16l256t1045r720b1134],
4	of	IN	O	of	_	0	SENT_190	[p16l795t1045r875b1113],
5	the	DT	O	the	det	7	SENT_190	[p16l938t1044r1062b1113],
6	UGTZB7	NN	O	ugtzb7	nn	7	SENT_190	[p16l1144t1048r1486b1113],
7	exon	NN	O	exon	prep_of	3	SENT_190	[p16l1553t1069r1746b1113],
8	2	CD	NUMBER	2	num	9	SENT_190	[p16l1819t1054r1856b1112],
9	SNPS	NNS	O	snp	dep	7	SENT_190	[p16l1936t1048r2144b1113],
10	c.	VBP	O	c.	_	0	SENT_190	[p16l12t1150r382b1224],
11	735AA	NNP	O	735AA	nn	13	SENT_190	[p16l12t1150r382b1224],
12	,	,	O	,	_	0	SENT_190	[p16l12t1150r382b1224],
13	AG	NNP	ORGANIZATION	AG	nsubj	19	SENT_190	[p16l412t1149r563b1224],
14	,	,	O	,	_	0	SENT_190	[p16l412t1149r563b1224],
15	and	CC	O	and	_	0	SENT_190	[p16l595t1145r743b1213],
16	GG	NNS	O	gg	nsubj	19	SENT_190	[p16l771t1149r896b1213],
17	were	VBD	O	be	cop	19	SENT_190	[p16l921t1169r1113b1213],
18	50.0	CD	PERCENT	50.0	num	19	SENT_190	[p16l1146t1145r1391b1219],
19	%	NN	PERCENT	%	ccomp	10	SENT_190	[p16l1146t1145r1391b1219],
20	(	CD	NUMBER	(	num	21	SENT_190	[p16l1432t1145r1556b1226],
21	n	NN	O	n	dep	19	SENT_190	[p16l1432t1145r1556b1226],
22	:	:	O	:	_	0	SENT_190	[p16l1432t1145r1556b1226],
23	8	CD	NUMBER	8	num	24	SENT_190	[p16l1585t1145r1678b1226],
24	)	NN	O	)	ccomp	10	SENT_190	[p16l1585t1145r1678b1226],
25	,	,	O	,	_	0	SENT_190	[p16l1585t1145r1678b1226],
26	37.5	CD	PERCENT	37.5	num	27	SENT_190	[p16l1713t1145r1958b1219],
27	%	NN	PERCENT	%	appos	24	SENT_190	[p16l1713t1145r1958b1219],
28	(	CD	NUMBER	(	num	29	SENT_190	[p16l1999t1145r2074b1226],
29	n	NN	O	n	dep	27	SENT_190	[p16l1999t1145r2074b1226],
30	=	JJ	O	=	amod	32	SENT_190	[p16l2100t1178r2147b1200],
31	6	CD	NUMBER	6	tmod	30	SENT_190	[p16l13t1247r107b1328],
32	)	NN	O	)	dep	29	SENT_190	[p16l13t1247r107b1328],
33	,	,	O	,	_	0	SENT_190	[p16l13t1247r107b1328],
34	and	CC	O	and	_	0	SENT_190	[p16l167t1247r315b1315],
35	12.5	CD	PERCENT	12.5	num	36	SENT_190	[p16l375t1247r620b1321],
36	%	NN	PERCENT	%	conj_and	19	SENT_190	[p16l375t1247r620b1321],
37	(	CD	NUMBER	(	num	38	SENT_190	[p16l688t1247r764b1328],
38	n	NN	O	n	npadvmod	39	SENT_190	[p16l688t1247r764b1328],
39	=	JJ	O	=	amod	36	SENT_190	[p16l818t1280r864b1302],
40	2	CD	NUMBER	2	number	41	SENT_190	[p16l922t1247r1015b1328],
41	)	CD	NUMBER	)	amod	36	SENT_190	[p16l922t1247r1015b1328],
42	,	,	O	,	_	0	SENT_190	[p16l922t1247r1015b1328],
43	respectively	RB	O	respectively	dep	41	SENT_190	[p16l1072t1247r1579b1337],
44	,	,	O	,	_	0	SENT_190	[p16l1072t1247r1579b1337],
45	in	IN	O	in	_	0	SENT_190	[p16l1638t1251r1718b1315],
46	the	DT	O	the	det	47	SENT_190	[p16l1772t1247r1896b1315],
47	HIV	NN	O	hiv	prep_in	36	SENT_190	[p16l1952t1247r2145b1315],
48	/	:	O	/	punct	56	SENT_190	[p16l1952t1247r2145b1315],
49	TB-coinfected	JJ	O	tb-coinfected	amod	51	SENT_190	[p16l11t1349r579b1417],
50	Ghanaian	JJ	MISC	ghanaian	amod	51	SENT_190	[p16l606t1349r990b1417],
51	patients	NNS	O	patient	dep	56	SENT_190	[p16l1016t1353r1335b1439],
52	and	CC	O	and	_	0	SENT_190	[p16l1364t1349r1512b1417],
53	76.9	CD	PERCENT	76.9	num	54	SENT_190	[p16l1543t1349r1787b1423],
54	%	NN	PERCENT	%	dep	56	SENT_190	[p16l1543t1349r1787b1423],
55	(	CD	NUMBER	(	num	56	SENT_190	[p16l1825t1349r1901b1430],
56	n	NN	O	n	dep	47	SENT_190	[p16l1825t1349r1901b1430],
57	=	JJ	O	=	amod	47	SENT_190	[p16l1925t1382r1972b1404],
58	40	CD	NUMBER	40	num	59	SENT_190	[p16l1997t1349r2143b1430],
59	)	NN	O	)	tmod	57	SENT_190	[p16l1997t1349r2143b1430],
60	,	,	O	,	_	0	SENT_190	[p16l1997t1349r2143b1430],
61	21.2	CD	PERCENT	21.2	number	62	SENT_190	[p16l14t1451r261b1524],
62	%	NN	PERCENT	%	amod	59	SENT_190	[p16l14t1451r261b1524],
63	(	CD	NUMBER	(	num	64	SENT_190	[p16l331t1451r406b1532],
64	n	NN	O	n	npadvmod	65	SENT_190	[p16l331t1451r406b1532],
65	=	JJ	O	=	amod	36	SENT_190	[p16l462t1484r508b1506],
66	11	CD	NUMBER	11	num	67	SENT_190	[p16l569t1451r710b1532],
67	)	NN	O	)	dep	36	SENT_190	[p16l569t1451r710b1532],
68	,	,	O	,	_	0	SENT_190	[p16l569t1451r710b1532],
69	and	CC	O	and	_	0	SENT_190	[p16l772t1451r920b1519],
70	1.9	CD	PERCENT	1.9	num	71	SENT_190	[p16l981t1451r1177b1524],
71	%	NN	PERCENT	%	dep	19	SENT_190	[p16l981t1451r1177b1524],
72	(	CD	NUMBER	(	num	73	SENT_190	[p16l1247t1451r1322b1532],
73	n	NN	O	n	ccomp	10	SENT_190	[p16l1247t1451r1322b1532],
74	=	JJ	O	=	amod	76	SENT_190	[p16l1378t1484r1424b1506],
75	1	CD	NUMBER	1	tmod	74	SENT_190	[p16l1485t1451r1577b1532],
76	)	NN	O	)	rcmod	73	SENT_190	[p16l1485t1451r1577b1532],
77	,	,	O	,	_	0	SENT_190	[p16l1485t1451r1577b1532],
78	respectively	RB	O	respectively	advmod	76	SENT_190	[p16l1636t1451r2143b1540],
79	,	,	O	,	_	0	SENT_190	[p16l1636t1451r2143b1540],
80	among	IN	O	among	_	0	SENT_190	[p16l12t1578r279b1643],
81	the	DT	O	the	det	83	SENT_190	[p16l318t1554r442b1622],
82	liver	NN	O	liver	nn	83	SENT_190	[p16l485t1554r669b1622],
83	samples	NNS	O	sample	prep_among	19	SENT_190	[p16l711t1554r1055b1643],
84	.	.	O	.	_	0	SENT_190	[p16l711t1554r1055b1643],

1	The	DT	O	the	det	2	SENT_191	[p16l1101t1554r1254b1622],
2	distributions	NNS	O	distribution	nsubj	7	SENT_191	[p16l1298t1554r1814b1622],
3	of	IN	O	of	_	0	SENT_191	[p16l1859t1554r1939b1622],
4	SNP	NN	ORGANIZATION	snp	nn	5	SENT_191	[p16l1975t1557r2144b1622],
5	genotypes	NNS	O	genotype	prep_of	2	SENT_191	[p16l10t1666r415b1745],
6	were	VBD	O	be	cop	7	SENT_191	[p16l457t1680r650b1724],
7	consistent	JJ	O	consistent	dep	21	SENT_191	[p16l694t1659r1105b1724],
8	with	IN	O	with	_	0	SENT_191	[p16l1144t1655r1329b1724],
9	those	DT	O	those	prep_with	7	SENT_191	[p16l1369t1655r1582b1724],
10	predicted	VBN	O	predict	partmod	9	SENT_191	[p16l1623t1655r2011b1745],
11	by	IN	O	by	_	0	SENT_191	[p16l2048t1655r2147b1745],
12	the	DT	O	the	det	14	SENT_191	[p16l10t1757r134b1825],
13	Hardy-Weinberg	JJ	LOCATION	hardy-weinberg	amod	14	SENT_191	[p16l193t1757r858b1847],
14	equilibrium	NN	O	equilibrium	agent	10	SENT_191	[p16l919t1757r1398b1847],
15	for	IN	O	for	_	0	SENT_191	[p16l1458t1757r1568b1825],
16	both	DT	O	both	preconj	20	SENT_191	[p16l1622t1757r1805b1825],
17	patient	NN	O	patient	nn	20	SENT_191	[p16l1863t1761r2147b1847],
18	and	CC	O	and	_	0	SENT_191	[p16l12t1859r160b1927],
19	liver	NN	O	liver	nn	20	SENT_191	[p16l192t1859r376b1927],
20	samples	NNS	O	sample	prep_for	14	SENT_191	[p16l409t1859r732b1949],
21	(	VBP	O	(	_	0	SENT_191	[p16l771t1859r852b1940],
22	P	NN	O	p	dep	23	SENT_191	[p16l771t1859r852b1940],
23	>	JJR	O	>	dobj	21	SENT_191	[p16l877t1880r922b1926],
24	.05	CD	NUMBER	.05	num	25	SENT_191	[p16l958t1859r1122b1940],
25	)	NN	O	)	nsubj	21	SENT_191	[p16l958t1859r1122b1940],
26	.	.	O	.	_	0	SENT_191	[p16l958t1859r1122b1940],

1	In	IN	O	in	_	0	SENT_192	[p16l117t1966r198b2029],
2	addition	NN	O	addition	prep_in	42	SENT_192	[p16l250t1961r591b2029],
3	to	TO	O	to	aux	4	SENT_192	[p16l642t1971r715b2029],
4	c.	VB	O	c.	infmod	2	SENT_192	[p16l771t1965r1150b2029],
5	802G	NN	O	802g	dobj	4	SENT_192	[p16l771t1965r1150b2029],
6	>	JJR	O	>	amod	7	SENT_192	[p16l771t1965r1150b2029],
7	T	NN	O	t	nsubjpass	17	SENT_192	[p16l771t1965r1150b2029],
8	being	VBG	O	be	cop	11	SENT_192	[p16l1199t1961r1420b2050],
9	nonsynonymous	JJ	O	nonsynonymous	amod	11	SENT_192	[p16l1471t1985r2144b2050],
10	(	NN	O	(	nn	11	SENT_192	[p16l15t2063r370b2144],
11	H268Y	NN	O	h268y	partmod	7	SENT_192	[p16l15t2063r370b2144],
12	)	CD	NUMBER	)	attr	11	SENT_192	[p16l15t2063r370b2144],
13	,	,	O	,	_	0	SENT_192	[p16l15t2063r370b2144],
14	both	CC	O	both	dep	12	SENT_192	[p16l415t2063r598b2131],
15	SNPs	NNS	O	snp	conj	12	SENT_192	[p16l646t2066r854b2131],
16	were	VBD	O	be	auxpass	17	SENT_192	[p16l900t2087r1094b2131],
17	chosen	VBN	O	choose	rcmod	5	SENT_192	[p16l1142t2063r1424b2131],
18	for	IN	O	for	_	0	SENT_192	[p16l1470t2063r1580b2131],
19	this	DT	O	this	det	20	SENT_192	[p16l1623t2063r1771b2131],
20	analysis	NN	O	analysis	prep_for	17	SENT_192	[p16l1820t2063r2144b2152],
21	because	IN	O	because	mark	23	SENT_192	[p16l8t2166r327b2234],
22	they	PRP	O	they	nsubj	23	SENT_192	[p16l368t2166r543b2255],
23	allowed	VBD	O	allow	advcl	17	SENT_192	[p16l584t2166r906b2234],
24	discrimination	NN	O	discrimination	dobj	23	SENT_192	[p16l949t2166r1546b2234],
25	of	IN	O	of	_	0	SENT_192	[p16l1588t2166r1668b2234],
26	the	DT	O	the	det	31	SENT_192	[p16l1701t2166r1825b2234],
27	3	CD	NUMBER	3	num	31	SENT_192	[p16l1870t2175r1906b2234],
28	most	RBS	O	most	advmod	29	SENT_192	[p16l1952t2176r2147b2234],
29	common	JJ	O	common	amod	31	SENT_192	[p16l12t2290r363b2334],
30	UGTZB7	NN	O	ugtzb7	nn	31	SENT_192	[p16l415t2270r756b2334],
31	alleles	NNS	O	allele	prep_of	24	SENT_192	[p16l793t2266r1048b2334],
32	that	WDT	O	that	nsubjpass	35	SENT_192	[p16l1092t2266r1247b2334],
33	have	VBP	O	have	aux	35	SENT_192	[p16l1287t2266r1476b2334],
34	been	VBN	O	be	auxpass	35	SENT_192	[p16l1515t2266r1708b2334],
35	identified	VBN	O	identify	rcmod	31	SENT_192	[p16l1750t2266r2146b2334],
36	to	TO	O	to	_	0	SENT_192	[p16l10t2378r83b2436],
37	date	NN	O	date	prep_to	35	SENT_192	[p16l115t2368r438b2436],
38	.27	CD	NUMBER	.27	number	39	SENT_192	[p16l115t2368r438b2436],
39	’28	CD	NUMBER	’28	num	40	SENT_192	[p16l115t2368r438b2436],
40	Alleles	NNS	O	allele	nsubjpass	42	SENT_192	[p16l465t2368r746b2436],
41	were	VBD	O	be	auxpass	42	SENT_192	[p16l773t2392r967b2436],
42	inferred	VBN	O	infer	_	0	SENT_192	[p16l994t2368r1317b2436],
43	for	IN	O	for	_	0	SENT_192	[p16l1343t2368r1453b2436],
44	each	DT	O	each	det	48	SENT_192	[p16l1480t2368r1662b2436],
45	patient	NN	O	patient	nn	48	SENT_192	[p16l1688t2372r1971b2458],
46	and	CC	O	and	_	0	SENT_192	[p16l1998t2368r2146b2436],
47	liver	NN	O	liver	nn	48	SENT_192	[p16l11t2470r195b2538],
48	sample	NN	O	sample	prep_for	42	SENT_192	[p16l233t2470r517b2560],
49	based	VBN	O	base	partmod	48	SENT_192	[p16l551t2470r783b2538],
50	on	IN	O	on	_	0	SENT_192	[p16l820t2494r919b2538],
51	the	DT	O	the	det	53	SENT_192	[p16l953t2470r1077b2538],
52	SNP	NN	ORGANIZATION	snp	nn	53	SENT_192	[p16l1117t2474r1287b2538],
53	genotypes	NNS	O	genotype	prep_on	49	SENT_192	[p16l1324t2480r1728b2560],
54	and	CC	O	and	_	0	SENT_192	[p16l1768t2470r1916b2538],
55	were	VBD	O	be	cop	57	SENT_192	[p16l1951t2494r2144b2538],
56	UGT2B7	NN	O	ugt2b7	nn	57	SENT_192	[p16l21t2575r450b2639],
57	*	NN	O	*	conj_and	42	SENT_192	[p16l21t2575r450b2639],
58	2	CD	NUMBER	2	number	59	SENT_192	[p16l21t2575r450b2639],
59	(	CD	NUMBER	(	num	61	SENT_192	[p16l504t2571r961b2651],
60	c.	NN	O	c.	nn	61	SENT_192	[p16l504t2571r961b2651],
61	802C	NN	O	802c	npadvmod	62	SENT_192	[p16l504t2571r961b2651],
62	>	JJR	O	>	amod	64	SENT_192	[p16l504t2571r961b2651],
63	T	NN	O	t	nn	64	SENT_192	[p16l504t2571r961b2651],
64	)	NN	O	)	dep	57	SENT_192	[p16l504t2571r961b2651],
65	,	,	O	,	_	0	SENT_192	[p16l504t2571r961b2651],
66	UGT2B7	NN	O	ugt2b7	conj_or	57	SENT_192	[p16l1019t2575r1496b2639],
67	*	CD	NUMBER	*	num	66	SENT_192	[p16l1019t2575r1496b2639],
68	1c	NN	O	1c	nn	71	SENT_192	[p16l1019t2575r1496b2639],
69	(	CD	NUMBER	(	num	71	SENT_192	[p16l1546t2571r2019b2651],
70	c.	NN	O	c.	nn	71	SENT_192	[p16l1546t2571r2019b2651],
71	735A	NN	O	735a	dep	66	SENT_192	[p16l1546t2571r2019b2651],
72	>	JJR	O	>	amod	74	SENT_192	[p16l1546t2571r2019b2651],
73	G	NN	O	g	nn	74	SENT_192	[p16l1546t2571r2019b2651],
74	)	NNS	O	)	dep	66	SENT_192	[p16l1546t2571r2019b2651],
75	,	,	O	,	_	0	SENT_192	[p16l1546t2571r2019b2651],
76	or	CC	O	or	_	0	SENT_192	[p16l2068t2595r2147b2639],
77	UGT2B7	NN	O	ugt2b7	nn	79	SENT_192	[p16l21t2676r501b2741],
78	*	CD	NUMBER	*	num	79	SENT_192	[p16l21t2676r501b2741],
79	1a	NN	O	1a	conj_or	57	SENT_192	[p16l21t2676r501b2741],
80	(	CD	NUMBER	(	num	81	SENT_192	[p16l552t2673r668b2754],
81	ie	NN	O	ie	dep	79	SENT_192	[p16l552t2673r668b2754],
82	,	,	O	,	_	0	SENT_192	[p16l552t2673r668b2754],
83	reference	NN	O	reference	nn	84	SENT_192	[p16l718t2673r1090b2741],
84	sequence	NN	O	sequence	appos	81	SENT_192	[p16l1140t2697r1509b2762],
85	by	IN	O	by	_	0	SENT_192	[p16l1554t2673r1653b2762],
86	exclusion	NN	O	exclusion	nn	87	SENT_192	[p16l1701t2673r2140b2754],
87	)	NN	O	)	prep_by	57	SENT_192	[p16l1701t2673r2140b2754],
88	.	.	O	.	_	0	SENT_192	[p16l1701t2673r2140b2754],

1	These	DT	O	these	det	3	SENT_193	[p16l11t2776r248b2844],
2	allele	NN	O	allele	nn	3	SENT_193	[p16l285t2776r501b2844],
3	designations	NNS	O	designation	nsubjpass	6	SENT_193	[p16l540t2776r1046b2865],
4	had	VBD	O	have	aux	6	SENT_193	[p16l1082t2776r1232b2844],
5	been	VBN	O	be	auxpass	6	SENT_193	[p16l1264t2776r1456b2844],
6	approved	VBN	O	approve	_	0	SENT_193	[p16l1492t2776r1873b2865],
7	previously	RB	DATE	previously	advmod	6	SENT_193	[p16l1908t2779r2145b2865, p16l13t2877r230b2967],
8	by	IN	O	by	_	0	SENT_193	[p16l268t2877r366b2967],
9	the	DT	O	the	det	14	SENT_193	[p16l406t2877r530b2946],
10	UGT	NNP	ORGANIZATION	UGT	nn	14	SENT_193	[p16l573t2881r761b2946],
11	Allele	NNP	ORGANIZATION	Allele	nn	14	SENT_193	[p16l803t2877r1045b2946],
12	Nomenclature	NNP	ORGANIZATION	Nomenclature	nn	14	SENT_193	[p16l1087t2877r1662b2946],
13	Committee	NNP	ORGANIZATION	Committee	nn	14	SENT_193	[p16l1705t2881r2145b2946],
14	(	NN	O	(	agent	6	SENT_193	[p16l15t2979r401b3060],
15	available	JJ	O	available	amod	14	SENT_193	[p16l15t2979r401b3060],
16	at	IN	O	at	_	0	SENT_193	[p16l436t2990r505b3047],
17	http://www.ugtalleles.ulaval.ca	NN	O	http://www.ugtalleles.ulaval.ca	nn	18	SENT_193	[p16l535t2979r1866b3069],
18	)	NN	O	)	prep_at	15	SENT_193	[p16l535t2979r1866b3069],
19	.	.	O	.	_	0	SENT_193	[p16l535t2979r1866b3069],

1	UGT2B7	NN	O	ugt2b7	nn	3	SENT_194	[p16l118t3085r461b3149],
2	allele	NN	O	allele	nn	3	SENT_194	[p16l534t3081r749b3149],
3	frequencies	NNS	O	frequency	nsubj	4	SENT_194	[p16l820t3081r1280b3171],
4	differed	VBD	O	differ	_	0	SENT_194	[p16l1355t3081r1667b3149],
5	somewhat	RB	O	somewhat	advmod	4	SENT_194	[p16l1739t3081r2147b3149],
6	between	IN	O	between	_	0	SENT_194	[p16l8t3183r346b3251],
7	the	DT	O	the	det	9	SENT_194	[p16l394t3183r517b3251],
8	Ghanaian	JJ	MISC	ghanaian	amod	9	SENT_194	[p16l568t3183r952b3251],
9	patients	NNS	O	patient	prep_between	4	SENT_194	[p16l1000t3187r1317b3273],
10	and	CC	O	and	_	0	SENT_194	[p16l1369t3183r1517b3251],
11	the	DT	O	the	det	12	SENT_194	[p16l1564t3183r1688b3251],
12	(	NN	O	(	prep_between	4	SENT_194	[p16l1742t3183r2147b3273],
13	primarily	RB	O	primarily	prep	4	SENT_194	[p16l1742t3183r2147b3273],
14	white	JJ	O	white	amod	19	SENT_194	[p16l10t3285r236b3353],
15	American	JJ	MISC	american	amod	19	SENT_194	[p16l271t3285r692b3366],
16	)	NN	O	)	nn	19	SENT_194	[p16l271t3285r692b3366],
17	liver	NN	O	liver	nn	19	SENT_194	[p16l731t3285r913b3353],
18	bank	NN	O	bank	nn	19	SENT_194	[p16l944t3285r1142b3353],
19	samples	NNS	O	sample	pobj	13	SENT_194	[p16l1176t3285r1519b3374],
20	.	.	O	.	_	0	SENT_194	[p16l1176t3285r1519b3374],

1	The	DT	O	the	det	2	SENT_195	[p16l1559t3285r1711b3353],
2	frequency	NN	O	frequency	nsubj	17	SENT_195	[p16l1748t3285r2147b3374],
3	of	IN	O	of	_	0	SENT_195	[p16l13t3388r93b3456],
4	UGT2B7	NN	O	ugt2b7	nn	5	SENT_195	[p16l143t3391r570b3456],
5	*	NN	O	*	prep_of	2	SENT_195	[p16l143t3391r570b3456],
6	2	CD	NUMBER	2	num	5	SENT_195	[p16l143t3391r570b3456],
7	in	IN	O	in	_	0	SENT_195	[p16l623t3391r702b3455],
8	the	DT	O	the	det	10	SENT_195	[p16l748t3388r871b3456],
9	Ghanaian	JJ	MISC	ghanaian	amod	10	SENT_195	[p16l920t3388r1304b3456],
10	patients	NNS	O	patient	prep_in	2	SENT_195	[p16l1351t3391r1669b3477],
11	(	IN	O	(	_	0	SENT_195	[p16l1723t3388r1941b3469],
12	0.19	CD	NUMBER	0.19	num	13	SENT_195	[p16l1723t3388r1941b3469],
13	)	NN	O	)	prep_(	17	SENT_195	[p16l1723t3388r1941b3469],
14	was	VBD	O	be	cop	17	SENT_195	[p16l1991t3412r2144b3456],
15	about	IN	O	about	advmod	17	SENT_195	[p16l12t3489r234b3558],
16	half	NN	O	half	dep	15	SENT_195	[p16l285t3489r447b3558],
17	that	DT	O	that	dep	24	SENT_195	[p16l492t3489r647b3558],
18	of	IN	O	of	_	0	SENT_195	[p16l701t3490r781b3558],
19	the	DT	O	the	det	23	SENT_195	[p16l826t3490r949b3558],
20	human	JJ	O	human	amod	23	SENT_195	[p16l1003t3489r1286b3558],
21	liver	NN	O	liver	nn	23	SENT_195	[p16l1340t3489r1522b3558],
22	bank	NN	O	bank	nn	23	SENT_195	[p16l1571t3489r1770b3558],
23	samples	NNS	O	sample	prep_of	17	SENT_195	[p16l1822t3489r2144b3579],
24	(	VBP	O	(	_	0	SENT_195	[p16l15t3591r229b3672],
25	0.38	CD	NUMBER	0.38	dobj	24	SENT_195	[p16l15t3591r229b3672],
26	;	:	O	;	_	0	SENT_195	[p16l15t3591r229b3672],
27	X2	NN	O	x2	dep	25	SENT_195	[p16l262t3591r333b3678],
28	=	JJ	O	=	amod	29	SENT_195	[p16l363t3625r409b3646],
29	9.9	CD	NUMBER	9.9	nsubj	24	SENT_195	[p16l439t3601r577b3670],
30	,	,	O	,	_	0	SENT_195	[p16l439t3601r577b3670],
31	P	NN	O	p	appos	29	SENT_195	[p16l607t3596r665b3659],
32	=	JJ	O	=	amod	34	SENT_195	[p16l686t3625r733b3646],
33	.002	CD	NUMBER	.002	tmod	32	SENT_195	[p16l765t3591r977b3672],
34	)	NN	O	)	dep	31	SENT_195	[p16l765t3591r977b3672],
35	.	.	O	.	_	0	SENT_195	[p16l765t3591r977b3672],

1	In	IN	O	in	_	0	SENT_196	[p16l1010t3596r1091b3659],
2	contrast	NN	O	contrast	pobj	1	SENT_196	[p16l1120t3601r1460b3670],
3	,	,	O	,	_	0	SENT_196	[p16l1120t3601r1460b3670],
4	the	DT	O	the	det	5	SENT_196	[p16l1491t3591r1614b3659],
5	frequency	NN	O	frequency	appos	2	SENT_196	[p16l1645t3591r2043b3681],
6	of	IN	O	of	prep	5	SENT_196	[p16l2074t3591r2153b3659],

1	1084	CD	DATE	1084	num	2	SENT_197	[p17l14t91r204b157],
2	o	NN	O	o	_	0	SENT_197	[p17l267t117r297b146],
3	I	PRP	O	I	nsubj	4	SENT_197	[p17l358t99r387b171],
4	Clin	VBP	O	clin	rcmod	2	SENT_197	[p17l415t95r568b156],
5	Pharmacol	NNP	O	Pharmacol	dep	12	SENT_197	[p17l594t95r997b156],
6	2009	CD	DATE	2009	num	8	SENT_197	[p17l1027t104r1716b167],
7	;	:	O	;	_	0	SENT_197	[p17l1027t104r1716b167],
8	419:1079	CD	DURATION	419:1079	dep	5	SENT_197	[p17l1027t104r1716b167],
9	-1090	CD	DURATION	-1090	num	10	SENT_197	[p17l1027t104r1716b167],
10	UGT2B7	NN	O	ugt2b7	dep	12	SENT_197	[p17l19t194r495b258],
11	*	CD	NUMBER	*	num	12	SENT_197	[p17l19t194r495b258],
12	1c	NN	O	1c	dep	23	SENT_197	[p17l19t194r495b258],
13	in	IN	O	in	_	0	SENT_197	[p17l558t194r637b258],
14	the	DT	O	the	det	16	SENT_197	[p17l696t190r820b258],
15	Ghanaian	JJ	MISC	ghanaian	amod	16	SENT_197	[p17l883t190r1268b258],
16	patients	NNS	O	patient	prep_in	12	SENT_197	[p17l1328t194r1646b280],
17	(	IN	O	(	_	0	SENT_197	[p17l1714t190r1932b271],
18	0.25	CD	NUMBER	0.25	num	19	SENT_197	[p17l1714t190r1932b271],
19	)	NN	O	)	prep_(	23	SENT_197	[p17l1714t190r1932b271],
20	was	VBD	O	be	cop	23	SENT_197	[p17l1996t214r2149b258],
21	more	JJR	O	more	dep	22	SENT_197	[p17l8t316r210b360],
22	than	IN	O	than	advmod	23	SENT_197	[p17l243t292r422b360],
23	double	JJ	O	double	dep	2	SENT_197	[p17l457t292r729b360],
24	that	IN	O	that	complm	25	SENT_197	[p17l761t292r917b360],
25	of	IN	O	of	dep	23	SENT_197	[p17l949t292r1029b360],
26	the	DT	O	the	det	30	SENT_197	[p17l1053t292r1176b360],
27	human	JJ	O	human	amod	30	SENT_197	[p17l1209t292r1492b360],
28	liver	NN	O	liver	nn	30	SENT_197	[p17l1524t292r1708b360],
29	bank	NN	O	bank	nn	30	SENT_197	[p17l1735t292r1934b360],
30	samples	NNS	O	sample	pobj	25	SENT_197	[p17l1965t316r2150b360, p17l9t394r170b483],

1	(	NN	O	(	_	0	SENT_198	[p17l204t394r418b475],
2	0.12	CD	NUMBER	0.12	dep	1	SENT_198	[p17l204t394r418b475],
3	;	:	O	;	_	0	SENT_198	[p17l204t394r418b475],
4	X2	NN	O	x2	dep	1	SENT_198	[p17l449t393r521b480],
5	=	JJ	O	=	amod	11	SENT_198	[p17l549t427r596b449],
6	5.6	CD	NUMBER	5.6	tmod	5	SENT_198	[p17l625t404r763b473],
7	,	,	O	,	_	0	SENT_198	[p17l625t404r763b473],
8	P	NN	O	p	appos	6	SENT_198	[p17l792t398r849b461],
9	=	JJ	O	=	amod	11	SENT_198	[p17l869t427r916b449],
10	.017	CD	NUMBER	.017	tmod	9	SENT_198	[p17l946t394r1159b475],
11	)	NN	O	)	dep	4	SENT_198	[p17l946t394r1159b475],
12	.	.	O	.	_	0	SENT_198	[p17l946t394r1159b475],

1	However	RB	O	however	advmod	13	SENT_199	[p17l1191t398r1569b473],
2	,	,	O	,	_	0	SENT_199	[p17l1191t398r1569b473],
3	the	DT	O	the	det	4	SENT_199	[p17l1599t394r1723b462],
4	frequency	NN	O	frequency	nsubj	13	SENT_199	[p17l1752t394r2152b483],
5	of	IN	O	of	_	0	SENT_199	[p17l11t498r91b566],
6	the	DT	O	the	det	11	SENT_199	[p17l111t498r235b566],
7	reference	NN	O	reference	nn	11	SENT_199	[p17l263t498r634b566],
8	allele	NN	O	allele	nn	11	SENT_199	[p17l665t498r880b566],
9	UGT2B7	NN	O	ugt2b7	nn	11	SENT_199	[p17l919t501r1399b566],
10	*	CD	NUMBER	*	num	11	SENT_199	[p17l919t501r1399b566],
11	1a	NN	O	1a	prep_of	4	SENT_199	[p17l919t501r1399b566],
12	was	VBD	O	be	cop	13	SENT_199	[p17l1425t522r1578b566],
13	similar	JJ	O	similar	_	0	SENT_199	[p17l1611t498r1891b566],
14	in	IN	O	in	_	0	SENT_199	[p17l1920t501r1999b565],
15	the	DT	O	the	prep_in	13	SENT_199	[p17l2026t498r2150b566],

1	Ghanaian	JJ	MISC	ghanaian	amod	2	SENT_200	[p17l9t600r395b669],
2	patients	NNS	O	patient	_	0	SENT_200	[p17l431t604r749b690],
3	(	IN	O	(	_	0	SENT_200	[p17l793t601r1011b681],
4	0.55	CD	NUMBER	0.55	number	5	SENT_200	[p17l793t601r1011b681],
5	)	CD	NUMBER	)	prep_(	2	SENT_200	[p17l793t601r1011b681],
6	compared	VBN	O	compare	_	0	SENT_200	[p17l1053t600r1453b690],
7	with	IN	O	with	prepc_compared_with	5	SENT_200	[p17l1487t600r1673b669],
8	the	DT	O	the	det	10	SENT_200	[p17l1707t600r1831b669],
9	human	JJ	O	human	amod	10	SENT_200	[p17l1868t600r2152b669],
10	liver	NN	O	liver	pobj	5	SENT_200	[p17l9t702r193b771],
11	bank	NN	O	bank	nn	12	SENT_200	[p17l219t702r418b771],
12	samples	NNS	O	sample	nsubj	13	SENT_200	[p17l449t702r771b792],
13	(	VBP	O	(	rcmod	10	SENT_200	[p17l809t703r1024b783],
14	0.50	CD	NUMBER	0.50	dobj	13	SENT_200	[p17l809t703r1024b783],
15	;	:	O	;	_	0	SENT_200	[p17l809t703r1024b783],
16	X2	NN	O	x2	dep	10	SENT_200	[p17l1059t702r1130b789],
17	=	JJ	O	=	amod	2	SENT_200	[p17l1162t736r1209b757],
18	1.8	CD	NUMBER	1.8	tmod	17	SENT_200	[p17l1244t712r1380b781],
19	,	,	O	,	_	0	SENT_200	[p17l1244t712r1380b781],
20	P	NN	O	p	appos	2	SENT_200	[p17l1413t707r1470b770],
21	=	JJ	O	=	amod	23	SENT_200	[p17l1495t736r1541b757],
22	.18	CD	NUMBER	.18	tmod	21	SENT_200	[p17l1576t703r1739b783],
23	)	NN	O	)	dep	20	SENT_200	[p17l1576t703r1739b783],
24	.	.	O	.	_	0	SENT_200	[p17l1576t703r1739b783],

1	We	PRP	O	we	nsubj	3	SENT_201	[p17l115t809r241b872],
2	next	RB	O	next	advmod	3	SENT_201	[p17l284t815r465b872],
3	evaluated	VBD	O	evaluate	_	0	SENT_201	[p17l507t804r910b872],
4	the	DT	O	the	det	6	SENT_201	[p17l951t804r1079b872],
5	possible	JJ	O	possible	amod	6	SENT_201	[p17l1122t804r1465b894],
6	effects	NNS	O	effect	dobj	3	SENT_201	[p17l1510t804r1773b872],
7	of	IN	O	of	_	0	SENT_201	[p17l1820t804r1902b872],
8	these	DT	O	these	det	10	SENT_201	[p17l1936t804r2150b872],
9	UGTZB7	NN	O	ugtzb7	nn	10	SENT_201	[p17l19t910r368b974],
10	alleles	NNS	O	allele	prep_of	6	SENT_201	[p17l406t906r671b974],
11	on	IN	O	on	_	0	SENT_201	[p17l717t930r817b974],
12	zidovudine	NN	O	zidovudine	nn	13	SENT_201	[p17l860t906r1333b974],
13	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	3	SENT_201	[p17l1378t906r2146b996],
14	.	.	O	.	_	0	SENT_201	[p17l1378t906r2146b996],

1	As	IN	O	as	mark	2	SENT_202	[p17l8t1013r113b1076],
2	shown	VBN	O	show	advcl	33	SENT_202	[p17l147t1008r420b1076],
3	in	IN	O	in	_	0	SENT_202	[p17l450t1011r532b1075],
4	Table	NNP	MISC	Table	nn	5	SENT_202	[p17l562t1008r782b1076],
5	II	NNP	MISC	II	prep_in	2	SENT_202	[p17l813t1012r893b1086],
6	,	,	O	,	_	0	SENT_202	[p17l813t1012r893b1086],
7	carriers	NNS	O	carrier	nsubj	33	SENT_202	[p17l928t1011r1238b1076],
8	of	IN	O	of	_	0	SENT_202	[p17l1273t1008r1354b1076],
9	either	CC	O	either	preconj	12	SENT_202	[p17l1379t1008r1620b1076],
10	UGT2B7	NN	O	ugt2b7	nn	12	SENT_202	[p17l1659t1011r2152b1076],
11	*	CD	NUMBER	*	num	12	SENT_202	[p17l1659t1011r2152b1076],
12	1a	NN	O	1a	prep_of	7	SENT_202	[p17l1659t1011r2152b1076],
13	or	CC	O	or	_	0	SENT_202	[p17l11t1135r91b1179],
14	UGT2B7	NN	O	ugt2b7	conj_or	12	SENT_202	[p17l140t1114r581b1179],
15	*	NN	O	*	nsubj	19	SENT_202	[p17l140t1114r581b1179],
16	2	CD	NUMBER	2	num	15	SENT_202	[p17l140t1114r581b1179],
17	did	VBD	O	do	aux	19	SENT_202	[p17l628t1111r763b1179],
18	not	RB	O	not	neg	19	SENT_202	[p17l802t1121r937b1179],
19	have	VB	O	have	parataxis	33	SENT_202	[p17l974t1111r1167b1179],
20	significant	JJ	O	significant	amod	21	SENT_202	[p17l1209t1111r1651b1200],
21	differences	NNS	O	difference	dobj	19	SENT_202	[p17l1692t1111r2149b1179],
22	as	IN	O	as	_	0	SENT_202	[p17l10t1237r88b1281],
23	compared	VBN	O	compare	prepc_as	19	SENT_202	[p17l130t1212r542b1302],
24	with	IN	O	with	pcomp	23	SENT_202	[p17l579t1212r770b1281],
25	noncarriers	NNS	O	noncarrier	pobj	24	SENT_202	[p17l807t1216r1282b1281],
26	for	IN	O	for	_	0	SENT_202	[p17l1324t1213r1437b1281],
27	any	DT	O	any	prep_for	25	SENT_202	[p17l1476t1237r1623b1302],
28	of	IN	O	of	_	0	SENT_202	[p17l1662t1213r1744b1281],
29	the	DT	O	the	det	32	SENT_202	[p17l1775t1212r1902b1281],
30	zidovudine	NN	O	zidovudine	nn	32	SENT_202	[p17l1942t1212r2150b1281, p17l7t1314r298b1383],
31	pharmacokinetic	JJ	O	pharmacokinetic	amod	32	SENT_202	[p17l385t1314r1088b1404],
32	parameters	NNS	O	parameter	prep_of	27	SENT_202	[p17l1175t1325r1634b1404],
33	evaluated	VBN	O	evaluate	_	0	SENT_202	[p17l1722t1314r2146b1383],
34	.	.	O	.	_	0	SENT_202	[p17l1722t1314r2146b1383],

1	However	RB	O	however	advmod	8	SENT_203	[p17l8t1421r399b1495],
2	,	,	O	,	_	0	SENT_203	[p17l8t1421r399b1495],
3	carriers	NNS	O	carrier	nsubj	8	SENT_203	[p17l437t1420r747b1484],
4	of	IN	O	of	_	0	SENT_203	[p17l785t1416r867b1484],
5	UGT2B7	NN	O	ugt2b7	nn	7	SENT_203	[p17l904t1420r1394b1484],
6	*	CD	NUMBER	*	num	7	SENT_203	[p17l904t1420r1394b1484],
7	1c	NN	O	1c	prep_of	3	SENT_203	[p17l904t1420r1394b1484],
8	appeared	VBD	O	appear	_	0	SENT_203	[p17l1431t1416r1814b1506],
9	to	TO	O	to	aux	10	SENT_203	[p17l1847t1426r1922b1484],
10	have	VB	O	have	xcomp	8	SENT_203	[p17l1957t1416r2150b1484],
11	higher	JJR	O	higher	amod	13	SENT_203	[p17l8t1518r276b1607],
12	zidovudine	NN	O	zidovudine	nn	13	SENT_203	[p17l341t1518r815b1586],
13	concentrations	NNS	O	concentration	dobj	10	SENT_203	[p17l883t1522r1499b1586],
14	at	IN	O	at	_	0	SENT_203	[p17l1568t1528r1640b1586],
15	each	DT	O	each	det	17	SENT_203	[p17l1705t1518r1893b1586],
16	sampling	NN	O	sampling	nn	17	SENT_203	[p17l1960t1542r2150b1586, p17l9t1620r224b1709],
17	point	NN	O	point	prep_at	13	SENT_203	[p17l250t1623r472b1709],
18	(	CD	NUMBER	(	num	21	SENT_203	[p17l501t1620r793b1709],
19	Figure	NNP	O	Figure	nn	21	SENT_203	[p17l501t1620r793b1709],
20	3A	NN	O	3a	nn	21	SENT_203	[p17l825t1620r989b1701],
21	)	NN	O	)	dep	17	SENT_203	[p17l825t1620r989b1701],
22	.	.	O	.	_	0	SENT_203	[p17l825t1620r989b1701],

1	The	DT	O	the	det	2	SENT_204	[p17l1021t1620r1177b1688],
2	carriers	NNS	O	carrier	_	0	SENT_204	[p17l1207t1623r1517b1688],
3	of	IN	O	of	_	0	SENT_204	[p17l1548t1620r1629b1688],
4	UGT2B7	NN	O	ugt2b7	prep_of	2	SENT_204	[p17l1659t1623r2149b1688],
5	*	CD	NUMBER	*	num	6	SENT_204	[p17l1659t1623r2149b1688],
6	1c	NN	O	1c	nsubj	7	SENT_204	[p17l1659t1623r2149b1688],
7	had	VBD	O	have	rcmod	4	SENT_204	[p17l8t1723r158b1791],
8	57	CD	PERCENT	57	num	9	SENT_204	[p17l187t1723r359b1796],
9	%	NN	PERCENT	%	npadvmod	10	SENT_204	[p17l187t1723r359b1796],
10	lower	JJR	O	lower	advmod	7	SENT_204	[p17l394t1723r622b1791],
11	mean	NN	O	mean	nn	12	SENT_204	[p17l647t1747r866b1791],
12	AUC	NN	O	auc	dobj	7	SENT_204	[p17l891t1726r1084b1791],
13	(	CD	NUMBER	(	num	14	SENT_204	[p17l1116t1723r1197b1804],
14	P	NN	O	p	dep	12	SENT_204	[p17l1116t1723r1197b1804],
15	=	JJ	O	=	amod	14	SENT_204	[p17l1216t1756r1262b1777],
16	.029	CD	NUMBER	.029	tmod	15	SENT_204	[p17l1292t1732r1478b1801],
17	,	,	O	,	_	0	SENT_204	[p17l1292t1732r1478b1801],
18	unpaired	JJ	O	unpaired	amod	20	SENT_204	[p17l1506t1723r1874b1812],
19	ttest	NN	O	ttest	nn	20	SENT_204	[p17l1903t1723r2148b1804],
20	)	NN	O	)	conj_and	12	SENT_204	[p17l1903t1723r2148b1804],
21	,	,	O	,	_	0	SENT_204	[p17l1903t1723r2148b1804],
22	196	CD	PERCENT	196	num	23	SENT_204	[p17l13t1824r239b1898],
23	%	NN	PERCENT	%	npadvmod	24	SENT_204	[p17l13t1824r239b1898],
24	higher	JJR	O	higher	advmod	12	SENT_204	[p17l281t1824r549b1914],
25	mean	NN	O	mean	nn	26	SENT_204	[p17l582t1849r806b1893],
26	CL/F	NN	O	cl/f	dep	12	SENT_204	[p17l841t1824r1043b1893],
27	(	CD	NUMBER	(	num	28	SENT_204	[p17l1083t1825r1166b1905],
28	P	NN	O	p	dep	26	SENT_204	[p17l1083t1825r1166b1905],
29	=	JJ	O	=	amod	28	SENT_204	[p17l1194t1858r1240b1879],
30	.004	CD	NUMBER	.004	tmod	29	SENT_204	[p17l1278t1834r1471b1903],
31	,	,	O	,	_	0	SENT_204	[p17l1278t1834r1471b1903],
32	unpaired	JJ	O	unpaired	amod	33	SENT_204	[p17l1508t1824r1887b1914],
33	ttest	NN	O	ttest	dobj	7	SENT_204	[p17l1925t1834r2148b1903],
34	;	:	O	;	_	0	SENT_204	[p17l1925t1834r2148b1903],
35	Figure	NNP	O	Figure	nn	37	SENT_204	[p17l9t1930r274b2016],
36	3B	NN	O	3b	nn	37	SENT_204	[p17l341t1927r497b2007],
37	)	NN	O	)	dep	33	SENT_204	[p17l341t1927r497b2007],
38	,	,	O	,	_	0	SENT_204	[p17l341t1927r497b2007],
39	and	CC	O	and	_	0	SENT_204	[p17l564t1926r715b1995],
40	67	CD	PERCENT	67	num	41	SENT_204	[p17l779t1926r956b2000],
41	%	NN	PERCENT	%	npadvmod	42	SENT_204	[p17l779t1926r956b2000],
42	shorter	JJR	O	shorter	amod	44	SENT_204	[p17l1027t1926r1319b1995],
43	mean	NN	O	mean	nn	44	SENT_204	[p17l1379t1951r1604b1995],
44	elimination	NN	O	elimination	conj_and	12	SENT_204	[p17l1667t1926r2152b1995],
45	half-life	NN	O	half-life	nn	47	SENT_204	[p17l8t2028r338b2096],
46	(	CD	NUMBER	(	num	47	SENT_204	[p17l382t2028r464b2109],
47	P	NN	O	p	dep	44	SENT_204	[p17l382t2028r464b2109],
48	=	JJ	O	=	amod	2	SENT_204	[p17l495t2062r542b2083],
49	.030	CD	NUMBER	.030	tmod	48	SENT_204	[p17l584t2038r777b2107],
50	,	,	O	,	_	0	SENT_204	[p17l584t2038r777b2107],
51	unpaired	JJ	O	unpaired	amod	53	SENT_204	[p17l817t2028r1197b2118],
52	ttest	NN	O	ttest	nn	53	SENT_204	[p17l1238t2028r1469b2109],
53	)	NN	O	)	appos	2	SENT_204	[p17l1238t2028r1469b2109],
54	compared	VBN	O	compare	_	0	SENT_204	[p17l1513t2028r1925b2118],
55	with	IN	O	with	prepc_compared_with	53	SENT_204	[p17l1962t2028r2152b2096],
56	noncarriers	NNS	O	noncarrier	pobj	53	SENT_204	[p17l8t2119r507b2182],
57	.	.	O	.	_	0	SENT_204	[p17l8t2119r507b2182],

1	We	PRP	O	we	nsubj	3	SENT_205	[p17l115t2221r240b2285],
2	then	RB	O	then	advmod	3	SENT_205	[p17l284t2217r465b2285],
3	sought	VBD	O	seek	_	0	SENT_205	[p17l510t2217r778b2306],
4	to	TO	O	to	aux	5	SENT_205	[p17l820t2227r894b2285],
5	confirm	VB	O	confirm	xcomp	3	SENT_205	[p17l941t2217r1259b2285],
6	these	DT	O	these	det	7	SENT_205	[p17l1301t2217r1510b2285],
7	findings	NNS	O	finding	nsubj	8	SENT_205	[p17l1556t2217r1886b2306],
8	using	VBG	O	use	dep	5	SENT_205	[p17l1931t2220r2151b2306],
9	the	DT	O	the	det	13	SENT_205	[p17l8t2320r132b2388],
10	human	JJ	O	human	amod	13	SENT_205	[p17l160t2320r445b2388],
11	liver	NN	O	liver	nn	13	SENT_205	[p17l473t2320r658b2388],
12	bank	NN	O	bank	nn	13	SENT_205	[p17l681t2320r881b2388],
13	samples	NNS	O	sample	dobj	8	SENT_205	[p17l908t2320r1254b2409],
14	.	.	O	.	_	0	SENT_205	[p17l908t2320r1254b2409],

1	As	IN	O	as	mark	2	SENT_206	[p17l1286t2324r1389b2388],
2	shown	VBN	O	show	advcl	14	SENT_206	[p17l1421t2320r1688b2388],
3	in	IN	O	in	_	0	SENT_206	[p17l1716t2323r1796b2387],
4	Table	NNP	MISC	Table	nn	5	SENT_206	[p17l1823t2320r2037b2388],
5	III	NNP	MISC	III	prep_in	2	SENT_206	[p17l2066t2324r2151b2387],
6	and	CC	O	and	_	0	SENT_206	[p17l10t2422r159b2490],
7	Figure	NNP	O	Figure	conj_and	5	SENT_206	[p17l220t2425r478b2511],
8	4	CD	NUMBER	4	num	7	SENT_206	[p17l541t2432r608b2500],
9	,	,	O	,	_	0	SENT_206	[p17l541t2432r608b2500],
10	UGT2B7	NN	O	ugt2b7	nsubj	14	SENT_206	[p17l683t2425r1162b2490],
11	*	CD	NUMBER	*	num	13	SENT_206	[p17l683t2425r1162b2490],
12	1c	NN	O	1c	nn	13	SENT_206	[p17l683t2425r1162b2490],
13	carriers	NNS	O	carrier	dep	10	SENT_206	[p17l1227t2425r1527b2490],
14	showed	VBD	O	show	_	0	SENT_206	[p17l1594t2421r1905b2490],
15	48	CD	PERCENT	48	num	16	SENT_206	[p17l1967t2421r2143b2495],
16	%	NN	PERCENT	%	npadvmod	17	SENT_206	[p17l1967t2421r2143b2495],
17	higher	JJR	O	higher	advmod	14	SENT_206	[p17l8t2523r264b2613],
18	mean	JJ	O	mean	amod	21	SENT_206	[p17l288t2548r505b2592],
19	zidovudine	NN	O	zidovudine	nn	21	SENT_206	[p17l531t2523r984b2592],
20	glucuronidation	NN	O	glucuronidation	nn	21	SENT_206	[p17l1010t2523r1655b2613],
21	activity	NN	O	activity	iobj	14	SENT_206	[p17l1681t2527r1978b2613],
22	(	CD	NUMBER	(	num	23	SENT_206	[p17l2007t2524r2088b2604],
23	P	NN	O	p	npadvmod	34	SENT_206	[p17l2007t2524r2088b2604],
24	=	JJ	O	=	amod	23	SENT_206	[p17l2106t2557r2152b2578],
25	.020	CD	NUMBER	.020	tmod	24	SENT_206	[p17l13t2635r200b2704],
26	,	,	O	,	_	0	SENT_206	[p17l13t2635r200b2704],
27	unpaired	JJ	O	unpaired	amod	30	SENT_206	[p17l284t2625r654b2715],
28	t	NN	O	t	nn	30	SENT_206	[p17l739t2635r766b2693],
29	test	NN	O	test	nn	30	SENT_206	[p17l842t2625r1008b2706],
30	)	NN	O	)	conj_and	25	SENT_206	[p17l842t2625r1008b2706],
31	and	CC	O	and	_	0	SENT_206	[p17l1095t2625r1244b2693],
32	33	CD	PERCENT	33	num	33	SENT_206	[p17l1329t2625r1501b2699],
33	%	NN	PERCENT	%	conj_and	25	SENT_206	[p17l1329t2625r1501b2699],
34	higher	JJR	O	higher	amod	21	SENT_206	[p17l1591t2625r1851b2715],
35	mean	JJ	O	mean	amod	39	SENT_206	[p17l1932t2649r2152b2693],
36	microsomal	JJ	O	microsomal	amod	39	SENT_206	[p17l8t2727r486b2795],
37	UGT2B7	NN	O	ugt2b7	nn	39	SENT_206	[p17l553t2731r899b2795],
38	protein	NN	O	protein	nn	39	SENT_206	[p17l969t2731r1262b2817],
39	content	NN	O	content	dobj	14	SENT_206	[p17l1330t2737r1634b2795],
40	(	CD	NUMBER	(	num	41	SENT_206	[p17l1703t2727r1785b2808],
41	P	NN	O	p	dobj	14	SENT_206	[p17l1703t2727r1785b2808],
42	=	JJ	O	=	amod	41	SENT_206	[p17l1845t2760r1891b2782],
43	.015	CD	NUMBER	.015	tmod	42	SENT_206	[p17l1962t2737r2148b2806],
44	,	,	O	,	_	0	SENT_206	[p17l1962t2737r2148b2806],
45	unpaired	JJ	O	unpaired	amod	48	SENT_206	[p17l8t2829r378b2918],
46	t	NN	O	t	nn	48	SENT_206	[p17l426t2838r452b2897],
47	test	NN	O	test	nn	48	SENT_206	[p17l490t2829r656b2910],
48	)	NN	O	)	dobj	14	SENT_206	[p17l490t2829r656b2910],
49	compared	VBN	O	compare	_	0	SENT_206	[p17l706t2829r1108b2918],
50	with	IN	O	with	prepc_compared_with	48	SENT_206	[p17l1151t2829r1337b2897],
51	noncarriers	NNS	O	noncarrier	pobj	48	SENT_206	[p17l1380t2832r1863b2897],
52	.	.	O	.	_	0	SENT_206	[p17l1380t2832r1863b2897],

1	These	DT	O	these	det	2	SENT_207	[p17l1913t2829r2150b2897],
2	effects	NNS	O	effect	nsubjpass	15	SENT_207	[p17l10t2932r266b3000],
3	of	IN	O	of	_	0	SENT_207	[p17l316t2932r397b3000],
4	UGT2B7	NN	O	ugt2b7	nn	6	SENT_207	[p17l446t2935r925b3000],
5	*	CD	NUMBER	*	num	6	SENT_207	[p17l446t2935r925b3000],
6	1c	NN	O	1c	prep_of	2	SENT_207	[p17l446t2935r925b3000],
7	on	IN	O	on	_	0	SENT_207	[p17l975t2956r1074b3000],
8	zidovudine	NN	O	zidovudine	nn	9	SENT_207	[p17l1121t2932r1581b3000],
9	glucuronidation	NN	O	glucuronidation	prep_on	6	SENT_207	[p17l1629t2932r2150b3021, p17l8t3037r169b3102],
10	and	CC	O	and	_	0	SENT_207	[p17l205t3033r354b3102],
11	UGT2B7	NN	O	ugt2b7	nn	12	SENT_207	[p17l389t3037r735b3102],
12	protein	NN	O	protein	prep_on	6	SENT_207	[p17l774t3037r1068b3123],
13	were	VBD	O	be	auxpass	15	SENT_207	[p17l1102t3058r1296b3102],
14	also	RB	O	also	advmod	15	SENT_207	[p17l1334t3033r1491b3102],
15	observed	VBN	O	observe	_	0	SENT_207	[p17l1530t3033r1892b3102],
16	when	WRB	O	when	advmod	24	SENT_207	[p17l1926t3033r2152b3102],
17	the	DT	O	the	det	19	SENT_207	[p17l8t3135r132b3204],
18	3	CD	NUMBER	3	num	19	SENT_207	[p17l184t3146r220b3204],
19	livers	NNS	O	liver	nsubjpass	24	SENT_207	[p17l272t3135r493b3204],
20	from	IN	O	from	_	0	SENT_207	[p17l543t3136r732b3204],
21	nonwhite	JJ	O	nonwhite	amod	22	SENT_207	[p17l777t3136r1164b3204],
22	donors	NNS	O	donor	prep_from	19	SENT_207	[p17l1215t3135r1489b3204],
23	were	VBD	O	be	auxpass	24	SENT_207	[p17l1536t3160r1730b3204],
24	excluded	VBN	O	exclude	advcl	15	SENT_207	[p17l1779t3135r2151b3204],
25	from	IN	O	from	_	0	SENT_207	[p17l10t3238r199b3306],
26	the	DT	O	the	det	27	SENT_207	[p17l232t3238r357b3306],
27	analysis	NN	O	analysis	prep_from	24	SENT_207	[p17l394t3238r719b3328],
28	(	CD	NUMBER	(	num	29	SENT_207	[p17l761t3238r957b3319],
29	data	NNS	O	datum	npadvmod	30	SENT_207	[p17l761t3238r957b3319],
30	not	RB	O	not	neg	31	SENT_207	[p17l990t3249r1122b3306],
31	shown	VBN	O	show	partmod	27	SENT_207	[p17l1158t3238r1474b3319],
32	)	NN	O	)	dobj	31	SENT_207	[p17l1158t3238r1474b3319],
33	.	.	O	.	_	0	SENT_207	[p17l1158t3238r1474b3319],

1	Although	IN	O	although	mark	8	SENT_208	[p17l1514t3238r1898b3328],
2	mean	JJ	O	mean	amod	5	SENT_208	[p17l1932t3262r2152b3306],
3	UGTZB7	NN	O	ugtzb7	nn	5	SENT_208	[p17l19t3344r361b3408],
4	mRNA	NN	O	mrna	nn	5	SENT_208	[p17l412t3345r687b3408],
5	content	NN	O	content	nsubj	8	SENT_208	[p17l745t3350r1049b3408],
6	was	VBD	O	be	cop	8	SENT_208	[p17l1103t3364r1256b3408],
7	somewhat	RB	O	somewhat	advmod	8	SENT_208	[p17l1317t3340r1730b3408],
8	lower	JJR	O	lower	_	0	SENT_208	[p17l1786t3340r2015b3408],
9	in	IN	O	in	prep	8	SENT_208	[p17l2072t3344r2152b3408],

1	U	NNP	O	U	nn	5	SENT_209	[p18l19t28r83b92],
2	GTZB7	NNP	O	GTZB7	nn	5	SENT_209	[p18l84t27r361b92],
3	*	CD	NUMBER	*	num	5	SENT_209	[p18l367t29r498b92],
4	1c	NN	O	1c	nn	5	SENT_209	[p18l367t29r498b92],
5	carriers	NNS	O	carrier	nsubj	17	SENT_209	[p18l526t27r826b92],
6	compared	VBN	O	compare	_	0	SENT_209	[p18l855t24r1256b113],
7	with	IN	O	with	prepc_compared_with	5	SENT_209	[p18l1280t24r1466b92],
8	noncarriers	NNS	O	noncarrier	pobj	5	SENT_209	[p18l1489t27r1974b103],
9	,	,	O	,	_	0	SENT_209	[p18l1489t27r1974b103],
10	this	DT	O	this	det	11	SENT_209	[p18l2001t24r2149b92],
11	difference	NN	O	difference	appos	8	SENT_209	[p18l12t127r415b195],
12	was	VBD	O	be	cop	17	SENT_209	[p18l457t151r610b195],
13	not	RB	O	not	neg	17	SENT_209	[p18l653t137r784b195],
14	statistically	RB	O	statistically	advmod	15	SENT_209	[p18l826t127r1292b216],
15	significant	JJ	O	significant	amod	17	SENT_209	[p18l1334t127r1761b216],
16	(	NN	O	(	nn	17	SENT_209	[p18l1805t127r1887b208],
17	P	NN	O	p	_	0	SENT_209	[p18l1805t127r1887b208],
18	>	JJR	O	>	amod	17	SENT_209	[p18l1921t148r1966b193],
19	.05	CD	NUMBER	.05	dep	17	SENT_209	[p18l2011t136r2148b206],
20	,	,	O	,	_	0	SENT_209	[p18l2011t136r2148b206],
21	unpaired	JJ	O	unpaired	amod	23	SENT_209	[p18l8t228r378b318],
22	ttest	NN	O	ttest	nn	23	SENT_209	[p18l411t229r651b309],
23	)	NN	O	)	appos	17	SENT_209	[p18l411t229r651b309],
24	.	.	O	.	_	0	SENT_209	[p18l411t229r651b309],

1	Neither	DT	O	neither	det	4	SENT_210	[p18l685t228r991b297],
2	UGT2B7	NN	O	ugt2b7	nn	4	SENT_210	[p18l1030t232r1512b297],
3	*	CD	NUMBER	*	num	4	SENT_210	[p18l1030t232r1512b297],
4	1a	NN	O	1a	nsubjpass	11	SENT_210	[p18l1030t232r1512b297],
5	nor	CC	O	nor	_	0	SENT_210	[p18l1540t253r1676b297],
6	UGT2B7	NN	O	ugt2b7	nn	9	SENT_210	[p18l1715t232r2147b297],
7	*	NN	O	*	nn	9	SENT_210	[p18l1715t232r2147b297],
8	2	CD	NUMBER	2	num	9	SENT_210	[p18l1715t232r2147b297],
9	carriers	NNS	O	carrier	nsubjpass	11	SENT_210	[p18l10t334r310b399],
10	were	VBD	O	be	auxpass	11	SENT_210	[p18l372t355r566b399],
11	associated	VBN	O	associate	_	0	SENT_210	[p18l628t330r1045b399],
12	with	IN	O	with	_	0	SENT_210	[p18l1104t330r1290b399],
13	altered	JJ	O	altered	amod	16	SENT_210	[p18l1351t330r1629b399],
14	zidovudine	NN	O	zidovudine	nn	16	SENT_210	[p18l1689t330r2150b399],
15	glucuronidation	NN	O	glucuronidation	nn	16	SENT_210	[p18l8t433r666b523],
16	activity	NN	O	activity	prep_with	11	SENT_210	[p18l710t437r1027b523],
17	,	,	O	,	_	0	SENT_210	[p18l710t437r1027b523],
18	micrcsomal	JJ	O	micrcsomal	amod	21	SENT_210	[p18l1073t433r1551b501],
19	UGTZB7	NN	O	ugtzb7	nn	21	SENT_210	[p18l1595t437r1941b501],
20	protein	NN	O	protein	nn	21	SENT_210	[p18l1987t457r2150b523, p18l8t539r164b603],
21	content	NN	O	content	prep_with	11	SENT_210	[p18l213t545r537b614],
22	,	,	O	,	_	0	SENT_210	[p18l213t545r537b614],
23	or	CC	O	or	_	0	SENT_210	[p18l590t560r670b603],
24	UGTZB7	NN	O	ugtzb7	nn	26	SENT_210	[p18l727t539r1069b603],
25	mRNA	NN	O	mrna	nn	26	SENT_210	[p18l1111t540r1386b603],
26	content	NN	O	content	prep_with	11	SENT_210	[p18l1436t545r1739b603],
27	(	CD	NUMBER	(	num	28	SENT_210	[p18l1790t535r1872b616],
28	P	NN	O	p	npadvmod	29	SENT_210	[p18l1790t535r1872b616],
29	>	JJR	O	>	amod	26	SENT_210	[p18l1914t556r1959b602],
30	.05	CD	NUMBER	.05	dep	11	SENT_210	[p18l2011t545r2148b615],
31	,	,	O	,	_	0	SENT_210	[p18l2011t545r2148b615],
32	unpaired	JJ	O	unpaired	amod	33	SENT_210	[p18l8t638r378b727],
33	ttest	NN	O	ttest	appos	30	SENT_210	[p18l413t647r627b717],
34	;	:	O	;	_	0	SENT_210	[p18l413t647r627b717],
35	Table	NNP	O	Table	nn	37	SENT_210	[p18l663t638r877b706],
36	III	NNP	O	III	nn	37	SENT_210	[p18l910t638r1044b719],
37	)	NN	O	)	dep	30	SENT_210	[p18l910t638r1044b719],
38	.	.	O	.	_	0	SENT_210	[p18l910t638r1044b719],

1	Finally	RB	O	finally	advmod	4	SENT_211	[p18l116t741r420b830],
2	,	,	O	,	_	0	SENT_211	[p18l116t741r420b830],
3	we	PRP	O	we	nsubj	4	SENT_211	[p18l444t765r559b809],
4	explored	VBD	O	explore	_	0	SENT_211	[p18l583t741r941b830],
5	the	DT	O	the	det	7	SENT_211	[p18l961t741r1086b809],
6	possible	JJ	O	possible	amod	7	SENT_211	[p18l1109t741r1441b830],
7	effect	NN	O	effect	dobj	4	SENT_211	[p18l1466t741r1685b809],
8	of	IN	O	of	_	0	SENT_211	[p18l1707t741r1788b809],
9	UGTZB7	NN	O	ugtzb7	nn	10	SENT_211	[p18l1803t744r2149b809],
10	diplotype	NN	O	diplotype	prep_of	7	SENT_211	[p18l12t842r401b932],
11	on	IN	O	on	_	0	SENT_211	[p18l443t867r542b911],
12	zidovudine	NN	O	zidovudine	nn	13	SENT_211	[p18l581t842r1042b911],
13	glucuronidation	NN	O	glucuronidation	prep_on	4	SENT_211	[p18l1082t842r1760b932],
14	,	,	O	,	_	0	SENT_211	[p18l1082t842r1760b932],
15	UGTZB7	NN	O	ugtzb7	nn	16	SENT_211	[p18l1803t846r2149b911],
16	protein	NN	O	protein	conj_and	13	SENT_211	[p18l9t948r324b1034],
17	,	,	O	,	_	0	SENT_211	[p18l9t948r324b1034],
18	and	CC	O	and	_	0	SENT_211	[p18l372t944r520b1013],
19	UGTZB7	NN	O	ugtzb7	nn	21	SENT_211	[p18l564t948r910b1013],
20	mRNA	NN	O	mrna	nn	21	SENT_211	[p18l955t949r1230b1012],
21	content	NN	O	content	conj_and	13	SENT_211	[p18l1275t955r1578b1013],
22	to	TO	O	to	aux	23	SENT_211	[p18l1619t955r1693b1013],
23	determine	VB	O	determine	xcomp	4	SENT_211	[p18l1742t944r2150b1013],
24	whether	IN	O	whether	complm	36	SENT_211	[p18l8t1046r343b1114],
25	particular	JJ	O	particular	amod	27	SENT_211	[p18l393t1046r793b1136],
26	diplotypes	NNS	O	diplotype	nn	27	SENT_211	[p18l845t1046r1273b1136],
27	(	NN	O	(	nsubj	36	SENT_211	[p18l1332t1046r1597b1127],
28	rather	RB	O	rather	_	0	SENT_211	[p18l1332t1046r1597b1127],
29	than	IN	O	than	_	0	SENT_211	[p18l1646t1046r1827b1114],
30	simple	JJ	O	simple	amod	32	SENT_211	[p18l1879t1046r2150b1136],
31	variant	JJ	O	variant	amod	32	SENT_211	[p18l8t1152r294b1216],
32	carrier	NN	O	carrier	conj_negcc	27	SENT_211	[p18l345t1152r608b1216],
33	status	NN	O	status	nn	34	SENT_211	[p18l660t1148r918b1229],
34	)	NN	O	)	dep	32	SENT_211	[p18l660t1148r918b1229],
35	might	MD	O	might	aux	36	SENT_211	[p18l972t1148r1208b1237],
36	explain	VB	O	explain	ccomp	23	SENT_211	[p18l1260t1148r1562b1238],
37	the	DT	O	the	det	40	SENT_211	[p18l1612t1148r1736b1216],
38	observed	VBN	O	observe	amod	40	SENT_211	[p18l1790t1148r2152b1216],
39	liver	NN	O	liver	nn	40	SENT_211	[p18l9t1250r194b1318],
40	phenotype	NN	O	phenotype	dobj	36	SENT_211	[p18l223t1250r675b1339],
41	.	.	O	.	_	0	SENT_211	[p18l223t1250r675b1339],

1	As	IN	O	as	_	0	SENT_212	[p18l709t1255r812b1318],
2	shown	VBN	O	show	prepc_as	45	SENT_212	[p18l846t1250r1113b1318],
3	in	IN	O	in	_	0	SENT_212	[p18l1143t1253r1222b1317],
4	Figure	NNP	O	Figure	prep_in	2	SENT_212	[p18l1251t1253r1509b1339],
5	5	CD	NUMBER	5	num	4	SENT_212	[p18l1543t1261r1607b1329],
6	,	,	O	,	_	0	SENT_212	[p18l1543t1261r1607b1329],
7	although	IN	O	although	mark	10	SENT_212	[p18l1640t1250r1998b1339],
8	the	DT	O	the	det	9	SENT_212	[p18l2026t1250r2150b1318],
9	ANOVA	NNP	O	ANOVA	nsubj	10	SENT_212	[p18l8t1356r341b1421],
10	indicated	VBD	O	indicate	dep	2	SENT_212	[p18l370t1353r753b1421],
11	significant	JJ	O	significant	amod	12	SENT_212	[p18l783t1353r1211b1442],
12	effects	NNS	O	effect	dobj	10	SENT_212	[p18l1239t1353r1495b1421],
13	of	IN	O	of	_	0	SENT_212	[p18l1527t1353r1608b1421],
14	diplotype	NN	O	diplotype	prep_of	12	SENT_212	[p18l1632t1353r2021b1442],
15	on	IN	O	on	_	0	SENT_212	[p18l2053t1377r2152b1421],
16	zidovudine	NN	O	zidovudine	nn	18	SENT_212	[p18l10t1454r470b1523],
17	glucuronidation	NN	O	glucuronidation	nn	18	SENT_212	[p18l502t1454r1160b1544],
18	activity	NN	O	activity	prep_on	10	SENT_212	[p18l1192t1458r1495b1544],
19	(	CD	NUMBER	(	num	20	SENT_212	[p18l1529t1455r1611b1535],
20	P	NN	O	p	dep	18	SENT_212	[p18l1529t1455r1611b1535],
21	=	JJ	O	=	amod	23	SENT_212	[p18l1635t1488r1682b1509],
22	.045	CD	NUMBER	.045	tmod	21	SENT_212	[p18l1716t1455r1933b1535],
23	)	NN	O	)	dep	20	SENT_212	[p18l1716t1455r1933b1535],
24	,	,	O	,	_	0	SENT_212	[p18l1716t1455r1933b1535],
25	with	IN	O	with	_	0	SENT_212	[p18l1966t1454r2152b1523],
26	higher	JJR	O	higher	amod	28	SENT_212	[p18l8t1556r269b1646],
27	mean	NN	O	mean	nn	28	SENT_212	[p18l305t1581r526b1625],
28	activities	NNS	O	activity	prep_with	10	SENT_212	[p18l564t1560r929b1625],
29	in	IN	O	in	_	0	SENT_212	[p18l970t1560r1049b1624],
30	UGT2B7	NN	O	ugt2b7	nn	33	SENT_212	[p18l1097t1560r1576b1625],
31	*	CD	NUMBER	*	num	33	SENT_212	[p18l1097t1560r1576b1625],
32	1c	NN	O	1c	nn	33	SENT_212	[p18l1097t1560r1576b1625],
33	carriers	NNS	O	carrier	prep_in	28	SENT_212	[p18l1617t1560r1941b1635],
34	,	,	O	,	_	0	SENT_212	[p18l1617t1560r1941b1635],
35	post	NN	O	post	amod	38	SENT_212	[p18l1982t1566r2153b1646],
36	hoc	FW	O	hoc	dep	35	SENT_212	[p18l8t1658r152b1726],
37	pairwise	JJ	O	pairwise	amod	38	SENT_212	[p18l187t1662r534b1748],
38	comparisons	NNS	O	comparison	nsubj	45	SENT_212	[p18l570t1662r1084b1748],
39	by	IN	O	by	_	0	SENT_212	[p18l1116t1658r1215b1748],
40	the	DT	O	the	det	42	SENT_212	[p18l1247t1658r1371b1726],
41	StudentNewmanKuels	NNP	O	StudentNewmanKuels	nn	42	SENT_212	[p18l1409t1658r2150b1726, p18l9t1760r236b1828],
42	method	NN	O	method	prep_by	38	SENT_212	[p18l291t1760r600b1828],
43	did	VBD	O	do	aux	45	SENT_212	[p18l656t1760r788b1828],
44	not	RB	O	not	neg	45	SENT_212	[p18l841t1770r972b1828],
45	identify	VB	O	identify	_	0	SENT_212	[p18l1025t1760r1344b1849],
46	individual	JJ	O	individual	amod	47	SENT_212	[p18l1397t1760r1824b1828],
47	groups	NNS	O	group	dobj	45	SENT_212	[p18l1877t1784r2149b1850],
48	that	WDT	O	that	nsubj	51	SENT_212	[p18l8t1862r165b1930],
49	were	VBD	O	be	cop	51	SENT_212	[p18l218t1886r412b1930],
50	significantly	RB	O	significantly	advmod	51	SENT_212	[p18l472t1862r978b1951],
51	different	JJ	O	different	rcmod	47	SENT_212	[p18l1035t1862r1382b1930],
52	from	IN	O	from	_	0	SENT_212	[p18l1438t1862r1627b1930],
53	each	DT	O	each	det	54	SENT_212	[p18l1684t1862r1867b1930],
54	other	JJ	O	other	prep_from	51	SENT_212	[p18l1924t1862r2146b1930],
55	.	.	O	.	_	0	SENT_212	[p18l1924t1862r2146b1930],

1	Importantly	RB	O	importantly	advmod	6	SENT_213	[p18l9t1965r506b2054],
2	,	,	O	,	_	0	SENT_213	[p18l9t1965r506b2054],
3	no	DT	O	no	det	4	SENT_213	[p18l549t1989r647b2033],
4	differences	NNS	O	difference	nsubjpass	6	SENT_213	[p18l692t1965r1134b2033],
5	were	VBD	O	be	auxpass	6	SENT_213	[p18l1175t1989r1369b2033],
6	observed	VBN	O	observe	_	0	SENT_213	[p18l1412t1965r1774b2033],
7	between	IN	O	between	_	0	SENT_213	[p18l1810t1965r2152b2033],
8	UGT2B7	NN	O	ugt2b7	nn	10	SENT_213	[p18l19t2066r677b2145],
9	*	CD	NUMBER	*	num	10	SENT_213	[p18l19t2066r677b2145],
10	1a	NN	O	1a	prep_between	6	SENT_213	[p18l19t2066r677b2145],
11	/	:	O	/	punct	13	SENT_213	[p18l19t2066r677b2145],
12	*	CD	NUMBER	*	num	13	SENT_213	[p18l19t2066r677b2145],
13	1a	NN	O	1a	dep	10	SENT_213	[p18l19t2066r677b2145],
14	,	,	O	,	_	0	SENT_213	[p18l19t2066r677b2145],
15	*	CD	NUMBER	*	num	16	SENT_213	[p18l710t2066r872b2135],
16	1a	NN	O	1a	appos	13	SENT_213	[p18l710t2066r872b2135],
17	/	:	O	/	punct	18	SENT_213	[p18l710t2066r872b2135],
18	*	NN	O	*	dep	10	SENT_213	[p18l882t2071r988b2145],
19	2	CD	NUMBER	2	dep	18	SENT_213	[p18l882t2071r988b2145],
20	,	,	O	,	_	0	SENT_213	[p18l882t2071r988b2145],
21	and	CC	O	and	_	0	SENT_213	[p18l1016t2066r1161b2135],
22	*	NN	O	*	dep	10	SENT_213	[p18l1191t2066r1402b2135],
23	2	CD	NUMBER	2	num	22	SENT_213	[p18l1191t2066r1402b2135],
24	/	:	O	/	punct	18	SENT_213	[p18l1191t2066r1402b2135],
25	*	CD	NUMBER	*	number	26	SENT_213	[p18l1191t2066r1402b2135],
26	2	CD	NUMBER	2	num	27	SENT_213	[p18l1191t2066r1402b2135],
27	groups	NNS	O	group	dobj	6	SENT_213	[p18l1429t2091r1715b2156],
28	,	,	O	,	_	0	SENT_213	[p18l1429t2091r1715b2156],
29	suggesting	VBG	O	suggest	partmod	27	SENT_213	[p18l1743t2070r2151b2156],

1	GENERIC	JJ	O	generic	amod	2	SENT_214	[p18l441t2232r623b2263],
2	NRTIS	NN	O	nrti	_	0	SENT_214	[p18l634t2232r761b2263],
3	IN	IN	O	in	_	0	SENT_214	[p18l774t2233r824b2263],
4	TB/HIV	NN	O	tb/hiv	prep_in	2	SENT_214	[p18l837t2231r1260b2263],
5	.	.	O	.	_	0	SENT_214	[p18l837t2231r1260b2263],

1	—	NN	O	—	_	0	SENT_215	[p18l837t2231r1260b2263],
2	.	.	O	.	_	0	SENT_215	[p18l837t2231r1260b2263],

1	COINFECTED	JJ	O	coinfected	_	0	SENT_216	[p18l837t2231r1260b2263],
2	GHANAIAN	JJ	MISC	ghanaian	amod	3	SENT_216	[p18l1275t2232r1511b2263],
3	PATIENTS	NNS	O	patient	dep	1	SENT_216	[p18l1521t2232r1723b2263],

1	Table	NNP	O	Table	nn	3	SENT_217	[p18l324t2357r427b2389],
2	II	NNP	O	II	nn	3	SENT_217	[p18l442t2359r473b2389],
3	Effect	NN	O	effect	_	0	SENT_217	[p18l516t2357r624b2389],
4	of	IN	O	of	_	0	SENT_217	[p18l639t2357r676b2389],
5	UGTZB7	NNP	O	UGTZB7	nn	6	SENT_217	[p18l692t2359r852b2389],
6	Allele	NNP	O	Allele	prep_of	3	SENT_217	[p18l864t2357r977b2389],
7	on	IN	O	on	_	0	SENT_217	[p18l994t2368r1040b2389],
8	Mean	NN	O	mean	prep_on	6	SENT_217	[p18l1054t2359r1159b2389],
9	i	FW	O	i	dep	3	SENT_217	[p18l1173t2362r1195b2389],
10	SD	NN	O	sd	dep	9	SENT_217	[p18l1210t2359r1261b2389],
11	Zidovudine	NNP	O	Zidovudine	dep	10	SENT_217	[p18l1277t2357r1499b2389],
12	Pharmacokinetic	JJ	O	pharmacokinetic	amod	10	SENT_217	[p18l1514t2357r1833b2389],

1	Parameters	NNS	O	parameter	nsubj	2	SENT_218	[p18l494t2407r702b2437],
2	Measured	VBN	O	measure	_	0	SENT_218	[p18l718t2405r904b2437],
3	in	IN	O	in	_	0	SENT_218	[p18l918t2407r956b2437],
4	16	CD	NUMBER	16	num	6	SENT_218	[p18l973t2410r1014b2437],
5	HIV/TB-Coinfected	JJ	O	hiv/tb-coinfected	amod	6	SENT_218	[p18l1029t2405r1396b2437],
6	Patients	NNS	O	patient	prep_in	2	SENT_218	[p18l1410t2407r1560b2437],
7	Who	WP	O	who	rcmod	6	SENT_218	[p18l1575t2405r1663b2437],

1	Were	VBD	O	be	aux	3	SENT_219	[p18l440t2455r535b2485],
2	Also	RB	O	also	advmod	3	SENT_219	[p18l550t2453r636b2485],
3	Receiving	VBG	O	receive	_	0	SENT_219	[p18l651t2455r837b2495],
4	Efavirenz	NNP	O	Efavirenz	dobj	3	SENT_219	[p18l851t2453r1044b2485],
5	-	:	O	-	_	0	SENT_219	[p18l851t2453r1044b2485],
6	and	CC	O	and	_	0	SENT_219	[p18l1061t2453r1130b2485],
7	Rifampin-Containing	JJ	O	rifampin-containing	amod	8	SENT_219	[p18l1144t2453r1546b2495],
8	Therapy	NN	O	therapy	dobj	3	SENT_219	[p18l1560t2453r1719b2495],

1	Parameter	NN	O	parameter	nn	2	SENT_220	[p18l42t2541r203b2565],
2	UGT2B7	NN	O	ugt2b7	dep	9	SENT_220	[p18l678t2540r863b2565],
3	*	CD	NUMBER	*	num	5	SENT_220	[p18l678t2540r863b2565],
4	1a	NN	O	1a	nn	5	SENT_220	[p18l678t2540r863b2565],
5	Noncarriers	NNS	O	noncarrier	dep	2	SENT_220	[p18l874t2540r1060b2565],
6	UGT2B7	NN	O	ugt2b7	dep	9	SENT_220	[p18l1357t2540r1543b2565],
7	*	CD	NUMBER	*	num	6	SENT_220	[p18l1357t2540r1543b2565],
8	1a	NN	O	1a	nn	9	SENT_220	[p18l1357t2540r1543b2565],
9	Carriers	NNS	O	carrier	_	0	SENT_220	[p18l1554t2540r1680b2565],
10	P	NN	O	p	nn	12	SENT_220	[p18l1977t2541r1999b2565],
11	Value	NN	O	value	nn	12	SENT_220	[p18l2009t2539r2108b2565],
12	“	NN	O	“	dep	9	SENT_220	[p18l2009t2539r2108b2565],

1	Number	NN	O	number	_	0	SENT_221	[p18l43t2632r181b2661],
2	of	IN	O	of	_	0	SENT_221	[p18l195t2632r229b2661],
3	patients	NNS	O	patient	prep_of	1	SENT_221	[p18l239t2634r374b2670],
4	5	CD	NUMBER	5	number	5	SENT_221	[p18l836t2637r852b2661],
5	11	CD	NUMBER	11	num	6	SENT_221	[p18l1462t2637r1498b2661],
6	CW	NN	ORGANIZATION	cw	dep	3	SENT_221	[p18l43t2677r119b2715],
7	,	,	O	,	_	0	SENT_221	[p18l43t2677r119b2715],
8	ng/mL	NN	O	ng/ml	appos	3	SENT_221	[p18l134t2676r244b2714],
9	830	CD	NUMBER	830	num	8	SENT_221	[p18l783t2680r842b2705],
10	:	:	O	:	_	0	SENT_221	[p18l855t2680r875b2705],
11	224	CD	NUMBER	224	number	12	SENT_221	[p18l889t2680r948b2705],
12	1310	CD	DATE	1310	dep	1	SENT_221	[p18l1409t2680r1488b2705],
13	:	:	O	:	_	0	SENT_221	[p18l1501t2680r1521b2705],
14	909	CD	NUMBER	909	number	15	SENT_221	[p18l1535t2680r1594b2705],
15	.271	CD	NUMBER	.271	num	16	SENT_221	[p18l1995t2680r2063b2705],
16	tm	NN	O	tm	dep	12	SENT_221	[p18l43t2723r107b2758],
17	,	,	O	,	_	0	SENT_221	[p18l43t2723r107b2758],
18	h	NN	O	h	appos	16	SENT_221	[p18l121t2719r143b2748],
19	1.5	CD	NUMBER	1.5	num	18	SENT_221	[p18l794t2724r840b2748],
20	.	.	O	.	_	0	SENT_221	[p18l855t2733r875b2748],

1	—	NN	O	—	_	0	SENT_222	[p18l855t2733r875b2748],
2	.	.	O	.	_	0	SENT_222	[p18l855t2733r875b2748],

1	_	NN	O	_	_	0	SENT_223	[p18l855t2733r875b2748],
2	0.6	CD	NUMBER	0.6	num	3	SENT_223	[p18l889t2723r937b2748],
3	1.6	CD	NUMBER	1.6	dep	1	SENT_223	[p18l1440t2723r1487b2748],
4	.	.	O	.	_	0	SENT_223	[p18l1501t2733r1521b2748],

1	—	NN	O	—	_	0	SENT_224	[p18l1501t2733r1521b2748],
2	.	.	O	.	_	0	SENT_224	[p18l1501t2733r1521b2748],

1	_	NN	O	_	_	0	SENT_225	[p18l1501t2733r1521b2748],
2	1.3	CD	NUMBER	1.3	number	3	SENT_225	[p18l1536t2723r1582b2748],
3	.884	CD	NUMBER	.884	num	4	SENT_225	[p18l1995t2723r2064b2748],
4	Half-life	NN	O	half-life	dep	1	SENT_225	[p18l43t2772r192b2805],
5	,	,	O	,	_	0	SENT_225	[p18l43t2772r192b2805],
6	h	NN	O	h	appos	4	SENT_225	[p18l206t2772r228b2800],
7	5.3	CD	NUMBER	5.3	num	6	SENT_225	[p18l794t2776r840b2801],
8	:	:	O	:	_	0	SENT_225	[p18l855t2776r875b2800],
9	7.2	CD	NUMBER	7.2	number	10	SENT_225	[p18l890t2776r936b2800],
10	9.4	CD	NUMBER	9.4	dep	4	SENT_225	[p18l1439t2776r1488b2801],
11	:	:	O	:	_	0	SENT_225	[p18l1501t2776r1521b2800],
12	8.3	CD	NUMBER	8.3	number	13	SENT_225	[p18l1535t2776r1582b2801],
13	.247	CD	NUMBER	.247	num	14	SENT_225	[p18l1996t2769r2077b2801],
14	‘	NN	O	‘	npadvmod	15	SENT_225	[p18l1996t2769r2077b2801],
15	=	JJ	O	=	amod	16	SENT_225	[p18l1996t2769r2077b2801],
16	AUC	NN	O	auc	dep	10	SENT_225	[p18l43t2816r134b2848],
17	,	,	O	,	_	0	SENT_225	[p18l43t2816r134b2848],
18	ng/mL-h	JJ	O	ng/ml-h	amod	19	SENT_225	[p18l148t2814r292b2852],
19	2945	CD	DATE	2945	appos	16	SENT_225	[p18l762t2819r840b2843],
20	:	:	DATE	:	_	0	SENT_225	[p18l855t2828r875b2843],
21	1739	CD	DATE	1739	number	22	SENT_225	[p18l890t2819r968b2843],
22	3867	CD	NUMBER	3867	dep	4	SENT_225	[p18l1408t2819r1487b2843],
23	:	:	O	:	_	0	SENT_225	[p18l1501t2828r1521b2843],
24	3061	CD	NUMBER	3061	number	25	SENT_225	[p18l1535t2819r1613b2843],
25	.552	CD	NUMBER	.552	num	27	SENT_225	[p18l1995t2812r2077b2843],
26	b	NN	O	b	nn	27	SENT_225	[p18l1995t2812r2077b2843],
27	CL/F	NN	O	cl/f	dep	22	SENT_225	[p18l43t2858r132b2891],
28	,	,	O	,	_	0	SENT_225	[p18l43t2858r132b2891],
29	mL/min/kg	NN	O	ml/min/kg	appos	27	SENT_225	[p18l146t2858r338b2896],
30	38.3	CD	NUMBER	38.3	num	29	SENT_225	[p18l773t2862r840b2887],
31	:	:	O	:	_	0	SENT_225	[p18l855t2862r875b2887],
32	28.6	CD	NUMBER	28.6	number	33	SENT_225	[p18l889t2862r958b2887],
33	28.9	CD	NUMBER	28.9	dep	4	SENT_225	[p18l1419t2862r1488b2887],
34	:	:	O	:	_	0	SENT_225	[p18l1501t2862r1521b2887],
35	36.5	CD	NUMBER	36.5	number	36	SENT_225	[p18l1535t2862r1603b2887],
36	.365	CD	NUMBER	.365	num	37	SENT_225	[p18l1995t2862r2063b2887],
37	Vd/F	NN	O	vd/f	dep	33	SENT_225	[p18l43t2902r134b2936],
38	,	,	O	,	_	0	SENT_225	[p18l43t2902r134b2936],
39	L/kg	NN	O	l/kg	appos	37	SENT_225	[p18l149t2902r224b2940],
40	8.5	CD	NUMBER	8.5	num	39	SENT_225	[p18l793t2906r840b2931],
41	:	:	O	:	_	0	SENT_225	[p18l855t2916r875b2931],
42	5.9	CD	NUMBER	5.9	number	43	SENT_225	[p18l889t2906r937b2931],
43	10.5	CD	NUMBER	10.5	num	45	SENT_225	[p18l1419t2906r1487b2931],
44	1	CD	NUMBER	1	number	45	SENT_225	[p18l1501t2907r1521b2931],
45	4.2	CD	NUMBER	4.2	dep	4	SENT_225	[p18l1534t2906r1582b2931],
46	.453	CD	NUMBER	.453	dep	45	SENT_225	[p18l1995t2906r2063b2931],

1	UGT2B7	NN	O	ugt2b7	_	0	SENT_226	[p18l679t2982r861b3006],
2	*	CD	NUMBER	*	num	4	SENT_226	[p18l679t2982r861b3006],
3	1c	NN	O	1c	nn	4	SENT_226	[p18l679t2982r861b3006],
4	Noncarriers	NNS	O	noncarrier	dep	1	SENT_226	[p18l873t2981r1059b3006],
5	UGT2B7	NN	O	ugt2b7	dep	4	SENT_226	[p18l1358t2982r1541b3006],
6	*	CD	NUMBER	*	num	8	SENT_226	[p18l1358t2982r1541b3006],
7	1c	NN	O	1c	nn	8	SENT_226	[p18l1358t2982r1541b3006],
8	Carriers	NNS	O	carrier	dep	1	SENT_226	[p18l1553t2981r1679b3006],

1	Number	NN	O	number	_	0	SENT_227	[p18l43t3073r181b3102],
2	of	IN	O	of	_	0	SENT_227	[p18l195t3073r229b3102],
3	patients	NNS	O	patient	prep_of	1	SENT_227	[p18l239t3075r374b3111],
4	8	CD	NUMBER	8	number	5	SENT_227	[p18l836t3077r853b3102],
5	8	CD	NUMBER	8	num	6	SENT_227	[p18l1482t3077r1499b3102],
6	Cm	NN	O	cm	dep	1	SENT_227	[p18l43t3118r119b3155],
7	,	,	O	,	_	0	SENT_227	[p18l43t3118r119b3155],
8	ng/mL	NN	O	ng/ml	appos	6	SENT_227	[p18l133t3116r244b3154],
9	1302	CD	DATE	1302	num	8	SENT_227	[p18l763t3120r841b3145],
10	.	.	O	.	_	0	SENT_227	[p18l855t3130r875b3145],

1	—	NN	O	—	_	0	SENT_228	[p18l855t3130r875b3145],
2	.	.	O	.	_	0	SENT_228	[p18l855t3130r875b3145],

1	_	NN	O	_	_	0	SENT_229	[p18l855t3130r875b3145],
2	968	CD	NUMBER	968	number	3	SENT_229	[p18l889t3120r947b3145],
3	1018	CD	DATE	1018	num	1	SENT_229	[p18l1409t3120r1487b3145],
4	.	.	O	.	_	0	SENT_229	[p18l1501t3130r1521b3145],

1	—	NN	O	—	_	0	SENT_230	[p18l1501t3130r1521b3145],
2	.	.	O	.	_	0	SENT_230	[p18l1501t3130r1521b3145],

1	_	NN	O	_	_	0	SENT_231	[p18l1501t3130r1521b3145],
2	550	CD	NUMBER	550	number	3	SENT_231	[p18l1535t3120r1594b3145],
3	.842	CD	NUMBER	.842	num	5	SENT_231	[p18l1995t3114r2077b3145],
4	”	NN	O	”	nn	5	SENT_231	[p18l1995t3114r2077b3145],
5	tm	NN	O	tm	dep	1	SENT_231	[p18l43t3164r107b3198],
6	,	,	O	,	_	0	SENT_231	[p18l43t3164r107b3198],
7	h	NN	O	h	appos	5	SENT_231	[p18l121t3160r143b3188],
8	1.4	CD	NUMBER	1.4	num	7	SENT_231	[p18l794t3164r842b3188],
9	:	:	O	:	_	0	SENT_231	[p18l855t3173r875b3188],
10	1.2	CD	NUMBER	1.2	number	11	SENT_231	[p18l890t3164r936b3188],
11	1.8	CD	NUMBER	1.8	dep	5	SENT_231	[p18l1440t3164r1487b3188],
12	:	:	O	:	_	0	SENT_231	[p18l1501t3173r1521b3188],
13	1.1	CD	NUMBER	1.1	number	14	SENT_231	[p18l1536t3164r1582b3188],
14	.274	CD	NUMBER	.274	dep	11	SENT_231	[p18l1995t3157r2077b3188],
15	‘	NN	O	‘	dep	14	SENT_231	[p18l1995t3157r2077b3188],
16	)	CD	NUMBER	)	num	17	SENT_231	[p18l1995t3157r2077b3188],
17	Half-life	NN	O	half-life	dep	1	SENT_231	[p18l43t3202r192b3236],
18	,	,	O	,	_	0	SENT_231	[p18l43t3202r192b3236],
19	h	NN	O	h	appos	17	SENT_231	[p18l206t3202r228b3231],
20	12.2	CD	NUMBER	12.2	num	19	SENT_231	[p18l773t3207r840b3231],
21	:	:	O	:	_	0	SENT_231	[p18l855t3216r875b3231],
22	9.0	CD	NUMBER	9.0	number	23	SENT_231	[p18l889t3207r937b3232],
23	4.0	CD	NUMBER	4.0	dep	17	SENT_231	[p18l1438t3207r1488b3232],
24	:	:	O	:	_	0	SENT_231	[p18l1501t3216r1521b3231],
25	4.0	CD	NUMBER	4.0	number	26	SENT_231	[p18l1534t3207r1583b3232],
26	.030	CD	NUMBER	.030	dep	23	SENT_231	[p18l1995t3200r2077b3232],
27	“	CD	NUMBER	“	num	28	SENT_231	[p18l1995t3200r2077b3232],
28	AUC	NN	O	auc	dep	26	SENT_231	[p18l43t3248r134b3279],
29	,	,	O	,	_	0	SENT_231	[p18l43t3248r134b3279],
30	ng/mL-h	JJ	O	ng/ml-h	amod	31	SENT_231	[p18l148t3246r292b3284],
31	4997	CD	NUMBER	4997	appos	1	SENT_231	[p18l761t3250r841b3275],
32	.	.	O	.	_	0	SENT_231	[p18l855t3260r875b3275],

1	—	NN	O	—	_	0	SENT_232	[p18l855t3260r875b3275],
2	.	.	O	.	_	0	SENT_232	[p18l855t3260r875b3275],

1	_	RB	O	_	dep	2	SENT_233	[p18l855t3260r875b3275],
2	3187	CD	NUMBER	3187	num	4	SENT_233	[p18l889t3250r968b3275],
3	2160	CD	DATE	2160	number	4	SENT_233	[p18l1408t3250r1488b3275],
4	1	CD	NUMBER	1	_	0	SENT_233	[p18l1501t3251r1521b3275],
5	879	CD	NUMBER	879	num	7	SENT_233	[p18l1535t3250r1594b3275],
6	.029	CD	NUMBER	.029	num	7	SENT_233	[p18l1995t3250r2064b3275],
7	CL/F	NN	O	cl/f	dep	4	SENT_233	[p18l43t3289r132b3323],
8	,	,	O	,	_	0	SENT_233	[p18l43t3289r132b3323],
9	mL/min/kg	NN	O	ml/min/kg	appos	7	SENT_233	[p18l146t3289r338b3327],
10	16.1	CD	NUMBER	16.1	num	9	SENT_233	[p18l773t3293r840b3318],
11	.	.	O	.	_	0	SENT_233	[p18l855t3303r875b3318],

1	—	NN	O	—	_	0	SENT_234	[p18l855t3303r875b3318],
2	.	.	O	.	_	0	SENT_234	[p18l855t3303r875b3318],

1	_	NN	O	_	_	0	SENT_235	[p18l855t3303r875b3318],
2	19.8	CD	NUMBER	19.8	number	3	SENT_235	[p18l890t3293r958b3318],
3	47.6	CD	NUMBER	47.6	num	1	SENT_235	[p18l1417t3293r1488b3318],
4	.	.	O	.	_	0	SENT_235	[p18l1501t3303r1521b3318],

1	—	NN	O	—	_	0	SENT_236	[p18l1501t3303r1521b3318],
2	.	.	O	.	_	0	SENT_236	[p18l1501t3303r1521b3318],

1	_	NN	O	_	_	0	SENT_237	[p18l1501t3303r1521b3318],
2	38.2	CD	NUMBER	38.2	number	3	SENT_237	[p18l1535t3293r1603b3318],
3	.004	CD	NUMBER	.004	dep	1	SENT_237	[p18l1996t3287r2077b3318],
4	‘	NN	O	‘	dep	3	SENT_237	[p18l1996t3287r2077b3318],
5	)	CD	NUMBER	)	num	6	SENT_237	[p18l1996t3287r2077b3318],
6	Vd/F	NN	O	vd/f	dep	1	SENT_237	[p18l43t3333r134b3366],
7	,	,	O	,	_	0	SENT_237	[p18l43t3333r134b3366],
8	L/kg	NN	O	l/kg	appos	6	SENT_237	[p18l148t3333r224b3371],
9	10.3	CD	NUMBER	10.3	num	8	SENT_237	[p18l773t3337r840b3362],
10	.	.	O	.	_	0	SENT_237	[p18l855t3347r875b3362],

1	—	NN	O	—	_	0	SENT_238	[p18l855t3347r875b3362],
2	.	.	O	.	_	0	SENT_238	[p18l855t3347r875b3362],

1	_	NN	O	_	_	0	SENT_239	[p18l855t3347r875b3362],
2	5.4	CD	NUMBER	5.4	number	3	SENT_239	[p18l889t3338r937b3362],
3	9.4	CD	NUMBER	9.4	num	1	SENT_239	[p18l1439t3337r1488b3362],
4	.	.	O	.	_	0	SENT_239	[p18l1501t3347r1521b3362],

1	—	NN	O	—	_	0	SENT_240	[p18l1501t3347r1521b3362],
2	.	.	O	.	_	0	SENT_240	[p18l1501t3347r1521b3362],

1	_	RB	O	_	dep	3	SENT_241	[p18l1501t3347r1521b3362],
2	4.2	CD	NUMBER	4.2	num	3	SENT_241	[p18l1534t3337r1582b3362],
3	.727	CD	NUMBER	.727	_	0	SENT_241	[p18l1995t3337r2064b3362],

1	UGT2B7	NN	O	ugt2b7	nn	2	SENT_242	[p18l687t3412r818b3437],
2	*	NN	O	*	_	0	SENT_242	[p18l820t3413r852b3437],
3	2	CD	NUMBER	2	num	4	SENT_242	[p18l820t3413r852b3437],
4	Noncarriers	NNS	O	noncarrier	dep	2	SENT_242	[p18l865t3412r1050b3437],
5	UGTZB	NN	O	ugtzb	nn	7	SENT_242	[p18l1367t3412r1478b3437],
6	7	CD	NUMBER	7	num	7	SENT_242	[p18l1481t3415r1498b3437],
7	*	NN	O	*	dep	4	SENT_242	[p18l1500t3413r1532b3437],
8	2	CD	NUMBER	2	num	9	SENT_242	[p18l1500t3413r1532b3437],
9	Carriers	NNS	O	carrier	dep	2	SENT_242	[p18l1545t3412r1671b3437],

1	Number	NN	O	number	dep	64	SENT_243	[p19l43t52r181b81],
2	of	IN	O	of	_	0	SENT_243	[p19l195t52r229b81],
3	patients	NNS	O	patient	prep_of	1	SENT_243	[p19l239t53r374b90],
4	10	CD	NUMBER	10	number	5	SENT_243	[p19l816t56r853b81],
5	6	CD	NUMBER	6	num	6	SENT_243	[p19l1482t56r1499b81],
6	Cum	NN	O	cum	dep	3	SENT_243	[p19l43t96r119b134],
7	,	,	O	,	_	0	SENT_243	[p19l43t96r119b134],
8	ng/mL	NN	O	ng/ml	dep	31	SENT_243	[p19l134t95r244b133],
9	1283	CD	DATE	1283	num	8	SENT_243	[p19l763t99r840b124],
10	i	FW	O	i	dep	8	SENT_243	[p19l855t100r875b124],
11	963	CD	NUMBER	963	number	12	SENT_243	[p19l889t99r947b124],
12	956	CD	NUMBER	956	dep	10	SENT_243	[p19l1429t99r1487b124],
13	i	FW	O	i	dep	12	SENT_243	[p19l1501t100r1521b124],
14	319	CD	NUMBER	319	number	15	SENT_243	[p19l1535t99r1594b124],
15	.444	CD	NUMBER	.444	num	16	SENT_243	[p19l1995t99r2064b124],
16	tm	NN	O	tm	dep	12	SENT_243	[p19l43t143r107b178],
17	,	,	O	,	_	0	SENT_243	[p19l43t143r107b178],
18	h	NN	O	h	appos	12	SENT_243	[p19l121t139r143b168],
19	1.8	CD	NUMBER	1.8	num	18	SENT_243	[p19l794t143r841b168],
20	:	:	O	:	_	0	SENT_243	[p19l855t143r875b168],
21	1.3	CD	NUMBER	1.3	number	22	SENT_243	[p19l890t143r936b168],
22	1.3	CD	NUMBER	1.3	dep	18	SENT_243	[p19l1440t143r1486b168],
23	:	:	O	:	_	0	SENT_243	[p19l1501t143r1521b168],
24	0.7	CD	NUMBER	0.7	dep	12	SENT_243	[p19l1535t143r1583b168],
25	.6341	CD	NUMBER	.6341	number	26	SENT_243	[p19l1995t136r2077b168],
26	’	CD	NUMBER	’	num	27	SENT_243	[p19l1995t136r2077b168],
27	Half-life	NN	O	half-life	dep	24	SENT_243	[p19l43t182r192b215],
28	,	,	O	,	_	0	SENT_243	[p19l43t182r192b215],
29	h	NN	O	h	dep	31	SENT_243	[p19l206t182r228b210],
30	6.7	CD	NUMBER	6.7	num	29	SENT_243	[p19l793t186r841b211],
31	i	FW	O	i	dep	41	SENT_243	[p19l855t187r875b210],
32	8.0	CD	NUMBER	8.0	number	33	SENT_243	[p19l889t186r937b211],
33	10.5	CD	NUMBER	10.5	dep	31	SENT_243	[p19l1419t186r1487b211],
34	i	FW	O	i	dep	33	SENT_243	[p19l1501t187r1521b210],
35	8.1	CD	NUMBER	8.1	number	36	SENT_243	[p19l1535t186r1582b211],
36	.369	CD	NUMBER	.369	num	37	SENT_243	[p19l1995t186r2064b211],
37	AUC	NN	O	auc	dep	33	SENT_243	[p19l43t226r134b258],
38	,	,	O	,	_	0	SENT_243	[p19l43t226r134b258],
39	ng/InL	NN	O	ng/inl	appos	37	SENT_243	[p19l148t225r292b263],
40	«	CD	NUMBER	«	num	39	SENT_243	[p19l148t225r292b263],
41	h	NN	O	h	dep	43	SENT_243	[p19l148t225r292b263],
42	3553	CD	NUMBER	3553	num	41	SENT_243	[p19l762t229r840b254],
43	i	FW	O	i	dep	54	SENT_243	[p19l855t229r875b254],
44	3346	CD	NUMBER	3346	number	45	SENT_243	[p19l889t229r968b254],
45	3623	CD	NUMBER	3623	dep	43	SENT_243	[p19l1408t229r1487b254],
46	i	FW	O	i	dep	45	SENT_243	[p19l1501t229r1521b254],
47	1262	CD	DATE	1262	number	48	SENT_243	[p19l1536t229r1614b254],
48	.2931	CD	NUMBER	.2931	num	50	SENT_243	[p19l1996t222r2077b254],
49	’	NN	O	’	nn	50	SENT_243	[p19l1996t222r2077b254],
50	CL/F	NN	O	cl/f	dep	45	SENT_243	[p19l43t268r132b302],
51	,	,	O	,	_	0	SENT_243	[p19l43t268r132b302],
52	mL/min/kg	NN	O	ml/min/kg	appos	50	SENT_243	[p19l146t268r338b306],
53	41.0	CD	NUMBER	41.0	num	52	SENT_243	[p19l771t272r842b297],
54	i	FW	O	i	dep	58	SENT_243	[p19l855t273r875b297],
55	39.5	CD	NUMBER	39.5	number	56	SENT_243	[p19l889t272r957b297],
56	16.7	CD	NUMBER	16.7	dep	54	SENT_243	[p19l1419t272r1488b297],
57	i	FW	O	i	dep	56	SENT_243	[p19l1501t273r1521b297],
58	11.6	CD	NUMBER	11.6	dep	60	SENT_243	[p19l1536t272r1604b297],
59	.168	CD	NUMBER	.168	num	60	SENT_243	[p19l1995t272r2064b297],
60	Vd/F	NN	O	vd/f	dep	3	SENT_243	[p19l43t312r134b345],
61	,	,	O	,	_	0	SENT_243	[p19l43t312r134b345],
62	L/kg	NN	O	l/kg	dep	64	SENT_243	[p19l148t312r224b350],
63	10.2	CD	NUMBER	10.2	num	62	SENT_243	[p19l773t316r840b341],
64	i	FW	O	i	dep	69	SENT_243	[p19l855t316r875b341],
65	5.1	CD	NUMBER	5.1	number	66	SENT_243	[p19l889t316r936b341],
66	9.3	CD	NUMBER	9.3	dep	64	SENT_243	[p19l1439t316r1487b341],
67	i	FW	O	i	dep	66	SENT_243	[p19l1501t316r1521b341],
68	4.2	CD	NUMBER	4.2	num	69	SENT_243	[p19l1534t316r1582b341],
69	.728	CD	NUMBER	.728	_	0	SENT_243	[p19l1996t316r2064b341],

1	Cm	NN	O	cm	nn	2	SENT_244	[p19l93t393r152b422],
2	“	NN	O	“	nsubj	25	SENT_244	[p19l93t393r152b422],
3	,	,	O	,	_	0	SENT_244	[p19l93t393r152b422],
4	peak	NN	O	peak	appos	2	SENT_244	[p19l166t392r229b422],
5	concentration	NN	O	concentration	dep	4	SENT_244	[p19l241t393r431b418],
6	;	:	O	;	_	0	SENT_244	[p19l241t393r431b418],
7	tmx	NN	O	tmx	dep	4	SENT_244	[p19l444t395r494b422],
8	,	,	O	,	_	0	SENT_244	[p19l444t395r494b422],
9	time	NN	O	time	nn	12	SENT_244	[p19l507t393r566b414],
10	o	NN	O	o	nn	12	SENT_244	[p19l589t400r603b414],
11	peak	NN	O	peak	nn	12	SENT_244	[p19l616t392r679b421],
12	concentration	NN	O	concentration	appos	7	SENT_244	[p19l691t393r881b418],
13	;	:	O	;	_	0	SENT_244	[p19l691t393r881b418],
14	AUC	NN	O	auc	dep	4	SENT_244	[p19l895t393r966b418],
15	,	,	O	,	_	0	SENT_244	[p19l895t393r966b418],
16	area	NN	O	area	appos	14	SENT_244	[p19l980t400r1034b414],
17	under	IN	O	under	_	0	SENT_244	[p19l1046t392r1124b414],
18	curve	NN	O	curve	prep_under	16	SENT_244	[p19l1137t400r1217b418],
19	;	:	O	;	_	0	SENT_244	[p19l1137t400r1217b418],
20	CL/F	NN	O	cl/f	dep	4	SENT_244	[p19l1231t392r1300b418],
21	,	,	O	,	_	0	SENT_244	[p19l1231t392r1300b418],
22	apparent	JJ	O	apparent	amod	24	SENT_244	[p19l1314t395r1431b421],
23	oral	JJ	O	oral	amod	24	SENT_244	[p19l1444t392r1494b414],
24	clearance	NN	O	clearance	appos	20	SENT_244	[p19l1507t392r1631b414],
25	normalized	VBD	O	normalize	_	0	SENT_244	[p19l1644t392r1795b414],
26	for	IN	O	for	_	0	SENT_244	[p19l1808t392r1844b414],
27	body	NN	O	body	nn	28	SENT_244	[p19l1855t392r1922b421],
28	wei	NNS	O	weus	prep_for	25	SENT_244	[p19l1934t393r1981b414],
29	;	:	O	;	_	0	SENT_244	[p19l2026t400r2031b418],
30	Vd/F	NN	O	vd/f	conj_or	28	SENT_244	[p19l2044t392r2115b418],
31	,	,	O	,	_	0	SENT_244	[p19l2044t392r2115b418],
32	volume	NN	O	volume	conj_or	28	SENT_244	[p19l93t424r192b447],
33	of	IN	O	of	_	0	SENT_244	[p19l202t424r229b447],
34	distribution	NN	O	distribution	prep_of	32	SENT_244	[p19l237t424r393b447],
35	normalize	VB	O	normalize	dep	32	SENT_244	[p19l403t424r536b447],
36	or	CC	O	or	_	0	SENT_244	[p19l574t432r600b447],
37	body	NN	O	body	nn	39	SENT_244	[p19l608t424r674b454],
38	w	NN	O	w	nn	39	SENT_244	[p19l684t432r707b447],
39	ight	NN	O	ight	prep_for	25	SENT_244	[p19l723t424r780b454],
40	.	.	O	.	_	0	SENT_244	[p19l723t424r780b454],

1	“	NNP	O	“	nn	3	SENT_245	[p19l791t425r882b454],
2	Group	NNP	O	Group	nn	3	SENT_245	[p19l791t425r882b454],
3	differences	NNS	O	difference	nsubjpass	5	SENT_245	[p19l893t424r1038b447],
4	were	VBD	O	be	auxpass	5	SENT_245	[p19l1048t432r1111b447],
5	evaluated	VBN	O	evaluate	_	0	SENT_245	[p19l1122t424r1250b447],
6	by	IN	O	by	_	0	SENT_245	[p19l1258t424r1290b454],
7	unpaired	JJ	O	unpaired	amod	8	SENT_245	[p19l1300t424r1420b454],
8	ttest	NN	O	ttest	agent	5	SENT_245	[p19l1431t427r1494b447],
9	or	CC	O	or	_	0	SENT_245	[p19l1504t432r1530b447],
10	by	IN	O	by	_	0	SENT_245	[p19l1538t424r1570b454],
11	brank	NN	O	brank	nn	13	SENT_245	[p19l1579t422r1649b447],
12	sum	NN	O	sum	nn	13	SENT_245	[p19l1658t432r1713b447],
13	test	NN	O	test	agent	5	SENT_245	[p19l1722t428r1769b447],
14	if	IN	O	if	mark	19	SENT_245	[p19l1778t424r1798b447],
15	data	NNS	O	datum	nsubjpass	21	SENT_245	[p19l1806t424r1861b447],
16	were	VBD	O	be	auxpass	19	SENT_245	[p19l1870t432r1934b447],
17	no	DT	O	no	dep	19	SENT_245	[p19l1944t432r1976b447],
18	normally	RB	O	normally	advmod	19	SENT_245	[p19l1996t424r2116b454],
19	distributed	VBN	O	distribute	advcl	5	SENT_245	[p19l115t470r426b517],
20	or	CC	O	or	_	0	SENT_245	[p19l450t487r505b517],
21	showed	VBN	O	show	advcl	5	SENT_245	[p19l528t470r746b517],
22	unequal	JJ	O	unequal	amod	23	SENT_245	[p19l767t470r997b532],
23	variance	NN	O	variance	dobj	19	SENT_245	[p19l1019t472r1273b517],
24	.	.	O	.	_	0	SENT_245	[p19l1019t472r1273b517],

1	that	IN	O	that	dep	8	SENT_246	[p19l6t693r161b762],
2	the	DT	O	the	det	5	SENT_246	[p19l185t693r309b762],
3	*	NN	O	*	nn	5	SENT_246	[p19l342t698r425b761],
4	2	CD	NUMBER	2	num	5	SENT_246	[p19l342t698r425b761],
5	allele	NN	O	allele	nsubj	8	SENT_246	[p19l457t693r673b762],
6	is	VBZ	O	be	cop	8	SENT_246	[p19l700t697r762b762],
7	not	RB	O	not	neg	8	SENT_246	[p19l790t704r921b762],
8	likely	JJ	O	likely	_	0	SENT_246	[p19l946t693r1174b783],
9	to	TO	O	to	aux	10	SENT_246	[p19l1198t704r1272b762],
10	have	VB	O	have	xcomp	8	SENT_246	[p19l1299t694r1486b762],
11	effects	NNS	O	effect	dobj	10	SENT_246	[p19l1515t694r1768b762],
12	on	IN	O	on	_	0	SENT_246	[p19l1799t718r1897b762],
13	activity	NN	O	activity	prep_on	11	SENT_246	[p19l1923t697r2145b762, p19l7t799r112b885],
14	independent	JJ	O	independent	amod	13	SENT_246	[p19l169t795r686b885],
15	of	IN	O	of	_	0	SENT_246	[p19l743t795r824b863],
16	any	DT	O	any	det	20	SENT_246	[p19l875t819r1019b885],
17	*	NN	O	*	nn	20	SENT_246	[p19l1081t800r1213b863],
18	1c	NN	O	1c	nn	20	SENT_246	[p19l1081t800r1213b863],
19	allele	NN	O	allele	nn	20	SENT_246	[p19l1273t795r1489b863],
20	effect	NN	O	effect	prep_of	13	SENT_246	[p19l1549t795r1785b863],
21	.	.	O	.	_	0	SENT_246	[p19l1549t795r1785b863],

1	Similar	JJ	O	similar	amod	2	SENT_247	[p19l1851t795r2147b863],
2	analyses	NNS	O	analysis	nsubj	19	SENT_247	[p19l8t897r347b986],
3	of	IN	O	of	_	0	SENT_247	[p19l388t897r468b965],
4	effects	NNS	O	effect	prep_of	2	SENT_247	[p19l499t897r753b965],
5	of	IN	O	of	_	0	SENT_247	[p19l794t897r874b965],
6	diplotype	NN	O	diplotype	prep_of	4	SENT_247	[p19l906t897r1294b987],
7	on	IN	O	on	_	0	SENT_247	[p19l1334t921r1432b965],
8	UGTZB7	NN	O	ugtzb7	nn	9	SENT_247	[p19l1468t901r1813b965],
9	protein	NN	O	protein	prep_on	6	SENT_247	[p19l1853t901r2146b987],
10	and	CC	O	and	_	0	SENT_247	[p19l8t999r156b1067],
11	mRNA	NN	O	mrna	nn	12	SENT_247	[p19l189t1003r464b1066],
12	content	NN	O	content	prep_on	6	SENT_247	[p19l498t1009r801b1067],
13	by	IN	O	by	_	0	SENT_247	[p19l831t999r929b1088],
14	ANOVA	NNP	ORGANIZATION	ANOVA	prep_by	9	SENT_247	[p19l962t1002r1294b1067],
15	were	VBD	O	be	cop	19	SENT_247	[p19l1326t1023r1521b1067],
16	not	RB	O	not	neg	19	SENT_247	[p19l1555t1009r1686b1067],
17	significant	JJ	O	significant	amod	19	SENT_247	[p19l1721t999r2147b1088],
18	(	NN	O	(	nn	19	SENT_247	[p19l11t1101r93b1181],
19	P	NN	O	p	_	0	SENT_247	[p19l11t1101r93b1181],
20	>	JJR	O	>	dep	19	SENT_247	[p19l118t1122r163b1167],
21	.05	CD	NUMBER	.05	dep	20	SENT_247	[p19l199t1110r336b1179],
22	,	,	O	,	_	0	SENT_247	[p19l199t1110r336b1179],
23	data	NNS	O	datum	npadvmod	24	SENT_247	[p19l374t1101r541b1168],
24	not	RB	O	not	advmod	20	SENT_247	[p19l571t1110r703b1168],
25	shown	VBN	O	show	partmod	19	SENT_247	[p19l735t1101r1051b1181],
26	)	NN	O	)	dobj	25	SENT_247	[p19l735t1101r1051b1181],
27	.	.	O	.	_	0	SENT_247	[p19l735t1101r1051b1181],

1	DISCUSSION	NN	O	discussion	_	0	SENT_248	[p19l6t1302r569b1366],

1	In	IN	O	in	_	0	SENT_249	[p19l6t1512r87b1575],
2	this	DT	O	this	det	3	SENT_249	[p19l132t1508r280b1576],
3	study	NN	O	study	prep_in	6	SENT_249	[p19l330t1508r567b1597],
4	,	,	O	,	_	0	SENT_249	[p19l330t1508r567b1597],
5	We	PRP	O	we	nsubj	6	SENT_249	[p19l615t1532r730b1576],
6	determined	VBD	O	determine	_	0	SENT_249	[p19l780t1508r1244b1576],
7	the	DT	O	the	det	9	SENT_249	[p19l1289t1508r1413b1576],
8	pharmacokinetic	JJ	O	pharmacokinetic	amod	9	SENT_249	[p19l1461t1508r2144b1597],
9	parameters	NNS	O	parameter	dobj	6	SENT_249	[p19l7t1620r451b1699],
10	of	IN	O	of	_	0	SENT_249	[p19l502t1610r582b1678],
11	3	CD	NUMBER	3	num	15	SENT_249	[p19l625t1619r661b1678],
12	commonly	RB	O	commonly	advmod	13	SENT_249	[p19l714t1610r1146b1699],
13	used	VBN	O	use	amod	15	SENT_249	[p19l1190t1609r1380b1678],
14	generic	JJ	O	generic	amod	15	SENT_249	[p19l1426t1613r1718b1699],
15	NRTIs	NNS	O	nrti	prep_of	9	SENT_249	[p19l1765t1614r2017b1678],
16	in	IN	O	in	_	0	SENT_249	[p19l2066t1613r2146b1677],
17	HIV/TB-coinfected	JJ	O	hiv/tb-coinfected	amod	18	SENT_249	[p19l6t1711r776b1779],
18	patients	NNS	O	patient	prep_in	6	SENT_249	[p19l805t1715r1126b1801],
19	who	WP	O	who	nsubj	22	SENT_249	[p19l1157t1711r1330b1779],
20	were	VBD	O	be	aux	22	SENT_249	[p19l1360t1735r1554b1779],
21	also	RB	O	also	advmod	22	SENT_249	[p19l1586t1711r1742b1779],
22	receiving	VBG	O	receive	rcmod	18	SENT_249	[p19l1772t1715r2146b1801],
23	4-drug	JJ	O	4-drug	amod	25	SENT_249	[p19l6t1813r270b1902],
24	antituberculosis	NN	O	antituberculosis	nn	25	SENT_249	[p19l312t1813r964b1881],
25	therapy	NN	O	therapy	dobj	22	SENT_249	[p19l1006t1813r1315b1903],
26	in	IN	O	in	_	0	SENT_249	[p19l1356t1817r1436b1881],
27	resource-limited	JJ	O	resource-limited	amod	28	SENT_249	[p19l1474t1813r2146b1881],
28	settings	NNS	O	setting	prep_in	25	SENT_249	[p19l8t1918r334b2004],
29	.	.	O	.	_	0	SENT_249	[p19l8t1918r334b2004],

1	To	TO	O	to	_	0	SENT_250	[p19l374t1920r468b1983],
2	our	PRP$	O	we	poss	3	SENT_250	[p19l507t1939r641b1983],
3	knowledge	NN	O	knowledge	prep_to	9	SENT_250	[p19l674t1915r1138b2004],
4	,	,	O	,	_	0	SENT_250	[p19l674t1915r1138b2004],
5	this	DT	O	this	nsubj	9	SENT_250	[p19l1175t1915r1323b1983],
6	is	VBZ	O	be	cop	9	SENT_250	[p19l1361t1918r1423b1983],
7	the	DT	O	the	det	9	SENT_250	[p19l1459t1915r1583b1983],
8	first	JJ	ORDINAL	first	amod	9	SENT_250	[p19l1619t1915r1779b1983],
9	study	NN	O	study	_	0	SENT_250	[p19l1814t1915r2037b2004],
10	to	TO	O	to	aux	11	SENT_250	[p19l2070t1925r2144b1983],
11	describe	VB	O	describe	infmod	9	SENT_250	[p19l9t2018r343b2086],
12	the	DT	O	the	det	15	SENT_250	[p19l370t2018r494b2086],
13	steady-state	JJ	O	steady-state	amod	15	SENT_250	[p19l524t2018r997b2107],
14	pharmacokinetic	JJ	O	pharmacokinetic	amod	15	SENT_250	[p19l1025t2018r1708b2107],
15	profiles	NNS	O	profile	dobj	11	SENT_250	[p19l1736t2018r2042b2107],
16	of	IN	O	of	_	0	SENT_250	[p19l2073t2018r2153b2086],
17	generic	JJ	O	generic	amod	18	SENT_250	[p19l6t2123r298b2209],
18	lamivudine	NN	O	lamivudine	prep_of	15	SENT_250	[p19l349t2120r836b2199],
19	,	,	O	,	_	0	SENT_250	[p19l349t2120r836b2199],
20	zidovudine	NN	O	zidovudine	conj_and	18	SENT_250	[p19l888t2120r1372b2198],
21	,	,	O	,	_	0	SENT_250	[p19l888t2120r1372b2198],
22	and	CC	O	and	_	0	SENT_250	[p19l1424t2120r1572b2188],
23	stavudine	NN	O	stavudine	conj_and	18	SENT_250	[p19l1622t2120r2016b2188],
24	in	IN	O	in	_	0	SENT_250	[p19l2066t2123r2146b2187],
25	patients	NNS	O	patient	prep_in	11	SENT_250	[p19l7t2225r327b2311],
26	with	IN	O	with	_	0	SENT_250	[p19l392t2221r578b2290],
27	TB/HIV	NN	O	tb/hiv	nn	28	SENT_250	[p19l642t2221r956b2290],
28	coinfection	NN	O	coinfection	prep_with	25	SENT_250	[p19l1020t2222r1476b2290],
29	on	IN	O	on	_	0	SENT_250	[p19l1542t2246r1640b2290],
30	concurrent	JJ	O	concurrent	amod	31	SENT_250	[p19l1705t2232r2147b2290],
31	therapy	NN	O	therapy	prep_on	11	SENT_250	[p19l6t2323r328b2413],
32	.	.	O	.	_	0	SENT_250	[p19l6t2323r328b2413],

1	Our	PRP$	O	we	poss	2	SENT_251	[p19l370t2327r524b2391],
2	study	NN	O	study	nsubj	6	SENT_251	[p19l560t2323r783b2413],
3	is	VBZ	O	be	cop	6	SENT_251	[p19l818t2327r880b2391],
4	also	RB	O	also	advmod	6	SENT_251	[p19l919t2323r1075b2391],
5	the	DT	O	the	det	6	SENT_251	[p19l1112t2323r1236b2391],
6	first	JJ	ORDINAL	first	_	0	SENT_251	[p19l1273t2323r1433b2391],
7	to	TO	O	to	aux	8	SENT_251	[p19l1466t2333r1540b2391],
8	identify	VB	O	identify	dep	6	SENT_251	[p19l1578t2323r1896b2413],
9	a	DT	O	a	det	12	SENT_251	[p19l1932t2347r1972b2391],
10	significant	JJ	O	significant	amod	12	SENT_251	[p19l2008t2327r2145b2413, p19l6t2425r321b2493],
11	pharmacogenetic	JJ	O	pharmacogenetic	amod	12	SENT_251	[p19l385t2425r1078b2515],
12	relationship	NN	O	relationship	dobj	8	SENT_251	[p19l1144t2425r1634b2515],
13	between	IN	O	between	_	0	SENT_251	[p19l1699t2425r2041b2493],
14	a	DT	O	a	det	17	SENT_251	[p19l2107t2449r2147b2493],
15	common	JJ	O	common	amod	17	SENT_251	[p19l8t2551r360b2595],
16	UGTZB7	NN	O	ugtzb7	nn	17	SENT_251	[p19l415t2530r757b2595],
17	allele	NN	O	allele	prep_between	12	SENT_251	[p19l798t2527r1014b2595],
18	and	CC	O	and	_	0	SENT_251	[p19l1062t2527r1211b2595],
19	zidovudine	NN	O	zidovudine	nn	20	SENT_251	[p19l1257t2527r1717b2595],
20	clearance	NN	O	clearance	prep_between	12	SENT_251	[p19l1765t2527r2145b2595],

1	SPECIAL	JJ	O	special	amod	2	SENT_252	[p19l7t2756r283b2817],
2	POPULATIONS	NNS	O	population	_	0	SENT_252	[p19l317t2756r818b2817],
3	in	IN	O	in	_	0	SENT_252	[p19l7t2855r87b2919],
4	human	JJ	O	human	amod	5	SENT_252	[p19l113t2851r398b2920],
5	patients	NNS	O	patient	nn	9	SENT_252	[p19l425t2855r746b2941],
6	and	CC	O	and	cc	5	SENT_252	[p19l777t2852r926b2920],
7	also	RB	O	also	advmod	5	SENT_252	[p19l954t2851r1110b2920],
8	zidovudine	NN	O	zidovudine	nn	9	SENT_252	[p19l1140t2851r1601b2920],
9	glucuronidation	NN	O	glucuronidation	prep_in	2	SENT_252	[p19l1628t2851r2151b2941, p19l6t2957r166b3022],
10	in	IN	O	in	_	0	SENT_252	[p19l199t2957r279b3021],
11	human	JJ	O	human	amod	12	SENT_252	[p19l309t2953r595b3022],
12	liver	NN	O	liver	prep_in	2	SENT_252	[p19l627t2953r825b3022],
13	.	.	O	.	_	0	SENT_252	[p19l627t2953r825b3022],

1	To	TO	O	to	_	0	SENT_253	[p19l114t3061r208b3124],
2	date	NN	O	date	prep_to	18	SENT_253	[p19l255t3056r442b3135],
3	,	,	O	,	_	0	SENT_253	[p19l255t3056r442b3135],
4	published	VBN	O	publish	amod	5	SENT_253	[p19l488t3056r892b3146],
5	studies	NNS	O	study	nsubj	18	SENT_253	[p19l936t3056r1218b3124],
6	of	IN	O	of	_	0	SENT_253	[p19l1265t3056r1345b3124],
7	the	DT	O	the	det	8	SENT_253	[p19l1379t3056r1503b3124],
8	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	5	SENT_253	[p19l1546t3056r2151b3146, p19l6t3161r143b3226],
9	of	IN	O	of	_	0	SENT_253	[p19l187t3158r267b3226],
10	generic	JJ	O	generic	amod	12	SENT_253	[p19l300t3161r589b3247],
11	antiretroviral	JJ	O	antiretroviral	amod	12	SENT_253	[p19l633t3158r1162b3226],
12	agents	NNS	O	agent	prep_of	8	SENT_253	[p19l1205t3168r1453b3247],
13	in	IN	O	in	_	0	SENT_253	[p19l1496t3161r1576b3225],
14	resourcelimited	JJ	O	resourcelimited	amod	15	SENT_253	[p19l1615t3158r2151b3226, p19l7t3261r160b3329],
15	settings	NNS	O	setting	prep_in	12	SENT_253	[p19l185t3264r487b3350],
16	have	VBP	O	have	aux	18	SENT_253	[p19l512t3261r699b3329],
17	not	RB	O	not	neg	18	SENT_253	[p19l724t3271r854b3329],
18	included	VBN	O	include	_	0	SENT_253	[p19l878t3261r1237b3329],
19	patients	NNS	O	patient	dobj	18	SENT_253	[p19l1261t3264r1579b3350],
20	taking	VBG	O	take	xcomp	18	SENT_253	[p19l1604t3261r1851b3350],
21	known	JJ	O	known	amod	22	SENT_253	[p19l1874t3261r2153b3329],
22	inducers	NNS	O	inducer	dobj	20	SENT_253	[p19l7t3363r354b3431],
23	or	CC	O	or	_	0	SENT_253	[p19l396t3387r475b3431],
24	inhibitors	NNS	O	inhibitor	conj_or	22	SENT_253	[p19l512t3363r903b3431],
25	of	IN	O	of	_	0	SENT_253	[p19l944t3363r1024b3431],
26	cytochrome	NN	O	cytochrome	nn	28	SENT_253	[p19l1056t3363r1527b3452],
27	P450	NN	O	p450	nn	28	SENT_253	[p19l1565t3367r1762b3431],
28	enzymes	NNS	O	enzyme	prep_of	22	SENT_253	[p19l1803t3387r2150b3452],
29	and	CC	O	and	_	0	SENT_253	[p19l8t3464r156b3533],
30	drug	NN	O	drug	nn	31	SENT_253	[p19l205t3464r386b3554],
31	transporters	NNS	O	transporter	prep_of	22	SENT_253	[p19l432t3464r1145b3554],
32	.	.	O	.	_	0	SENT_253	[p19l432t3464r1145b3554],

1	“’	NN	O	“’	ccomp	9	SENT_254	[p19l432t3464r1145b3554],
2	”’	CD	NUMBER	”’	num	3	SENT_254	[p19l432t3464r1145b3554],
3	29	CD	NUMBER	29	dep	1	SENT_254	[p19l432t3464r1145b3554],
4	Consequently	RB	O	consequently	advmod	3	SENT_254	[p19l1194t3464r1760b3554],
5	,	,	O	,	_	0	SENT_254	[p19l1194t3464r1760b3554],
6	it	PRP	O	it	nsubjpass	9	SENT_254	[p19l1811t3468r1866b3533],
7	is	VBZ	O	be	auxpass	9	SENT_254	[p19l1912t3468r1974b3533],
8	not	RB	O	not	neg	9	SENT_254	[p19l2023t3475r2153b3533],
9	known	VBN	O	know	_	0	SENT_254	[p19l6t3566r284b3634],
10	if	IN	O	if	mark	14	SENT_254	[p19l325t3566r387b3634],
11	these	DT	O	these	det	12	SENT_254	[p19l420t3566r627b3634],
12	patients	NNS	O	patient	nsubj	14	SENT_254	[p19l670t3570r988b3656],
13	would	MD	O	would	aux	14	SENT_254	[p19l1030t3566r1289b3634],
14	achieve	VB	O	achieve	advcl	9	SENT_254	[p19l1331t3566r1634b3634],
15	similar	JJ	O	similar	amod	16	SENT_254	[p19l1679t3566r1959b3634],
16	bioavailability	NN	O	bioavailability	dobj	14	SENT_254	[p19l1996t3566r2151b3634, p19l8t3668r460b3757],
17	of	IN	O	of	_	0	SENT_254	[p19l491t3668r571b3736],
18	these	DT	O	these	det	19	SENT_254	[p19l592t3668r799b3736],
19	drugs	NNS	O	drug	prep_of	16	SENT_254	[p19l833t3668r1071b3757],
20	.	.	O	.	_	0	SENT_254	[p19l833t3668r1071b3757],

1	We	PRP	O	we	nsubj	2	SENT_255	[p19l1105t3673r1229b3736],
2	found	VBD	O	find	dep	52	SENT_255	[p19l1261t3668r1497b3736],
3	the	DT	O	the	det	6	SENT_255	[p19l1526t3668r1649b3736],
4	steady-state	JJ	O	steady-state	amod	6	SENT_255	[p19l1682t3668r2151b3757],
5	plasma	NN	O	plasma	nn	6	SENT_255	[p20l7t13r294b102],
6	AUC	NN	O	auc	dobj	2	SENT_255	[p20l326t16r520b81],
7	of	IN	O	of	_	0	SENT_255	[p20l557t13r637b81],
8	lamivudine	NN	O	lamivudine	prep_of	6	SENT_255	[p20l665t13r1127b81],
9	to	TO	O	to	aux	12	SENT_255	[p20l1162t23r1235b81],
10	be	VB	O	be	cop	12	SENT_255	[p20l1269t13r1360b81],
11	0.98	CD	NUMBER	0.98	number	12	SENT_255	[p20l1398t23r1561b81],
12	times	NNS	O	time	xcomp	2	SENT_255	[p20l1598t16r1813b81],
13	and	CC	O	and	_	0	SENT_255	[p20l1852t13r1999b81],
14	1.1	CD	NUMBER	1.1	number	15	SENT_255	[p20l2038t24r2147b81],
15	times	NNS	O	time	xcomp	2	SENT_255	[p20l6t119r224b184],
16	that	WDT	O	that	nsubj	17	SENT_255	[p20l289t116r446b184],
17	reported	VBD	O	report	rcmod	12	SENT_255	[p20l508t116r853b205],
18	for	IN	O	for	_	0	SENT_255	[p20l918t116r1028b184],
19	generic	JJ	O	generic	prep_for	17	SENT_255	[p20l1091t119r1383b205],
20	and	CC	O	and	_	0	SENT_255	[p20l1451t116r1600b184],
21	brand-name	JJ	O	brand-name	amod	23	SENT_255	[p20l1661t116r2151b184],
22	lamivudine	NN	O	lamivudine	nn	23	SENT_255	[p20l7t218r470b286],
23	(	NN	O	(	prep_for	17	SENT_255	[p20l523t218r1058b307],
24	respectively	RB	O	respectively	advmod	17	SENT_255	[p20l523t218r1058b307],
25	)	RB	O	)	advmod	17	SENT_255	[p20l523t218r1058b307],
26	in	IN	O	in	_	0	SENT_255	[p20l1110t221r1190b285],
27	HIV-infected	JJ	O	hiv-infected	amod	29	SENT_255	[p20l1236t218r1746b286],
28	Ugandan	JJ	MISC	ugandan	amod	29	SENT_255	[p20l1793t218r2153b307],
29	patients	NNS	O	patient	prep_in	17	SENT_255	[p20l7t323r331b409],
30	who	WP	O	who	nsubj	33	SENT_255	[p20l401t319r576b388],
31	were	VBD	O	be	cop	33	SENT_255	[p20l647t344r842b388],
32	given	VBN	O	give	amod	33	SENT_255	[p20l912t323r1135b409],
33	lamiVudine/stavudine	NN	O	lamivudine/stavudine	rcmod	29	SENT_255	[p20l1205t319r2151b388],
34	/	:	O	/	punct	37	SENT_255	[p20l1205t319r2151b388],
35	nevirapine	NN	O	nevirapine	nn	37	SENT_255	[p20l6t425r442b511],
36	(	CD	NUMBER	(	num	37	SENT_255	[p20l475t421r910b502],
37	Triomune	NN	O	triomune	dep	33	SENT_255	[p20l475t421r910b502],
38	,	,	O	,	_	0	SENT_255	[p20l475t421r910b502],
39	Cipla	NNP	ORGANIZATION	Cipla	dep	33	SENT_255	[p20l942t421r1174b511],
40	,	,	O	,	_	0	SENT_255	[p20l942t421r1174b511],
41	Goa	NNP	LOCATION	Goa	dep	33	SENT_255	[p20l1206t425r1379b500],
42	,	,	O	,	_	0	SENT_255	[p20l1206t425r1379b500],
43	India	NNP	LOCATION	India	nn	44	SENT_255	[p20l1409t421r1641b502],
44	)	NNP	O	)	conj_and	37	SENT_255	[p20l1409t421r1641b502],
45	and	CC	O	and	_	0	SENT_255	[p20l1674t421r1821b489],
46	the	DT	O	the	det	48	SENT_255	[p20l1847t421r1971b489],
47	patented	JJ	O	patented	amod	48	SENT_255	[p20l1999t431r2151b511, p20l8t523r228b591],
48	Versions	NNS	O	version	conj_and	37	SENT_255	[p20l253t527r586b591],
49	of	IN	O	of	_	0	SENT_255	[p20l616t523r695b591],
50	the	DT	O	the	det	51	SENT_255	[p20l713t523r836b591],
51	drugs	NNS	O	drug	prep_of	33	SENT_255	[p20l866t523r1083b612],
52	(	VBP	O	(	_	0	SENT_255	[p20l1115t523r1402b613],
53	Epivir	NNP	O	Epivir	nn	59	SENT_255	[p20l1115t523r1402b613],
54	,	,	O	,	_	0	SENT_255	[p20l1115t523r1402b613],
55	GlaXoSmithKline	NNP	ORGANIZATION	GlaXoSmithKline	appos	59	SENT_255	[p20l1431t523r2149b602],
56	,	,	O	,	_	0	SENT_255	[p20l1431t523r2149b602],
57	Research	NNP	O	Research	appos	59	SENT_255	[p20l6t625r366b693],
58	Triangle	NNP	O	Triangle	nn	59	SENT_255	[p20l396t625r720b714],
59	Park	NNP	O	Park	dobj	52	SENT_255	[p20l751t625r950b704],
60	,	,	O	,	_	0	SENT_255	[p20l751t625r950b704],
61	North	NNP	LOCATION	North	nn	75	SENT_255	[p20l984t625r1217b693],
62	Carolina	NNP	LOCATION	Carolina	nn	75	SENT_255	[p20l1248t625r1606b704],
63	;	:	O	;	_	0	SENT_255	[p20l1248t625r1606b704],
64	Zerit	NNP	O	Zerit	dep	75	SENT_255	[p20l1641t628r1853b704],
65	,	,	O	,	_	0	SENT_255	[p20l1641t628r1853b704],
66	Bristol	NNP	ORGANIZATION	Bristol	nn	68	SENT_255	[p20l1887t625r2152b693],
67	Myers	NNP	ORGANIZATION	Myers	nn	68	SENT_255	[p20l6t732r251b817],
68	Squibb	NNP	ORGANIZATION	Squibb	appos	64	SENT_255	[p20l320t728r619b817],
69	,	,	O	,	_	0	SENT_255	[p20l320t728r619b817],
70	Princeton	NNP	ORGANIZATION	Princeton	appos	64	SENT_255	[p20l685t731r1095b806],
71	,	,	O	,	_	0	SENT_255	[p20l685t731r1095b806],
72	New	NNP	LOCATION	New	nn	73	SENT_255	[p20l1162t732r1347b796],
73	Iersey	NNP	LOCATION	Iersey	appos	64	SENT_255	[p20l1407t732r1666b817],
74	;	:	O	;	_	0	SENT_255	[p20l1407t732r1666b817],
75	Viramune	NNP	O	Viramune	appos	59	SENT_255	[p20l1733t731r2149b807],
76	,	,	O	,	_	0	SENT_255	[p20l1733t731r2149b807],
77	Boehringer	NNP	PERSON	Boehringer	nn	78	SENT_255	[p20l7t830r448b919],
78	Ingelman	NNP	PERSON	Ingelman	nsubj	52	SENT_255	[p20l457t830r850b919],
79	,	,	O	,	_	0	SENT_255	[p20l457t830r850b919],
80	Columbus	NNP	LOCATION	Columbus	dep	83	SENT_255	[p20l864t830r1292b908],
81	,	,	O	,	_	0	SENT_255	[p20l864t830r1292b908],
82	Ohio	NNP	LOCATION	Ohio	dep	80	SENT_255	[p20l1307t830r1527b911],
83	)	NN	O	)	appos	78	SENT_255	[p20l1307t830r1527b911],
84	.	.	O	.	_	0	SENT_255	[p20l1539t886r1550b898],

1	“	NN	O	“	nsubj	11	SENT_256	[p20l1560t830r1611b864],
2	Furthermore	RB	O	furthermore	advmod	1	SENT_256	[p20l1624t830r2149b909],
3	,	,	O	,	_	0	SENT_256	[p20l1624t830r2149b909],
4	the	DT	O	the	det	7	SENT_256	[p20l6t931r129b1000],
5	steady-state	JJ	O	steady-state	amod	7	SENT_256	[p20l179t931r646b1021],
6	plasma	NN	O	plasma	nn	7	SENT_256	[p20l695t931r982b1021],
7	AUC	NN	O	auc	nsubj	11	SENT_256	[p20l1027t935r1220b1000],
8	of	IN	O	of	_	0	SENT_256	[p20l1270t932r1351b1000],
9	stavudine	NN	O	stavudine	prep_of	7	SENT_256	[p20l1392t931r1782b1000],
10	was	VBD	O	be	cop	11	SENT_256	[p20l1830t956r1983b1000],
11	1.5	CD	NUMBER	1.5	_	0	SENT_256	[p20l2038t942r2147b1000],

1	KWARA	NNP	LOCATION	KWARA	nn	3	SENT_257	[p20l936t1324r1089b1354],
2	ET	NNP	O	ET	nn	3	SENT_257	[p20l1104t1324r1160b1354],
3	AL	NNP	O	AL	_	0	SENT_257	[p20l1169t1324r1225b1354],

1	r	NN	O	r	nn	2	SENT_258	[p21l1855t410r1874b449],
2	E	NN	O	e	_	0	SENT_258	[p21l1801t398r1848b450],
3	r	NN	O	r	nn	4	SENT_258	[p21l1778t410r1796b449],
4	r	NN	O	r	dep	2	SENT_258	[p21l1755t410r1773b449],
5	a	DT	O	a	det	10	SENT_258	[p21l1713t410r1748b450],
6	C	NN	O	c	nn	10	SENT_258	[p21l1678t410r1709b450],
7	u	NN	O	u	nn	10	SENT_258	[p21l1688t493r1694b501],
8	n	NN	O	n	nn	10	SENT_258	[p21l1641t410r1672b449],
9	O	NN	O	o	nn	10	SENT_258	[p21l1600t410r1634b449],
10	N	NN	O	n	dep	2	SENT_258	[p21l1553t398r1593b449],

1	O	NN	O	o	_	0	SENT_259	[p21l281t800r315b851],
2	O	CD	PERCENT	o	num	3	SENT_259	[p21l281t977r315b1027],
3	%	NN	PERCENT	%	dep	1	SENT_259	[p21l258t3295r332b3346],
4	O	NN	O	o	nn	5	SENT_259	[p21l242t800r277b851],
5	O	NN	O	o	dep	3	SENT_259	[p21l242t977r277b1027],
6	O	NN	O	o	nn	7	SENT_259	[p21l242t1153r277b1205],
7	O	NN	O	o	dep	1	SENT_259	[p21l204t800r238b851],
8	8	CD	NUMBER	8	number	9	SENT_259	[p21l204t977r238b1027],
9	6	CD	NUMBER	6	dep	7	SENT_259	[p21l204t1153r238b1204],
10	4	CD	NUMBER	4	number	11	SENT_259	[p21l203t1330r238b1380],
11	1	CD	NUMBER	1	dep	1	SENT_259	[p21l169t800r188b850],
12	A	DT	O	a	det	15	SENT_259	[p21l77t177r137b240],
13	SE35	NN	O	se35	nn	15	SENT_259	[p21l69t405r137b656],
14	cozmbcmocoo	NN	O	cozmbcmocoo	nn	15	SENT_259	[p21l70t683r123b1138],
15	m	NN	O	m	dep	11	SENT_259	[p21l70t1161r123b1531],
16	:	:	O	:	_	0	SENT_259	[p21l70t1161r123b1531],
17	__	CD	NUMBER	__	dep	11	SENT_259	[p21l70t1161r123b1531],
18	u	NN	O	u	dep	17	SENT_259	[p21l70t1161r123b1531],
19	:	:	O	:	_	0	SENT_259	[p21l70t1161r123b1531],
20	>	JJR	O	>	amod	22	SENT_259	[p21l70t1161r123b1531],
21	o_o_N	NN	O	o_o_n	nn	22	SENT_259	[p21l70t1161r123b1531],
22	Amv	NN	O	amv	dep	11	SENT_259	[p21l99t2313r166b2705],
23	=	JJ	O	=	amod	22	SENT_259	[p21l99t2313r166b2705],
24	:	:	O	:	_	0	SENT_259	[p21l99t2313r166b2705],
25	_	CD	NUMBER	_	num	26	SENT_259	[p21l99t2313r166b2705],
26	E	NN	O	e	dep	11	SENT_259	[p21l99t2313r166b2705],
27	\	NN	O	\	dep	26	SENT_259	[p21l99t2313r166b2705],
28	.	.	O	.	_	0	SENT_259	[p21l99t2313r166b2705],

1	_	NN	O	_	_	0	SENT_260	[p21l99t2313r166b2705],
2	.	.	O	.	_	0	SENT_260	[p21l99t2313r166b2705],

1	.5	CD	NUMBER	.5	_	0	SENT_261	[p21l99t2313r166b2705],
2	"	``	O	"	punct	1	SENT_261	[p21l99t2728r152b2879],
3	.30	CD	NUMBER	.30	dep	1	SENT_261	[p21l99t2728r152b2879],
4	_	CD	NUMBER	_	num	5	SENT_261	[p21l100t2905r152b3273],
5	owN	NN	O	own	dep	1	SENT_261	[p21l100t2905r152b3273],
6	__	CD	NUMBER	__	num	7	SENT_261	[p21l100t2905r152b3273],
7	mE	NN	O	me	dep	5	SENT_261	[p21l100t2905r152b3273],
8	.	.	O	.	_	0	SENT_261	[p21l100t2905r152b3273],

1	_	NN	O	_	nn	2	SENT_262	[p21l100t2905r152b3273],
2	oz	NN	O	oz	_	0	SENT_262	[p21l100t2905r152b3273],

1	Figure	NNP	O	Figure	_	0	SENT_263	[p22l18t71r224b139],
2	3	CD	NUMBER	3	dep	1	SENT_263	[p22l252t76r302b122],
3	.	.	O	.	_	0	SENT_263	[p22l252t76r302b122],

1	Effect	NN	O	effect	dep	14	SENT_264	[p22l379t68r567b139],
2	of	IN	O	of	_	0	SENT_264	[p22l592t68r662b139],
3	UGT2B7	NN	O	ugt2b7	nn	6	SENT_264	[p22l676t71r1067b122],
4	*	CD	NUMBER	*	num	6	SENT_264	[p22l676t71r1067b122],
5	1c	NN	O	1c	nn	6	SENT_264	[p22l676t71r1067b122],
6	allele	NN	O	allele	prep_of	1	SENT_264	[p22l1098t68r1273b122],
7	on	IN	O	on	_	0	SENT_264	[p22l1300t87r1376b122],
8	[	NN	O	[	nn	9	SENT_264	[p22l1407t68r1504b133],
9	A	NN	O	a	prep_on	6	SENT_264	[p22l1407t68r1504b133],
10	]	CD	NUMBER	]	num	11	SENT_264	[p22l1407t68r1504b133],
11	mean	NN	O	mean	dep	14	SENT_264	[p22l1528t87r1707b122],
12	t	NN	O	t	nn	14	SENT_264	[p22l1734t77r1771b122],
13	SE	NN	O	se	nn	14	SENT_264	[p22l1800t71r1886b122],
14	zidovudine	NN	O	zidovudine	dep	21	SENT_264	[p22l1908t68r2150b122, p22l23t157r162b212],
15	concentration-time	JJ	O	concentration-time	amod	16	SENT_264	[p22l191t160r810b212],
16	proﬁle	NN	O	proﬁle	dep	14	SENT_264	[p22l833t157r1049b229],
17	and	CC	O	and	_	0	SENT_264	[p22l1078t157r1202b212],
18	{	NN	O	{	nn	19	SENT_264	[p22l1229t157r1319b222],
19	B	NN	O	b	conj_and	16	SENT_264	[p22l1229t157r1319b222],
20	}	CD	NUMBER	}	num	21	SENT_264	[p22l1229t157r1319b222],
21	body	NN	O	body	dep	22	SENT_264	[p22l1346t157r1508b229],
22	weight	NN	O	weight	dep	24	SENT_264	[p22l1532t157r2153b229],
23	—	CD	NUMBER	—	num	22	SENT_264	[p22l1532t157r2153b229],
24	normalized	VBD	O	normalize	_	0	SENT_264	[p22l1532t157r2153b229],
25	apparent	JJ	O	apparent	amod	27	SENT_264	[p22l21t253r316b317],
26	oral	JJ	O	oral	amod	27	SENT_264	[p22l339t246r466b300],
27	clearance	NN	O	clearance	dobj	24	SENT_264	[p22l489t246r815b300],
28	.	.	O	.	_	0	SENT_264	[p22l489t246r815b300],

1	Differences	NNS	O	difference	nsubjpass	10	SENT_265	[p22l841t246r1207b317],
2	between	IN	O	between	_	0	SENT_265	[p22l1232t246r1493b300],
3	carrier	NN	O	carrier	nn	8	SENT_265	[p22l1521t249r1737b300],
4	and	CC	O	and	_	0	SENT_265	[p22l1757t245r1882b300],
5	noncar	JJ	O	noncar	nn	8	SENT_265	[p22l1902t265r2150b300],
6	—	NN	O	—	nn	8	SENT_265	[p22l1902t265r2150b300],
7	rier	NN	O	rier	nn	8	SENT_265	[p22l18t337r135b388],
8	groups	NNS	O	group	prep_between	1	SENT_265	[p22l173t353r394b406],
9	were	VBD	O	be	auxpass	10	SENT_265	[p22l442t353r590b388],
10	evaluated	VBN	O	evaluate	_	0	SENT_265	[p22l636t334r955b388],
11	by	IN	O	by	_	0	SENT_265	[p22l999t334r1077b406],
12	Mann-Whitney	JJ	O	mann-whitney	amod	15	SENT_265	[p22l1114t334r1607b406],
13	rank	NN	O	rank	nn	15	SENT_265	[p22l1645t334r1797b388],
14	sum	NN	O	sum	nn	15	SENT_265	[p22l1839t353r1971b388],
15	test	NN	O	test	agent	10	SENT_265	[p22l2022t341r2147b388],
16	.	.	O	.	_	0	SENT_265	[p22l2022t341r2147b388],

1	Horizontal	JJ	O	horizontal	amod	2	SENT_266	[p22l18t422r369b477],
2	bars	NNS	O	bar	nsubj	3	SENT_266	[p22l393t422r528b477],
3	represent	VBP	O	represent	_	0	SENT_266	[p22l550t430r857b494],
4	median	NN	O	median	dobj	3	SENT_266	[p22l878t422r1139b477],
5	.	.	O	.	_	0	SENT_266	[p22l878t422r1139b477],

1	and	CC	O	and	dep	3	SENT_267	[p22l15t655r161b723],
2	1.3	CD	NUMBER	1.3	num	3	SENT_267	[p22l212t665r320b723],
3	times	NNS	O	time	_	0	SENT_267	[p22l370t659r583b723],
4	that	WDT	O	that	nsubj	5	SENT_267	[p22l631t655r784b723],
5	reported	VBD	O	report	rcmod	3	SENT_267	[p22l827t655r1165b745],
6	for	IN	O	for	_	0	SENT_267	[p22l1211t655r1319b723],
7	generic	JJ	O	generic	amod	11	SENT_267	[p22l1363t659r1649b744],
8	and	CC	O	and	_	0	SENT_267	[p22l1698t655r1845b723],
9	brandname	JJ	O	brandname	amod	11	SENT_267	[p22l1887t655r2148b723, p22l13t781r229b825],
10	stavudine	NN	O	stavudine	nn	11	SENT_267	[p22l251t757r637b825],
11	(	NN	O	(	prep_for	5	SENT_267	[p22l663t757r1192b846],
12	respectively	RB	O	respectively	advmod	5	SENT_267	[p22l663t757r1192b846],
13	)	RB	O	)	advmod	5	SENT_267	[p22l663t757r1192b846],
14	in	IN	O	in	_	0	SENT_267	[p22l1217t760r1295b824],
15	the	DT	O	the	det	17	SENT_267	[p22l1313t757r1435b825],
16	above-mentioned	JJ	O	above-mentioned	amod	17	SENT_267	[p22l1457t757r2149b825],
17	study	NN	O	study	prep_in	5	SENT_267	[p22l16t860r309b949],
18	.	.	O	.	_	0	SENT_267	[p22l16t860r309b949],

1	“	NN	O	“	nsubj	5	SENT_268	[p22l16t860r309b949],
2	We	PRP	O	we	nsubj	5	SENT_268	[p22l340t864r464b928],
3	were	VBD	O	be	cop	5	SENT_268	[p22l494t884r686b928],
4	not	RB	O	not	neg	5	SENT_268	[p22l717t870r847b928],
5	able	JJ	O	able	_	0	SENT_268	[p22l877t860r1036b928],
6	to	TO	O	to	aux	7	SENT_268	[p22l1067t870r1140b928],
7	identify	VB	O	identify	xcomp	5	SENT_268	[p22l1173t860r1486b949],
8	published	VBN	O	publish	amod	9	SENT_268	[p22l1515t860r1918b949],
9	studies	NNS	O	study	dobj	7	SENT_268	[p22l1950t860r2148b928, p22l14t965r120b1030],
10	that	WDT	O	that	nsubj	12	SENT_268	[p22l147t961r301b1030],
11	have	VBP	O	have	aux	12	SENT_268	[p22l325t961r512b1030],
12	evaluated	VBN	O	evaluate	rcmod	9	SENT_268	[p22l540t961r926b1030],
13	zidovudine	NN	O	zidovudine	nn	14	SENT_268	[p22l952t961r1406b1030],
14	pharmacokinetics	NNS	O	pharmacokinetic	dobj	12	SENT_268	[p22l1433t962r2147b1051],
15	in	IN	O	in	_	0	SENT_268	[p22l14t1066r94b1129],
16	HIV-infected	JJ	MISC	hiv-infected	amod	18	SENT_268	[p22l121t1062r629b1130],
17	black	JJ	O	black	amod	18	SENT_268	[p22l654t1062r871b1130],
18	Africans	NNS	MISC	african	prep_in	12	SENT_268	[p22l896t1062r1254b1130],
19	.	.	O	.	_	0	SENT_268	[p22l896t1062r1254b1130],

1	However	RB	O	however	advmod	10	SENT_269	[p22l1286t1067r1662b1141],
2	,	,	O	,	_	0	SENT_269	[p22l1286t1067r1662b1141],
3	the	DT	O	the	det	5	SENT_269	[p22l1693t1062r1815b1130],
4	zidovudine	NN	O	zidovudine	nn	5	SENT_269	[p22l1845t1062r2148b1130, p22l17t1164r190b1232],
5	AUC	NN	O	auc	nsubj	10	SENT_269	[p22l217t1168r409b1232],
6	in	IN	O	in	_	0	SENT_269	[p22l438t1168r517b1232],
7	our	PRP$	O	we	poss	8	SENT_269	[p22l546t1188r678b1232],
8	patients	NNS	O	patient	prep_in	5	SENT_269	[p22l704t1168r1020b1254],
9	was	VBD	O	be	cop	10	SENT_269	[p22l1048t1188r1200b1232],
10	0.78	CD	NUMBER	0.78	_	0	SENT_269	[p22l1231t1174r1394b1232],
11	and	CC	O	and	_	0	SENT_269	[p22l1424t1164r1571b1232],
12	0.84	CD	NUMBER	0.84	conj_and	10	SENT_269	[p22l1601t1174r1763b1232],
13	of	IN	O	of	_	0	SENT_269	[p22l1795t1164r1874b1232],
14	values	NNS	O	value	prep_of	10	SENT_269	[p22l1893t1164r2147b1232],
15	reported	VBN	O	report	partmod	14	SENT_269	[p22l13t1266r353b1356],
16	for	IN	O	for	_	0	SENT_269	[p22l416t1266r524b1334],
17	generic	JJ	O	generic	prep_for	15	SENT_269	[p22l586t1270r874b1355],
18	and	CC	O	and	_	0	SENT_269	[p22l940t1266r1087b1334],
19	brand-name	JJ	O	brand-name	amod	21	SENT_269	[p22l1146t1266r1629b1334],
20	zidovudine	NN	O	zidovudine	nn	21	SENT_269	[p22l1693t1266r2148b1334],
21	(	NN	O	(	prep_for	15	SENT_269	[p22l19t1367r560b1456],
22	respectively	RB	O	respectively	advmod	15	SENT_269	[p22l19t1367r560b1456],
23	)	RB	O	)	advmod	15	SENT_269	[p22l19t1367r560b1456],
24	in	IN	O	in	_	0	SENT_269	[p22l649t1370r728b1434],
25	HIV-negative	JJ	O	hiv-negative	amod	27	SENT_269	[p22l811t1370r1335b1456],
26	Indian	JJ	MISC	indian	amod	27	SENT_269	[p22l1420t1367r1684b1435],
27	women	NNS	O	woman	prep_in	15	SENT_269	[p22l1766t1366r2149b1435],
28	.	.	O	.	_	0	SENT_269	[p22l1766t1366r2149b1435],

1	”	NN	O	”	_	0	SENT_270	[p22l1766t1366r2149b1435],
2	These	DT	O	these	det	3	SENT_270	[p22l14t1471r251b1539],
3	comparisons	NNS	O	comparison	nsubj	7	SENT_270	[p22l301t1474r813b1560],
4	to	TO	O	to	_	0	SENT_270	[p22l862t1481r935b1539],
5	published	VBN	O	publish	amod	6	SENT_270	[p22l985t1471r1392b1560],
6	data	NNS	O	datum	prep_to	3	SENT_270	[p22l1441t1471r1609b1539],
7	suggest	VBP	O	suggest	rcmod	1	SENT_270	[p22l1657t1481r1949b1560],
8	that	IN	O	that	dep	12	SENT_270	[p22l1994t1471r2150b1539],
9	lamivudine	NN	O	lamivudine	nn	12	SENT_270	[p22l14t1571r479b1639],
10	and	CC	O	and	_	0	SENT_270	[p22l545t1572r693b1639],
11	stavudine	NN	O	stavudine	nn	12	SENT_270	[p22l759t1571r1152b1639],
12	concentrations	NNS	O	concentration	dep	1	SENT_270	[p22l1219t1575r1815b1639],
13	in	IN	O	in	_	0	SENT_270	[p22l1881t1575r1961b1638],
14	the	DT	O	the	prep_in	12	SENT_270	[p22l2024t1572r2148b1639],

1	1086	CD	DATE	1086	_	0	SENT_271	[p22l17t1800r207b1866],
2	-	:	O	-	_	0	SENT_271	[p22l270t1826r300b1855],
3	]	CD	NUMBER	]	num	5	SENT_271	[p22l361t1804r571b1880],
4	Clin	NNP	O	Clin	nn	5	SENT_271	[p22l361t1804r571b1880],
5	Pharmacol	NNP	O	Pharmacol	dep	1	SENT_271	[p22l597t1804r1000b1865],
6	2009	CD	DATE	2009	num	5	SENT_271	[p22l1030t1813r1719b1876],
7	;	:	O	;	_	0	SENT_271	[p22l1030t1813r1719b1876],
8	419:1079	CD	DURATION	419:1079	num	11	SENT_271	[p22l1030t1813r1719b1876],
9	-1090	CD	DURATION	-1090	num	11	SENT_271	[p22l1030t1813r1719b1876],
10	HIV/TB-coinfected	JJ	O	hiv/tb-coinfected	amod	11	SENT_271	[p22l9t1899r773b1967],
11	patients	NNS	O	patient	nsubj	19	SENT_271	[p22l797t1903r1113b1989],
12	in	IN	O	in	_	0	SENT_271	[p22l1140t1903r1219b1967],
13	the	DT	O	the	det	15	SENT_271	[p22l1241t1899r1365b1967],
14	present	JJ	DATE	present	amod	15	SENT_271	[p22l1389t1910r1685b1989],
15	study	NN	O	study	prep_in	11	SENT_271	[p22l1710t1899r1930b1989],
16	were	VBD	O	be	cop	19	SENT_271	[p22l1952t1923r2144b1967],
17	at	IN	O	at	advmod	19	SENT_271	[p22l11t2011r80b2069],
18	least	JJS	O	least	pobj	17	SENT_271	[p22l109t2001r292b2069],
19	similar	JJ	O	similar	dep	5	SENT_271	[p22l322t2001r601b2069],
20	to	TO	O	to	_	0	SENT_271	[p22l628t2011r702b2069],
21	(	CD	NUMBER	(	prep_to	19	SENT_271	[p22l738t2001r843b2082],
22	or	CC	O	or	_	0	SENT_271	[p22l738t2001r843b2082],
23	perhaps	RB	O	perhaps	advmod	24	SENT_271	[p22l872t2001r1189b2091],
24	slightly	RB	O	slightly	conj_or	19	SENT_271	[p22l1223t2001r1520b2090],
25	higher	JJR	O	higher	dep	26	SENT_271	[p22l1549t2001r1806b2090],
26	than	IN	O	than	advmod	19	SENT_271	[p22l1834t2001r2033b2080],
27	,	,	O	,	_	0	SENT_271	[p22l1834t2001r2033b2080],
28	in	IN	O	in	_	0	SENT_271	[p22l2066t2005r2146b2069],
29	the	DT	O	the	det	30	SENT_271	[p22l9t2103r131b2171],
30	case	NN	O	case	prep_in	19	SENT_271	[p22l176t2127r340b2171],
31	of	IN	O	of	_	0	SENT_271	[p22l385t2103r465b2171],
32	stavudine	NN	O	stavudine	prep_of	30	SENT_271	[p22l500t2103r916b2184],
33	)	CD	NUMBER	)	num	35	SENT_271	[p22l500t2103r916b2184],
34	other	JJ	O	other	amod	35	SENT_271	[p22l963t2103r1169b2171],
35	patients	NNS	O	patient	dep	5	SENT_271	[p22l1209t2106r1525b2192],
36	who	WP	O	who	nsubj	39	SENT_271	[p22l1568t2103r1740b2171],
37	were	VBD	O	be	aux	39	SENT_271	[p22l1782t2127r1974b2171],
38	not	RB	O	not	neg	39	SENT_271	[p22l2016t2113r2146b2171],
39	taking	VBG	O	take	rcmod	35	SENT_271	[p22l9t2206r255b2295],
40	TB	NN	O	tb	nn	41	SENT_271	[p22l285t2210r395b2273],
41	medications	NNS	O	medication	dobj	39	SENT_271	[p22l428t2206r939b2274],
42	.	.	O	.	_	0	SENT_271	[p22l428t2206r939b2274],

1	The	DT	O	the	det	9	SENT_272	[p22l974t2206r1126b2274],
2	14	CD	PERCENT	14	num	6	SENT_272	[p22l1162t2206r1332b2279],
3	%	NN	PERCENT	%	nn	6	SENT_272	[p22l1162t2206r1332b2279],
4	to	TO	O	to	dep	6	SENT_272	[p22l1369t2216r1442b2274],
5	21	CD	PERCENT	21	num	6	SENT_272	[p22l1478t2206r1649b2279],
6	%	NN	PERCENT	%	npadvmod	7	SENT_272	[p22l1478t2206r1649b2279],
7	lower	JJR	O	lower	amod	9	SENT_272	[p22l1688t2206r1915b2274],
8	zidovudine	NN	O	zidovudine	nn	9	SENT_272	[p22l1944t2206r2144b2274, p22l8t2308r289b2376],
9	AUC	NN	O	auc	nsubj	14	SENT_272	[p22l316t2311r509b2376],
10	in	IN	O	in	_	0	SENT_272	[p22l538t2311r617b2375],
11	our	PRP$	O	we	poss	12	SENT_272	[p22l645t2332r777b2376],
12	patients	NNS	O	patient	prep_in	9	SENT_272	[p22l804t2311r1120b2397],
13	is	VBZ	O	be	cop	14	SENT_272	[p22l1150t2311r1212b2376],
14	consistent	JJ	O	consistent	_	0	SENT_272	[p22l1243t2311r1649b2376],
15	with	IN	O	with	_	0	SENT_272	[p22l1674t2308r1858b2376],
16	induction	NN	O	induction	prep_with	14	SENT_272	[p22l1885t2308r2144b2376, p22l9t2413r168b2478],
17	of	IN	O	of	_	0	SENT_272	[p22l197t2410r277b2478],
18	zidovudine	NN	O	zidovudine	nn	19	SENT_272	[p22l298t2409r752b2478],
19	clearance	NN	O	clearance	prep_of	16	SENT_272	[p22l783t2409r1157b2478],
20	by	IN	O	by	_	0	SENT_272	[p22l1184t2409r1281b2499],
21	rifampin	NN	O	rifampin	prep_by	14	SENT_272	[p22l1308t2410r1678b2499],
22	,	,	O	,	_	0	SENT_272	[p22l1308t2410r1678b2499],
23	although	IN	O	although	mark	34	SENT_272	[p22l1710t2409r2063b2499],
24	it	PRP	O	it	nsubj	34	SENT_272	[p22l2091t2413r2146b2478],
25	is	VBZ	O	be	cop	34	SENT_272	[p22l10t2515r72b2579],
26	lower	JJR	O	lower	dep	27	SENT_272	[p22l111t2511r338b2579],
27	than	IN	O	than	advmod	34	SENT_272	[p22l372t2511r550b2579],
28	the	DT	O	the	det	34	SENT_272	[p22l585t2511r708b2579],
29	47	CD	PERCENT	47	number	33	SENT_272	[p22l746t2511r920b2585],
30	%	NN	PERCENT	%	dep	33	SENT_272	[p22l746t2511r920b2585],
31	to	TO	O	to	dep	33	SENT_272	[p22l964t2521r1037b2579],
32	50	CD	PERCENT	50	number	33	SENT_272	[p22l1079t2511r1250b2585],
33	%	NN	PERCENT	%	num	34	SENT_272	[p22l1079t2511r1250b2585],
34	reduction	NN	O	reduction	advcl	14	SENT_272	[p22l1293t2511r1682b2579],
35	previously	RB	DATE	previously	advmod	36	SENT_272	[p22l1718t2511r2146b2601],
36	reported	VBN	O	report	amod	34	SENT_272	[p22l8t2613r445b2703],
37	.	.	O	.	_	0	SENT_272	[p22l8t2613r445b2703],

1	“	NN	O	“	nsubj	16	SENT_273	[p22l8t2613r445b2703],
2	The	DT	O	the	det	5	SENT_273	[p22l481t2613r632b2681],
3	apparent	JJ	O	apparent	amod	4	SENT_273	[p22l670t2623r1025b2703],
4	minimal	JJ	O	minimal	amod	5	SENT_273	[p22l1058t2613r1398b2681],
5	effect	NN	O	effect	dep	1	SENT_273	[p22l1435t2613r1652b2681],
6	of	IN	O	of	_	0	SENT_273	[p22l1687t2613r1767b2681],
7	rifampin	NN	O	rifampin	prep_of	1	SENT_273	[p22l1794t2613r2145b2703],
8	on	IN	O	on	_	0	SENT_273	[p22l12t2739r109b2783],
9	zidovudine	NN	O	zidovudine	nn	10	SENT_273	[p22l155t2715r611b2783],
10	AUC	NN	O	auc	prep_on	7	SENT_273	[p22l657t2718r850b2783],
11	in	IN	O	in	_	0	SENT_273	[p22l898t2718r977b2782],
12	our	PRP$	O	we	poss	13	SENT_273	[p22l1024t2739r1156b2783],
13	study	NN	O	study	prep_in	10	SENT_273	[p22l1203t2715r1424b2804],
14	could	MD	O	could	aux	16	SENT_273	[p22l1470t2715r1696b2783],
15	be	VB	O	be	cop	16	SENT_273	[p22l1738t2715r1830b2783],
16	due	JJ	O	due	_	0	SENT_273	[p22l1879t2715r2024b2783],
17	to	TO	O	to	_	0	SENT_273	[p22l2070t2725r2143b2783],
18	population	NN	O	population	nn	19	SENT_273	[p22l10t2818r453b2907],
19	differences	NNS	O	difference	prep_to	16	SENT_273	[p22l487t2818r925b2886],
20	between	IN	O	between	_	0	SENT_273	[p22l955t2818r1294b2886],
21	our	PRP$	O	we	poss	22	SENT_273	[p22l1327t2842r1460b2886],
22	patients	NNS	O	patient	prep_between	19	SENT_273	[p22l1490t2821r1808b2907],
23	and	CC	O	and	_	0	SENT_273	[p22l1843t2818r1990b2886],
24	the	DT	O	the	det	26	SENT_273	[p22l2020t2818r2144b2886],
25	historical	JJ	O	historical	amod	26	SENT_273	[p22l9t2918r388b2986],
26	controls	NNS	O	control	conj_and	16	SENT_273	[p22l442t2918r763b2986],
27	and	CC	O	and	_	0	SENT_273	[p22l819t2918r999b2986],
28	/	:	O	/	punct	29	SENT_273	[p22l819t2918r999b2986],
29	or	CC	O	or	dep	16	SENT_273	[p22l1006t2942r1085b2986],
30	the	DT	O	the	det	31	SENT_273	[p22l1135t2918r1258b2986],
31	effect	NN	O	effect	dep	29	SENT_273	[p22l1313t2919r1529b2986],
32	of	IN	O	of	dep	29	SENT_273	[p22l1582t2919r1662b2986],
33	concurrent	JJ	O	concurrent	amod	34	SENT_273	[p22l1708t2929r2146b2986],
34	medications	NNS	O	medication	pobj	32	SENT_273	[p22l9t3020r499b3089],
35	such	JJ	O	such	mwe	36	SENT_273	[p22l526t3020r712b3089],
36	as	IN	O	as	conj_and	16	SENT_273	[p22l735t3045r811b3089],
37	trimethoprim/sulfamethoxazole	NN	O	trimethoprim/sulfamethoxazole	pobj	36	SENT_273	[p22l835t3020r2139b3110],
38	.	.	O	.	_	0	SENT_273	[p22l835t3020r2139b3110],

1	Trimethoprim	NN	MISC	trimethoprim	conj_or	1	SENT_274	[p22l10t3122r571b3212],
2	with	IN	O	with	_	0	SENT_274	[p22l602t3122r785b3190],
3	or	CC	O	or	_	0	SENT_274	[p22l819t3146r897b3190],
4	without	IN	O	without	_	0	SENT_274	[p22l927t3122r1243b3190],
5	sulfamethoxazole	NN	O	sulfamethoxazole	prep_without	1	SENT_274	[p22l1276t3122r1979b3190],
6	has	VBZ	O	have	aux	8	SENT_274	[p22l2011t3122r2143b3190],
7	been	VBN	O	be	auxpass	8	SENT_274	[p22l7t3223r197b3290],
8	shown	VBN	O	show	_	0	SENT_274	[p22l215t3223r479b3290],
9	to	TO	O	to	aux	10	SENT_274	[p22l494t3233r567b3290],
10	decrease	VB	O	decrease	xcomp	8	SENT_274	[p22l588t3223r928b3290],
11	zidovudine	NN	O	zidovudine	nn	13	SENT_274	[p22l946t3223r1400b3290],
12	renal	JJ	O	renal	amod	13	SENT_274	[p22l1416t3223r1618b3290],
13	clearance3	NN	O	clearance3	dobj	10	SENT_274	[p22l1637t3223r2143b3290],
14	°	CD	NUMBER	°	num	15	SENT_274	[p22l1637t3223r2143b3290],
15	’31	CD	NUMBER	’31	dep	13	SENT_274	[p22l1637t3223r2143b3290],
16	and	CC	O	and	_	0	SENT_274	[p22l11t3325r158b3393],
17	could	MD	O	could	aux	21	SENT_274	[p22l214t3325r439b3393],
18	have	VB	O	have	aux	21	SENT_274	[p22l493t3325r680b3393],
19	in	IN	O	in	_	0	SENT_274	[p22l737t3328r816b3392],
20	part	NN	O	part	prep_in	21	SENT_274	[p22l870t3335r1029b3414],
21	minimized	VBD	O	minimize	conj_and	8	SENT_274	[p22l1082t3325r1520b3393],
22	the	DT	O	the	det	24	SENT_274	[p22l1573t3325r1696b3393],
23	induction	NN	O	induction	nn	24	SENT_274	[p22l1753t3325r2146b3393],
24	effect	NN	O	effect	dobj	21	SENT_274	[p22l11t3428r227b3496],
25	of	IN	O	of	_	0	SENT_274	[p22l258t3428r338b3496],
26	rifampin	NN	O	rifampin	prep_of	24	SENT_274	[p22l360t3428r710b3517],
27	in	IN	O	in	_	0	SENT_274	[p22l741t3431r819b3495],
28	our	PRP$	O	we	poss	30	SENT_274	[p22l852t3452r984b3496],
29	study	NN	O	study	nn	30	SENT_274	[p22l1016t3428r1235b3517],
30	population	NN	O	population	prep_in	21	SENT_274	[p22l1265t3428r1725b3517],
31	.	.	O	.	_	0	SENT_274	[p22l1265t3428r1725b3517],

1	We	PRP	O	we	nsubj	2	SENT_275	[p22l115t3534r240b3598],
2	observed	VBD	O	observe	_	0	SENT_275	[p22l274t3530r634b3598],
3	high	JJ	O	high	amod	4	SENT_275	[p22l664t3529r845b3619],
4	variability	NN	O	variability	dobj	2	SENT_275	[p22l873t3529r1292b3619],
5	in	IN	O	in	_	0	SENT_275	[p22l1323t3533r1402b3597],
6	zidovudine	NN	O	zidovudine	nn	8	SENT_275	[p22l1433t3529r1892b3598],
7	clearance	NN	O	clearance	nn	8	SENT_275	[p22l1926t3529r2144b3598, p22l11t3654r192b3698],
8	(	NN	O	(	prep_in	2	SENT_275	[p22l233t3631r433b3711],
9	over	IN	O	over	_	0	SENT_275	[p22l233t3631r433b3711],
10	100	CD	PERCENT	100	number	11	SENT_275	[p22l471t3630r692b3704],
11	%	NN	PERCENT	%	amod	12	SENT_275	[p22l471t3630r692b3704],
12	coefficient	NN	O	coefficient	prep_over	2	SENT_275	[p22l736t3631r1163b3698],
13	of	IN	O	of	_	0	SENT_275	[p22l1198t3631r1278b3698],
14	variation	NN	O	variation	nn	15	SENT_275	[p22l1305t3631r1693b3711],
15	)	NN	O	)	prep_of	12	SENT_275	[p22l1305t3631r1693b3711],
16	relative	JJ	O	relative	advmod	15	SENT_275	[p22l1731t3630r2034b3698],
17	to	TO	O	to	_	0	SENT_275	[p22l2069t3641r2143b3698],
18	the	DT	O	the	det	19	SENT_275	[p22l9t3731r132b3799],
19	clearance	NN	O	clearance	prep_to	16	SENT_275	[p22l196t3731r575b3799],
20	of	IN	O	of	_	0	SENT_275	[p22l639t3731r719b3799],
21	stavudine	NN	O	stavudine	prep_of	19	SENT_275	[p22l774t3731r1168b3799],
22	and	CC	O	and	_	0	SENT_275	[p22l1231t3731r1379b3799],
23	lamivudine	NN	O	lamivudine	prep_of	19	SENT_275	[p22l1440t3731r1925b3799],
24	.	.	O	.	_	0	SENT_275	[p22l1440t3731r1925b3799],

1	The	DT	O	the	det	2	SENT_276	[p22l1991t3731r2144b3799],
2	mechanism	NN	O	mechanism	nsubjpass	12	SENT_276	[p23l9t24r476b92],
3	underlying	VBG	O	underlie	partmod	2	SENT_276	[p23l508t24r955b113],
4	this	DT	O	this	det	6	SENT_276	[p23l988t24r1136b92],
5	high	JJ	O	high	amod	6	SENT_276	[p23l1170t24r1351b113],
6	variability	NN	O	variability	dobj	3	SENT_276	[p23l1382t24r1800b113],
7	of	IN	O	of	_	0	SENT_276	[p23l1835t24r1916b92],
8	zidovudine	NN	O	zidovudine	prep_of	6	SENT_276	[p23l1942t24r2144b92, p23l8t126r293b194],
9	is	VBZ	O	be	auxpass	12	SENT_276	[p23l354t129r416b194],
10	not	RB	O	not	neg	12	SENT_276	[p23l477t136r608b194],
11	well	RB	O	well	advmod	12	SENT_276	[p23l665t126r840b194],
12	understood	VBN	O	understand	_	0	SENT_276	[p23l899t126r1364b194],
13	but	CC	O	but	_	0	SENT_276	[p23l1419t126r1554b194],
14	may	MD	O	may	aux	15	SENT_276	[p23l1611t150r1782b215],
15	involve	VB	O	involve	conj_but	12	SENT_276	[p23l1841t126r2144b194],
16	polymorphisms	NNS	O	polymorphism	dobj	15	SENT_276	[p23l10t229r651b318],
17	in	IN	O	in	_	0	SENT_276	[p23l678t232r757b296],
18	genes	NNS	O	gene	nn	20	SENT_276	[p23l779t253r1003b318],
19	encoding	VBG	O	encode	amod	20	SENT_276	[p23l1031t229r1403b318],
20	proteins	NNS	O	protein	prep_in	15	SENT_276	[p23l1427t232r1759b318],
21	involved	VBN	O	involve	partmod	20	SENT_276	[p23l1786t229r2145b297],
22	in	IN	O	in	_	0	SENT_276	[p23l10t334r90b398],
23	zidovudine	NN	O	zidovudine	nn	24	SENT_276	[p23l142t330r604b399],
24	disposition	NN	O	disposition	prep_in	21	SENT_276	[p23l660t330r1139b420],
25	,	,	O	,	_	0	SENT_276	[p23l660t330r1139b420],
26	including	VBG	O	include	_	0	SENT_276	[p23l1195t330r1588b420],
27	UGTZB7	NN	O	ugtzb7	prep_including	15	SENT_276	[p23l1650t334r2008b399],
28	.	.	O	.	_	0	SENT_276	[p23l1650t334r2008b399],

1	In	IN	O	in	_	0	SENT_277	[p23l2064t335r2145b398],
2	previous	JJ	O	previous	amod	3	SENT_277	[p23l10t436r361b522],
3	work	NN	O	work	prep_in	11	SENT_277	[p23l423t432r630b501],
4	using	VBG	O	use	partmod	3	SENT_277	[p23l687t436r907b522],
5	our	PRP$	O	we	poss	8	SENT_277	[p23l970t457r1103b501],
6	human	JJ	O	human	amod	8	SENT_277	[p23l1162t432r1446b501],
7	liver	NN	O	liver	nn	8	SENT_277	[p23l1507t432r1691b501],
8	bank	NN	O	bank	dobj	4	SENT_277	[p23l1748t432r1966b511],
9	,	,	O	,	_	0	SENT_277	[p23l1748t432r1966b511],
10	We	PRP	O	we	nsubj	11	SENT_277	[p23l2029t457r2144b501],
11	determined	VBD	O	determine	_	0	SENT_277	[p23l12t534r476b602],
12	that	IN	O	that	complm	31	SENT_277	[p23l503t534r659b602],
13	the	DT	O	the	det	16	SENT_277	[p23l685t534r809b602],
14	most	RBS	O	most	advmod	16	SENT_277	[p23l838t544r1034b602],
15	common	JJ	O	common	amod	16	SENT_277	[p23l1063t558r1414b602],
16	UGTZB7	NN	O	ugtzb7	nsubjpass	31	SENT_277	[p23l1441t538r1786b602],
17	nonsynonymous	JJ	O	nonsynonymous	amod	18	SENT_277	[p23l1817t558r2143b624, p23l12t660r379b725],
18	SNP	NN	O	snp	dep	16	SENT_277	[p23l419t640r588b704],
19	(	CD	NUMBER	(	num	21	SENT_277	[p23l628t636r1048b717],
20	c.	NN	O	c.	nn	21	SENT_277	[p23l628t636r1048b717],
21	802C	NN	O	802c	dep	16	SENT_277	[p23l628t636r1048b717],
22	>	JJR	O	>	amod	23	SENT_277	[p23l628t636r1048b717],
23	T	NN	O	t	dep	21	SENT_277	[p23l628t636r1048b717],
24	,	,	O	,	_	0	SENT_277	[p23l628t636r1048b717],
25	UGT2B7	NN	O	ugt2b7	nn	26	SENT_277	[p23l1096t636r1556b717],
26	*	NN	O	*	appos	23	SENT_277	[p23l1096t636r1556b717],
27	2	CD	NUMBER	2	num	28	SENT_277	[p23l1096t636r1556b717],
28	)	NN	O	)	dep	26	SENT_277	[p23l1096t636r1556b717],
29	was	VBD	O	be	auxpass	31	SENT_277	[p23l1593t660r1747b704],
30	not	RB	O	not	neg	31	SENT_277	[p23l1782t646r1913b704],
31	associated	VBN	O	associate	ccomp	11	SENT_277	[p23l1947t660r2144b704, p23l11t738r253b806],
32	with	IN	O	with	_	0	SENT_277	[p23l299t738r484b806],
33	altered	JJ	O	altered	amod	35	SENT_277	[p23l532t738r809b806],
34	zidovudine	NN	O	zidovudine	nn	35	SENT_277	[p23l856t738r1315b806],
35	glucuronidation	NN	O	glucuronidation	prep_with	31	SENT_277	[p23l1363t738r2018b827],
36	or	CC	O	or	_	0	SENT_277	[p23l2067t762r2146b806],
37	UGTZB7	NN	O	ugtzb7	nn	39	SENT_277	[p23l10t844r355b909],
38	protein	NN	O	protein	nn	39	SENT_277	[p23l399t844r692b930],
39	expression	NN	O	expression	conj_or	35	SENT_277	[p23l735t840r1252b930],
40	.	.	O	.	_	0	SENT_277	[p23l735t840r1252b930],

1	”	NN	O	”	tmod	56	SENT_278	[p23l735t840r1252b930],
2	These	DT	O	these	det	3	SENT_278	[p23l1297t841r1534b909],
3	findings	NNS	O	finding	nsubjpass	6	SENT_278	[p23l1578t841r1907b930],
4	were	VBD	O	be	auxpass	6	SENT_278	[p23l1950t865r2144b909],
5	independently	RB	O	independently	advmod	6	SENT_278	[p23l10t942r605b1032],
6	confirmed	VBN	O	confirm	rcmod	1	SENT_278	[p23l642t942r1058b1011],
7	in	IN	O	in	_	0	SENT_278	[p23l1094t946r1173b1010],
8	a	DT	O	a	det	11	SENT_278	[p23l1210t967r1251b1011],
9	more	RBR	O	more	advmod	10	SENT_278	[p23l1285t967r1488b1011],
10	recent	JJ	O	recent	amod	11	SENT_278	[p23l1525t953r1775b1011],
11	study	NN	O	study	prep_in	6	SENT_278	[p23l1812t942r2034b1032],
12	of	IN	O	of	_	0	SENT_278	[p23l2072t943r2152b1011],
13	human	JJ	O	human	amod	16	SENT_278	[p23l9t1044r293b1113],
14	liver	NN	O	liver	nn	16	SENT_278	[p23l363t1044r547b1113],
15	bank	NN	O	bank	nn	16	SENT_278	[p23l613t1044r813b1113],
16	samples	NNS	O	sample	prep_of	11	SENT_278	[p23l883t1044r1206b1134],
17	by	IN	O	by	_	0	SENT_278	[p23l1275t1044r1373b1134],
18	Peterkin	NNP	PERSON	Peterkin	agent	6	SENT_278	[p23l1442t1044r1781b1113],
19	et	FW	O	et	nn	20	SENT_278	[p23l1852t1055r1921b1113],
20	al.	FW	O	al.	nsubj	42	SENT_278	[p23l1992t1044r2143b1113],
21	32	CD	NUMBER	32	num	24	SENT_278	[p23l1992t1044r2143b1113],
22	UGTZB7	NN	O	ugtzb7	nn	24	SENT_278	[p23l20t1150r361b1214],
23	gene	NN	O	gene	nn	24	SENT_278	[p23l402t1170r585b1236],
24	resequencing	NN	O	resequencing	nsubj	29	SENT_278	[p23l633t1150r1170b1236],
25	by	IN	O	by	_	0	SENT_278	[p23l1214t1146r1312b1236],
26	several	JJ	O	several	amod	27	SENT_278	[p23l1361t1146r1642b1214],
27	groups	NNS	O	group	prep_by	24	SENT_278	[p23l1689t1170r1961b1236],
28	has	VBZ	O	have	aux	29	SENT_278	[p23l2010t1146r2142b1214],
29	identified	VBN	O	identify	rcmod	20	SENT_278	[p23l10t1248r406b1316],
30	other	JJ	O	other	amod	31	SENT_278	[p23l456t1248r663b1316],
31	polymorphisms	NNS	O	polymorphism	dobj	29	SENT_278	[p23l710t1248r1370b1338],
32	,	,	O	,	_	0	SENT_278	[p23l710t1248r1370b1338],
33	many	JJ	O	many	appos	31	SENT_278	[p23l1420t1272r1645b1337],
34	of	IN	O	of	_	0	SENT_278	[p23l1694t1248r1774b1316],
35	them	PRP	O	they	prep_of	33	SENT_278	[p23l1813t1248r2018b1316],
36	in	IN	O	in	_	0	SENT_278	[p23l2066t1252r2146b1316],
37	linkage	NN	O	linkage	nn	38	SENT_278	[p23l10t1350r301b1439],
38	disequilibrium	NN	O	disequilibrium	prep_in	29	SENT_278	[p23l366t1350r969b1439],
39	within	IN	O	within	_	0	SENT_278	[p23l1029t1350r1298b1418],
40	discrete	JJ	O	discrete	amod	41	SENT_278	[p23l1362t1350r1675b1418],
41	haplotype	NN	O	haplotype	prep_within	29	SENT_278	[p23l1738t1350r2144b1439],
42	blocks	VBZ	O	block	rcmod	18	SENT_278	[p23l7t1452r425b1521],
43	.27	CD	NUMBER	.27	num	44	SENT_278	[p23l7t1452r425b1521],
44	’28	CD	NUMBER	’28	dobj	42	SENT_278	[p23l7t1452r425b1521],
45	Consequently	RB	O	consequently	advmod	42	SENT_278	[p23l463t1453r1032b1542],
46	,	,	O	,	_	0	SENT_278	[p23l463t1453r1032b1542],
47	in	IN	O	in	_	0	SENT_278	[p23l1072t1456r1151b1520],
48	addition	NN	O	addition	_	0	SENT_278	[p23l1188t1453r1530b1521],
49	to	TO	O	to	_	0	SENT_278	[p23l1564t1463r1638b1521],
50	UGT2B7	NN	O	ugt2b7	nn	51	SENT_278	[p23l1685t1456r2141b1531],
51	*	NN	O	*	prep_in_addition_to	56	SENT_278	[p23l1685t1456r2141b1531],
52	2	CD	NUMBER	2	num	51	SENT_278	[p23l1685t1456r2141b1531],
53	,	,	O	,	_	0	SENT_278	[p23l1685t1456r2141b1531],
54	We	PRP	O	we	nsubj	74	SENT_278	[p23l9t1579r123b1623],
55	also	RB	O	also	advmod	56	SENT_278	[p23l181t1555r337b1623],
56	assayed	VBD	O	assay	_	0	SENT_278	[p23l397t1555r708b1644],
57	for	IN	O	for	_	0	SENT_278	[p23l765t1555r875b1623],
58	the	DT	O	the	det	61	SENT_278	[p23l929t1555r1052b1623],
59	common	JJ	O	common	amod	61	SENT_278	[p23l1112t1579r1463b1623],
60	SNP	NN	O	snp	nn	61	SENT_278	[p23l1522t1558r1691b1623],
61	c.	NN	O	c.	prep_for	56	SENT_278	[p23l1750t1558r2146b1623],
62	735A	CD	NUMBER	735a	num	64	SENT_278	[p23l1750t1558r2146b1623],
63	>	JJR	O	>	amod	64	SENT_278	[p23l1750t1558r2146b1623],
64	G	NN	O	g	dep	61	SENT_278	[p23l1750t1558r2146b1623],
65	(	CD	NUMBER	(	dep	64	SENT_278	[p23l14t1656r376b1746],
66	defining	VBG	O	define	xcomp	56	SENT_278	[p23l14t1656r376b1746],
67	the	DT	O	the	det	72	SENT_278	[p23l407t1656r531b1725],
68	UGT2B7	NN	O	ugt2b7	nn	72	SENT_278	[p23l573t1660r1050b1725],
69	*	CD	NUMBER	*	num	72	SENT_278	[p23l573t1660r1050b1725],
70	1c	NN	O	1c	nn	72	SENT_278	[p23l573t1660r1050b1725],
71	allele	NN	O	allele	nn	72	SENT_278	[p23l1085t1656r1327b1737],
72	)	NN	O	)	dobj	66	SENT_278	[p23l1085t1656r1327b1737],
73	and	CC	O	and	_	0	SENT_278	[p23l1364t1656r1512b1725],
74	showed	VBD	O	show	conj_and	56	SENT_278	[p23l1545t1656r1856b1725],
75	higher	JJR	O	higher	acomp	74	SENT_278	[p23l1886t1656r2146b1746],
76	in	FW	O	in	nn	77	SENT_278	[p23l10t1762r90b1826],
77	vivo	FW	O	vivo	advmod	74	SENT_278	[p23l125t1762r298b1826],
78	clearance	NN	O	clearance	dobj	56	SENT_278	[p23l337t1758r717b1826],
79	and	CC	O	and	_	0	SENT_278	[p23l756t1758r904b1826],
80	also	RB	O	also	advmod	78	SENT_278	[p23l941t1758r1096b1826],
81	faster	RBR	O	faster	advmod	82	SENT_278	[p23l1136t1758r1354b1826],
82	hepatic	JJ	O	hepatic	amod	83	SENT_278	[p23l1389t1758r1685b1848],
83	glucuronidation	NN	O	glucuronidation	dobj	56	SENT_278	[p23l1723t1758r2144b1848, p23l12t1860r268b1928],
84	of	IN	O	of	_	0	SENT_278	[p23l322t1860r402b1928],
85	zidovudine	NN	O	zidovudine	prep_of	83	SENT_278	[p23l448t1860r907b1928],
86	in	IN	O	in	_	0	SENT_278	[p23l961t1864r1041b1928],
87	individuals	NNS	O	individual	prep_in	56	SENT_278	[p23l1094t1860r1556b1928],
88	carrying	VBG	O	carry	partmod	87	SENT_278	[p23l1613t1864r1944b1949],
89	this	DT	O	this	det	90	SENT_278	[p23l1995t1860r2143b1928],
90	allele	NN	O	allele	dobj	88	SENT_278	[p23l11t1962r247b2030],
91	.	.	O	.	_	0	SENT_278	[p23l11t1962r247b2030],

1	Such	JJ	O	such	amod	3	SENT_279	[p23l317t1962r519b2030],
2	similar	JJ	O	similar	amod	3	SENT_279	[p23l582t1962r864b2030],
3	results	NNS	O	result	nsubj	9	SENT_279	[p23l923t1962r1190b2030],
4	in	IN	O	in	_	0	SENT_279	[p23l1255t1965r1335b2029],
5	2	CD	NUMBER	2	num	8	SENT_279	[p23l1399t1972r1436b2029],
6	clearly	RB	O	clearly	advmod	7	SENT_279	[p23l1505t1962r1777b2051],
7	distinct	JJ	O	distinct	amod	8	SENT_279	[p23l1840t1962r2146b2030],
8	populations	NNS	O	population	prep_in	3	SENT_279	[p23l10t2065r493b2154],
9	(	VBP	O	(	_	0	SENT_279	[p23l531t2065r647b2145],
10	ie	FW	O	ie	nsubj	20	SENT_279	[p23l531t2065r647b2145],
11	,	,	O	,	_	0	SENT_279	[p23l531t2065r647b2145],
12	HIV-infected	JJ	O	hiv-infected	amod	14	SENT_279	[p23l681t2065r1195b2133],
13	Ghanaian	JJ	MISC	ghanaian	amod	14	SENT_279	[p23l1226t2065r1613b2133],
14	patients	NNS	O	patient	conj_and	10	SENT_279	[p23l1643t2068r1963b2154],
15	and	CC	O	and	_	0	SENT_279	[p23l1997t2065r2145b2133],
16	white	JJ	O	white	amod	19	SENT_279	[p23l9t2166r236b2235],
17	American	JJ	MISC	american	amod	19	SENT_279	[p23l298t2170r696b2235],
18	liver	NN	O	liver	nn	19	SENT_279	[p23l757t2166r941b2235],
19	donors	NNS	O	donor	conj_and	10	SENT_279	[p23l1003t2166r1304b2247],
20	)	VBP	O	)	ccomp	9	SENT_279	[p23l1003t2166r1304b2247],
21	suggest	VBP	O	suggest	ccomp	20	SENT_279	[p23l1370t2177r1662b2256],
22	that	IN	O	that	complm	27	SENT_279	[p23l1721t2166r1877b2235],
23	these	DT	O	these	det	25	SENT_279	[p23l1935t2166r2144b2235],
24	genotype-phenotype	JJ	O	genotype-phenotype	amod	25	SENT_279	[p23l9t2269r841b2359],
25	associations	NNS	O	association	nsubj	27	SENT_279	[p23l914t2273r1401b2338],
26	are	VBP	O	be	cop	27	SENT_279	[p23l1475t2294r1591b2338],
27	unlikely	JJ	O	unlikely	ccomp	21	SENT_279	[p23l1662t2269r2001b2359],
28	to	TO	O	to	aux	30	SENT_279	[p23l2069t2280r2143b2338],
29	have	VB	O	have	aux	30	SENT_279	[p23l9t2371r197b2439],
30	occurred	VBN	O	occur	xcomp	27	SENT_279	[p23l239t2371r594b2439],
31	simply	RB	O	simply	advmod	30	SENT_279	[p23l634t2371r911b2461],
32	by	IN	O	by	_	0	SENT_279	[p23l945t2371r1044b2461],
33	chance	NN	O	chance	prep_by	30	SENT_279	[p23l1083t2371r1384b2439],
34	.	.	O	.	_	0	SENT_279	[p23l1083t2371r1384b2439],

1	Rather	RB	O	rather	advmod	4	SENT_280	[p23l1427t2371r1707b2450],
2	,	,	O	,	_	0	SENT_280	[p23l1427t2371r1707b2450],
3	it	PRP	O	it	nsubj	4	SENT_280	[p23l1750t2375r1805b2439],
4	implies	VBZ	O	imply	_	0	SENT_280	[p23l1843t2371r2143b2461],
5	that	IN	O	that	complm	30	SENT_280	[p23l9t2473r165b2541],
6	the	DT	O	the	det	8	SENT_280	[p23l190t2473r313b2541],
7	c.	NN	O	c.	nn	8	SENT_280	[p23l343t2477r739b2541],
8	735A	NN	O	735a	nsubj	30	SENT_280	[p23l343t2477r739b2541],
9	>	JJR	O	>	amod	11	SENT_280	[p23l343t2477r739b2541],
10	G	NN	O	g	nn	11	SENT_280	[p23l343t2477r739b2541],
11	SNP	NN	O	snp	dep	8	SENT_280	[p23l768t2477r937b2541],
12	or	CC	O	or	_	0	SENT_280	[p23l968t2497r1046b2541],
13	perhaps	RB	O	perhaps	advmod	8	SENT_280	[p23l1072t2473r1392b2563],
14	another	DT	O	another	det	15	SENT_280	[p23l1422t2473r1730b2541],
15	variant	NN	O	variant	nsubj	30	SENT_280	[p23l1754t2477r2040b2541],
16	in	IN	O	in	_	0	SENT_280	[p23l2066t2477r2146b2541],
17	significant	JJ	O	significant	amod	19	SENT_280	[p23l11t2575r437b2664],
18	linkage	NN	O	linkage	nn	19	SENT_280	[p23l469t2575r760b2664],
19	disequilibrium	NN	O	disequilibrium	prep_in	15	SENT_280	[p23l797t2575r1399b2664],
20	with	IN	O	with	_	0	SENT_280	[p23l1430t2575r1615b2643],
21	this	DT	O	this	det	23	SENT_280	[p23l1647t2575r1794b2643],
22	SNP	NN	O	snp	nn	23	SENT_280	[p23l1832t2578r2001b2643],
23	(	NN	O	(	prep_with	19	SENT_280	[p23l2040t2575r2145b2656],
24	in	IN	O	in	_	0	SENT_280	[p23l2040t2575r2145b2656],
25	both	CC	O	both	preconj	26	SENT_280	[p23l7t2678r189b2746],
26	White	NNP	O	White	prep_in	23	SENT_280	[p23l234t2678r462b2746],
27	and	CC	O	and	_	0	SENT_280	[p23l512t2678r660b2746],
28	black	JJ	O	black	amod	29	SENT_280	[p23l703t2678r923b2746],
29	populations	NNS	O	population	prep_in	23	SENT_280	[p23l967t2678r1478b2767],
30	)	VBP	O	)	ccomp	4	SENT_280	[p23l967t2678r1478b2767],
31	may	MD	O	may	aux	32	SENT_280	[p23l1528t2702r1699b2767],
32	provide	VB	O	provide	ccomp	30	SENT_280	[p23l1745t2678r2056b2767],
33	a	DT	O	a	det	35	SENT_280	[p23l2106t2702r2146b2746],
34	mechanistic	JJ	O	mechanistic	amod	35	SENT_280	[p23l9t2779r498b2848],
35	explanation	NN	O	explanation	dobj	32	SENT_280	[p23l529t2779r1008b2869],
36	for	IN	O	for	_	0	SENT_280	[p23l1035t2780r1145b2848],
37	enhanced	VBN	O	enhance	amod	40	SENT_280	[p23l1172t2779r1563b2848],
38	UGTZB7	NN	O	ugtzb7	nn	40	SENT_280	[p23l1599t2783r1940b2848],
39	gene	NN	O	gene	nn	40	SENT_280	[p23l1960t2804r2144b2869],
40	expression	NN	O	expression	prep_for	35	SENT_280	[p23l11t2886r465b2972],
41	.	.	O	.	_	0	SENT_280	[p23l11t2886r465b2972],

1	An	DT	O	a	det	5	SENT_281	[p23l116t2989r236b3052],
2	important	JJ	O	important	amod	5	SENT_281	[p23l280t2988r677b3074],
3	and	CC	O	and	_	0	SENT_281	[p23l720t2984r867b3052],
4	novel	JJ	O	novel	conj_and	2	SENT_281	[p23l910t2984r1131b3052],
5	finding	NN	O	finding	nsubj	9	SENT_281	[p23l1176t2984r1463b3074],
6	of	IN	O	of	_	0	SENT_281	[p23l1509t2984r1589b3052],
7	this	DT	O	this	det	8	SENT_281	[p23l1624t2984r1770b3052],
8	study	NN	O	study	prep_of	5	SENT_281	[p23l1818t2984r2038b3074],
9	is	VBZ	O	be	_	0	SENT_281	[p23l2081t2988r2143b3052],
10	that	IN	O	that	complm	22	SENT_281	[p23l9t3086r163b3154],
11	c.	NN	O	c.	nsubjpass	22	SENT_281	[p23l190t3090r581b3154],
12	735A	CD	NUMBER	735a	num	14	SENT_281	[p23l190t3090r581b3154],
13	>	JJR	O	>	amod	14	SENT_281	[p23l190t3090r581b3154],
14	G	NN	O	g	dep	11	SENT_281	[p23l190t3090r581b3154],
15	(	CD	NUMBER	(	num	16	SENT_281	[p23l610t3086r1143b3167],
16	UGT2B7	NN	O	ugt2b7	dep	11	SENT_281	[p23l610t3086r1143b3167],
17	*	CD	NUMBER	*	num	19	SENT_281	[p23l610t3086r1143b3167],
18	1c	NN	O	1c	nn	19	SENT_281	[p23l610t3086r1143b3167],
19	)	NN	O	)	dep	16	SENT_281	[p23l610t3086r1143b3167],
20	was	VBD	O	be	auxpass	22	SENT_281	[p23l1173t3110r1324b3154],
21	significantly	RB	O	significantly	advmod	22	SENT_281	[p23l1355t3086r1850b3175],
22	associated	VBN	O	associate	ccomp	9	SENT_281	[p23l1878t3090r2144b3154, p23l11t3188r176b3256],
23	with	IN	O	with	_	0	SENT_281	[p23l202t3188r386b3256],
24	higher	JJR	O	higher	amod	27	SENT_281	[p23l411t3188r668b3277],
25	zidovudine	NN	O	zidovudine	nn	27	SENT_281	[p23l695t3188r1147b3256],
26	glucuronidation	NN	O	glucuronidation	nn	27	SENT_281	[p23l1175t3188r1820b3277],
27	activity	NN	O	activity	prep_with	22	SENT_281	[p23l1848t3191r2146b3277],
28	as	RB	O	as	_	0	SENT_281	[p23l11t3315r86b3359],
29	well	RB	O	well	_	0	SENT_281	[p23l120t3291r293b3359],
30	as	IN	O	as	_	0	SENT_281	[p23l327t3315r403b3359],
31	UGTZB7	NN	O	ugtzb7	nn	33	SENT_281	[p23l438t3294r779b3359],
32	protein	NN	O	protein	nn	33	SENT_281	[p23l814t3294r1103b3380],
33	content	NN	O	content	prep_with	22	SENT_281	[p23l1137t3301r1435b3359],
34	in	IN	O	in	_	0	SENT_281	[p23l1467t3294r1546b3358],
35	a	DT	O	a	det	38	SENT_281	[p23l1580t3315r1620b3359],
36	human	JJ	O	human	amod	38	SENT_281	[p23l1651t3291r1932b3359],
37	liver	NN	O	liver	nn	38	SENT_281	[p23l1965t3291r2146b3359],
38	bank	NN	O	bank	prep_in	22	SENT_281	[p23l7t3392r222b3471],
39	,	,	O	,	_	0	SENT_281	[p23l7t3392r222b3471],
40	confirming	VBG	O	confirm	xcomp	22	SENT_281	[p23l282t3393r720b3482],
41	the	DT	O	the	dobj	40	SENT_281	[p23l774t3392r896b3461],
42	in	FW	O	in	nn	43	SENT_281	[p23l953t3396r1032b3460],
43	vivo	FW	O	vivo	dep	44	SENT_281	[p23l1085t3396r1256b3461],
44	association	NN	O	association	dep	41	SENT_281	[p23l1314t3396r1757b3461],
45	between	IN	O	between	prep	40	SENT_281	[p23l1808t3392r2145b3461],

1	GENERIC	JJ	O	generic	amod	2	SENT_282	[p23l441t3558r623b3589],
2	NRTIS	NN	O	nrti	_	0	SENT_282	[p23l634t3558r761b3589],
3	IN	IN	O	in	_	0	SENT_282	[p23l774t3559r824b3589],
4	TB/HIV	NN	O	tb/hiv	prep_in	2	SENT_282	[p23l837t3557r1260b3589],
5	.	.	O	.	_	0	SENT_282	[p23l837t3557r1260b3589],

1	—	NN	O	—	_	0	SENT_283	[p23l837t3557r1260b3589],
2	.	.	O	.	_	0	SENT_283	[p23l837t3557r1260b3589],

1	COINFECTED	JJ	O	coinfected	_	0	SENT_284	[p23l837t3557r1260b3589],
2	GHANAIAN	JJ	MISC	ghanaian	amod	3	SENT_284	[p23l1275t3558r1511b3589],
3	PATIENTS	NNS	O	patient	dep	1	SENT_284	[p23l1521t3558r1723b3589],

1	Table	NNP	MISC	Table	nn	3	SENT_285	[p23l235t3683r338b3715],
2	III	NNP	MISC	III	nn	3	SENT_285	[p23l353t3685r400b3715],
3	Effect	NN	MISC	effect	dep	13	SENT_285	[p23l443t3683r551b3715],
4	of	IN	MISC	of	_	0	SENT_285	[p23l566t3683r604b3715],
5	UGTZB7	NNP	MISC	UGTZB7	nn	6	SENT_285	[p23l619t3685r779b3715],
6	Allele	NNP	MISC	Allele	prep_of	3	SENT_285	[p23l791t3683r904b3715],
7	on	IN	MISC	on	_	0	SENT_285	[p23l921t3694r967b3715],
8	Mean	NN	MISC	mean	prep_on	6	SENT_285	[p23l981t3685r1086b3715],
9	i	FW	MISC	i	dep	8	SENT_285	[p23l1100t3688r1122b3715],
10	SD	NN	MISC	sd	nn	11	SENT_285	[p23l1137t3685r1189b3715],
11	Zidovudine	NN	MISC	zidovudine	dep	13	SENT_285	[p23l1204t3683r1426b3715],
12	Glucuronidation	NN	MISC	glucuronidation	nn	13	SENT_285	[p23l1442t3683r1757b3715],
13	Activity	NN	MISC	activity	dep	20	SENT_285	[p23l1771t3685r1925b3725],
14	and	CC	O	and	_	0	SENT_285	[p23l171t3730r240b3762],
15	Relative	JJ	O	relative	amod	16	SENT_285	[p23l254t3730r407b3762],
16	UGTZB7	NN	O	ugtzb7	conj_and	13	SENT_285	[p23l423t3732r584b3762],
17	Protein	NN	O	protein	nn	20	SENT_285	[p23l599t3732r737b3762],
18	and	CC	O	and	_	0	SENT_285	[p23l752t3730r822b3762],
19	mRNA	NN	O	mrna	nn	20	SENT_285	[p23l836t3732r964b3762],
20	Content	NN	O	content	_	0	SENT_285	[p23l979t3732r1128b3762],
21	Measured	VBN	O	measure	partmod	20	SENT_285	[p23l1142t3730r1328b3762],
22	in	IN	O	in	_	0	SENT_285	[p23l1342t3732r1380b3762],
23	52	CD	NUMBER	52	num	25	SENT_285	[p23l1396t3735r1436b3762],
24	Human	JJ	ORGANIZATION	human	amod	25	SENT_285	[p23l1453t3732r1593b3762],
25	Liver	NN	ORGANIZATION	liver	prep_in	21	SENT_285	[p23l1607t3732r1705b3762],
26	Bank	NNP	ORGANIZATION	Bank	nn	27	SENT_285	[p23l1720t3730r1816b3762],
27	Samples	NNP	ORGANIZATION	Samples	dep	25	SENT_285	[p23l1831t3730r1989b3772],

1	Parameter	NN	O	parameter	_	0	SENT_286	[p24l42t19r203b43],

1	Number	NN	O	number	_	0	SENT_287	[p24l43t108r181b137],
2	of	IN	O	of	_	0	SENT_287	[p24l195t108r229b137],
3	livers	NNS	O	liver	prep_of	1	SENT_287	[p24l239t108r332b137],
4	Zidovudine	NNP	O	Zidovudine	nn	5	SENT_287	[p24l43t152r243b181],
5	glucuronidation	NN	O	glucuronidation	dep	1	SENT_287	[p24l256t152r541b190],
6	,	,	O	,	_	0	SENT_287	[p24l256t152r541b190],
7	nmoles/min/mg	NN	O	nmoles/min/mg	nn	11	SENT_287	[p24l80t196r354b234],
8	protein	NN	O	protein	nn	11	SENT_287	[p24l367t198r491b234],
9	UGTZB7	NN	O	ugtzb7	nn	11	SENT_287	[p24l43t241r188b269],
10	protein	NN	O	protein	nn	11	SENT_287	[p24l203t241r326b278],
11	(	NN	O	(	appos	5	SENT_287	[p24l341t240r479b274],
12	relative	JJ	O	relative	amod	11	SENT_287	[p24l341t240r479b274],
13	to	TO	O	to	_	0	SENT_287	[p24l492t244r523b269],
14	lowest	JJS	O	lowest	prep_to	12	SENT_287	[p24l537t240r659b274],
15	)	CD	NUMBER	)	num	18	SENT_287	[p24l537t240r659b274],
16	UGTZB7	NN	O	ugtzb7	nn	18	SENT_287	[p24l43t285r188b313],
17	mRNA	NN	O	mrna	nn	18	SENT_287	[p24l202t285r318b312],
18	(	NN	O	(	dep	14	SENT_287	[p24l333t283r470b318],
19	relative	JJ	O	relative	advmod	11	SENT_287	[p24l333t283r470b318],
20	to	TO	O	to	_	0	SENT_287	[p24l483t288r515b313],
21	lowest	JJS	O	lowest	prep_to	19	SENT_287	[p24l529t283r650b318],
22	)	CD	NUMBER	)	dep	11	SENT_287	[p24l529t283r650b318],

1	Number	NN	O	number	_	0	SENT_288	[p24l43t470r181b499],
2	of	IN	O	of	_	0	SENT_288	[p24l195t470r229b499],
3	livers	NNS	O	liver	prep_of	1	SENT_288	[p24l239t470r332b499],
4	Zidovudine	NNP	O	Zidovudine	nn	5	SENT_288	[p24l43t514r243b543],
5	glucuronidation	NN	O	glucuronidation	dep	1	SENT_288	[p24l256t514r541b552],
6	,	,	O	,	_	0	SENT_288	[p24l256t514r541b552],
7	nmoles/min/mg	NN	O	nmoles/min/mg	nn	11	SENT_288	[p24l80t558r354b596],
8	protein	NN	O	protein	nn	11	SENT_288	[p24l367t560r491b596],
9	UGTZB7	NN	O	ugtzb7	nn	11	SENT_288	[p24l43t602r188b630],
10	protein	NN	O	protein	nn	11	SENT_288	[p24l202t602r326b639],
11	(	NN	O	(	appos	5	SENT_288	[p24l341t601r478b635],
12	relative	JJ	O	relative	amod	11	SENT_288	[p24l341t601r478b635],
13	to	TO	O	to	_	0	SENT_288	[p24l492t605r523b630],
14	lowest	JJS	O	lowest	prep_to	12	SENT_288	[p24l537t601r658b635],
15	)	CD	NUMBER	)	num	18	SENT_288	[p24l537t601r658b635],
16	UGTZB7	NN	O	ugtzb7	nn	18	SENT_288	[p24l43t646r188b673],
17	mRNA	NN	O	mrna	nn	18	SENT_288	[p24l202t646r318b673],
18	(	NN	O	(	dep	14	SENT_288	[p24l333t644r470b678],
19	relative	JJ	O	relative	advmod	11	SENT_288	[p24l333t644r470b678],
20	to	TO	O	to	_	0	SENT_288	[p24l483t648r515b673],
21	lowest	JJS	O	lowest	prep_to	19	SENT_288	[p24l529t644r650b678],
22	)	CD	NUMBER	)	dep	11	SENT_288	[p24l529t644r650b678],

1	Number	NN	O	number	_	0	SENT_289	[p24l43t830r181b859],
2	of	IN	O	of	_	0	SENT_289	[p24l195t830r229b859],
3	livers	NNS	O	liver	prep_of	1	SENT_289	[p24l239t830r332b859],
4	Zidovudine	NNP	O	Zidovudine	nn	5	SENT_289	[p24l43t873r243b902],
5	glucuronidation	NN	O	glucuronidation	dep	1	SENT_289	[p24l256t873r541b911],
6	,	,	O	,	_	0	SENT_289	[p24l256t873r541b911],
7	nmoles/min/mg	NN	O	nmoles/min/mg	nn	8	SENT_289	[p24l80t917r354b955],
8	protein	NN	O	protein	appos	5	SENT_289	[p24l367t919r491b955],

1	UGTZB	NN	O	ugtzb	_	0	SENT_290	[p24l828t18r939b43],
2	7	CD	NUMBER	7	number	3	SENT_290	[p24l942t21r959b43],
3	*	CD	NUMBER	*	dep	1	SENT_290	[p24l961t19r1013b43],
4	1a	NN	O	1a	nn	5	SENT_290	[p24l961t19r1013b43],
5	Noncarriers	NNS	O	noncarrier	dep	3	SENT_290	[p24l1024t18r1210b43],

1	0.059	CD	NUMBER	0.059	num	2	SENT_291	[p24l904t156r994b181],
2	t	NN	O	t	_	0	SENT_291	[p24l1008t156r1027b181],
3	0.027	CD	NUMBER	0.027	dep	2	SENT_291	[p24l1041t156r1131b181],

1	7.75	CD	NUMBER	7.75	_	0	SENT_292	[p24l926t244r993b269],
2	i	FW	O	i	dep	1	SENT_292	[p24l1008t244r1027b269],
3	2.86	CD	NUMBER	2.86	number	4	SENT_292	[p24l1042t244r1110b269],
4	3.73	CD	NUMBER	3.73	dep	2	SENT_292	[p24l925t288r993b313],
5	i	FW	O	i	dep	4	SENT_292	[p24l1008t288r1027b312],
6	2.25	CD	NUMBER	2.25	dep	1	SENT_292	[p24l1042t288r1109b313],

1	UGTZB	NN	O	ugtzb	_	0	SENT_293	[p24l829t380r940b405],
2	7	CD	NUMBER	7	number	3	SENT_293	[p24l943t383r960b405],
3	*	CD	NUMBER	*	dep	1	SENT_293	[p24l962t381r1011b405],
4	1c	NN	O	1c	nn	5	SENT_293	[p24l962t381r1011b405],
5	Noncarriers	NNS	O	noncarrier	dep	3	SENT_293	[p24l1023t380r1209b405],

1	0.052	CD	NUMBER	0.052	_	0	SENT_294	[p24l904t518r993b543],
2	i	FW	O	i	dep	1	SENT_294	[p24l1007t519r1027b543],
3	0.022	CD	NUMBER	0.022	dep	1	SENT_294	[p24l1041t518r1130b543],

1	7.14	CD	NUMBER	7.14	_	0	SENT_295	[p24l926t605r994b630],
2	i	FW	O	i	dep	1	SENT_295	[p24l1008t606r1027b630],
3	3.00	CD	NUMBER	3.00	number	4	SENT_295	[p24l1042t605r1110b630],
4	3.75	CD	NUMBER	3.75	dep	2	SENT_295	[p24l925t648r993b673],
5	i	FW	O	i	dep	4	SENT_295	[p24l1008t649r1027b672],
6	2.03	CD	NUMBER	2.03	dep	1	SENT_295	[p24l1042t648r1109b673],

1	UGT2B7	NN	O	ugt2b7	nn	2	SENT_296	[p24l837t741r1002b765],
2	*	NN	O	*	_	0	SENT_296	[p24l837t741r1002b765],
3	2	CD	NUMBER	2	num	4	SENT_296	[p24l837t741r1002b765],
4	Noncarriers	NNS	O	noncarrier	dep	2	SENT_296	[p24l1015t740r1200b765],

1	0.066	CD	NUMBER	0.066	num	2	SENT_297	[p24l904t877r994b902],
2	t	NN	O	t	_	0	SENT_297	[p24l1008t878r1027b902],
3	0.032	CD	NUMBER	0.032	dep	2	SENT_297	[p24l1041t877r1130b902],

1	UGT2B7	NN	O	ugt2b7	_	0	SENT_298	[p24l1403t18r1589b43],
2	*	CD	NUMBER	*	num	4	SENT_298	[p24l1403t18r1589b43],
3	1a	NN	O	1a	nn	4	SENT_298	[p24l1403t18r1589b43],
4	Carriers	NNS	O	carrier	dep	1	SENT_298	[p24l1600t18r1726b43],

1	0.054	CD	NUMBER	0.054	num	2	SENT_299	[p24l1450t156r1540b181],
2	t	NN	O	t	_	0	SENT_299	[p24l1554t156r1573b181],
3	0.025	CD	NUMBER	0.025	dep	2	SENT_299	[p24l1587t156r1676b181],

1	7.25	CD	NUMBER	7.25	dep	4	SENT_300	[p24l1472t244r1539b269],
2	i	FW	O	i	dep	1	SENT_300	[p24l1554t244r1573b269],
3	4.10	CD	NUMBER	4.10	dep	4	SENT_300	[p24l1586t244r1656b269],
4	3.56	CD	NUMBER	3.56	dep	6	SENT_300	[p24l1471t288r1540b313],
5	i	FW	O	i	dep	4	SENT_300	[p24l1554t288r1573b312],
6	2.03	CD	NUMBER	2.03	_	0	SENT_300	[p24l1587t288r1655b313],

1	UGT2B7	NN	O	ugt2b7	_	0	SENT_301	[p24l1404t380r1587b405],
2	*	CD	NUMBER	*	num	4	SENT_301	[p24l1404t380r1587b405],
3	1c	NN	O	1c	nn	4	SENT_301	[p24l1404t380r1587b405],
4	Carriers	NNS	O	carrier	dep	1	SENT_301	[p24l1599t380r1725b405],

1	0.077	CD	NUMBER	0.077	num	2	SENT_302	[p24l1450t518r1540b543],
2	t	NN	O	t	_	0	SENT_302	[p24l1554t519r1573b543],
3	0.032	CD	NUMBER	0.032	dep	2	SENT_302	[p24l1587t518r1676b543],

1	9.51	CD	NUMBER	9.51	dep	4	SENT_303	[p24l1471t605r1538b630],
2	i	FW	O	i	dep	1	SENT_303	[p24l1554t606r1573b630],
3	2.32	CD	NUMBER	2.32	dep	4	SENT_303	[p24l1587t605r1655b630],
4	3.61	CD	NUMBER	3.61	dep	6	SENT_303	[p24l1471t648r1539b673],
5	i	FW	O	i	dep	4	SENT_303	[p24l1554t649r1573b672],
6	2.77	CD	NUMBER	2.77	_	0	SENT_303	[p24l1588t648r1656b673],

1	UGTZB	NN	O	ugtzb	_	0	SENT_304	[p24l1413t740r1524b765],
2	7	CD	NUMBER	7	num	3	SENT_304	[p24l1527t743r1543b765],
3	*	NN	O	*	dep	1	SENT_304	[p24l1546t741r1578b765],
4	2	CD	NUMBER	2	num	5	SENT_304	[p24l1546t741r1578b765],
5	Carriers	NNS	O	carrier	dep	1	SENT_304	[p24l1591t740r1717b765],

1	0.056	CD	NUMBER	0.056	num	2	SENT_305	[p24l1450t877r1540b902],
2	t	NN	O	t	_	0	SENT_305	[p24l1554t878r1573b902],
3	0.024	CD	NUMBER	0.024	dep	2	SENT_305	[p24l1587t877r1677b902],

1	P	NN	O	p	_	0	SENT_306	[p24l1977t19r1999b43],
2	Value	NN	O	value	nn	3	SENT_306	[p24l2009t17r2108b43],
3	“	NN	O	“	dep	1	SENT_306	[p24l2009t17r2108b43],

1	.646	CD	NUMBER	.646	_	0	SENT_307	[p24l2009t156r2077b181],
2	.864	CD	NUMBER	.864	num	3	SENT_307	[p24l2003t237r2085b269],
3	b	NN	O	b	dep	1	SENT_307	[p24l2003t237r2085b269],
4	.969	CD	NUMBER	.969	num	5	SENT_307	[p24l2003t281r2085b313],
5	b	NN	O	b	dep	1	SENT_307	[p24l2003t281r2085b313],

1	.02	NN	NUMBER	.02	nn	2	SENT_308	[p24l2003t511r2085b543],
2	ob	NN	O	ob	_	0	SENT_308	[p24l2003t511r2085b543],

1	.238	CD	NUMBER	.238	num	4	SENT_309	[p24l2009t877r2077b902],
2	UGTZB7	NN	O	ugtzb7	nn	4	SENT_309	[p24l43t962r188b989],
3	protein	NN	O	protein	nn	4	SENT_309	[p24l203t962r326b998],
4	(	NN	O	(	dep	10	SENT_309	[p24l341t960r479b995],
5	relative	JJ	O	relative	advmod	4	SENT_309	[p24l341t960r479b995],
6	to	TO	O	to	_	0	SENT_309	[p24l492t965r523b989],
7	lowest	JJS	O	lowest	prep_to	4	SENT_309	[p24l537t960r659b994],
8	)	CD	NUMBER	)	dep	7	SENT_309	[p24l537t960r659b994],
9	8.62	CD	NUMBER	8.62	dep	10	SENT_309	[p24l925t965r993b989],
10	i	FW	O	i	dep	19	SENT_309	[p24l1008t965r1027b989],
11	3.73	CD	NUMBER	3.73	number	12	SENT_309	[p24l1042t965r1109b989],
12	7.40	CD	NUMBER	7.40	dep	10	SENT_309	[p24l1472t965r1540b989],
13	i	FW	O	i	dep	12	SENT_309	[p24l1554t965r1573b989],
14	2.75	CD	NUMBER	2.75	number	15	SENT_309	[p24l1588t965r1655b989],
15	.160	CD	NUMBER	.160	num	19	SENT_309	[p24l2003t958r2085b989],
16	”	NN	O	”	nn	19	SENT_309	[p24l2003t958r2085b989],
17	UGTZB7	NN	O	ugtzb7	nn	19	SENT_309	[p24l43t1005r188b1032],
18	mRNA	NN	O	mrna	nn	19	SENT_309	[p24l202t1005r318b1032],
19	(	NN	O	(	dep	25	SENT_309	[p24l333t1003r470b1037],
20	relative	JJ	O	relative	advmod	19	SENT_309	[p24l333t1003r470b1037],
21	to	TO	O	to	_	0	SENT_309	[p24l483t1007r515b1032],
22	lowest	JJS	O	lowest	prep_to	19	SENT_309	[p24l529t1003r650b1037],
23	)	CD	NUMBER	)	num	24	SENT_309	[p24l529t1003r650b1037],
24	2.91	CD	NUMBER	2.91	dep	22	SENT_309	[p24l925t1007r992b1032],
25	i	FW	O	i	dep	30	SENT_309	[p24l1008t1008r1027b1032],
26	1.63	CD	NUMBER	1.63	number	27	SENT_309	[p24l1042t1007r1109b1032],
27	3.97	CD	NUMBER	3.97	dep	25	SENT_309	[p24l1471t1007r1540b1032],
28	i	FW	O	i	dep	27	SENT_309	[p24l1554t1008r1573b1032],
29	2.32	CD	NUMBER	2.32	num	30	SENT_309	[p24l1587t1007r1655b1032],
30	.188	CD	NUMBER	.188	_	0	SENT_309	[p24l2009t1007r2077b1032],

1	“	NNP	O	“	nn	3	SENT_310	[p24l93t1102r183b1131],
2	Group	NNP	O	Group	nn	3	SENT_310	[p24l93t1102r183b1131],
3	differences	NNS	O	difference	nsubjpass	5	SENT_310	[p24l195t1101r339b1124],
4	were	VBD	O	be	auxpass	5	SENT_310	[p24l350t1109r413b1124],
5	evaluated	VBN	O	evaluate	_	0	SENT_310	[p24l424t1101r552b1124],
6	by	IN	O	by	_	0	SENT_310	[p24l560t1101r593b1131],
7	unpaired	JJ	O	unpaired	amod	8	SENT_310	[p24l603t1101r723b1131],
8	ttest	NN	O	ttest	agent	5	SENT_310	[p24l734t1104r797b1124],
9	or	CC	O	or	_	0	SENT_310	[p24l807t1109r833b1124],
10	by	IN	O	by	_	0	SENT_310	[p24l842t1101r874b1131],
11	“	CD	NUMBER	“	num	14	SENT_310	[p24l883t1099r953b1124],
12	rank	NN	O	rank	nn	14	SENT_310	[p24l883t1099r953b1124],
13	sum	NN	O	sum	nn	14	SENT_310	[p24l963t1109r1018b1124],
14	test	NN	O	test	agent	5	SENT_310	[p24l1028t1104r1074b1124],
15	if	IN	O	if	mark	20	SENT_310	[p24l1084t1101r1104b1124],
16	data	NNS	O	datum	nsubjpass	20	SENT_310	[p24l1113t1101r1167b1124],
17	were	VBD	O	be	auxpass	20	SENT_310	[p24l1177t1109r1240b1124],
18	not	RB	O	not	neg	20	SENT_310	[p24l1250t1104r1293b1124],
19	normally	RB	O	normally	advmod	20	SENT_310	[p24l1303t1101r1423b1131],
20	distributed	VBN	O	distribute	advcl	5	SENT_310	[p24l1434t1101r1579b1124],
21	or	CC	O	or	_	0	SENT_310	[p24l1589t1109r1615b1124],
22	showed	VBN	O	show	conj_or	20	SENT_310	[p24l1626t1101r1727b1124],
23	unequal	JJ	O	unequal	amod	24	SENT_310	[p24l1737t1101r1844b1131],
24	variance	NN	O	variance	dobj	20	SENT_310	[p24l1854t1102r1972b1124],
25	.	.	O	.	_	0	SENT_310	[p24l1854t1102r1972b1124],

1	UGT2B7	NN	O	ugt2b7	_	0	SENT_311	[p24l19t1296r492b1360],
2	*	CD	NUMBER	*	num	3	SENT_311	[p24l19t1296r492b1360],
3	1c	NN	O	1c	dep	1	SENT_311	[p24l19t1296r492b1360],
4	and	CC	O	and	_	0	SENT_311	[p24l527t1292r675b1360],
5	zidovudine	NN	O	zidovudine	nn	6	SENT_311	[p24l707t1292r1161b1360],
6	clearance	NN	O	clearance	dep	1	SENT_311	[p24l1196t1292r1591b1360],
7	.	.	O	.	_	0	SENT_311	[p24l1196t1292r1591b1360],

1	This	DT	O	this	det	2	SENT_312	[p24l1629t1292r1803b1360],
2	association	NN	O	association	nsubjpass	5	SENT_312	[p24l1839t1296r2150b1360, p24l8t1398r166b1463],
3	is	VBZ	O	be	auxpass	5	SENT_312	[p24l209t1398r270b1463],
4	also	RB	O	also	advmod	5	SENT_312	[p24l315t1395r470b1463],
5	confirmed	VBN	O	confirm	_	0	SENT_312	[p24l515t1395r926b1463],
6	in	IN	O	in	_	0	SENT_312	[p24l969t1398r1047b1462],
7	part	NN	O	part	prep_in	5	SENT_312	[p24l1089t1405r1248b1484],
8	by	IN	O	by	_	0	SENT_312	[p24l1285t1395r1383b1484],
9	a	DT	O	a	det	11	SENT_312	[p24l1426t1419r1466b1463],
10	recent	JJ	O	recent	amod	11	SENT_312	[p24l1505t1405r1753b1463],
11	study	NN	O	study	agent	5	SENT_312	[p24l1796t1395r2016b1484],
12	by	IN	O	by	_	0	SENT_312	[p24l2054t1395r2152b1484],
13	Innocenti	NNP	PERSON	Innocenti	agent	5	SENT_312	[p24l8t1501r397b1566],
14	et	FW	O	et	nn	16	SENT_312	[p24l447t1508r517b1566],
15	al	FW	O	al	nn	16	SENT_312	[p24l564t1497r692b1566],
16	“	FW	O	“	dep	5	SENT_312	[p24l564t1497r692b1566],
17	that	WDT	O	that	nsubj	18	SENT_312	[p24l739t1498r897b1566],
18	showed	VBD	O	show	dep	16	SENT_312	[p24l944t1498r1257b1566],
19	about	IN	O	about	_	0	SENT_312	[p24l1306t1498r1531b1566],
20	45	CD	PERCENT	45	number	21	SENT_312	[p24l1576t1498r1753b1571],
21	%	NN	PERCENT	%	amod	23	SENT_312	[p24l1576t1498r1753b1571],
22	faster	JJR	O	faster	amod	23	SENT_312	[p24l1809t1498r2030b1566],
23	3hydroxy-glucuronidation	NN	O	3hydroxy-glucuronidation	prep_about	18	SENT_312	[p24l2080t1508r2150b1566, p24l8t1599r1024b1689],
24	of	IN	O	of	_	0	SENT_312	[p24l1135t1600r1215b1668],
25	morphine	NN	O	morphine	nn	26	SENT_312	[p24l1315t1599r1708b1689],
26	(	NN	O	(	prep_of	23	SENT_312	[p24l1822t1599r2152b1680],
27	another	DT	O	another	det	30	SENT_312	[p24l1822t1599r2152b1680],
28	UGTZB7	NN	O	ugtzb7	nn	30	SENT_312	[p24l9t1705r351b1770],
29	substrate	NN	O	substrate	nn	30	SENT_312	[p24l395t1701r775b1782],
30	)	NN	O	)	dobj	18	SENT_312	[p24l395t1701r775b1782],
31	in	IN	O	in	_	0	SENT_312	[p24l820t1705r898b1769],
32	human	JJ	O	human	amod	33	SENT_312	[p24l937t1701r1219b1770],
33	livers	NNS	O	liver	prep_in	30	SENT_312	[p24l1259t1701r1476b1770],
34	that	WDT	O	that	nsubj	35	SENT_312	[p24l1516t1701r1671b1770],
35	carried	VBD	O	carry	rcmod	30	SENT_312	[p24l1711t1701r1989b1770],
36	the	DT	O	the	det	41	SENT_312	[p24l2027t1701r2150b1770],
37	intron	NN	O	intron	nn	41	SENT_312	[p24l9t1808r254b1872],
38	1	CD	NUMBER	1	num	41	SENT_312	[p24l296t1815r330b1872],
39	SNP	NN	ORGANIZATION	snp	nn	41	SENT_312	[p24l376t1808r545b1872],
40	(	CD	NUMBER	(	num	41	SENT_312	[p24l588t1804r799b1885],
41	IVS1	NN	O	ivs1	nsubj	46	SENT_312	[p24l588t1804r799b1885],
42	+985	CD	NUMBER	+985	num	46	SENT_312	[p24l840t1804r1262b1885],
43	A	DT	O	a	dep	44	SENT_312	[p24l840t1804r1262b1885],
44	>	JJR	O	>	amod	46	SENT_312	[p24l840t1804r1262b1885],
45	G	NN	O	g	nn	46	SENT_312	[p24l840t1804r1262b1885],
46	)	NNS	O	)	xcomp	35	SENT_312	[p24l840t1804r1262b1885],
47	.	.	O	.	_	0	SENT_312	[p24l840t1804r1262b1885],

1	This	DT	O	this	det	3	SENT_313	[p24l1305t1804r1479b1872],
2	latter	JJ	O	latter	amod	3	SENT_313	[p24l1519t1804r1725b1872],
3	SNP	NN	O	snp	nsubj	13	SENT_313	[p24l1764t1808r1932b1872],
4	is	VBZ	O	be	cop	13	SENT_313	[p24l1971t1808r2033b1872],
5	in	IN	O	in	_	0	SENT_313	[p24l2073t1808r2152b1872],
6	significant	JJ	O	significant	amod	8	SENT_313	[p24l10t1907r430b1996],
7	linkage	NN	O	linkage	nn	8	SENT_313	[p24l495t1907r782b1996],
8	disequilibrium	NN	O	disequilibrium	prep_in	13	SENT_313	[p24l852t1907r1447b1997],
9	with	IN	O	with	_	0	SENT_313	[p24l1510t1907r1694b1975],
10	c.	NN	O	c.	prep_with	8	SENT_313	[p24l1760t1910r2153b1975],
11	735A	CD	NUMBER	735a	num	13	SENT_313	[p24l1760t1910r2153b1975],
12	>	JJR	O	>	amod	13	SENT_313	[p24l1760t1910r2153b1975],
13	G	NN	O	g	_	0	SENT_313	[p24l1760t1910r2153b1975],
14	and	CC	O	and	_	0	SENT_313	[p24l10t2009r157b2077],
15	also	RB	O	also	advmod	13	SENT_313	[p24l188t2009r342b2077],
16	the	DT	O	the	det	19	SENT_313	[p24l374t2009r497b2077],
17	exon	NN	O	exon	nn	19	SENT_313	[p24l530t2033r721b2077],
18	4	CD	NUMBER	4	num	19	SENT_313	[p24l751t2020r794b2076],
19	SNP	NN	ORGANIZATION	snp	conj_and	13	SENT_313	[p24l830t2012r998b2077],
20	(	CD	NUMBER	(	num	22	SENT_313	[p24l1035t2009r1535b2090],
21	c.	NN	O	c.	nn	22	SENT_313	[p24l1035t2009r1535b2090],
22	1062C	NN	O	1062c	dep	19	SENT_313	[p24l1035t2009r1535b2090],
23	>	JJR	O	>	amod	25	SENT_313	[p24l1035t2009r1535b2090],
24	T	NN	O	t	nn	25	SENT_313	[p24l1035t2009r1535b2090],
25	)	NN	O	)	dep	19	SENT_313	[p24l1035t2009r1535b2090],
26	.	.	O	.	_	0	SENT_313	[p24l1035t2009r1535b2090],

1	Although	IN	O	although	mark	5	SENT_314	[p24l1569t2009r1949b2098],
2	they	PRP	O	they	nsubj	5	SENT_314	[p24l1978t2009r2152b2098],
3	did	VBD	O	do	aux	5	SENT_314	[p24l11t2112r142b2180],
4	not	RB	O	not	neg	5	SENT_314	[p24l190t2122r321b2180],
5	measure	VB	O	measure	advcl	13	SENT_314	[p24l368t2136r701b2180],
6	hepatic	JJ	O	hepatic	amod	9	SENT_314	[p24l751t2112r1044b2201],
7	UGTZB7	NN	O	ugtzb7	nn	9	SENT_314	[p24l1095t2115r1437b2180],
8	protein	NN	O	protein	nn	9	SENT_314	[p24l1489t2115r1779b2201],
9	content	NN	O	content	dobj	5	SENT_314	[p24l1829t2122r2148b2191],
10	,	,	O	,	_	0	SENT_314	[p24l1829t2122r2148b2191],
11	they	PRP	O	they	nsubj	13	SENT_314	[p24l8t2213r182b2303],
12	did	VBD	O	do	aux	13	SENT_314	[p24l215t2213r346b2282],
13	evaluate	VB	O	evaluate	_	0	SENT_314	[p24l378t2213r709b2282],
14	UGTZB7	NN	O	ugtzb7	nn	16	SENT_314	[p24l741t2217r1084b2282],
15	mRNA	NN	O	mrna	nn	16	SENT_314	[p24l1117t2218r1390b2281],
16	content	NN	O	content	dobj	13	SENT_314	[p24l1422t2224r1722b2282],
17	and	CC	O	and	_	0	SENT_314	[p24l1753t2213r1900b2282],
18	splicing	NN	O	splicing	conj_and	16	SENT_314	[p24l1933t2213r2150b2303, p24l9t2319r151b2405],
19	.	.	O	.	_	0	SENT_314	[p24l1933t2213r2150b2303, p24l9t2319r151b2405],

1	Similar	JJ	O	similar	ccomp	10	SENT_315	[p24l206t2315r499b2383],
2	to	TO	O	to	_	0	SENT_315	[p24l544t2325r617b2383],
3	our	PRP$	O	we	poss	4	SENT_315	[p24l668t2339r801b2383],
4	findings	NNS	O	finding	prep_to	1	SENT_315	[p24l847t2315r1173b2405],
5	with	IN	O	with	_	0	SENT_315	[p24l1221t2315r1405b2383],
6	zidovudine	NN	O	zidovudine	prep_with	4	SENT_315	[p24l1452t2315r1929b2394],
7	,	,	O	,	_	0	SENT_315	[p24l1452t2315r1929b2394],
8	they	PRP	O	they	nsubj	10	SENT_315	[p24l1978t2315r2152b2405],
9	also	RB	O	also	advmod	10	SENT_315	[p24l10t2417r164b2485],
10	found	VBD	O	find	_	0	SENT_315	[p24l228t2417r463b2485],
11	no	DT	O	no	det	12	SENT_315	[p24l523t2441r621b2485],
12	effect	NN	O	effect	dobj	10	SENT_315	[p24l686t2417r901b2485],
13	of	IN	O	of	_	0	SENT_315	[p24l963t2417r1042b2485],
14	UGT2B7	NN	O	ugt2b7	nn	15	SENT_315	[p24l1106t2421r1532b2485],
15	*	NN	O	*	prep_of	12	SENT_315	[p24l1106t2421r1532b2485],
16	2	CD	NUMBER	2	num	15	SENT_315	[p24l1106t2421r1532b2485],
17	on	IN	O	on	_	0	SENT_315	[p24l1600t2441r1698b2485],
18	morphine	NN	O	morphine	nn	19	SENT_315	[p24l1758t2417r2150b2507],
19	3-glucuronidation	NN	O	3-glucuronidation	prep_on	10	SENT_315	[p24l12t2519r734b2608],
20	or	CC	O	or	_	0	SENT_315	[p24l757t2543r835b2587],
21	on	IN	O	on	_	0	SENT_315	[p24l858t2543r956b2587],
22	UGTZB7	NN	O	ugtzb7	nn	24	SENT_315	[p24l977t2523r1319b2587],
23	mRNA	NN	O	mrna	nn	24	SENT_315	[p24l1343t2524r1616b2587],
24	expression	NN	O	expression	prep_on	10	SENT_315	[p24l1639t2518r2151b2609],
25	.	.	O	.	_	0	SENT_315	[p24l1639t2518r2151b2609],

1	“	NN	O	“	nsubj	18	SENT_316	[p24l1639t2518r2151b2609],
2	However	RB	O	however	advmod	1	SENT_316	[p24l8t2625r384b2700],
3	,	,	O	,	_	0	SENT_316	[p24l8t2625r384b2700],
4	in	IN	O	in	_	0	SENT_316	[p24l434t2624r514b2688],
5	contrast	NN	O	contrast	prep_in	18	SENT_316	[p24l562t2631r880b2689],
6	to	TO	O	to	_	0	SENT_316	[p24l925t2631r998b2689],
7	our	PRP$	O	we	poss	8	SENT_316	[p24l1049t2645r1181b2689],
8	study	NN	O	study	prep_to	5	SENT_316	[p24l1229t2621r1463b2710],
9	,	,	O	,	_	0	SENT_316	[p24l1229t2621r1463b2710],
10	where	WRB	O	where	advmod	15	SENT_316	[p24l1512t2621r1758b2689],
11	UGTZB7	NN	O	ugtzb7	nn	13	SENT_316	[p24l1806t2624r2148b2689],
12	mRNA	NN	O	mrna	nn	13	SENT_316	[p24l8t2728r281b2791],
13	levels	NNS	O	level	nsubj	15	SENT_316	[p24l334t2724r562b2792],
14	were	VBD	O	be	cop	15	SENT_316	[p24l616t2748r808b2792],
15	unchanged	JJ	O	unchanged	advcl	18	SENT_316	[p24l861t2724r1325b2813],
16	,	,	O	,	_	0	SENT_316	[p24l861t2724r1325b2813],
17	they	PRP	O	they	nsubj	18	SENT_316	[p24l1381t2724r1554b2813],
18	found	VBD	O	find	_	0	SENT_316	[p24l1607t2724r1843b2792],
19	higher	JJR	O	higher	amod	22	SENT_316	[p24l1895t2724r2152b2813],
20	UGTZB7	NN	O	ugtzb7	nn	22	SENT_316	[p24l9t2829r354b2894],
21	mRNA	NN	O	mrna	nn	22	SENT_316	[p24l392t2830r667b2893],
22	expression	NN	O	expression	dobj	18	SENT_316	[p24l704t2829r1141b2915],
23	in	IN	O	in	_	0	SENT_316	[p24l1177t2829r1257b2893],
24	carriers	NNS	O	carrier	prep_in	22	SENT_316	[p24l1293t2829r1593b2894],
25	of	IN	O	of	_	0	SENT_316	[p24l1633t2826r1714b2894],
26	the	DT	O	the	det	29	SENT_316	[p24l1741t2825r1865b2894],
27	intron	NN	O	intron	nn	29	SENT_316	[p24l1903t2829r2152b2894],
28	1	CD	NUMBER	1	num	29	SENT_316	[p24l13t2938r48b2995],
29	SNP	NN	ORGANIZATION	snp	prep_of	24	SENT_316	[p24l83t2931r261b2995],
30	.	.	O	.	_	0	SENT_316	[p24l83t2931r261b2995],

1	This	DT	O	this	det	2	SENT_317	[p24l291t2927r466b2995],
2	discrepancy	NN	O	discrepancy	nsubj	4	SENT_317	[p24l496t2927r979b3017],
3	may	MD	O	may	aux	4	SENT_317	[p24l1003t2951r1172b3017],
4	relate	VB	O	relate	_	0	SENT_317	[p24l1195t2927r1416b2995],
5	to	TO	O	to	_	0	SENT_317	[p24l1441t2937r1514b2995],
6	the	DT	O	the	det	7	SENT_317	[p24l1540t2927r1663b2995],
7	mechanism	NN	O	mechanism	prep_to	4	SENT_317	[p24l1689t2927r2152b2995],
8	by	IN	O	by	_	0	SENT_317	[p24l6t3029r104b3118],
9	which	WDT	O	which	rel	14	SENT_317	[p24l163t3029r415b3097],
10	these	DT	O	these	det	12	SENT_317	[p24l475t3029r680b3097],
11	noncoding	JJ	O	noncoding	amod	12	SENT_317	[p24l742t3029r1170b3118],
12	SNPS	NN	O	snp	nsubj	14	SENT_317	[p24l1233t3033r1440b3097],
13	may	MD	O	may	aux	14	SENT_317	[p24l1502t3053r1672b3118],
14	alter	VB	O	alter	rcmod	7	SENT_317	[p24l1733t3029r1909b3097],
15	gene	NN	O	gene	nn	16	SENT_317	[p24l1968t3053r2150b3118],
16	expression	NN	O	expression	dobj	14	SENT_317	[p24l10t3135r440b3221],
17	through	IN	O	through	_	0	SENT_317	[p24l464t3131r780b3220],
18	alteration	NN	O	alteration	prep_through	14	SENT_317	[p24l805t3131r1186b3199],
19	of	IN	O	of	_	0	SENT_317	[p24l1213t3131r1292b3199],
20	mRNA	NN	O	mrna	nn	23	SENT_317	[p24l1309t3136r1582b3199],
21	splicing	NN	O	splicing	nn	23	SENT_317	[p24l1608t3131r1925b3221],
22	regulatory	JJ	O	regulatory	amod	23	SENT_317	[p24l1948t3155r2150b3220, p24l9t3232r240b3321],
23	elements	NNS	O	element	prep_of	18	SENT_317	[p24l269t3232r646b3311],
24	,	,	O	,	_	0	SENT_317	[p24l269t3232r646b3311],
25	as	RB	O	as	advmod	27	SENT_317	[p24l679t3256r755b3300],
26	was	VBD	O	be	auxpass	27	SENT_317	[p24l784t3256r936b3300],
27	proposed	VBN	O	propose	dep	14	SENT_317	[p24l967t3232r1341b3321],
28	by	IN	O	by	_	0	SENT_317	[p24l1365t3232r1464b3321],
29	Innocenti	NNP	PERSON	Innocenti	agent	27	SENT_317	[p24l1491t3235r1873b3300],
30	et	FW	O	et	nn	34	SENT_317	[p24l1903t3242r1972b3300],
31	al.	FW	O	al.	nn	34	SENT_317	[p24l2000t3231r2151b3300],
32	“	FW	O	“	nn	34	SENT_317	[p24l2000t3231r2151b3300],
33	Several	JJ	O	several	amod	34	SENT_317	[p24l11t3336r302b3404],
34	splice	NN	O	splice	tmod	27	SENT_317	[p24l322t3336r554b3425],
35	variants	NNS	O	variant	nsubjpass	41	SENT_317	[p24l571t3339r888b3404],
36	of	IN	O	of	_	0	SENT_317	[p24l910t3336r989b3404],
37	UGTZB	NN	O	ugtzb	prep_of	35	SENT_317	[p24l999t3339r1290b3404],
38	7	CD	NUMBER	7	num	37	SENT_317	[p24l1304t3346r1341b3403],
39	have	VBP	O	have	aux	41	SENT_317	[p24l1359t3336r1546b3404],
40	been	VBN	O	be	auxpass	41	SENT_317	[p24l1561t3336r1752b3404],
41	observed	VBN	O	observe	rcmod	34	SENT_317	[p24l1771t3336r2148b3414],
42	,	,	O	,	_	0	SENT_317	[p24l1771t3336r2148b3414],
43	and	CC	O	and	_	0	SENT_317	[p24l10t3437r157b3506],
44	it	PRP	O	it	nsubj	46	SENT_317	[p24l188t3441r243b3506],
45	is	VBZ	O	be	cop	46	SENT_317	[p24l273t3441r335b3506],
46	possible	JJ	O	possible	conj_and	4	SENT_317	[p24l368t3437r695b3527],
47	that	IN	O	that	complm	51	SENT_317	[p24l726t3437r881b3506],
48	our	PRP$	O	we	poss	50	SENT_317	[p24l913t3462r1045b3506],
49	mRNA	NN	O	mrna	nn	50	SENT_317	[p24l1074t3442r1347b3505],
50	assay	NN	O	assay	nsubj	51	SENT_317	[p24l1379t3462r1590b3527],
51	differed	VBD	O	differ	ccomp	46	SENT_317	[p24l1623t3437r1933b3506],
52	from	IN	O	from	_	0	SENT_317	[p24l1965t3438r2151b3506],
53	Innocenti	NNP	PERSON	Innocenti	prep_from	51	SENT_317	[p24l8t3543r390b3607],
54	et	FW	O	et	nn	55	SENT_317	[p24l417t3549r486b3607],
55	al	FW	O	al	nn	57	SENT_317	[p24l510t3539r634b3607],
56	’s	POS	O	’s	possessive	57	SENT_317	[p24l510t3539r634b3607],
57	assay	NN	O	assay	dobj	51	SENT_317	[p24l662t3563r873b3629],
58	in	IN	O	in	_	0	SENT_317	[p24l897t3543r976b3607],
59	the	DT	O	the	det	60	SENT_317	[p24l999t3539r1122b3607],
60	splice	NN	O	splice	prep_in	51	SENT_317	[p24l1149t3539r1381b3629],
61	forms	VBZ	O	form	rcmod	60	SENT_317	[p24l1408t3539r1631b3607],
62	quantified	VBN	O	quantify	dep	61	SENT_317	[p24l1658t3539r2151b3629],
63	.	.	O	.	_	0	SENT_317	[p24l1658t3539r2151b3629],

1	“	NN	O	“	npadvmod	10	SENT_318	[p24l1658t3539r2151b3629],
2	For	IN	O	for	_	0	SENT_318	[p24l9t3646r143b3709],
3	example	NN	O	example	prep_for	10	SENT_318	[p24l181t3641r540b3731],
4	,	,	O	,	_	0	SENT_318	[p24l181t3641r540b3731],
5	our	PRP$	O	we	poss	7	SENT_318	[p24l582t3665r715b3709],
6	mRNA	NN	O	mrna	nn	7	SENT_318	[p24l751t3646r1023b3709],
7	assay	NN	O	assay	nsubj	10	SENT_318	[p24l1062t3665r1273b3730],
8	may	MD	O	may	aux	10	SENT_318	[p24l1309t3665r1478b3730],
9	have	VB	O	have	aux	10	SENT_318	[p24l1514t3641r1701b3709],
10	quantified	VBN	O	quantify	_	0	SENT_318	[p24l1741t3641r2152b3731],
11	total	JJ	O	total	amod	14	SENT_318	[p24l8t3743r184b3811],
12	UGTZB7	NN	O	ugtzb7	nn	14	SENT_318	[p24l243t3747r586b3811],
13	mRNA	NN	O	mrna	nn	14	SENT_318	[p24l646t3748r918b3811],
14	forms	NNS	O	form	dobj	10	SENT_318	[p24l977t3743r1223b3822],
15	,	,	O	,	_	0	SENT_318	[p24l977t3743r1223b3822],
16	including	VBG	O	include	_	0	SENT_318	[p24l1285t3743r1671b3832],
17	those	DT	O	those	prep_including	10	SENT_318	[p24l1729t3743r1940b3811],
18	that	WDT	O	that	nsubjpass	21	SENT_318	[p24l1998t3743r2152b3811],
19	were	VBD	O	be	auxpass	21	SENT_318	[p25l8t43r199b87],
20	aberrantly	RB	O	aberrantly	advmod	21	SENT_318	[p25l252t19r657b108],
21	spliced	VBN	O	splice	rcmod	17	SENT_318	[p25l708t19r996b108],
22	and	CC	O	and	_	0	SENT_318	[p25l1046t19r1193b87],
23	predicted	VBN	O	predict	conj_and	21	SENT_318	[p25l1242t19r1625b108],
24	to	TO	O	to	aux	25	SENT_318	[p25l1673t29r1746b87],
25	result	VB	O	result	xcomp	21	SENT_318	[p25l1796t19r2024b87],
26	in	IN	O	in	_	0	SENT_318	[p25l2072t22r2152b86],
27	truncated	VBN	O	truncate	prepc_in	25	SENT_318	[p25l8t122r391b190],
28	UGTZB7	NN	O	ugtzb7	nn	29	SENT_318	[p25l421t125r764b190],
29	protein	NN	O	protein	dobj	27	SENT_318	[p25l797t125r1105b211],
30	.	.	O	.	_	0	SENT_318	[p25l797t125r1105b211],

1	SPECIAL	JJ	O	special	amod	2	SENT_319	[p25l9t372r286b433],
2	POPULATIONS	NNS	O	population	_	0	SENT_319	[p25l319t372r822b433],

1	Polymorphisms	NNS	O	polymorphism	nsubj	17	SENT_320	[p25l116t467r754b557],
2	in	IN	O	in	_	0	SENT_320	[p25l812t471r892b535],
3	other	JJ	O	other	amod	4	SENT_320	[p25l948t467r1156b535],
4	genes	NNS	O	gene	prep_in	1	SENT_320	[p25l1210t491r1432b556],
5	associated	VBN	O	associate	partmod	4	SENT_320	[p25l1491t467r1906b535],
6	with	IN	O	with	_	0	SENT_320	[p25l1960t467r2146b535],
7	zidovudine	NN	O	zidovudine	nn	8	SENT_320	[p25l10t569r469b637],
8	disposition	NN	O	disposition	prep_with	5	SENT_320	[p25l500t569r974b658],
9	,	,	O	,	_	0	SENT_320	[p25l500t569r974b658],
10	such	JJ	O	such	_	0	SENT_320	[p25l1005t569r1193b637],
11	as	IN	O	as	_	0	SENT_320	[p25l1219t593r1295b637],
12	those	DT	O	those	prep_such_as	8	SENT_320	[p25l1323t569r1536b637],
13	encoding	VBG	O	encode	partmod	12	SENT_320	[p25l1565t569r1935b658],
14	drug	NN	O	drug	nn	15	SENT_320	[p25l1964t569r2145b658],
15	transporters	NNS	O	transporter	dobj	13	SENT_320	[p25l9t682r517b761],
16	,	,	O	,	_	0	SENT_320	[p25l9t682r517b761],
17	have	VBP	O	have	_	0	SENT_320	[p25l557t672r745b740],
18	the	DT	O	the	det	19	SENT_320	[p25l784t672r907b740],
19	potential	JJ	O	potential	dobj	17	SENT_320	[p25l946t672r1308b761],
20	to	TO	O	to	aux	21	SENT_320	[p25l1345t682r1419b740],
21	explain	VB	O	explain	dep	19	SENT_320	[p25l1460t672r1762b761],
22	the	DT	O	the	det	23	SENT_320	[p25l1798t672r1922b740],
23	variability	NN	O	variability	dobj	21	SENT_320	[p25l1959t675r2143b740, p25l11t773r268b863],
24	in	IN	O	in	_	0	SENT_320	[p25l329t777r408b841],
25	zidovudine	NN	O	zidovudine	nn	26	SENT_320	[p25l469t773r928b842],
26	clearance	NN	O	clearance	prep_in	21	SENT_320	[p25l992t773r1371b842],
27	observed	VBN	O	observe	partmod	26	SENT_320	[p25l1435t774r1795b842],
28	in	IN	O	in	_	0	SENT_320	[p25l1856t777r1936b841],
29	this	DT	O	this	det	30	SENT_320	[p25l1995t773r2143b842],
30	study	NN	O	study	prep_in	27	SENT_320	[p25l11t875r234b965],
31	and	CC	O	and	_	0	SENT_320	[p25l278t875r426b943],
32	warrant	NN	O	warrant	nn	34	SENT_320	[p25l469t886r784b943],
33	future	JJ	DATE	future	amod	34	SENT_320	[p25l828t875r1069b943],
34	evaluation	NN	O	evaluation	prep_in	27	SENT_320	[p25l1116t875r1560b943],
35	.	.	O	.	_	0	SENT_320	[p25l1116t875r1560b943],

1	A	DT	O	a	det	2	SENT_321	[p25l1609t880r1675b943],
2	trend	NN	O	trend	dep	7	SENT_321	[p25l1718t875r1933b943],
3	(	CD	NUMBER	(	num	4	SENT_321	[p25l1981t875r2062b956],
4	P	NN	O	p	dep	2	SENT_321	[p25l1981t875r2062b956],
5	=	JJ	O	=	dep	7	SENT_321	[p25l2099t909r2146b930],
6	.06	CD	NUMBER	.06	num	7	SENT_321	[p25l14t977r155b1058],
7	)	NN	O	)	dep	14	SENT_321	[p25l14t977r155b1058],
8	for	IN	O	for	_	0	SENT_321	[p25l194t977r304b1045],
9	elevated	JJ	O	elevated	amod	11	SENT_321	[p25l340t977r676b1045],
10	peripheral	JJ	O	peripheral	amod	11	SENT_321	[p25l711t977r1131b1067],
11	blood	NN	O	blood	prep_for	7	SENT_321	[p25l1163t977r1396b1045],
12	mononuclear	JJ	O	mononuclear	amod	14	SENT_321	[p25l1430t977r1967b1045],
13	cell	NN	O	cell	nn	14	SENT_321	[p25l2002t977r2144b1045],
14	zidovudine	NN	O	zidovudine	_	0	SENT_321	[p25l10t1079r469b1147],
15	triphosphate	NN	O	triphosphate	nn	16	SENT_321	[p25l500t1079r1016b1169],
16	levels	NNS	O	level	nsubjpass	18	SENT_321	[p25l1048t1079r1279b1147],
17	was	VBD	O	be	auxpass	18	SENT_321	[p25l1310t1103r1463b1147],
18	observed	VBN	O	observe	rcmod	14	SENT_321	[p25l1498t1079r1859b1147],
19	in	IN	O	in	_	0	SENT_321	[p25l1890t1083r1969b1147],
20	carriers	NNS	O	carrier	prep_in	18	SENT_321	[p25l2001t1103r2144b1147, p25l8t1183r186b1247],
21	of	IN	O	of	_	0	SENT_321	[p25l222t1180r302b1247],
22	the	DT	O	the	det	25	SENT_321	[p25l326t1180r450b1247],
23	ABCC4	NN	O	abcc4	nn	25	SENT_321	[p25l480t1183r771b1247],
24	(	CD	NUMBER	(	num	25	SENT_321	[p25l808t1180r1102b1260],
25	MRP4	NN	O	mrp4	prep_of	20	SENT_321	[p25l808t1180r1102b1260],
26	)	CD	NUMBER	)	num	28	SENT_321	[p25l808t1180r1102b1260],
27	c.	NN	O	c.	nn	28	SENT_321	[p25l1140t1183r1584b1247],
28	3724G	NN	O	3724g	dep	29	SENT_321	[p25l1140t1183r1584b1247],
29	>	JJR	O	>	dep	25	SENT_321	[p25l1140t1183r1584b1247],
30	A	DT	O	a	det	32	SENT_321	[p25l1140t1183r1584b1247],
31	variant	JJ	O	variant	amod	32	SENT_321	[p25l1615t1180r1952b1247],
32	.4	NN	NUMBER	.4	dep	29	SENT_321	[p25l1615t1180r1952b1247],

1	The	DT	O	the	det	3	SENT_322	[p25l117t1282r271b1349],
2	clinical	JJ	O	clinical	amod	3	SENT_322	[p25l302t1282r608b1349],
3	relevance	NN	O	relevance	nsubj	19	SENT_322	[p25l635t1282r1029b1349],
4	of	IN	O	of	_	0	SENT_322	[p25l1060t1282r1141b1349],
5	the	DT	O	the	det	6	SENT_322	[p25l1160t1282r1286b1349],
6	association	NN	O	association	prep_of	3	SENT_322	[p25l1316t1285r1775b1349],
7	between	IN	O	between	_	0	SENT_322	[p25l1799t1282r2145b1349],
8	UGTZB7	NNP	O	UGTZB7	nn	10	SENT_322	[p25l20t1387r365b1452],
9	genetic	JJ	O	genetic	amod	10	SENT_322	[p25l394t1387r686b1473],
10	variation	NN	O	variation	prep_between	6	SENT_322	[p25l721t1387r1093b1452],
11	and	CC	O	and	_	0	SENT_322	[p25l1128t1383r1278b1452],
12	zidovudine	NN	O	zidovudine	nn	13	SENT_322	[p25l1314t1383r1781b1452],
13	metabolism	NN	O	metabolism	conj_and	10	SENT_322	[p25l1817t1383r2144b1452, p25l10t1485r187b1553],
14	and	CC	O	and	_	0	SENT_322	[p25l221t1485r371b1553],
15	disposition	NN	O	disposition	conj_and	10	SENT_322	[p25l408t1485r870b1575],
16	is	VBZ	O	be	cop	19	SENT_322	[p25l904t1489r967b1553],
17	as	RB	O	as	advmod	19	SENT_322	[p25l1004t1509r1081b1553],
18	yet	RB	O	yet	advmod	19	SENT_322	[p25l1116t1496r1240b1575],
19	unclear	JJ	O	unclear	_	0	SENT_322	[p25l1272t1485r1596b1553],
20	.	.	O	.	_	0	SENT_322	[p25l1272t1485r1596b1553],

1	Zidovudine	NNP	O	Zidovudine	nsubj	7	SENT_323	[p25l1635t1485r2141b1564],
2	,	,	O	,	_	0	SENT_323	[p25l1635t1485r2141b1564],
3	like	IN	O	like	_	0	SENT_323	[p25l10t1587r160b1655],
4	all	DT	O	all	det	5	SENT_323	[p25l204t1587r303b1655],
5	NRTIS	NNS	O	nrti	prep_like	7	SENT_323	[p25l344t1592r624b1666],
6	,	,	O	,	_	0	SENT_323	[p25l344t1592r624b1666],
7	requires	VBZ	O	require	_	0	SENT_323	[p25l667t1591r999b1677],
8	intracellular	JJ	O	intracellular	amod	9	SENT_323	[p25l1043t1587r1555b1655],
9	phosphorylation	NN	O	phosphorylation	dobj	7	SENT_323	[p25l1594t1587r2143b1677, p25l9t1693r172b1757],
10	to	TO	O	to	aux	11	SENT_323	[p25l214t1699r289b1757],
11	form	VB	O	form	infmod	9	SENT_323	[p25l336t1689r527b1757],
12	the	DT	O	the	det	15	SENT_323	[p25l569t1689r695b1757],
13	active	JJ	O	active	amod	15	SENT_323	[p25l742t1693r982b1757],
14	triphosphate	NN	O	triphosphate	nn	15	SENT_323	[p25l1026t1689r1551b1779],
15	moieties	NNS	O	moiety	dobj	11	SENT_323	[p25l1596t1693r1942b1757],
16	that	WDT	O	that	nsubj	17	SENT_323	[p25l1987t1689r2146b1757],
17	exert	VBP	O	exert	rcmod	15	SENT_323	[p25l11t1800r213b1858],
18	clinical	JJ	O	clinical	amod	19	SENT_323	[p25l262t1790r569b1858],
19	effect	NN	O	effect	dobj	17	SENT_323	[p25l620t1789r926b1858],
20	.	.	O	.	_	0	SENT_323	[p25l620t1789r926b1858],

1	”	NN	O	”	dep	6	SENT_324	[p25l620t1789r926b1858],
2	Although	IN	O	although	dep	6	SENT_324	[p25l975t1790r1365b1879],
3	zidovudine	NN	O	zidovudine	nn	5	SENT_324	[p25l1414t1790r1881b1858],
4	pharmacologic	JJ	O	pharmacologic	amod	5	SENT_324	[p25l1931t1790r2144b1879, p25l9t1894r426b1983],
5	variability	NN	O	variability	nsubj	6	SENT_324	[p25l473t1894r900b1983],
6	affects	VBZ	O	affect	advcl	22	SENT_324	[p25l947t1894r1207b1962],
7	treatment	NN	O	treatment	nn	8	SENT_324	[p25l1254t1904r1650b1962],
8	response	NN	O	response	dobj	6	SENT_324	[p25l1694t1893r2144b1983],
9	,	,	O	,	_	0	SENT_324	[p25l1694t1893r2144b1983],
10	“	CD	NUMBER	“	nsubjpass	22	SENT_324	[p25l1694t1893r2144b1983],
11	no	DT	O	no	det	12	SENT_324	[p25l9t2020r108b2064],
12	relationship	NN	O	relationship	dep	10	SENT_324	[p25l160t1995r658b2085],
13	between	IN	O	between	_	0	SENT_324	[p25l709t1995r1055b2064],
14	plasma	NN	O	plasma	nn	16	SENT_324	[p25l1105t1996r1399b2085],
15	zidovudine	NN	O	zidovudine	nn	16	SENT_324	[p25l1449t1995r1916b2064],
16	concentrations	NNS	O	concentration	prep_between	12	SENT_324	[p25l1970t2020r2143b2064, p25l11t2100r467b2164],
17	and	CC	O	and	_	0	SENT_324	[p25l496t2096r646b2164],
18	clinic	NN	O	clinic	nn	19	SENT_324	[p25l672t2096r902b2164],
19	effect	NN	O	effect	nsubjpass	22	SENT_324	[p25l930t2096r1153b2164],
20	has	VBZ	O	have	aux	22	SENT_324	[p25l1176t2096r1310b2164],
21	been	VBN	O	be	auxpass	22	SENT_324	[p25l1335t2096r1530b2164],
22	demonstrated	VBN	O	demonstrate	_	0	SENT_324	[p25l1557t2096r2139b2164],
23	.	.	O	.	_	0	SENT_324	[p25l1557t2096r2139b2164],

1	However	RB	O	however	advmod	47	SENT_325	[p25l9t2203r356b2277],
2	,	,	O	,	_	0	SENT_325	[p25l9t2203r356b2277],
3	percentage	NN	O	percentage	nn	4	SENT_325	[p25l395t2208r794b2288],
4	change	NN	O	change	nsubjpass	47	SENT_325	[p25l832t2198r1088b2287],
5	in	IN	O	in	_	0	SENT_325	[p25l1126t2202r1198b2266],
6	CD4	NN	O	cd4	nn	7	SENT_325	[p25l1234t2202r1385b2266],
7	cell	NN	O	cell	prep_in	4	SENT_325	[p25l1425t2198r1555b2266],
8	count	NN	O	count	nsubjpass	22	SENT_325	[p25l1593t2208r1801b2266],
9	and	CC	O	and	_	0	SENT_325	[p25l1837t2198r1972b2266],
10	rate	NN	O	rate	nsubjpass	22	SENT_325	[p25l2007t2208r2144b2266],
11	of	IN	O	of	_	0	SENT_325	[p25l11t2300r88b2368],
12	decline	NN	O	decline	prep_of	8	SENT_325	[p25l118t2300r402b2368],
13	in	IN	O	in	_	0	SENT_325	[p25l438t2304r514b2368],
14	HIV	NN	O	hiv	nn	15	SENT_325	[p25l548t2305r702b2368],
15	RNA	NN	O	rna	prep_in	12	SENT_325	[p25l734t2305r921b2368],
16	in	IN	O	in	_	0	SENT_325	[p25l956t2304r1032b2368],
17	plasma	NN	O	plasma	prep_in	15	SENT_325	[p25l1066t2300r1344b2390],
18	during	IN	O	during	_	0	SENT_325	[p25l1380t2300r1636b2389],
19	zidovudinecontaining	NN	O	zidovudinecontaining	nn	20	SENT_325	[p25l1671t2300r2144b2368, p25l11t2405r449b2491],
20	therapy	NN	O	therapy	prep_during	17	SENT_325	[p25l512t2402r826b2491],
21	were	VBD	O	be	auxpass	22	SENT_325	[p25l887t2426r1084b2470],
22	related	VBN	O	relate	rcmod	4	SENT_325	[p25l1147t2402r1431b2470],
23	to	TO	O	to	_	0	SENT_325	[p25l1494t2412r1568b2470],
24	intracellular	JJ	O	intracellular	amod	25	SENT_325	[p25l1634t2402r2146b2470],
25	concentrations	NNS	O	concentration	prep_to	22	SENT_325	[p25l11t2508r619b2573],
26	of	IN	O	of	_	0	SENT_325	[p25l720t2505r801b2573],
27	zidovudine	NN	O	zidovudine	nn	28	SENT_325	[p25l892t2505r1358b2573],
28	triphosphate	NN	O	triphosphate	prep_of	25	SENT_325	[p25l1456t2504r2144b2594],
29	.35	CD	NUMBER	.35	number	30	SENT_325	[p25l1456t2504r2144b2594],
30	’	CD	NUMBER	’	dep	28	SENT_325	[p25l1456t2504r2144b2594],
31	3	CD	NUMBER	3	num	32	SENT_325	[p25l1456t2504r2144b2594],
32	“	NN	O	“	dep	30	SENT_325	[p25l1456t2504r2144b2594],
33	Furthermore	RB	O	furthermore	advmod	22	SENT_325	[p25l10t2606r552b2685],
34	,	,	O	,	_	0	SENT_325	[p25l10t2606r552b2685],
35	a	DT	O	a	det	39	SENT_325	[p25l588t2631r628b2675],
36	higher	JJR	O	higher	dep	37	SENT_325	[p25l658t2606r922b2696],
37	total	JJ	O	total	amod	39	SENT_325	[p25l952t2606r1135b2675],
38	intracellular	JJ	O	intracellular	amod	39	SENT_325	[p25l1168t2606r1679b2675],
39	concentration	NN	O	concentration	nsubjpass	47	SENT_325	[p25l1712t2617r2143b2675, p25l9t2712r172b2776],
40	of	IN	O	of	_	0	SENT_325	[p25l211t2708r292b2776],
41	the	DT	O	the	prep_of	39	SENT_325	[p25l322t2708r448b2776],
42	phosphorylated	VBN	O	phosphorylate	partmod	41	SENT_325	[p25l487t2708r1138b2798],
43	moieties	NNS	O	moiety	dobj	42	SENT_325	[p25l1175t2712r1522b2776],
44	of	IN	O	of	_	0	SENT_325	[p25l1564t2708r1645b2776],
45	zidovudine	NN	O	zidovudine	prep_of	43	SENT_325	[p25l1677t2708r2144b2776],
46	was	VBD	O	be	auxpass	47	SENT_325	[p25l9t2834r163b2878],
47	associated	VBN	O	associate	_	0	SENT_325	[p25l255t2810r679b2878],
48	with	IN	O	with	_	0	SENT_325	[p25l766t2810r954b2878],
49	increased	VBN	O	increase	amod	50	SENT_325	[p25l1043t2810r1437b2878],
50	probability	NN	O	probability	prep_with	47	SENT_325	[p25l1525t2810r1981b2900],
51	of	IN	O	of	_	0	SENT_325	[p25l2071t2810r2152b2878],
52	reduced	VBN	O	reduce	amod	54	SENT_325	[p25l8t2912r343b2980],
53	hemoglobin	NN	O	hemoglobin	nn	54	SENT_325	[p25l393t2912r883b3001],
54	levels	NNS	O	level	prep_of	50	SENT_325	[p25l935t2911r1258b2980],
55	.37	CD	NUMBER	.37	nsubj	69	SENT_325	[p25l935t2911r1258b2980],
56	As	IN	O	as	_	0	SENT_325	[p25l1309t2917r1413b2980],
57	the	DT	O	the	det	58	SENT_325	[p25l1466t2912r1592b2980],
58	relationship	NN	O	relationship	prep_as	55	SENT_325	[p25l1643t2912r2142b3002],
59	between	IN	O	between	_	0	SENT_325	[p25l7t3014r353b3082],
60	zidovudine	NN	O	zidovudine	nn	62	SENT_325	[p25l386t3014r852b3082],
61	plasma	NN	O	plasma	nn	62	SENT_325	[p25l886t3014r1180b3103],
62	exposure	NN	O	exposure	prep_between	58	SENT_325	[p25l1213t3038r1583b3103],
63	and	CC	O	and	_	0	SENT_325	[p25l1618t3014r1768b3082],
64	intracellular	JJ	O	intracellular	amod	66	SENT_325	[p25l1801t3014r2143b3082, p25l10t3117r203b3185],
65	triphosphate	NN	O	triphosphate	nn	66	SENT_325	[p25l247t3117r772b3206],
66	concentrations	NNS	O	concentration	prep_between	58	SENT_325	[p25l821t3120r1428b3185],
67	is	VBZ	O	be	cop	69	SENT_325	[p25l1478t3120r1540b3185],
68	currently	RB	DATE	currently	advmod	69	SENT_325	[p25l1590t3117r1968b3206],
69	not	RB	O	not	rcmod	54	SENT_325	[p25l2013t3127r2146b3185],

1	KWARA	NNP	LOCATION	KWARA	nn	3	SENT_326	[p25l936t3508r1089b3538],
2	ET	NNP	O	ET	nn	3	SENT_326	[p25l1104t3508r1160b3538],
3	AL	NNP	O	AL	_	0	SENT_326	[p25l1169t3508r1225b3538],

1	Carrier	NN	O	carrier	_	0	SENT_327	[p26l1375t1677r1581b1734],

1	Noncarrier	NN	O	noncarrier	_	0	SENT_328	[p26l829t1678r1143b1734],

1	6	CD	NUMBER	6	num	2	SENT_329	[p26l411t1015r444b1070],
2	O	NN	O	o	_	0	SENT_329	[p26l373t1015r407b1070],
3	o.	NN	O	o.	dep	2	SENT_329	[p26l316t1015r365b1070],

1	:	:	O	:	_	0	SENT_330	[p26l199t573r270b796],
2	_	CD	NUMBER	_	_	0	SENT_330	[p26l199t573r270b796],
3	2o	NN	O	2o	dep	2	SENT_330	[p26l199t573r270b796],
4	.	.	O	.	_	0	SENT_330	[p26l199t573r270b796],

1	_	NN	O	_	nn	2	SENT_331	[p26l199t573r270b796],
2	n	NN	O	n	nsubj	3	SENT_331	[p26l199t573r270b796],
3	_	VBG	O	_	_	0	SENT_331	[p26l199t573r270b796],
4	mE	NN	O	me	dobj	3	SENT_331	[p26l198t823r270b1316],
5	\	CD	NUMBER	\	num	4	SENT_331	[p26l198t823r270b1316],
6	:	:	O	:	_	0	SENT_331	[p26l198t823r270b1316],
7	_	CD	NUMBER	_	num	8	SENT_331	[p26l198t823r270b1316],
8	E	NN	O	e	dep	4	SENT_331	[p26l198t823r270b1316],
9	\	CD	NUMBER	\	num	10	SENT_331	[p26l198t823r270b1316],
10	mw_oE	NN	O	mw_oe	dep	8	SENT_331	[p26l198t823r270b1316],
11	:	:	O	:	_	0	SENT_331	[p26l198t823r270b1316],

1	4	CD	NUMBER	4	num	3	SENT_332	[p26l410t1215r445b1269],
2	O	NN	O	o	nn	3	SENT_332	[p26l373t1215r407b1270],
3	o.	NN	O	o.	_	0	SENT_332	[p26l316t1215r365b1270],
4	0.14	CD	NUMBER	0.14	dep	3	SENT_332	[p26l316t214r445b268],
5	0.12	CD	NUMBER	0.12	dep	4	SENT_332	[p26l316t414r443b469],

1	070	CD	NUMBER	070	num	2	SENT_333	[p26l1410t2246r1529b2397],
2	O	NN	O	o	_	0	SENT_333	[p26l1464t2434r1502b2484],
3	to	TO	O	to	dep	2	SENT_333	[p26l1464t2516r1502b2591],

1	Carrier	NN	O	carrier	_	0	SENT_334	[p26l1381t3230r1587b3287],

1	Noncarrier	NN	O	noncarrier	_	0	SENT_335	[p26l829t3231r1143b3287],

1	:35	CD	NUMBER	:35	_	0	SENT_336	[p26l236t1941r307b2169],
2	.	.	O	.	_	0	SENT_336	[p26l236t1941r307b2169],

1	2	CD	NUMBER	2	number	2	SENT_337	[p26l240t2195r293b2257],
2	¢	CD	NUMBER	¢	num	3	SENT_337	[p26l236t2278r307b2536],
3	>	JJR	O	>	_	0	SENT_337	[p26l236t2278r307b2536],
4	_	CD	MONEY	_	number	5	SENT_337	[p26l236t2278r307b2536],
5	§	CD	MONEY	§	num	3	SENT_337	[p26l236t2278r307b2536],
6	$	$	MONEY	$	amod	3	SENT_337	[p26l236t2278r307b2536],
7	=	JJ	MONEY	=	dep	6	SENT_337	[p26l237t2561r307b2784],
8	_	CD	NUMBER	_	num	10	SENT_337	[p26l237t2561r307b2784],
9	2oa	JJ	O	2oa	amod	10	SENT_337	[p26l237t2561r307b2784],
10	ENE	NN	O	ene	dep	3	SENT_337	[p26l236t2809r293b3072],
11	:	:	O	:	_	0	SENT_337	[p26l236t2809r293b3072],

1	amuse	VB	O	amuse	_	0	SENT_338	[p26l242t3450r313b3678],
2	.	.	O	.	_	0	SENT_338	[p26l242t3450r313b3678],

1	2	CD	NUMBER	2	number	2	SENT_339	[p26l246t3704r298b3766],
2	9	CD	NUMBER	9	_	0	SENT_339	[p26l256t3787r298b3834],
3	'	''	O	'	_	0	SENT_339	[p27l243t6r298b111],

1	-	:	O	-	_	0	SENT_340	[p27l243t6r298b111],
2	E	NN	O	e	dep	5	SENT_340	[p27l243t6r298b111],
3	7	CD	NUMBER	7	number	4	SENT_340	[p27l393t18r426b70],
4	3	CD	NUMBER	3	amod	2	SENT_340	[p27l972t33r1008b126],
5	7	CD	NUMBER	7	_	0	SENT_340	[p27l243t117r298b193],
6	.	.	O	.	_	0	SENT_340	[p27l243t117r298b193],

1	’	NN	O	’	_	0	SENT_341	[p27l243t117r298b193],
2	°	CD	NUMBER	°	num	1	SENT_341	[p27l972t138r1008b175],
3	o	NN	O	o	dep	1	SENT_341	[p27l1487t156r1523b193],
4	‘	CD	NUMBER	‘	num	3	SENT_341	[p27l243t239r297b332],
5	z	SYM	O	z	dep	7	SENT_341	[p27l243t239r297b332],
6	‘	CD	NUMBER	‘	number	7	SENT_341	[p27l243t239r297b332],
7	5	CD	NUMBER	5	dep	3	SENT_341	[p27l392t281r425b334],
8	.	.	O	.	_	0	SENT_341	[p27l972t198r1008b234],

1	9	CD	NUMBER	9	_	0	SENT_342	[p27l243t339r297b442],
2	i	FW	O	i	dep	1	SENT_342	[p27l972t247r1008b392],
3	:5	SYM	O	:5	dep	1	SENT_342	[p27l1487t322r1523b358, p27l243t467r297b548],
4	-	:	O	-	_	0	SENT_342	[p27l949t405r1239b570],
5	!	.	O	!	_	0	SENT_342	[p27l949t405r1239b570],

1	-	:	O	-	_	0	SENT_343	[p27l949t405r1239b570],
2	\	NN	O	\	nsubj	9	SENT_343	[p27l949t405r1239b570],
3	/	:	O	/	punct	8	SENT_343	[p27l949t405r1239b570],
4	3	CD	NUMBER	3	dep	8	SENT_343	[p27l949t405r1239b570],
5	:	:	O	:	_	0	SENT_343	[p27l949t405r1239b570],
6	0.86	CD	NUMBER	0.86	num	7	SENT_343	[p27l1262t454r1391b508],
7	o	NN	O	o	dep	4	SENT_343	[p27l1487t461r1523b498],
8	I	PRP	O	I	dep	2	SENT_343	[p27l243t555r297b632],
9	‘	VBP	O	‘	_	0	SENT_343	[p27l243t555r297b632],
10	:	:	O	:	_	0	SENT_343	[p27l243t555r297b632],
11	3	CD	NUMBER	3	num	12	SENT_343	[p27l393t542r426b597],
12	\	NN	O	\	dobj	9	SENT_343	[p27l1249t565r1397b629],
13	\	CD	NUMBER	\	number	14	SENT_343	[p27l1249t565r1397b629],
14	\	CD	NUMBER	\	num	15	SENT_343	[p27l1249t565r1397b629],
15	Q	NNP	O	Q	dep	12	SENT_343	[p27l1487t601r1523b637],
16	<	JJR	O	<	amod	15	SENT_343	[p27l242t636r299b683],
17	5	CD	NUMBER	5	num	19	SENT_343	[p27l242t636r299b683],
18	‘	NN	O	‘	nn	19	SENT_343	[p27l1410t630r1549b663, p27l243t690r299b730],
19	D	NN	O	d	dep	16	SENT_343	[p27l1410t630r1549b663, p27l243t690r299b730],

1	Noncarrier	NN	O	noncarrier	nn	2	SENT_344	[p27l836t914r1150b970],
2	Carrier	NN	O	carrier	_	0	SENT_344	[p27l1403t913r1609b970],

1	Figure	NNP	O	Figure	_	0	SENT_345	[p27l10t1158r216b1226],
2	4	CD	NUMBER	4	dep	1	SENT_345	[p27l246t1163r296b1209],
3	.	.	O	.	_	0	SENT_345	[p27l246t1163r296b1209],

1	Effect	NN	O	effect	_	0	SENT_346	[p27l372t1155r560b1226],
2	of	IN	O	of	_	0	SENT_346	[p27l587t1155r656b1226],
3	UGT2B7	NN	O	ugt2b7	nn	6	SENT_346	[p27l673t1158r1063b1209],
4	*	CD	NUMBER	*	num	6	SENT_346	[p27l673t1158r1063b1209],
5	1c	NN	O	1c	nn	6	SENT_346	[p27l673t1158r1063b1209],
6	allele	NN	O	allele	prep_of	1	SENT_346	[p27l1096t1155r1269b1209],
7	on	IN	O	on	_	0	SENT_346	[p27l1299t1174r1375b1209],
8	{	NN	O	{	nn	11	SENT_346	[p27l1407t1155r1504b1219],
9	A	NN	O	a	nn	11	SENT_346	[p27l1407t1155r1504b1219],
10	}	NN	O	}	nn	11	SENT_346	[p27l1407t1155r1504b1219],
11	glucuronidation	NN	O	glucuronidation	prep_on	1	SENT_346	[p27l1529t1155r2052b1226],
12	of	IN	O	of	_	0	SENT_346	[p27l2085t1155r2153b1226],
13	zidovudine	NN	O	zidovudine	prep_of	11	SENT_346	[p27l11t1242r391b1305],
14	,	,	O	,	_	0	SENT_346	[p27l11t1242r391b1305],
15	[	NN	O	[	nn	17	SENT_346	[p27l426t1243r515b1307],
16	B	NN	O	b	nn	17	SENT_346	[p27l426t1243r515b1307],
17	]	NN	O	]	prep_on	1	SENT_346	[p27l426t1243r515b1307],
18	relative	JJ	O	relative	amod	21	SENT_346	[p27l541t1243r784b1296],
19	UGT2B7	NN	O	ugt2b7	nn	21	SENT_346	[p27l820t1245r1092b1296],
20	protein	NN	O	protein	nn	21	SENT_346	[p27l1114t1246r1348b1313],
21	content	NN	O	content	dep	17	SENT_346	[p27l1381t1250r1624b1296],
22	in	IN	O	in	_	0	SENT_346	[p27l1648t1246r1710b1296],
23	human	JJ	O	human	amod	25	SENT_346	[p27l1740t1242r1969b1296],
24	liver	NN	O	liver	nn	25	SENT_346	[p27l1999t1243r2147b1296],
25	microsomes	NNS	O	microsome	prep_in	21	SENT_346	[p27l11t1334r415b1393],
26	,	,	O	,	_	0	SENT_346	[p27l11t1334r415b1393],
27	and	CC	O	and	_	0	SENT_346	[p27l447t1331r572b1384],
28	[	NN	O	[	nn	30	SENT_346	[p27l599t1331r622b1395],
29	C	NN	O	c	nn	30	SENT_346	[p27l623t1333r670b1384],
30	}	NN	O	}	conj_and	11	SENT_346	[p27l666t1331r689b1395],
31	relative	JJ	O	relative	amod	32	SENT_346	[p27l714t1331r956b1384],
32	mRNA	NN	O	mrna	dep	30	SENT_346	[p27l982t1334r1216b1385],
33	.	.	O	.	_	0	SENT_346	[p27l982t1334r1216b1385],

1	Differences	NNS	O	difference	nsubjpass	8	SENT_347	[p27l1246t1331r1611b1401],
2	between	IN	O	between	_	0	SENT_347	[p27l1639t1331r1899b1384],
3	carrier	NN	O	carrier	nn	6	SENT_347	[p27l1931t1334r2147b1384],
4	and	CC	O	and	_	0	SENT_347	[p27l13t1419r138b1473],
5	noncarrier	NN	O	noncarrier	conj_and	3	SENT_347	[p27l159t1422r504b1473],
6	groups	NNS	O	group	prep_between	1	SENT_347	[p27l522t1438r743b1490],
7	were	VBD	O	be	auxpass	8	SENT_347	[p27l771t1438r918b1473],
8	evaluated	VBN	O	evaluate	_	0	SENT_347	[p27l944t1419r1262b1473],
9	by	IN	O	by	_	0	SENT_347	[p27l1286t1419r1364b1490],
10	unpaired	JJ	O	unpaired	amod	14	SENT_347	[p27l1387t1419r1681b1490],
11	t	NN	O	t	nn	14	SENT_347	[p27l1703t1427r1724b1473],
12	test	NN	O	test	nn	14	SENT_347	[p27l1752t1426r1864b1473],
13	[	NN	O	[	nn	14	SENT_347	[p27l1888t1419r1911b1483],
14	protein	NN	O	protein	agent	8	SENT_347	[p27l1906t1422r2140b1490],
15	and	CC	O	and	_	0	SENT_347	[p27l13t1507r138b1561],
16	mRNA	NN	O	mrna	agent	8	SENT_347	[p27l180t1507r422b1572],
17	}	CD	NUMBER	}	num	16	SENT_347	[p27l180t1507r422b1572],
18	or	CC	O	or	_	0	SENT_347	[p27l470t1526r536b1561],
19	by	IN	O	by	_	0	SENT_347	[p27l578t1507r657b1579],
20	Mann-Whitney	JJ	O	mann-whitney	amod	22	SENT_347	[p27l694t1507r1185b1579],
21	rank	NN	O	rank	nn	22	SENT_347	[p27l1223t1507r1375b1561],
22	sum	NN	O	sum	conj_or	14	SENT_347	[p27l1418t1526r1550b1561],
23	test	NN	O	test	nn	26	SENT_347	[p27l1601t1514r1712b1561],
24	{	CD	NUMBER	{	num	26	SENT_347	[p27l1757t1506r2142b1571],
25	zidovudine	NN	O	zidovudine	nn	26	SENT_347	[p27l1757t1506r2142b1571],
26	glucuronidationj	NN	O	glucuronidationj	dep	8	SENT_347	[p27l9t1596r574b1666],
27	.	.	O	.	_	0	SENT_347	[p27l9t1596r574b1666],

1	1088	CD	DATE	1088	num	2	SENT_348	[p27l13t1826r202b1892],
2	o	NN	O	o	_	0	SENT_348	[p27l265t1852r294b1881],
3	I	PRP	O	I	nsubj	4	SENT_348	[p27l356t1834r385b1906],
4	Clin	VBP	O	clin	rcmod	2	SENT_348	[p27l413t1830r565b1891],
5	Pharmacol	NNP	O	Pharmacol	dobj	4	SENT_348	[p27l591t1830r993b1891],
6	2009	CD	DATE	2009	num	5	SENT_348	[p27l1023t1839r1710b1902],
7	;	:	O	;	_	0	SENT_348	[p27l1023t1839r1710b1902],
8	419:1079	CD	DURATION	419:1079	num	9	SENT_348	[p27l1023t1839r1710b1902],
9	-1090	CD	DURATION	-1090	dep	5	SENT_348	[p27l1023t1839r1710b1902],

1	ANOVA	NNP	O	ANOVA	_	0	SENT_349	[p27l471t2215r720b2269],
2	*	CD	NUMBER	*	num	3	SENT_349	[p27l430t2305r508b2357],
3	P	NN	O	p	dep	1	SENT_349	[p27l430t2305r508b2357],
4	=	JJ	O	=	amod	3	SENT_349	[p27l525t2328r562b2348],
5	0.045	CD	NUMBER	0.045	tmod	4	SENT_349	[p27l587t2306r760b2358],

1	nmoles/min/mg	NN	O	nmoles/min/mg	nn	2	SENT_350	[p27l98t2554r166b3069],
2	protein	NN	O	protein	_	0	SENT_350	[p27l98t2293r165b2526],

1	*	NN	O	*	_	0	SENT_351	[p27l422t3236r651b3291],
2	1a	NN	O	1a	dep	1	SENT_351	[p27l422t3236r651b3291],
3	/	:	O	/	punct	1	SENT_351	[p27l422t3236r651b3291],
4	*	CD	NUMBER	*	num	5	SENT_351	[p27l422t3236r651b3291],
5	1a	NN	O	1a	dep	1	SENT_351	[p27l422t3236r651b3291],
6	*	CD	NUMBER	*	num	7	SENT_351	[p27l720t3236r909b3291],
7	1a	NN	O	1a	dep	5	SENT_351	[p27l720t3236r909b3291],
8	/	:	O	/	punct	5	SENT_351	[p27l720t3236r909b3291],
9	*	CD	NUMBER	*	number	10	SENT_351	[p27l720t3236r909b3291],
10	2	CD	NUMBER	2	num	11	SENT_351	[p27l720t3236r909b3291],
11	*	NN	O	*	dep	5	SENT_351	[p27l1018t3236r1167b3291],
12	2	CD	NUMBER	2	dep	11	SENT_351	[p27l1018t3236r1167b3291],
13	/	:	O	/	punct	5	SENT_351	[p27l1018t3236r1167b3291],
14	*	CD	NUMBER	*	num	15	SENT_351	[p27l1018t3236r1167b3291],
15	2	CD	NUMBER	2	dep	5	SENT_351	[p27l1018t3236r1167b3291],
16	*	CD	NUMBER	*	num	17	SENT_351	[p27l1259t3236r1485b3291],
17	1a	NN	O	1a	dep	15	SENT_351	[p27l1259t3236r1485b3291],
18	/	:	O	/	punct	15	SENT_351	[p27l1259t3236r1485b3291],
19	*	CD	NUMBER	*	num	20	SENT_351	[p27l1259t3236r1485b3291],
20	1c	NN	O	1c	dep	15	SENT_351	[p27l1259t3236r1485b3291],
21	*	CD	NUMBER	*	num	22	SENT_351	[p27l1557t3236r1742b3291],
22	1c	NN	O	1c	dep	20	SENT_351	[p27l1557t3236r1742b3291],
23	/	:	O	/	punct	20	SENT_351	[p27l1557t3236r1742b3291],
24	*	NN	O	*	dep	20	SENT_351	[p27l1557t3236r1742b3291],
25	2	CD	NUMBER	2	number	26	SENT_351	[p27l1557t3236r1742b3291],
26	*	CD	NUMBER	*	num	27	SENT_351	[p27l1818t3236r2040b3291],
27	1c	NN	O	1c	dep	24	SENT_351	[p27l1818t3236r2040b3291],
28	/	:	O	/	punct	20	SENT_351	[p27l1818t3236r2040b3291],
29	*	CD	NUMBER	*	dep	20	SENT_351	[p27l1818t3236r2040b3291],
30	1c	NN	O	1c	dep	29	SENT_351	[p27l1818t3236r2040b3291],

1	UGT2B7	NN	O	ugt2b7	nn	2	SENT_352	[p27l928t3345r1203b3400],
2	diplotype	NN	O	diplotype	_	0	SENT_352	[p27l1227t3346r1540b3414],

1	Figure	NNP	O	Figure	_	0	SENT_353	[p27l10t3564r213b3632],
2	5	CD	NUMBER	5	dep	1	SENT_353	[p27l228t3569r277b3615],
3	.	.	O	.	_	0	SENT_353	[p27l228t3569r277b3615],

1	Effect	NN	O	effect	nn	2	SENT_354	[p27l352t3561r536b3632],
2	ofUGT2B	NN	O	ofugt2b	nsubj	9	SENT_354	[p27l548t3561r850b3632],
3	7	CD	NUMBER	7	num	4	SENT_354	[p27l861t3569r890b3615],
4	genotype	NN	O	genotype	dep	2	SENT_354	[p27l904t3569r1193b3633],
5	on	IN	O	on	_	0	SENT_354	[p27l1208t3580r1283b3615],
6	liver	NN	O	liver	nn	8	SENT_354	[p27l1297t3561r1442b3615],
7	zidovudine	NN	O	zidovudine	nn	8	SENT_354	[p27l1451t3561r1808b3615],
8	glucuroni	NNS	O	glucuronus	prep_on	2	SENT_354	[p27l1819t3561r2148b3632],
9	—	VBP	O	—	_	0	SENT_354	[p27l1819t3561r2148b3632],
10	dation	NN	O	dation	nn	11	SENT_354	[p27l15t3650r215b3705],
11	activity	NN	O	activity	dobj	9	SENT_354	[p27l242t3653r482b3722],
12	.	.	O	.	_	0	SENT_354	[p27l242t3653r482b3722],

1	Bars	NNS	O	bar	nsubj	2	SENT_355	[p27l508t3654r650b3705],
2	represent	VBP	O	represent	_	0	SENT_355	[p27l670t3657r970b3722],
3	mean	JJ	O	mean	amod	4	SENT_355	[p27l989t3669r1165b3705],
4	i	FW	O	i	dobj	2	SENT_355	[p27l1188t3659r1226b3704],
5	SD	NN	O	sd	nn	6	SENT_355	[p27l1251t3653r1342b3705],
6	Values	NNS	O	value	dep	4	SENT_355	[p27l1364t3650r1581b3714],
7	,	,	O	,	_	0	SENT_355	[p27l1364t3650r1581b3714],
8	and	CC	O	and	_	0	SENT_355	[p27l1609t3650r1732b3705],
9	group	NN	O	group	nn	10	SENT_355	[p27l1750t3669r1935b3722],
10	differences	NNS	O	difference	nsubjpass	12	SENT_355	[p27l1962t3650r2148b3722, p27l14t3758r188b3794],
11	were	VBD	O	be	auxpass	12	SENT_355	[p27l214t3758r359b3794],
12	evaluated	VBN	O	evaluate	conj_and	2	SENT_355	[p27l383t3739r695b3794],
13	by	IN	O	by	_	0	SENT_355	[p27l717t3739r795b3811],
14	analysis	NN	O	analysis	agent	12	SENT_355	[p27l813t3739r1072b3811],
15	of	IN	O	of	_	0	SENT_355	[p27l1096t3739r1165b3811],
16	variance	NN	O	variance	prep_of	14	SENT_355	[p27l1179t3742r1449b3794],
17	{	CD	NUMBER	{	num	16	SENT_355	[p27l1475t3739r1792b3804],
18	ANOVA	NNP	O	ANOVA	tmod	12	SENT_355	[p27l1475t3739r1792b3804],
19	}	CD	NUMBER	}	num	18	SENT_355	[p27l1475t3739r1792b3804],
20	.	.	O	.	_	0	SENT_355	[p27l1475t3739r1792b3804],

1	predictable	JJ	O	predictable	amod	4	SENT_356	[p28l10t156r497b246],
2	,	,	O	,	_	0	SENT_356	[p28l10t156r497b246],
3	further	JJ	O	further	amod	4	SENT_356	[p28l554t156r837b224],
4	studies	NNS	O	study	nsubjpass	6	SENT_356	[p28l891t156r1180b224],
5	are	VBP	O	be	auxpass	6	SENT_356	[p28l1236t180r1355b224],
6	needed	VBN	O	need	_	0	SENT_356	[p28l1408t156r1706b224],
7	to	TO	O	to	aux	8	SENT_356	[p28l1758t166r1832b224],
8	define	VB	O	define	xcomp	6	SENT_356	[p28l1890t156r2144b224],
9	the	DT	O	the	det	10	SENT_356	[p28l9t257r134b324],
10	influence	NN	O	influence	dobj	8	SENT_356	[p28l168t257r555b324],
11	of	IN	O	of	_	0	SENT_356	[p28l590t257r671b324],
12	UGT2B7	NN	O	ugt2b7	nn	16	SENT_356	[p28l705t260r1192b324],
13	*	CD	NUMBER	*	num	16	SENT_356	[p28l705t260r1192b324],
14	1c	NN	O	1c	nn	16	SENT_356	[p28l705t260r1192b324],
15	carrier	NN	O	carrier	nn	16	SENT_356	[p28l1222t260r1490b324],
16	status	NN	O	status	prep_of	10	SENT_356	[p28l1523t267r1756b324],
17	on	IN	O	on	_	0	SENT_356	[p28l1792t281r1891b324],
18	intracellular	JJ	O	intracellular	prep_on	8	SENT_356	[p28l1923t260r2144b324, p28l11t360r324b428],

1	concentrations	NNS	O	concentration	_	0	SENT_357	[p28l351t363r958b428],
2	of	IN	O	of	_	0	SENT_357	[p28l989t360r1070b428],
3	zidovudine-triphosphate	NN	O	zidovudine-triphosphate	prep_of	1	SENT_357	[p28l1089t360r2141b449],
4	,	,	O	,	_	0	SENT_357	[p28l1089t360r2141b449],
5	as	RB	O	as	_	0	SENT_357	[p28l11t486r88b530],
6	well	RB	O	well	_	0	SENT_357	[p28l122t461r299b530],
7	as	IN	O	as	_	0	SENT_357	[p28l335t486r412b530],
8	clinical	JJ	O	clinical	amod	11	SENT_357	[p28l450t461r756b530],
9	effect	NN	O	effect	nn	11	SENT_357	[p28l792t462r1014b530],
10	(	NN	O	(	nn	11	SENT_357	[p28l1051t462r1397b551],
11	efficacy	NN	O	efficacy	prep_of	1	SENT_357	[p28l1051t462r1397b551],
12	and	CC	O	and	_	0	SENT_357	[p28l1431t461r1580b530],
13	toxicity	NN	O	toxicity	nn	14	SENT_357	[p28l1613t462r1978b551],
14	)	NN	O	)	conj_and	3	SENT_357	[p28l1613t462r1978b551],
15	.	.	O	.	_	0	SENT_357	[p28l1613t462r1978b551],

1	We	PRP	O	we	nsubj	3	SENT_358	[p28l115t568r240b631],
2	also	RB	O	also	advmod	3	SENT_358	[p28l305t563r464b631],
3	investigated	VBD	O	investigate	_	0	SENT_358	[p28l528t563r1028b653],
4	potential	JJ	O	potential	amod	6	SENT_358	[p28l1090t563r1459b653],
5	patient	NN	O	patient	nn	6	SENT_358	[p28l1522t567r1811b653],
6	factors	NNS	O	factor	dobj	3	SENT_358	[p28l1872t563r2142b631],
7	that	WDT	O	that	nsubj	9	SENT_358	[p28l9t665r168b733],
8	may	MD	O	may	aux	9	SENT_358	[p28l207t689r379b754],
9	influence	VB	O	influence	rcmod	6	SENT_358	[p28l420t665r807b733],
10	the	DT	O	the	det	12	SENT_358	[p28l849t665r974b733],
11	pharmacokinetic	JJ	O	pharmacokinetic	amod	12	SENT_358	[p28l1017t665r1711b755],
12	profile	NN	O	profile	dobj	9	SENT_358	[p28l1755t665r2027b755],
13	of	IN	O	of	_	0	SENT_358	[p28l2071t665r2152b733],
14	each	DT	O	each	prep_of	12	SENT_358	[p28l11t767r197b835],
15	of	IN	O	of	_	0	SENT_358	[p28l239t767r320b835],
16	the	DT	O	the	det	17	SENT_358	[p28l353t767r479b835],
17	drugs	NNS	O	drug	prep_of	14	SENT_358	[p28l524t767r745b856],
18	evaluated	VBN	O	evaluate	partmod	17	SENT_358	[p28l790t767r1208b835],
19	.	.	O	.	_	0	SENT_358	[p28l790t767r1208b835],

1	Except	IN	O	except	mark	21	SENT_359	[p28l1253t772r1533b857],
2	for	IN	O	for	mark	12	SENT_359	[p28l1573t767r1685b835],
3	a	DT	O	a	det	6	SENT_359	[p28l1726t791r1766b835],
4	possible	JJ	O	possible	amod	6	SENT_359	[p28l1806t767r2143b857],
5	small	JJ	O	small	amod	6	SENT_359	[p28l11t868r231b935],
6	effect	NN	O	effect	nsubj	12	SENT_359	[p28l277t868r500b935],
7	of	IN	O	of	_	0	SENT_359	[p28l545t868r626b935],
8	sex	NN	O	sex	prep_of	6	SENT_359	[p28l665t892r795b935],
9	on	IN	O	on	_	0	SENT_359	[p28l840t892r938b935],
10	stavudine	NN	O	stavudine	nn	11	SENT_359	[p28l984t868r1385b935],
11	CL/F	NN	O	cl/f	prep_on	8	SENT_359	[p28l1431t868r1631b935],
12	normalized	VBD	O	normalize	csubj	21	SENT_359	[p28l1675t868r2145b935],
13	for	IN	O	for	_	0	SENT_359	[p28l10t971r122b1039],
14	body	NN	O	body	nn	15	SENT_359	[p28l159t971r364b1060],
15	weight	NN	O	weight	prep_for	12	SENT_359	[p28l402t971r682b1060],
16	and	CC	O	and	_	0	SENT_359	[p28l723t971r872b1039],
17	age	NN	O	age	prep_for	12	SENT_359	[p28l914t995r1043b1060],
18	on	IN	O	on	_	0	SENT_359	[p28l1086t995r1185b1039],
19	lamivudine	NN	O	lamivudine	nn	20	SENT_359	[p28l1226t971r1698b1039],
20	CL/F	NN	O	cl/f	prep_on	12	SENT_359	[p28l1741t971r1940b1039],
21	normalized	VBD	O	normalize	advcl	30	SENT_359	[p28l1981t995r2144b1039, p28l9t1072r338b1141],
22	for	IN	O	for	_	0	SENT_359	[p28l369t1073r481b1141],
23	body	NN	O	body	nn	24	SENT_359	[p28l508t1072r713b1162],
24	weight	NN	O	weight	prep_for	21	SENT_359	[p28l743t1072r1044b1162],
25	,	,	O	,	_	0	SENT_359	[p28l743t1072r1044b1162],
26	patient	NN	O	patient	nn	27	SENT_359	[p28l1078t1076r1367b1162],
27	demographics	NNS	O	demographic	nsubj	30	SENT_359	[p28l1401t1072r1975b1162],
28	did	VBD	O	do	aux	30	SENT_359	[p28l2012t1072r2145b1141],
29	not	RB	O	not	neg	30	SENT_359	[p28l9t1184r142b1242],
30	appear	VB	O	appear	_	0	SENT_359	[p28l173t1198r450b1264],
31	to	TO	O	to	_	0	SENT_359	[p28l478t1185r553b1242],
32	inﬂuence	NN	O	inﬂuence	nn	34	SENT_359	[p28l586t1174r973b1242],
33	drug	NN	O	drug	nn	34	SENT_359	[p28l1007t1174r1191b1264],
34	exposure	NN	O	exposure	prep_to	30	SENT_359	[p28l1223t1198r1594b1264],
35	in	IN	O	in	_	0	SENT_359	[p28l1626t1178r1706b1242],
36	our	PRP$	O	we	poss	37	SENT_359	[p28l1738t1198r1874b1242],
37	population	NN	O	population	prep_in	34	SENT_359	[p28l1903t1198r2143b1264, p28l10t1276r268b1344],
38	.	.	O	.	_	0	SENT_359	[p28l1903t1198r2143b1264, p28l10t1276r268b1344],

1	However	RB	O	however	advmod	7	SENT_360	[p28l300t1281r686b1355],
2	,	,	O	,	_	0	SENT_360	[p28l300t1281r686b1355],
3	these	DT	O	these	det	4	SENT_360	[p28l715t1276r927b1344],
4	results	NNS	O	result	nsubjpass	7	SENT_360	[p28l955t1276r1227b1344],
5	should	MD	O	should	aux	7	SENT_360	[p28l1259t1276r1539b1344],
6	be	VB	O	be	auxpass	7	SENT_360	[p28l1563t1276r1656b1344],
7	interpreted	VBN	O	interpret	_	0	SENT_360	[p28l1685t1276r2145b1366],
8	with	IN	O	with	_	0	SENT_360	[p28l9t1378r197b1446],
9	caution	NN	O	caution	prep_with	7	SENT_360	[p28l238t1382r567b1457],
10	,	,	O	,	_	0	SENT_360	[p28l238t1382r567b1457],
11	as	IN	O	as	mark	16	SENT_360	[p28l612t1402r689b1446],
12	the	DT	O	the	det	13	SENT_360	[p28l731t1378r857b1446],
13	study	NN	O	study	nsubjpass	16	SENT_360	[p28l900t1378r1126b1467],
14	was	VBD	O	be	auxpass	16	SENT_360	[p28l1165t1402r1320b1446],
15	not	RB	O	not	neg	16	SENT_360	[p28l1362t1388r1494b1446],
16	powered	VBN	O	power	advcl	7	SENT_360	[p28l1534t1378r1892b1468],
17	sufficiently	RB	O	sufficiently	advmod	16	SENT_360	[p28l1934t1378r2144b1446, p28l11t1480r294b1569],
18	to	TO	O	to	aux	19	SENT_360	[p28l339t1490r413b1548],
19	detect	VB	O	detect	dep	17	SENT_360	[p28l465t1480r711b1548],
20	relatively	RB	O	relatively	advmod	21	SENT_360	[p28l755t1480r1147b1569],
21	small	JJ	O	small	amod	22	SENT_360	[p28l1195t1480r1414b1548],
22	differences	NNS	O	difference	dobj	19	SENT_360	[p28l1464t1480r1937b1548],
23	.	.	O	.	_	0	SENT_360	[p28l1464t1480r1937b1548],

1	The	DT	O	the	det	2	SENT_361	[p28l1989t1480r2144b1548],
2	effect	NN	O	effect	nsubjpass	10	SENT_361	[p28l11t1582r234b1649],
3	of	IN	O	of	_	0	SENT_361	[p28l263t1582r344b1649],
4	sex	NN	O	sex	prep_of	2	SENT_361	[p28l366t1605r496b1649],
5	on	IN	O	on	_	0	SENT_361	[p28l526t1605r625b1649],
6	stavudine	NN	O	stavudine	nn	7	SENT_361	[p28l654t1582r1055b1649],
7	clearance	NN	O	clearance	prep_on	4	SENT_361	[p28l1086t1582r1472b1649],
8	is	VBZ	O	be	auxpass	10	SENT_361	[p28l1502t1585r1565b1649],
9	not	RB	O	not	neg	10	SENT_361	[p28l1595t1592r1727b1649],
10	known	VBN	O	know	_	0	SENT_361	[p28l1754t1582r2037b1649],
11	as	IN	O	as	mark	15	SENT_361	[p28l2065t1605r2143b1649],
12	few	JJ	O	few	amod	13	SENT_361	[p28l10t1684r156b1752],
13	studies	NNS	O	study	nsubj	15	SENT_361	[p28l197t1683r486b1752],
14	have	VBP	O	have	aux	15	SENT_361	[p28l528t1683r719b1752],
15	explored	VBN	O	explore	advcl	10	SENT_361	[p28l761t1683r1123b1773],
16	the	DT	O	the	det	17	SENT_361	[p28l1162t1683r1288b1752],
17	inﬂuence	NN	O	inﬂuence	dobj	15	SENT_361	[p28l1329t1683r1717b1752],
18	of	IN	O	of	_	0	SENT_361	[p28l1760t1684r1841b1752],
19	sex	NN	O	sex	prep_of	17	SENT_361	[p28l1876t1708r2006b1752],
20	on	IN	O	on	_	0	SENT_361	[p28l2046t1708r2146b1752],
21	the	DT	O	the	det	22	SENT_361	[p28l9t1785r134b1853],
22	disposition	NN	O	disposition	prep_on	15	SENT_361	[p28l180t1785r643b1875],
23	of	IN	O	of	_	0	SENT_361	[p28l686t1785r767b1853],
24	antiretrovirals	NNS	O	antiretroviral	prep_of	22	SENT_361	[p28l803t1785r1474b1864],
25	,38	CD	NUMBER	,38	num	24	SENT_361	[p28l803t1785r1474b1864],
26	and	CC	O	and	_	0	SENT_361	[p28l1518t1785r1668b1853],
27	the	DT	O	the	det	28	SENT_361	[p28l1708t1785r1834b1853],
28	largest	JJS	O	largest	prep_of	22	SENT_361	[p28l1877t1785r2146b1875],
29	and	CC	O	and	_	0	SENT_361	[p28l11t1888r161b1956],
30	most	RBS	O	most	advmod	31	SENT_361	[p28l185t1898r384b1956],
31	comprehensive	JJ	O	comprehensive	amod	34	SENT_361	[p28l410t1888r1037b1978],
32	previous	JJ	O	previous	amod	34	SENT_361	[p28l1064t1892r1420b1978],
33	pharmacokinetic	JJ	O	pharmacokinetic	amod	34	SENT_361	[p28l1448t1888r2143b1978],
34	study	NN	O	study	nsubj	38	SENT_361	[p28l11t1990r237b2079],
35	of	IN	O	of	_	0	SENT_361	[p28l276t1990r357b2058],
36	81	CD	NUMBER	81	num	37	SENT_361	[p28l390t2000r477b2058],
37	patients	NNS	O	patient	prep_of	34	SENT_361	[p28l521t1994r847b2080],
38	included	VBD	O	include	conj_and	15	SENT_361	[p28l887t1990r1255b2058],
39	only	RB	O	only	quantmod	40	SENT_361	[p28l1295t1990r1475b2079],
40	7	CD	NUMBER	7	num	41	SENT_361	[p28l1517t2001r1554b2057],
41	women	NNS	O	woman	dobj	38	SENT_361	[p28l1593t1989r1951b2058],
42	.8	CD	NUMBER	.8	tmod	38	SENT_361	[p28l1593t1989r1951b2058],
43	The	DT	O	the	det	45	SENT_361	[p28l1989t1990r2144b2058],
44	observed	VBN	O	observe	amod	45	SENT_361	[p28l12t2092r378b2160],
45	influence	NN	O	influence	nsubj	51	SENT_361	[p28l444t2092r832b2160],
46	of	IN	O	of	_	0	SENT_361	[p28l901t2092r982b2160],
47	age	NN	O	age	prep_of	45	SENT_361	[p28l1041t2116r1170b2181],
48	on	IN	O	on	_	0	SENT_361	[p28l1239t2116r1338b2160],
49	lamivudine	NN	O	lamivudine	nn	50	SENT_361	[p28l1404t2092r1876b2160],
50	CL/F	NN	O	cl/f	prep_on	47	SENT_361	[p28l1944t2092r2144b2160],
51	needs	VBZ	O	need	rcmod	42	SENT_361	[p28l9t2195r244b2263],
52	to	TO	O	to	aux	54	SENT_361	[p28l319t2205r394b2263],
53	be	VB	O	be	auxpass	54	SENT_361	[p28l466t2195r558b2263],
54	validated	VBN	O	validate	xcomp	51	SENT_361	[p28l632t2195r1018b2263],
55	in	IN	O	in	_	0	SENT_361	[p28l1092t2198r1172b2262],
56	a	DT	O	a	det	58	SENT_361	[p28l1246t2219r1287b2263],
57	larger	JJR	O	larger	amod	58	SENT_361	[p28l1359t2195r1593b2284],
58	population	NN	O	population	prep_in	54	SENT_361	[p28l1665t2195r2140b2284],
59	.	.	O	.	_	0	SENT_361	[p28l1665t2195r2140b2284],

1	Although	IN	O	although	mark	5	SENT_362	[p28l9t2296r398b2386],
2	it	PRP	O	it	nsubjpass	5	SENT_362	[p28l435t2300r491b2365],
3	has	VBZ	O	have	aux	5	SENT_362	[p28l526t2296r660b2365],
4	been	VBN	O	be	auxpass	5	SENT_362	[p28l696t2296r891b2365],
5	shown	VBN	O	show	advcl	34	SENT_362	[p28l928t2296r1198b2365],
6	that	IN	O	that	complm	13	SENT_362	[p28l1234t2296r1392b2365],
7	children	NNS	O	child	dep	8	SENT_362	[p28l1429t2296r1776b2365],
8	younger	JJR	O	younger	nsubj	13	SENT_362	[p28l1811t2321r2146b2386],
9	than	IN	O	than	advmod	13	SENT_362	[p28l9t2398r191b2466],
10	12	CD	DURATION	12	num	11	SENT_362	[p28l243t2408r329b2466],
11	years	NNS	NUMBER	year	npadvmod	12	SENT_362	[p28l381t2422r592b2488],
12	old	JJ	DURATION	old	pobj	9	SENT_362	[p28l644t2398r773b2466],
13	tend	VBP	O	tend	ccomp	5	SENT_362	[p28l820t2398r1003b2466],
14	to	TO	O	to	aux	15	SENT_362	[p28l1049t2408r1124b2466],
15	have	VB	O	have	xcomp	13	SENT_362	[p28l1173t2398r1364b2466],
16	higher	JJR	O	higher	amod	17	SENT_362	[p28l1412t2398r1676b2488],
17	values	NNS	O	value	dobj	15	SENT_362	[p28l1722t2398r1983b2466],
18	for	IN	O	for	_	0	SENT_362	[p28l2034t2398r2146b2466],
19	lamivudine	NN	O	lamivudine	nn	20	SENT_362	[p28l10t2500r482b2568],
20	CL/F	NN	O	cl/f	prep_for	17	SENT_362	[p28l517t2500r717b2568],
21	than	IN	O	than	_	0	SENT_362	[p28l750t2500r933b2568],
22	children	NNS	O	child	prep_than	15	SENT_362	[p28l967t2500r1315b2568],
23	aged	JJ	O	aged	amod	22	SENT_362	[p28l1348t2500r1534b2589],
24	12	CD	DURATION	12	tmod	23	SENT_362	[p28l1571t2510r1657b2568],
25	to	TO	DURATION	to	_	0	SENT_362	[p28l1694t2510r1769b2568],
26	18	CD	DURATION	18	num	27	SENT_362	[p28l1809t2510r1897b2568],
27	years	NNS	NUMBER	year	npadvmod	28	SENT_362	[p28l1931t2524r2143b2589],
28	old	JJ	DURATION	old	prep_to	23	SENT_362	[p28l12t2602r163b2681],
29	,	,	O	,	_	0	SENT_362	[p28l12t2602r163b2681],
30	age	NN	O	age	nsubjpass	34	SENT_362	[p28l210t2626r338b2691],
31	has	VBZ	O	have	aux	34	SENT_362	[p28l380t2602r515b2670],
32	not	RB	O	not	neg	34	SENT_362	[p28l559t2612r692b2670],
33	been	VBN	O	be	auxpass	34	SENT_362	[p28l729t2602r924b2670],
34	shown	VBN	O	show	_	0	SENT_362	[p28l967t2602r1237b2670],
35	to	TO	O	to	aux	36	SENT_362	[p28l1278t2612r1352b2670],
36	influence	VB	O	influence	xcomp	34	SENT_362	[p28l1397t2602r1784b2670],
37	lamivudine	NN	O	lamivudine	nn	38	SENT_362	[p28l1828t2602r2144b2670, p28l12t2703r190b2770],
38	CL/F	NN	O	cl/f	dobj	36	SENT_362	[p28l225t2703r425b2770],
39	in	IN	O	in	_	0	SENT_362	[p28l460t2706r541b2770],
40	adults	NNS	O	adult	prep_in	36	SENT_362	[p28l575t2702r912b2770],
41	.	.	O	.	_	0	SENT_362	[p28l575t2702r912b2770],

1	”	NN	O	”	_	0	SENT_363	[p28l575t2702r912b2770],

1	There	EX	O	there	expl	2	SENT_364	[p28l117t2805r349b2872],
2	are	VBP	O	be	_	0	SENT_364	[p28l379t2828r496b2872],
3	no	DT	O	no	det	5	SENT_364	[p28l525t2828r623b2872],
4	known	JJ	O	known	amod	5	SENT_364	[p28l652t2805r931b2872],
5	interactions	NNS	O	interaction	nsubj	2	SENT_364	[p28l959t2808r1437b2872],
6	between	IN	O	between	_	0	SENT_364	[p28l1464t2805r1805b2872],
7	lamivudine	NN	O	lamivudine	prep_between	5	SENT_364	[p28l1833t2805r2144b2872, p28l12t2905r187b2973],

1	and	CC	O	and	dep	2	SENT_365	[p28l244t2905r392b2973],
2	zidovudine	NN	O	zidovudine	_	0	SENT_365	[p28l448t2905r907b2973],
3	or	CC	O	or	_	0	SENT_365	[p28l965t2929r1044b2973],
4	stavudine	NN	O	stavudine	conj_or	2	SENT_365	[p28l1099t2905r1651b2973],
5	.4	CD	NUMBER	.4	number	6	SENT_365	[p28l1099t2905r1651b2973],
6	°	CD	NUMBER	°	dep	10	SENT_365	[p28l1099t2905r1651b2973],
7	"	``	O	"	punct	8	SENT_365	[p28l1099t2905r1651b2973],
8	“	CD	NUMBER	“	npadvmod	10	SENT_365	[p28l1099t2905r1651b2973],
9	The	DT	O	the	dep	8	SENT_365	[p28l1708t2905r1860b2973],
10	lower	JJR	O	lower	amod	2	SENT_365	[p28l1917t2905r2146b2973],

1	AUC	NN	O	auc	_	0	SENT_366	[p28l9t3011r202b3075],
2	of	IN	O	of	_	0	SENT_366	[p28l254t3007r334b3075],
3	lamivudine	NN	O	lamivudine	prepc_of	1	SENT_366	[p28l376t3007r840b3075],
4	observed	VBN	O	observe	dep	3	SENT_366	[p28l891t3007r1251b3075],
5	in	IN	O	in	_	0	SENT_366	[p28l1300t3011r1380b3075],
6	the	DT	O	the	det	7	SENT_366	[p28l1427t3007r1551b3075],
7	patients	NNS	O	patient	prep_in	4	SENT_366	[p28l1600t3011r1920b3097],
8	who	WP	O	who	dep	9	SENT_366	[p28l1970t3007r2143b3075],
9	received	VBD	O	receive	dep	4	SENT_366	[p28l8t3108r362b3175],
10	the	DT	O	the	det	12	SENT_366	[p28l439t3108r566b3175],
11	coformulated	JJ	O	coformulated	amod	12	SENT_366	[p28l648t3108r1202b3175],
12	tablets	NNS	O	tablet	nsubj	9	SENT_366	[p28l1279t3108r1550b3175],
13	lamivudine	NN	O	lamivudine	dep	12	SENT_366	[p28l1631t3108r2144b3175],
14	/	:	O	/	punct	13	SENT_366	[p28l1631t3108r2144b3175],

1	zidovudine	NN	O	zidovudine	nsubj	13	SENT_367	[p28l10t3210r475b3278],
2	compared	VBN	O	compare	_	0	SENT_367	[p28l532t3210r932b3300],
3	to	TO	O	to	prepc_compared_to	1	SENT_367	[p28l985t3220r1059b3278],
4	the	DT	O	the	det	7	SENT_367	[p28l1114t3210r1238b3278],
5	separate	JJ	O	separate	amod	7	SENT_367	[p28l1295t3220r1624b3300],
6	lamivudine	NN	O	lamivudine	nn	7	SENT_367	[p28l1679t3210r2144b3278],
7	tablets	NNS	O	tablet	pobj	1	SENT_367	[p28l9t3312r270b3380],
8	given	VBN	O	give	prep	7	SENT_367	[p28l302t3315r521b3401],
9	with	IN	O	with	pcomp	8	SENT_367	[p28l549t3312r735b3380],
10	stavudine	NN	O	stavudine	pobj	9	SENT_367	[p28l766t3312r1159b3380],
11	could	MD	O	could	aux	13	SENT_367	[p28l1192t3312r1419b3380],
12	be	VB	O	be	cop	13	SENT_367	[p28l1446t3312r1537b3380],
13	due	JJ	O	due	_	0	SENT_367	[p28l1571t3312r1716b3380],
14	to	TO	O	to	_	0	SENT_367	[p28l1746t3322r1820b3380],
15	the	DT	O	the	det	17	SENT_367	[p28l1850t3312r1975b3380],
16	significant	JJ	O	significant	amod	17	SENT_367	[p28l2007t3315r2143b3401, p28l9t3415r323b3483],
17	differences	NNS	O	difference	prep_to	13	SENT_367	[p28l359t3415r800b3483],
18	in	IN	O	in	_	0	SENT_367	[p28l837t3418r917b3482],
19	body	NN	O	body	nn	20	SENT_367	[p28l947t3415r1150b3504],
20	weight	NN	O	weight	prep_in	17	SENT_367	[p28l1182t3415r1458b3504],
21	or	CC	O	or	_	0	SENT_367	[p28l1493t3439r1571b3483],
22	BMI	NN	O	bmus	conj_or	20	SENT_367	[p28l1605t3419r1774b3482],
23	between	IN	O	between	_	0	SENT_367	[p28l1804t3415r2146b3483],
24	the	DT	O	the	det	26	SENT_367	[p28l9t3516r132b3585],
25	2	CD	NUMBER	2	num	26	SENT_367	[p28l175t3526r212b3584],
26	groups	NNS	O	group	prep_between	13	SENT_367	[p28l254t3540r547b3606],
27	.	.	O	.	_	0	SENT_367	[p28l254t3540r547b3606],

1	Clearance	NN	O	clearance	_	0	SENT_368	[p28l591t3516r985b3585],
2	and	CC	O	and	_	0	SENT_368	[p28l1025t3516r1173b3585],
3	half-life	NN	O	half-life	conj_and	1	SENT_368	[p28l1210t3516r1527b3585],
4	of	IN	O	of	_	0	SENT_368	[p28l1568t3517r1648b3585],
5	lamivudine	NN	O	lamivudine	prep_of	1	SENT_368	[p28l1679t3516r2144b3585],

1	GENERIC	JJ	O	generic	amod	2	SENT_369	[p28l441t3682r623b3713],
2	NRTIS	NN	O	nrti	_	0	SENT_369	[p28l634t3682r761b3713],
3	IN	IN	O	in	_	0	SENT_369	[p28l774t3683r824b3713],
4	TB/HIV	NN	O	tb/hiv	prep_in	2	SENT_369	[p28l837t3681r1260b3713],
5	.	.	O	.	_	0	SENT_369	[p28l837t3681r1260b3713],

1	—	NN	O	—	_	0	SENT_370	[p28l837t3681r1260b3713],
2	.	.	O	.	_	0	SENT_370	[p28l837t3681r1260b3713],

1	COINFECTED	JJ	O	coinfected	_	0	SENT_371	[p28l837t3681r1260b3713],
2	GHANAIAN	JJ	MISC	ghanaian	amod	3	SENT_371	[p28l1275t3682r1511b3713],
3	PATIENTS	NNS	O	patient	dep	1	SENT_371	[p28l1521t3682r1723b3713],

1	did	VBD	O	do	aux	3	SENT_372	[p29l12t117r144b185],
2	not	RB	O	not	neg	3	SENT_372	[p29l173t127r303b185],
3	differ	VB	O	differ	_	0	SENT_372	[p29l334t117r551b185],
4	between	IN	O	between	_	0	SENT_372	[p29l575t117r916b185],
5	the	DT	O	the	det	7	SENT_372	[p29l944t117r1068b185],
6	2	CD	NUMBER	2	num	7	SENT_372	[p29l1102t127r1138b185],
7	groups	NNS	O	group	prep_between	3	SENT_372	[p29l1172t141r1443b207],
8	to	TO	O	to	aux	9	SENT_372	[p29l1474t128r1547b185],
9	suggest	VB	O	suggest	xcomp	3	SENT_372	[p29l1580t128r1872b207],
10	differences	NNS	O	difference	dobj	9	SENT_372	[p29l1903t117r2144b185, p29l11t243r231b287],
11	in	IN	O	in	_	0	SENT_372	[p29l265t223r345b287],
12	elimination	NN	O	elimination	prep_in	9	SENT_372	[p29l378t219r848b287],
13	of	IN	O	of	_	0	SENT_372	[p29l881t219r961b287],
14	the	DT	O	the	det	15	SENT_372	[p29l985t219r1108b287],
15	drug	NN	O	drug	prep_of	12	SENT_372	[p29l1144t219r1344b308],
16	.	.	O	.	_	0	SENT_372	[p29l1144t219r1344b308],

1	We	PRP	O	we	nsubj	2	SENT_373	[p29l115t325r239b389],
2	recognize	VBP	O	recognize	_	0	SENT_373	[p29l267t324r651b410],
3	that	IN	O	that	complm	6	SENT_373	[p29l679t321r834b389],
4	our	PRP$	O	we	poss	5	SENT_373	[p29l863t345r995b389],
5	study	NN	O	study	nsubj	6	SENT_373	[p29l1024t321r1245b410],
6	had	VBD	O	have	ccomp	2	SENT_373	[p29l1271t321r1420b389],
7	some	DT	O	some	det	8	SENT_373	[p29l1450t345r1654b389],
8	limitations	NNS	O	limitation	dobj	6	SENT_373	[p29l1683t321r2139b389],
9	.	.	O	.	_	0	SENT_373	[p29l1683t321r2139b389],

1	The	DT	O	the	det	2	SENT_374	[p29l10t424r162b492],
2	size	NN	O	size	nsubj	8	SENT_374	[p29l203t427r352b492],
3	of	IN	O	of	_	0	SENT_374	[p29l393t424r473b492],
4	the	DT	O	the	det	6	SENT_374	[p29l502t424r626b492],
5	study	NN	O	study	nn	6	SENT_374	[p29l666t424r887b513],
6	population	NN	O	population	prep_of	2	SENT_374	[p29l924t424r1367b513],
7	was	VBD	O	be	cop	8	SENT_374	[p29l1403t448r1555b492],
8	small	JJ	O	small	_	0	SENT_374	[p29l1597t424r1833b502],
9	,	,	O	,	_	0	SENT_374	[p29l1597t424r1833b502],
10	and	CC	O	and	cc	8	SENT_374	[p29l1876t424r2023b492],
11	so	RB	O	so	advmod	8	SENT_374	[p29l2062t448r2143b492],
12	failure	NN	O	failure	nsubj	38	SENT_374	[p29l10t525r269b594],
13	to	TO	O	to	aux	14	SENT_374	[p29l294t536r367b594],
14	find	VB	O	find	infmod	12	SENT_374	[p29l394t525r556b594],
15	significant	JJ	O	significant	amod	16	SENT_374	[p29l582t526r1004b615],
16	relationships	NNS	O	relationship	dobj	14	SENT_374	[p29l1025t525r1551b615],
17	between	IN	O	between	_	0	SENT_374	[p29l1574t525r1912b594],
18	pharmacokinetic	JJ	O	pharmacokinetic	amod	19	SENT_374	[p29l1936t526r2144b615, p29l9t627r500b696],
19	parameters	NNS	O	parameter	prep_between	16	SENT_374	[p29l540t638r981b717],
20	of	IN	O	of	_	0	SENT_374	[p29l1023t628r1103b696],
21	some	DT	O	some	prep_of	19	SENT_374	[p29l1135t652r1340b696],
22	of	IN	O	of	_	0	SENT_374	[p29l1381t628r1461b696],
23	these	DT	O	these	det	24	SENT_374	[p29l1491t627r1697b696],
24	drugs	NNS	O	drug	prep_of	21	SENT_374	[p29l1739t627r1956b717],
25	and	CC	O	and	_	0	SENT_374	[p29l1998t627r2145b696],
26	patient	NN	O	patient	nn	27	SENT_374	[p29l10t733r292b819],
27	factors	NNS	O	factor	prep_of	21	SENT_374	[p29l334t729r597b797],
28	such	JJ	O	such	_	0	SENT_374	[p29l644t729r831b797],
29	as	IN	O	as	_	0	SENT_374	[p29l874t753r950b797],
30	age	NN	O	age	prep_such_as	16	SENT_374	[p29l997t753r1145b819],
31	,	,	O	,	_	0	SENT_374	[p29l997t753r1145b819],
32	sex	NN	O	sex	conj_and	30	SENT_374	[p29l1193t753r1341b808],
33	,	,	O	,	_	0	SENT_374	[p29l1193t753r1341b808],
34	and	CC	O	and	_	0	SENT_374	[p29l1389t729r1536b797],
35	BMI	NN	O	bmus	conj_and	30	SENT_374	[p29l1579t734r1748b797],
36	does	VBZ	O	do	aux	38	SENT_374	[p29l1793t729r1971b797],
37	not	RB	O	not	neg	38	SENT_374	[p29l2016t739r2146b797],
38	exclude	VB	O	exclude	ccomp	8	SENT_374	[p29l11t831r324b899],
39	the	DT	O	the	det	40	SENT_374	[p29l379t831r502b899],
40	existence	NN	O	existence	dobj	38	SENT_374	[p29l560t835r931b899],
41	of	IN	O	of	_	0	SENT_374	[p29l989t831r1069b899],
42	significant	JJ	O	significant	amod	43	SENT_374	[p29l1118t831r1540b920],
43	relationships	NNS	O	relationship	prep_of	40	SENT_374	[p29l1593t831r2139b921],
44	.	.	O	.	_	0	SENT_374	[p29l1593t831r2139b921],

1	Comparison	NN	O	comparison	nsubj	26	SENT_375	[p29l10t937r498b1023],
2	of	IN	O	of	_	0	SENT_375	[p29l538t934r618b1002],
3	drug	NN	O	drug	nn	4	SENT_375	[p29l652t934r832b1023],
4	exposure	NN	O	exposure	prep_of	1	SENT_375	[p29l872t958r1234b1023],
5	in	IN	O	in	_	0	SENT_375	[p29l1275t937r1354b1001],
6	our	PRP$	O	we	poss	8	SENT_375	[p29l1394t958r1527b1002],
7	study	NN	O	study	nn	8	SENT_375	[p29l1567t934r1787b1023],
8	patients	NNS	O	patient	prep_in	4	SENT_375	[p29l1825t937r2143b1023],
9	to	TO	O	to	_	0	SENT_375	[p29l9t1047r82b1105],
10	historical	JJ	O	historical	amod	11	SENT_375	[p29l113t1037r492b1105],
11	controls	NNS	O	control	prep_to	4	SENT_375	[p29l524t1037r845b1105],
12	rather	RB	O	rather	_	0	SENT_375	[p29l876t1037r1114b1105],
13	than	IN	O	than	_	0	SENT_375	[p29l1142t1037r1322b1105],
14	an	DT	O	a	det	16	SENT_375	[p29l1352t1061r1446b1105],
15	appropriate	JJ	O	appropriate	amod	16	SENT_375	[p29l1476t1040r1941b1126],
16	control	NN	O	control	conj_negcc	4	SENT_375	[p29l1974t1061r2144b1105, p29l9t1138r147b1207],
17	that	WDT	O	that	nsubj	20	SENT_375	[p29l208t1138r363b1207],
18	did	VBD	O	do	aux	20	SENT_375	[p29l427t1138r558b1207],
19	not	RB	O	not	neg	20	SENT_375	[p29l618t1149r749b1207],
20	receive	VB	O	receive	rcmod	16	SENT_375	[p29l808t1142r1093b1207],
21	rifampin-containing	JJ	O	rifampin-containing	amod	23	SENT_375	[p29l1155t1139r1968b1228],
22	TB	NN	O	tb	nn	23	SENT_375	[p29l2031t1143r2141b1206],
23	therapy	NN	O	therapy	dobj	20	SENT_375	[p29l9t1240r312b1330],
24	does	VBZ	O	do	aux	26	SENT_375	[p29l361t1240r537b1309],
25	not	RB	O	not	neg	26	SENT_375	[p29l585t1251r714b1309],
26	allow	VB	O	allow	_	0	SENT_375	[p29l761t1240r980b1309],
27	us	PRP	O	we	nsubj	29	SENT_375	[p29l1025t1264r1113b1309],
28	to	TO	O	to	aux	29	SENT_375	[p29l1161t1251r1234b1309],
29	exclude	VB	O	exclude	xcomp	26	SENT_375	[p29l1285t1240r1593b1309],
30	the	DT	O	the	det	31	SENT_375	[p29l1641t1240r1763b1309],
31	effect	NN	O	effect	dobj	29	SENT_375	[p29l1813t1241r2025b1309],
32	of	IN	O	of	_	0	SENT_375	[p29l2073t1241r2152b1309],
33	population	NN	O	population	nn	34	SENT_375	[p29l10t1342r447b1432],
34	differences	NNS	O	difference	prep_of	31	SENT_375	[p29l473t1342r924b1410],
35	.	.	O	.	_	0	SENT_375	[p29l473t1342r924b1410],

1	The	DT	O	the	det	2	SENT_376	[p29l954t1342r1104b1410],
2	differences	NNS	O	difference	_	0	SENT_376	[p29l1132t1342r1562b1410],
3	in	IN	O	in	_	0	SENT_376	[p29l1589t1346r1667b1410],
4	lamivudine	NN	O	lamivudine	nn	5	SENT_376	[p29l1692t1342r2144b1410],
5	exposure	NN	O	exposure	prep_in	2	SENT_376	[p29l11t1468r363b1534],
6	between	IN	O	between	_	0	SENT_376	[p29l391t1444r721b1512],
7	patients	NNS	O	patient	prep_between	5	SENT_376	[p29l751t1448r1059b1534],
8	who	WP	O	who	nsubj	9	SENT_376	[p29l1090t1444r1259b1512],
9	received	VBD	O	receive	rcmod	2	SENT_376	[p29l1290t1444r1622b1512],
10	lamivudine	NN	O	lamivudine	dobj	9	SENT_376	[p29l1652t1444r2144b1512],
11	/	:	O	/	punct	2	SENT_376	[p29l1652t1444r2144b1512],
12	zidovudine	NN	O	zidovudine	nsubjpass	18	SENT_376	[p29l10t1545r469b1612],
13	and	CC	O	and	_	0	SENT_376	[p29l518t1545r667b1612],
14	lamivudine/stavudine	NN	O	lamivudine/stavudine	nsubjpass	18	SENT_376	[p29l714t1545r1614b1612],
15	should	MD	O	should	aux	18	SENT_376	[p29l1663t1545r1939b1612],
16	also	RB	O	also	advmod	18	SENT_376	[p29l1987t1545r2143b1612],
17	be	VB	O	be	auxpass	18	SENT_376	[p29l7t1648r98b1716],
18	interpreted	VBN	O	interpret	dep	2	SENT_376	[p29l141t1648r592b1737],
19	with	IN	O	with	_	0	SENT_376	[p29l632t1648r817b1716],
20	caution	NN	O	caution	prep_with	18	SENT_376	[p29l860t1651r1161b1716],
21	as	IN	O	as	mark	25	SENT_376	[p29l1203t1672r1280b1716],
22	they	PRP	O	they	nsubj	25	SENT_376	[p29l1322t1648r1498b1737],
23	may	MD	O	may	aux	25	SENT_376	[p29l1538t1672r1708b1737],
24	be	VB	O	be	cop	25	SENT_376	[p29l1745t1648r1837b1716],
25	due	JJ	O	due	advcl	18	SENT_376	[p29l1882t1648r2028b1716],
26	to	TO	O	to	_	0	SENT_376	[p29l2069t1658r2143b1716],
27	differences	NNS	O	difference	prep_to	25	SENT_376	[p29l12t1749r453b1818],
28	in	IN	O	in	_	0	SENT_376	[p29l511t1753r591b1817],
29	disease	NN	O	disease	nn	30	SENT_376	[p29l648t1750r936b1818],
30	state	NN	O	state	prep_in	27	SENT_376	[p29l994t1760r1198b1828],
31	,	,	O	,	_	0	SENT_376	[p29l994t1760r1198b1828],
32	as	IN	O	as	_	0	SENT_376	[p29l1257t1774r1333b1818],
33	patients	NNS	O	patient	prep_as	25	SENT_376	[p29l1390t1753r1710b1839],
34	who	WP	O	who	nsubj	35	SENT_376	[p29l1766t1749r1939b1818],
35	had	VBD	O	have	rcmod	33	SENT_376	[p29l1995t1749r2145b1818],
36	hemoglobin	NN	O	hemoglobin	nsubjpass	42	SENT_376	[p29l9t1851r491b1941],
37	<	JJR	O	<	dep	42	SENT_376	[p29l519t1861r610b1920],
38	8	CD	NUMBER	8	num	39	SENT_376	[p29l519t1861r610b1920],
39	g/dL	NN	O	g/dl	nsubjpass	42	SENT_376	[p29l641t1851r825b1941],
40	were	VBD	O	be	auxpass	42	SENT_376	[p29l853t1876r1046b1920],
41	preferentially	RB	O	preferentially	advmod	42	SENT_376	[p29l1077t1851r1627b1941],
42	given	VBN	O	give	xcomp	35	SENT_376	[p29l1654t1855r1874b1941],
43	stavudine	NN	O	stavudine	dobj	42	SENT_376	[p29l1904t1861r2144b1920, p29l12t1953r208b2021],
44	.	.	O	.	_	0	SENT_376	[p29l1904t1861r2144b1920, p29l12t1953r208b2021],

1	Rifampin	NNP	O	Rifampin	nsubjpass	3	SENT_377	[p29l257t1953r635b2043],
2	is	VBZ	O	be	auxpass	3	SENT_377	[p29l680t1957r742b2021],
3	known	VBN	O	know	_	0	SENT_377	[p29l789t1953r1067b2021],
4	to	TO	O	to	aux	5	SENT_377	[p29l1111t1964r1185b2021],
5	induce	VB	O	induce	xcomp	3	SENT_377	[p29l1232t1953r1508b2021],
6	the	DT	O	the	det	7	SENT_377	[p29l1553t1953r1677b2021],
7	activity	NN	O	activity	dobj	5	SENT_377	[p29l1724t1957r2026b2043],
8	of	IN	O	of	_	0	SENT_377	[p29l2072t1953r2152b2021],
9	UGT2B7	NN	O	ugt2b7	nn	11	SENT_377	[p29l10t2055r455b2134],
10	,5	CD	NUMBER	,5	num	11	SENT_377	[p29l10t2055r455b2134],
11	’	NN	O	’	prep_of	7	SENT_377	[p29l10t2055r455b2134],
12	6	CD	NUMBER	6	num	11	SENT_377	[p29l10t2055r455b2134],
13	and	CC	O	and	_	0	SENT_377	[p29l512t2055r660b2123],
14	trimethoprim	NN	O	trimethoprim	nsubjpass	30	SENT_377	[p29l714t2055r1261b2145],
15	has	VBZ	O	have	aux	17	SENT_377	[p29l1314t2055r1447b2123],
16	been	VBN	O	be	auxpass	17	SENT_377	[p29l1501t2055r1693b2123],
17	shown	VBN	O	show	conj_and	3	SENT_377	[p29l1750t2055r2016b2123],
18	to	TO	O	to	aux	19	SENT_377	[p29l2069t2065r2143b2123],
19	decrease	VB	O	decrease	xcomp	17	SENT_377	[p29l12t2157r356b2225],
20	renal	JJ	O	renal	amod	21	SENT_377	[p29l387t2157r591b2225],
21	clearance	NN	O	clearance	dobj	19	SENT_377	[p29l625t2157r1004b2225],
22	of	IN	O	of	_	0	SENT_377	[p29l1040t2157r1120b2225],
23	zidovudine	NN	O	zidovudine	prep_of	21	SENT_377	[p29l1145t2157r1604b2225],
24	by	IN	O	by	_	0	SENT_377	[p29l1634t2157r1733b2246],
25	58	CD	PERCENT	58	num	26	SENT_377	[p29l1767t2157r1939b2230],
26	%	NN	PERCENT	%	prep_by	19	SENT_377	[p29l1767t2157r1939b2230],
27	during	IN	O	during	_	0	SENT_377	[p29l1982t2157r2144b2225, p29l10t2263r134b2349],
28	coadministration	NN	O	coadministration	prep_during	19	SENT_377	[p29l183t2260r876b2328],
29	but	CC	O	but	_	0	SENT_377	[p29l920t2260r1054b2328],
30	had	VBD	O	have	conj_but	17	SENT_377	[p29l1099t2260r1249b2328],
31	no	DT	O	no	det	32	SENT_377	[p29l1296t2284r1394b2328],
32	inﬂuence	NN	O	inﬂuence	dobj	30	SENT_377	[p29l1445t2260r1825b2328],
33	on	IN	O	on	_	0	SENT_377	[p29l1875t2284r1973b2328],
34	the	DT	O	the	det	35	SENT_377	[p29l2020t2260r2144b2328],
35	ratio	NN	O	ratio	prep_on	32	SENT_377	[p29l8t2365r191b2430],
36	of	IN	O	of	_	0	SENT_377	[p29l241t2362r322b2430],
37	zidovudine	NN	O	zidovudine	nn	38	SENT_377	[p29l361t2361r820b2430],
38	glucuronide	NN	O	glucuronide	prep_of	35	SENT_377	[p29l867t2361r1357b2451],
39	to	TO	O	to	_	0	SENT_377	[p29l1404t2371r1477b2430],
40	zidovudine	NN	O	zidovudine	nn	41	SENT_377	[p29l1526t2361r2143b2430],
41	.3	NN	NUMBER	.3	prep_to	30	SENT_377	[p29l1526t2361r2143b2430],
42	°	CD	NUMBER	°	number	43	SENT_377	[p29l1526t2361r2143b2430],
43	’31	CD	NUMBER	’31	num	41	SENT_377	[p29l1526t2361r2143b2430],
44	Although	IN	O	although	mark	47	SENT_377	[p29l9t2463r392b2553],
45	these	DT	O	these	det	46	SENT_377	[p29l425t2463r633b2532],
46	patients	NNS	O	patient	nsubj	47	SENT_377	[p29l668t2467r988b2553],
47	were	VBD	O	be	dep	3	SENT_377	[p29l1024t2488r1217b2532],
48	on	IN	O	on	_	0	SENT_377	[p29l1255t2488r1353b2532],
49	several	JJ	O	several	amod	51	SENT_377	[p29l1388t2463r1669b2532],
50	concurrent	JJ	O	concurrent	amod	51	SENT_377	[p29l1705t2474r2146b2532],
51	medications	NNS	O	medication	prep_on	47	SENT_377	[p29l9t2565r527b2644],
52	,	,	O	,	_	0	SENT_377	[p29l9t2565r527b2644],
53	including	VBG	O	include	_	0	SENT_377	[p29l567t2565r958b2655],
54	rifampin	NN	O	rifampin	prep_including	61	SENT_377	[p29l994t2565r1348b2655],
55	and	CC	O	and	_	0	SENT_377	[p29l1385t2565r1533b2633],
56	trimethoprimsulfamethoxazole	NN	O	trimethoprimsulfamethoxazole	prep_including	61	SENT_377	[p29l1569t2565r2144b2655, p29l11t2666r745b2744],
57	,	,	O	,	_	0	SENT_377	[p29l1569t2565r2144b2655, p29l11t2666r745b2744],
58	we	PRP	O	we	nsubj	61	SENT_377	[p29l793t2690r907b2734],
59	do	VBP	O	do	aux	61	SENT_377	[p29l957t2666r1051b2734],
60	not	RB	O	not	neg	61	SENT_377	[p29l1099t2676r1230b2734],
61	think	VB	O	think	conj_and	47	SENT_377	[p29l1273t2666r1490b2734],
62	the	DT	O	the	det	64	SENT_377	[p29l1533t2666r1657b2734],
63	concurrent	JJ	O	concurrent	amod	64	SENT_377	[p29l1705t2676r2146b2734],
64	medications	NNS	O	medication	nsubj	65	SENT_377	[p29l9t2768r503b2836],
65	confounded	VBD	O	confound	ccomp	61	SENT_377	[p29l557t2768r1042b2836],
66	the	DT	O	the	det	67	SENT_377	[p29l1091t2768r1215b2836],
67	relationship	NN	O	relationship	dobj	65	SENT_377	[p29l1265t2768r1754b2857],
68	between	IN	O	between	_	0	SENT_377	[p29l1804t2768r2146b2836],
69	UGTZB7	NN	O	ugtzb7	nn	70	SENT_377	[p29l10t2874r354b2939],
70	polymorphism	NN	O	polymorphism	prep_between	67	SENT_377	[p29l384t2871r984b2960],
71	and	CC	O	and	_	0	SENT_377	[p29l1011t2871r1160b2939],
72	zidovudine	NN	O	zidovudine	nn	73	SENT_377	[p29l1187t2871r1646b2939],
73	metabolism	NN	O	metabolism	nsubj	77	SENT_377	[p29l1673t2871r2146b2939],
74	as	IN	O	as	_	0	SENT_377	[p29l11t2997r87b3041],
75	all	DT	O	all	det	76	SENT_377	[p29l117t2972r215b3041],
76	patients	NNS	O	patient	prep_as	73	SENT_377	[p29l242t2976r562b3062],
77	received	VBD	O	receive	conj_and	47	SENT_377	[p29l590t2972r934b3041],
78	these	DT	O	these	det	79	SENT_377	[p29l960t2972r1168b3041],
79	medications	NNS	O	medication	dobj	77	SENT_377	[p29l1195t2972r1689b3041],
80	at	IN	O	at	_	0	SENT_377	[p29l1720t2983r1790b3041],
81	the	DT	O	the	det	82	SENT_377	[p29l1814t2972r1938b3041],
82	time	NN	O	time	prep_at	77	SENT_377	[p29l1966t2976r2144b3041],
83	of	IN	O	of	_	0	SENT_377	[p29l12t3075r92b3143],
84	initiation	NN	O	initiation	prep_of	82	SENT_377	[p29l124t3078r501b3143],
85	of	IN	O	of	_	0	SENT_377	[p29l542t3075r622b3143],
86	HAART	NNP	O	HAART	prep_of	84	SENT_377	[p29l653t3079r975b3142],
87	and	CC	O	and	_	0	SENT_377	[p29l1016t3074r1165b3143],
88	at	IN	O	at	_	0	SENT_377	[p29l1205t3085r1274b3143],
89	the	DT	O	the	det	90	SENT_377	[p29l1311t3074r1435b3143],
90	time	NN	O	time	prep_at	77	SENT_377	[p29l1475t3078r1653b3143],
91	of	IN	O	of	_	0	SENT_377	[p29l1695t3075r1776b3143],
92	pharmacokinetic	JJ	O	pharmacokinetic	amod	93	SENT_377	[p29l1807t3074r2144b3164, p29l11t3176r380b3244],
93	testing	NN	O	testing	prep_of	90	SENT_377	[p29l412t3180r700b3266],
94	.	.	O	.	_	0	SENT_377	[p29l412t3180r700b3266],

1	Despite	IN	O	despite	_	0	SENT_378	[p29l116t3282r418b3368],
2	the	DT	O	the	det	4	SENT_378	[p29l475t3278r599b3346],
3	above	JJ	O	above	amod	4	SENT_378	[p29l658t3278r890b3346],
4	limitations	NNS	O	limitation	prep_despite	9	SENT_378	[p29l948t3278r1410b3357],
5	,	,	O	,	_	0	SENT_378	[p29l948t3278r1410b3357],
6	this	DT	O	this	det	8	SENT_378	[p29l1469t3278r1617b3346],
7	pilot	NN	O	pilot	nn	8	SENT_378	[p29l1676t3278r1866b3368],
8	study	NN	O	study	nsubj	26	SENT_378	[p29l1924t3278r2146b3367],
9	provides	VBZ	O	provide	_	0	SENT_378	[p29l10t3381r360b3470],
10	important	JJ	O	important	amod	12	SENT_378	[p29l408t3384r811b3470],
11	pharmacokinetic	JJ	O	pharmacokinetic	amod	12	SENT_378	[p29l856t3381r1538b3470],
12	data	NNS	O	datum	dobj	9	SENT_378	[p29l1589t3381r1756b3449],
13	on	IN	O	on	_	0	SENT_378	[p29l1803t3405r1901b3449],
14	commonly	RB	O	commonly	advmod	15	SENT_378	[p29l1948t3405r2144b3449, p29l9t3484r268b3573],
15	used	VBN	O	use	amod	17	SENT_378	[p29l326t3484r516b3552],
16	generic	JJ	O	generic	amod	17	SENT_378	[p29l574t3487r865b3573],
17	NRTIs	NNS	O	nrti	prep_on	9	SENT_378	[p29l925t3488r1177b3552],
18	in	IN	O	in	_	0	SENT_378	[p29l1238t3487r1318b3551],
19	HIV/TB-coinfected	JJ	O	hiv/tb-coinfected	amod	20	SENT_378	[p29l1376t3484r2145b3552],
20	patients	NNS	O	patient	prep_in	9	SENT_378	[p29l10t3589r330b3675],
21	receiving	VBG	O	receive	partmod	20	SENT_378	[p29l358t3589r730b3675],
22	concurrent	JJ	O	concurrent	amod	24	SENT_378	[p29l759t3595r1200b3654],
23	TB	NN	O	tb	nn	24	SENT_378	[p29l1226t3590r1336b3653],
24	therapy	NN	O	therapy	dobj	21	SENT_378	[p29l1366t3586r1675b3675],
25	and	CC	O	and	_	0	SENT_378	[p29l1702t3586r1850b3654],
26	identifies	VBZ	O	identify	conj_and	9	SENT_378	[p29l1877t3586r2143b3654, p29l10t3688r146b3756],
27	a	DT	O	a	det	29	SENT_378	[p29l202t3712r242b3756],
28	novel	JJ	O	novel	amod	29	SENT_378	[p29l292t3687r515b3756],
29	association	NN	O	association	dobj	26	SENT_378	[p29l569t3691r1019b3756],
30	between	IN	O	between	_	0	SENT_378	[p29l1067t3688r1408b3756],
31	UGTZB7	NNP	O	UGTZB7	nn	33	SENT_378	[p29l1469t3691r1811b3756],
32	genetic	JJ	O	genetic	amod	33	SENT_378	[p29l1857t3691r2143b3777],
33	variation	NN	O	variation	prep_between	29	SENT_378	[p30l8t17r372b81],
34	and	CC	O	and	_	0	SENT_378	[p30l417t13r565b81],
35	zidovudine	NN	O	zidovudine	nn	36	SENT_378	[p30l610t13r1069b81],
36	metabolism	NN	O	metabolism	prep_between	29	SENT_378	[p30l1113t13r1585b81],
37	and	CC	O	and	_	0	SENT_378	[p30l1631t13r1779b81],
38	disposition	NN	O	disposition	conj_and	36	SENT_378	[p30l1826t13r2144b103, p30l9t118r188b181],
39	.	.	O	.	_	0	SENT_378	[p30l1826t13r2144b103, p30l9t118r188b181],

1	The	DT	O	the	det	2	SENT_379	[p30l230t114r383b181],
2	inﬂuence	NN	O	inﬂuence	nsubj	29	SENT_379	[p30l421t114r801b181],
3	of	IN	O	of	_	0	SENT_379	[p30l841t114r921b181],
4	UGT2B7	NN	O	ugt2b7	nn	8	SENT_379	[p30l960t118r1438b181],
5	*	CD	NUMBER	*	num	8	SENT_379	[p30l960t118r1438b181],
6	1c	NN	O	1c	nn	8	SENT_379	[p30l960t118r1438b181],
7	carrier	NN	O	carrier	nn	8	SENT_379	[p30l1478t118r1740b181],
8	status	NN	O	status	prep_of	2	SENT_379	[p30l1777t124r2007b181],
9	on	IN	O	on	_	0	SENT_379	[p30l2047t138r2145b181],
10	intracellular	JJ	O	intracellular	amod	11	SENT_379	[p30l10t215r511b282],
11	concentrations	NNS	O	concentration	prep_on	2	SENT_379	[p30l563t218r1159b282],
12	of	IN	O	of	_	0	SENT_379	[p30l1214t215r1294b282],
13	zidovudine	NN	O	zidovudine	prep_of	11	SENT_379	[p30l1339t215r1798b282],
14	and	CC	O	and	_	0	SENT_379	[p30l1851t215r1999b282],
15	its	PRP$	O	its	poss	16	SENT_379	[p30l2051t218r2143b282],
16	anabolites	NNS	O	anabolite	prep_of	11	SENT_379	[p30l11t318r443b396],
17	,	,	O	,	_	0	SENT_379	[p30l11t318r443b396],
18	as	RB	O	as	_	0	SENT_379	[p30l498t342r574b386],
19	well	RB	O	well	_	0	SENT_379	[p30l625t318r800b386],
20	as	IN	O	as	_	0	SENT_379	[p30l852t342r928b386],
21	clinical	JJ	O	clinical	amod	24	SENT_379	[p30l983t318r1283b386],
22	effect	NN	O	effect	nn	24	SENT_379	[p30l1336t318r1554b386],
23	(	NN	O	(	nn	24	SENT_379	[p30l1608t318r1946b407],
24	efficacy	NN	O	efficacy	conj_and	2	SENT_379	[p30l1608t318r1946b407],
25	and	CC	O	and	_	0	SENT_379	[p30l1997t318r2145b386],
26	toxicity	NN	O	toxicity	nn	27	SENT_379	[p30l9t420r369b509],
27	)	NN	O	)	conj_and	2	SENT_379	[p30l9t420r369b509],
28	,	,	O	,	_	0	SENT_379	[p30l9t420r369b509],
29	needs	VBZ	O	need	_	0	SENT_379	[p30l420t419r652b488],
30	to	TO	O	to	aux	32	SENT_379	[p30l702t430r776b488],
31	be	VB	O	be	auxpass	32	SENT_379	[p30l824t419r915b488],
32	investigated	VBN	O	investigate	xcomp	29	SENT_379	[p30l966t419r1457b509],
33	as	IN	O	as	mark	36	SENT_379	[p30l1507t444r1583b488],
34	it	PRP	O	it	nsubj	36	SENT_379	[p30l1635t423r1690b488],
35	may	MD	O	may	aux	36	SENT_379	[p30l1738t444r1907b509],
36	have	VB	O	have	advcl	32	SENT_379	[p30l1955t420r2144b488],
37	implications	NNS	O	implication	dobj	36	SENT_379	[p30l10t522r518b611],
38	for	IN	O	for	_	0	SENT_379	[p30l552t522r662b590],
39	individualized	JJ	O	individualized	amod	40	SENT_379	[p30l692t521r1291b590],
40	therapy	NN	O	therapy	prep_for	37	SENT_379	[p30l1321t521r1630b611],
41	or	CC	O	or	_	0	SENT_379	[p30l1663t546r1741b590],
42	dosing	NN	O	dosing	prep_for	37	SENT_379	[p30l1774t521r2039b611],
43	of	IN	O	of	_	0	SENT_379	[p30l2072t522r2152b590],
44	zidovudine	NN	O	zidovudine	prep_of	37	SENT_379	[p30l10t622r490b690],
45	.	.	O	.	_	0	SENT_379	[p30l10t622r490b690],

1	We	PRP	O	we	nsubj	2	SENT_380	[p30l115t852r215b903],
2	thank	VBP	O	thank	_	0	SENT_380	[p30l235t849r421b903],
3	the	DT	O	the	det	5	SENT_380	[p30l438t849r538b903],
4	study	NN	O	study	nn	5	SENT_380	[p30l560t849r738b920],
5	participants	NNS	O	participant	dobj	2	SENT_380	[p30l758t851r1164b921],
6	,	,	O	,	_	0	SENT_380	[p30l758t851r1164b921],
7	the	DT	O	the	det	9	SENT_380	[p30l1186t849r1285b903],
8	study	NN	O	study	nn	9	SENT_380	[p30l1308t849r1486b920],
9	coordinators	NNS	O	coordinator	conj_and	5	SENT_380	[p30l1507t849r1932b912],
10	,	,	O	,	_	0	SENT_380	[p30l1507t849r1932b912],
11	Adjoa	NNP	ORGANIZATION	Adjoa	nn	12	SENT_380	[p30l1954t849r2146b920],
12	Obo-Akwa	NNP	ORGANIZATION	Obo-Akwa	conj_and	5	SENT_380	[p30l10t937r355b992],
13	and	CC	O	and	_	0	SENT_380	[p30l389t937r507b992],
14	Esther	NNP	PERSON	Esther	conj_and	5	SENT_380	[p30l539t937r743b992],
15	Manche	FW	PERSON	manche	dep	5	SENT_380	[p30l775t937r1050b1000],
16	,	,	O	,	_	0	SENT_380	[p30l775t937r1050b1000],
17	and	CC	O	and	_	0	SENT_380	[p30l1087t937r1206b992],
18	the	DT	O	the	det	20	SENT_380	[p30l1238t937r1337b992],
19	study	NN	O	study	nn	20	SENT_380	[p30l1373t937r1550b1009],
20	nurse	NN	O	nurse	dobj	2	SENT_380	[p30l1582t956r1779b1000],
21	,	,	O	,	_	0	SENT_380	[p30l1582t956r1779b1000],
22	Janet	NNP	PERSON	Janet	nn	24	SENT_380	[p30l1812t940r1974b1005],
23	May	NNP	PERSON	May	nn	24	SENT_380	[p30l2006t941r2146b1009],
24	Ayi	NNP	PERSON	Ayi	appos	20	SENT_380	[p30l9t1027r138b1096],
25	,	,	O	,	_	0	SENT_380	[p30l9t1027r138b1096],
26	of	IN	O	of	_	0	SENT_380	[p30l167t1024r232b1079],
27	Korle	NNP	PERSON	Korle	nn	30	SENT_380	[p30l251t1024r425b1079],
28	Bu	NNP	O	Bu	nn	30	SENT_380	[p30l451t1028r539b1079],
29	Teaching	NNP	O	Teaching	nn	30	SENT_380	[p30l564t1024r855b1096],
30	Hospital	NNP	O	Hospital	prep_of	20	SENT_380	[p30l880t1024r1170b1096],
31	.	.	O	.	_	0	SENT_380	[p30l880t1024r1170b1096],

1	Financial	NNP	O	Financial	nn	2	SENT_381	[p30l116t1113r421b1167],
2	disclosure	NN	O	disclosure	_	0	SENT_381	[p30l458t1113r805b1167],
3	:	:	O	:	_	0	SENT_381	[p30l458t1113r805b1167],
4	This	DT	O	this	det	5	SENT_381	[p30l842t1113r984b1167],
5	research	NN	O	research	nsubjpass	7	SENT_381	[p30l1018t1113r1290b1167],
6	was	VBD	O	be	auxpass	7	SENT_381	[p30l1322t1132r1445b1167],
7	funded	VBN	O	fund	dep	2	SENT_381	[p30l1481t1113r1711b1167],
8	in	IN	O	in	_	0	SENT_381	[p30l1745t1115r1809b1167],
9	part	NN	O	part	prep_in	7	SENT_381	[p30l1842t1121r1970b1185],
10	by	IN	O	by	_	0	SENT_381	[p30l2001t1113r2080b1184],
11	a	DT	O	a	det	14	SENT_381	[p30l2114t1132r2146b1167],
12	2004	CD	DATE	2004	num	14	SENT_381	[p30l12t1209r162b1256],
13	developmental	JJ	O	developmental	amod	14	SENT_381	[p30l193t1201r674b1273],
14	grant	NN	O	grant	agent	7	SENT_381	[p30l700t1209r865b1273],
15	from	IN	O	from	_	0	SENT_381	[p30l891t1201r1042b1256],
16	the	DT	O	the	det	18	SENT_381	[p30l1067t1201r1166b1256],
17	Lifespan/Tufts/Brown	NNP	O	Lifespan/Tufts/Brown	nn	18	SENT_381	[p30l1193t1201r1909b1273],
18	Center	NNP	O	Center	prep_from	7	SENT_381	[p30l1935t1204r2146b1256],
19	for	IN	O	for	_	0	SENT_381	[p30l10t1289r98b1343],
20	AIDS	NNP	MISC	AIDS	nn	23	SENT_381	[p30l132t1292r301b1344],
21	Research	NNP	MISC	Research	nn	23	SENT_381	[p30l338t1289r629b1344],
22	Grant	NNP	MISC	Grant	nn	23	SENT_381	[p30l665t1292r844b1344],
23	Number	NNP	MISC	Number	prep_for	18	SENT_381	[p30l878t1289r1141b1344],
24	(	CD	NUMBER	(	num	26	SENT_381	[p30l1180t1289r1657b1354],
25	P3OAI042853	NN	O	p3oai042853	nn	26	SENT_381	[p30l1180t1289r1657b1354],
26	)	NN	O	)	dep	36	SENT_381	[p30l1180t1289r1657b1354],
27	and	CC	O	and	_	0	SENT_381	[p30l1697t1289r1816b1344],
28	NIH	NNP	O	NIH	nn	31	SENT_381	[p30l1850t1293r1983b1343],
29	K23	NN	O	k23	nn	31	SENT_381	[p30l2018t1293r2141b1344],
30	developmental	JJ	O	developmental	amod	31	SENT_381	[p30l11t1376r493b1448],
31	award	NN	O	award	dep	36	SENT_381	[p30l517t1376r715b1430],
32	(	CD	NUMBER	(	dep	36	SENT_381	[p30l741t1376r893b1441],
33	NIH	NNP	O	NIH	nn	36	SENT_381	[p30l741t1376r893b1441],
34	K23	NN	O	k23	nn	36	SENT_381	[p30l915t1379r1038b1430],
35	AI071760	NN	O	ai071760	nn	36	SENT_381	[p30l1065t1376r1399b1441],
36	)	NN	O	)	dep	18	SENT_381	[p30l1065t1376r1399b1441],
37	to	TO	O	to	_	0	SENT_381	[p30l1424t1384r1484b1430],
38	A.	NN	O	a.	nn	39	SENT_381	[p30l1508t1379r1576b1430],
39	Kwara	NNP	LOCATION	Kwara	prep_to	36	SENT_381	[p30l1603t1379r1825b1430],
40	.	.	O	.	_	0	SENT_381	[p30l1603t1379r1825b1430],

1	The	DT	O	the	det	3	SENT_382	[p30l1852t1376r1974b1430],
2	drug	NN	O	drug	nn	3	SENT_382	[p30l2000t1376r2145b1447],
3	assays	NNS	O	assay	nsubjpass	5	SENT_382	[p30l10t1483r210b1536],
4	were	VBD	O	be	auxpass	5	SENT_382	[p30l233t1483r388b1519],
5	supported	VBN	O	support	_	0	SENT_382	[p30l412t1464r740b1536],
6	in	IN	O	in	_	0	SENT_382	[p30l763t1467r827b1518],
7	part	NN	O	part	prep_in	5	SENT_382	[p30l848t1472r976b1536],
8	by	IN	O	by	_	0	SENT_382	[p30l995t1464r1074b1536],
9	the	DT	O	the	det	10	SENT_382	[p30l1095t1464r1194b1519],
10	University	NNP	ORGANIZATION	University	agent	5	SENT_382	[p30l1217t1467r1559b1536],
11	of	IN	ORGANIZATION	of	_	0	SENT_382	[p30l1582t1464r1646b1519],
12	North	NNP	ORGANIZATION	North	nn	13	SENT_382	[p30l1662t1464r1850b1519],
13	Carolina	NNP	ORGANIZATION	Carolina	prep_of	10	SENT_382	[p30l1872t1464r2146b1519],
14	at	IN	O	at	_	0	SENT_382	[p30l10t1559r66b1606],
15	Chapel	NN	LOCATION	chapel	nn	18	SENT_382	[p30l88t1551r313b1623],
16	Hill	NNP	LOCATION	Hill	nn	18	SENT_382	[p30l335t1551r476b1615],
17	,	,	O	,	_	0	SENT_382	[p30l335t1551r476b1615],
18	Center	NNP	O	Center	prep_at	5	SENT_382	[p30l501t1554r712b1606],
19	for	IN	O	for	_	0	SENT_382	[p30l734t1551r822b1606],
20	AIDS	NNP	MISC	AIDS	nn	23	SENT_382	[p30l842t1554r1012b1606],
21	research	NN	O	research	nn	23	SENT_382	[p30l1035t1551r1306b1606],
22	grant	NN	O	grant	nn	23	SENT_382	[p30l1327t1559r1492b1623],
23	#AI	NN	O	#ai	prep_for	18	SENT_382	[p30l1513t1555r1664b1606],
24	5	CD	NUMBER	5	number	25	SENT_382	[p30l1513t1555r1664b1606],
25	0410	CD	DATE	0410	num	23	SENT_382	[p30l1674t1559r1842b1606],
26	.	.	O	.	_	0	SENT_382	[p30l1674t1559r1842b1606],

1	Dr	NNP	O	Dr	nn	2	SENT_383	[p30l1868t1555r1945b1605],
2	Court	NNP	O	Court	nsubjpass	4	SENT_383	[p30l1967t1554r2146b1606],
3	was	VBD	O	be	auxpass	4	SENT_383	[p30l8t1659r130b1694],
4	supported	VBN	O	support	_	0	SENT_383	[p30l155t1640r483b1712],
5	by	IN	O	by	_	0	SENT_383	[p30l501t1640r580b1711],
6	grant	NN	O	grant	nn	7	SENT_383	[p30l599t1648r764b1711],
7	R01GM061834	NN	O	r01gm061834	agent	4	SENT_383	[p30l783t1642r1262b1694],
8	from	IN	O	from	_	0	SENT_383	[p30l1285t1640r1436b1694],
9	the	DT	O	the	det	11	SENT_383	[p30l1456t1640r1555b1694],
10	National	NNP	ORGANIZATION	National	nn	11	SENT_383	[p30l1576t1640r1854b1694],
11	Institute	NNP	ORGANIZATION	Institute	prep_from	4	SENT_383	[p30l1876t1643r2144b1694],

1	SPECIAL	JJ	O	special	amod	2	SENT_384	[p30l10t1874r286b1934],
2	POPULATIONS	NNS	O	population	_	0	SENT_384	[p30l319t1873r820b1934],
3	of	IN	O	of	_	0	SENT_384	[p30l13t1968r77b2022],
4	General	NNP	ORGANIZATION	General	nn	6	SENT_384	[p30l120t1968r369b2022],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_384	[p30l418t1968r679b2022],
6	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	2	SENT_384	[p30l730t1971r1008b2022],
7	(	FW	O	(	nn	8	SENT_384	[p30l1062t1968r1361b2032],
8	NIGMS	FW	O	nigms	rcmod	6	SENT_384	[p30l1062t1968r1361b2032],
9	)	FW	O	)	dep	8	SENT_384	[p30l1062t1968r1361b2032],
10	,	,	O	,	_	0	SENT_384	[p30l1062t1968r1361b2032],
11	National	NNP	ORGANIZATION	National	nn	12	SENT_384	[p30l1411t1968r1689b2022],
12	Institutes	NNPS	ORGANIZATION	Institutes	appos	2	SENT_384	[p30l1738t1971r2038b2022],
13	of	IN	ORGANIZATION	of	_	0	SENT_384	[p30l2089t1968r2153b2022],
14	Health	NNP	ORGANIZATION	Health	nn	16	SENT_384	[p30l11t2055r226b2109],
15	(	NNP	O	(	nn	16	SENT_384	[p30l257t2055r588b2120],
16	Bethesda	NNP	LOCATION	Bethesda	prep_of	12	SENT_384	[p30l257t2055r588b2120],
17	,	,	O	,	_	0	SENT_384	[p30l257t2055r588b2120],
18	Maryland	NNP	LOCATION	Maryland	nn	19	SENT_384	[p30l618t2054r971b2126],
19	)	NN	O	)	appos	2	SENT_384	[p30l618t2054r971b2126],
20	.	.	O	.	_	0	SENT_384	[p30l618t2054r971b2126],

1	The	DT	O	the	det	2	SENT_385	[p30l1004t2055r1126b2109],
2	content	NN	O	content	nsubj	14	SENT_385	[p30l1156t2063r1398b2109],
3	is	VBZ	O	be	cop	6	SENT_385	[p30l1425t2057r1475b2109],
4	solely	RB	O	solely	advmod	6	SENT_385	[p30l1506t2054r1695b2126],
5	the	DT	O	the	det	6	SENT_385	[p30l1722t2054r1821b2109],
6	responsibility	NN	O	responsibility	_	0	SENT_385	[p30l1849t2057r2146b2126, p30l9t2143r183b2215],
7	of	IN	O	of	_	0	SENT_385	[p30l204t2143r268b2198],
8	the	DT	O	the	det	9	SENT_385	[p30l282t2143r382b2198],
9	authors	NNS	O	author	prep_of	6	SENT_385	[p30l404t2143r644b2198],
10	and	CC	O	and	_	0	SENT_385	[p30l667t2143r785b2198],
11	does	VBZ	O	do	aux	14	SENT_385	[p30l808t2143r951b2198],
12	not	RB	O	not	neg	14	SENT_385	[p30l973t2151r1078b2198],
13	necessarily	RB	O	necessarily	advmod	14	SENT_385	[p30l1097t2143r1459b2215],
14	represent	VB	O	represent	conj_and	6	SENT_385	[p30l1478t2151r1781b2215],
15	the	DT	O	the	det	17	SENT_385	[p30l1800t2143r1900b2198],
16	official	JJ	O	official	amod	17	SENT_385	[p30l1923t2143r2147b2198],
17	views	NNS	O	view	dobj	14	SENT_385	[p30l10t2234r196b2286],
18	of	IN	O	of	_	0	SENT_385	[p30l225t2231r289b2286],
19	the	DT	O	the	det	21	SENT_385	[p30l308t2231r407b2286],
20	funding	NN	O	funding	nn	21	SENT_385	[p30l434t2231r687b2303],
21	organizations	NNS	O	organization	prep_of	17	SENT_385	[p30l714t2234r1165b2303],
22	.	.	O	.	_	0	SENT_385	[p30l714t2234r1165b2303],

1	Conﬂict	NN	O	conﬂict	_	0	SENT_386	[p30l119t2319r377b2373],
2	of	IN	O	of	_	0	SENT_386	[p30l403t2319r467b2373],
3	interest	NN	O	interest	prep_of	1	SENT_386	[p30l487t2321r745b2373],
4	:	:	O	:	_	0	SENT_386	[p30l487t2321r745b2373],
5	All	DT	O	all	det	6	SENT_386	[p30l773t2318r873b2373],
6	authors	NNS	O	author	nsubj	7	SENT_386	[p30l900t2319r1139b2373],
7	report	VBP	O	report	dep	1	SENT_386	[p30l1165t2326r1362b2390],
8	no	DT	O	no	det	9	SENT_386	[p30l1386t2338r1464b2373],
9	conﬂict	NN	O	conﬂict	dobj	7	SENT_386	[p30l1493t2318r1738b2373],
10	of	IN	O	of	_	0	SENT_386	[p30l1764t2319r1829b2373],
11	interest	NN	O	interest	prep_of	9	SENT_386	[p30l1848t2321r2105b2373],
12	.	.	O	.	_	0	SENT_386	[p30l1848t2321r2105b2373],

1	REFERENCES	NNS	O	reference	_	0	SENT_387	[p30l12t2551r590b2615],

1	1	LS	NUMBER	1	_	0	SENT_388	[p30l13t2767r63b2813],
2	.	.	O	.	_	0	SENT_388	[p30l13t2767r63b2813],

1	US	NNP	ORGANIZATION	US	nn	2	SENT_389	[p30l91t2761r183b2813],
2	Department	NNP	ORGANIZATION	Department	nsubj	10	SENT_389	[p30l209t2762r579b2831],
3	of	IN	ORGANIZATION	of	_	0	SENT_389	[p30l605t2759r667b2813],
4	Health	NNP	ORGANIZATION	Health	nn	7	SENT_389	[p30l686t2759r894b2813],
5	and	CC	ORGANIZATION	and	_	0	SENT_389	[p30l920t2759r1035b2813],
6	Human	NNP	ORGANIZATION	Human	conj_and	4	SENT_389	[p30l1060t2762r1293b2813],
7	Services	NNPS	ORGANIZATION	Services	prep_of	2	SENT_389	[p30l1320t2761r1576b2813],
8	(	CD	NUMBER	(	num	9	SENT_389	[p30l1606t2759r1842b2824],
9	DHHS	NNS	ORGANIZATION	dhh	dep	2	SENT_389	[p30l1606t2759r1842b2824],
10	)	VBD	O	)	_	0	SENT_389	[p30l1606t2759r1842b2824],
11	Panel	NN	O	panel	dobj	10	SENT_389	[p30l1870t2759r2043b2813],
12	on	IN	O	on	_	0	SENT_389	[p30l2070t2778r2148b2813],
13	Antiretroviral	JJ	O	antiretroviral	amod	14	SENT_389	[p30l11t2845r440b2900],
14	Guideline	NN	O	guideline	prep_on	10	SENT_389	[p30l465t2845r773b2900],
15	for	IN	O	for	_	0	SENT_389	[p30l798t2845r883b2900],
16	Adults	NNS	O	adult	prep_for	10	SENT_389	[p30l904t2845r1114b2900],
17	and	CC	O	and	_	0	SENT_389	[p30l1141t2845r1256b2900],
18	Adolescents	NNS	O	adolescent	conj_and	16	SENT_389	[p30l1279t2845r1676b2900],
19	.	.	O	.	_	0	SENT_389	[p30l1279t2845r1676b2900],

1	Guidelines	NNS	O	guideline	_	0	SENT_390	[p30l1708t2845r2041b2900],
2	for	IN	O	for	_	0	SENT_390	[p30l2056t2845r2153b2917],
3	the	DT	O	the	det	4	SENT_390	[p30l15t2931r109b2986],
4	Use	NN	O	use	prep_for	1	SENT_390	[p30l163t2935r273b2986],
5	of	IN	O	of	_	0	SENT_390	[p30l322t2931r390b3003],
6	Antiretroviral	JJ	O	antiretroviral	amod	7	SENT_390	[p30l423t2931r854b2986],
7	Agents	NNS	O	agent	prep_of	4	SENT_390	[p30l896t2935r1113b3003],
8	in	IN	O	in	_	0	SENT_390	[p30l1159t2934r1219b2985],
9	HIV-1-Infected	JJ	O	hiv-1-infected	amod	10	SENT_390	[p30l1266t2931r1727b3003],
10	Adults	NNS	O	adult	prep_in	1	SENT_390	[p30l1769t2931r1981b2986],
11	and	CC	O	and	_	0	SENT_390	[p30l2029t2931r2151b2986],
12	Adolescents	NNS	O	adolescent	conj_and	10	SENT_390	[p30l10t3016r405b3071],
13	.	.	O	.	_	0	SENT_390	[p30l10t3016r405b3071],

1	November	NNP	DATE	November	_	0	SENT_391	[p30l435t3017r760b3071],
2	2008	CD	DATE	2008	dep	1	SENT_391	[p30l788t3024r950b3071],
3	.	.	O	.	_	0	SENT_391	[p30l788t3024r950b3071],

1	http://WWW.aidsinfo.nih.gov/Content	JJ	O	http://www.aidsinfo.nih.gov/content	amod	2	SENT_392	[p30l980t3016r2148b3088],
2	Files/AdultandAdolescentGL	NN	O	files/adultandadolescentgl	_	0	SENT_392	[p30l11t3103r1074b3175],
3	.	.	O	.	_	0	SENT_392	[p30l11t3103r1074b3175],

1	pdf	NN	O	pdf	_	0	SENT_393	[p30l11t3103r1074b3175],
2	.	.	O	.	_	0	SENT_393	[p30l11t3103r1074b3175],

1	Accessed	VBN	O	access	_	0	SENT_394	[p30l1100t3103r1393b3157],
2	January	NNP	DATE	January	tmod	1	SENT_394	[p30l1412t3106r1653b3174],
3	10	CD	DATE	10	num	2	SENT_394	[p30l1678t3110r1765b3166],
4	,	,	DATE	,	_	0	SENT_394	[p30l1678t3110r1765b3166],
5	2009	CD	DATE	2009	num	2	SENT_394	[p30l1793t3110r1955b3157],
6	.	.	O	.	_	0	SENT_394	[p30l1793t3110r1955b3157],

1	2	LS	NUMBER	2	_	0	SENT_395	[p30l13t3205r65b3252],
2	.	.	O	.	_	0	SENT_395	[p30l13t3205r65b3252],

1	Hammer	NNP	O	Hammer	nn	2	SENT_396	[p30l95t3201r374b3252],
2	SM	NNP	O	SM	_	0	SENT_396	[p30l404t3200r526b3260],
3	,	,	O	,	_	0	SENT_396	[p30l404t3200r526b3260],
4	Eron	NNP	PERSON	Eron	nn	7	SENT_396	[p30l556t3201r708b3252],
5	J	NNP	PERSON	J	nn	7	SENT_396	[p30l733t3201r781b3265],
6	]	CD	PERSON	]	num	7	SENT_396	[p30l733t3201r781b3265],
7	Jr	NNP	PERSON	Jr	appos	2	SENT_396	[p30l805t3201r869b3265],
8	,	,	O	,	_	0	SENT_396	[p30l805t3201r869b3265],
9	Reiss	NNP	PERSON	Reiss	nn	10	SENT_396	[p30l899t3201r1065b3252],
10	P	NN	O	p	appos	2	SENT_396	[p30l1094t3201r1143b3260],
11	,	,	O	,	_	0	SENT_396	[p30l1094t3201r1143b3260],
12	et	FW	O	et	nn	13	SENT_396	[p30l1175t3205r1231b3252],
13	al.	FW	O	al.	appos	2	SENT_396	[p30l1259t3198r1329b3252],
14	.	.	O	.	_	0	SENT_396	[p30l1259t3198r1329b3252],

1	Antiretroviral	JJ	O	antiretroviral	amod	2	SENT_397	[p30l1361t3198r1809b3252],
2	treatment	NN	O	treatment	_	0	SENT_397	[p30l1837t3205r2148b3252],
3	of	IN	O	of	_	0	SENT_397	[p30l13t3283r77b3338],
4	adult	JJ	O	adult	amod	6	SENT_397	[p30l91t3283r258b3338],
5	HIV	NN	O	hiv	nn	6	SENT_397	[p30l276t3287r405b3337],
6	infection	NN	O	infection	prep_of	2	SENT_397	[p30l424t3283r729b3338],
7	:	:	O	:	_	0	SENT_397	[p30l424t3283r729b3338],
8	2008	CD	DATE	2008	num	9	SENT_397	[p30l755t3291r905b3338],
9	recommendations	NNS	O	recommendation	dep	2	SENT_397	[p30l926t3283r1508b3338],
10	of	IN	O	of	_	0	SENT_397	[p30l1530t3283r1595b3338],
11	the	DT	O	the	det	14	SENT_397	[p30l1607t3283r1706b3338],
12	International	NNP	O	International	nn	14	SENT_397	[p30l1727t3283r2147b3338],
13	AIDS	NNP	O	AIDS	nn	14	SENT_397	[p30l11t3372r180b3424],
14	Society	NNP	O	Society	prep_of	9	SENT_397	[p30l210t3372r640b3441],
15	.	.	O	.	_	0	SENT_397	[p30l210t3372r640b3441],

1	—	NN	O	—	_	0	SENT_398	[p30l210t3372r640b3441],
2	.	.	O	.	_	0	SENT_398	[p30l210t3372r640b3441],

1	USA	NNP	LOCATION	USA	_	0	SENT_399	[p30l210t3372r640b3441],
2	panel	NN	O	panel	dep	1	SENT_399	[p30l665t3369r860b3441],
3	.	.	O	.	_	0	SENT_399	[p30l665t3369r860b3441],

1	IAMA	NNP	ORGANIZATION	IAMA	_	0	SENT_400	[p30l884t3373r1096b3437],
2	.	.	O	.	_	0	SENT_400	[p30l884t3373r1096b3437],

1	2008	CD	DATE	2008	_	0	SENT_401	[p30l1129t3377r1717b3432],
2	;	:	O	;	_	0	SENT_401	[p30l1129t3377r1717b3432],
3	300:555	CD	NUMBER	300:555	number	4	SENT_401	[p30l1129t3377r1717b3432],
4	-570	CD	NUMBER	-570	dep	1	SENT_401	[p30l1129t3377r1717b3432],
5	.	.	O	.	_	0	SENT_401	[p30l1129t3377r1717b3432],

1	3	LS	NUMBER	3	_	0	SENT_402	[p31l13t26r65b73],
2	.	.	O	.	_	0	SENT_402	[p31l13t26r65b73],

1	World	NNP	ORGANIZATION	World	nn	2	SENT_403	[p31l95t18r294b73],
2	Health	NNP	ORGANIZATION	Health	_	0	SENT_403	[p31l322t18r537b73],
3	Organization	NNP	ORGANIZATION	Organization	nn	4	SENT_403	[p31l566t21r986b90],
4	(	NNP	O	(	dep	2	SENT_403	[p31l1017t18r1256b83],
5	WHO	WP	O	who	rcmod	4	SENT_403	[p31l1017t18r1256b83],
6	)	RB	O	)	advmod	5	SENT_403	[p31l1017t18r1256b83],
7	.	.	O	.	_	0	SENT_403	[p31l1017t18r1256b83],

1	Ant1	NN	O	ant1	dep	6	SENT_404	[p31l1286t18r1735b73],
2	'	''	O	'	_	0	SENT_404	[p31l1286t18r1735b73],
3	retroV1	NN	O	retrov1	dep	1	SENT_404	[p31l1286t18r1735b73],
4	'	''	O	'	_	0	SENT_404	[p31l1286t18r1735b73],
5	raI	NNP	O	raI	dep	6	SENT_404	[p31l1286t18r1735b73],
6	Therapy	NN	O	therapy	dep	18	SENT_404	[p31l1767t18r2039b90],
7	for	IN	O	for	_	0	SENT_404	[p31l2053t18r2153b90],
8	HIV	NN	O	hiv	nn	9	SENT_404	[p31l10t107r147b157],
9	Infection	NN	O	infection	prep_for	6	SENT_404	[p31l180t103r468b175],
10	in	IN	O	in	_	0	SENT_404	[p31l511t107r572b157],
11	Adults	NNS	O	adult	prep_in	9	SENT_404	[p31l614t103r833b158],
12	and	CC	O	and	_	0	SENT_404	[p31l875t103r1000b158],
13	Adolescents	NNS	MISC	adolescent	conj_and	11	SENT_404	[p31l1037t103r1434b158],
14	in	IN	O	in	_	0	SENT_404	[p31l1474t107r1536b157],
15	Resource-Limited	NNP	O	Resource-Limited	nn	16	SENT_404	[p31l1578t103r2151b158],
16	Settings	NNPS	O	Settings	prep_in	11	SENT_404	[p31l14t192r291b261],
17	:	:	O	:	_	0	SENT_404	[p31l14t192r291b261],
18	Towards	IN	O	towards	_	0	SENT_404	[p31l321t190r590b244],
19	Universal	NNP	O	Universal	nn	20	SENT_404	[p31l624t190r932b244],
20	Access	NN	O	access	pobj	18	SENT_404	[p31l954t193r1192b244],
21	.	.	O	.	_	0	SENT_404	[p31l954t193r1192b244],

1	Geneva	NNP	LOCATION	Geneva	nn	3	SENT_405	[p31l1224t192r1479b253],
2	,	,	O	,	_	0	SENT_405	[p31l1224t192r1479b253],
3	Switzerland	NNP	LOCATION	Switzerland	_	0	SENT_405	[p31l1511t190r1918b244],
4	:	:	O	:	_	0	SENT_405	[p31l1511t190r1918b244],
5	WHO	WP	O	who	dep	3	SENT_405	[p31l1948t192r2145b253],
6	;	:	O	;	_	0	SENT_405	[p31l1948t192r2145b253],
7	2	CD	NUMBER	2	dep	5	SENT_405	[p31l14t284r44b330],
8	006	CD	NUMBER	006	dep	7	SENT_405	[p31l53t284r182b331],
9	.	.	O	.	_	0	SENT_405	[p31l53t284r182b331],

1	http	NN	O	http	_	0	SENT_406	[p31l210t276r340b348],
2	:	:	O	:	_	0	SENT_406	[p31l350t276r2146b348],
3	/	:	O	/	dep	5	SENT_406	[p31l350t276r2146b348],
4	/	:	O	/	punct	5	SENT_406	[p31l350t276r2146b348],
5	www.who.int/hiv/pub/guidelines/artadultguidelines	NNS	O	www.who.int/hiv/pub/guidelines/artadultguidelines	dep	1	SENT_406	[p31l350t276r2146b348],
6	.	.	O	.	_	0	SENT_406	[p31l15t362r154b434],

1	pdf	NN	O	pdf	_	0	SENT_407	[p31l15t362r154b434],
2	.	.	O	.	_	0	SENT_407	[p31l15t362r154b434],

1	Accessed	VBN	O	access	_	0	SENT_408	[p31l183t362r485b417],
2	January	NNP	DATE	January	tmod	1	SENT_408	[p31l508t366r757b434],
3	10	CD	DATE	10	num	2	SENT_408	[p31l786t370r875b426],
4	,	,	DATE	,	_	0	SENT_408	[p31l786t370r875b426],
5	2009	CD	DATE	2009	num	2	SENT_408	[p31l906t370r1074b417],
6	.	.	O	.	_	0	SENT_408	[p31l906t370r1074b417],

1	4	LS	NUMBER	4	_	0	SENT_409	[p31l11t465r65b512],
2	.	.	O	.	_	0	SENT_409	[p31l11t465r65b512],

1	Anderson	NNP	PERSON	Anderson	nn	2	SENT_410	[p31l95t457r414b512],
2	PL	NNP	O	PL	_	0	SENT_410	[p31l441t461r543b520],
3	,	,	O	,	_	0	SENT_410	[p31l441t461r543b520],
4	Lamba	NNP	PERSON	Lamba	nn	5	SENT_410	[p31l574t457r789b512],
5	J	NNP	PERSON	J	appos	2	SENT_410	[p31l813t461r854b525],
6	,	,	O	,	_	0	SENT_410	[p31l813t461r854b525],
7	Aquilante	NNP	O	Aquilante	nn	8	SENT_410	[p31l884t457r1205b529],
8	CL	NN	O	cl	appos	2	SENT_410	[p31l1235t460r1340b520],
9	,	,	O	,	_	0	SENT_410	[p31l1235t460r1340b520],
10	Schuetz	NNP	PERSON	Schuetz	nn	11	SENT_410	[p31l1373t457r1628b512],
11	E	NNP	O	E	appos	2	SENT_410	[p31l1656t461r1715b520],
12	,	,	O	,	_	0	SENT_410	[p31l1656t461r1715b520],
13	Fletcher	NNP	PERSON	Fletcher	nn	14	SENT_410	[p31l1746t457r2012b512],
14	CV	NNP	O	CV	appos	2	SENT_410	[p31l2040t460r2143b512],
15	.	.	O	.	_	0	SENT_410	[p31l2040t460r2143b512],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_411	[p31l11t542r565b614],
2	characteristics	NNS	O	characteristic	_	0	SENT_411	[p31l613t542r1078b597],
3	of	IN	O	of	_	0	SENT_411	[p31l1127t542r1191b597],
4	indinavir	NN	O	indinavir	prep_of	2	SENT_411	[p31l1231t542r1546b606],
5	,	,	O	,	_	0	SENT_411	[p31l1231t542r1546b606],
6	zidovudine	NN	O	zidovudine	prep_of	2	SENT_411	[p31l1594t542r1980b606],
7	,	,	O	,	_	0	SENT_411	[p31l1594t542r1980b606],
8	and	CC	O	and	_	0	SENT_411	[p31l2029t542r2148b597],
9	lamivudine	NN	O	lamivudine	nn	10	SENT_411	[p31l12t629r383b683],
10	therapy	NN	O	therapy	conj_and	4	SENT_411	[p31l406t629r654b701],
11	in	IN	O	in	prep	10	SENT_411	[p31l677t632r741b683],
12	HIV-infected	JJ	O	hiv-infected	amod	13	SENT_411	[p31l763t629r1174b683],
13	adults	NNS	O	adult	dep	11	SENT_411	[p31l1198t629r1412b683],
14	:	:	O	:	_	0	SENT_411	[p31l1198t629r1412b683],
15	a	DT	O	a	det	17	SENT_411	[p31l1439t648r1472b683],
16	pilot	NN	O	pilot	nn	17	SENT_411	[p31l1494t629r1646b701],
17	study	NN	O	study	dep	13	SENT_411	[p31l1669t629r1857b700],
18	.	.	O	.	_	0	SENT_411	[p31l1669t629r1857b700],
19	]	SYM	O	]	dep	10	SENT_411	[p31l1879t632r2153b701],

1	Acqu1	NN	O	acqu1	nn	3	SENT_412	[p31l1879t632r2153b701],
2	'	''	O	'	_	0	SENT_412	[p31l1879t632r2153b701],
3	r	NN	O	r	_	0	SENT_412	[p31l1879t632r2153b701],
4	Immune	JJ	MISC	immune	amod	6	SENT_412	[p31l11t719r283b770],
5	Defic	JJ	MISC	defic	amod	6	SENT_412	[p31l305t715r475b787],
6	Syndr	NN	MISC	syndr	dep	3	SENT_412	[p31l500t715r705b787],
7	.	.	O	.	_	0	SENT_412	[p31l500t715r705b787],

1	2006	CD	DATE	2006	_	0	SENT_413	[p31l737t723r1286b778],
2	;	:	O	;	_	0	SENT_413	[p31l737t723r1286b778],
3	42:441	CD	NUMBER	42:441	number	4	SENT_413	[p31l737t723r1286b778],
4	-449	CD	NUMBER	-449	dep	1	SENT_413	[p31l737t723r1286b778],
5	.	.	O	.	_	0	SENT_413	[p31l737t723r1286b778],

1	5	CD	NUMBER	5	_	0	SENT_414	[p31l13t818r45b865],
2	.	.	O	.	_	0	SENT_414	[p31l54t852r65b865],

1	Burger	NNP	O	Burger	nn	2	SENT_415	[p31l80t814r295b882],
2	DM	NN	O	dm	_	0	SENT_415	[p31l306t814r440b873],
3	,	,	O	,	_	0	SENT_415	[p31l306t814r440b873],
4	Meenhorst	NNP	ORGANIZATION	Meenhorst	nn	5	SENT_415	[p31l455t810r801b865],
5	PL	NNP	ORGANIZATION	PL	appos	2	SENT_415	[p31l812t814r914b873],
6	,	,	O	,	_	0	SENT_415	[p31l812t814r914b873],
7	Koks	NNP	O	Koks	nn	8	SENT_415	[p31l929t810r1087b865],
8	CH	NN	O	ch	appos	2	SENT_415	[p31l1101t813r1218b873],
9	,	,	O	,	_	0	SENT_415	[p31l1101t813r1218b873],
10	Beijnen	NNP	O	Beijnen	nn	11	SENT_415	[p31l1233t813r1479b882],
11	IH	NN	O	ih	appos	2	SENT_415	[p31l1489t814r1583b878],
12	.	.	O	.	_	0	SENT_415	[p31l1489t814r1583b878],

1	Pharmacokinetic	JJ	O	pharmacokinetic	amod	2	SENT_416	[p31l1600t810r2146b865],
2	interaction	NN	O	interaction	_	0	SENT_416	[p31l12t899r365b951],
3	between	IN	O	between	_	0	SENT_416	[p31l384t896r657b951],
4	rifampin	NN	O	rifampin	prep_between	2	SENT_416	[p31l678t896r961b968],
5	and	CC	O	and	_	0	SENT_416	[p31l984t896r1102b951],
6	zidovudine	NN	O	zidovudine	conj_and	4	SENT_416	[p31l1125t896r1509b951],
7	.	.	O	.	_	0	SENT_416	[p31l1125t896r1509b951],

1	Antimicrob	NNP	O	Antimicrob	nn	2	SENT_417	[p31l1533t896r1905b951],
2	Agents	NNPS	O	Agents	_	0	SENT_417	[p31l1925t900r2149b968],
3	Chemother	NNP	O	Chemother	dep	2	SENT_417	[p31l15t982r384b1037],
4	.	.	O	.	_	0	SENT_417	[p31l15t982r384b1037],

1	1993	CD	DATE	1993	_	0	SENT_418	[p31l417t990r1044b1045],
2	;	:	O	;	_	0	SENT_418	[p31l417t990r1044b1045],
3	37:1426	CD	DURATION	37:1426	number	4	SENT_418	[p31l417t990r1044b1045],
4	-1431	CD	DURATION	-1431	dep	1	SENT_418	[p31l417t990r1044b1045],
5	.	.	O	.	_	0	SENT_418	[p31l417t990r1044b1045],

1	6	CD	NUMBER	6	_	0	SENT_419	[p31l13t1084r65b1130],
2	.	.	O	.	_	0	SENT_419	[p31l13t1084r65b1130],

1	Gallicano	NNP	O	Gallicano	nn	2	SENT_420	[p31l98t1076r405b1130],
2	KD	NN	O	kd	_	0	SENT_420	[p31l437t1080r554b1139],
3	,	,	O	,	_	0	SENT_420	[p31l437t1080r554b1139],
4	Sahai	FW	PERSON	sahai	appos	2	SENT_420	[p31l589t1076r765b1130],
5	I	PRP	O	I	dep	4	SENT_420	[p31l792t1080r833b1144],
6	,	,	O	,	_	0	SENT_420	[p31l792t1080r833b1144],
7	Shukla	NNP	PERSON	Shukla	nn	8	SENT_420	[p31l868t1076r1093b1130],
8	VK	NNP	O	VK	appos	2	SENT_420	[p31l1121t1080r1239b1139],
9	,	,	O	,	_	0	SENT_420	[p31l1121t1080r1239b1139],
10	et	FW	O	et	nn	11	SENT_420	[p31l1273t1084r1329b1130],
11	al.	FW	O	al.	appos	2	SENT_420	[p31l1359t1076r1429b1130],
12	.	.	O	.	_	0	SENT_420	[p31l1359t1076r1429b1130],

1	Induction	NN	O	induction	_	0	SENT_421	[p31l1463t1076r1781b1130],
2	of	IN	O	of	_	0	SENT_421	[p31l1813t1076r1877b1130],
3	zidovudine	NN	O	zidovudine	nn	4	SENT_421	[p31l1902t1076r2147b1130, p31l14t1160r154b1215],
4	glucuronidation	NN	O	glucuronidation	prep_of	1	SENT_421	[p31l187t1160r711b1232],
5	and	CC	O	and	_	0	SENT_421	[p31l745t1160r863b1215],
6	amination	NN	O	amination	nn	7	SENT_421	[p31l897t1163r1226b1215],
7	pathways	NNS	O	pathway	prep_of	1	SENT_421	[p31l1258t1160r1566b1232],
8	by	IN	O	by	_	0	SENT_421	[p31l1598t1160r1677b1232],
9	rifampicin	NN	O	rifampicin	prep_by	1	SENT_421	[p31l1708t1161r2051b1232],
10	in	IN	O	in	_	0	SENT_421	[p31l2084t1163r2148b1215],
11	HIV-infected	JJ	O	hiv-infected	amod	12	SENT_421	[p31l11t1247r423b1302],
12	patients	NNS	O	patient	prep_in	1	SENT_421	[p31l448t1250r721b1319],
13	.	.	O	.	_	0	SENT_421	[p31l448t1250r721b1319],

1	Br	NN	O	br	_	0	SENT_422	[p31l750t1251r875b1315],
2	]	CD	NUMBER	]	num	1	SENT_422	[p31l750t1251r875b1315],
3	Clin	NNP	PERSON	Clin	nn	4	SENT_422	[p31l896t1247r1024b1302],
4	Pharmacol	NNP	PERSON	Pharmacol	dep	1	SENT_422	[p31l1049t1247r1417b1302],
5	.	.	O	.	_	0	SENT_422	[p31l1049t1247r1417b1302],

1	1999	CD	DATE	1999	_	0	SENT_423	[p31l1451t1255r1998b1310],
2	;	:	O	;	_	0	SENT_423	[p31l1451t1255r1998b1310],
3	48:168	CD	NUMBER	48:168	number	4	SENT_423	[p31l1451t1255r1998b1310],
4	-179	CD	NUMBER	-179	dep	1	SENT_423	[p31l1451t1255r1998b1310],
5	.	.	O	.	_	0	SENT_423	[p31l1451t1255r1998b1310],

1	7	CD	NUMBER	7	_	0	SENT_424	[p31l15t1350r65b1396],
2	.	.	O	.	_	0	SENT_424	[p31l15t1350r65b1396],

1	Hoetelmans	NNP	O	Hoetelmans	_	0	SENT_425	[p31l94t1342r478b1396],
2	RM	NN	O	rm	dep	1	SENT_425	[p31l505t1345r633b1396],
3	.	.	O	.	_	0	SENT_425	[p31l505t1345r633b1396],

1	Pharmacology	NN	O	pharmacology	_	0	SENT_426	[p31l664t1342r1125b1413],
2	of	IN	O	of	_	0	SENT_426	[p31l1153t1342r1218b1396],
3	antiretroviral	JJ	O	antiretroviral	amod	4	SENT_426	[p31l1240t1342r1666b1396],
4	drugs	NNS	O	drug	prep_of	1	SENT_426	[p31l1697t1342r1889b1413],
5	.	.	O	.	_	0	SENT_426	[p31l1697t1342r1889b1413],

1	Ant1	NN	O	ant1	_	0	SENT_427	[p31l1918t1345r2153b1396],
2	'	''	O	'	_	0	SENT_427	[p31l1918t1345r2153b1396],
3	V1	NN	O	v1	nn	5	SENT_427	[p31l1918t1345r2153b1396],
4	'	''	O	'	_	0	SENT_427	[p31l1918t1345r2153b1396],
5	r	NN	O	r	dep	1	SENT_427	[p31l1918t1345r2153b1396],
6	Ther	NNP	O	Ther	dep	5	SENT_427	[p31l18t1428r178b1483],
7	.	.	O	.	_	0	SENT_427	[p31l18t1428r178b1483],

1	1999	CD	DATE	1999	_	0	SENT_428	[p31l211t1428r632b1500],
2	;	:	O	;	_	0	SENT_428	[p31l211t1428r632b1500],
3	4	CD	NUMBER	4	number	4	SENT_428	[p31l211t1428r632b1500],
4	(	CD	NUMBER	(	num	5	SENT_428	[p31l211t1428r632b1500],
5	suppl	NN	O	suppl	dep	1	SENT_428	[p31l211t1428r632b1500],
6	3	CD	NUMBER	3	num	7	SENT_428	[p31l660t1428r935b1493],
7	)	NN	O	)	dep	5	SENT_428	[p31l660t1428r935b1493],
8	:29	CD	NUMBER	:29	num	9	SENT_428	[p31l660t1428r935b1493],
9	-41	CD	NUMBER	-41	dep	5	SENT_428	[p31l660t1428r935b1493],
10	.	.	O	.	_	0	SENT_428	[p31l660t1428r935b1493],

1	8	CD	NUMBER	8	_	0	SENT_429	[p31l13t1531r65b1578],
2	.	.	O	.	_	0	SENT_429	[p31l13t1531r65b1578],

1	Horton	NNP	ORGANIZATION	Horton	nn	2	SENT_430	[p31l91t1527r318b1578],
2	CM	NN	ORGANIZATION	cm	_	0	SENT_430	[p31l342t1526r470b1586],
3	,	,	O	,	_	0	SENT_430	[p31l342t1526r470b1586],
4	Dudley	NNP	PERSON	Dudley	nn	5	SENT_430	[p31l497t1523r732b1595],
5	MN	NN	PERSON	mn	appos	2	SENT_430	[p31l755t1527r892b1586],
6	,	,	O	,	_	0	SENT_430	[p31l755t1527r892b1586],
7	Kaul	NNP	PERSON	Kaul	nn	8	SENT_430	[p31l919t1523r1069b1578],
8	S	NNP	O	S	appos	2	SENT_430	[p31l1096t1526r1151b1586],
9	,	,	O	,	_	0	SENT_430	[p31l1096t1526r1151b1586],
10	et	FW	O	et	nn	11	SENT_430	[p31l1179t1531r1235b1578],
11	al.	FW	O	al.	appos	2	SENT_430	[p31l1259t1523r1329b1578],
12	.	.	O	.	_	0	SENT_430	[p31l1259t1523r1329b1578],

1	Population	NNP	O	Population	nn	2	SENT_431	[p31l1357t1523r1715b1595],
2	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_431	[p31l1739t1523r2146b1595, p31l11t1611r200b1663],
3	of	IN	O	of	_	0	SENT_431	[p31l246t1608r310b1663],
4	stavudine	NN	O	stavudine	nn	7	SENT_431	[p31l348t1608r663b1663],
5	(	CD	NUMBER	(	num	7	SENT_431	[p31l710t1608r877b1673],
6	d4T	NN	O	d4t	nn	7	SENT_431	[p31l710t1608r877b1673],
7	)	NN	O	)	prep_of	2	SENT_431	[p31l710t1608r877b1673],
8	in	IN	O	in	_	0	SENT_431	[p31l924t1611r987b1662],
9	patients	NNS	O	patient	prep_in	2	SENT_431	[p31l1029t1611r1285b1680],
10	with	IN	O	with	_	0	SENT_431	[p31l1328t1608r1477b1663],
11	AIDS	NN	MISC	aid	prep_with	9	SENT_431	[p31l1518t1611r1687b1663],
12	or	CC	O	or	_	0	SENT_431	[p31l1733t1627r1797b1663],
13	advanced	JJ	O	advanced	amod	15	SENT_431	[p31l1839t1608r2148b1663],
14	AIDS-related	JJ	MISC	aids-related	amod	15	SENT_431	[p31l11t1695r432b1749],
15	complex	NN	O	complex	prep_with	9	SENT_431	[p31l468t1695r760b1766],
16	.	.	O	.	_	0	SENT_431	[p31l468t1695r760b1766],

1	Antimicrob	NNP	O	Antimicrob	nn	2	SENT_432	[p31l798t1695r1170b1749],
2	Agents	NNPS	O	Agents	_	0	SENT_432	[p31l1203t1698r1427b1766],
3	Chemother	NNP	O	Chemother	dep	2	SENT_432	[p31l1465t1694r1834b1749],
4	.	.	O	.	_	0	SENT_432	[p31l1465t1694r1834b1749],

1	1995	CD	DATE	1995	_	0	SENT_433	[p31l1877t1702r2144b1758],
2	;	:	O	;	_	0	SENT_433	[p31l1877t1702r2144b1758],
3	39	CD	NUMBER	39	num	5	SENT_433	[p31l1877t1702r2144b1758],
4	:	:	O	:	_	0	SENT_433	[p31l1877t1702r2144b1758],
5	2309-2315	CD	DATE	2309-2315	dep	1	SENT_433	[p31l14t1789r365b1835],
6	.	.	O	.	_	0	SENT_433	[p31l14t1789r365b1835],

1	9	CD	NUMBER	9	_	0	SENT_434	[p31l12t1883r63b1930],
2	.	.	O	.	_	0	SENT_434	[p31l12t1883r63b1930],

1	Johnson	NNP	PERSON	Johnson	nn	2	SENT_435	[p31l83t1876r340b1944],
2	MA	NNP	PERSON	MA	_	0	SENT_435	[p31l359t1879r494b1939],
3	,	,	O	,	_	0	SENT_435	[p31l359t1879r494b1939],
4	Moore	NNP	ORGANIZATION	Moore	nn	5	SENT_435	[p31l515t1879r716b1930],
5	KH	NNP	ORGANIZATION	KH	appos	2	SENT_435	[p31l737t1879r855b1939],
6	,	,	O	,	_	0	SENT_435	[p31l737t1879r855b1939],
7	Yuen	NNP	PERSON	Yuen	nn	9	SENT_435	[p31l876t1879r1040b1930],
8	G	NNP	PERSON	G	nn	9	SENT_435	[p31l1060t1878r1146b1944],
9	]	NNP	O	]	appos	2	SENT_435	[p31l1060t1878r1146b1944],
10	,	,	O	,	_	0	SENT_435	[p31l1060t1878r1146b1944],
11	Bye	NNP	O	Bye	nn	12	SENT_435	[p31l1168t1879r1284b1947],
12	A	NNP	O	A	appos	2	SENT_435	[p31l1304t1879r1372b1939],
13	,	,	O	,	_	0	SENT_435	[p31l1304t1879r1372b1939],
14	Pakes	NNP	O	Pakes	nn	15	SENT_435	[p31l1393t1876r1570b1930],
15	GE	NNP	O	GE	appos	2	SENT_435	[p31l1592t1878r1696b1930],
16	.	.	O	.	_	0	SENT_435	[p31l1592t1878r1696b1930],

1	Clinical	JJ	O	clinical	amod	2	SENT_436	[p31l1720t1876r1964b1930],
2	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_436	[p31l1984t1876r2146b1948, p31l11t1962r424b2016],
3	of	IN	O	of	_	0	SENT_436	[p31l450t1962r513b2016],
4	lamivudine	NN	O	lamivudine	prep_of	2	SENT_436	[p31l530t1962r905b2016],
5	.	.	O	.	_	0	SENT_436	[p31l530t1962r905b2016],

1	CI1	NN	O	ci1	_	0	SENT_437	[p31l936t1962r1060b2016],
2	'n	CC	O	'n	cc	3	SENT_437	[p31l936t1962r1060b2016],
3	Pharmacokinet	NN	O	pharmacokinet	dep	1	SENT_437	[p31l1082t1962r1577b2016],
4	.	.	O	.	_	0	SENT_437	[p31l1082t1962r1577b2016],

1	1999	CD	DATE	1999	_	0	SENT_438	[p31l1608t1970r2059b2025],
2	;	:	O	;	_	0	SENT_438	[p31l1608t1970r2059b2025],
3	36:41	CD	NUMBER	36:41	number	4	SENT_438	[p31l1608t1970r2059b2025],
4	-66	CD	NUMBER	-66	dep	1	SENT_438	[p31l1608t1970r2059b2025],
5	.	.	O	.	_	0	SENT_438	[p31l1608t1970r2059b2025],

1	10	CD	NUMBER	10	_	0	SENT_439	[p31l13t2064r104b2111],
2	.	.	O	.	_	0	SENT_439	[p31l13t2064r104b2111],

1	Panhard	NN	O	panhard	nn	2	SENT_440	[p31l144t2056r415b2111],
2	X	NN	O	x	dep	20	SENT_440	[p31l451t2059r517b2119],
3	,	,	O	,	_	0	SENT_440	[p31l451t2059r517b2119],
4	Legrand	NNP	ORGANIZATION	Legrand	nn	5	SENT_440	[p31l557t2056r819b2128],
5	M	NNP	ORGANIZATION	M	appos	2	SENT_440	[p31l856t2060r937b2119],
6	,	,	O	,	_	0	SENT_440	[p31l856t2060r937b2119],
7	Taburet	NNP	ORGANIZATION	Taburet	nn	8	SENT_440	[p31l978t2056r1222b2111],
8	AM	NNP	ORGANIZATION	AM	appos	2	SENT_440	[p31l1258t2060r1395b2119],
9	,	,	O	,	_	0	SENT_440	[p31l1258t2060r1395b2119],
10	Diquet	NNP	O	Diquet	nn	11	SENT_440	[p31l1434t2059r1650b2128],
11	B	NNP	O	B	appos	2	SENT_440	[p31l1687t2060r1748b2119],
12	,	,	O	,	_	0	SENT_440	[p31l1687t2060r1748b2119],
13	Goujard	NNP	O	Goujard	nn	14	SENT_440	[p31l1789t2056r2046b2128],
14	C	NNP	O	C	appos	2	SENT_440	[p31l2084t2059r2145b2119],
15	,	,	O	,	_	0	SENT_440	[p31l2084t2059r2145b2119],
16	Mentre	NNP	O	Mentre	nn	18	SENT_440	[p31l11t2146r241b2197],
17	F.	NNP	O	F.	nn	18	SENT_440	[p31l281t2146r328b2197],
18	Population	NNP	O	Population	appos	2	SENT_440	[p31l371t2142r729b2214],
19	pharmacokinetic	JJ	O	pharmacokinetic	amod	20	SENT_440	[p31l768t2142r1313b2214],
20	analysis	NN	O	analysis	_	0	SENT_440	[p31l1356t2142r1615b2214],
21	of	IN	O	of	_	0	SENT_440	[p31l1657t2142r1721b2197],
22	lamivudine	NN	O	lamivudine	prep_of	20	SENT_440	[p31l1755t2142r2145b2206],
23	,	,	O	,	_	0	SENT_440	[p31l1755t2142r2145b2206],
24	stavudine	NN	O	stavudine	prep_of	20	SENT_440	[p31l13t2228r328b2282],
25	and	CC	O	and	_	0	SENT_440	[p31l356t2228r475b2282],
26	zidovudine	NN	O	zidovudine	prep_of	20	SENT_440	[p31l501t2227r869b2282],
27	in	IN	O	in	_	0	SENT_440	[p31l897t2230r960b2282],
28	controlled	JJ	O	controlled	amod	30	SENT_440	[p31l988t2227r1320b2282],
29	HIV-infected	JJ	MISC	hiv-infected	amod	30	SENT_440	[p31l1346t2228r1757b2282],
30	patients	NNS	O	patient	prep_in	20	SENT_440	[p31l1784t2230r2040b2299],
31	on	IN	O	on	_	0	SENT_440	[p31l2069t2247r2148b2282],
32	HAART	NNP	O	HAART	prep_on	30	SENT_440	[p31l11t2317r279b2368],
33	.	.	O	.	_	0	SENT_440	[p31l11t2317r279b2368],

1	Eur	NNP	MISC	Eur	nn	4	SENT_441	[p31l307t2317r474b2381],
2	]	NNP	O	]	nn	4	SENT_441	[p31l307t2317r474b2381],
3	Clin	NNP	PERSON	Clin	nn	4	SENT_441	[p31l495t2314r622b2368],
4	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_441	[p31l647t2314r1016b2368],
5	.	.	O	.	_	0	SENT_441	[p31l647t2314r1016b2368],

1	2007	CD	DATE	2007	_	0	SENT_442	[p31l1048t2321r1676b2376],
2	;	:	O	;	_	0	SENT_442	[p31l1048t2321r1676b2376],
3	63:1019	CD	NUMBER	63:1019	number	4	SENT_442	[p31l1048t2321r1676b2376],
4	—	CD	NUMBER	—	dep	1	SENT_442	[p31l1048t2321r1676b2376],
5	1029	CD	DATE	1029	dep	4	SENT_442	[p31l1048t2321r1676b2376],
6	.	.	O	.	_	0	SENT_442	[p31l1048t2321r1676b2376],

1	11	CD	NUMBER	11	_	0	SENT_443	[p31l13t2416r104b2462],
2	.	.	O	.	_	0	SENT_443	[p31l13t2416r104b2462],

1	Byakika-Kibwika	NNP	PERSON	Byakika-Kibwika	nn	2	SENT_444	[p31l140t2408r696b2479],
2	P	NN	PERSON	p	_	0	SENT_444	[p31l728t2411r776b2471],
3	,	,	O	,	_	0	SENT_444	[p31l728t2411r776b2471],
4	Lamorde	NN	O	lamorde	nn	5	SENT_444	[p31l812t2408r1097b2462],
5	M	NN	O	m	appos	2	SENT_444	[p31l1130t2411r1212b2471],
6	,	,	O	,	_	0	SENT_444	[p31l1130t2411r1212b2471],
7	Kalemeera	NN	O	kalemeera	nn	8	SENT_444	[p31l1248t2408r1590b2462],
8	F	NN	O	f	appos	2	SENT_444	[p31l1622t2411r1672b2471],
9	,	,	O	,	_	0	SENT_444	[p31l1622t2411r1672b2471],
10	et	FW	O	et	nn	11	SENT_444	[p31l1709t2415r1764b2462],
11	al.	FW	O	al.	appos	2	SENT_444	[p31l1797t2408r1868b2462],
12	.	.	O	.	_	0	SENT_444	[p31l1797t2408r1868b2462],

1	Steadystate	NNP	O	Steadystate	_	0	SENT_445	[p31l1907t2408r2146b2479, p31l13t2502r157b2549],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_445	[p31l182t2494r727b2566],
3	comparison	NN	O	comparison	dep	1	SENT_445	[p31l754t2497r1134b2566],
4	of	IN	O	of	prep	3	SENT_445	[p31l1158t2494r1222b2549],
5	generic	JJ	O	generic	amod	8	SENT_445	[p31l1239t2497r1472b2566],
6	and	CC	O	and	_	0	SENT_445	[p31l1498t2494r1617b2549],
7	branded	JJ	O	branded	amod	8	SENT_445	[p31l1637t2494r1906b2549],
8	formulations	NNS	O	formulation	dep	4	SENT_445	[p31l1929t2494r2146b2549, p31l12t2580r228b2635],
9	of	IN	O	of	_	0	SENT_445	[p31l260t2580r325b2635],
10	stavudine	NN	O	stavudine	prep_of	8	SENT_445	[p31l349t2580r682b2643],
11	,	,	O	,	_	0	SENT_445	[p31l349t2580r682b2643],
12	lamivudine	NN	O	lamivudine	conj_and	10	SENT_445	[p31l715t2580r1087b2635],
13	and	CC	O	and	_	0	SENT_445	[p31l1117t2580r1236b2635],
14	nevirapine	NN	O	nevirapine	conj_and	10	SENT_445	[p31l1265t2583r1613b2652],
15	in	IN	O	in	_	0	SENT_445	[p31l1644t2583r1708b2634],
16	HIV-infected	JJ	O	hiv-infected	amod	18	SENT_445	[p31l1736t2580r2148b2635],
17	Ugandan	JJ	MISC	ugandan	amod	18	SENT_445	[p31l11t2666r301b2737],
18	adults	NNS	O	adult	prep_in	8	SENT_445	[p31l327t2665r540b2720],
19	.	.	O	.	_	0	SENT_445	[p31l327t2665r540b2720],
20	]	SYM	O	]	dep	3	SENT_445	[p31l565t2666r986b2734],

1	Ant1	NN	O	ant1	_	0	SENT_446	[p31l565t2666r986b2734],
2	'm	VBP	O	be	cop	6	SENT_446	[p31l565t2666r986b2734],
3	1	CD	NUMBER	1	attr	6	SENT_446	[p31l565t2666r986b2734],
4	'	''	O	'	_	0	SENT_446	[p31l565t2666r986b2734],
5	crob	JJ	O	crob	amod	6	SENT_446	[p31l565t2666r986b2734],
6	Chemother	NNP	PERSON	Chemother	dep	1	SENT_446	[p31l1014t2665r1383b2720],
7	.	.	O	.	_	0	SENT_446	[p31l1014t2665r1383b2720],

1	2008	CD	DATE	2008	_	0	SENT_447	[p31l1415t2673r2043b2729],
2	;	:	O	;	_	0	SENT_447	[p31l1415t2673r2043b2729],
3	62:1113	CD	DURATION	62:1113	number	4	SENT_447	[p31l1415t2673r2043b2729],
4	-1117	CD	DURATION	-1117	dep	1	SENT_447	[p31l1415t2673r2043b2729],
5	.	.	O	.	_	0	SENT_447	[p31l1415t2673r2043b2729],

1	12	CD	NUMBER	12	_	0	SENT_448	[p31l13t2768r103b2815],
2	.	.	O	.	_	0	SENT_448	[p31l13t2768r103b2815],

1	Hosseinipour	NNP	O	Hosseinipour	nn	2	SENT_449	[p31l115t2763r546b2832],
2	MC	NNP	O	MC	_	0	SENT_449	[p31l555t2763r682b2823],
3	,	,	O	,	_	0	SENT_449	[p31l555t2763r682b2823],
4	Corbett	NNP	PERSON	Corbett	nn	5	SENT_449	[p31l695t2760r926b2815],
5	AH	NNP	O	AH	appos	2	SENT_449	[p31l934t2764r1059b2824],
6	,	,	O	,	_	0	SENT_449	[p31l934t2764r1059b2824],
7	KanyamaC	NNP	O	KanyamaC	appos	2	SENT_449	[p31l1071t2763r1439b2832],
8	,	,	O	,	_	0	SENT_449	[p31l1071t2763r1439b2832],
9	et	FW	O	et	nn	10	SENT_449	[p31l1452t2768r1508b2815],
10	al.	FW	O	al.	appos	2	SENT_449	[p31l1517t2760r1586b2815],
11	.	.	O	.	_	0	SENT_449	[p31l1517t2760r1586b2815],

1	Pharmacokinetic	JJ	O	pharmacokinetic	amod	2	SENT_450	[p31l1600t2760r2146b2815],
2	comparison	NN	O	comparison	_	0	SENT_450	[p31l12t2849r392b2919],
3	of	IN	O	of	_	0	SENT_450	[p31l438t2847r502b2901],
4	generic	JJ	O	generic	amod	7	SENT_450	[p31l540t2849r773b2918],
5	and	CC	O	and	_	0	SENT_450	[p31l820t2847r939b2901],
6	trade	NN	O	trade	amod	7	SENT_450	[p31l982t2847r1144b2901],
7	formulations	NNS	O	formulation	prep_of	2	SENT_450	[p31l1191t2847r1604b2901],
8	of	IN	O	of	_	0	SENT_450	[p31l1652t2847r1717b2901],
9	lamivudine	NN	O	lamivudine	prep_of	2	SENT_450	[p31l1755t2847r2145b2910],
10	,	,	O	,	_	0	SENT_450	[p31l1755t2847r2145b2910],
11	stavudine	NN	O	stavudine	conj_and	9	SENT_450	[p31l13t2933r328b2988],
12	and	CC	O	and	_	0	SENT_450	[p31l350t2933r469b2988],
13	nevirapine	NN	O	nevirapine	conj_and	9	SENT_450	[p31l489t2936r838b3005],
14	in	IN	O	in	_	0	SENT_450	[p31l861t2936r924b2987],
15	HIV-infected	JJ	O	hiv-infected	amod	17	SENT_450	[p31l944t2933r1356b2988],
16	Malawian	JJ	MISC	malawian	amod	17	SENT_450	[p31l1376t2933r1698b2988],
17	adults	NNS	O	adult	prep_in	2	SENT_450	[p31l1720t2933r1933b2988],
18	.	.	O	.	_	0	SENT_450	[p31l1720t2933r1933b2988],

1	AIDS	NNP	MISC	AIDS	_	0	SENT_451	[p31l1956t2936r2130b2988],
2	.	.	O	.	_	0	SENT_451	[p31l2135t2978r2143b2988],

1	2007	CD	DATE	2007	_	0	SENT_452	[p31l14t3027r483b3083],
2	;	:	O	;	_	0	SENT_452	[p31l14t3027r483b3083],
3	21:59	CD	TIME	21:59	number	4	SENT_452	[p31l14t3027r483b3083],
4	-64	CD	NUMBER	-64	dep	1	SENT_452	[p31l14t3027r483b3083],
5	.	.	O	.	_	0	SENT_452	[p31l14t3027r483b3083],

1	13	CD	NUMBER	13	_	0	SENT_453	[p31l13t3122r104b3169],
2	.	.	O	.	_	0	SENT_453	[p31l13t3122r104b3169],

1	Kwara	NNP	LOCATION	Kwara	nn	2	SENT_454	[p31l146t3118r353b3169],
2	A	NNP	O	A	_	0	SENT_454	[p31l390t3118r460b3178],
3	,	,	O	,	_	0	SENT_454	[p31l390t3118r460b3178],
4	Lartey	NNP	O	Lartey	nn	5	SENT_454	[p31l501t3118r704b3186],
5	M	NNP	O	M	appos	2	SENT_454	[p31l742t3118r823b3177],
6	,	,	O	,	_	0	SENT_454	[p31l742t3118r823b3177],
7	Sagoe	NNP	O	Sagoe	nn	8	SENT_454	[p31l867t3117r1050b3186],
8	KW	NNP	O	KW	appos	2	SENT_454	[p31l1090t3118r1219b3177],
9	,	,	O	,	_	0	SENT_454	[p31l1090t3118r1219b3177],
10	et	FW	O	et	nn	11	SENT_454	[p31l1262t3122r1318b3169],
11	al.	FW	O	al.	appos	2	SENT_454	[p31l1356t3114r1427b3169],
12	.	.	O	.	_	0	SENT_454	[p31l1356t3114r1427b3169],

1	Pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_455	[p31l1469t3114r2047b3169],
2	of	IN	O	of	_	0	SENT_455	[p31l2089t3114r2153b3169],
3	efavirenz	NN	O	efavirenz	prep_of	1	SENT_455	[p31l13t3200r313b3255],
4	when	WRB	O	when	advmod	10	SENT_455	[p31l351t3200r533b3255],
5	co-administered	VBN	O	co-administer	csubj	10	SENT_455	[p31l572t3200r1107b3255],
6	with	IN	O	with	_	0	SENT_455	[p31l1144t3200r1294b3255],
7	rifampin	NN	O	rifampin	prep_with	5	SENT_455	[p31l1331t3200r1618b3272],
8	in	IN	O	in	_	0	SENT_455	[p31l1657t3203r1721b3255],
9	TB/HIV	NN	O	tb/hiv	prep_in	7	SENT_455	[p31l1759t3200r2013b3255],
10	coinfected	VBD	O	coinfect	dep	1	SENT_455	[p31l2052t3219r2146b3255, p31l12t3286r282b3340],
11	patients	NNS	O	patient	dobj	10	SENT_455	[p31l312t3289r594b3358],
12	:	:	O	:	_	0	SENT_455	[p31l312t3289r594b3358],
13	pharmacogenetic	JJ	O	pharmacogenetic	amod	14	SENT_455	[p31l627t3286r1195b3358],
14	effect	NN	O	effect	dep	11	SENT_455	[p31l1228t3286r1407b3340],
15	of	IN	O	of	prep	14	SENT_455	[p31l1438t3286r1504b3340],
16	CYP2B6	NN	O	cyp2b6	nn	17	SENT_455	[p31l1528t3288r1797b3340],
17	variation	NN	O	variation	dep	15	SENT_455	[p31l1828t3288r2143b3340],
18	.	.	O	.	_	0	SENT_455	[p31l1828t3288r2143b3340],
19	]	SYM	O	]	dep	11	SENT_455	[p31l6t3375r40b3439],

1	Clin	NNP	PERSON	Clin	nn	2	SENT_456	[p31l63t3372r190b3426],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_456	[p31l215t3372r584b3426],
3	.	.	O	.	_	0	SENT_456	[p31l215t3372r584b3426],

1	2008	CD	DATE	2008	_	0	SENT_457	[p31l617t3379r1245b3434],
2	;	:	O	;	_	0	SENT_457	[p31l617t3379r1245b3434],
3	48:1032	CD	NUMBER	48:1032	number	4	SENT_457	[p31l617t3379r1245b3434],
4	—	CD	NUMBER	—	dep	1	SENT_457	[p31l617t3379r1245b3434],
5	1040	CD	DATE	1040	dep	4	SENT_457	[p31l617t3379r1245b3434],
6	.	.	O	.	_	0	SENT_457	[p31l617t3379r1245b3434],

1	14	CD	NUMBER	14	_	0	SENT_458	[p31l13t3474r102b3521],
2	.	.	O	.	_	0	SENT_458	[p31l13t3474r102b3521],

1	Lopez-Cortes	NNP	O	Lopez-Cortes	nn	2	SENT_459	[p31l114t3469r524b3538],
2	LF	NNP	O	LF	_	0	SENT_459	[p31l534t3470r625b3529],
3	,	,	O	,	_	0	SENT_459	[p31l534t3470r625b3529],
4	Ruiz-Valderas	NNP	PERSON	Ruiz-Valderas	nn	5	SENT_459	[p31l635t3466r1071b3521],
5	R	NNP	PERSON	R	appos	2	SENT_459	[p31l1081t3470r1141b3529],
6	,	,	O	,	_	0	SENT_459	[p31l1081t3470r1141b3529],
7	Viciana	NNP	PERSON	Viciana	nn	8	SENT_459	[p31l1152t3469r1389b3521],
8	P	NN	PERSON	p	appos	2	SENT_459	[p31l1396t3470r1444b3529],
9	,	,	O	,	_	0	SENT_459	[p31l1396t3470r1444b3529],
10	et	FW	O	et	nn	11	SENT_459	[p31l1456t3474r1510b3521],
11	al.	FW	O	al.	appos	2	SENT_459	[p31l1519t3466r1587b3521],
12	.	.	O	.	_	0	SENT_459	[p31l1519t3466r1587b3521],

1	Pharmacokinetic	JJ	O	pharmacokinetic	amod	2	SENT_460	[p31l1600t3466r2146b3521],
2	interactions	NNS	O	interaction	_	0	SENT_460	[p31l12t3555r394b3607],
3	between	IN	O	between	_	0	SENT_460	[p31l435t3552r708b3607],
4	efavirenz	NN	O	efavirenz	prep_between	2	SENT_460	[p31l750t3552r1046b3607],
5	and	CC	O	and	_	0	SENT_460	[p31l1089t3552r1208b3607],
6	rifampicin	NN	O	rifampicin	conj_and	4	SENT_460	[p31l1248t3552r1590b3624],
7	in	IN	O	in	_	0	SENT_460	[p31l1632t3555r1695b3606],
8	HIV-infected	JJ	MISC	hiv-infected	amod	9	SENT_460	[p31l1736t3552r2148b3607],
9	patients	NNS	O	patient	prep_in	2	SENT_460	[p31l11t3641r265b3710],
10	with	IN	O	with	_	0	SENT_460	[p31l291t3638r438b3693],
11	tuberculosis	NN	O	tuberculosis	prep_with	2	SENT_460	[p31l462t3638r872b3693],
12	.	.	O	.	_	0	SENT_460	[p31l462t3638r872b3693],

1	CI1	NN	O	ci1	_	0	SENT_461	[p31l905t3638r1031b3693],
2	'n	CC	O	'n	cc	3	SENT_461	[p31l905t3638r1031b3693],
3	Pharmacokinet	NN	O	pharmacokinet	dep	1	SENT_461	[p31l1056t3638r1564b3693],
4	.	.	O	.	_	0	SENT_461	[p31l1056t3638r1564b3693],

1	2002	CD	DATE	2002	_	0	SENT_462	[p31l1595t3646r2140b3702],
2	;	:	O	;	_	0	SENT_462	[p31l1595t3646r2140b3702],
3	41:681	CD	NUMBER	41:681	number	4	SENT_462	[p31l1595t3646r2140b3702],
4	-690	CD	NUMBER	-690	dep	1	SENT_462	[p31l1595t3646r2140b3702],
5	.	.	O	.	_	0	SENT_462	[p31l1595t3646r2140b3702],

1	KWARA	NNP	LOCATION	KWARA	nn	3	SENT_463	[p32l936t247r1089b277],
2	ET	NNP	O	ET	nn	3	SENT_463	[p32l1104t247r1160b277],
3	AL	NNP	O	AL	_	0	SENT_463	[p32l1169t247r1225b277],

1	15	CD	NUMBER	15	_	0	SENT_464	[p32l13t466r104b512],
2	.	.	O	.	_	0	SENT_464	[p32l13t466r104b512],

1	Gurumurthy	NNP	PERSON	Gurumurthy	nn	2	SENT_465	[p32l136t457r541b529],
2	P	NN	PERSON	p	_	0	SENT_465	[p32l568t461r617b520],
3	,	,	O	,	_	0	SENT_465	[p32l568t461r617b520],
4	Ramachandran	NNP	PERSON	Ramachandran	nn	5	SENT_465	[p32l648t457r1137b512],
5	G	NNP	PERSON	G	appos	2	SENT_465	[p32l1165t460r1230b520],
6	,	,	O	,	_	0	SENT_465	[p32l1165t460r1230b520],
7	Hemanth	NNP	PERSON	Hemanth	nn	9	SENT_465	[p32l1261t457r1560b512],
8	Kumar	NNP	PERSON	Kumar	nn	9	SENT_465	[p32l1588t461r1807b512],
9	AK	NNP	O	AK	appos	2	SENT_465	[p32l1834t461r1956b520],
10	,	,	O	,	_	0	SENT_465	[p32l1834t461r1956b520],
11	et	FW	O	et	nn	12	SENT_465	[p32l1988t465r2044b512],
12	al.	FW	O	al.	appos	2	SENT_465	[p32l2073t457r2143b512],
13	.	.	O	.	_	0	SENT_465	[p32l2073t457r2143b512],

1	Malabsorption	NN	O	malabsorption	conj_and	1	SENT_466	[p32l11t543r483b614],
2	of	IN	O	of	_	0	SENT_466	[p32l510t543r574b597],
3	rifampin	NN	O	rifampin	prep_of	1	SENT_466	[p32l591t543r875b614],
4	and	CC	O	and	_	0	SENT_466	[p32l900t542r1018b597],
5	isoniazid	NN	O	isoniazid	prep_of	1	SENT_466	[p32l1043t543r1341b597],
6	in	IN	O	in	_	0	SENT_466	[p32l1366t545r1429b597],
7	HIV-infected	JJ	MISC	hiv-infected	amod	8	SENT_466	[p32l1453t542r1865b597],
8	patients	NNS	O	patient	prep_in	1	SENT_466	[p32l1890t545r2146b614],
9	with	IN	O	with	_	0	SENT_466	[p32l10t629r159b683],
10	and	CC	O	and	_	0	SENT_466	[p32l185t629r303b683],
11	without	IN	O	without	_	0	SENT_466	[p32l327t629r583b683],
12	tuberculosis	NN	O	tuberculosis	prep_without	1	SENT_466	[p32l607t629r1020b683],
13	.	.	O	.	_	0	SENT_466	[p32l607t629r1020b683],

1	Clin	NNP	O	Clin	nn	3	SENT_467	[p32l1053t629r1181b683],
2	Infect	NNP	O	Infect	nn	3	SENT_467	[p32l1206t629r1394b700],
3	Dis	NNP	O	Dis	_	0	SENT_467	[p32l1414t632r1533b683],
4	.	.	O	.	_	0	SENT_467	[p32l1414t632r1533b683],

1	2004	CD	DATE	2004	_	0	SENT_468	[p32l1565t636r2114b692],
2	;	:	O	;	_	0	SENT_468	[p32l1565t636r2114b692],
3	38:280	CD	NUMBER	38:280	number	4	SENT_468	[p32l1565t636r2114b692],
4	-283	CD	NUMBER	-283	dep	1	SENT_468	[p32l1565t636r2114b692],
5	.	.	O	.	_	0	SENT_468	[p32l1565t636r2114b692],

1	16	CD	NUMBER	16	_	0	SENT_469	[p32l13t731r104b778],
2	.	.	O	.	_	0	SENT_469	[p32l13t731r104b778],

1	Sahai	FW	PERSON	sahai	_	0	SENT_470	[p32l135t724r311b778],
2	I	PRP	O	I	dep	1	SENT_470	[p32l335t727r375b792],
3	,	,	O	,	_	0	SENT_470	[p32l335t727r375b792],
4	Gallicano	NNP	O	Gallicano	nn	5	SENT_470	[p32l405t724r712b778],
5	K	NNP	O	K	appos	2	SENT_470	[p32l740t727r805b787],
6	,	,	O	,	_	0	SENT_470	[p32l740t727r805b787],
7	Swick	NNP	PERSON	Swick	nn	8	SENT_470	[p32l836t724r1034b778],
8	L	NNP	O	L	appos	2	SENT_470	[p32l1059t727r1116b787],
9	,	,	O	,	_	0	SENT_470	[p32l1059t727r1116b787],
10	et	FW	O	et	nn	11	SENT_470	[p32l1146t732r1202b778],
11	al.	FW	O	al.	appos	2	SENT_470	[p32l1228t724r1298b778],
12	.	.	O	.	_	0	SENT_470	[p32l1228t724r1298b778],

1	Reduced	VBN	O	reduce	amod	3	SENT_471	[p32l1328t724r1611b778],
2	plasma	NN	O	plasma	nn	3	SENT_471	[p32l1637t724r1868b796],
3	concentrations	NNS	O	concentration	_	0	SENT_471	[p32l1894t743r2146b778, p32l11t813r255b865],
4	of	IN	O	of	_	0	SENT_471	[p32l287t810r351b865],
5	antituberculosis	JJ	O	antituberculosis	amod	6	SENT_471	[p32l374t810r894b865],
6	drugs	NNS	O	drug	prep_of	3	SENT_471	[p32l926t810r1101b882],
7	in	IN	O	in	_	0	SENT_471	[p32l1131t813r1195b864],
8	patients	NNS	O	patient	prep_in	6	SENT_471	[p32l1222t813r1478b882],
9	with	IN	O	with	_	0	SENT_471	[p32l1507t810r1656b865],
10	HIV	NN	MISC	hiv	nn	11	SENT_471	[p32l1682t814r1811b864],
11	infection	NN	O	infection	prep_with	8	SENT_471	[p32l1838t810r2143b865],
12	.	.	O	.	_	0	SENT_471	[p32l1838t810r2143b865],

1	Ann	NNP	O	Ann	nn	3	SENT_472	[p32l10t900r148b950],
2	Intern	NNP	O	Intern	nn	3	SENT_472	[p32l174t900r368b951],
3	Med	NNP	O	Med	_	0	SENT_472	[p32l393t896r549b951],
4	.	.	O	.	_	0	SENT_472	[p32l393t896r549b951],

1	1997	CD	DATE	1997	_	0	SENT_473	[p32l582t904r1170b959],
2	;	:	O	;	_	0	SENT_473	[p32l582t904r1170b959],
3	127:289	CD	NUMBER	127:289	number	4	SENT_473	[p32l582t904r1170b959],
4	-293	CD	NUMBER	-293	dep	1	SENT_473	[p32l582t904r1170b959],
5	.	.	O	.	_	0	SENT_473	[p32l582t904r1170b959],

1	17	CD	NUMBER	17	_	0	SENT_474	[p32l13t998r105b1045],
2	.	.	O	.	_	0	SENT_474	[p32l13t998r105b1045],

1	Kullak-Ublick	NNP	O	Kullak-Ublick	nn	2	SENT_475	[p32l142t990r602b1045],
2	GA	NNP	O	GA	_	0	SENT_475	[p32l635t993r755b1053],
3	,	,	O	,	_	0	SENT_475	[p32l635t993r755b1053],
4	Becker	NNP	PERSON	Becker	nn	5	SENT_475	[p32l792t990r1012b1045],
5	MB	NNP	O	MB	appos	2	SENT_475	[p32l1046t994r1173b1045],
6	.	.	O	.	_	0	SENT_475	[p32l1046t994r1173b1045],

1	Regulation	NN	O	regulation	_	0	SENT_476	[p32l1211t990r1563b1062],
2	of	IN	O	of	_	0	SENT_476	[p32l1599t990r1663b1045],
3	drug	NN	O	drug	nn	7	SENT_476	[p32l1694t990r1839b1062],
4	and	CC	O	and	_	0	SENT_476	[p32l1875t990r1994b1045],
5	bile	NN	O	bile	nn	7	SENT_476	[p32l2025t990r2146b1045],
6	salt	NN	O	salt	nn	7	SENT_476	[p32l13t1075r124b1130],
7	transporters	NNS	O	transporter	prep_of	1	SENT_476	[p32l148t1083r538b1147],
8	in	IN	O	in	_	0	SENT_476	[p32l566t1078r630b1130],
9	liver	NN	O	liver	prep_in	1	SENT_476	[p32l656t1075r804b1130],
10	and	CC	O	and	_	0	SENT_476	[p32l830t1076r949b1130],
11	intestine	NN	O	intestine	conj_and	9	SENT_476	[p32l975t1078r1273b1130],
12	.	.	O	.	_	0	SENT_476	[p32l975t1078r1273b1130],

1	Drug	NN	O	drug	nn	3	SENT_477	[p32l1302t1079r1463b1147],
2	Metab	NNP	O	Metab	nn	3	SENT_477	[p32l1483t1075r1685b1130],
3	Rev.	NNP	O	Rev.	_	0	SENT_477	[p32l1709t1079r1842b1130],
4	2003	CD	DATE	2003	num	3	SENT_477	[p32l1875t1083r2024b1130],
5	;	:	O	;	_	0	SENT_477	[p32l2035t1083r2144b1139],
6	35	CD	NUMBER	35	num	8	SENT_477	[p32l2035t1083r2144b1139],
7	:	:	O	:	_	0	SENT_477	[p32l2035t1083r2144b1139],
8	305-317	CD	NUMBER	305-317	dep	3	SENT_477	[p32l14t1170r286b1216],
9	.	.	O	.	_	0	SENT_477	[p32l14t1170r286b1216],

1	18	CD	NUMBER	18	_	0	SENT_478	[p32l13t1264r104b1311],
2	.	.	O	.	_	0	SENT_478	[p32l13t1264r104b1311],

1	Schuetz	NNP	PERSON	Schuetz	nn	2	SENT_479	[p32l141t1257r396b1311],
2	JD	NNP	O	JD	_	0	SENT_479	[p32l425t1260r517b1325],
3	,	,	O	,	_	0	SENT_479	[p32l425t1260r517b1325],
4	Connelly	NNP	PERSON	Connelly	nn	5	SENT_479	[p32l552t1257r846b1328],
5	MC	NNP	O	MC	appos	2	SENT_479	[p32l876t1259r1005b1320],
6	,	,	O	,	_	0	SENT_479	[p32l876t1259r1005b1320],
7	Sun	NNP	O	Sun	nn	8	SENT_479	[p32l1042t1259r1167b1311],
8	D	NNP	O	D	appos	2	SENT_479	[p32l1197t1260r1263b1320],
9	,	,	O	,	_	0	SENT_479	[p32l1197t1260r1263b1320],
10	et	FW	O	et	nn	11	SENT_479	[p32l1299t1265r1355b1311],
11	al.	FW	O	al.	appos	2	SENT_479	[p32l1386t1257r1457b1311],
12	.	.	O	.	_	0	SENT_479	[p32l1386t1257r1457b1311],

1	MRP4	NN	O	mrp4	_	0	SENT_480	[p32l1492t1260r1704b1311],
2	:	:	O	:	_	0	SENT_480	[p32l1492t1260r1704b1311],
3	a	DT	O	a	det	6	SENT_480	[p32l1740t1276r1772b1311],
4	previously	RB	DATE	previously	advmod	6	SENT_480	[p32l1802t1257r2148b1329],
5	unidentified	JJ	O	unidentified	amod	6	SENT_480	[p32l11t1343r416b1398],
6	factor	NN	O	factor	dep	1	SENT_480	[p32l461t1343r644b1398],
7	in	IN	O	in	_	0	SENT_480	[p32l688t1346r752b1397],
8	resistance	NN	O	resistance	prep_in	6	SENT_480	[p32l795t1346r1116b1398],
9	to	TO	O	to	_	0	SENT_480	[p32l1161t1351r1220b1398],
10	nucleoside-based	JJ	O	nucleoside-based	amod	12	SENT_480	[p32l1266t1343r1829b1398],
11	antiviral	JJ	O	antiviral	amod	12	SENT_480	[p32l1875t1343r2147b1398],
12	drugs	NNS	O	drug	prep_to	8	SENT_480	[p32l14t1429r206b1501],
13	.	.	O	.	_	0	SENT_480	[p32l14t1429r206b1501],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_481	[p32l235t1433r355b1484],
2	Med	NNP	PERSON	Med	_	0	SENT_481	[p32l375t1429r531b1484],
3	.	.	O	.	_	0	SENT_481	[p32l375t1429r531b1484],

1	1999	CD	DATE	1999	_	0	SENT_482	[p32l564t1437r1151b1492],
2	;	:	O	;	_	0	SENT_482	[p32l564t1437r1151b1492],
3	5:1048	CD	DURATION	5:1048	number	4	SENT_482	[p32l564t1437r1151b1492],
4	-1051	CD	DURATION	-1051	dep	1	SENT_482	[p32l564t1437r1151b1492],
5	.	.	O	.	_	0	SENT_482	[p32l564t1437r1151b1492],

1	19	CD	NUMBER	19	_	0	SENT_483	[p32l13t1532r104b1579],
2	.	.	O	.	_	0	SENT_483	[p32l13t1532r104b1579],

1	Corpechot	NN	O	corpechot	nn	2	SENT_484	[p32l130t1524r464b1596],
2	C	NN	O	c	dep	18	SENT_484	[p32l485t1527r546b1587],
3	,	,	O	,	_	0	SENT_484	[p32l485t1527r546b1587],
4	Ping	NN	O	ping	nn	5	SENT_484	[p32l570t1527r714b1596],
5	C	NN	O	c	appos	2	SENT_484	[p32l736t1527r797b1588],
6	,	,	O	,	_	0	SENT_484	[p32l736t1527r797b1588],
7	Wendum	NN	O	wendum	nn	8	SENT_484	[p32l821t1524r1116b1579],
8	D	NN	O	d	appos	2	SENT_484	[p32l1137t1528r1203b1587],
9	,	,	O	,	_	0	SENT_484	[p32l1137t1528r1203b1587],
10	Matsuda	NNP	PERSON	Matsuda	nn	11	SENT_484	[p32l1227t1524r1507b1579],
11	F	NN	O	f	appos	2	SENT_484	[p32l1528t1528r1577b1587],
12	,	,	O	,	_	0	SENT_484	[p32l1528t1528r1577b1587],
13	Barbu	NNP	PERSON	Barbu	nn	14	SENT_484	[p32l1602t1524r1793b1579],
14	V	NNP	O	V	appos	2	SENT_484	[p32l1814t1528r1872b1588],
15	,	,	O	,	_	0	SENT_484	[p32l1814t1528r1872b1588],
16	Poupon	NNP	PERSON	Poupon	nn	17	SENT_484	[p32l1896t1528r2148b1596],
17	R.	NNP	PERSON	R.	appos	2	SENT_484	[p32l11t1613r71b1664],
18	Identification	NN	PERSON	identification	_	0	SENT_484	[p32l111t1609r552b1664],
19	of	IN	O	of	_	0	SENT_484	[p32l589t1609r653b1664],
20	a	DT	O	a	det	27	SENT_484	[p32l683t1629r716b1664],
21	novel	JJ	O	novel	amod	27	SENT_484	[p32l750t1609r929b1664],
22	974C	NN	O	974c	npadvmod	24	SENT_484	[p32l967t1612r1251b1664],
23	—	CD	NUMBER	—	num	22	SENT_484	[p32l967t1612r1251b1664],
24	>	JJR	O	>	amod	27	SENT_484	[p32l967t1612r1251b1664],
25	G	NN	O	g	nn	27	SENT_484	[p32l967t1612r1251b1664],
26	nonsense	NN	O	nonsense	nn	27	SENT_484	[p32l1285t1629r1586b1664],
27	mutation	NN	O	mutation	prep_of	18	SENT_484	[p32l1622t1612r1917b1664],
28	of	IN	O	of	_	0	SENT_484	[p32l1954t1609r2018b1664],
29	the	DT	O	the	det	31	SENT_484	[p32l2047t1609r2146b1664],
30	MRP2/ABCC2	NN	O	mrp2/abcc2	nn	31	SENT_484	[p32l11t1696r467b1750],
31	gene	NN	O	gene	prep_of	27	SENT_484	[p32l507t1715r653b1767],
32	in	IN	O	in	_	0	SENT_484	[p32l691t1699r754b1750],
33	a	DT	O	a	det	34	SENT_484	[p32l791t1715r823b1750],
34	patient	NN	O	patient	prep_in	31	SENT_484	[p32l858t1698r1085b1768],
35	with	IN	O	with	_	0	SENT_484	[p32l1119t1696r1267b1750],
36	Dubin-Johnson	NN	MISC	dubin-johnson	nn	37	SENT_484	[p32l1302t1696r1791b1764],
37	syndrome	NN	O	syndrome	prep_with	34	SENT_484	[p32l1828t1696r2147b1767],
38	and	CC	O	and	_	0	SENT_484	[p32l12t1782r131b1837],
39	analysis	NN	O	analysis	conj_and	37	SENT_484	[p32l153t1782r413b1854],
40	of	IN	O	of	_	0	SENT_484	[p32l437t1782r502b1837],
41	the	DT	O	the	det	42	SENT_484	[p32l516t1782r616b1837],
42	effects	NNS	O	effect	prep_of	27	SENT_484	[p32l639t1782r843b1837],
43	of	IN	O	of	_	0	SENT_484	[p32l868t1782r932b1837],
44	rifampicin	NN	O	rifampicin	prep_of	42	SENT_484	[p32l947t1782r1289b1854],
45	and	CC	O	and	_	0	SENT_484	[p32l1311t1782r1430b1837],
46	ursodeoxycholic	JJ	O	ursodeoxycholic	amod	47	SENT_484	[p32l1451t1782r1989b1854],
47	acid	NN	O	acid	conj_and	18	SENT_484	[p32l2013t1782r2148b1837],
48	on	IN	O	on	_	0	SENT_484	[p32l13t1887r92b1922],
49	serum	NN	O	serum	nn	50	SENT_484	[p32l119t1887r317b1922],
50	bilirubin	NN	O	bilirubin	prep_on	47	SENT_484	[p32l341t1868r629b1922],
51	and	CC	O	and	_	0	SENT_484	[p32l656t1868r775b1922],
52	bile	NN	O	bile	nn	53	SENT_484	[p32l799t1868r920b1922],
53	acids	NNS	O	acid	prep_on	47	SENT_484	[p32l948t1868r1130b1922],
54	.	.	O	.	_	0	SENT_484	[p32l948t1868r1130b1922],

1	Am	VBP	O	be	dep	2	SENT_485	[p32l1159t1872r1274b1921],
2	]	CD	NUMBER	]	_	0	SENT_485	[p32l1296t1872r1330b1936],
3	Gastroenterol	NNP	O	Gastroenterol	dep	2	SENT_485	[p32l1353t1868r1803b1922],
4	.	.	O	.	_	0	SENT_485	[p32l1353t1868r1803b1922],

1	2006	CD	DATE	2006	_	0	SENT_486	[p32l1836t1876r2144b1931],
2	;	:	O	;	_	0	SENT_486	[p32l1836t1876r2144b1931],
3	101	CD	NUMBER	101	num	5	SENT_486	[p32l1836t1876r2144b1931],
4	:	:	O	:	_	0	SENT_486	[p32l1836t1876r2144b1931],
5	2427-2432	CD	DATE	2427-2432	dep	1	SENT_486	[p32l14t1961r365b2007],
6	.	.	O	.	_	0	SENT_486	[p32l14t1961r365b2007],

1	20	CD	NUMBER	20	_	0	SENT_487	[p32l13t2056r104b2103],
2	.	.	O	.	_	0	SENT_487	[p32l13t2056r104b2103],

1	Barbier	NNP	PERSON	Barbier	nn	2	SENT_488	[p32l120t2048r355b2103],
2	O	NNP	PERSON	O	_	0	SENT_488	[p32l368t2051r436b2112],
3	,	,	O	,	_	0	SENT_488	[p32l368t2051r436b2112],
4	Turgeon	NNP	PERSON	Turgeon	appos	2	SENT_488	[p32l453t2052r716b2120],
5	D	NNP	O	D	rcmod	4	SENT_488	[p32l728t2052r794b2112],
6	,	,	O	,	_	0	SENT_488	[p32l728t2052r794b2112],
7	Girard	NNP	PERSON	Girard	dep	8	SENT_488	[p32l810t2048r1016b2103],
8	C	NNP	O	C	dep	5	SENT_488	[p32l1030t2051r1090b2112],
9	,	,	O	,	_	0	SENT_488	[p32l1030t2051r1090b2112],
10	et	FW	O	et	nn	11	SENT_488	[p32l1107t2056r1163b2103],
11	al.	FW	O	al.	appos	8	SENT_488	[p32l1176t2048r1246b2103],
12	3	CD	NUMBER	3	dep	5	SENT_488	[p32l1267t2056r1296b2103],
13	'	''	O	'	_	0	SENT_488	[p32l1306t2048r1579b2103],
14	-	:	O	-	_	0	SENT_488	[p32l1306t2048r1579b2103],
15	azido-3	NN	O	azido-3	dep	4	SENT_488	[p32l1306t2048r1579b2103],
16	’	SYM	O	’	dep	18	SENT_488	[p32l1589t2048r2146b2120],
17	-	:	O	-	_	0	SENT_488	[p32l1589t2048r2146b2120],
18	deoxythimidine	NN	O	deoxythimidine	dep	15	SENT_488	[p32l1589t2048r2146b2120],
19	(	CD	NUMBER	(	num	18	SENT_488	[p32l15t2134r203b2199],
20	AZT	NNP	O	AZT	nsubjpass	23	SENT_488	[p32l15t2134r203b2199],
21	)	CD	NUMBER	)	num	20	SENT_488	[p32l15t2134r203b2199],
22	is	VBZ	O	be	auxpass	23	SENT_488	[p32l235t2137r284b2188],
23	glucuronidated	VBN	O	glucuronidate	rcmod	18	SENT_488	[p32l314t2134r810b2205],
24	by	IN	O	by	_	0	SENT_488	[p32l835t2134r914b2205],
25	human	JJ	O	human	amod	27	SENT_488	[p32l941t2134r1168b2188],
26	UDP-glucuronosyltransferase	NN	O	udp-glucuronosyltransferase	nn	27	SENT_488	[p32l1196t2134r2147b2205],
27	2B7	NN	O	2b7	agent	23	SENT_488	[p32l14t2224r133b2274],
28	(	CD	NUMBER	(	number	30	SENT_488	[p32l164t2220r501b2285],
29	UGTZB7	NN	O	ugtzb7	dep	30	SENT_488	[p32l164t2220r501b2285],
30	)	NN	O	)	amod	27	SENT_488	[p32l164t2220r501b2285],
31	.	.	O	.	_	0	SENT_488	[p32l164t2220r501b2285],

1	Drug	NN	O	drug	_	0	SENT_489	[p32l530t2224r691b2292],
2	Metab	NNP	O	Metab	nn	3	SENT_489	[p32l710t2220r910b2275],
3	Dispos	NNP	O	Dispos	dep	1	SENT_489	[p32l934t2223r1168b2292],
4	.	.	O	.	_	0	SENT_489	[p32l934t2223r1168b2292],

1	2000	CD	DATE	2000	_	0	SENT_490	[p32l1200t2228r1748b2283],
2	;	:	O	;	_	0	SENT_490	[p32l1200t2228r1748b2283],
3	28:497	CD	NUMBER	28:497	number	4	SENT_490	[p32l1200t2228r1748b2283],
4	-502	CD	NUMBER	-502	dep	1	SENT_490	[p32l1200t2228r1748b2283],
5	.	.	O	.	_	0	SENT_490	[p32l1200t2228r1748b2283],

1	21	CD	NUMBER	21	_	0	SENT_491	[p32l13t2323r104b2370],
2	.	.	O	.	_	0	SENT_491	[p32l13t2323r104b2370],

1	Mentre	NNP	O	Mentre	nn	2	SENT_492	[p32l128t2319r357b2370],
2	F	NN	O	f	_	0	SENT_492	[p32l379t2319r429b2378],
3	,	,	O	,	_	0	SENT_492	[p32l379t2319r429b2378],
4	Escolano	NNP	O	Escolano	nn	5	SENT_492	[p32l452t2315r741b2370],
5	S	NNP	O	S	appos	2	SENT_492	[p32l766t2318r821b2378],
6	,	,	O	,	_	0	SENT_492	[p32l766t2318r821b2378],
7	Diquet	NNP	O	Diquet	nn	8	SENT_492	[p32l844t2318r1060b2387],
8	B	NNP	O	B	appos	2	SENT_492	[p32l1080t2319r1141b2378],
9	,	,	O	,	_	0	SENT_492	[p32l1080t2319r1141b2378],
10	Golmard	NNP	PERSON	Golmard	nn	11	SENT_492	[p32l1166t2315r1447b2370],
11	IL	NN	PERSON	il	appos	2	SENT_492	[p32l1465t2318r1549b2383],
12	,	,	O	,	_	0	SENT_492	[p32l1465t2318r1549b2383],
13	Mallet	NNP	O	Mallet	nn	16	SENT_492	[p32l1573t2315r1781b2370],
14	A.	NNP	O	A.	nn	16	SENT_492	[p32l1800t2319r1868b2370],
15	Clinical	JJ	O	clinical	amod	16	SENT_492	[p32l1894t2315r2147b2370],
16	pharmacokinetics	NNS	O	pharmacokinetic	appos	2	SENT_492	[p32l11t2401r588b2473],
17	of	IN	O	of	_	0	SENT_492	[p32l624t2401r689b2456],
18	zidovudine	NN	O	zidovudine	prep_of	16	SENT_492	[p32l716t2401r1101b2456],
19	:	:	O	:	_	0	SENT_492	[p32l716t2401r1101b2456],
20	inter	NN	O	inter	dep	2	SENT_492	[p32l1137t2404r1289b2456],
21	and	CC	O	and	_	0	SENT_492	[p32l1321t2401r1440b2456],
22	intraindividual	JJ	O	intraindividual	amod	23	SENT_492	[p32l1473t2401r1967b2456],
23	variability	NN	O	variability	dep	2	SENT_492	[p32l1999t2404r2146b2456, p32l12t2486r226b2558],
24	and	CC	O	and	_	0	SENT_492	[p32l257t2486r378b2541],
25	relationship	NN	O	relationship	conj_and	20	SENT_492	[p32l407t2486r812b2558],
26	to	TO	O	to	_	0	SENT_492	[p32l844t2494r905b2541],
27	long	JJ	O	long	amod	29	SENT_492	[p32l937t2486r1079b2558],
28	term	NN	O	term	nn	29	SENT_492	[p32l1109t2494r1261b2541],
29	efficacy	NN	O	efficacy	prep_to	25	SENT_492	[p32l1292t2486r1550b2558],
30	and	CC	O	and	_	0	SENT_492	[p32l1581t2486r1702b2541],
31	toxicity	NN	O	toxicity	prep_to	25	SENT_492	[p32l1731t2489r1999b2558],
32	.	.	O	.	_	0	SENT_492	[p32l1731t2489r1999b2558],

1	Eur	NNP	MISC	Eur	nn	4	SENT_493	[p32l2032t2490r2153b2541],
2	I	NNP	O	I	nn	4	SENT_493	[p32l6t2576r40b2640],
3	Clin	NNP	O	Clin	nn	4	SENT_493	[p32l64t2573r191b2627],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_493	[p32l216t2573r585b2627],
5	.	.	O	.	_	0	SENT_493	[p32l216t2573r585b2627],

1	1993	CD	DATE	1993	_	0	SENT_494	[p32l618t2580r1166b2635],
2	;	:	O	;	_	0	SENT_494	[p32l618t2580r1166b2635],
3	45:397	CD	NUMBER	45:397	number	4	SENT_494	[p32l618t2580r1166b2635],
4	-407	CD	NUMBER	-407	dep	1	SENT_494	[p32l618t2580r1166b2635],
5	.	.	O	.	_	0	SENT_494	[p32l618t2580r1166b2635],

1	22	CD	NUMBER	22	_	0	SENT_495	[p32l13t2674r104b2721],
2	.	.	O	.	_	0	SENT_495	[p32l13t2674r104b2721],

1	Pacifici	NNP	ORGANIZATION	Pacifici	nn	2	SENT_496	[p32l127t2667r370b2721],
2	GM	NNP	ORGANIZATION	GM	dep	16	SENT_496	[p32l391t2669r524b2730],
3	,	,	O	,	_	0	SENT_496	[p32l391t2669r524b2730],
4	Evangelisti	NNP	ORGANIZATION	Evangelisti	nn	5	SENT_496	[p32l546t2667r904b2738],
5	L	NNP	ORGANIZATION	L	appos	2	SENT_496	[p32l925t2670r982b2730],
6	,	,	O	,	_	0	SENT_496	[p32l925t2670r982b2730],
7	Giuliani	NNP	PERSON	Giuliani	nn	8	SENT_496	[p32l1006t2667r1271b2721],
8	L	NNP	PERSON	L	appos	2	SENT_496	[p32l1293t2670r1350b2730],
9	,	,	O	,	_	0	SENT_496	[p32l1293t2670r1350b2730],
10	Metelli	NNP	ORGANIZATION	Metelli	nn	11	SENT_496	[p32l1373t2666r1603b2721],
11	RM	NN	ORGANIZATION	rm	appos	2	SENT_496	[p32l1624t2670r1753b2730],
12	,	,	O	,	_	0	SENT_496	[p32l1624t2670r1753b2730],
13	Giordani	NNP	PERSON	Giordani	nn	14	SENT_496	[p32l1777t2666r2062b2721],
14	R.	NNP	O	R.	appos	2	SENT_496	[p32l2083t2670r2143b2721],
15	Zidovudine	NNP	O	Zidovudine	dep	16	SENT_496	[p32l12t2753r391b2808],
16	glucuronidation	NN	O	glucuronidation	dep	22	SENT_496	[p32l448t2753r972b2825],
17	in	IN	O	in	_	0	SENT_496	[p32l1028t2756r1091b2807],
18	human	JJ	O	human	amod	19	SENT_496	[p32l1146t2753r1373b2808],
19	liver	NN	O	liver	prep_in	16	SENT_496	[p32l1430t2753r1593b2808],
20	:	:	O	:	_	0	SENT_496	[p32l1430t2753r1593b2808],
21	interindividual	JJ	O	interindividual	amod	22	SENT_496	[p32l1652t2753r2147b2808],
22	variability	NN	O	variability	_	0	SENT_496	[p32l10t2839r355b2911],
23	.	.	O	.	_	0	SENT_496	[p32l10t2839r355b2911],

1	Int	NN	O	int	_	0	SENT_497	[p32l384t2843r526b2907],
2	]	CD	NUMBER	]	num	1	SENT_497	[p32l384t2843r526b2907],
3	Clin	NNP	O	Clin	nn	5	SENT_497	[p32l547t2839r675b2894],
4	Pharmacol	NNP	O	Pharmacol	nn	5	SENT_497	[p32l700t2839r1056b2894],
5	Ther	NNP	O	Ther	dep	1	SENT_497	[p32l1084t2839r1245b2894],
6	.	.	O	.	_	0	SENT_497	[p32l1084t2839r1245b2894],

1	1996	CD	DATE	1996	_	0	SENT_498	[p32l1278t2847r1826b2902],
2	;	:	O	;	_	0	SENT_498	[p32l1278t2847r1826b2902],
3	34:329	CD	NUMBER	34:329	number	4	SENT_498	[p32l1278t2847r1826b2902],
4	-334	CD	NUMBER	-334	dep	1	SENT_498	[p32l1278t2847r1826b2902],
5	.	.	O	.	_	0	SENT_498	[p32l1278t2847r1826b2902],

1	23	CD	NUMBER	23	_	0	SENT_499	[p32l13t2942r104b2989],
2	.	.	O	.	_	0	SENT_499	[p32l13t2942r104b2989],

1	Court	NNP	O	Court	nn	2	SENT_500	[p32l151t2937r330b2989],
2	MH	NNP	O	MH	_	0	SENT_500	[p32l373t2938r510b2997],
3	,	,	O	,	_	0	SENT_500	[p32l373t2938r510b2997],
4	Krishnaswamy	NNP	PERSON	Krishnaswamy	nn	5	SENT_500	[p32l557t2934r1040b3006],
5	S	NNP	PERSON	S	appos	2	SENT_500	[p32l1086t2937r1141b2997],
6	,	,	O	,	_	0	SENT_500	[p32l1086t2937r1141b2997],
7	Hao	NNP	O	Hao	nn	8	SENT_500	[p32l1188t2938r1313b2989],
8	Q	NNP	O	Q	appos	2	SENT_500	[p32l1360t2937r1428b3003],
9	,	,	O	,	_	0	SENT_500	[p32l1360t2937r1428b3003],
10	et	FW	O	et	nn	11	SENT_500	[p32l1477t2942r1532b2989],
11	al.	FW	O	al.	appos	2	SENT_500	[p32l1576t2934r1647b2989],
12	.	.	O	.	_	0	SENT_500	[p32l1576t2934r1647b2989],

1	Evaluation	NN	O	evaluation	_	0	SENT_501	[p32l1695t2934r2044b2989],
2	of	IN	O	of	_	0	SENT_501	[p32l2090t2934r2153b2989],
3	3	CD	NUMBER	3	prep_of	1	SENT_501	[p32l14t3020r924b3092],
4	'	''	O	'	_	0	SENT_501	[p32l14t3020r924b3092],
5	-	:	O	-	_	0	SENT_501	[p32l14t3020r924b3092],
6	azido-3	NN	O	azido-3	dep	1	SENT_501	[p32l14t3020r924b3092],
7	'	''	O	'	_	0	SENT_501	[p32l14t3020r924b3092],
8	-	:	O	-	_	0	SENT_501	[p32l14t3020r924b3092],
9	deoxythymidine	NN	O	deoxythymidine	dep	1	SENT_501	[p32l14t3020r924b3092],
10	,	,	O	,	_	0	SENT_501	[p32l14t3020r924b3092],
11	morphine	NN	O	morphine	conj_and	9	SENT_501	[p32l948t3020r1282b3092],
12	,	,	O	,	_	0	SENT_501	[p32l948t3020r1282b3092],
13	and	CC	O	and	_	0	SENT_501	[p32l1308t3020r1426b3075],
14	codeine	NN	O	codeine	conj_and	9	SENT_501	[p32l1449t3020r1700b3075],
15	as	IN	O	as	_	0	SENT_501	[p32l1724t3039r1785b3075],
16	probe	NN	O	probe	prep_as	9	SENT_501	[p32l1808t3020r1990b3092],
17	substrates	NNS	O	substrate	dep	25	SENT_501	[p32l2014t3020r2146b3075, p32l13t3113r215b3160],
18	for	IN	O	for	_	0	SENT_501	[p32l244t3106r331b3160],
19	UDP	NNP	O	UDP	prep_for	17	SENT_501	[p32l357t3105r1304b3177],
20	—	CD	NUMBER	—	num	21	SENT_501	[p32l357t3105r1304b3177],
21	glucuronosyltransferase	NN	O	glucuronosyltransferase	dep	25	SENT_501	[p32l357t3105r1304b3177],
22	2B7	NN	O	2b7	nn	25	SENT_501	[p32l1334t3109r1452b3160],
23	(	CD	NUMBER	(	num	25	SENT_501	[p32l1484t3106r1802b3171],
24	UGTZB7	NN	O	ugtzb7	nn	25	SENT_501	[p32l1484t3106r1802b3171],
25	)	NN	O	)	dep	9	SENT_501	[p32l1484t3106r1802b3171],
26	in	IN	O	in	_	0	SENT_501	[p32l1832t3108r1895b3160],
27	human	JJ	O	human	amod	29	SENT_501	[p32l1921t3105r2148b3160],
28	liver	NN	O	liver	nn	29	SENT_501	[p32l12t3192r159b3247],
29	microsomes	NNS	O	microsome	prep_in	25	SENT_501	[p32l201t3195r605b3247],
30	:	:	O	:	_	0	SENT_501	[p32l201t3195r605b3247],
31	specificity	NN	O	specificity	dep	1	SENT_501	[p32l654t3192r989b3264],
32	and	CC	O	and	_	0	SENT_501	[p32l1034t3192r1152b3247],
33	inﬂuence	NN	O	inﬂuence	dep	1	SENT_501	[p32l1196t3192r1499b3247],
34	of	IN	O	of	_	0	SENT_501	[p32l1546t3192r1610b3247],
35	the	DT	O	the	det	39	SENT_501	[p32l1647t3192r1746b3247],
36	UGT2B7	NN	O	ugt2b7	nn	39	SENT_501	[p32l1791t3195r2143b3247],
37	*	NN	O	*	nn	39	SENT_501	[p32l1791t3195r2143b3247],
38	2	CD	NUMBER	2	num	39	SENT_501	[p32l1791t3195r2143b3247],
39	polymorphism	NN	O	polymorphism	prep_of	31	SENT_501	[p32l11t3278r505b3350],
40	.	.	O	.	_	0	SENT_501	[p32l11t3278r505b3350],

1	Drug	NN	O	drug	_	0	SENT_502	[p32l533t3282r694b3350],
2	Metab	NNP	O	Metab	nn	3	SENT_502	[p32l713t3278r913b3333],
3	Dispos	NNP	O	Dispos	dep	1	SENT_502	[p32l936t3281r1169b3350],
4	.	.	O	.	_	0	SENT_502	[p32l936t3281r1169b3350],

1	2003	CD	DATE	2003	_	0	SENT_503	[p32l1201t3286r1826b3341],
2	;	:	O	;	_	0	SENT_503	[p32l1201t3286r1826b3341],
3	31:1125	CD	DURATION	31:1125	number	4	SENT_503	[p32l1201t3286r1826b3341],
4	-1133	CD	DURATION	-1133	dep	1	SENT_503	[p32l1201t3286r1826b3341],
5	.	.	O	.	_	0	SENT_503	[p32l1201t3286r1826b3341],

1	24	CD	NUMBER	24	_	0	SENT_504	[p32l13t3381r104b3428],
2	.	.	O	.	_	0	SENT_504	[p32l13t3381r104b3428],

1	Innocenti	NNP	PERSON	Innocenti	nn	2	SENT_505	[p32l146t3376r454b3428],
2	F	NN	O	f	_	0	SENT_505	[p32l494t3377r543b3436],
3	,	,	O	,	_	0	SENT_505	[p32l494t3377r543b3436],
4	Liu	NNP	PERSON	Liu	nn	5	SENT_505	[p32l585t3376r692b3428],
5	W	NNP	O	W	appos	2	SENT_505	[p32l729t3377r809b3436],
6	,	,	O	,	_	0	SENT_505	[p32l729t3377r809b3436],
7	Fackenthal	NNP	O	Fackenthal	nn	8	SENT_505	[p32l850t3373r1207b3428],
8	D	NNP	O	D	appos	2	SENT_505	[p32l1245t3377r1311b3436],
9	,	,	O	,	_	0	SENT_505	[p32l1245t3377r1311b3436],
10	et	FW	O	et	nn	11	SENT_505	[p32l1354t3381r1409b3428],
11	al.	FW	O	al.	appos	2	SENT_505	[p32l1448t3373r1518b3428],
12	.	.	O	.	_	0	SENT_505	[p32l1448t3373r1518b3428],

1	Single	JJ	O	single	amod	4	SENT_506	[p32l1563t3373r1763b3445],
2	nucleotide	NN	O	nucleotide	nn	4	SENT_506	[p32l1802t3373r2147b3428],
3	polymorphism	NN	O	polymorphism	nn	4	SENT_506	[p32l11t3458r492b3530],
4	discovery	NN	O	discovery	_	0	SENT_506	[p32l524t3458r835b3530],
5	and	CC	O	and	_	0	SENT_506	[p32l866t3458r984b3513],
6	functional	JJ	O	functional	amod	7	SENT_506	[p32l1015t3458r1347b3513],
7	assessment	NN	O	assessment	conj_and	4	SENT_506	[p32l1378t3466r1739b3513],
8	of	IN	O	of	_	0	SENT_506	[p32l1770t3458r1834b3513],
9	variation	NN	O	variation	prep_of	4	SENT_506	[p32l1857t3461r2148b3513],
10	in	IN	O	in	_	0	SENT_506	[p32l12t3547r76b3599],
11	the	DT	O	the	det	14	SENT_506	[p32l120t3545r219b3599],
12	UDP-glucuronosyltransferase	NN	O	udp-glucuronosyltransferase	nn	14	SENT_506	[p32l266t3544r1216b3616],
13	2B7	NN	O	2b7	nn	14	SENT_506	[p32l1265t3548r1384b3599],
14	gene	NN	O	gene	prep_in	4	SENT_506	[p32l1431t3564r1594b3616],
15	.	.	O	.	_	0	SENT_506	[p32l1431t3564r1594b3616],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_507	[p32l1643t3545r2151b3616],
2	Genomics	NNPS	O	Genomics	_	0	SENT_507	[p32l16t3635r347b3686],
3	.	.	O	.	_	0	SENT_507	[p32l16t3635r347b3686],

1	2008	CD	DATE	2008	_	0	SENT_508	[p32l379t3639r928b3695],
2	;	:	O	;	_	0	SENT_508	[p32l379t3639r928b3695],
3	18:683	CD	NUMBER	18:683	number	4	SENT_508	[p32l379t3639r928b3695],
4	-697	CD	NUMBER	-697	dep	1	SENT_508	[p32l379t3639r928b3695],
5	.	.	O	.	_	0	SENT_508	[p32l379t3639r928b3695],

1	25	CD	NUMBER	25	_	0	SENT_509	[p32l13t3733r104b3780],
2	.	.	O	.	_	0	SENT_509	[p32l13t3733r104b3780],

1	Rezk	NNP	ORGANIZATION	Rezk	nn	2	SENT_510	[p32l132t3726r290b3780],
2	NL	NNP	ORGANIZATION	NL	_	0	SENT_510	[p32l313t3729r427b3789],
3	,	,	O	,	_	0	SENT_510	[p32l313t3729r427b3789],
4	Tidwell	NNP	ORGANIZATION	Tidwell	nn	5	SENT_510	[p32l455t3726r704b3780],
5	RR	NNP	ORGANIZATION	RR	appos	2	SENT_510	[p32l729t3729r839b3788],
6	,	,	O	,	_	0	SENT_510	[p32l729t3729r839b3788],
7	Kashuba	NNP	LOCATION	Kashuba	nn	8	SENT_510	[p32l868t3726r1146b3780],
8	AD	NN	O	ad	appos	5	SENT_510	[p32l1171t3729r1290b3780],
9	.	.	O	.	_	0	SENT_510	[p32l1171t3729r1290b3780],

1	Simultaneous	JJ	O	simultaneous	amod	2	SENT_511	[p32l1323t3726r1767b3780],
2	determination	NN	O	determination	_	0	SENT_511	[p32l1797t3726r2147b3780, p33l11t21r139b73],

1	of	IN	O	of	_	0	SENT_512	[p33l168t18r232b73],
2	six	CD	NUMBER	six	num	8	SENT_512	[p33l256t21r346b73],
3	HIV	NN	MISC	hiv	nn	8	SENT_512	[p33l373t22r502b72],
4	nucleoside	NN	O	nucleoside	nn	8	SENT_512	[p33l528t18r880b73],
5	analogue	NN	O	analogue	nn	8	SENT_512	[p33l910t18r1198b90],
6	reverse	JJ	O	reverse	amod	8	SENT_512	[p33l1226t37r1456b73],
7	transcriptase	NN	O	transcriptase	nn	8	SENT_512	[p33l1484t21r1900b90],
8	inhibitors	NNS	O	inhibitor	pobj	1	SENT_512	[p33l1930t18r2146b73, p33l11t111r129b158],
9	and	CC	O	and	_	0	SENT_512	[p33l169t103r288b158],
10	nevirapine	NN	O	nevirapine	conj_and	8	SENT_512	[p33l325t106r673b175],
11	by	IN	O	by	_	0	SENT_512	[p33l709t103r788b175],
12	liquid	JJ	O	liquid	amod	13	SENT_512	[p33l825t103r1019b175],
13	chromatography	NN	O	chromatography	prep_by	8	SENT_512	[p33l1058t103r1589b175],
14	with	IN	O	with	_	0	SENT_512	[p33l1625t103r1773b158],
15	ultraviolet	JJ	O	ultraviolet	amod	17	SENT_512	[p33l1809t103r2148b158],
16	absorbance	NN	O	absorbance	nn	17	SENT_512	[p33l12t189r371b244],
17	detection	NN	O	detection	prep_with	13	SENT_512	[p33l395t190r710b244],
18	.	.	O	.	_	0	SENT_512	[p33l395t190r710b244],

1	I	PRP	O	I	nsubj	2	SENT_513	[p33l730t193r764b258],
2	Chromatogr	VBP	O	chromatogr	_	0	SENT_513	[p33l780t189r1167b261],
3	B	NN	O	b	nn	5	SENT_513	[p33l1181t193r1227b244],
4	Analyt	JJ	O	analyt	amod	5	SENT_513	[p33l1243t189r1466b262],
5	Techn0IB1	NN	O	techn0ib1	dobj	2	SENT_513	[p33l1488t189r2012b244],
6	'	''	O	'	_	0	SENT_513	[p33l1488t189r2012b244],
7	omed	VBD	O	ome	rcmod	5	SENT_513	[p33l1488t189r2012b244],
8	Life	NNP	O	Life	nn	9	SENT_513	[p33l2028t190r2149b261],
9	Sci	NNP	O	Sci	dobj	7	SENT_513	[p33l14t280r125b331],
10	.	.	O	.	_	0	SENT_513	[p33l14t280r125b331],

1	2003	CD	DATE	2003	_	0	SENT_514	[p33l158t284r746b340],
2	;	:	O	;	_	0	SENT_514	[p33l158t284r746b340],
3	791:137	CD	NUMBER	791:137	number	4	SENT_514	[p33l158t284r746b340],
4	-147	CD	NUMBER	-147	dep	1	SENT_514	[p33l158t284r746b340],
5	.	.	O	.	_	0	SENT_514	[p33l158t284r746b340],

1	26	CD	NUMBER	26	_	0	SENT_515	[p33l13t378r104b425],
2	.	.	O	.	_	0	SENT_515	[p33l13t378r104b425],

1	Hesse	NNP	ORGANIZATION	Hesse	nn	2	SENT_516	[p33l146t374r332b425],
2	LM	NNP	ORGANIZATION	LM	_	0	SENT_516	[p33l374t374r498b434],
3	,	,	O	,	_	0	SENT_516	[p33l374t374r498b434],
4	He	PRP	O	he	dep	5	SENT_516	[p33l540t374r627b425],
5	P	NN	O	p	appos	2	SENT_516	[p33l667t374r715b434],
6	,	,	O	,	_	0	SENT_516	[p33l667t374r715b434],
7	Krishnaswamy	NNP	PERSON	Krishnaswamy	nn	8	SENT_516	[p33l758t371r1242b442],
8	S	NNP	PERSON	S	appos	2	SENT_516	[p33l1284t373r1339b434],
9	,	,	O	,	_	0	SENT_516	[p33l1284t373r1339b434],
10	et	FW	O	et	nn	11	SENT_516	[p33l1382t379r1438b425],
11	al.	FW	O	al.	appos	2	SENT_516	[p33l1478t371r1548b425],
12	.	.	O	.	_	0	SENT_516	[p33l1478t371r1548b425],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_517	[p33l1591t371r2146b442],
2	determinants	NNS	O	determinant	_	0	SENT_517	[p33l14t457r438b512],
3	of	IN	O	of	_	0	SENT_517	[p33l468t457r532b512],
4	interindividual	JJ	O	interindividual	amod	5	SENT_517	[p33l553t457r1048b512],
5	variability	NN	O	variability	prep_of	2	SENT_517	[p33l1074t457r1409b529],
6	in	IN	O	in	_	0	SENT_517	[p33l1435t460r1499b511],
7	bupropion	NN	O	bupropion	nn	8	SENT_517	[p33l1523t457r1867b529],
8	hydroxylation	NN	O	hydroxylation	prep_in	2	SENT_517	[p33l1893t457r2146b529, p33l10t543r238b615],
9	by	IN	O	by	_	0	SENT_517	[p33l275t543r355b615],
10	cytochrome	NN	O	cytochrome	nn	12	SENT_517	[p33l396t543r774b615],
11	P450	NN	O	p450	nn	12	SENT_517	[p33l815t547r973b598],
12	2B6	NN	O	2b6	prep_by	2	SENT_517	[p33l1018t547r1137b598],
13	in	IN	O	in	_	0	SENT_517	[p33l1180t546r1244b597],
14	human	JJ	O	human	amod	16	SENT_517	[p33l1283t543r1511b598],
15	liver	NN	O	liver	nn	16	SENT_517	[p33l1552t543r1699b598],
16	microsomes	NNS	O	microsome	prep_in	12	SENT_517	[p33l1738t546r2143b598],
17	.	.	O	.	_	0	SENT_517	[p33l1738t546r2143b598],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_518	[p33l10t628r620b700],
2	.	.	O	.	_	0	SENT_518	[p33l10t628r620b700],

1	2004	CD	DATE	2004	_	0	SENT_519	[p33l653t636r1201b692],
2	;	:	O	;	_	0	SENT_519	[p33l653t636r1201b692],
3	14:225	CD	NUMBER	14:225	number	4	SENT_519	[p33l653t636r1201b692],
4	-238	CD	NUMBER	-238	dep	1	SENT_519	[p33l653t636r1201b692],
5	.	.	O	.	_	0	SENT_519	[p33l653t636r1201b692],

1	27	CD	NUMBER	27	_	0	SENT_520	[p33l13t731r104b778],
2	.	.	O	.	_	0	SENT_520	[p33l13t731r104b778],

1	Holthe	NNP	O	Holthe	nn	2	SENT_521	[p33l135t724r354b778],
2	M	NNP	O	M	_	0	SENT_521	[p33l383t727r464b787],
3	,	,	O	,	_	0	SENT_521	[p33l383t727r464b787],
4	Rakvag	NNP	ORGANIZATION	Rakvag	nn	5	SENT_521	[p33l495t723r726b795],
5	TN	NN	ORGANIZATION	tn	appos	2	SENT_521	[p33l756t727r872b787],
6	,	,	O	,	_	0	SENT_521	[p33l756t727r872b787],
7	Klepstad	NNP	PERSON	Klepstad	nn	8	SENT_521	[p33l904t723r1189b795],
8	P	NN	PERSON	p	appos	2	SENT_521	[p33l1217t727r1266b787],
9	,	,	O	,	_	0	SENT_521	[p33l1217t727r1266b787],
10	et	FW	O	et	nn	11	SENT_521	[p33l1299t732r1355b778],
11	al.	FW	O	al.	appos	2	SENT_521	[p33l1384t724r1454b778],
12	.	.	O	.	_	0	SENT_521	[p33l1384t724r1454b778],

1	Sequence	NN	O	sequence	nn	2	SENT_522	[p33l1490t726r1796b795],
2	variations	NNS	O	variation	nsubj	20	SENT_522	[p33l1825t726r2146b778],
3	in	IN	O	in	_	0	SENT_522	[p33l12t812r76b864],
4	the	DT	O	the	det	8	SENT_522	[p33l98t810r198b864],
5	UDP-glucuronosyltransferase	NN	O	udp-glucuronosyltransferase	nn	8	SENT_522	[p33l223t810r1173b881],
6	2B7	NN	O	2b7	nn	8	SENT_522	[p33l1201t813r1319b864],
7	(	CD	NUMBER	(	num	8	SENT_522	[p33l1349t810r1604b875],
8	UGT2B	NN	O	ugt2b	prep_in	2	SENT_522	[p33l1349t810r1604b875],
9	7	CD	NUMBER	7	num	11	SENT_522	[p33l1616t810r1667b875],
10	)	NN	O	)	nn	11	SENT_522	[p33l1616t810r1667b875],
11	gene	NN	O	gene	dep	8	SENT_522	[p33l1694t829r1858b881],
12	:	:	O	:	_	0	SENT_522	[p33l1694t829r1858b881],
13	identification	NN	O	identification	dep	8	SENT_522	[p33l1886t810r2146b864, p33l12t899r210b951],
14	of	IN	O	of	_	0	SENT_522	[p33l241t896r306b951],
15	10	CD	NUMBER	10	num	19	SENT_522	[p33l333t904r403b951],
16	novel	JJ	O	novel	amod	19	SENT_522	[p33l434t896r613b951],
17	single	JJ	O	single	amod	19	SENT_522	[p33l645t896r833b968],
18	nucleotide	NN	O	nucleotide	nn	19	SENT_522	[p33l863t896r1208b951],
19	polymorphisms	NNS	O	polymorphism	prep_of	13	SENT_522	[p33l1238t896r1748b968],
20	(	VBP	O	(	_	0	SENT_522	[p33l1784t896r1995b961],
21	SNPs	NNS	O	snp	dobj	20	SENT_522	[p33l1784t896r1995b961],
22	)	CD	NUMBER	)	dep	21	SENT_522	[p33l1784t896r1995b961],
23	and	CC	O	and	_	0	SENT_522	[p33l2029t896r2148b951],
24	analysis	NN	O	analysis	conj_and	21	SENT_522	[p33l12t981r271b1053],
25	of	IN	O	of	_	0	SENT_522	[p33l297t981r361b1036],
26	their	PRP$	O	they	poss	27	SENT_522	[p33l377t981r529b1036],
27	relevance	NN	O	relevance	prep_of	24	SENT_522	[p33l550t981r860b1036],
28	to	TO	O	to	_	0	SENT_522	[p33l882t989r941b1036],
29	morphine	NN	O	morphine	nn	30	SENT_522	[p33l965t981r1281b1053],
30	glucuronidation	NN	O	glucuronidation	prep_to	20	SENT_522	[p33l1304t981r1829b1053],
31	in	IN	O	in	_	0	SENT_522	[p33l1851t984r1915b1035],
32	cancer	NN	O	cancer	nn	33	SENT_522	[p33l1938t1000r2148b1036],
33	patients	NNS	O	patient	prep_in	30	SENT_522	[p33l11t1070r285b1139],
34	.	.	O	.	_	0	SENT_522	[p33l11t1070r285b1139],

1	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	2	SENT_523	[p33l313t1067r953b1139],
2	I.	NNP	O	I.	_	0	SENT_523	[p33l972t1071r1013b1136],
3	2003	CD	DATE	2003	num	2	SENT_523	[p33l1045t1075r1475b1131],
4	;	:	O	;	_	0	SENT_523	[p33l1045t1075r1475b1131],
5	3:17	CD	TIME	3:17	number	6	SENT_523	[p33l1045t1075r1475b1131],
6	-26	CD	NUMBER	-26	dep	2	SENT_523	[p33l1045t1075r1475b1131],
7	.	.	O	.	_	0	SENT_523	[p33l1045t1075r1475b1131],

1	1090	CD	DATE	1090	num	2	SENT_524	[p33l15t1300r205b1366],
2	o	NN	O	o	_	0	SENT_524	[p33l268t1326r298b1355],
3	1	CD	NUMBER	1	num	5	SENT_524	[p33l359t1308r388b1380],
4	Clin	NNP	O	Clin	nn	5	SENT_524	[p33l416t1304r569b1365],
5	Pharmacol	NNP	O	Pharmacol	dep	2	SENT_524	[p33l595t1304r998b1365],
6	2009	CD	DATE	2009	num	5	SENT_524	[p33l1028t1313r1717b1376],
7	;	:	O	;	_	0	SENT_524	[p33l1028t1313r1717b1376],
8	419:1079	CD	DURATION	419:1079	number	9	SENT_524	[p33l1028t1313r1717b1376],
9	-1090	CD	DURATION	-1090	dep	2	SENT_524	[p33l1028t1313r1717b1376],
10	28	CD	NUMBER	28	dep	9	SENT_524	[p33l12t1404r103b1451],
11	.	.	O	.	_	0	SENT_524	[p33l12t1404r103b1451],

1	Sael	NNP	PERSON	Sael	_	0	SENT_525	[p33l139t1396r311b1451],
2	<	JJR	O	<	dep	1	SENT_525	[p33l139t1396r311b1451],
3	i	FW	O	i	dep	2	SENT_525	[p33l139t1396r311b1451],
4	M	NN	O	m	dep	1	SENT_525	[p33l342t1400r423b1459],
5	,	,	O	,	_	0	SENT_525	[p33l342t1400r423b1459],
6	Saito	NNP	PERSON	Saito	nn	7	SENT_525	[p33l460t1399r619b1451],
7	Y	NN	PERSON	y	appos	4	SENT_525	[p33l651t1400r710b1459],
8	,	,	O	,	_	0	SENT_525	[p33l651t1400r710b1459],
9	Jinno	NN	PERSON	jinno	nn	10	SENT_525	[p33l741t1399r913b1465],
10	H	NN	O	h	appos	1	SENT_525	[p33l945t1400r1015b1459],
11	,	,	O	,	_	0	SENT_525	[p33l945t1400r1015b1459],
12	et	FW	O	et	nn	13	SENT_525	[p33l1050t1404r1105b1451],
13	al.	FW	O	al.	appos	1	SENT_525	[p33l1136t1396r1206b1451],
14	.	.	O	.	_	0	SENT_525	[p33l1136t1396r1206b1451],

1	Single	JJ	O	single	amod	3	SENT_526	[p33l1244t1396r1443b1468],
2	nucleotide	NN	O	nucleotide	nn	3	SENT_526	[p33l1475t1396r1819b1451],
3	polymorphisms	NNS	O	polymorphism	_	0	SENT_526	[p33l1851t1396r2146b1468, p33l10t1482r243b1554],
4	and	CC	O	and	_	0	SENT_526	[p33l273t1482r392b1537],
5	haplotype	NN	O	haplotype	nn	6	SENT_526	[p33l420t1482r744b1554],
6	frequencies	NNS	O	frequency	conj_and	3	SENT_526	[p33l774t1482r1145b1554],
7	of	IN	O	of	_	0	SENT_526	[p33l1176t1482r1241b1537],
8	UGT2B4	NN	O	ugt2b4	prep_of	3	SENT_526	[p33l1263t1485r1539b1537],
9	and	CC	O	and	_	0	SENT_526	[p33l1570t1482r1689b1537],
10	UGT2B7	NN	O	ugt2b7	prep_of	3	SENT_526	[p33l1716t1485r1992b1537],
11	in	IN	O	in	_	0	SENT_526	[p33l2023t1485r2087b1537],
12	a	DT	O	a	det	14	SENT_526	[p33l2115t1501r2148b1537],
13	Japanese	JJ	MISC	japanese	amod	14	SENT_526	[p33l7t1571r291b1639],
14	population	NN	O	population	prep_in	3	SENT_526	[p33l317t1568r690b1639],
15	.	.	O	.	_	0	SENT_526	[p33l317t1568r690b1639],

1	Drug	NN	O	drug	_	0	SENT_527	[p33l718t1571r879b1639],
2	Metab	NNP	O	Metab	nn	3	SENT_527	[p33l898t1567r1099b1622],
3	Dispos	NNP	O	Dispos	dep	1	SENT_527	[p33l1123t1571r1356b1639],
4	.	.	O	.	_	0	SENT_527	[p33l1123t1571r1356b1639],

1	2004	CD	DATE	2004	_	0	SENT_528	[p33l1388t1575r2016b1631],
2	;	:	O	;	_	0	SENT_528	[p33l1388t1575r2016b1631],
3	32:1048	CD	DURATION	32:1048	number	4	SENT_528	[p33l1388t1575r2016b1631],
4	-1054	CD	DURATION	-1054	dep	1	SENT_528	[p33l1388t1575r2016b1631],
5	.	.	O	.	_	0	SENT_528	[p33l1388t1575r2016b1631],

1	29	CD	NUMBER	29	_	0	SENT_529	[p33l12t1671r103b1718],
2	.	.	O	.	_	0	SENT_529	[p33l12t1671r103b1718],

1	Vezina	NNP	O	Vezina	nn	5	SENT_530	[p33l126t1666r343b1718],
2	HE	PRP	O	he	dep	5	SENT_530	[p33l362t1667r476b1727],
3	,	,	O	,	_	0	SENT_530	[p33l362t1667r476b1727],
4	Henry	NNP	PERSON	Henry	dep	5	SENT_530	[p33l499t1667r698b1735],
5	K	NNP	PERSON	K	_	0	SENT_530	[p33l718t1667r784b1727],
6	,	,	O	,	_	0	SENT_530	[p33l718t1667r784b1727],
7	Ravindran	NNP	PERSON	Ravindran	nn	8	SENT_530	[p33l806t1664r1144b1718],
8	GD	NN	MISC	gd	appos	5	SENT_530	[p33l1165t1666r1281b1727],
9	,	,	O	,	_	0	SENT_530	[p33l1165t1666r1281b1727],
10	et	FW	O	et	nn	11	SENT_530	[p33l1306t1672r1362b1718],
11	al.	FW	O	al.	appos	8	SENT_530	[p33l1382t1663r1453b1718],
12	.	.	O	.	_	0	SENT_530	[p33l1382t1663r1453b1718],

1	A	DT	O	a	det	4	SENT_531	[p33l1477t1667r1530b1718],
2	randomized	JJ	O	randomized	amod	4	SENT_531	[p33l1549t1663r1939b1718],
3	crossover	NN	O	crossover	nn	4	SENT_531	[p33l1961t1683r2146b1718, p33l12t1769r150b1804],
4	study	NN	O	study	nsubj	6	SENT_531	[p33l193t1750r371b1821],
5	to	TO	O	to	aux	6	SENT_531	[p33l412t1758r471b1804],
6	determine	VB	O	determine	_	0	SENT_531	[p33l517t1750r843b1804],
7	bioequivalence	NN	O	bioequivalence	dep	13	SENT_531	[p33l883t1750r1377b1822],
8	of	IN	O	of	_	0	SENT_531	[p33l1422t1750r1486b1804],
9	generic	JJ	O	generic	amod	12	SENT_531	[p33l1522t1753r1755b1821],
10	and	CC	O	and	_	0	SENT_531	[p33l1799t1750r1918b1804],
11	brand	NN	O	brand	amod	12	SENT_531	[p33l1957t1750r2147b1804],
12	name	NN	O	name	prep_of	7	SENT_531	[p33l10t1855r184b1891],
13	nevirapine	NN	O	nevirapine	dep	25	SENT_531	[p33l223t1839r589b1908],
14	,	,	O	,	_	0	SENT_531	[p33l223t1839r589b1908],
15	zidovudine	NN	O	zidovudine	dep	25	SENT_531	[p33l631t1836r1016b1899],
16	,	,	O	,	_	0	SENT_531	[p33l631t1836r1016b1899],
17	and	CC	O	and	_	0	SENT_531	[p33l1058t1836r1177b1891],
18	lamivudine	NN	O	lamivudine	dep	25	SENT_531	[p33l1215t1836r1586b1891],
19	in	IN	O	in	_	0	SENT_531	[p33l1626t1839r1690b1890],
20	HIV-negative	JJ	MISC	hiv-negative	amod	21	SENT_531	[p33l1727t1839r2145b1908],
21	women	NNS	O	woman	prep_in	13	SENT_531	[p33l9t1940r249b1976],
22	in	IN	O	in	_	0	SENT_531	[p33l274t1924r338b1975],
23	India	NNP	LOCATION	India	prep_in	21	SENT_531	[p33l363t1921r545b1976],
24	.	.	O	.	_	0	SENT_531	[p33l363t1921r545b1976],
25	]	NN	O	]	dep	6	SENT_531	[p33l570t1925r846b1993],

1	Acqu1	NN	O	acqu1	nn	3	SENT_532	[p33l570t1925r846b1993],
2	'	''	O	'	_	0	SENT_532	[p33l570t1925r846b1993],
3	r	NN	O	r	_	0	SENT_532	[p33l570t1925r846b1993],
4	Immune	JJ	MISC	immune	amod	6	SENT_532	[p33l865t1925r1137b1976],
5	Defic	JJ	MISC	defic	amod	6	SENT_532	[p33l1160t1921r1329b1993],
6	Syndr	NN	MISC	syndr	dep	3	SENT_532	[p33l1354t1921r1559b1993],
7	.	.	O	.	_	0	SENT_532	[p33l1354t1921r1559b1993],

1	2006	CD	DATE	2006	_	0	SENT_533	[p33l1591t1929r2140b1985],
2	;	:	O	;	_	0	SENT_533	[p33l1591t1929r2140b1985],
3	41:131	CD	NUMBER	41:131	number	4	SENT_533	[p33l1591t1929r2140b1985],
4	-136	CD	NUMBER	-136	dep	1	SENT_533	[p33l1591t1929r2140b1985],
5	.	.	O	.	_	0	SENT_533	[p33l1591t1929r2140b1985],

1	30	CD	NUMBER	30	_	0	SENT_534	[p33l12t2025r103b2072],
2	.	.	O	.	_	0	SENT_534	[p33l12t2025r103b2072],

1	Chatton	NNP	O	Chatton	nn	2	SENT_535	[p33l130t2017r384b2072],
2	IY	NNP	O	IY	_	0	SENT_535	[p33l405t2021r490b2086],
3	,	,	O	,	_	0	SENT_535	[p33l405t2021r490b2086],
4	Munafo	NNP	O	Munafo	nn	5	SENT_535	[p33l516t2017r765b2072],
5	A	NNP	O	A	appos	2	SENT_535	[p33l790t2021r860b2081],
6	,	,	O	,	_	0	SENT_535	[p33l790t2021r860b2081],
7	Chave	NNP	O	Chave	nn	8	SENT_535	[p33l886t2017r1084b2072],
8	JP	NNP	O	JP	appos	2	SENT_535	[p33l1106t2021r1181b2086],
9	,	,	O	,	_	0	SENT_535	[p33l1106t2021r1181b2086],
10	et	FW	O	et	nn	11	SENT_535	[p33l1208t2026r1264b2072],
11	al.	FW	O	al.	appos	2	SENT_535	[p33l1288t2017r1358b2072],
12	.	.	O	.	_	0	SENT_535	[p33l1288t2017r1358b2072],

1	Trimethoprim	NNP	O	Trimethoprim	nsubj	10	SENT_536	[p33l1387t2017r1858b2089],
2	,	,	O	,	_	0	SENT_536	[p33l1387t2017r1858b2089],
3	alone	RB	O	alone	dep	1	SENT_536	[p33l1885t2017r2058b2072],
4	or	CC	O	or	_	0	SENT_536	[p33l2084t2037r2147b2072],
5	in	IN	O	in	dep	1	SENT_536	[p33l11t2106r74b2158],
6	combination	NN	O	combination	pobj	5	SENT_536	[p33l124t2103r531b2158],
7	with	IN	O	with	_	0	SENT_536	[p33l579t2103r727b2158],
8	sulphamethoxazole	NN	O	sulphamethoxazole	prep_with	6	SENT_536	[p33l776t2103r1427b2175],
9	,	,	O	,	_	0	SENT_536	[p33l776t2103r1427b2175],
10	decreases	VBZ	O	decrease	_	0	SENT_536	[p33l1480t2103r1785b2158],
11	the	DT	O	the	det	13	SENT_536	[p33l1835t2104r1934b2158],
12	renal	JJ	O	renal	amod	13	SENT_536	[p33l1983t2103r2146b2158],
13	excretion	NN	O	excretion	dobj	10	SENT_536	[p33l11t2193r312b2244],
14	of	IN	O	of	_	0	SENT_536	[p33l336t2190r400b2244],
15	zidovudine	NN	O	zidovudine	prep_of	13	SENT_536	[p33l417t2190r785b2244],
16	and	CC	O	and	_	0	SENT_536	[p33l809t2190r928b2244],
17	its	PRP$	O	its	poss	18	SENT_536	[p33l951t2193r1024b2244],
18	glucuronide	NN	O	glucuronide	prep_of	13	SENT_536	[p33l1048t2190r1457b2261],
19	.	.	O	.	_	0	SENT_536	[p33l1048t2190r1457b2261],

1	Br	NN	O	br	_	0	SENT_537	[p33l1483t2193r1606b2258],
2	]	CD	NUMBER	]	num	1	SENT_537	[p33l1483t2193r1606b2258],
3	Clin	NNP	PERSON	Clin	nn	4	SENT_537	[p33l1623t2190r1751b2244],
4	Pharmacol	NNP	PERSON	Pharmacol	dep	1	SENT_537	[p33l1773t2190r2142b2244],
5	.	.	O	.	_	0	SENT_537	[p33l1773t2190r2142b2244],

1	1992	CD	DATE	1992	_	0	SENT_538	[p33l14t2284r561b2340],
2	;	:	O	;	_	0	SENT_538	[p33l14t2284r561b2340],
3	34:551	CD	NUMBER	34:551	number	4	SENT_538	[p33l14t2284r561b2340],
4	-554	CD	NUMBER	-554	dep	1	SENT_538	[p33l14t2284r561b2340],
5	.	.	O	.	_	0	SENT_538	[p33l14t2284r561b2340],

1	31	CD	NUMBER	31	_	0	SENT_539	[p33l12t2380r101b2427],
2	.	.	O	.	_	0	SENT_539	[p33l12t2380r101b2427],

1	Lee	NNP	PERSON	Lee	nn	2	SENT_540	[p33l140t2376r248b2427],
2	BL	NN	O	bl	_	0	SENT_540	[p33l285t2376r388b2435],
3	,	,	O	,	_	0	SENT_540	[p33l285t2376r388b2435],
4	Safrin	NNP	O	Safrin	nn	5	SENT_540	[p33l429t2372r616b2427],
5	S	NNP	O	S	appos	2	SENT_540	[p33l654t2375r708b2435],
6	,	,	O	,	_	0	SENT_540	[p33l654t2375r708b2435],
7	Makrides	NNP	O	Makrides	nn	8	SENT_540	[p33l746t2372r1038b2427],
8	V	NNP	O	V	appos	2	SENT_540	[p33l1076t2375r1133b2435],
9	,	,	O	,	_	0	SENT_540	[p33l1076t2375r1133b2435],
10	Gambertoglio	NNP	O	Gambertoglio	nn	11	SENT_540	[p33l1172t2372r1594b2444],
11	JG	NNP	O	JG	appos	2	SENT_540	[p33l1629t2375r1717b2440],
12	.	.	O	.	_	0	SENT_540	[p33l1629t2375r1717b2440],

1	Zidovudine	NNP	O	Zidovudine	_	0	SENT_541	[p33l1757t2372r2144b2435],
2	,	,	O	,	_	0	SENT_541	[p33l1757t2372r2144b2435],
3	trimethoprim	NN	O	trimethoprim	conj_and	1	SENT_541	[p33l9t2477r450b2549],
4	,	,	O	,	_	0	SENT_541	[p33l9t2477r450b2549],
5	and	CC	O	and	_	0	SENT_541	[p33l469t2477r585b2532],
6	dapsone	NN	O	dapsone	nn	8	SENT_541	[p33l602t2477r862b2549],
7	pharmacokinetic	JJ	O	pharmacokinetic	amod	8	SENT_541	[p33l878t2477r1407b2549],
8	interactions	NNS	O	interaction	conj_and	1	SENT_541	[p33l1424t2480r1794b2532],
9	in	IN	O	in	_	0	SENT_541	[p33l1811t2480r1874b2532],
10	patients	NNS	O	patient	prep_in	8	SENT_541	[p33l1889t2480r2145b2549],
11	with	IN	O	with	_	0	SENT_541	[p33l9t2563r158b2618],
12	human	JJ	O	human	amod	15	SENT_541	[p33l218t2564r445b2618],
13	immunodeficiency	NN	O	immunodeficiency	nn	15	SENT_541	[p33l507t2564r1122b2635],
14	virus	NN	O	virus	nn	15	SENT_541	[p33l1181t2566r1343b2618],
15	infection	NN	O	infection	prep_with	10	SENT_541	[p33l1407t2564r1712b2618],
16	.	.	O	.	_	0	SENT_541	[p33l1407t2564r1712b2618],

1	Antimicrob	NNP	O	Antimicrob	nn	2	SENT_542	[p33l1775t2564r2148b2618],
2	Agents	NNPS	O	Agents	_	0	SENT_542	[p33l8t2653r233b2721],
3	Chemother	NNP	O	Chemother	dep	2	SENT_542	[p33l261t2650r629b2704],
4	.	.	O	.	_	0	SENT_542	[p33l261t2650r629b2704],

1	1996	CD	DATE	1996	_	0	SENT_543	[p33l663t2657r1290b2713],
2	;	:	O	;	_	0	SENT_543	[p33l663t2657r1290b2713],
3	40:1231	CD	DURATION	40:1231	number	4	SENT_543	[p33l663t2657r1290b2713],
4	-1236	CD	DURATION	-1236	dep	1	SENT_543	[p33l663t2657r1290b2713],
5	.	.	O	.	_	0	SENT_543	[p33l663t2657r1290b2713],

1	32	CD	NUMBER	32	_	0	SENT_544	[p33l12t2753r103b2800],
2	.	.	O	.	_	0	SENT_544	[p33l12t2753r103b2800],

1	Peterkin	NNP	PERSON	Peterkin	nn	2	SENT_545	[p33l130t2746r401b2800],
2	VC	NNP	O	VC	_	0	SENT_545	[p33l425t2748r539b2808],
3	,	,	O	,	_	0	SENT_545	[p33l425t2748r539b2808],
4	Bauman	NNP	PERSON	Bauman	appos	2	SENT_545	[p33l567t2749r833b2800],
5	IN	IN	O	in	amod	4	SENT_545	[p33l855t2749r951b2813],
6	,	,	O	,	_	0	SENT_545	[p33l855t2749r951b2813],
7	Goosen	NNP	ORGANIZATION	Goosen	nn	8	SENT_545	[p33l980t2748r1218b2800],
8	TC	NNP	ORGANIZATION	TC	appos	2	SENT_545	[p33l1243t2748r1352b2808],
9	,	,	O	,	_	0	SENT_545	[p33l1243t2748r1352b2808],
10	et	FW	O	et	nn	11	SENT_545	[p33l1381t2754r1437b2800],
11	al.	FW	O	al.	appos	2	SENT_545	[p33l1462t2746r1532b2800],
12	.	.	O	.	_	0	SENT_545	[p33l1462t2746r1532b2800],

1	Limited	JJ	O	limited	amod	2	SENT_546	[p33l1562t2746r1816b2800],
2	inﬂuence	NN	O	inﬂuence	_	0	SENT_546	[p33l1842t2746r2146b2800],
3	of	IN	O	of	_	0	SENT_546	[p33l12t2831r76b2886],
4	UGT1A1	NN	O	ugt1a1	prep_of	2	SENT_546	[p33l106t2834r509b2886],
5	*	CD	NUMBER	*	number	6	SENT_546	[p33l106t2834r509b2886],
6	28	CD	NUMBER	28	dep	4	SENT_546	[p33l106t2834r509b2886],
7	and	CC	O	and	_	0	SENT_546	[p33l548t2831r667b2886],
8	no	DT	O	no	det	9	SENT_546	[p33l702t2850r781b2886],
9	effect	NN	O	effect	conj_and	4	SENT_546	[p33l820t2831r994b2886],
10	of	IN	O	of	_	0	SENT_546	[p33l1031t2831r1095b2886],
11	UGT2B7	NN	O	ugt2b7	nn	12	SENT_546	[p33l1126t2834r1479b2886],
12	*	NN	O	*	prep_of	9	SENT_546	[p33l1126t2834r1479b2886],
13	2	CD	NUMBER	2	num	14	SENT_546	[p33l1126t2834r1479b2886],
14	polymorphisms	NNS	O	polymorphism	dep	2	SENT_546	[p33l1519t2831r2029b2903],
15	on	IN	O	on	_	0	SENT_546	[p33l2068t2850r2147b2886],
16	UGT1A1	NN	O	ugt1a1	nn	19	SENT_546	[p33l10t2920r292b2972],
17	or	CC	O	or	_	0	SENT_546	[p33l326t2936r389b2972],
18	UGT2B7	NN	O	ugt2b7	nn	19	SENT_546	[p33l415t2920r691b2972],
19	activities	NNS	O	activity	prep_on	14	SENT_546	[p33l722t2920r1013b2972],
20	and	CC	O	and	_	0	SENT_546	[p33l1043t2917r1162b2972],
21	protein	NN	O	protein	nn	22	SENT_546	[p33l1190t2920r1424b2989],
22	expression	NN	O	expression	conj_and	14	SENT_546	[p33l1453t2920r1801b2989],
23	in	IN	O	in	_	0	SENT_546	[p33l1829t2920r1892b2972],
24	human	JJ	O	human	amod	26	SENT_546	[p33l1919t2917r2147b2972],
25	liver	NN	O	liver	nn	26	SENT_546	[p33l11t3002r158b3056],
26	microsomes	NNS	O	microsome	prep_in	22	SENT_546	[p33l182t3005r587b3056],
27	.	.	O	.	_	0	SENT_546	[p33l182t3005r587b3056],

1	Br	NN	O	br	_	0	SENT_547	[p33l616t3006r741b3070],
2	]	CD	NUMBER	]	num	1	SENT_547	[p33l616t3006r741b3070],
3	Clin	NNP	PERSON	Clin	nn	4	SENT_547	[p33l762t3003r890b3056],
4	Pharmacol	NNP	PERSON	Pharmacol	dep	1	SENT_547	[p33l915t3002r1283b3056],
5	.	.	O	.	_	0	SENT_547	[p33l915t3002r1283b3056],

1	2007	CD	DATE	2007	_	0	SENT_548	[p33l1315t3010r1864b3065],
2	;	:	O	;	_	0	SENT_548	[p33l1315t3010r1864b3065],
3	64:458	CD	NUMBER	64:458	number	4	SENT_548	[p33l1315t3010r1864b3065],
4	-468	CD	NUMBER	-468	dep	1	SENT_548	[p33l1315t3010r1864b3065],
5	.	.	O	.	_	0	SENT_548	[p33l1315t3010r1864b3065],

1	33	CD	NUMBER	33	_	0	SENT_549	[p33l12t3105r103b3152],
2	.	.	O	.	_	0	SENT_549	[p33l12t3105r103b3152],

1	Anderson	NNP	PERSON	Anderson	nn	2	SENT_550	[p33l149t3097r469b3152],
2	PL	NNP	O	PL	_	0	SENT_550	[p33l512t3101r614b3160],
3	,	,	O	,	_	0	SENT_550	[p33l512t3101r614b3160],
4	Kakuda	NNP	ORGANIZATION	Kakuda	nn	5	SENT_550	[p33l660t3097r908b3152],
5	TN	NN	ORGANIZATION	tn	appos	2	SENT_550	[p33l951t3101r1068b3160],
6	,	,	O	,	_	0	SENT_550	[p33l951t3101r1068b3160],
7	Lichtenstein	NN	PERSON	lichtenstein	nn	8	SENT_550	[p33l1114t3098r1521b3152],
8	KA	NN	O	ka	appos	5	SENT_550	[p33l1564t3101r1684b3152],
9	.	.	O	.	_	0	SENT_550	[p33l1564t3101r1684b3152],

1	The	DT	O	the	det	3	SENT_551	[p33l1732t3098r1855b3152],
2	cellular	JJ	O	cellular	amod	3	SENT_551	[p33l1900t3097r2147b3152],
3	pharmacology	NN	O	pharmacology	_	0	SENT_551	[p33l10t3183r473b3255],
4	of	IN	O	of	_	0	SENT_551	[p33l513t3183r577b3237],
5	nucleoside	NN	O	nucleoside	prep_of	3	SENT_551	[p33l610t3183r988b3237],
6	-	:	O	-	_	0	SENT_551	[p33l610t3183r988b3237],
7	and	CC	O	and	_	0	SENT_551	[p33l1029t3183r1148b3237],
8	nucleotide-analogue	JJ	O	nucleotide-analogue	amod	10	SENT_551	[p33l1187t3183r1851b3254],
9	reversetranscriptase	NN	O	reversetranscriptase	nn	10	SENT_551	[p33l1891t3202r2145b3237, p33l9t3272r426b3341],
10	inhibitors	NNS	O	inhibitor	prep_of	3	SENT_551	[p33l455t3269r771b3324],
11	and	CC	O	and	_	0	SENT_551	[p33l801t3269r920b3324],
12	its	PRP$	O	its	poss	13	SENT_551	[p33l948t3272r1021b3324],
13	relationship	NN	O	relationship	conj_and	5	SENT_551	[p33l1050t3269r1441b3341],
14	to	TO	O	to	_	0	SENT_551	[p33l1470t3277r1530b3324],
15	clinical	JJ	O	clinical	amod	16	SENT_551	[p33l1560t3269r1800b3324],
16	toxicities	NNS	O	toxicity	prep_to	3	SENT_551	[p33l1828t3272r2142b3324],
17	.	.	O	.	_	0	SENT_551	[p33l1828t3272r2142b3324],

1	Clin	NNP	O	Clin	nn	3	SENT_552	[p33l14t3355r142b3410],
2	Infect	NNP	O	Infect	nn	3	SENT_552	[p33l167t3355r355b3427],
3	Dis	NNP	O	Dis	_	0	SENT_552	[p33l375t3359r494b3410],
4	.	.	O	.	_	0	SENT_552	[p33l375t3359r494b3410],

1	2004	CD	DATE	2004	_	0	SENT_553	[p33l526t3363r1075b3418],
2	;	:	O	;	_	0	SENT_553	[p33l526t3363r1075b3418],
3	38:743	CD	NUMBER	38:743	number	4	SENT_553	[p33l526t3363r1075b3418],
4	-753	CD	NUMBER	-753	dep	1	SENT_553	[p33l526t3363r1075b3418],
5	.	.	O	.	_	0	SENT_553	[p33l526t3363r1075b3418],

1	34	CD	NUMBER	34	_	0	SENT_554	[p33l12t3458r104b3505],
2	.	.	O	.	_	0	SENT_554	[p33l12t3458r104b3505],

1	Fletcher	NNP	ORGANIZATION	Fletcher	nn	2	SENT_555	[p33l157t3450r428b3505],
2	CV	NNP	ORGANIZATION	CV	_	0	SENT_555	[p33l478t3453r583b3514],
3	,	,	O	,	_	0	SENT_555	[p33l478t3453r583b3514],
4	Acosta	NNP	PERSON	Acosta	nn	5	SENT_555	[p33l635t3454r859b3505],
5	EP	NNP	O	EP	appos	2	SENT_555	[p33l906t3454r1000b3514],
6	,	,	O	,	_	0	SENT_555	[p33l906t3454r1000b3514],
7	Henry	NNP	PERSON	Henry	nn	8	SENT_555	[p33l1051t3454r1254b3522],
8	K	NNP	PERSON	K	appos	2	SENT_555	[p33l1303t3454r1369b3514],
9	,	,	O	,	_	0	SENT_555	[p33l1303t3454r1369b3514],
10	et	FW	O	et	nn	11	SENT_555	[p33l1422t3459r1478b3505],
11	al.	FW	O	al.	appos	2	SENT_555	[p33l1528t3451r1600b3505],
12	.	.	O	.	_	0	SENT_555	[p33l1528t3451r1600b3505],

1	Concentrationcontrolled	JJ	O	concentrationcontrolled	amod	2	SENT_556	[p33l1654t3453r2146b3505, p33l11t3537r350b3591],
2	zidovudine	NN	O	zidovudine	_	0	SENT_556	[p33l386t3537r759b3591],
3	therapy	NN	O	therapy	dep	2	SENT_556	[p33l794t3537r1057b3609],
4	.	.	O	.	_	0	SENT_556	[p33l794t3537r1057b3609],

1	Clin	NNP	O	Clin	nn	3	SENT_557	[p33l1100t3537r1230b3591],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_557	[p33l1265t3537r1627b3591],
3	Ther	NNP	O	Ther	_	0	SENT_557	[p33l1664t3537r1828b3591],
4	.	.	O	.	_	0	SENT_557	[p33l1664t3537r1828b3591],

1	1998	CD	DATE	1998	_	0	SENT_558	[p33l1871t3544r2143b3600],
2	;	:	O	;	_	0	SENT_558	[p33l1871t3544r2143b3600],
3	64	CD	NUMBER	64	num	5	SENT_558	[p33l1871t3544r2143b3600],
4	:	:	O	:	_	0	SENT_558	[p33l1871t3544r2143b3600],
5	331-338	CD	NUMBER	331-338	dep	1	SENT_558	[p33l13t3631r289b3678],
6	.	.	O	.	_	0	SENT_558	[p33l13t3631r289b3678],

1	35	CD	NUMBER	35	_	0	SENT_559	[p33l12t3744r103b3791],
2	.	.	O	.	_	0	SENT_559	[p33l12t3744r103b3791],

1	Anderson	NNP	PERSON	Anderson	nn	2	SENT_560	[p33l142t3736r460b3791],
2	PL	NNP	O	PL	_	0	SENT_560	[p33l495t3740r596b3799],
3	,	,	O	,	_	0	SENT_560	[p33l495t3740r596b3799],
4	Kakuda	NNP	ORGANIZATION	Kakuda	nn	5	SENT_560	[p33l635t3736r882b3791],
5	TN	NN	ORGANIZATION	tn	appos	2	SENT_560	[p33l917t3740r1034b3799],
6	,	,	O	,	_	0	SENT_560	[p33l917t3740r1034b3799],
7	Kawle	NNP	LOCATION	Kawle	nn	8	SENT_560	[p33l1073t3736r1274b3791],
8	S	NNP	LOCATION	S	appos	2	SENT_560	[p33l1314t3739r1369b3799],
9	,	,	O	,	_	0	SENT_560	[p33l1314t3739r1369b3799],
10	Fletcher	NNP	PERSON	Fletcher	nn	11	SENT_560	[p33l1407t3736r1674b3791],
11	CV	NNP	O	CV	appos	2	SENT_560	[p33l1710t3739r1813b3791],
12	.	.	O	.	_	0	SENT_560	[p33l1710t3739r1813b3791],

1	Antiviral	JJ	O	antiviral	amod	2	SENT_561	[p33l1852t3736r2146b3791],
2	dynamics	NNS	O	dynamics	_	0	SENT_561	[p34l12t19r322b90],
3	and	CC	O	and	_	0	SENT_561	[p34l371t18r489b73],
4	sex	NN	O	sex	nn	5	SENT_561	[p34l536t38r639b73],
5	differences	NNS	O	difference	conj_and	2	SENT_561	[p34l687t19r1040b73],
6	of	IN	O	of	_	0	SENT_561	[p34l1089t19r1153b73],
7	zidovudine	NN	O	zidovudine	nn	11	SENT_561	[p34l1194t19r1562b73],
8	and	CC	O	and	_	0	SENT_561	[p34l1609t18r1728b73],
9	lamivudine	NN	O	lamivudine	nn	11	SENT_561	[p34l1774t19r2146b73],
10	triphosphate	NN	O	triphosphate	nn	11	SENT_561	[p34l9t106r421b178],
11	concentrations	NNS	O	concentration	prep_of	2	SENT_561	[p34l461t109r938b161],
12	in	IN	O	in	_	0	SENT_561	[p34l978t109r1042b160],
13	HIV-infected	JJ	O	hiv-infected	amod	14	SENT_561	[p34l1078t106r1490b161],
14	individuals	NNS	O	individual	prep_in	2	SENT_561	[p34l1527t106r1915b161],
15	.	.	O	.	_	0	SENT_561	[p34l1527t106r1915b161],

1	AIDS	NNP	MISC	AIDS	_	0	SENT_562	[p34l1955t109r2142b161],
2	.	.	O	.	_	0	SENT_562	[p34l1955t109r2142b161],

1	2003	CD	DATE	2003	_	0	SENT_563	[p34l13t201r641b257],
2	;	:	O	;	_	0	SENT_563	[p34l13t201r641b257],
3	17:2159	CD	DURATION	17:2159	number	4	SENT_563	[p34l13t201r641b257],
4	-2168	CD	DURATION	-2168	dep	1	SENT_563	[p34l13t201r641b257],
5	.	.	O	.	_	0	SENT_563	[p34l13t201r641b257],

1	36	CD	NUMBER	36	_	0	SENT_564	[p34l12t296r103b343],
2	.	.	O	.	_	0	SENT_564	[p34l12t296r103b343],

1	Fletcher	NNP	PERSON	Fletcher	nn	2	SENT_565	[p34l130t288r397b343],
2	CV	NNP	O	CV	_	0	SENT_565	[p34l420t291r524b352],
3	,	,	O	,	_	0	SENT_565	[p34l420t291r524b352],
4	Kawle	NNP	ORGANIZATION	Kawle	nn	5	SENT_565	[p34l551t288r752b343],
5	SP	NN	ORGANIZATION	sp	appos	2	SENT_565	[p34l779t291r869b352],
6	,	,	O	,	_	0	SENT_565	[p34l779t291r869b352],
7	Kakuda	NNP	PERSON	Kakuda	nn	8	SENT_565	[p34l895t288r1142b343],
8	TN	NN	O	tn	appos	2	SENT_565	[p34l1165t292r1282b352],
9	,	,	O	,	_	0	SENT_565	[p34l1165t292r1282b352],
10	et	FW	O	et	nn	11	SENT_565	[p34l1310t296r1365b343],
11	al.	FW	O	al.	appos	2	SENT_565	[p34l1389t288r1460b343],
12	.	.	O	.	_	0	SENT_565	[p34l1389t288r1460b343],

1	Zidovudine	NN	O	zidovudine	nn	2	SENT_566	[p34l1488t288r1868b343],
2	triphosphate	NN	O	triphosphate	_	0	SENT_566	[p34l1892t288r2145b360, p34l10t375r188b447],
3	and	CC	O	and	_	0	SENT_566	[p34l220t375r338b429],
4	lamivudine	NN	O	lamivudine	nn	5	SENT_566	[p34l368t375r740b429],
5	triphosphate	NN	O	triphosphate	conj_and	2	SENT_566	[p34l770t375r1182b447],
6	concentration-response	JJ	O	concentration-response	amod	7	SENT_566	[p34l1214t378r1973b447],
7	relationships	NNS	O	relationship	dep	2	SENT_566	[p34l2002t375r2145b429, p34l9t462r310b534],
8	in	IN	O	in	_	0	SENT_566	[p34l337t465r401b516],
9	HIV-infected	JJ	O	hiv-infected	amod	10	SENT_566	[p34l426t462r837b517],
10	persons	NNS	O	person	prep_in	7	SENT_566	[p34l863t481r1128b534],
11	.	.	O	.	_	0	SENT_566	[p34l863t481r1128b534],

1	AIDS	NNP	MISC	AIDS	_	0	SENT_567	[p34l1156t465r1343b517],
2	.	.	O	.	_	0	SENT_567	[p34l1156t465r1343b517],

1	2000	CD	DATE	2000	_	0	SENT_568	[p34l1375t470r2003b525],
2	;	:	O	;	_	0	SENT_568	[p34l1375t470r2003b525],
3	141:2137	CD	DURATION	141:2137	number	4	SENT_568	[p34l1375t470r2003b525],
4	-2144	CD	DURATION	-2144	dep	1	SENT_568	[p34l1375t470r2003b525],
5	.	.	O	.	_	0	SENT_568	[p34l1375t470r2003b525],

1	37	CD	NUMBER	37	_	0	SENT_569	[p34l12t565r103b612],
2	.	.	O	.	_	0	SENT_569	[p34l12t565r103b612],

1	Stretcher	NNP	O	Stretcher	nn	2	SENT_570	[p34l140t557r432b612],
2	BN	NNP	O	BN	_	0	SENT_570	[p34l463t561r580b621],
3	,	,	O	,	_	0	SENT_570	[p34l463t561r580b621],
4	Pesce	NNP	PERSON	Pesce	nn	6	SENT_570	[p34l614t561r792b612],
5	A	NNP	O	A	nn	6	SENT_570	[p34l824t561r918b626],
6	]	NN	O	]	appos	2	SENT_570	[p34l824t561r918b626],
7	,	,	O	,	_	0	SENT_570	[p34l824t561r918b626],
8	Frame	NNP	O	Frame	nn	9	SENT_570	[p34l953t561r1154b612],
9	PT	NN	O	pt	appos	2	SENT_570	[p34l1186t561r1285b620],
10	,	,	O	,	_	0	SENT_570	[p34l1186t561r1285b620],
11	Greenberg	NNP	ORGANIZATION	Greenberg	nn	12	SENT_570	[p34l1321t557r1649b629],
12	KA	NN	ORGANIZATION	ka	appos	2	SENT_570	[p34l1681t561r1802b620],
13	,	,	O	,	_	0	SENT_570	[p34l1681t561r1802b620],
14	Stein	NNP	PERSON	Stein	nn	15	SENT_570	[p34l1838t560r2004b612],
15	DS	NN	O	d	appos	2	SENT_570	[p34l2034t560r2142b612],
16	.	.	O	.	_	0	SENT_570	[p34l2034t560r2142b612],

1	Correlates	NNS	O	correlate	_	0	SENT_571	[p34l11t643r334b698],
2	of	IN	O	of	_	0	SENT_571	[p34l373t644r437b698],
3	zidovudine	NN	O	zidovudine	nn	4	SENT_571	[p34l468t643r835b698],
4	phosphorylation	NN	O	phosphorylation	prep_of	1	SENT_571	[p34l872t643r1412b715],
5	with	IN	O	with	_	0	SENT_571	[p34l1446t643r1594b698],
6	markers	NNS	O	marker	prep_with	1	SENT_571	[p34l1629t644r1886b698],
7	of	IN	O	of	_	0	SENT_571	[p34l1925t644r1989b698],
8	HIV	NN	MISC	hiv	nn	10	SENT_571	[p34l2019t647r2148b698],
9	disease	NN	O	disease	nn	10	SENT_571	[p34l12t731r244b785],
10	progression	NN	O	progression	prep_of	6	SENT_571	[p34l270t734r647b803],
11	and	CC	O	and	_	0	SENT_571	[p34l673t731r791b785],
12	drug	NN	O	drug	nn	13	SENT_571	[p34l819t731r964b802],
13	toxicity	NN	O	toxicity	prep_of	6	SENT_571	[p34l988t734r1245b802],
14	.	.	O	.	_	0	SENT_571	[p34l988t734r1245b802],

1	AIDS	NNP	MISC	AIDS	_	0	SENT_572	[p34l1273t733r1460b785],
2	.	.	O	.	_	0	SENT_572	[p34l1273t733r1460b785],

1	1994	CD	DATE	1994	_	0	SENT_573	[p34l1493t738r2001b794],
2	;	:	O	;	_	0	SENT_573	[p34l1493t738r2001b794],
3	8:763	CD	NUMBER	8:763	number	4	SENT_573	[p34l1493t738r2001b794],
4	-769	CD	NUMBER	-769	dep	1	SENT_573	[p34l1493t738r2001b794],
5	.	.	O	.	_	0	SENT_573	[p34l1493t738r2001b794],

1	38	CD	NUMBER	38	_	0	SENT_574	[p34l12t834r103b881],
2	.	.	O	.	_	0	SENT_574	[p34l12t834r103b881],

1	Rotger	NNP	O	Rotger	nn	2	SENT_575	[p34l128t830r336b898],
2	M	NNP	O	M	_	0	SENT_575	[p34l357t829r438b889],
3	,	,	O	,	_	0	SENT_575	[p34l357t829r438b889],
4	Csajka	NNP	PERSON	Csajka	nn	5	SENT_575	[p34l464t826r671b897],
5	C	NNP	PERSON	C	conj_and	2	SENT_575	[p34l693t829r754b889],
6	,	,	O	,	_	0	SENT_575	[p34l693t829r754b889],
7	Telenti	NNP	PERSON	Telenti	nn	9	SENT_575	[p34l779t826r1002b881],
8	A.	NNP	PERSON	A.	nn	9	SENT_575	[p34l1024t830r1093b881],
9	Genetic	NNP	PERSON	Genetic	conj_and	2	SENT_575	[p34l1120t829r1383b889],
10	,	,	O	,	_	0	SENT_575	[p34l1120t829r1383b889],
11	ethnic	JJ	O	ethnic	conj_and	2	SENT_575	[p34l1409t826r1627b889],
12	,	,	O	,	_	0	SENT_575	[p34l1409t826r1627b889],
13	and	CC	O	and	_	0	SENT_575	[p34l1653t826r1772b881],
14	gender	NN	O	gender	nn	15	SENT_575	[p34l1794t826r2013b898],
15	differences	NNS	O	difference	conj_and	2	SENT_575	[p34l2037t826r2145b881, p34l11t912r274b967],
16	in	IN	O	in	_	0	SENT_575	[p34l316t915r380b967],
17	the	DT	O	the	det	18	SENT_575	[p34l418t912r517b967],
18	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	15	SENT_575	[p34l557t912r1134b984],
19	of	IN	O	of	_	0	SENT_575	[p34l1177t912r1241b967],
20	antiretroviral	JJ	O	antiretroviral	amod	21	SENT_575	[p34l1275t912r1702b967],
21	agents	NNS	O	agent	prep_of	18	SENT_575	[p34l1743t920r1960b984],
22	.	.	O	.	_	0	SENT_575	[p34l1743t920r1960b984],

1	Curr	NN	O	curr	nn	2	SENT_576	[p34l2007t915r2152b967],
2	HIV/AIDS	NN	O	hiv/aids	_	0	SENT_576	[p34l9t1000r340b1054],
3	Rep.	NNP	O	Rep.	dep	2	SENT_576	[p34l363t1003r502b1071],
4	2006	CD	DATE	2006	num	3	SENT_576	[p34l534t1007r1044b1063],
5	;	:	O	;	_	0	SENT_576	[p34l534t1007r1044b1063],
6	3:118	CD	NUMBER	3:118	num	7	SENT_576	[p34l534t1007r1044b1063],
7	-125	CD	NUMBER	-125	dep	2	SENT_576	[p34l534t1007r1044b1063],
8	.	.	O	.	_	0	SENT_576	[p34l534t1007r1044b1063],

1	39	CD	NUMBER	39	_	0	SENT_577	[p34l12t1102r103b1149],
2	.	.	O	.	_	0	SENT_577	[p34l12t1102r103b1149],

1	Moore	NNP	ORGANIZATION	Moore	nn	2	SENT_578	[p34l132t1098r338b1149],
2	KH	NNP	ORGANIZATION	KH	_	0	SENT_578	[p34l365t1098r486b1158],
3	,	,	O	,	_	0	SENT_578	[p34l365t1098r486b1158],
4	Yuen	NNP	PERSON	Yuen	nn	6	SENT_578	[p34l514t1098r682b1149],
5	G	NNP	PERSON	G	nn	6	SENT_578	[p34l708t1097r797b1163],
6	]	NNS	O	]	appos	2	SENT_578	[p34l708t1097r797b1163],
7	,	,	O	,	_	0	SENT_578	[p34l708t1097r797b1163],
8	Hussey	NNP	ORGANIZATION	Hussey	nn	9	SENT_578	[p34l825t1098r1060b1166],
9	EK	NNP	ORGANIZATION	EK	appos	6	SENT_578	[p34l1085t1098r1195b1158],
10	,	,	O	,	_	0	SENT_578	[p34l1085t1098r1195b1158],
11	Pakes	NNP	ORGANIZATION	Pakes	nn	12	SENT_578	[p34l1223t1095r1404b1149],
12	GE	NNP	ORGANIZATION	GE	appos	6	SENT_578	[p34l1433t1097r1541b1158],
13	,	,	O	,	_	0	SENT_578	[p34l1433t1097r1541b1158],
14	Eron	NNP	PERSON	Eron	nn	17	SENT_578	[p34l1569t1098r1722b1149],
15	J	NNP	PERSON	J	nn	17	SENT_578	[p34l1744t1098r1792b1163],
16	]	CD	PERSON	]	num	17	SENT_578	[p34l1744t1098r1792b1163],
17	Jr	NNP	PERSON	Jr	appos	6	SENT_578	[p34l1815t1098r1879b1163],
18	,	,	O	,	_	0	SENT_578	[p34l1815t1098r1879b1163],
19	Bartlett	NNP	PERSON	Bartlett	nn	20	SENT_578	[p34l1908t1095r2147b1149],
20	IA	NNP	O	IA	appos	6	SENT_578	[p34l7t1186r101b1250],
21	.	.	O	.	_	0	SENT_578	[p34l7t1186r101b1250],

1	Population	NNP	O	Population	nn	2	SENT_579	[p34l136t1182r494b1254],
2	pharmacokinetics	NNS	O	pharmacokinetic	nsubj	13	SENT_579	[p34l524t1182r1101b1254],
3	of	IN	O	of	_	0	SENT_579	[p34l1135t1182r1200b1237],
4	lamivudine	NN	O	lamivudine	prep_of	2	SENT_579	[p34l1225t1182r1596b1237],
5	in	IN	O	in	_	0	SENT_579	[p34l1628t1185r1692b1236],
6	adult	JJ	O	adult	amod	9	SENT_579	[p34l1723t1182r1890b1237],
7	human	JJ	O	human	amod	9	SENT_579	[p34l1919t1182r2147b1237],
8	immunodeficiency	NN	O	immunodeficiency	nn	9	SENT_579	[p34l11t1268r625b1340],
9	virus	NN	O	virus	prep_in	4	SENT_579	[p34l692t1268r1161b1323],
10	—	RB	O	—	advmod	4	SENT_579	[p34l692t1268r1161b1323],
11	infected	JJ	O	infected	amod	12	SENT_579	[p34l692t1268r1161b1323],
12	patients	NNS	O	patient	dep	4	SENT_579	[p34l1230t1271r1486b1340],
13	enrolled	VBN	O	enrol	_	0	SENT_579	[p34l1558t1268r1827b1323],
14	in	IN	O	in	_	0	SENT_579	[p34l1895t1271r1959b1323],
15	two	CD	NUMBER	two	num	16	SENT_579	[p34l2027t1276r2145b1323],
16	phase	NN	O	phase	prep_in	13	SENT_579	[p34l10t1356r196b1427],
17	III	CD	NUMBER	iii	num	19	SENT_579	[p34l227t1359r296b1410],
18	clinical	JJ	O	clinical	amod	19	SENT_579	[p34l328t1355r568b1410],
19	trials	NNS	O	trial	dep	16	SENT_579	[p34l598t1356r778b1410],
20	.	.	O	.	_	0	SENT_579	[p34l598t1356r778b1410],

1	Antimicrob	NNP	O	Antimicrob	nn	2	SENT_580	[p34l811t1355r1183b1410],
2	Agents	NNPS	O	Agents	_	0	SENT_580	[p34l1211t1359r1435b1427],
3	Chemother	NNP	O	Chemother	dep	2	SENT_580	[p34l1469t1356r1837b1410],
4	.	.	O	.	_	0	SENT_580	[p34l1469t1356r1837b1410],

1	1999	CD	DATE	1999	_	0	SENT_581	[p34l1876t1363r2143b1419],
2	;	:	O	;	_	0	SENT_581	[p34l1876t1363r2143b1419],
3	43	CD	NUMBER	43	num	5	SENT_581	[p34l1876t1363r2143b1419],
4	:	:	O	:	_	0	SENT_581	[p34l1876t1363r2143b1419],
5	3025-3029	CD	DURATION	3025-3029	dep	1	SENT_581	[p34l13t1451r363b1498],
6	.	.	O	.	_	0	SENT_581	[p34l13t1451r363b1498],

1	40	CD	NUMBER	40	_	0	SENT_582	[p34l10t1564r103b1611],
2	.	.	O	.	_	0	SENT_582	[p34l10t1564r103b1611],

1	Barry	NNP	PERSON	Barry	nn	2	SENT_583	[p34l170t1560r345b1628],
2	M	NNP	PERSON	M	_	0	SENT_583	[p34l408t1560r489b1620],
3	,	,	O	,	_	0	SENT_583	[p34l408t1560r489b1620],
4	Mulcahy	NNP	PERSON	Mulcahy	nn	5	SENT_583	[p34l555t1556r842b1628],
5	F	NN	O	f	conj_and	2	SENT_583	[p34l905t1560r954b1619],
6	,	,	O	,	_	0	SENT_583	[p34l905t1560r954b1619],
7	Merry	NNP	O	Merry	nn	8	SENT_583	[p34l1020t1560r1216b1628],
8	C	NNP	O	C	conj_and	2	SENT_583	[p34l1279t1559r1340b1619],
9	,	,	O	,	_	0	SENT_583	[p34l1279t1559r1340b1619],
10	Gibbons	NNP	PERSON	Gibbons	nn	11	SENT_583	[p34l1407t1556r1671b1611],
11	S	NNP	O	S	conj_and	2	SENT_583	[p34l1738t1559r1794b1619],
12	,	,	O	,	_	0	SENT_583	[p34l1738t1559r1794b1619],
13	Back	NNP	O	Back	nn	15	SENT_583	[p34l1860t1556r2017b1611],
14	D.	NNP	O	D.	nn	15	SENT_583	[p34l2078t1560r2142b1611],
15	Pharmacokinetics	NNP	O	Pharmacokinetics	conj_and	2	SENT_583	[p34l9t1642r587b1697],
16	and	CC	O	and	_	0	SENT_583	[p34l611t1642r727b1697],
17	potential	JJ	O	potential	amod	18	SENT_583	[p34l747t1642r1030b1714],
18	interactions	NNS	O	interaction	conj_and	2	SENT_583	[p34l1050t1645r1423b1697],
19	amongst	IN	O	amongst	dep	2	SENT_583	[p34l1446t1650r1710b1714],
20	antiretroviral	JJ	O	antiretroviral	amod	21	SENT_583	[p34l1730t1642r2146b1697],
21	agents	NNS	O	agent	pobj	19	SENT_583	[p34l11t1738r207b1801],
22	used	VBN	O	use	partmod	21	SENT_583	[p34l223t1730r372b1784],
23	to	TO	O	to	aux	24	SENT_583	[p34l386t1738r444b1784],
24	treat	VB	O	treat	xcomp	22	SENT_583	[p34l460t1737r601b1784],
25	patients	NNS	O	patient	dobj	24	SENT_583	[p34l615t1732r865b1802],
26	with	IN	O	with	_	0	SENT_583	[p34l881t1730r1027b1784],
27	HIV	NN	MISC	hiv	nn	28	SENT_583	[p34l1041t1733r1168b1784],
28	infection	NN	O	infection	prep_with	24	SENT_583	[p34l1182t1730r1479b1784],
29	.	.	O	.	_	0	SENT_583	[p34l1182t1730r1479b1784],

1	Clin	NNP	O	Clin	_	0	SENT_584	[p34l1502t1730r1627b1784],
2	Ph	NN	O	ph	nn	3	SENT_584	[p34l1642t1730r1724b1784],
3	armacokinet	NN	O	armacokinet	dep	1	SENT_584	[p34l1731t1730r2142b1784],
4	.	.	O	.	_	0	SENT_584	[p34l1731t1730r2142b1784],

1	1999	CD	DATE	1999	_	0	SENT_585	[p34l14t1825r549b1881],
2	;	:	O	;	_	0	SENT_585	[p34l14t1825r549b1881],
3	36:289	CD	NUMBER	36:289	number	4	SENT_585	[p34l14t1825r549b1881],
4	-304	CD	NUMBER	-304	dep	1	SENT_585	[p34l14t1825r549b1881],
5	.	.	O	.	_	0	SENT_585	[p34l14t1825r549b1881],

1	41	CD	NUMBER	41	_	0	SENT_586	[p34l10t1922r103b1968],
2	.	.	O	.	_	0	SENT_586	[p34l10t1922r103b1968],

1	BMS	NNS	O	bm	_	0	SENT_587	[p34l141t1916r311b1968],
2	.	.	O	.	_	0	SENT_587	[p34l141t1916r311b1968],

1	Zerit	NN	O	zerit	_	0	SENT_588	[p34l350t1916r506b1968],
2	(	CD	NUMBER	(	num	5	SENT_588	[p34l543t1913r901b1978],
3	stavudine	NN	O	stavudine	nn	5	SENT_588	[p34l543t1913r901b1978],
4	)	NN	O	)	nn	5	SENT_588	[p34l543t1913r901b1978],
5	capsules	NNS	O	capsule	dep	1	SENT_588	[p34l941t1913r1215b1985],
6	and	CC	O	and	_	0	SENT_588	[p34l1253t1913r1371b1968],
7	oral	JJ	O	oral	amod	12	SENT_588	[p34l1407t1913r1529b1968],
8	solution	NN	O	solution	nn	12	SENT_588	[p34l1566t1913r1830b1968],
9	[	NN	O	[	nn	12	SENT_588	[p34l1870t1913r2146b1985],
10	package	NN	O	package	nn	12	SENT_588	[p34l1870t1913r2146b1985],
11	insert	NN	O	insert	nn	12	SENT_588	[p34l11t2000r232b2063],
12	]	NN	O	]	conj_and	5	SENT_588	[p34l11t2000r232b2063],
13	.	.	O	.	_	0	SENT_588	[p34l11t2000r232b2063],

1	Princeton	NNP	ORGANIZATION	Princeton	nn	3	SENT_589	[p34l261t2002r592b2063],
2	,	,	O	,	_	0	SENT_589	[p34l261t2002r592b2063],
3	NJ	NNP	O	NJ	_	0	SENT_589	[p34l620t2003r712b2068],
4	:	:	O	:	_	0	SENT_589	[p34l620t2003r712b2068],
5	Bristol-Myers	NNP	O	Bristol-Myers	nn	6	SENT_589	[p34l742t2000r1180b2071],
6	Squibb	NNP	O	Squibb	dep	3	SENT_589	[p34l1209t2000r1450b2071],
7	;	:	O	;	_	0	SENT_589	[p34l1209t2000r1450b2071],
8	2008	CD	DATE	2008	dep	6	SENT_589	[p34l1481t2007r1649b2054],
9	.	.	O	.	_	0	SENT_589	[p34l1481t2007r1649b2054],

